data_2m88_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m88 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.5 tp -85.49 105.92 16.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.42 141.71 35.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.636 0.774 . . . . 0.0 110.448 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mm -127.74 109.44 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.26 161.55 12.92 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 122.18 -0.325 . . . . 0.0 112.483 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.88 73.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.303 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -54.09 120.78 26.57 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.185 0.993 . . . . 0.0 111.062 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -67.03 -12.84 37.67 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.595 2.863 . . . . 0.0 112.539 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -84.67 157.96 20.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.325 0.65 . . . . 0.0 110.988 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -79.71 53.99 1.72 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.9 mtm 53.47 55.74 8.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.448 1.099 . . . . 0.0 112.551 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.19 104.27 13.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.69 -17.0 63.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -82.7 -11.88 58.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.053 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.25 -16.59 22.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.642 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.09 -25.98 47.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.49 -21.3 38.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 171.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.217 -0.302 . . . . 0.0 111.233 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.28 -6.39 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.967 0.348 . . . . 0.0 111.657 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.93 17.01 21.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.65 0.78 . . . . 0.0 110.003 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -76.14 -45.33 3.71 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.107 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.37 136.49 11.25 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.198 1.932 . . . . 0.0 111.672 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 50.1 24.24 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.027 1.331 . . . . 0.0 113.783 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.14 33.62 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.719 0.407 . . . . 0.0 110.816 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -133.53 59.72 1.73 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.325 0.65 . . . . 0.0 110.331 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.31 138.48 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -133.31 4.61 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 t -151.06 137.84 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.113 0.415 . . . . 0.0 110.484 173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.3 t -136.81 133.2 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.578 0.751 . . . . 0.0 109.468 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.03 138.87 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.484 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -126.47 117.78 23.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.108 1.363 . . . . 0.0 108.545 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -135.78 162.71 32.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.217 0.607 . . . . 0.0 111.425 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.1 t30 65.58 149.93 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.812 1.245 . . . . 0.0 112.81 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -81.74 25.01 0.57 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.169 0.588 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -127.9 24.63 6.04 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.532 0.733 . . . . 0.0 111.147 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 54.64 55.17 8.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.055 0.942 . . . . 0.0 112.002 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -104.79 120.31 41.07 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.89 153.12 51.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 112.073 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.24 147.89 49.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.45 150.63 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.21 130.35 56.89 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.738 0.415 . . . . 0.0 110.182 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.09 149.16 18.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 C-N-CA 124.056 0.942 . . . . 0.0 109.823 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -97.12 14.92 24.12 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -154.99 139.96 17.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.158 0.583 . . . . 0.0 109.848 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -84.9 -6.55 59.34 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.735 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -90.46 -28.76 18.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.34 -17.87 40.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -46.05 73.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -74.94 -11.82 60.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.352 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.66 -22.26 40.65 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.683 0.674 . . . . 0.0 110.685 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -77.76 -45.28 28.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.04 -17.72 64.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.557 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -69.66 -53.87 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.639 -0.663 . . . . 0.0 109.37 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -80.04 -45.03 19.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.738 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -89.6 9.37 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -139.46 6.88 2.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.6 0.636 . . . . 0.0 112.512 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -143.63 14.99 1.78 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.15 7.82 40.77 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.414 1.006 . . . . 0.0 112.052 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.2 4.26 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.519 0.581 . . . . 0.0 113.983 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.61 55.27 1.88 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.959 0.879 . . . . 0.0 109.318 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.84 115.73 17.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.075 0.95 . . . . 0.0 110.728 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.08 -17.26 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.234 2.623 . . . . 0.0 110.802 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.7 mt -135.77 146.11 47.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.276 1.03 . . . . 0.0 109.916 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.59 88.04 6.16 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.7 p -93.87 125.75 38.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.844 0.458 . . . . 0.0 111.664 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -140.54 145.21 36.51 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 124.243 1.017 . . . . 0.0 108.743 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -135.68 157.97 45.56 Favored 'General case' 0 C--O 1.229 0.019 0 CA-C-N 118.337 0.517 . . . . 0.0 112.195 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 157.33 29.41 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.11 140.06 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 123.506 0.723 . . . . 0.0 110.551 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 173.101 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 121' ' ' MET . 16.9 tt . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.45 -16.77 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.314 2.676 . . . . 0.0 113.51 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.426 ' H ' HG12 ' A' ' 119' ' ' ILE . 1.7 mpt? -79.82 21.02 0.56 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.009 0.524 . . . . 0.0 112.079 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -130.01 -15.55 3.78 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.651 0.38 . . . . 0.0 110.465 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.58 -11.32 59.67 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.37 -25.7 51.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.1 m -79.18 -49.47 12.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.516 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.46 -17.37 34.42 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.658 -0.817 . . . . 0.0 113.12 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.4 -21.65 17.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.17 0.896 . . . . 0.0 112.365 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 -26.02 15.91 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.417 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -84.65 -23.94 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.857 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -81.54 -49.78 10.16 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.689 0.677 . . . . 0.0 110.627 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -94.9 4.87 53.31 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.1 m -135.86 -4.92 2.2 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.54 0.609 . . . . 0.0 112.418 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 14.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.142 0.883 . . . . 0.0 111.595 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 t -147.52 55.62 1.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.609 -0.682 . . . . 0.0 111.23 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.29 -42.15 0.97 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.437 0.295 . . . . 0.0 110.731 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -139.36 16.87 2.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.136 0.574 . . . . 0.0 110.434 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -146.42 156.86 43.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.707 0.803 . . . . 0.0 110.086 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.91 149.08 39.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.07 156.61 53.57 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 66.46 116.69 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.828 1.251 . . . . 0.0 112.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m 64.98 30.8 11.68 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.611 1.164 . . . . 0.0 112.791 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.15 -13.33 52.85 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -146.38 160.67 41.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.108 0.963 . . . . 0.0 109.354 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.94 0.64 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.449 3.433 . . . . 0.0 114.644 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.44 6.58 6.7 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.726 0.693 . . . . 0.0 112.419 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.5 m -85.36 19.91 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.394 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.7 m -128.6 27.66 5.5 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.34 -48.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 118.101 0.951 . . . . 0.0 111.516 -178.396 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.5 tp -114.81 127.69 55.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -105.95 143.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.36 0.664 . . . . 0.0 110.257 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.43 143.33 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.845 0.858 . . . . 0.0 110.173 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.03 172.64 42.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.93 64.79 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -59.29 138.52 88.59 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 117.368 0.584 . . . . 0.0 111.599 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.84 -11.1 10.29 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.881 3.054 . . . . 0.0 111.526 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 45' ' ' LYS . 2.0 pp -84.39 161.02 20.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.467 0.707 . . . . 0.0 111.234 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -81.52 55.44 2.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.8 ptt? 46.61 55.16 7.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.918 1.287 . . . . 0.0 112.812 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' H ' HD11 ' A' ' 42' ' ' LEU . 54.8 mtmt -111.24 119.28 38.37 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.354 0.662 . . . . 0.0 109.292 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -70.47 -15.88 62.86 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.976 -0.102 . . . . 0.0 111.143 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -93.85 -9.89 35.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.314 -0.241 . . . . 0.0 111.484 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.01 -17.2 15.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -78.38 -28.2 46.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.2 -21.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.49 -19.16 61.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.176 0.444 . . . . 0.0 110.98 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.96 -6.52 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 117.945 0.339 . . . . 0.0 111.586 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.92 20.07 18.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.785 0.834 . . . . 0.0 110.067 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -88.34 -49.43 0.42 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.426 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.08 141.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.089 1.859 . . . . 0.0 110.643 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 48.96 34.5 5.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.781 0.833 . . . . 0.0 112.369 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.89 156.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.083 -0.386 . . . . 0.0 111.378 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.37 54.92 1.92 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.422 0.689 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.88 138.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -117.79 -7.4 10.98 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -146.52 134.11 20.98 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.025 -0.422 . . . . 0.0 110.573 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.1 117.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.37 131.39 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.013 0.435 . . . . 0.0 111.578 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.32 132.9 41.32 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.503 1.121 . . . . 0.0 109.27 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.69 160.09 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.133 0.573 . . . . 0.0 111.688 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 68' ' ' ARG . 41.2 t30 64.66 153.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.054 1.342 . . . . 0.0 112.719 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -78.82 32.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.504 0.722 . . . . 0.0 111.144 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 66' ' ' ASN . 45.6 ttp180 -134.75 24.48 3.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.64 0.776 . . . . 0.0 110.289 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 45.91 48.21 12.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 114.001 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -106.61 146.54 30.58 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.24 39.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 111.656 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -131.16 129.78 42.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.17 151.7 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.437 0.161 . . . . 0.0 110.986 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.78 137.62 51.63 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.893 0.378 . . . . 0.0 111.168 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 m -108.77 156.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.624 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.64 6.08 29.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -155.54 137.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.126 0.57 . . . . 0.0 109.801 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.19 -13.35 61.9 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.287 -0.258 . . . . 0.0 111.628 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -88.13 -14.65 38.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -92.01 -11.55 35.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.64 -44.47 61.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.0 -15.27 61.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -83.03 -19.15 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 122.03 -0.419 . . . . 0.0 110.873 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.6 t -75.21 -37.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.65 -21.74 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.894 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.19 -19.8 53.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -85.66 -23.37 27.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -77.93 -8.89 58.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -122.51 3.42 9.64 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -139.82 24.09 2.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.712 0.687 . . . . 0.0 112.835 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -135.45 49.88 2.15 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.667 -0.645 . . . . 0.0 111.016 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.7 4.3 87.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.481 -0.621 . . . . 0.0 113.088 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.91 55.78 8.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.827 0.814 . . . . 0.0 111.679 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -56.48 153.49 20.28 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.287 0.635 . . . . 0.0 110.973 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.63 -2.14 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.925 3.083 . . . . 0.0 112.088 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.88 114.69 5.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -85.31 127.62 34.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.887 0.375 . . . . 0.0 110.734 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 t -137.43 137.48 38.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.326 0.65 . . . . 0.0 109.89 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -147.94 146.41 28.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.187 0.595 . . . . 0.0 110.484 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -106.72 155.89 19.21 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.612 0.365 . . . . 0.0 111.221 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.13 35.58 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.72 148.98 27.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 175.417 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.817 0.342 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.17 -1.87 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.872 3.048 . . . . 0.0 113.413 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.12 21.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.835 0.743 . . . . 0.0 112.399 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -97.45 -10.51 25.27 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.796 -0.565 . . . . 0.0 110.105 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -79.84 -7.71 58.86 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.36 -41.59 13.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.161 0.984 . . . . 0.0 109.673 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 p -76.92 -25.46 52.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.845 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.04 -46.71 11.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.7 0.227 . . . . 0.0 111.531 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 -9.36 57.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.72 -36.78 8.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.45 -24.4 62.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.996 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -87.26 -57.05 3.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.047 -0.408 . . . . 0.0 111.244 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -83.04 5.5 22.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -139.12 -8.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.803 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.81 24.37 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.538 1.063 . . . . 0.0 112.064 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -123.85 34.28 5.11 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.87 -0.519 . . . . 0.0 111.036 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.56 25.3 3.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.083 0.553 . . . . 0.0 111.324 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.14 25.07 3.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.813 0.445 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.5 m95 53.56 38.8 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.238 0.615 . . . . 0.0 111.839 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.47 -160.65 19.42 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -167.13 159.74 33.2 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 117.168 0.484 . . . . 0.0 111.964 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 77.0 p 51.38 24.44 2.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.629 1.572 . . . . 0.0 114.089 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -156.53 24.12 0.34 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.953 0.342 . . . . 0.0 111.789 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.92 -10.96 27.33 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.485 -0.62 . . . . 0.0 114.134 -172.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -145.86 160.4 43.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.197 0.998 . . . . 0.0 110.232 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -60.65 -3.52 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.129 3.219 . . . . 0.0 113.788 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -75.12 -2.71 28.87 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.375 0.534 . . . . 0.0 111.836 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 m -84.77 8.85 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.524 0.329 . . . . 0.0 111.237 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.1 p -129.63 38.07 3.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.19 0.996 . . . . 0.0 108.45 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.04 -59.09 0.02 OUTLIER Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 117.543 0.671 . . . . 0.0 109.962 179.303 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.562 0.22 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.76 108.55 12.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -86.78 139.63 30.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.371 0.668 . . . . 0.0 110.023 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.04 142.38 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.36 171.07 40.55 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.186 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.38 23.7 68.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -56.36 126.01 67.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 117.321 0.561 . . . . 0.0 111.799 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.25 -2.68 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.576 2.85 . . . . 0.0 110.82 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.19 159.98 33.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.221 0.608 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -79.11 38.59 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.799 0.839 . . . . 0.0 111.74 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp 57.48 54.26 6.68 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.9 0.88 . . . . 0.0 111.98 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.13 131.89 37.39 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.668 0.787 . . . . 0.0 109.185 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.8 -8.0 55.1 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -85.15 -17.94 35.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.156 -0.34 . . . . 0.0 110.946 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -87.13 -22.51 25.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.868 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.44 -37.23 77.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.36 -18.85 62.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.829 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -88.2 -4.22 58.76 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.857 -0.527 . . . . 0.0 111.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.46 -2.01 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 118.124 0.42 . . . . 0.0 111.672 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -131.27 6.68 4.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -171.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HA ' ' CE ' ' A' ' 54' ' ' LYS . 3.2 mmpt? -96.52 -29.36 0.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 97.6 Cg_endo -74.74 134.98 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 121.779 1.671 . . . . 0.0 109.968 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 50.3 36.77 13.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.419 0.688 . . . . 0.0 111.612 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.69 165.38 29.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.658 0.783 . . . . 0.0 110.577 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -135.13 49.79 2.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 110.761 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.99 137.04 22.3 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.269 0.627 . . . . 0.0 109.915 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -125.45 1.97 7.67 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 m -138.53 138.73 38.28 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.629 0.65 . . . . 0.0 111.524 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.2 t -135.75 130.92 50.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 123.502 0.721 . . . . 0.0 109.368 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.87 137.84 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.96 142.11 51.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.741 0.816 . . . . 0.0 110.49 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -129.18 129.09 44.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.855 0.862 . . . . 0.0 109.057 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -78.39 43.46 0.46 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.137 0.975 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -135.44 104.91 6.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.7 0.8 . . . . 0.0 109.186 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 52.08 36.58 19.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.928 0.891 . . . . 0.0 111.919 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 53.8 55.77 8.03 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.435 0.694 . . . . 0.0 112.038 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -96.67 129.46 44.06 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.73 152.13 50.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.959 0.504 . . . . 0.0 110.974 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -135.67 136.86 41.26 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.24 155.36 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.595 0.236 . . . . 0.0 110.395 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.92 136.04 47.08 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.993 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -122.26 156.98 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 126.366 1.866 . . . . 0.0 108.192 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -117.94 17.91 14.07 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -143.44 122.94 13.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.757 0.823 . . . . 0.0 109.052 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 ttt-85 -70.26 -20.41 63.06 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.18 0.446 . . . . 0.0 110.679 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -75.75 -21.57 57.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.041 -0.412 . . . . 0.0 110.162 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.59 -11.76 19.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.0 64.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.95 -21.2 51.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.371 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -78.06 -20.57 52.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.972 -0.455 . . . . 0.0 110.855 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.97 -40.67 22.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 O-C-N 121.77 -0.581 . . . . 0.0 110.345 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.24 -21.72 62.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.468 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -81.65 -18.08 45.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.81 -0.557 . . . . 0.0 110.533 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.42 -26.5 32.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -91.8 2.64 56.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -119.84 -0.84 10.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.454 0.302 . . . . 0.0 111.49 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.32 16.18 3.44 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.96 49.05 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 110.595 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.34 9.04 85.91 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.343 -0.698 . . . . 0.0 112.892 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.73 81.18 0.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.083 0.953 . . . . 0.0 111.408 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.37 151.17 60.77 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.15 0.58 . . . . 0.0 111.107 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.27 -9.39 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.787 2.991 . . . . 0.0 111.468 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.87 124.05 25.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -85.15 136.72 33.42 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 122.368 0.267 . . . . 0.0 111.167 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 p -135.47 142.19 45.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.234 0.614 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.49 137.95 27.27 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.788 0.835 . . . . 0.0 109.061 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -135.2 155.57 50.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 0.0 111.677 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.36 176.49 45.32 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.319 0.4 . . . . 0.0 112.421 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.48 131.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.25 1.02 . . . . 0.0 109.921 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 120.194 0.045 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -56.59 -22.16 42.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.609 2.206 . . . . 0.0 113.248 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 41.4 ttp -80.08 36.34 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.023 0.529 . . . . 0.0 110.737 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -135.65 -36.95 0.76 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.393 0.677 . . . . 0.0 110.429 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -85.96 -13.49 47.53 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.579 0.172 . . . . 0.0 110.716 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.57 -24.97 14.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.209 0.604 . . . . 0.0 109.449 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.2 m -77.47 -26.04 51.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -91.0 -40.16 11.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.288 -0.258 . . . . 0.0 110.886 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.49 -9.41 59.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -112.5 -17.23 12.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.36 -24.47 62.98 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 170.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.57 -52.5 5.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -86.69 16.41 4.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.6 t -143.24 -20.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 135' ' ' ALA . 20.4 m -140.16 33.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.384 0.993 . . . . 0.0 113.058 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.7 p -72.81 22.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.521 -0.737 . . . . 0.0 111.887 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.53 36.52 2.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.44 1.096 . . . . 0.0 109.202 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -133.4 162.3 32.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.231 1.012 . . . . 0.0 109.449 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -75.73 44.64 0.3 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.433 0.693 . . . . 0.0 111.936 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.9 1.02 90.14 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.368 0.508 . . . . 0.0 112.597 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 167.02 54.86 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.765 0.783 . . . . 0.0 111.925 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.8 t -140.01 22.34 2.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.811 0.845 . . . . 0.0 109.353 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -135.3 20.02 3.4 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 109.786 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.25 -5.1 83.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -137.69 160.33 65.39 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.029 0.532 . . . . 0.0 110.133 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.77 20.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 125.27 3.98 . . . . 0.0 115.157 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.413 ' CD1' HG13 ' A' ' 149' ' ' ILE . 3.4 pp -83.33 1.62 40.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.14 0.882 . . . . 0.0 111.201 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.87 21.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.564 -0.71 . . . . 0.0 112.328 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -135.71 24.55 3.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.843 0.354 . . . . 0.0 111.796 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.96 -9.51 0.03 OUTLIER Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.593 -0.692 . . . . 0.0 112.915 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.413 HG13 ' CD1' ' A' ' 145' ' ' LEU . 29.5 mm . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 121.889 0.852 . . . . 0.0 109.548 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.0 tp -122.55 125.46 45.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.127 0.489 . . . . 0.0 110.406 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -109.04 141.58 40.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.902 0.881 . . . . 0.0 109.653 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.99 145.1 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 109.177 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.12 40.09 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.479 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.34 24.31 65.45 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.756 -0.537 . . . . 0.0 111.756 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.18 130.14 89.09 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.427 0.614 . . . . 0.0 111.574 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.45 -2.94 12.27 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.459 2.772 . . . . 0.0 110.86 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.45 156.95 37.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.229 0.612 . . . . 0.0 110.413 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -80.5 43.16 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.409 0.684 . . . . 0.0 111.155 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 88.3 mtp 52.52 55.13 9.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.093 0.957 . . . . 0.0 112.277 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -130.83 125.97 35.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.01 -8.38 52.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -80.86 -15.65 55.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.047 -0.408 . . . . 0.0 110.974 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.02 -24.3 17.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.577 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.86 -26.28 60.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.3 -19.13 36.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.15 -8.47 59.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.953 -0.467 . . . . 0.0 110.806 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.17 -4.21 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -112.46 14.13 20.25 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.332 0.653 . . . . 0.0 111.045 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.514 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 56.3 tttp -117.71 -19.13 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 92.4 Cg_endo -78.16 -21.54 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 121.932 1.726 . . . . 0.0 112.307 -177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.84 16.41 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.129 0.571 . . . . 0.0 111.201 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.07 -175.78 5.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.439 1.096 . . . . 0.0 108.526 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -145.63 104.22 3.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.001 -0.437 . . . . 0.0 110.09 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.38 139.86 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.103 0.561 . . . . 0.0 110.123 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.57 2.72 6.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.201 0.2 . . . . 0.0 111.429 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 t -135.88 119.7 17.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.905 -0.497 . . . . 0.0 110.268 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.7 t -140.38 127.12 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.656 0.782 . . . . 0.0 109.671 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 136.18 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 122.751 0.42 . . . . 0.0 110.133 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.19 145.19 39.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.569 1.148 . . . . 0.0 110.311 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -135.15 138.21 43.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.079 0.552 . . . . 0.0 110.108 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.9 50.45 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -128.18 98.77 5.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 54.9 25.36 6.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.628 0.771 . . . . 0.0 111.693 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.08 60.96 3.28 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.206 1.002 . . . . 0.0 110.946 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.99 151.36 34.3 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.258 0.623 . . . . 0.0 111.122 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.18 160.15 40.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.647 0.779 . . . . 0.0 110.987 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -126.45 137.09 53.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.66 151.25 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-O 121.015 0.436 . . . . 0.0 111.464 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -135.0 134.79 40.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.8 156.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 125.212 1.405 . . . . 0.0 109.1 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -104.51 21.22 17.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.524 0.202 . . . . 0.0 111.216 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -142.71 115.35 8.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.934 0.893 . . . . 0.0 108.955 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -72.96 -20.05 61.12 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -89.79 -16.96 29.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.269 -0.27 . . . . 0.0 110.636 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.31 -18.62 28.11 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.15 84.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -70.48 -20.8 62.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -83.73 -14.09 52.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.99 0.359 . . . . 0.0 111.456 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -75.23 -50.2 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.27 -20.89 65.72 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.664 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -67.81 -46.42 71.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -84.07 -23.73 30.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.913 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.28 -2.86 43.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.095 0.407 . . . . 0.0 111.341 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -131.22 9.13 4.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -135.23 12.61 3.55 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -103.23 -11.84 17.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.043 0.838 . . . . 0.0 111.323 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.81 5.91 4.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.856 0.741 . . . . 0.0 114.392 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.71 29.61 3.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.589 1.195 . . . . 0.0 112.222 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.24 95.69 30.13 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.89 -2.48 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.904 3.069 . . . . 0.0 111.163 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.48 121.08 14.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.565 0.746 . . . . 0.0 109.022 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -83.07 136.11 34.6 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.615 0.366 . . . . 0.0 111.187 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 p -135.69 143.98 45.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.325 0.65 . . . . 0.0 110.81 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.03 131.32 25.01 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -125.47 155.43 40.52 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.333 0.253 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 180.0 -178.54 48.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.69 148.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.132 0.573 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 175.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.707 ' H ' ' HD2' ' A' ' 120' ' ' PRO . 61.0 mt . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 118.447 -0.787 . . . . 0.0 112.356 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.707 ' HD2' ' H ' ' A' ' 119' ' ' ILE . 87.9 Cg_endo -77.29 -8.18 17.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.75 1.633 . . . . 0.0 111.834 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.94 24.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.665 0.386 . . . . 0.0 111.753 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.87 -26.61 1.53 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.476 0.311 . . . . 0.0 110.771 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -87.48 -9.83 53.49 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.26 -52.62 8.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.892 0.877 . . . . 0.0 108.689 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -71.69 -19.68 62.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.097 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.7 -60.72 2.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.5 -26.02 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -172.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.22 -42.13 6.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.377 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -77.04 -21.26 54.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.224 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.18 -46.69 8.61 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.723 0.692 . . . . 0.0 111.111 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -84.63 5.03 29.6 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.493 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.3 m -138.83 -5.02 1.53 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.58 19.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.493 1.042 . . . . 0.0 112.571 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -82.87 49.79 1.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.322 -0.861 . . . . 0.0 111.557 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.92 8.0 3.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.923 0.489 . . . . 0.0 110.491 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -145.52 156.92 44.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.287 1.035 . . . . 0.0 109.547 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -76.2 104.53 6.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.55 178.8 33.8 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.04 136.87 25.86 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -146.2 32.75 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.928 0.364 . . . . 0.0 111.331 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 m 57.1 40.71 28.2 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.841 0.456 . . . . 0.0 111.901 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.98 -19.0 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -146.88 162.08 34.72 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.718 0.807 . . . . 0.0 109.287 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.02 3.82 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.46 3.44 . . . . 0.0 114.43 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.02 -5.76 28.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.69 0.677 . . . . 0.0 111.659 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.36 14.69 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.45 0.7 . . . . 0.0 111.042 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -133.43 44.33 2.81 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.78 -57.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.641 0.734 . . . . 0.0 109.653 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 tp -135.2 126.29 27.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -100.7 143.02 31.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.534 0.333 . . . . 0.0 110.695 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.73 102.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.23 164.5 18.15 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.31 72.63 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.019 -0.878 . . . . 0.0 113.77 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -53.59 117.51 12.33 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 118.548 1.174 . . . . 0.0 111.09 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.97 -9.49 25.16 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.373 2.715 . . . . 0.0 112.413 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -135.09 67.84 1.48 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.78 0.832 . . . . 0.0 110.856 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.52 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.608 0.763 . . . . 0.0 112.323 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 42' ' ' LEU . 12.1 tpt -147.87 22.81 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.128 0.571 . . . . 0.0 110.902 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 47' ' ' TRP . 29.0 tptt -145.43 78.63 1.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.35 -20.46 66.12 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.06 -0.4 . . . . 0.0 111.745 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.494 ' CE2' ' HE3' ' A' ' 45' ' ' LYS . 63.9 p-90 -92.09 1.7 57.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.95 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.83 -28.51 28.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.39 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.49 -40.39 85.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.49 65.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.229 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -92.06 -3.41 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.214 0.461 . . . . 0.0 112.142 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.16 -2.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 O-C-N 121.996 -0.44 . . . . 0.0 111.75 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tp -124.95 -6.41 7.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 98.5 mttt -96.01 -29.75 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.286 -0.864 . . . . 0.0 113.284 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.51 -18.66 47.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.427 2.085 . . . . 0.0 114.117 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.66 8.53 3.32 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.75 150.12 28.17 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.597 0.635 . . . . 0.0 110.427 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -87.94 40.06 0.92 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.686 0.394 . . . . 0.0 111.642 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.92 141.34 16.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 O-C-N 122.052 -0.405 . . . . 0.0 109.995 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -135.29 7.83 3.38 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 124.25 25.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.206 0.457 . . . . 0.0 110.789 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.09 130.54 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 123.737 0.815 . . . . 0.0 109.337 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.78 131.73 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.81 119.5 22.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -86.64 104.08 15.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -84.5 18.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.273 0.629 . . . . 0.0 112.049 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.6 3.79 3.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.425 0.29 . . . . 0.0 111.588 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -141.18 14.08 2.22 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.95 0.5 . . . . 0.0 111.036 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.1 pttt 44.5 40.7 4.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.727 1.211 . . . . 0.0 112.89 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -127.25 138.5 53.1 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.113 0.565 . . . . 0.0 109.918 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.77 147.0 48.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.752 0.31 . . . . 0.0 111.187 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.86 144.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.5 156.69 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.09 139.39 44.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.58 154.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 126.284 1.834 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.2 15.41 17.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 t -155.91 137.63 14.26 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.055 0.542 . . . . 0.0 110.35 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -68.06 -11.4 58.95 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -81.39 -17.37 49.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.797 -0.564 . . . . 0.0 110.706 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -90.98 -23.13 20.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.02 -22.09 56.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -82.51 -21.59 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -78.04 -20.47 52.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.074 -0.391 . . . . 0.0 110.559 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.8 t -81.58 -40.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.458 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.8 -18.36 60.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.243 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -82.29 -19.2 39.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.999 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -79.09 -26.01 43.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -84.15 -8.85 58.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.952 0.501 . . . . 0.0 111.409 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -127.24 12.19 7.05 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' HZ2' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -134.94 10.06 3.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.397 0.544 . . . . 0.0 112.459 174.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -122.77 -20.02 6.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.531 0.605 . . . . 0.0 111.353 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.93 9.73 5.85 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.038 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.3 43.78 2.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.851 1.326 . . . . 0.0 112.26 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.36 119.78 26.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.52 -8.28 12.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.8 3.0 . . . . 0.0 111.404 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.04 138.96 50.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.996 0.519 . . . . 0.0 111.113 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -95.29 84.68 4.09 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.1 p -79.58 122.64 26.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.464 0.705 . . . . 0.0 110.872 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -140.61 118.3 11.65 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.121 0.568 . . . . 0.0 110.281 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -86.83 155.29 20.34 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.673 0.389 . . . . 0.0 111.359 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.78 -171.74 37.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -135.95 136.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.381 0.672 . . . . 0.0 110.338 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 174.676 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.6 tt . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 122' ' ' HIS . 52.1 Cg_exo -57.75 177.56 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.844 3.029 . . . . 0.0 112.801 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -71.67 24.11 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' ' 120' ' ' PRO . 46.1 t-80 -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.603 -0.685 . . . . 0.0 110.909 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -87.08 -8.04 57.45 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 tp -103.66 -39.32 6.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.593 0.757 . . . . 0.0 109.262 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -70.61 -26.58 63.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.74 -45.55 9.22 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 117.915 0.325 . . . . 0.0 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.23 -10.95 59.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.923 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -106.7 -24.44 12.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.451 0.569 . . . . 0.0 111.275 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.03 -16.71 59.9 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.267 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -85.15 -55.56 3.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -86.6 11.67 12.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 t -137.37 -21.97 1.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.57 19.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.855 1.207 . . . . 0.0 114.117 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 t -101.95 37.55 1.83 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.313 0.96 . . . . 0.0 110.888 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.32 19.69 3.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -152.79 -41.32 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -136.41 13.01 3.25 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.86 15.08 66.43 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.425 0.557 . . . . 0.0 112.865 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.35 -176.58 41.92 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.74 0.77 . . . . 0.0 112.542 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 25.2 m 64.26 107.85 0.03 OUTLIER 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.895 1.278 . . . . 0.0 111.831 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t 60.74 31.7 20.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.989 0.915 . . . . 0.0 112.18 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.13 -29.77 24.54 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.643 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -152.23 165.44 17.49 Favored Pre-proline 0 C--N 1.34 0.158 0 CA-C-N 117.96 0.88 . . . . 0.0 110.052 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.6 -1.97 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.259 3.306 . . . . 0.0 114.622 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.52 -10.01 59.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.63 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.228 -0.065 0 C-N-CA 123.06 0.544 . . . . 0.0 112.455 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.2 p -135.53 -8.75 2.19 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 122.237 -0.29 . . . . 0.0 111.089 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.32 -31.05 14.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.374 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.63 129.0 49.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -97.33 139.75 32.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.687 0.28 . . . . 0.0 111.666 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.2 mm -125.87 139.3 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.422 1.089 . . . . 0.0 108.544 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.7 163.58 29.35 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.98 79.36 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.53 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.78 124.59 51.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.091 0.945 . . . . 0.0 111.294 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -82.57 -3.61 11.37 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.434 2.756 . . . . 0.0 110.867 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.78 153.68 43.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 110.453 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.13 46.08 0.99 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.499 0.72 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.2 mmt 54.3 54.92 8.79 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.114 0.966 . . . . 0.0 111.982 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.2 118.07 25.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -70.49 -16.98 62.96 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -84.88 -6.46 59.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.017 -0.427 . . . . 0.0 111.468 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.6 -23.11 19.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.527 0.603 . . . . 0.0 110.141 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.58 -28.21 56.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.15 -21.27 46.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.292 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -79.46 -12.4 59.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.924 0.329 . . . . 0.0 111.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.85 -2.84 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.114 -0.367 . . . . 0.0 111.596 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.87 13.39 24.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.794 0.838 . . . . 0.0 109.857 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.5 tttt -78.17 -38.82 1.67 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.11 170.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.87 118.76 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.678 2.252 . . . . 0.0 112.332 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 50.29 22.99 1.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.075 1.35 . . . . 0.0 113.661 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.49 162.27 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.0 110.453 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -135.07 59.41 1.73 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.789 0.436 . . . . 0.0 110.515 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.92 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 O-C-N 121.904 -0.497 . . . . 0.0 109.691 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -134.78 11.13 3.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 m -135.35 122.0 20.83 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.8 t -135.2 128.1 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.396 0.678 . . . . 0.0 109.229 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.91 104.37 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.14 112.72 25.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.637 0.375 . . . . 0.0 110.187 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -85.94 105.37 16.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.145 0.498 . . . . 0.0 109.777 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -71.59 162.86 28.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.986 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m 61.51 11.09 3.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -148.76 22.24 1.0 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.103 0.41 . . . . 0.0 111.666 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 35.08 45.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.103 1.761 . . . . 0.0 114.744 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -128.97 143.66 50.94 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.91 152.88 39.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.063 0.459 . . . . 0.0 111.437 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -122.56 131.86 54.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.2 151.47 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.37 139.53 44.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.347 0.594 . . . . 0.0 111.733 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.72 153.38 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 125.597 1.559 . . . . 0.0 109.496 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -89.96 9.53 27.48 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -152.57 137.09 16.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.312 0.645 . . . . 0.0 109.792 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -78.74 -4.01 47.11 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -88.04 -23.4 23.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.959 0.345 . . . . 0.0 110.334 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.68 -18.28 33.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.26 72.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.62 -22.45 61.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.393 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -80.06 -17.42 52.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.393 0.542 . . . . 0.0 111.501 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.46 -38.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.456 0.571 . . . . 0.0 110.002 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.55 -17.71 61.16 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.194 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -83.46 -15.3 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.892 -0.505 . . . . 0.0 110.072 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.05 -28.01 39.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.61 -7.0 59.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.124 0.57 . . . . 0.0 110.591 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.37 10.45 9.23 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -135.28 6.55 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.28 0.491 . . . . 0.0 112.119 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.48 -24.32 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.828 -0.545 . . . . 0.0 110.784 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.48 4.93 3.16 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 118.938 -0.923 . . . . 0.0 114.967 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.64 24.85 3.41 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.956 1.378 . . . . 0.0 112.976 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.56 135.21 43.75 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -6.36 12.19 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 124.094 3.196 . . . . 0.0 112.173 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.96 140.67 30.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -92.19 89.97 7.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.0 p -95.25 129.8 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.964 0.505 . . . . 0.0 111.099 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -146.38 148.43 32.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.901 0.48 . . . . 0.0 110.678 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.47 146.34 48.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.178 0.591 . . . . 0.0 111.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.36 16.83 5.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.994 0.807 . . . . 0.0 111.293 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.85 137.57 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 117.364 0.582 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 173.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.11 -169.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 124.849 3.7 . . . . 0.0 112.815 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -73.63 43.31 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.836 0.854 . . . . 0.0 112.43 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -85.19 -7.91 58.83 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.807 -0.558 . . . . 0.0 110.042 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -77.01 -4.11 42.48 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.0 tp -71.21 -45.71 62.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.663 0.785 . . . . 0.0 109.733 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.6 p -84.99 -22.28 29.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.613 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -81.4 -48.58 11.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.234 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.97 -4.61 54.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.68 -29.25 8.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.135 0.88 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -76.64 -21.28 55.7 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.143 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.31 -50.61 7.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -91.26 14.93 13.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -135.91 -21.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.32 30.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.196 0.907 . . . . 0.0 113.372 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.7 t -77.21 50.12 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.784 0.72 . . . . 0.0 110.671 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.47 126.08 16.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.872 0.869 . . . . 0.0 108.941 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.96 -174.52 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.872 0.469 . . . . 0.0 111.703 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -73.85 43.0 0.15 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.27 1.028 . . . . 0.0 112.227 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.08 -154.5 7.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.816 0.722 . . . . 0.0 111.834 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.08 -8.42 75.91 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.771 -0.461 . . . . 0.0 112.486 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.1 m -135.57 -17.28 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.426 0.613 . . . . 0.0 111.798 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -148.43 24.17 1.01 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.8 0.44 . . . . 0.0 111.107 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.41 -34.49 7.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.469 -0.629 . . . . 0.0 113.538 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -149.93 164.35 21.1 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.924 . . . . 0.0 110.124 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.81 6.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 124.916 3.744 . . . . 0.0 115.162 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.18 -12.4 58.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.684 0.674 . . . . 0.0 110.595 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.54 19.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.499 0.72 . . . . 0.0 111.846 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.8 p -119.06 20.56 12.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.276 0.23 . . . . 0.0 111.328 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.46 -25.33 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.812 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-N 117.962 0.881 . . . . 0.0 109.696 -178.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.6 tp -135.47 112.19 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.43 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -86.56 135.91 33.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.854 0.862 . . . . 0.0 110.302 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.42 143.05 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.23 166.59 36.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.86 66.76 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.176 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.3 m -52.93 134.83 47.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.789 0.794 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -83.93 -12.25 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.198 3.265 . . . . 0.0 111.362 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.87 166.23 20.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.031 0.932 . . . . 0.0 111.105 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.9 44.56 0.66 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.258 0.623 . . . . 0.0 111.511 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.6 mtt 49.34 55.27 9.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.232 1.013 . . . . 0.0 112.194 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.59 132.98 54.54 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.218 0.607 . . . . 0.0 109.443 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -70.74 -10.1 58.72 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -99.64 -11.88 20.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.983 0.356 . . . . 0.0 111.952 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -96.19 -22.93 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.81 -39.67 63.93 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.81 -17.41 61.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.932 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -81.99 -14.38 56.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.616 0.644 . . . . 0.0 111.842 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.4 m -110.26 -4.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 118.227 0.467 . . . . 0.0 111.78 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -126.14 6.17 7.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -171.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 1.1 tmmt? -101.32 -38.61 0.22 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.929 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 61.9 Cg_exo -55.16 131.78 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.261 1.974 . . . . 0.0 111.182 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 p90 46.83 27.48 0.7 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 113.047 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.65 170.46 15.97 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.909 0.883 . . . . 0.0 110.274 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -135.07 55.13 1.9 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 110.957 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.08 130.14 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -123.35 4.16 9.11 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -140.84 121.34 14.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -135.75 120.22 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 136.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.31 110.77 9.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -83.55 104.38 13.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -84.21 25.81 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.0 p -131.86 3.85 4.13 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.3 0.56 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.998 0.363 . . . . 0.0 111.928 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.3 pttt 45.93 47.12 12.48 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.692 1.197 . . . . 0.0 112.37 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -124.94 129.94 51.36 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.275 0.63 . . . . 0.0 110.277 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.21 147.53 49.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.317 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.3 136.6 35.04 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.666 0.386 . . . . 0.0 110.082 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.57 159.7 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 122.323 0.249 . . . . 0.0 110.739 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.55 132.0 34.6 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.945 0.402 . . . . 0.0 111.513 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -101.1 154.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 124.383 1.073 . . . . 0.0 109.23 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -81.1 -4.62 55.9 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.1 t -147.01 139.08 24.51 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.726 0.41 . . . . 0.0 110.712 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -78.69 -5.84 54.17 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -90.0 -22.05 22.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.64 -15.36 45.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.28 -42.11 60.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.3 -22.49 66.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -81.25 -22.49 38.69 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.103 -0.373 . . . . 0.0 111.093 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.53 -38.65 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.88 -18.39 63.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.912 173.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -77.73 -23.12 49.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.302 0.501 . . . . 0.0 109.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -72.78 -49.64 29.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.877 -0.514 . . . . 0.0 109.614 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -89.47 10.16 23.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -135.65 6.57 3.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.356 0.526 . . . . 0.0 112.284 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -136.96 7.16 2.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.539 0.608 . . . . 0.0 112.396 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.12 -18.95 15.33 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.6 0.636 . . . . 0.0 110.909 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.58 4.55 4.1 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.337 0.97 . . . . 0.0 115.172 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.8 35.14 2.88 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.009 1.405 . . . . 0.0 112.745 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.83 127.94 23.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -84.85 -10.44 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.087 3.191 . . . . 0.0 112.61 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.37 134.97 44.22 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -111.64 136.88 50.24 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -141.65 145.2 34.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.042 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -143.34 126.78 16.79 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.29 0.636 . . . . 0.0 110.257 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -85.84 156.74 20.43 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.14 -164.97 14.72 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.13 136.76 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.988 0.515 . . . . 0.0 110.452 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 174.55 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 9.5 tp . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 118.09 -0.957 . . . . 0.0 113.551 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 31.8 Cg_exo -63.96 176.26 2.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.46 2.107 . . . . 0.0 111.828 174.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -74.15 24.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.833 0.453 . . . . 0.0 111.507 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.439 ' H ' ' C ' ' A' ' 120' ' ' PRO . 7.8 m-70 -91.29 -7.6 50.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.17 -9.21 59.71 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.82 -46.88 11.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.992 0.917 . . . . 0.0 109.503 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -77.68 -16.07 58.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.968 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.96 -43.94 12.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.103 -0.373 . . . . 0.0 111.401 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.21 -12.09 53.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.59 -24.32 11.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.679 0.672 . . . . 0.0 111.189 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -74.81 -22.68 58.6 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.544 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -90.35 -52.73 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.952 -0.467 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -83.16 7.23 16.68 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -143.94 -4.32 0.84 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.78 23.18 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.16 0.891 . . . . 0.0 111.851 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.7 t -84.9 32.86 0.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.624 -0.672 . . . . 0.0 111.374 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.07 20.6 3.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.023 0.529 . . . . 0.0 110.241 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -135.92 147.25 48.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.756 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -65.91 104.8 1.17 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.51 65.42 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.947 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 61.71 -148.26 47.6 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 118.18 0.99 . . . . 0.0 110.787 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.4 m 70.77 114.93 0.05 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.021 0.928 . . . . 0.0 111.507 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.6 t 59.22 31.01 20.87 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.62 -18.59 44.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -149.68 160.02 34.94 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 108.959 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.66 -10.83 10.07 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.661 2.908 . . . . 0.0 113.682 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.13 -36.63 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.786 0.434 . . . . 0.0 111.24 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -8.32 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 O-C-N 122.045 -0.409 . . . . 0.0 110.682 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -83.09 24.02 0.81 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.093 0.473 . . . . 0.0 109.86 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.99 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 CA--C 1.527 0.087 0 CA-C-N 117.559 0.679 . . . . 0.0 109.896 174.426 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.32 127.91 41.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.55 141.21 38.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.056 0.542 . . . . 0.0 110.475 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.9 mm -123.04 147.68 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.337 1.055 . . . . 0.0 108.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.03 164.21 36.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.534 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.55 27.04 70.3 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.96 128.87 85.38 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.338 0.569 . . . . 0.0 112.146 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.9 -1.81 11.44 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.934 3.089 . . . . 0.0 111.166 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.88 162.4 29.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.067 0.547 . . . . 0.0 110.97 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -80.1 38.14 0.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.03 0.932 . . . . 0.0 112.169 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.1 mtt 56.92 44.67 22.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.0 113.125 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.14 137.88 46.43 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.186 0.594 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -72.93 -12.07 60.82 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -84.12 -7.37 59.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.149 -0.344 . . . . 0.0 110.943 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -93.56 -24.29 18.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.881 0.309 . . . . 0.0 110.312 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.87 -28.72 55.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.99 -21.37 47.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -81.34 -14.55 57.16 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.245 0.475 . . . . 0.0 111.701 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.1 -4.47 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.252 0.478 . . . . 0.0 111.459 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.2 8.29 23.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.672 0.789 . . . . 0.0 110.371 170.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 59.3 tptt -72.59 -44.8 9.6 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.8 Cg_endo -84.12 -20.65 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.266 1.978 . . . . 0.0 114.546 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -142.98 24.51 1.83 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.46 165.69 27.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.905 -0.497 . . . . 0.0 111.105 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.32 55.36 1.22 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.358 0.663 . . . . 0.0 109.548 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.9 140.58 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.075 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -131.44 -0.12 4.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -143.55 134.41 25.33 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.751 -0.593 . . . . 0.0 110.734 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.0 t -137.96 130.05 39.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.421 0.688 . . . . 0.0 109.829 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 111.11 14.08 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.3 0.24 . . . . 0.0 110.37 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -88.99 88.7 7.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -76.87 24.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.559 0.744 . . . . 0.0 112.474 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.7 p -128.24 5.96 5.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -144.16 14.99 1.68 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.972 0.509 . . . . 0.0 110.606 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 52.88 31.44 10.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.325 1.05 . . . . 0.0 112.185 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -133.69 149.82 51.53 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 122.965 0.506 . . . . 0.0 110.817 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.73 158.2 43.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.12 0.568 . . . . 0.0 110.114 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -130.15 138.72 50.78 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.82 153.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.313 0.101 . . . . 0.0 110.736 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -125.23 130.39 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.081 0.467 . . . . 0.0 111.727 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.11 150.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.705 1.602 . . . . 0.0 108.565 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -109.03 24.15 13.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -145.43 121.84 10.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.14 0.976 . . . . 0.0 108.73 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -78.85 -9.14 59.38 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.478 -0.139 . . . . 0.0 111.094 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -84.89 -24.42 28.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -88.68 -14.43 37.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.59 -42.78 64.19 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -74.08 -16.2 61.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.185 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -83.31 -17.89 40.9 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.069 -0.394 . . . . 0.0 110.78 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.3 t -73.69 -47.43 44.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.05 -16.88 63.8 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.757 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.48 -44.86 66.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.72 -26.14 30.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.789 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -81.78 0.11 40.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.114 0.415 . . . . 0.0 111.025 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.17 5.37 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.094 0.406 . . . . 0.0 111.968 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -143.27 24.1 1.8 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.91 -8.74 14.48 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.62 -0.675 . . . . 0.0 111.182 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.51 2.55 4.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.082 -0.843 . . . . 0.0 114.708 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.75 26.14 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.735 1.268 . . . . 0.0 112.482 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt -131.22 96.51 21.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.86 -0.78 11.04 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.998 3.132 . . . . 0.0 111.346 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.41 125.06 23.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.52 0.728 . . . . 0.0 109.268 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -89.75 126.68 35.76 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.469 0.308 . . . . 0.0 110.797 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 m -136.4 137.9 40.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.402 0.681 . . . . 0.0 110.247 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -141.37 144.64 34.63 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.113 0.965 . . . . 0.0 109.087 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -102.65 130.48 49.57 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.545 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.5 156.7 21.19 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.2 138.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.459 0.704 . . . . 0.0 110.205 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 174.331 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.4 pt . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 71.9 Cg_endo -67.98 -8.08 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.397 2.731 . . . . 0.0 112.51 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 12.1 tpt -134.89 25.18 3.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.1 0.56 . . . . 0.0 110.221 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -135.15 -16.29 1.91 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.078 -0.388 . . . . 0.0 111.337 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -82.15 -19.66 39.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 173.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 32.0 tp -92.28 -25.62 18.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.414 0.686 . . . . 0.0 110.027 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.0 m -84.51 -21.47 30.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.2 -40.84 11.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.167 -0.333 . . . . 0.0 110.783 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.47 45.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -106.43 -25.2 11.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.682 0.674 . . . . 0.0 111.437 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -76.78 -24.84 52.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.773 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.06 -49.09 9.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.863 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -95.96 11.3 34.45 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -135.13 -16.85 1.88 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.824 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.69 21.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.408 1.003 . . . . 0.0 113.307 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 m -132.55 2.74 3.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 111.187 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.74 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.809 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -148.54 168.9 21.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.46 1.504 . . . . 0.0 108.373 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -129.61 27.81 5.21 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.501 0.321 . . . . 0.0 111.012 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.48 -12.65 77.86 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.666 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.95 -177.48 25.05 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 117.803 0.801 . . . . 0.0 111.802 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 p -77.81 -69.58 0.53 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 122.288 -0.537 . . . . 0.0 110.957 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 28.81 1.77 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.0 110.228 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.87 85.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.385 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.453 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 37.3 tp60 -162.3 -42.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.687 1.244 . . . . 0.0 113.258 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.453 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 39.5 Cg_exo -63.07 2.05 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.902 2.401 . . . . 0.0 114.741 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 3.41 7.0 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.872 0.76 . . . . 0.0 111.891 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.61 9.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.412 0.685 . . . . 0.0 111.789 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -135.64 24.13 3.4 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.97 0.908 . . . . 0.0 108.8 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.03 29.93 0.12 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.781 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 124.665 1.186 . . . . 0.0 112.635 177.532 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.232 0.182 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.21 123.28 48.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -93.98 140.5 29.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.974 0.509 . . . . 0.0 111.008 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.3 137.08 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.001 0.921 . . . . 0.0 108.878 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.66 166.83 31.41 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.85 20.23 74.18 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.629 -0.54 . . . . 0.0 112.023 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.04 124.74 46.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.763 0.782 . . . . 0.0 111.646 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.26 -4.95 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.374 2.716 . . . . 0.0 110.656 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.85 149.54 39.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.113 0.565 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -84.74 52.44 2.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.992 0.517 . . . . 0.0 110.168 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 55.28 55.66 7.25 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.051 0.94 . . . . 0.0 112.05 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.08 111.84 17.03 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.6 -13.7 62.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -88.61 -6.45 57.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.97 -0.456 . . . . 0.0 111.042 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -92.77 -20.03 21.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.209 0.459 . . . . 0.0 109.971 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.24 -28.41 53.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.79 45.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.019 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.43 -15.99 58.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.961 0.346 . . . . 0.0 111.557 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.79 -4.28 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.222 0.465 . . . . 0.0 111.482 172.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.52 12.05 26.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.665 0.786 . . . . 0.0 109.804 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.2 tttp -75.15 -39.29 3.17 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 95.1 Cg_endo -75.03 125.73 9.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.564 1.51 . . . . 0.0 111.576 -174.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 t80 51.63 23.93 2.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.124 1.37 . . . . 0.0 113.093 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.94 160.03 42.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.462 0.705 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.03 55.85 1.87 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.491 0.316 . . . . 0.0 111.597 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.53 139.0 21.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 O-C-N 121.958 -0.464 . . . . 0.0 109.813 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -131.71 4.17 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.4 m -135.59 124.22 23.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.01 0.368 . . . . 0.0 110.334 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.14 115.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -111.62 104.58 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 104.81 14.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -81.05 104.2 11.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.064 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -85.67 24.34 1.24 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.44 0.696 . . . . 0.0 112.06 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -130.09 7.58 5.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -147.72 19.19 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.153 0.581 . . . . 0.0 110.235 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 37.51 38.03 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.704 1.602 . . . . 0.0 113.658 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -138.06 159.77 41.15 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.985 0.914 . . . . 0.0 109.769 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.67 159.29 42.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.979 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.45 135.31 47.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.12 154.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -135.21 139.04 44.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 0.0 111.357 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.63 150.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.48 1.512 . . . . 0.0 109.33 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -90.15 15.14 10.8 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -154.09 138.09 16.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.157 0.583 . . . . 0.0 109.886 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.24 -8.15 59.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.58 -28.87 24.56 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.41 -14.15 55.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.71 65.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.05 -13.69 60.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.146 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.72 -16.6 41.14 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.452 0.569 . . . . 0.0 111.213 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.64 -41.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -17.76 61.79 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.188 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -70.23 -40.29 74.58 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -62.56 -40.9 98.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -84.18 11.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.444 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -130.31 12.98 5.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.382 0.273 . . . . 0.0 111.234 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -135.78 3.63 2.99 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.57 -8.96 22.47 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.771 0.714 . . . . 0.0 111.981 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.88 -8.02 0.63 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.109 0.861 . . . . 0.0 114.552 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.55 72.84 1.42 Allowed 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.36 1.08 . . . . 0.0 109.929 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.52 119.67 30.49 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.135 0.574 . . . . 0.0 110.375 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.54 -11.72 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.67 2.913 . . . . 0.0 111.287 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.86 149.67 49.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.451 0.701 . . . . 0.0 111.115 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -103.7 98.52 8.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.6 t -117.52 147.94 42.32 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.089 0.556 . . . . 0.0 111.751 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.82 145.43 46.45 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.548 1.139 . . . . 0.0 108.869 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -127.9 152.19 48.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.93 146.68 14.16 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.98 136.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.004 0.522 . . . . 0.0 110.77 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.266 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.57 4.39 5.07 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.195 3.263 . . . . 0.0 112.441 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.61 11.51 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.234 0.47 . . . . 0.0 112.186 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -135.8 3.79 3.0 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.185 0.594 . . . . 0.0 110.418 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -91.38 -20.1 22.18 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.187 0.195 . . . . 0.0 110.842 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.32 -12.65 37.11 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 m -74.83 -47.34 31.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.12 -68.4 0.56 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.605 0.241 . . . . 0.0 111.039 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.73 -17.27 56.1 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.26 -16.95 13.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.986 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.49 -13.92 53.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.365 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -91.64 -32.99 15.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.371 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.84 9.22 25.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.535 0.607 . . . . 0.0 111.705 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -126.52 -11.21 6.23 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.938 -0.553 . . . . 0.0 112.05 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.426 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.2 t -127.27 24.97 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.6 t -74.59 55.48 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.227 -0.921 . . . . 0.0 109.85 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.04 156.15 47.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.095 0.958 . . . . 0.0 110.448 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -86.2 49.59 1.82 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.904 0.482 . . . . 0.0 111.079 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -135.93 55.56 1.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.725 0.81 . . . . 0.0 109.515 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.14 152.87 21.18 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.79 -16.2 71.01 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.488 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 76.7 p -145.71 12.71 1.31 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.221 1.01 . . . . 0.0 111.624 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 t -135.95 24.37 3.32 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.408 0.549 . . . . 0.0 112.15 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.47 81.34 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.425 ' C ' ' H ' ' A' ' 145' ' ' LEU . 8.6 tp-100 -146.45 149.18 36.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.32 14.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.434 3.423 . . . . 0.0 115.307 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.426 HD21 ' CG2' ' A' ' 133' ' ' VAL . 4.6 pp -67.57 -8.57 35.24 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.902 0.774 . . . . 0.0 111.693 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.27 7.92 2.46 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 123.968 0.907 . . . . 0.0 111.005 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.8 m -134.79 30.46 3.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.04 -56.76 0.05 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.943 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.516 -0.344 0 CA-C-N 117.91 0.855 . . . . 0.0 112.759 -178.411 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.45 142.16 51.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.425 0.557 . . . . 0.0 112.256 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.24 143.34 50.72 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -122.74 150.49 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.87 171.0 34.87 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.865 -0.522 . . . . 0.0 112.143 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.58 73.96 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.34 128.49 59.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 117.464 0.632 . . . . 0.0 111.883 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -87.67 -7.54 6.46 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.267 3.311 . . . . 0.0 111.457 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.56 156.35 30.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.329 1.051 . . . . 0.0 111.953 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.19 57.97 4.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.938 0.895 . . . . 0.0 112.226 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 38.5 ttm 53.54 55.74 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.654 0.782 . . . . 0.0 112.083 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -126.92 108.44 10.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.252 0.621 . . . . 0.0 109.563 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.97 -17.7 65.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.95 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -85.64 -3.06 58.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.202 -0.311 . . . . 0.0 111.2 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -94.43 -23.7 17.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.466 0.575 . . . . 0.0 109.973 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.81 -35.89 75.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 170.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.3 60.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.555 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -78.22 -11.67 59.94 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.707 -0.621 . . . . 0.0 110.703 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.88 -1.27 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.58 12.29 14.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.767 0.827 . . . . 0.0 110.595 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.8 tttt -109.69 -32.28 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 59.0 Cg_exo -57.04 -21.17 40.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.492 2.128 . . . . 0.0 114.259 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.6 5.8 1.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.0 174.14 11.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.462 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.52 55.52 1.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.176 0.591 . . . . 0.0 110.662 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.74 139.7 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -115.39 -2.02 12.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -172.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.1 m -141.64 131.21 23.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.432 0.56 . . . . 0.0 110.58 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -143.19 125.19 12.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.205 0.602 . . . . 0.0 109.865 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.59 139.96 45.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.985 0.514 . . . . 0.0 110.055 173.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -109.29 138.6 45.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.82 0.848 . . . . 0.0 111.219 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -102.08 105.24 15.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -79.92 24.56 0.4 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.837 0.855 . . . . 0.0 113.253 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.2 m -133.16 6.5 3.89 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.847 0.294 . . . . 0.0 111.63 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -152.73 11.47 0.5 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.718 0.235 . . . . 0.0 111.228 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 47.44 47.03 17.36 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -128.44 150.64 50.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.121 0.569 . . . . 0.0 110.312 -173.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.34 155.42 50.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.306 0.574 . . . . 0.0 111.742 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -127.3 127.16 43.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.39 150.75 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.465 0.174 . . . . 0.0 111.188 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.47 131.32 43.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.95 0.405 . . . . 0.0 111.617 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -106.36 157.57 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 124.759 1.224 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -86.96 -2.02 58.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -153.42 150.21 28.58 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.082 -0.386 . . . . 0.0 110.366 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -70.26 -12.63 61.73 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.358 -0.214 . . . . 0.0 111.414 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -77.85 -16.92 57.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.924 -0.485 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.64 -14.92 36.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.145 -0.347 . . . . 0.0 110.219 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.55 -40.41 35.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -73.48 -25.56 60.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -79.1 -22.59 45.01 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.317 0.508 . . . . 0.0 111.203 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.9 t -74.75 -42.65 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.27 -16.08 62.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.452 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -78.86 -24.63 44.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.29 0.496 . . . . 0.0 110.412 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -99.14 -17.32 18.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.107 -0.371 . . . . 0.0 110.671 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.96 0.26 57.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.018 -0.426 . . . . 0.0 110.077 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.34 -2.58 2.48 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -144.14 20.47 1.75 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.092 0.86 . . . . 0.0 113.007 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -135.99 55.59 1.85 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.1 -2.82 72.3 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.476 -0.624 . . . . 0.0 112.798 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 50.86 74.76 0.21 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.91 0.884 . . . . 0.0 112.085 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.8 151.86 40.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.846 0.458 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.24 -6.82 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.895 3.064 . . . . 0.0 112.231 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.64 128.62 36.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.878 0.308 . . . . 0.0 110.281 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -89.32 100.36 13.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.1 m -104.95 135.39 46.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.754 0.422 . . . . 0.0 111.059 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -141.27 149.25 41.06 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.646 0.779 . . . . 0.0 109.933 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -103.85 140.62 37.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.98 151.51 22.22 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.31 151.64 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.488 0.715 . . . . 0.0 111.094 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.569 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.66 1.81 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.682 2.922 . . . . 0.0 112.497 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.8 ttt -84.51 -4.14 58.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.913 -0.492 . . . . 0.0 111.221 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -135.68 10.46 3.4 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.549 0.339 . . . . 0.0 111.403 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -74.62 -10.34 59.44 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.4 -23.78 32.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.3 m -89.94 -15.6 31.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -77.51 -50.4 12.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.613 0.365 . . . . 0.0 110.065 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.24 -15.28 41.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -91.3 -41.47 10.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.672 0.669 . . . . 0.0 110.876 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -68.77 -28.85 67.15 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.405 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -70.9 -62.53 1.36 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -98.1 21.58 10.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 -10.46 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.48 3.42 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.2 0.909 . . . . 0.0 112.744 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.9 m -87.79 31.13 0.78 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.244 -0.91 . . . . 0.0 111.2 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.47 24.9 6.62 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.177 0.991 . . . . 0.0 109.42 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -135.36 169.17 17.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.855 1.262 . . . . 0.0 109.144 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -76.21 24.22 0.14 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.04 137.35 2.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.02 152.78 20.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.0 m 55.24 36.45 27.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.576 0.703 . . . . 0.0 109.274 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.8 m -147.66 14.34 1.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.852 1.261 . . . . 0.0 109.042 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.21 -106.45 2.99 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 82.3 mt-30 -152.29 -42.24 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.58 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 50.2 Cg_exo -60.47 -20.51 64.16 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.849 2.366 . . . . 0.0 115.653 -171.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.97 1.2 1.64 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.07 -4.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 39.3 p -133.72 11.71 4.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.88 -71.74 1.31 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.593 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.378 0.132 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.45 131.01 54.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.289 0.636 . . . . 0.0 109.366 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -115.26 142.91 46.04 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.202 0.601 . . . . 0.0 110.804 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.93 141.81 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.835 0.854 . . . . 0.0 109.085 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.09 29.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.03 75.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.582 -0.565 . . . . 0.0 111.931 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 m -55.85 124.54 58.4 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.85 0.825 . . . . 0.0 110.87 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.5 -2.83 13.08 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.324 2.683 . . . . 0.0 111.076 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.54 157.91 34.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.32 0.648 . . . . 0.0 110.133 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -85.09 47.85 1.47 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.51 55.92 6.81 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.915 0.886 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -126.87 116.65 21.16 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.31 -12.58 61.78 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -83.78 -11.43 57.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.085 -0.384 . . . . 0.0 110.896 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -95.73 -18.53 20.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.392 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.49 -26.79 51.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.96 -22.63 42.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.94 -14.75 59.83 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.112 -0.368 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 -2.64 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 118.243 0.474 . . . . 0.0 111.783 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.33 14.3 22.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.6 0.76 . . . . 0.0 109.837 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 64.9 tttp -88.56 -37.23 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.937 169.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 49.8 Cg_exo -59.4 116.91 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.252 1.968 . . . . 0.0 111.111 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 51.67 23.89 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.398 1.079 . . . . 0.0 113.178 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 159.45 44.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.116 0.416 . . . . 0.0 110.9 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -135.34 59.18 1.73 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.894 0.477 . . . . 0.0 111.301 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -70.15 142.59 15.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 O-C-N 121.856 -0.527 . . . . 0.0 109.996 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -132.45 6.62 4.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.0 m -135.51 119.75 17.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.213 0.46 . . . . 0.0 110.472 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.16 123.91 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.284 0.633 . . . . 0.0 109.406 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 104.66 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.22 117.62 34.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -135.09 155.95 49.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.806 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 60.24 177.21 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.137 1.375 . . . . 0.0 112.349 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -70.22 78.54 0.52 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.509 0.723 . . . . 0.0 111.141 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 50.09 32.27 5.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.915 1.686 . . . . 0.0 114.833 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -135.56 4.17 3.09 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -139.47 55.26 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.226 0.921 . . . . 0.0 111.294 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.01 137.21 36.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.052 0.454 . . . . 0.0 110.228 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -135.5 133.49 38.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.552 0.741 . . . . 0.0 109.939 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.66 152.34 31.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.549 0.214 . . . . 0.0 111.137 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -135.74 142.45 45.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.241 0.544 . . . . 0.0 111.93 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.75 151.02 22.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.479 1.511 . . . . 0.0 109.174 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -87.77 11.12 16.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.3 t -149.7 136.06 19.07 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.821 0.448 . . . . 0.0 109.839 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -72.59 -17.7 61.67 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 122.401 -0.187 . . . . 0.0 110.585 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -82.53 -22.06 35.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.23 -19.07 37.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.72 66.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.21 -14.51 60.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.93 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.5 -19.86 37.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.238 0.472 . . . . 0.0 111.002 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.77 -44.06 46.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.27 -18.57 63.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -75.28 -28.54 59.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.53 0.604 . . . . 0.0 109.593 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -72.14 -28.91 63.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.4 5.55 51.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.529 0.332 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.7 17.26 5.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.896 0.478 . . . . 0.0 110.577 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -129.56 -6.52 4.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.654 0.382 . . . . 0.0 111.209 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -97.84 -6.61 32.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.472 0.578 . . . . 0.0 112.041 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 5.32 3.91 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.176 0.893 . . . . 0.0 114.093 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.02 50.11 0.52 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.392 1.096 . . . . 0.0 109.874 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.82 127.99 53.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 122.712 0.405 . . . . 0.0 111.395 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.03 0.71 8.8 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.4 3.4 . . . . 0.0 112.238 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.47 150.66 50.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.85 104.25 16.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 p -121.76 133.73 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.481 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -137.31 145.0 42.89 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 123.459 0.704 . . . . 0.0 110.16 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -133.1 157.4 45.38 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.041 0.537 . . . . 0.0 110.026 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.91 -176.07 40.57 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.546 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.55 143.33 36.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 125.049 1.34 . . . . 0.0 109.951 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 175.119 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 121' ' ' MET . 26.5 mt . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.564 0.221 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.79 -7.32 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.305 2.67 . . . . 0.0 112.889 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.493 ' H ' HG22 ' A' ' 119' ' ' ILE . 5.4 mpp? -85.81 25.87 1.05 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.385 0.539 . . . . 0.0 111.388 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -72.2 -20.71 61.53 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -92.47 10.15 31.36 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.227 -0.296 . . . . 0.0 110.949 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.55 -32.61 12.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 t -84.86 -27.68 26.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.7 -59.68 2.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.557 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.69 -24.77 41.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.82 -27.54 10.68 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 113.142 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -85.08 -18.77 33.27 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.6 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -87.37 -55.26 3.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.539 0.609 . . . . 0.0 109.738 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -87.3 4.49 42.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 m -139.58 -5.56 1.37 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 172.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.43 21.18 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.052 1.297 . . . . 0.0 112.092 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 t -100.63 30.14 4.11 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.371 -0.831 . . . . 0.0 111.384 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.57 24.36 8.57 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 110.218 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' GLY . 25.7 tt0 -140.43 156.51 46.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.354 1.062 . . . . 0.0 108.834 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -74.87 24.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.32 0.648 . . . . 0.0 112.082 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' GLN . . . 166.06 160.67 13.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.17 -169.2 42.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.1 m 68.63 112.0 0.04 OUTLIER 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.331 1.053 . . . . 0.0 112.366 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.7 t 59.36 24.93 13.53 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.345 1.058 . . . . 0.0 112.606 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.44 -9.1 82.28 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -156.82 147.24 16.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.26 7.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.445 3.43 . . . . 0.0 115.67 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.72 6.0 5.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.031 0.832 . . . . 0.0 111.663 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.08 17.57 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.125 0.57 . . . . 0.0 111.645 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -135.12 40.41 2.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.01 0.924 . . . . 0.0 109.136 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.84 -53.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.814 0.816 . . . . 0.0 110.395 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.66 126.05 53.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -112.4 140.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.752 0.821 . . . . 0.0 110.312 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mm -125.45 144.66 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.42 176.97 37.91 Favored Glycine 0 CA--C 1.524 0.651 0 O-C-N 121.863 -0.523 . . . . 0.0 112.206 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.78 19.7 73.55 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 m -62.55 130.0 93.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 117.563 0.682 . . . . 0.0 111.242 -173.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.76 -10.35 6.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.13 3.22 . . . . 0.0 111.307 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 45' ' ' LYS . 4.0 pp -82.03 156.08 24.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.684 1.193 . . . . 0.0 111.666 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -80.7 55.93 2.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.736 0.815 . . . . 0.0 112.109 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.1 mtm 50.73 55.34 9.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.14 0.976 . . . . 0.0 112.495 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 88.5 tttt -115.55 106.06 13.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.64 -15.71 63.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -84.17 -7.5 59.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.158 -0.339 . . . . 0.0 110.827 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -96.85 -20.74 17.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.405 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.72 -29.28 62.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.84 50.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.235 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -76.63 -13.11 60.09 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.792 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.96 -2.6 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -118.22 18.28 13.79 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.688 0.795 . . . . 0.0 110.291 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.3 ttmt -105.71 -35.51 0.19 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.442 -0.79 . . . . 0.0 113.035 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.1 Cg_exo -58.97 -23.97 70.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.645 2.23 . . . . 0.0 114.161 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -143.82 13.71 1.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.78 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.121 0.569 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -134.56 57.86 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.483 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.32 138.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -130.65 9.31 5.02 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -135.44 113.64 11.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.42 128.14 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.13 131.49 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mt -107.78 122.68 47.26 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -118.19 161.71 19.44 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 62.1 24.9 14.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.24 1.816 . . . . 0.0 112.783 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 m 52.6 26.44 4.35 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.841 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -141.05 -174.79 4.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.29 1.436 . . . . 0.0 109.122 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.58 30.65 0.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -87.95 81.36 7.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.379 0.991 . . . . 0.0 108.728 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.16 138.73 32.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.424 0.631 . . . . 0.0 112.242 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -136.02 131.67 35.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.952 0.901 . . . . 0.0 108.866 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -133.0 151.66 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 111.617 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -135.47 142.28 45.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.421 0.629 . . . . 0.0 111.597 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.22 152.77 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 125.103 1.361 . . . . 0.0 109.156 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -98.33 24.14 7.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.6 t -149.99 138.57 20.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.959 0.504 . . . . 0.0 110.09 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -38.48 73.82 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -76.35 -15.94 59.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.241 -0.287 . . . . 0.0 111.587 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -86.28 -18.78 31.13 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.873 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.91 -22.56 42.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.94 -19.26 37.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.292 -0.255 . . . . 0.0 111.366 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -78.39 -43.38 26.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.466 0.575 . . . . 0.0 110.157 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -14.97 60.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.002 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -71.55 -43.3 66.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.764 0.711 . . . . 0.0 109.144 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -76.04 -12.4 60.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.419 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -92.35 -1.26 57.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.1 -0.375 . . . . 0.0 110.325 170.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -112.36 3.19 16.84 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.797 0.439 . . . . 0.0 111.429 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -135.02 1.69 3.01 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.15 55.17 1.77 Allowed 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.2 -0.28 20.65 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.804 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.02 3.02 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.912 0.856 . . . . 0.0 111.798 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -89.15 153.58 49.0 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 122.859 0.463 . . . . 0.0 109.776 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.53 -11.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.688 2.925 . . . . 0.0 112.062 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.08 153.14 21.5 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.786 0.435 . . . . 0.0 111.755 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -125.41 137.44 54.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 109.025 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -135.46 141.98 45.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -137.53 147.49 45.21 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.224 1.01 . . . . 0.0 109.552 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -135.13 160.49 38.2 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.12 175.08 33.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.36 148.83 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.122 0.969 . . . . 0.0 109.952 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.093 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 35.9 mm . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 46.8 Cg_exo -61.04 -13.38 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.633 2.888 . . . . 0.0 115.797 -171.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.88 23.85 3.34 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -91.11 -12.4 35.69 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 121.641 -0.662 . . . . 0.0 110.911 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -88.59 -6.22 57.67 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.6 tp -101.41 -27.62 13.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.709 0.804 . . . . 0.0 109.601 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -80.98 -21.68 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.29 -44.44 10.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 0.0 111.199 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.58 -13.94 59.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.46 -17.31 11.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.903 0.774 . . . . 0.0 111.747 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.405 ' HB3' ' HZ3' ' A' ' 129' ' ' LYS . 8.0 ttpm? -70.97 -25.65 62.81 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.867 169.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.89 -63.43 1.32 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.296 0.238 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -80.7 8.48 7.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -143.91 -17.69 0.59 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.6 24.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.914 1.234 . . . . 0.0 113.693 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.5 m -103.92 26.61 8.47 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.179 -0.951 . . . . 0.0 111.665 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.07 24.02 3.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.788 0.435 . . . . 0.0 111.218 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -148.14 -74.99 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.274 -0.266 . . . . 0.0 111.265 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -140.5 158.1 44.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.853 0.861 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.67 157.39 50.53 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.57 171.63 27.09 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 123.372 0.511 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 34.7 p -87.13 -5.55 58.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.206 0.602 . . . . 0.0 110.564 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.9 m -89.43 13.52 13.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.504 0.322 . . . . 0.0 110.167 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.51 -12.4 81.88 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -141.69 158.26 63.23 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.976 0.51 . . . . 0.0 110.135 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.15 14.47 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.297 3.332 . . . . 0.0 112.927 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.49 -6.0 27.71 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.899 0.772 . . . . 0.0 111.148 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -75.13 -1.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -137.62 34.03 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.47 1.108 . . . . 0.0 109.403 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.43 -16.99 0.38 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.475 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.623 1.212 . . . . 0.0 112.353 178.017 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.231 0.086 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -110.9 141.58 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -133.39 144.61 49.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.991 0.516 . . . . 0.0 110.634 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.87 155.04 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.705 0.802 . . . . 0.0 108.935 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.22 170.22 36.23 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.0 77.35 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.119 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 m -47.97 114.34 3.26 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.682 0.793 . . . . 0.0 111.714 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.21 -8.17 10.84 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.533 2.822 . . . . 0.0 113.058 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.93 -18.2 31.37 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.974 0.806 . . . . 0.0 111.182 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 33.71 49.98 0.28 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.032 1.333 . . . . 0.0 112.608 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.3 tpp -135.58 -75.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -150.94 166.76 29.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.286 0.565 . . . . 0.0 111.675 -169.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.37 -4.77 31.97 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.683 0.793 . . . . 0.0 112.31 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -83.84 -8.86 59.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.03 -0.419 . . . . 0.0 111.57 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.95 -30.13 19.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.73 -26.41 59.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.1 -19.43 36.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.33 -13.37 59.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.044 0.383 . . . . 0.0 110.798 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.5 -5.5 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.32 12.77 20.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.243 0.617 . . . . 0.0 110.991 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 16.8 tppt? -91.45 -39.69 0.38 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.327 -0.844 . . . . 0.0 113.215 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 93.7 Cg_endo -78.72 -20.01 10.84 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.794 1.663 . . . . 0.0 113.43 -173.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -136.25 17.23 3.19 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.751 0.705 . . . . 0.0 112.694 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.25 170.23 22.35 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.994 -0.442 . . . . 0.0 110.952 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.9 55.9 1.17 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.602 0.761 . . . . 0.0 109.722 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.76 138.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.105 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -131.27 7.28 4.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -145.89 127.83 15.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -141.35 128.18 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 123.33 0.652 . . . . 0.0 109.629 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.4 138.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 122.912 0.485 . . . . 0.0 109.972 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mt -107.86 104.79 14.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.031 0.932 . . . . 0.0 109.739 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -80.91 94.0 6.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.0 m120 63.21 127.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.774 1.23 . . . . 0.0 110.473 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -76.06 22.0 0.16 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -146.69 25.48 1.18 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.966 0.507 . . . . 0.0 110.52 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -135.45 -88.38 0.34 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.125 -0.359 . . . . 0.0 111.695 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -137.42 159.25 42.47 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 123.16 0.584 . . . . 0.0 111.708 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.6 143.86 45.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.57 0.748 . . . . 0.0 109.181 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.34 133.18 56.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -135.71 151.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -135.16 135.64 41.24 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.716 0.406 . . . . 0.0 111.003 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -109.17 152.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 124.675 1.19 . . . . 0.0 110.011 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -82.2 -1.4 48.98 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.4 m -144.78 127.42 16.14 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.751 0.82 . . . . 0.0 109.222 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -8.99 58.14 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.214 -0.304 . . . . 0.0 111.755 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -87.29 -14.85 39.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.095 0.407 . . . . 0.0 110.225 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -88.61 -17.71 29.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.24 -41.01 70.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -69.94 -20.32 63.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -86.39 -9.54 56.12 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.115 -0.366 . . . . 0.0 111.581 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.63 -49.38 19.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -25.44 67.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -71.16 -44.89 64.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -77.42 -26.63 51.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.553 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.87 -0.63 52.04 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.244 -0.285 . . . . 0.0 110.436 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -125.96 8.14 7.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.734 0.243 . . . . 0.0 111.575 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -135.42 15.29 3.45 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.68 49.83 2.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.337 0.517 . . . . 0.0 110.73 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.34 10.04 81.7 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.445 -0.642 . . . . 0.0 112.63 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.75 98.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.916 1.286 . . . . 0.0 111.78 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.28 154.32 93.06 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -10.98 29.78 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.601 2.868 . . . . 0.0 112.109 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.26 119.71 23.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.82 104.54 14.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -111.73 139.2 47.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.986 0.422 . . . . 0.0 111.455 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -146.14 159.17 43.66 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.482 1.113 . . . . 0.0 109.427 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -127.62 156.27 42.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.06 -175.04 14.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.21 141.22 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.127 0.464 . . . . 0.0 110.837 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 123.627 0.632 . . . . 0.0 113.932 -176.371 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.514 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 43.7 Cg_endo -60.39 -35.97 88.92 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.142 2.561 . . . . 0.0 112.627 -169.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.17 14.26 3.04 Favored 'General case' 0 C--N 1.337 0.046 0 CA-C-N 118.117 0.417 . . . . 0.0 111.022 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -82.87 -18.15 41.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.148 -0.345 . . . . 0.0 111.054 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -97.88 -2.41 40.81 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 tp -109.8 -27.11 9.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -80.67 -26.58 37.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.45 -42.13 13.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.763 0.256 . . . . 0.0 111.539 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.36 -10.45 59.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.142 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -104.78 -20.69 13.52 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.912 0.778 . . . . 0.0 110.937 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.18 -13.82 58.22 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.012 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.12 -61.61 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -78.32 -0.42 28.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -138.97 -2.53 1.68 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.75 24.35 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.749 1.159 . . . . 0.0 111.208 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.5 p -72.84 55.06 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.755 -0.591 . . . . 0.0 111.828 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 137.68 42.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.195 0.598 . . . . 0.0 110.487 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 53.13 27.5 5.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.973 . . . . 0.0 112.432 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 78.4 m95 54.26 24.98 5.4 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.05 0.94 . . . . 0.0 112.759 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.01 170.38 54.66 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 176.18 147.0 6.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.4 m 58.2 7.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.325 1.45 . . . . 0.0 113.197 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.9 p -160.21 19.83 0.15 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.768 -0.583 . . . . 0.0 111.375 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -93.46 -21.89 28.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.206 -0.775 . . . . 0.0 114.001 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -149.09 160.77 34.23 Favored Pre-proline 0 C--O 1.227 -0.096 0 CA-C-N 118.515 1.158 . . . . 0.0 110.187 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.51 -1.27 0.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.28 3.32 . . . . 0.0 114.415 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.54 -8.14 56.0 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.809 0.732 . . . . 0.0 110.712 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.61 9.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.028 0.531 . . . . 0.0 110.553 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.1 p -128.31 31.51 5.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.05 0.54 . . . . 0.0 109.964 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.22 -26.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.556 0.693 . . . . 0.0 110.229 173.561 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.124 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.5 tp -121.32 115.46 23.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -89.02 135.96 33.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.218 1.007 . . . . 0.0 110.445 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.8 mm -127.48 104.69 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.56 164.07 13.03 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.225 0.347 . . . . 0.0 113.232 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 -47.74 3.0 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.99 1.281 . . . . 0.0 112.596 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' LEU . 27.6 m 37.64 48.64 1.35 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.375 1.47 . . . . 0.0 114.741 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.81 1.95 4.01 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.829 2.352 . . . . 0.0 110.159 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 40' ' ' VAL . 16.2 tp -79.44 43.49 0.55 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.874 1.67 . . . . 0.0 110.775 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 56.88 24.13 8.94 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.974 1.31 . . . . 0.0 112.57 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.3 ptt? 34.35 55.21 0.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.324 1.45 . . . . 0.0 113.575 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -128.68 129.32 45.64 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.96 -13.88 62.28 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -82.77 -14.67 54.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.284 0.493 . . . . 0.0 110.594 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -95.42 -24.81 16.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.191 -0.318 . . . . 0.0 110.347 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.71 -26.59 62.55 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 -20.36 36.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -79.44 -6.56 57.13 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.109 -0.369 . . . . 0.0 111.168 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.83 -3.25 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.17 -0.331 . . . . 0.0 111.889 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -113.44 15.68 19.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.532 0.733 . . . . 0.0 110.202 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttm -101.62 -40.06 0.21 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.566 169.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 32.5 Cg_exo -61.55 114.61 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.233 1.955 . . . . 0.0 110.344 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.81 30.88 5.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.55 0.74 . . . . 0.0 112.008 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.46 161.97 40.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.028 0.531 . . . . 0.0 110.883 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -138.7 85.74 2.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.672 0.389 . . . . 0.0 111.025 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.6 140.42 25.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -135.17 8.15 3.43 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.0 m -135.7 119.6 17.4 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.59 128.52 33.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.149 0.579 . . . . 0.0 110.122 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.39 143.77 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 171.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -125.4 137.86 54.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.626 1.17 . . . . 0.0 110.838 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -112.03 98.43 7.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -83.15 43.21 0.85 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.037 0.535 . . . . 0.0 111.765 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.02 -7.04 2.35 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.636 0.374 . . . . 0.0 110.914 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -153.21 35.03 0.47 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.735 0.414 . . . . 0.0 110.63 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 33.99 55.59 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.803 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -125.83 141.57 51.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.323 0.649 . . . . 0.0 111.029 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.98 154.28 47.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.293 0.568 . . . . 0.0 111.227 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -135.24 132.76 38.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.73 38.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.688 0.28 . . . . 0.0 111.379 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -135.42 129.97 34.1 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.117 0.484 . . . . 0.0 110.885 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.96 148.13 9.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.127 1.371 . . . . 0.0 108.984 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.17 24.26 11.75 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.4 t -148.72 132.16 16.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.848 0.859 . . . . 0.0 108.813 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -78.19 -14.63 59.38 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.137 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.58 -25.45 24.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -87.47 -16.37 34.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -47.84 67.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.11 -14.37 59.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.76 -11.37 48.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.477 0.581 . . . . 0.0 111.09 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.14 -41.5 17.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.08 -21.91 64.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.884 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -77.17 -26.2 52.71 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.707 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -68.56 -42.25 78.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -83.34 10.24 9.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.367 -0.208 . . . . 0.0 111.342 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -116.35 1.27 13.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.262 0.625 . . . . 0.0 109.716 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -135.58 18.57 3.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.875 0.47 . . . . 0.0 111.406 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -134.75 48.04 2.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.178 0.513 . . . . 0.0 110.957 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.88 -13.63 12.91 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.614 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.18 33.84 18.9 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.056 0.928 . . . . 0.0 113.413 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.663 ' H ' ' CD ' ' A' ' 95' ' ' PRO . 80.4 mt -136.21 -28.23 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.663 ' CD ' ' H ' ' A' ' 94' ' ' LEU . 76.9 Cg_exo -55.35 -31.64 78.05 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.075 1.85 . . . . 0.0 113.246 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt -143.2 143.22 31.68 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.422 0.689 . . . . 0.0 109.892 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -94.85 97.07 9.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.0 p -114.41 138.03 51.09 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -173.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -146.05 146.21 30.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.277 1.031 . . . . 0.0 109.127 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -135.08 160.52 38.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 110.917 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 165.7 37.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.13 142.28 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.743 0.817 . . . . 0.0 109.692 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 177.199 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.19 176.92 8.5 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.557 2.838 . . . . 0.0 110.618 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.65 27.63 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.343 0.657 . . . . 0.0 112.483 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -15.43 51.75 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.711 -0.618 . . . . 0.0 111.294 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -85.43 -6.76 59.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.02 -42.8 9.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.53 0.732 . . . . 0.0 109.6 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -76.29 -16.74 59.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.56 -51.2 6.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.737 -0.602 . . . . 0.0 110.398 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.26 -8.68 58.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -112.81 -15.86 12.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.759 0.709 . . . . 0.0 111.487 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HZ1' ' HB2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -72.78 -20.99 61.07 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.142 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.54 -54.28 4.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.509 0.324 . . . . 0.0 110.561 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -82.91 6.14 19.53 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -147.37 0.68 0.7 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.53 15.25 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.269 0.94 . . . . 0.0 111.133 174.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.8 m -135.0 24.74 3.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.991 0.517 . . . . 0.0 109.911 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.5 151.24 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.057 0.943 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.81 20.79 1.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -141.91 24.27 2.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.458 0.703 . . . . 0.0 110.413 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.56 -159.74 35.75 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.479 0.562 . . . . 0.0 112.135 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.68 -154.28 2.37 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.091 0.853 . . . . 0.0 111.747 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.7 m -103.77 70.6 1.02 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 t 60.71 32.03 20.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.707 0.803 . . . . 0.0 111.829 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.27 79.6 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.959 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.7 -44.38 0.5 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 118.361 1.081 . . . . 0.0 113.305 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -90.53 -19.57 1.07 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.544 2.163 . . . . 0.0 113.43 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.65 -7.66 59.15 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -171.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.8 m -74.85 -0.8 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 CA-C-N 117.877 0.308 . . . . 0.0 111.241 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 t -147.67 23.22 1.12 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.367 1.067 . . . . 0.0 108.41 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.5 34.15 0.3 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.605 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.7 mm . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 117.582 0.691 . . . . 0.0 111.956 173.645 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 m . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -101.89 140.5 36.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -130.12 137.75 50.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.34 0.656 . . . . 0.0 110.124 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -120.33 113.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.83 160.7 16.92 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.31 17.98 74.71 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.639 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.44 130.15 34.12 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.388 1.094 . . . . 0.0 110.789 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.52 -0.6 10.54 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.43 2.753 . . . . 0.0 111.425 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.68 152.41 33.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.371 0.605 . . . . 0.0 111.44 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -97.28 55.36 1.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.1 ttt 62.96 70.14 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.564 1.145 . . . . 0.0 112.198 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.35 88.75 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.09 -11.58 20.87 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.613 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -82.91 -12.41 57.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.082 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -93.88 -22.59 18.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 118.938 -1.105 . . . . 0.0 110.55 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.65 -25.51 59.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.11 -18.07 38.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -76.47 -10.39 59.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.057 -0.402 . . . . 0.0 110.595 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.5 -4.69 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.44 17.52 19.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.45 0.7 . . . . 0.0 110.519 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' H ' ' CD ' ' A' ' 55' ' ' PRO . 88.6 tttt -114.13 -35.95 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 60.4 Cg_exo -56.91 -31.73 90.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.402 2.068 . . . . 0.0 113.648 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.18 22.78 2.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.856 0.298 . . . . 0.0 111.642 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.96 176.81 11.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.626 0.37 . . . . 0.0 110.733 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.49 76.05 1.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.003 0.43 . . . . 0.0 110.505 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.03 140.57 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -131.86 7.16 4.37 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -142.8 125.85 16.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.977 0.511 . . . . 0.0 109.729 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.75 127.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 122.965 0.506 . . . . 0.0 109.759 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.14 135.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -128.67 143.29 50.91 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.068 0.547 . . . . 0.0 111.639 -176.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -123.26 104.68 9.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.27 1.028 . . . . 0.0 108.371 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -83.52 24.67 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -120.38 -3.5 9.94 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.232 -0.292 . . . . 0.0 111.725 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtm-85 -144.97 8.54 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.889 0.476 . . . . 0.0 111.304 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 51.76 42.45 29.9 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.23 0.612 . . . . 0.0 111.221 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -111.27 145.61 38.47 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.735 0.814 . . . . 0.0 110.113 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.64 43.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -125.03 127.18 46.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.9 151.1 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.476 0.125 . . . . 0.0 110.692 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.58 136.39 41.04 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.41 155.53 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 124.48 1.112 . . . . 0.0 110.567 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -93.71 10.58 32.33 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.2 t -151.33 134.88 16.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.13 0.572 . . . . 0.0 109.913 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.55 -16.13 58.84 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.45 -25.35 33.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -83.91 -13.74 52.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.77 67.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -71.12 -18.88 62.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.777 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -82.01 -18.9 41.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.46 0.573 . . . . 0.0 111.6 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.47 -44.16 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 118.565 0.621 . . . . 0.0 109.809 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.26 -23.02 64.73 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.42 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -83.16 -10.42 58.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.884 -0.51 . . . . 0.0 110.77 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.0 -27.9 24.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -94.82 4.92 53.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.267 -0.271 . . . . 0.0 111.245 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -134.8 6.03 3.41 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -149.44 15.01 0.88 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -135.37 55.16 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.84 0.745 . . . . 0.0 110.931 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.27 83.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.201 -0.777 . . . . 0.0 113.394 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.1 74.08 0.26 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.995 0.897 . . . . 0.0 111.625 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.96 159.62 13.14 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.068 0.547 . . . . 0.0 111.265 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 -9.4 9.06 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.483 3.455 . . . . 0.0 114.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.95 128.57 36.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.587 0.63 . . . . 0.0 110.552 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -90.59 71.52 6.83 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.56 0.744 . . . . 0.0 109.083 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.6 m -74.89 129.86 38.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.146 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -135.68 149.11 49.17 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.387 1.075 . . . . 0.0 109.022 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -128.34 150.77 49.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.983 0.42 . . . . 0.0 111.575 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.51 -164.35 28.6 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.9 138.2 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.187 0.493 . . . . 0.0 110.394 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 C-N-CA 123.429 0.538 . . . . 0.0 112.539 -179.66 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.05 166.66 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.434 2.756 . . . . 0.0 111.012 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -124.85 25.66 7.31 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.823 0.449 . . . . 0.0 111.48 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -83.59 -9.87 58.63 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.813 -0.554 . . . . 0.0 111.217 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -88.8 3.25 51.74 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.407 0.283 . . . . 0.0 110.589 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.66 -50.4 5.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.741 0.816 . . . . 0.0 108.887 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.6 m -77.65 -19.9 54.66 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.197 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.35 -45.82 12.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.043 -0.411 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.5 -19.12 39.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.273 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.87 -20.8 17.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.693 0.679 . . . . 0.0 110.997 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -67.36 -35.17 78.83 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.667 170.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.6 -77.66 0.1 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.145 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -89.15 18.71 4.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.5 t -138.89 -4.31 1.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.67 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 t -136.44 24.22 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.294 0.952 . . . . 0.0 111.27 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.8 p -73.64 24.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.133 -0.979 . . . . 0.0 112.952 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.06 24.13 3.56 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.958 -0.464 . . . . 0.0 111.087 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -147.0 144.07 28.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.668 0.787 . . . . 0.0 109.355 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -72.79 104.71 4.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.98 -179.8 49.5 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -81.81 -153.98 12.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 67.4 104.56 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.227 1.411 . . . . 0.0 113.371 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m 54.47 30.11 12.33 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.4 -33.27 53.53 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -140.78 167.05 18.85 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 146' ' ' VAL . 50.3 Cg_exo -58.29 5.56 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.462 1 C-N-CA 125.437 4.091 . . . . 0.0 116.332 -175.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.25 22.89 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.56 1.073 . . . . 0.0 111.769 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 144' ' ' PRO . 34.8 m -69.73 1.48 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.785 0.834 . . . . 0.0 111.171 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.6 p -127.68 24.83 6.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.4 -21.85 4.27 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mm . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 117.45 0.625 . . . . 0.0 111.028 174.253 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.82 133.62 47.05 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.59 145.22 46.7 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.307 0.575 . . . . 0.0 111.521 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.91 153.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.007 0.923 . . . . 0.0 109.361 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.29 164.47 30.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.25 19.97 79.29 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.35 -0.694 . . . . 0.0 112.724 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -48.63 129.72 13.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.114 0.957 . . . . 0.0 111.175 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -85.0 5.57 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.309 3.339 . . . . 0.0 111.458 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.98 159.63 24.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 112.291 -170.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.06 63.55 6.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.559 0.744 . . . . 0.0 109.764 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.5 ptm 51.31 104.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.126 2.17 . . . . 0.0 114.475 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HZ1' ' HB2' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -143.75 102.43 3.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.26 -19.33 65.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -85.21 -7.08 59.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.139 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -98.14 -21.57 16.67 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.306 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.09 -28.87 62.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.07 -22.26 45.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.521 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.22 -14.14 60.5 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.181 -0.324 . . . . 0.0 111.202 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.19 -0.67 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.194 -0.316 . . . . 0.0 111.783 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.1 10.89 28.0 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.421 0.688 . . . . 0.0 109.585 170.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 25.3 ttmm -78.77 -33.89 0.93 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.622 171.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.0 Cg_exo -57.7 115.04 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.444 2.096 . . . . 0.0 111.951 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 51.22 24.27 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.703 1.201 . . . . 0.0 113.455 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.8 157.29 41.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.124 0.57 . . . . 0.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -132.46 56.47 1.83 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.123 0.569 . . . . 0.0 110.298 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.42 139.04 15.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -129.3 3.37 5.16 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -135.05 121.25 20.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.051 -0.405 . . . . 0.0 110.288 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.98 129.17 43.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.497 0.719 . . . . 0.0 109.925 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.65 141.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 tt -134.23 121.72 21.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.214 . . . . 0.0 110.476 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -100.87 104.4 15.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.068 0.547 . . . . 0.0 109.976 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -86.94 24.49 1.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.056 0.542 . . . . 0.0 111.812 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -127.37 2.61 6.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.735 0.414 . . . . 0.0 110.649 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -136.12 7.74 3.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.2 32.5 10.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.07 0.948 . . . . 0.0 111.446 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -134.39 152.62 51.91 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.409 0.683 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.76 156.3 49.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.548 0.739 . . . . 0.0 110.235 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.85 134.39 49.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.78 151.45 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -135.1 139.37 44.64 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.453 0.644 . . . . 0.0 112.018 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.71 161.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 125.988 1.715 . . . . 0.0 109.172 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -108.27 22.59 15.72 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -152.59 137.48 17.14 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.201 0.6 . . . . 0.0 109.734 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.97 -9.59 58.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.316 -0.24 . . . . 0.0 111.502 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -86.84 -18.02 31.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -88.12 -22.1 24.29 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.24 43.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.09 -21.86 33.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.35 -0.219 . . . . 0.0 110.657 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.59 -19.47 38.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.014 -0.429 . . . . 0.0 110.871 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.76 -43.16 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.93 -17.0 62.7 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.075 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -74.46 -28.45 61.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.463 0.574 . . . . 0.0 109.532 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -76.1 -28.29 57.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.973 -0.454 . . . . 0.0 109.827 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -93.09 6.94 46.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.409 0.284 . . . . 0.0 111.013 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.02 16.28 3.51 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.381 0.272 . . . . 0.0 111.313 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -135.72 -8.02 2.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 -23.12 15.15 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.04 0.836 . . . . 0.0 110.786 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.21 1.16 0.63 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.832 1.206 . . . . 0.0 115.614 172.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.55 45.1 1.94 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.064 1.432 . . . . 0.0 112.159 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.81 142.69 28.19 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.52 -11.66 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.311 3.341 . . . . 0.0 112.821 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -86.51 146.13 26.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.973 0.351 . . . . 0.0 110.799 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.13 104.59 10.97 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.4 m -103.49 134.7 46.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.313 0.645 . . . . 0.0 111.327 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -136.81 153.45 50.81 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.335 1.054 . . . . 0.0 108.925 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -123.4 144.8 49.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.934 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.22 148.62 17.24 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.88 138.24 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.082 0.553 . . . . 0.0 110.694 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.92 0 C-N-CA 123.62 0.629 . . . . 0.0 112.788 -178.274 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.411 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.3 pt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 92.1 Cg_endo -69.47 -2.4 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.582 2.855 . . . . 0.0 112.626 -174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 mtt -121.87 20.36 10.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.783 0.433 . . . . 0.0 111.004 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -135.01 -8.82 2.33 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -89.71 -4.52 57.68 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.248 0.476 . . . . 0.0 109.938 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -92.5 -45.54 8.08 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.397 1.079 . . . . 0.0 109.303 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -80.83 -23.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.59 -48.57 8.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.018 0.372 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.95 -14.13 56.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.166 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -98.37 -41.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.612 0.642 . . . . 0.0 110.891 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -76.34 -16.16 59.81 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -93.71 -52.42 4.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.982 -0.449 . . . . 0.0 110.523 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -83.49 3.8 30.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.16 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -135.85 -4.24 2.24 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 25.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.734 1.152 . . . . 0.0 112.263 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.4 p -72.46 55.71 0.35 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.937 -0.477 . . . . 0.0 111.638 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 53.89 46.41 25.72 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 111.161 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -82.0 49.76 1.44 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.588 0.755 . . . . 0.0 111.062 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 75.3 m95 54.5 35.2 22.79 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -173.47 45.31 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.57 -170.64 50.54 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 t -132.71 45.28 2.77 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.0 m 53.21 34.21 17.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.383 -172.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.96 -49.61 0.08 OUTLIER Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.01 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 62.06 170.53 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 119.166 1.483 . . . . 0.0 112.414 -175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.32 -9.9 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.744 3.629 . . . . 0.0 115.702 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -64.03 -61.39 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.91 0.777 . . . . 0.0 109.477 174.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.3 20.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.596 . . . . 0.0 111.445 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 145' ' ' LEU . 17.3 m -101.47 30.84 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 -25.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 146' ' ' VAL . 5.1 pt . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 123.645 0.778 . . . . 0.0 111.213 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.61 130.58 55.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.673 1.189 . . . . 0.0 108.521 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -107.28 143.27 35.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.21 0.604 . . . . 0.0 110.602 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.0 mm -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.91 0.884 . . . . 0.0 108.876 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.56 31.45 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.32 23.25 74.94 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.1 m -53.04 123.8 34.9 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 117.527 0.663 . . . . 0.0 112.013 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.26 -4.26 13.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.734 2.956 . . . . 0.0 111.07 171.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' MET . 2.7 mm? -70.85 162.7 28.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.145 0.578 . . . . 0.0 110.5 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.22 32.79 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.537 0.735 . . . . 0.0 111.347 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' LEU . 63.7 mtm 57.41 47.98 15.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.154 0.981 . . . . 0.0 112.251 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -128.55 133.71 48.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.811 0.844 . . . . 0.0 109.134 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.02 -6.77 47.69 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -85.11 -15.77 42.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.029 -0.419 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -89.53 -26.19 21.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.96 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.01 -29.9 65.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.1 -17.66 58.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.796 -0.565 . . . . 0.0 110.422 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.21 -4.44 58.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.19 -4.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.14 0.26 5.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 39.6 ttpt -88.04 -38.78 0.47 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.28 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.7 Cg_exo -59.33 135.46 65.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.481 2.121 . . . . 0.0 111.997 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 51.48 28.23 4.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.168 0.987 . . . . 0.0 113.078 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.87 167.95 21.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.152 0.581 . . . . 0.0 110.683 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.08 40.91 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.662 0.385 . . . . 0.0 111.251 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.84 136.93 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -129.85 -3.43 4.64 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -137.1 136.45 38.33 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.074 -0.391 . . . . 0.0 111.047 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.46 115.03 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.91 104.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.22 110.57 23.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -76.52 104.3 6.96 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -82.46 24.17 0.71 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.861 0.864 . . . . 0.0 111.134 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -135.14 5.47 3.28 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.233 0.613 . . . . 0.0 110.319 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -140.38 -0.67 1.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.239 0.615 . . . . 0.0 110.859 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 51.46 34.9 12.98 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.897 0.879 . . . . 0.0 111.774 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -135.4 151.86 50.86 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 123.599 0.76 . . . . 0.0 109.46 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.25 154.0 51.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -117.26 125.18 50.7 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.009 1.324 . . . . 0.0 107.711 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.03 148.58 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 120.486 0.184 . . . . 0.0 110.56 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -130.2 135.76 48.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.927 0.394 . . . . 0.0 111.942 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.92 148.55 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.275 1.43 . . . . 0.0 109.32 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -82.54 -3.18 55.53 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.2 m -143.3 132.91 23.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -72.58 -18.02 61.65 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.385 . . . . 0.0 110.808 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -74.81 -14.28 60.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.99 -0.444 . . . . 0.0 109.983 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -93.1 -8.6 42.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.04 -43.31 44.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 -17.93 60.64 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.489 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.72 -16.2 54.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.196 0.453 . . . . 0.0 110.388 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -85.47 -23.74 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 O-C-N 121.938 -0.476 . . . . 0.0 110.526 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.74 -23.93 53.02 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.014 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.69 -15.51 57.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.42 -45.42 31.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -76.84 -0.27 23.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.337 -0.227 . . . . 0.0 111.387 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -112.35 -4.76 14.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.984 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.44 22.51 3.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.701 0.682 . . . . 0.0 112.574 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -135.23 55.18 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.285 0.493 . . . . 0.0 111.278 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.83 82.83 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.473 -0.626 . . . . 0.0 113.254 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.63 60.51 3.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.836 0.818 . . . . 0.0 111.72 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.79 151.43 15.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.089 0.556 . . . . 0.0 110.857 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.47 -0.93 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.102 3.201 . . . . 0.0 113.113 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.5 mt -63.63 138.11 58.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.494 0.588 . . . . 0.0 110.318 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -105.51 121.4 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.7 p -135.34 145.05 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 111.997 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -143.23 148.41 36.39 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 109.405 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 -128.41 158.75 37.44 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.863 0.363 . . . . 0.0 111.888 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.4 168.94 25.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 p -133.69 144.5 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.059 0.544 . . . . 0.0 110.541 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.163 -177.795 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.29 -14.2 34.17 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 111.783 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -81.19 15.89 1.76 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.925 0.329 . . . . 0.0 111.763 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -135.33 1.73 2.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.545 0.738 . . . . 0.0 109.957 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -86.02 -13.42 47.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.118 -0.364 . . . . 0.0 110.581 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.402 ' C ' HD11 ' A' ' 124' ' ' LEU . 3.9 pp -101.0 -12.89 18.52 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.606 0.185 . . . . 0.0 110.722 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 50.4 p -88.98 -22.07 23.2 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.87 -41.12 12.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -16.27 50.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -113.33 -15.63 12.64 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.013 0.824 . . . . 0.0 112.019 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.98 -20.66 48.58 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.649 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.56 -63.23 1.34 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -79.81 -1.14 37.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.4 m -139.91 6.3 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.1 t -137.77 20.51 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.19 1.359 . . . . 0.0 110.384 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.4 t -106.12 52.69 0.72 Allowed 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.49 172.03 13.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.04 0.936 . . . . 0.0 110.679 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -58.63 151.63 20.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.243 0.617 . . . . 0.0 110.791 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -64.1 147.96 50.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.22 0.608 . . . . 0.0 111.646 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.06 -15.29 0.59 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.376 -0.689 . . . . 0.0 111.376 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.62 161.87 10.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.725 0.679 . . . . 0.0 112.365 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.677 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 90.2 m 68.45 102.38 0.05 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m 54.6 43.45 30.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.39 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.534 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.442 ' H ' ' HD2' ' A' ' 144' ' ' PRO . 64.5 tt0 -164.81 -51.86 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 120.234 2.017 . . . . 0.0 115.884 175.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.677 ' CD ' ' H ' ' A' ' 140' ' ' THR . 22.9 Cg_endo -85.93 -5.79 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.696 2.931 . . . . 0.0 115.753 -166.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.71 -2.62 15.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.098 1.317 . . . . 0.0 111.959 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.84 0.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 123.186 0.594 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -142.14 24.68 1.96 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.511 1.124 . . . . 0.0 108.487 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.55 43.57 0.12 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.561 1.145 . . . . 0.0 112.278 174.522 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -85.52 104.57 15.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -82.34 140.32 33.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.348 0.659 . . . . 0.0 110.313 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.1 129.8 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.01 166.53 26.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.081 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.74 75.59 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.415 -0.658 . . . . 0.0 112.195 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -53.57 125.34 44.77 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 117.996 0.898 . . . . 0.0 111.186 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.31 -2.68 12.15 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.444 2.763 . . . . 0.0 111.364 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.32 154.53 27.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.923 0.489 . . . . 0.0 111.017 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -84.43 53.66 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.28 0.632 . . . . 0.0 110.38 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.2 ttt 56.48 64.74 1.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.387 1.075 . . . . 0.0 112.708 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -131.13 107.94 9.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.84 -13.08 58.89 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 112.011 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -81.84 -12.23 58.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 122.244 -0.285 . . . . 0.0 111.077 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -93.32 -22.73 18.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.518 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 -27.88 60.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.57 -23.74 42.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.911 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.64 -6.93 58.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.007 0.367 . . . . 0.0 111.638 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.58 -4.62 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 118.153 0.433 . . . . 0.0 111.243 171.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -109.52 15.36 23.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.08 0.952 . . . . 0.0 109.247 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.7 ttmt -75.53 -34.77 1.64 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 82.4 Cg_endo -73.55 124.27 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 CA-C-N 121.356 1.52 . . . . 0.0 111.068 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 51.53 23.06 1.71 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.98 1.312 . . . . 0.0 113.062 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.83 154.58 35.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.964 0.506 . . . . 0.0 110.546 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.51 64.68 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.91 128.61 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -103.71 -3.76 24.62 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -168.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -142.24 131.15 22.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.053 0.388 . . . . 0.0 110.904 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.15 129.86 38.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.26 139.54 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 110.7 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -122.73 120.31 33.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.133 1.373 . . . . 0.0 108.387 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -138.74 157.17 46.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.837 0.455 . . . . 0.0 111.337 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 65.5 151.49 0.05 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.857 1.263 . . . . 0.0 113.13 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -82.79 25.08 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.267 0.627 . . . . 0.0 111.216 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.72 24.4 7.75 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.813 0.845 . . . . 0.0 110.702 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 53.48 49.49 19.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.146 0.978 . . . . 0.0 112.599 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -96.57 104.75 16.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.93 148.33 44.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.114 0.483 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -135.52 145.11 46.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.397 0.679 . . . . 0.0 109.375 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.92 155.5 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.21 135.68 41.17 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.969 0.414 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.15 148.66 15.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 124.519 1.128 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.46 19.18 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.8 t -151.25 141.25 22.07 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.795 0.438 . . . . 0.0 110.198 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -74.46 -22.7 58.97 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -82.35 -14.74 54.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.62 -20.67 23.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.66 53.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.19 -15.8 35.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.262 -0.274 . . . . 0.0 110.732 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.38 -22.87 38.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.272 0.487 . . . . 0.0 110.607 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.53 -46.19 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.42 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.55 -19.77 65.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.614 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -75.89 -40.77 53.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.382 0.992 . . . . 0.0 109.659 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -76.33 -13.44 60.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -117.28 15.1 14.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -128.2 3.89 5.79 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -142.36 -8.19 0.88 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -153.0 24.75 0.56 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.241 0.928 . . . . 0.0 112.035 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 15.69 0.04 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.964 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.98 3.8 16.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.648 1.224 . . . . 0.0 111.791 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.7 -54.78 0.19 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.715 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.5 -23.52 14.87 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.355 2.036 . . . . 0.0 112.867 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -137.84 149.12 46.05 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.13 0.423 . . . . 0.0 111.219 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -106.09 102.7 12.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.3 p -98.15 130.79 44.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.246 0.618 . . . . 0.0 111.276 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -143.94 136.86 27.34 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.973 0.909 . . . . 0.0 109.028 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -118.58 126.91 52.99 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.096 0.407 . . . . 0.0 111.175 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.64 145.48 18.36 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.42 148.37 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.933 0.893 . . . . 0.0 109.529 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 176.013 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.2 -13.49 38.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.418 2.745 . . . . 0.0 113.746 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.5 ptm -83.97 8.26 15.76 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -95.06 -17.37 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.185 -0.322 . . . . 0.0 111.149 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.13 -4.13 58.79 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.96 -32.49 13.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.108 0.563 . . . . 0.0 109.582 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.5 t -82.59 -19.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.049 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.94 -47.06 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.911 -0.493 . . . . 0.0 110.968 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -76.48 -13.79 60.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.49 -9.6 11.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.818 0.736 . . . . 0.0 112.264 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -73.33 -18.25 61.21 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 166.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -87.51 -60.13 2.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.318 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -80.4 9.96 5.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -147.16 -6.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.65 17.17 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 119.619 1.099 . . . . 0.0 112.036 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 m -81.01 35.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.403 -0.811 . . . . 0.0 111.247 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 24.47 3.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.45 0.7 . . . . 0.0 110.223 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -138.55 147.33 42.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.777 0.831 . . . . 0.0 109.653 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -81.72 42.79 0.72 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.307 0.643 . . . . 0.0 111.05 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.99 -169.9 36.72 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.69 157.68 27.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.1 p 48.74 24.55 0.83 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.008 1.323 . . . . 0.0 112.913 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -154.92 24.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.34 0.656 . . . . 0.0 111.024 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.34 -12.11 16.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.507 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -146.37 164.98 21.65 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 118.622 1.211 . . . . 0.0 110.053 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.49 -12.18 16.33 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.363 2.708 . . . . 0.0 113.311 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.48 -6.43 46.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.12 0.418 . . . . 0.0 112.123 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -77.55 25.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -135.41 -15.43 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.208 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.43 -11.34 17.84 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 118.797 -1.002 . . . . 0.0 113.221 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--N 1.34 0.183 0 CA-C-O 122.312 1.053 . . . . 0.0 109.067 167.409 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.412 0.149 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.2 tp -117.97 126.0 51.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.995 0.518 . . . . 0.0 109.668 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.53 146.21 32.14 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.398 0.679 . . . . 0.0 110.444 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mm -128.02 135.01 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.22 165.87 13.66 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.77 15.43 80.75 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.289 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' N ' ' CD ' ' A' ' 41' ' ' PRO . 34.0 m -70.19 -14.22 0.25 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -176.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 40' ' ' VAL . 70.2 Cg_exo -56.99 -2.81 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.259 1.973 . . . . 0.0 114.612 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.89 -14.91 60.71 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.337 0.971 . . . . 0.0 112.68 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -148.59 -12.54 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.2 mtt 51.6 28.85 4.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -135.81 142.77 44.9 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.193 0.451 . . . . 0.0 110.79 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.66 -6.63 42.43 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -86.74 -10.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.296 -0.252 . . . . 0.0 111.067 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.69 -27.09 18.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.86 -30.09 65.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.02 -19.38 44.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.458 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -76.54 -15.51 59.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.058 -0.401 . . . . 0.0 111.155 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.75 -3.34 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.61 10.65 22.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.384 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.8 pttt -88.61 -28.04 0.35 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.582 170.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 27.2 Cg_exo -65.14 117.88 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.782 1.655 . . . . 0.0 110.945 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 50.27 24.37 1.47 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.405 1.082 . . . . 0.0 113.191 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.5 155.38 43.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.956 0.502 . . . . 0.0 110.497 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -133.73 60.63 1.7 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.976 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -70.12 141.53 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -129.75 5.82 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -135.8 119.36 17.02 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 118.064 0.393 . . . . 0.0 110.457 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.89 127.66 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.531 0.732 . . . . 0.0 109.526 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.55 139.62 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 122.847 0.459 . . . . 0.0 110.048 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.5 mt -114.94 122.66 46.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.541 0.737 . . . . 0.0 109.036 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -123.02 173.02 8.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.087 0.955 . . . . 0.0 111.064 -171.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 55.59 55.6 7.07 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.799 0.84 . . . . 0.0 111.258 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t 55.68 43.16 28.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.078 0.551 . . . . 0.0 110.924 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? 55.48 44.16 27.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.195 0.998 . . . . 0.0 111.248 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -124.3 0.97 8.41 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 111.052 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -146.48 142.89 28.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 149.13 48.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.14 134.43 45.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.298 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.34 149.78 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -135.14 135.63 41.27 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.013 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.16 157.35 14.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 124.782 1.233 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -102.85 9.06 39.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -146.41 138.51 24.96 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.057 0.543 . . . . 0.0 109.973 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.62 -13.62 60.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -85.27 -23.0 28.37 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.2 -18.08 37.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.29 -45.49 59.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.85 -20.51 62.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.005 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -82.01 -16.79 49.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.408 0.549 . . . . 0.0 111.338 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.6 -25.5 8.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-N 118.566 0.621 . . . . 0.0 110.25 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.21 -22.18 55.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.913 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -76.08 -22.26 55.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -79.88 -23.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -83.53 -4.0 58.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.7 3.76 11.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.7 0.4 . . . . 0.0 111.049 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -135.77 17.9 3.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -86.36 -1.31 57.42 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.481 -0.762 . . . . 0.0 111.573 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.49 -15.0 0.45 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.798 1.19 . . . . 0.0 115.548 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.42 12.39 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.486 1.643 . . . . 0.0 113.483 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 35.09 53.05 1.59 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.694 1.198 . . . . 0.0 113.751 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.9 -11.93 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.425 2.75 . . . . 0.0 111.275 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -133.82 133.93 42.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.411 1.084 . . . . 0.0 108.312 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -100.01 98.47 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.3 m -93.49 129.36 39.72 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.96 0.504 . . . . 0.0 111.198 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -145.69 142.13 28.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.31 0.644 . . . . 0.0 109.91 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -97.04 150.21 21.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.941 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.83 160.46 14.04 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.07 139.69 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 124.014 0.926 . . . . 0.0 110.097 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 176.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.47 170.11 21.0 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.708 2.939 . . . . 0.0 111.283 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.55 13.27 0.49 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -87.27 -8.8 56.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.959 -0.463 . . . . 0.0 110.448 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -81.9 -9.13 59.68 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -88.18 -40.31 13.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.2 p -75.21 -17.76 60.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.995 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.69 -19.34 14.36 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.593 0.633 . . . . 0.0 112.141 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.87 -12.07 45.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.89 0.768 . . . . 0.0 110.814 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.74 -21.72 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.78 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -74.33 -21.36 59.73 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.794 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.452 ' HE3' ' CE2' ' A' ' 131' ' ' TRP . 38.8 ttpt -91.2 -60.04 2.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.415 -0.178 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.452 ' CE2' ' HE3' ' A' ' 130' ' ' LYS . 8.6 m95 -77.26 0.89 20.32 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 m -142.12 -5.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 135' ' ' ALA . 2.4 t -137.86 23.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.949 1.25 . . . . 0.0 112.083 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -75.11 38.02 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.407 -0.808 . . . . 0.0 111.523 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.48 24.22 3.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.597 0.759 . . . . 0.0 110.07 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -141.77 140.22 33.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.748 0.819 . . . . 0.0 109.438 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -84.83 52.63 2.47 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.842 0.457 . . . . 0.0 111.824 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.95 -7.37 0.39 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.292 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 68.51 -166.39 45.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.12 0.96 . . . . 0.0 111.212 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.0 p 67.33 116.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.848 1.659 . . . . 0.0 112.51 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.1 m 61.4 27.61 17.18 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.6 1.16 . . . . 0.0 112.893 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.56 -16.48 68.41 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 145' ' ' LEU . 61.2 tt0 -155.56 151.71 22.86 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.05 10.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.992 3.128 . . . . 0.0 115.236 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 143' ' ' GLN . 4.5 pp -73.99 -0.1 15.23 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.277 0.944 . . . . 0.0 110.966 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.45 22.34 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.109 0.564 . . . . 0.0 112.071 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 10.2 5.12 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.301 0.24 . . . . 0.0 111.57 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.04 -19.46 0.32 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.3 mm . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 121.753 0.787 . . . . 0.0 109.322 177.005 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.5 tp -102.85 122.08 43.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -114.21 131.09 56.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.352 0.261 . . . . 0.0 110.748 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -104.3 143.42 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.9 163.56 27.99 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.72 18.28 70.07 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -54.21 138.38 57.35 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.78 0.79 . . . . 0.0 110.982 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.11 -15.39 20.53 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.166 2.577 . . . . 0.0 110.969 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.16 123.46 14.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -106.98 24.6 12.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.506 0.322 . . . . 0.0 110.463 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.3 ttp -139.31 24.21 2.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -147.08 85.84 1.62 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.7 -14.51 52.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 110.717 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -83.11 -8.21 59.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.883 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -94.99 -21.16 18.79 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.411 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.76 -26.79 60.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.32 -21.4 39.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.45 -13.16 60.37 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.088 -0.383 . . . . 0.0 110.739 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.52 -3.05 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.9 12.01 25.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.478 0.711 . . . . 0.0 110.371 170.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttp -95.22 -31.77 0.27 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 71.9 Cg_exo -54.63 -33.96 81.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.629 2.219 . . . . 0.0 114.728 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -139.38 17.06 2.57 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.463 0.574 . . . . 0.0 112.444 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.31 172.82 17.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.703 0.401 . . . . 0.0 110.088 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.76 55.61 1.89 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.016 0.526 . . . . 0.0 110.071 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.23 140.77 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.558 0.743 . . . . 0.0 110.215 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -120.26 3.52 10.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.7 m -139.16 126.86 21.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.341 0.518 . . . . 0.0 110.866 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.13 128.16 21.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 123.435 0.694 . . . . 0.0 109.348 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.63 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 109.732 173.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.42 147.37 46.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.292 1.037 . . . . 0.0 110.383 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -134.47 135.37 42.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.128 0.571 . . . . 0.0 109.906 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -80.87 41.3 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.682 0.793 . . . . 0.0 111.27 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -128.89 105.12 8.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 55.36 26.87 9.2 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.659 0.784 . . . . 0.0 111.448 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 49.46 54.65 10.63 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.348 1.059 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -88.53 141.31 28.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.527 0.331 . . . . 0.0 110.766 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.45 148.6 49.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.717 0.407 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -135.17 131.35 36.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.42 151.27 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.811 0.444 . . . . 0.0 110.028 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -137.33 136.82 38.3 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.42 164.64 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.664 1.585 . . . . 0.0 109.677 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.2 16.88 25.0 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.613 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -151.94 137.12 17.44 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.674 0.79 . . . . 0.0 109.018 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -12.68 61.33 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -87.13 -15.53 38.15 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -83.71 -21.03 32.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.56 54.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.0 -21.19 63.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.214 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -89.45 -9.61 49.51 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.953 -0.467 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 t -87.41 -25.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.794 -0.566 . . . . 0.0 109.919 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.82 -27.88 60.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -81.44 -14.78 56.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.698 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.19 -43.92 66.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -85.02 -1.44 56.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.465 -0.147 . . . . 0.0 111.346 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.35 -0.61 26.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.424 0.29 . . . . 0.0 110.811 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.492 ' HZ1' ' HB3' ' A' ' 90' ' ' LYS . 9.0 mtpm? -131.89 11.9 4.75 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 176.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.6 -5.37 59.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.423 0.556 . . . . 0.0 110.736 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.91 -3.1 10.43 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.684 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.63 4.54 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.238 1.519 . . . . 0.0 113.542 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.3 mp 38.45 55.56 4.79 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 112.057 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.68 -15.83 26.97 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.221 2.614 . . . . 0.0 112.175 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.4 mt -136.86 146.06 45.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.532 0.733 . . . . 0.0 110.752 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -107.03 130.8 54.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -135.04 140.55 45.68 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.847 0.459 . . . . 0.0 111.338 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -138.84 147.47 42.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.147 0.979 . . . . 0.0 109.232 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -121.66 157.5 30.71 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.774 0.321 . . . . 0.0 111.227 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.51 -178.85 31.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.86 137.59 48.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.115 0.566 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.153 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.429 ' N ' ' HD3' ' A' ' 120' ' ' PRO . 24.8 pt . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 119.584 -0.246 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 119' ' ' ILE . 51.5 Cg_exo -58.76 -21.52 56.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.366 2.044 . . . . 0.0 112.442 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 46.3 ttp -85.27 49.48 1.76 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.629 0.771 . . . . 0.0 110.216 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -135.43 -41.5 0.71 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.524 0.33 . . . . 0.0 111.039 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -79.78 -14.44 58.71 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.774 0.261 . . . . 0.0 110.337 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 tp -88.78 -26.94 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -78.39 -20.76 50.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.28 -47.6 7.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.173 -0.33 . . . . 0.0 110.932 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.93 -14.56 58.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.56 -22.32 13.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.415 0.552 . . . . 0.0 111.321 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.98 -28.71 63.6 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.36 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.508 ' HZ1' ' HB3' ' A' ' 130' ' ' LYS . 4.2 mmmp? -84.04 -57.38 3.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.703 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.2 7.14 26.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -171.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.3 m -143.14 -0.53 1.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.0 t -135.28 14.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.563 1.074 . . . . 0.0 112.12 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.9 m -90.35 24.13 2.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.817 -0.552 . . . . 0.0 109.773 169.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.75 43.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.569 1.148 . . . . 0.0 109.347 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -86.3 33.35 0.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -135.79 26.35 3.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.58 165.9 33.13 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.877 -0.514 . . . . 0.0 112.659 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.18 163.45 15.11 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.107 0.86 . . . . 0.0 112.686 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.6 t -98.29 -30.08 12.8 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.725 -0.28 . . . . 0.0 111.464 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -151.79 22.69 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.703 0.401 . . . . 0.0 111.334 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.61 -9.41 68.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.352 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 59.9 tt0 -163.78 -39.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 118.45 1.125 . . . . 0.0 113.335 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 46.0 Cg_exo -61.65 11.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.98 3.12 . . . . 0.0 115.878 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.2 14.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.112 0.869 . . . . 0.0 112.019 177.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 144' ' ' PRO . 33.2 m -78.22 6.84 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.684 0.794 . . . . 0.0 111.59 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -136.03 30.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.627 1.171 . . . . 0.0 108.213 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.91 29.04 0.07 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 149' ' ' ILE . 16.5 mm . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 118.13 0.965 . . . . 0.0 111.632 175.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 N--CA 1.471 0.164 0 N-CA-C 112.477 0.145 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -135.51 143.8 45.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.164 0.586 . . . . 0.0 110.419 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -93.42 55.07 2.18 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.105 0.562 . . . . 0.0 110.023 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.3 145.89 54.67 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.708 0.403 . . . . 0.0 111.604 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -83.41 136.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.848 0.459 . . . . 0.0 110.101 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.51 24.38 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.268 0.627 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -81.57 151.74 27.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.976 0.51 . . . . 0.0 110.648 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -135.31 126.89 28.85 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.912 0.485 . . . . 0.0 109.785 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -147.94 119.07 4.43 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.12 165.6 32.14 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.398 2.732 . . . . 0.0 111.602 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -68.51 151.61 46.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.024 0.53 . . . . 0.0 110.813 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -69.97 139.66 52.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.529 0.204 . . . . 0.0 110.46 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -139.37 163.66 44.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.0 109.923 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.77 159.69 4.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.964 3.109 . . . . 0.0 112.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -118.9 159.32 45.07 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.683 0.793 . . . . 0.0 110.346 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.79 172.71 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.586 2.857 . . . . 0.0 110.728 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 t -78.49 57.09 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 121.342 0.591 . . . . 0.0 110.799 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -164.06 24.94 0.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.231 0.612 . . . . 0.0 111.24 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -129.82 86.44 2.41 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.767 -0.583 . . . . 0.0 110.955 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.67 33.29 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.437 1.495 . . . . 0.0 112.652 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -135.87 24.42 3.35 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.732 -0.605 . . . . 0.0 111.953 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -138.34 24.25 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.82 134.86 71.54 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 122.441 0.296 . . . . 0.0 111.141 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.18 162.5 34.01 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.289 3.326 . . . . 0.0 110.53 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.9 -2.48 12.6 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.944 3.096 . . . . 0.0 112.198 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.44 154.02 51.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.181 0.592 . . . . 0.0 111.399 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 53.78 46.73 25.21 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.819 0.848 . . . . 0.0 112.002 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.8 tp -135.32 141.77 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.455 0.702 . . . . 0.0 110.113 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -142.92 26.81 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.5 t -85.14 125.94 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 O-C-N 121.698 -0.627 . . . . 0.0 109.572 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 54.5 27.1 7.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.369 1.067 . . . . 0.0 113.003 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.0 m -137.74 112.04 8.6 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -80.05 -15.64 56.76 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.4 p 53.42 -174.5 0.03 OUTLIER 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.428 1.491 . . . . 0.0 112.654 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.5 tp -85.49 105.92 16.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.42 141.71 35.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.636 0.774 . . . . 0.0 110.448 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mm -127.74 109.44 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.26 161.55 12.92 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 122.18 -0.325 . . . . 0.0 112.483 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.88 73.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.303 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -54.09 120.78 26.57 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.185 0.993 . . . . 0.0 111.062 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -67.03 -12.84 37.67 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.595 2.863 . . . . 0.0 112.539 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -84.67 157.96 20.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.325 0.65 . . . . 0.0 110.988 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -79.71 53.99 1.72 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.9 mtm 53.47 55.74 8.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.448 1.099 . . . . 0.0 112.551 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.19 104.27 13.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.69 -17.0 63.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -82.7 -11.88 58.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.053 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.25 -16.59 22.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.642 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.09 -25.98 47.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.49 -21.3 38.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 171.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.217 -0.302 . . . . 0.0 111.233 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.28 -6.39 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.967 0.348 . . . . 0.0 111.657 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.93 17.01 21.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.65 0.78 . . . . 0.0 110.003 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -76.14 -45.33 3.71 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.107 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.37 136.49 11.25 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.198 1.932 . . . . 0.0 111.672 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 50.1 24.24 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.027 1.331 . . . . 0.0 113.783 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.14 33.62 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.719 0.407 . . . . 0.0 110.816 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -133.53 59.72 1.73 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.325 0.65 . . . . 0.0 110.331 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.31 138.48 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -133.31 4.61 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 t -151.06 137.84 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.113 0.415 . . . . 0.0 110.484 173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.3 t -136.81 133.2 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.578 0.751 . . . . 0.0 109.468 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.03 138.87 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.484 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -126.47 117.78 23.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.108 1.363 . . . . 0.0 108.545 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -135.78 162.71 32.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.217 0.607 . . . . 0.0 111.425 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.1 t30 65.58 149.93 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.812 1.245 . . . . 0.0 112.81 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -81.74 25.01 0.57 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.169 0.588 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -127.9 24.63 6.04 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.532 0.733 . . . . 0.0 111.147 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 54.64 55.17 8.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.055 0.942 . . . . 0.0 112.002 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -104.79 120.31 41.07 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.89 153.12 51.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 112.073 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.24 147.89 49.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.45 150.63 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.21 130.35 56.89 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.738 0.415 . . . . 0.0 110.182 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.09 149.16 18.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 C-N-CA 124.056 0.942 . . . . 0.0 109.823 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -97.12 14.92 24.12 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -154.99 139.96 17.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.158 0.583 . . . . 0.0 109.848 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -84.9 -6.55 59.34 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.735 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -90.46 -28.76 18.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.34 -17.87 40.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -46.05 73.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -74.94 -11.82 60.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.352 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.66 -22.26 40.65 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.683 0.674 . . . . 0.0 110.685 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -77.76 -45.28 28.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.04 -17.72 64.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.557 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -69.66 -53.87 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.639 -0.663 . . . . 0.0 109.37 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -80.04 -45.03 19.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.738 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -89.6 9.37 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -139.46 6.88 2.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.6 0.636 . . . . 0.0 112.512 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -143.63 14.99 1.78 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.15 7.82 40.77 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.414 1.006 . . . . 0.0 112.052 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.2 4.26 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.519 0.581 . . . . 0.0 113.983 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.61 55.27 1.88 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.959 0.879 . . . . 0.0 109.318 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.84 115.73 17.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.075 0.95 . . . . 0.0 110.728 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.08 -17.26 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.234 2.623 . . . . 0.0 110.802 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.7 mt -135.77 146.11 47.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.276 1.03 . . . . 0.0 109.916 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.59 88.04 6.16 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.7 p -93.87 125.75 38.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.844 0.458 . . . . 0.0 111.664 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -140.54 145.21 36.51 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 124.243 1.017 . . . . 0.0 108.743 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -135.68 157.97 45.56 Favored 'General case' 0 C--O 1.229 0.019 0 CA-C-N 118.337 0.517 . . . . 0.0 112.195 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 157.33 29.41 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.11 140.06 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 123.506 0.723 . . . . 0.0 110.551 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.1 144.21 16.76 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -92.11 19.79 6.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.154 0.582 . . . . 0.0 111.645 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 63.47 74.54 0.43 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -54.53 150.05 36.49 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.077 3.185 . . . . 0.0 113.077 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -135.57 150.12 49.61 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.029 0.932 . . . . 0.0 109.719 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 46.32 40.43 7.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.173 0.989 . . . . 0.0 112.257 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 27.0 p -79.18 39.67 0.39 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.864 0.866 . . . . 0.0 111.542 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 74.5 m -80.62 55.63 2.4 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.941 0.896 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -132.36 157.41 44.56 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.799 0.84 . . . . 0.0 110.147 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -69.17 -5.91 25.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -80.93 1.32 31.52 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -135.14 23.09 3.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.632 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.59 -15.1 1.63 Allowed Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.721 -0.488 . . . . 0.0 112.084 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -129.55 24.67 5.43 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.656 0.728 . . . . 0.0 110.498 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.9 m -135.48 132.55 37.49 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.355 0.662 . . . . 0.0 109.857 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.43 149.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.629 0.372 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 121' ' ' MET . 16.9 tt -146.94 138.15 13.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.45 -16.77 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.314 2.676 . . . . 0.0 113.51 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.426 ' H ' HG12 ' A' ' 119' ' ' ILE . 1.7 mpt? -79.82 21.02 0.56 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.009 0.524 . . . . 0.0 112.079 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -130.01 -15.55 3.78 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.651 0.38 . . . . 0.0 110.465 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.58 -11.32 59.67 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.37 -25.7 51.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.1 m -79.18 -49.47 12.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.516 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.46 -17.37 34.42 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.658 -0.817 . . . . 0.0 113.12 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.4 -21.65 17.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.17 0.896 . . . . 0.0 112.365 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 -26.02 15.91 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.417 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -84.65 -23.94 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.857 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -81.54 -49.78 10.16 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.689 0.677 . . . . 0.0 110.627 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -94.9 4.87 53.31 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.1 m -135.86 -4.92 2.2 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.54 0.609 . . . . 0.0 112.418 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 14.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.142 0.883 . . . . 0.0 111.595 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 t -147.52 55.62 1.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.609 -0.682 . . . . 0.0 111.23 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.29 -42.15 0.97 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.437 0.295 . . . . 0.0 110.731 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -139.36 16.87 2.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.136 0.574 . . . . 0.0 110.434 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -146.42 156.86 43.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.707 0.803 . . . . 0.0 110.086 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.91 149.08 39.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.07 156.61 53.57 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 66.46 116.69 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.828 1.251 . . . . 0.0 112.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m 64.98 30.8 11.68 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.611 1.164 . . . . 0.0 112.791 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.15 -13.33 52.85 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -146.38 160.67 41.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.108 0.963 . . . . 0.0 109.354 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.94 0.64 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.449 3.433 . . . . 0.0 114.644 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.44 6.58 6.7 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.726 0.693 . . . . 0.0 112.419 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.5 m -85.36 19.91 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.394 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.7 m -128.6 27.66 5.5 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.34 -48.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.563 HG21 ' H ' ' A' ' 151' ' ' PHE . 1.6 mp -58.08 -40.94 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.101 0.951 . . . . 0.0 111.516 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.8 m 43.83 20.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.183 1.793 . . . . 0.0 115.151 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.563 ' H ' HG21 ' A' ' 149' ' ' ILE . 29.1 m-85 -117.27 131.41 56.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.798 0.839 . . . . 0.0 109.594 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.66 55.39 1.87 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.09 0.472 . . . . 0.0 110.232 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.73 151.45 45.66 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.29 0.69 8.73 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.167 3.245 . . . . 0.0 112.232 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.28 138.1 43.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.976 0.353 . . . . 0.0 111.188 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.17 164.93 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.789 0.836 . . . . 0.0 109.359 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.63 104.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 110.761 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.7 t -142.09 135.64 28.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 124.13 0.972 . . . . 0.0 109.432 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 172.29 169.31 34.84 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.34 149.95 49.85 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.956 0.902 . . . . 0.0 109.554 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -70.07 146.73 43.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.82 139.45 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.447 0.699 . . . . 0.0 109.686 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -135.67 139.21 43.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.008 0.523 . . . . 0.0 110.289 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.7 m -135.16 26.66 3.53 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.348 0.659 . . . . 0.0 110.596 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.17 141.66 47.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.917 0.487 . . . . 0.0 110.636 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.56 129.23 32.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 109.988 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.62 156.58 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 34.7 t -135.35 137.68 42.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.078 0.551 . . . . 0.0 109.95 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -85.4 143.29 28.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.74 0.416 . . . . 0.0 110.671 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -135.47 155.61 50.25 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.474 0.71 . . . . 0.0 110.61 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 61.5 ttp -141.55 142.91 27.69 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.926 0.49 . . . . 0.0 109.741 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.11 163.7 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.585 2.857 . . . . 0.0 112.776 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t -108.39 154.72 21.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.351 0.661 . . . . 0.0 110.334 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -135.17 128.52 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.949 0.5 . . . . 0.0 110.355 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 82.6 p -138.25 155.42 48.64 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.464 0.706 . . . . 0.0 110.708 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -133.78 163.12 24.49 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -135.36 111.2 9.38 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 123.087 0.555 . . . . 0.0 110.034 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -118.99 105.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.458 0.703 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.6 165.64 54.41 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.26 160.76 18.4 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.185 3.257 . . . . 0.0 112.64 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -135.69 136.61 41.01 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.742 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.1 t -135.74 144.57 45.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.903 0.481 . . . . 0.0 110.538 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.06 -178.22 46.84 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -146.84 161.32 37.83 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.192 0.597 . . . . 0.0 110.474 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.847 3.031 . . . . 0.0 111.71 174.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.471 0.188 0 N-CA-C 112.751 0.25 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -135.63 151.62 50.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.129 0.571 . . . . 0.0 110.634 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -135.7 146.21 47.5 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.091 0.556 . . . . 0.0 110.072 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.84 145.03 51.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.469 0.708 . . . . 0.0 110.323 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.16 28.86 3.41 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.311 0.644 . . . . 0.0 111.171 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.37 24.48 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.247 0.619 . . . . 0.0 110.783 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 t -92.72 51.63 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.102 0.561 . . . . 0.0 109.947 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -135.92 134.24 38.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.36 0.664 . . . . 0.0 109.881 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -145.52 151.68 47.56 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 123.019 0.528 . . . . 0.0 110.709 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.43 167.79 25.9 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.721 2.948 . . . . 0.0 110.807 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -76.88 150.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.348 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -91.97 -13.76 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.167 0.187 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -155.01 148.86 18.88 Favored Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.132 1.373 . . . . 0.0 108.397 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.62 147.3 57.06 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.961 2.44 . . . . 0.0 109.732 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.39 152.27 56.73 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.046 0.539 . . . . 0.0 109.962 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.94 177.58 7.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.814 3.009 . . . . 0.0 110.182 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.74 98.9 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -154.29 151.89 29.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.172 0.589 . . . . 0.0 110.499 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.82 104.63 10.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.96 151.9 44.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.619 0.767 . . . . 0.0 111.104 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.9 m -78.31 34.44 0.21 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.613 0.765 . . . . 0.0 112.464 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m -135.78 29.03 3.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.83 127.68 83.4 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 123.102 0.561 . . . . 0.0 110.555 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.3 160.1 36.12 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.821 3.014 . . . . 0.0 111.373 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.94 11.6 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.835 3.69 . . . . 0.0 111.792 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -60.77 153.6 23.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -56.98 137.63 55.32 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.342 0.657 . . . . 0.0 111.187 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.2 tp -135.99 149.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 123.101 0.561 . . . . 0.0 110.738 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.549 ' H ' HD13 ' A' ' 28' ' ' ILE . 97.5 mttt -119.73 24.74 10.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.202 0.601 . . . . 0.0 111.842 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.561 ' H ' HG13 ' A' ' 28' ' ' ILE . 44.3 t -109.06 -4.07 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.485 0.714 . . . . 0.0 109.543 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -141.42 152.49 44.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.401 0.681 . . . . 0.0 110.076 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.7 t -133.5 132.67 41.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -101.62 143.21 31.87 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.873 0.469 . . . . 0.0 111.338 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -106.02 160.68 15.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.055 0.942 . . . . 0.0 109.773 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.5 tp -114.81 127.69 55.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -105.95 143.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.36 0.664 . . . . 0.0 110.257 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.43 143.33 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.845 0.858 . . . . 0.0 110.173 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.03 172.64 42.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.93 64.79 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -59.29 138.52 88.59 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 117.368 0.584 . . . . 0.0 111.599 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.84 -11.1 10.29 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.881 3.054 . . . . 0.0 111.526 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 45' ' ' LYS . 2.0 pp -84.39 161.02 20.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.467 0.707 . . . . 0.0 111.234 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -81.52 55.44 2.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.8 ptt? 46.61 55.16 7.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.918 1.287 . . . . 0.0 112.812 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' H ' HD11 ' A' ' 42' ' ' LEU . 54.8 mtmt -111.24 119.28 38.37 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.354 0.662 . . . . 0.0 109.292 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -70.47 -15.88 62.86 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.976 -0.102 . . . . 0.0 111.143 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -93.85 -9.89 35.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.314 -0.241 . . . . 0.0 111.484 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.01 -17.2 15.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -78.38 -28.2 46.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.2 -21.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.49 -19.16 61.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.176 0.444 . . . . 0.0 110.98 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.96 -6.52 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 117.945 0.339 . . . . 0.0 111.586 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.92 20.07 18.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.785 0.834 . . . . 0.0 110.067 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -88.34 -49.43 0.42 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.426 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.08 141.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.089 1.859 . . . . 0.0 110.643 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 48.96 34.5 5.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.781 0.833 . . . . 0.0 112.369 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.89 156.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.083 -0.386 . . . . 0.0 111.378 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.37 54.92 1.92 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.422 0.689 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.88 138.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -117.79 -7.4 10.98 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -146.52 134.11 20.98 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.025 -0.422 . . . . 0.0 110.573 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.1 117.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.37 131.39 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.013 0.435 . . . . 0.0 111.578 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.32 132.9 41.32 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.503 1.121 . . . . 0.0 109.27 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.69 160.09 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.133 0.573 . . . . 0.0 111.688 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 68' ' ' ARG . 41.2 t30 64.66 153.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.054 1.342 . . . . 0.0 112.719 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -78.82 32.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.504 0.722 . . . . 0.0 111.144 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 66' ' ' ASN . 45.6 ttp180 -134.75 24.48 3.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.64 0.776 . . . . 0.0 110.289 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 45.91 48.21 12.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 114.001 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -106.61 146.54 30.58 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.24 39.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 111.656 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -131.16 129.78 42.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.17 151.7 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.437 0.161 . . . . 0.0 110.986 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.78 137.62 51.63 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.893 0.378 . . . . 0.0 111.168 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 m -108.77 156.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.624 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.64 6.08 29.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -155.54 137.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.126 0.57 . . . . 0.0 109.801 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.19 -13.35 61.9 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.287 -0.258 . . . . 0.0 111.628 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -88.13 -14.65 38.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -92.01 -11.55 35.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.64 -44.47 61.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.0 -15.27 61.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -83.03 -19.15 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 122.03 -0.419 . . . . 0.0 110.873 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.6 t -75.21 -37.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.65 -21.74 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.894 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.19 -19.8 53.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -85.66 -23.37 27.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -77.93 -8.89 58.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -122.51 3.42 9.64 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -139.82 24.09 2.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.712 0.687 . . . . 0.0 112.835 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -135.45 49.88 2.15 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.667 -0.645 . . . . 0.0 111.016 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.7 4.3 87.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.481 -0.621 . . . . 0.0 113.088 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.91 55.78 8.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.827 0.814 . . . . 0.0 111.679 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -56.48 153.49 20.28 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.287 0.635 . . . . 0.0 110.973 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.63 -2.14 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.925 3.083 . . . . 0.0 112.088 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.88 114.69 5.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -85.31 127.62 34.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.887 0.375 . . . . 0.0 110.734 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 t -137.43 137.48 38.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.326 0.65 . . . . 0.0 109.89 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -147.94 146.41 28.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.187 0.595 . . . . 0.0 110.484 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -106.72 155.89 19.21 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.612 0.365 . . . . 0.0 111.221 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.13 35.58 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.72 148.98 27.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.53 143.2 10.2 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -75.53 152.25 37.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.532 0.333 . . . . 0.0 110.994 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.0 -175.49 15.95 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.324 0.488 . . . . 0.0 112.392 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.59 170.55 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.191 3.261 . . . . 0.0 111.245 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -119.79 31.09 6.71 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.322 0.649 . . . . 0.0 111.721 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.88 33.37 0.38 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.473 0.709 . . . . 0.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 68.1 m -86.5 40.73 0.9 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.806 0.842 . . . . 0.0 110.956 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.8 t -87.72 24.44 1.73 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.903 0.481 . . . . 0.0 111.443 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -144.01 144.28 31.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.558 0.743 . . . . 0.0 109.084 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -70.15 -19.93 63.18 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -88.28 7.65 31.17 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -135.56 24.25 3.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.389 1.076 . . . . 0.0 109.009 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -125.91 -34.31 0.65 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -135.91 21.75 3.29 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.69 0.745 . . . . 0.0 111.788 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -135.76 24.5 3.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.053 0.541 . . . . 0.0 110.772 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 tt -140.71 152.3 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.504 0.722 . . . . 0.0 109.481 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 mp 63.34 129.67 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.271 1.428 . . . . 0.0 111.639 -173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.17 -1.87 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.872 3.048 . . . . 0.0 113.413 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.12 21.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.835 0.743 . . . . 0.0 112.399 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -97.45 -10.51 25.27 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.796 -0.565 . . . . 0.0 110.105 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -79.84 -7.71 58.86 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.36 -41.59 13.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.161 0.984 . . . . 0.0 109.673 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 p -76.92 -25.46 52.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.845 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.04 -46.71 11.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.7 0.227 . . . . 0.0 111.531 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 -9.36 57.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.72 -36.78 8.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.402 ' HZ3' ' CD ' ' A' ' 153' ' ' GLU . 39.2 ttpt -70.45 -24.4 62.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.996 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -87.26 -57.05 3.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.047 -0.408 . . . . 0.0 111.244 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -83.04 5.5 22.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -139.12 -8.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.803 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.81 24.37 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.538 1.063 . . . . 0.0 112.064 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -123.85 34.28 5.11 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.87 -0.519 . . . . 0.0 111.036 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.56 25.3 3.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.083 0.553 . . . . 0.0 111.324 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.14 25.07 3.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.813 0.445 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.5 m95 53.56 38.8 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.238 0.615 . . . . 0.0 111.839 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.47 -160.65 19.42 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -167.13 159.74 33.2 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 117.168 0.484 . . . . 0.0 111.964 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 77.0 p 51.38 24.44 2.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.629 1.572 . . . . 0.0 114.089 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -156.53 24.12 0.34 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.953 0.342 . . . . 0.0 111.789 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.92 -10.96 27.33 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.485 -0.62 . . . . 0.0 114.134 -172.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -145.86 160.4 43.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.197 0.998 . . . . 0.0 110.232 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -60.65 -3.52 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.129 3.219 . . . . 0.0 113.788 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -75.12 -2.71 28.87 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.375 0.534 . . . . 0.0 111.836 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 m -84.77 8.85 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.524 0.329 . . . . 0.0 111.237 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.1 p -129.63 38.07 3.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.19 0.996 . . . . 0.0 108.45 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.04 -59.09 0.02 OUTLIER Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.467 HG21 ' H ' ' A' ' 151' ' ' PHE . 1.8 mp -58.97 -53.25 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 117.543 0.671 . . . . 0.0 109.962 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.3 m 35.86 33.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 126.069 1.748 . . . . 0.0 114.521 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.467 ' H ' HG21 ' A' ' 149' ' ' ILE . 55.4 t80 -135.15 155.12 51.24 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.007 -0.433 . . . . 0.0 111.184 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.62 161.22 28.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.499 0.72 . . . . 0.0 111.278 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.402 ' CD ' ' HZ3' ' A' ' 129' ' ' LYS . 16.6 pt-20 -137.44 152.15 72.56 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 122.789 0.435 . . . . 0.0 111.269 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.07 -19.58 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.514 2.81 . . . . 0.0 111.126 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.2 t70 53.1 55.37 8.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.192 0.997 . . . . 0.0 112.21 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.0 pt -113.41 11.53 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.5 tp 46.38 55.79 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 112.824 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.8 t -117.37 135.09 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 C-N-CA 123.287 0.635 . . . . 0.0 109.385 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -173.62 -12.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.34 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -135.8 141.14 44.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.262 1.031 . . . . 0.0 110.366 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -179.76 9.42 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.074 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.54 144.89 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 118.119 0.96 . . . . 0.0 110.935 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.8 p -135.69 155.62 50.11 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.738 0.815 . . . . 0.0 110.411 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.6 t -135.65 146.6 48.0 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.892 0.477 . . . . 0.0 110.853 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -135.4 154.25 51.53 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.84 0.856 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.36 36.66 3.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.281 0.633 . . . . 0.0 110.757 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 37.0 pt -82.51 38.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.803 0.841 . . . . 0.0 111.497 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 77.3 p -133.53 30.15 3.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.691 0.796 . . . . 0.0 111.193 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 162.79 27.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.91 0.484 . . . . 0.0 111.68 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -135.25 146.86 49.01 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.605 0.762 . . . . 0.0 109.905 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -139.95 154.34 70.47 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.322 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.51 172.45 15.05 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.901 3.068 . . . . 0.0 111.339 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.4 p -130.89 153.87 48.69 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.551 0.741 . . . . 0.0 110.37 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -66.36 130.35 42.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.796 0.438 . . . . 0.0 111.15 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.3 p -135.43 22.64 3.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.661 0.784 . . . . 0.0 110.428 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -85.68 -132.23 2.83 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 49.27 29.77 2.83 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.481 1.513 . . . . 0.0 113.458 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -135.99 145.51 46.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.66 0.784 . . . . 0.0 109.584 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.47 173.1 45.29 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.22 171.0 18.52 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 124.491 3.461 . . . . 0.0 111.353 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -135.21 134.2 39.81 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.514 0.725 . . . . 0.0 109.709 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.0 m -73.75 140.12 45.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.731 0.412 . . . . 0.0 111.078 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.56 171.53 40.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 41.1 ttmt -87.45 -44.48 0.51 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.736 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 85.2 Cg_endo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.233 1.955 . . . . 0.0 111.207 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo . . . . . 0 C--O 1.231 0.143 0 N-CA-C 112.445 0.133 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -135.82 39.51 2.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.172 0.589 . . . . 0.0 111.084 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -65.76 145.11 56.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.867 0.365 . . . . 0.0 111.322 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 pp -135.93 164.7 27.36 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.355 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -81.91 148.3 28.82 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.85 0.46 . . . . 0.0 110.412 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.72 31.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 111.146 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.7 t -69.91 145.33 52.04 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.772 0.429 . . . . 0.0 110.79 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -75.93 153.05 36.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.98 0.512 . . . . 0.0 110.961 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.97 159.31 53.62 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 123.084 0.554 . . . . 0.0 110.591 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.95 164.4 12.12 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.004 3.136 . . . . 0.0 112.277 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -119.7 24.7 10.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.163 0.585 . . . . 0.0 110.889 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -143.63 139.85 29.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.454 0.702 . . . . 0.0 109.983 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -134.53 91.99 20.9 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 123.282 0.633 . . . . 0.0 109.324 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.45 136.87 77.14 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.911 3.074 . . . . 0.0 112.393 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -163.45 162.38 17.33 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.179 0.992 . . . . 0.0 109.141 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.86 158.96 53.88 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.499 2.132 . . . . 0.0 110.176 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.25 104.93 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.7 p -141.21 149.3 41.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.27 0.628 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -38.23 122.91 1.1 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.818 1.247 . . . . 0.0 111.687 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -47.88 104.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.341 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.9 m -142.43 -2.49 1.1 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.848 0.459 . . . . 0.0 111.35 169.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -148.1 24.05 1.05 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.52 146.38 53.47 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 121.475 -0.766 . . . . 0.0 111.601 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 26' ' ' ASP . 92.4 Cg_endo -75.52 168.36 24.62 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.904 3.736 . . . . 0.0 110.591 175.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.04 18.85 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.485 3.457 . . . . 0.0 112.404 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 24' ' ' PRO . 81.0 m-20 -71.02 175.37 5.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.688 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -52.52 154.31 2.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.05 1.34 . . . . 0.0 113.149 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 119.45 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -82.44 35.59 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -172.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 12.73 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.77 55.89 1.26 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.055 0.942 . . . . 0.0 108.613 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.4 t -62.11 109.04 1.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.942 0.497 . . . . 0.0 111.124 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.16 54.26 1.94 Allowed 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.6 m -76.11 135.44 39.84 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.446 -171.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.76 108.55 12.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -86.78 139.63 30.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.371 0.668 . . . . 0.0 110.023 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.04 142.38 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.36 171.07 40.55 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.186 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.38 23.7 68.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -56.36 126.01 67.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 117.321 0.561 . . . . 0.0 111.799 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.25 -2.68 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.576 2.85 . . . . 0.0 110.82 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.19 159.98 33.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.221 0.608 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -79.11 38.59 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.799 0.839 . . . . 0.0 111.74 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp 57.48 54.26 6.68 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.9 0.88 . . . . 0.0 111.98 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.13 131.89 37.39 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.668 0.787 . . . . 0.0 109.185 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.8 -8.0 55.1 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -85.15 -17.94 35.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.156 -0.34 . . . . 0.0 110.946 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -87.13 -22.51 25.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.868 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.44 -37.23 77.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.36 -18.85 62.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.829 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -88.2 -4.22 58.76 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.857 -0.527 . . . . 0.0 111.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.46 -2.01 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 118.124 0.42 . . . . 0.0 111.672 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -131.27 6.68 4.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -171.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HA ' ' CE ' ' A' ' 54' ' ' LYS . 3.2 mmpt? -96.52 -29.36 0.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 97.6 Cg_endo -74.74 134.98 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 121.779 1.671 . . . . 0.0 109.968 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 50.3 36.77 13.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.419 0.688 . . . . 0.0 111.612 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.69 165.38 29.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.658 0.783 . . . . 0.0 110.577 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -135.13 49.79 2.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 110.761 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.99 137.04 22.3 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.269 0.627 . . . . 0.0 109.915 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -125.45 1.97 7.67 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 m -138.53 138.73 38.28 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.629 0.65 . . . . 0.0 111.524 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.2 t -135.75 130.92 50.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 123.502 0.721 . . . . 0.0 109.368 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.87 137.84 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.96 142.11 51.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.741 0.816 . . . . 0.0 110.49 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -129.18 129.09 44.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.855 0.862 . . . . 0.0 109.057 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -78.39 43.46 0.46 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.137 0.975 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -135.44 104.91 6.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.7 0.8 . . . . 0.0 109.186 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 52.08 36.58 19.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.928 0.891 . . . . 0.0 111.919 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 53.8 55.77 8.03 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.435 0.694 . . . . 0.0 112.038 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -96.67 129.46 44.06 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.73 152.13 50.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.959 0.504 . . . . 0.0 110.974 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -135.67 136.86 41.26 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.24 155.36 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.595 0.236 . . . . 0.0 110.395 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.92 136.04 47.08 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.993 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -122.26 156.98 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 126.366 1.866 . . . . 0.0 108.192 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -117.94 17.91 14.07 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -143.44 122.94 13.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.757 0.823 . . . . 0.0 109.052 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 ttt-85 -70.26 -20.41 63.06 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.18 0.446 . . . . 0.0 110.679 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -75.75 -21.57 57.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.041 -0.412 . . . . 0.0 110.162 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.59 -11.76 19.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.0 64.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.95 -21.2 51.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.371 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -78.06 -20.57 52.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.972 -0.455 . . . . 0.0 110.855 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.97 -40.67 22.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 O-C-N 121.77 -0.581 . . . . 0.0 110.345 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.24 -21.72 62.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.468 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -81.65 -18.08 45.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.81 -0.557 . . . . 0.0 110.533 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.42 -26.5 32.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -91.8 2.64 56.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -119.84 -0.84 10.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.454 0.302 . . . . 0.0 111.49 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.32 16.18 3.44 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.96 49.05 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 110.595 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.34 9.04 85.91 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.343 -0.698 . . . . 0.0 112.892 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.73 81.18 0.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.083 0.953 . . . . 0.0 111.408 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.37 151.17 60.77 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.15 0.58 . . . . 0.0 111.107 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.27 -9.39 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.787 2.991 . . . . 0.0 111.468 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.87 124.05 25.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -85.15 136.72 33.42 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 122.368 0.267 . . . . 0.0 111.167 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 p -135.47 142.19 45.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.234 0.614 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.49 137.95 27.27 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.788 0.835 . . . . 0.0 109.061 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -135.2 155.57 50.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 0.0 111.677 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.36 176.49 45.32 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.319 0.4 . . . . 0.0 112.421 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.48 131.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.25 1.02 . . . . 0.0 109.921 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.24 135.98 14.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -135.69 142.52 45.11 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.008 0.523 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.4 -172.22 48.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.75 171.02 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.657 3.571 . . . . 0.0 112.726 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -57.83 144.21 39.54 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.106 0.562 . . . . 0.0 110.98 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -108.25 24.39 13.07 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.45 0.7 . . . . 0.0 112.001 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -99.73 24.37 8.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.866 0.467 . . . . 0.0 111.383 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.4 m -76.79 154.17 34.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.991 0.517 . . . . 0.0 110.395 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -78.21 146.52 34.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -74.95 3.74 7.75 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -78.75 -8.6 58.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.252 0.478 . . . . 0.0 109.945 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -135.22 4.64 3.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.855 0.862 . . . . 0.0 110.055 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.95 -12.77 45.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.84 134.21 56.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.429 0.614 . . . . 0.0 110.782 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.3 p -143.34 149.64 38.04 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.249 0.62 . . . . 0.0 110.296 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.5 tp -92.37 108.58 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm 62.57 140.96 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 111.089 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -56.59 -22.16 42.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.609 2.206 . . . . 0.0 113.248 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 41.4 ttp -80.08 36.34 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.023 0.529 . . . . 0.0 110.737 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -135.65 -36.95 0.76 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.393 0.677 . . . . 0.0 110.429 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -85.96 -13.49 47.53 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.579 0.172 . . . . 0.0 110.716 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.57 -24.97 14.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.209 0.604 . . . . 0.0 109.449 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.2 m -77.47 -26.04 51.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -91.0 -40.16 11.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.288 -0.258 . . . . 0.0 110.886 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.49 -9.41 59.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -112.5 -17.23 12.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.36 -24.47 62.98 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 170.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.57 -52.5 5.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -86.69 16.41 4.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.6 t -143.24 -20.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 135' ' ' ALA . 20.4 m -140.16 33.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.384 0.993 . . . . 0.0 113.058 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.7 p -72.81 22.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.521 -0.737 . . . . 0.0 111.887 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.53 36.52 2.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.44 1.096 . . . . 0.0 109.202 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -133.4 162.3 32.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.231 1.012 . . . . 0.0 109.449 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -75.73 44.64 0.3 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.433 0.693 . . . . 0.0 111.936 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.9 1.02 90.14 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.368 0.508 . . . . 0.0 112.597 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 167.02 54.86 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.765 0.783 . . . . 0.0 111.925 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.8 t -140.01 22.34 2.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.811 0.845 . . . . 0.0 109.353 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -135.3 20.02 3.4 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 109.786 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.25 -5.1 83.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -137.69 160.33 65.39 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.029 0.532 . . . . 0.0 110.133 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.77 20.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 125.27 3.98 . . . . 0.0 115.157 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.413 ' CD1' HG13 ' A' ' 149' ' ' ILE . 3.4 pp -83.33 1.62 40.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.14 0.882 . . . . 0.0 111.201 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.87 21.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.564 -0.71 . . . . 0.0 112.328 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -135.71 24.55 3.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.843 0.354 . . . . 0.0 111.796 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.96 -9.51 0.03 OUTLIER Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.593 -0.692 . . . . 0.0 112.915 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.413 HG13 ' CD1' ' A' ' 145' ' ' LEU . 29.5 mm -86.39 42.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.889 0.852 . . . . 0.0 109.548 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.14 24.71 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.184 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.12 161.79 28.36 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.39 55.7 1.87 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.107 0.563 . . . . 0.0 109.72 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.9 151.93 71.99 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 122.964 0.506 . . . . 0.0 110.527 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.42 5.82 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.075 3.183 . . . . 0.0 112.339 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -80.9 55.31 2.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.294 0.637 . . . . 0.0 110.902 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.3 pt -80.31 158.13 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.296 0.638 . . . . 0.0 110.808 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.3 pt -77.59 29.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.21 26.14 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.893 0.477 . . . . 0.0 110.715 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 79.78 -173.97 55.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -135.37 142.33 45.7 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.155 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.42 179.15 45.01 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.1 150.82 29.95 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 C-N-CA 123.324 0.65 . . . . 0.0 110.455 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.6 m -135.4 148.57 49.4 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.286 0.635 . . . . 0.0 110.521 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.2 m -135.16 145.51 47.84 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.454 0.701 . . . . 0.0 110.202 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -135.32 34.6 3.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.063 0.545 . . . . 0.0 110.433 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.98 107.98 10.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.631 0.372 . . . . 0.0 110.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.2 tp -135.81 143.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.182 0.593 . . . . 0.0 110.279 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.6 t -135.83 136.68 40.83 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.226 0.611 . . . . 0.0 110.0 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -135.5 138.01 42.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.19 0.596 . . . . 0.0 109.976 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -136.06 152.39 50.84 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.171 0.589 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.4 ttm -147.58 136.81 11.75 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.86 146.37 47.67 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.178 2.585 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 62.7 p -135.98 24.63 3.32 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.471 0.708 . . . . 0.0 110.687 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.92 24.59 11.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.43 0.692 . . . . 0.0 111.703 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.9 p -99.37 130.41 45.64 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.045 0.538 . . . . 0.0 110.572 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 167.3 -177.03 42.01 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -135.55 119.43 17.36 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 123.336 0.654 . . . . 0.0 109.752 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -135.85 27.05 3.31 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.241 0.616 . . . . 0.0 111.541 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.44 157.24 51.93 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.07 168.09 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 124.312 3.341 . . . . 0.0 111.333 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -82.55 154.64 24.91 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.168 0.587 . . . . 0.0 110.25 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.6 m -132.78 132.11 41.86 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.882 0.473 . . . . 0.0 110.356 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 169.91 176.62 39.72 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.88 -50.77 0.72 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.433 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 C--O 1.25 1.115 0 C-N-CA 122.429 2.086 . . . . 0.0 111.07 179.171 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.47 0.137 0 N-CA-C 112.52 0.161 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -135.16 26.71 3.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.151 0.581 . . . . 0.0 110.731 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.29 133.29 40.08 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.588 0.355 . . . . 0.0 110.529 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.22 104.75 16.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -81.21 138.92 35.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.973 0.509 . . . . 0.0 110.777 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.36 135.18 56.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.421 0.688 . . . . 0.0 109.85 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.9 m -134.61 27.73 3.66 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.287 0.635 . . . . 0.0 110.873 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -135.49 147.3 48.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.436 0.695 . . . . 0.0 110.105 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -78.69 119.83 78.74 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.13 169.74 21.51 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.453 2.769 . . . . 0.0 111.492 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -135.4 140.16 44.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.288 0.635 . . . . 0.0 110.093 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -136.73 127.76 27.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.055 0.542 . . . . 0.0 110.054 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -146.79 80.2 9.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.39 -9.77 13.64 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.763 2.976 . . . . 0.0 111.36 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -93.38 140.84 23.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.608 0.763 . . . . 0.0 110.46 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.29 -174.4 0.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.768 2.979 . . . . 0.0 110.316 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -56.93 135.27 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -78.64 177.26 8.75 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.494 0.717 . . . . 0.0 110.771 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -119.87 96.09 5.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.645 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 57.55 46.47 17.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -79.64 -174.81 4.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.489 0.715 . . . . 0.0 111.133 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -109.37 63.84 0.61 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.483 1.113 . . . . 0.0 108.621 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.597 HD22 ' H ' ' A' ' 23' ' ' LEU . 1.1 mm? -61.76 155.18 62.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.386 0.674 . . . . 0.0 110.831 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.05 161.94 10.02 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 111.728 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.39 126.75 17.56 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.864 2.376 . . . . 0.0 109.756 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -150.16 166.7 29.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.578 0.751 . . . . 0.0 109.785 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.85 55.64 0.54 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.719 0.808 . . . . 0.0 110.08 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.48 138.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.684 1.194 . . . . 0.0 109.474 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -114.15 31.22 6.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.45 -9.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 122.774 0.43 . . . . 0.0 110.465 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.26 149.27 32.54 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.532 0.733 . . . . 0.0 109.884 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -82.62 124.71 30.42 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -69.04 144.43 54.03 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.041 0.536 . . . . 0.0 111.315 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.6 p -99.5 159.91 14.67 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.846 0.859 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.0 tp -122.55 125.46 45.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.127 0.489 . . . . 0.0 110.406 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -109.04 141.58 40.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.902 0.881 . . . . 0.0 109.653 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.99 145.1 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 109.177 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.12 40.09 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.479 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.34 24.31 65.45 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.756 -0.537 . . . . 0.0 111.756 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.18 130.14 89.09 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.427 0.614 . . . . 0.0 111.574 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.45 -2.94 12.27 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.459 2.772 . . . . 0.0 110.86 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.45 156.95 37.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.229 0.612 . . . . 0.0 110.413 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -80.5 43.16 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.409 0.684 . . . . 0.0 111.155 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 88.3 mtp 52.52 55.13 9.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.093 0.957 . . . . 0.0 112.277 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -130.83 125.97 35.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.01 -8.38 52.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -80.86 -15.65 55.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.047 -0.408 . . . . 0.0 110.974 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.02 -24.3 17.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.577 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.86 -26.28 60.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.3 -19.13 36.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.15 -8.47 59.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.953 -0.467 . . . . 0.0 110.806 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.17 -4.21 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -112.46 14.13 20.25 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.332 0.653 . . . . 0.0 111.045 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.514 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 56.3 tttp -117.71 -19.13 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 92.4 Cg_endo -78.16 -21.54 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 121.932 1.726 . . . . 0.0 112.307 -177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.84 16.41 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.129 0.571 . . . . 0.0 111.201 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.07 -175.78 5.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.439 1.096 . . . . 0.0 108.526 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -145.63 104.22 3.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.001 -0.437 . . . . 0.0 110.09 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.38 139.86 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.103 0.561 . . . . 0.0 110.123 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.57 2.72 6.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.201 0.2 . . . . 0.0 111.429 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 t -135.88 119.7 17.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.905 -0.497 . . . . 0.0 110.268 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.7 t -140.38 127.12 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.656 0.782 . . . . 0.0 109.671 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 136.18 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 122.751 0.42 . . . . 0.0 110.133 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.19 145.19 39.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.569 1.148 . . . . 0.0 110.311 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -135.15 138.21 43.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.079 0.552 . . . . 0.0 110.108 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.9 50.45 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -128.18 98.77 5.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 54.9 25.36 6.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.628 0.771 . . . . 0.0 111.693 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.08 60.96 3.28 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.206 1.002 . . . . 0.0 110.946 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.99 151.36 34.3 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.258 0.623 . . . . 0.0 111.122 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.18 160.15 40.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.647 0.779 . . . . 0.0 110.987 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -126.45 137.09 53.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.66 151.25 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-O 121.015 0.436 . . . . 0.0 111.464 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -135.0 134.79 40.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.8 156.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 125.212 1.405 . . . . 0.0 109.1 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -104.51 21.22 17.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.524 0.202 . . . . 0.0 111.216 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -142.71 115.35 8.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.934 0.893 . . . . 0.0 108.955 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -72.96 -20.05 61.12 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -89.79 -16.96 29.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.269 -0.27 . . . . 0.0 110.636 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.31 -18.62 28.11 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.15 84.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -70.48 -20.8 62.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -83.73 -14.09 52.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.99 0.359 . . . . 0.0 111.456 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -75.23 -50.2 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.27 -20.89 65.72 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.664 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -67.81 -46.42 71.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -84.07 -23.73 30.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.913 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.28 -2.86 43.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.095 0.407 . . . . 0.0 111.341 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -131.22 9.13 4.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -135.23 12.61 3.55 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -103.23 -11.84 17.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.043 0.838 . . . . 0.0 111.323 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.81 5.91 4.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.856 0.741 . . . . 0.0 114.392 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.71 29.61 3.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.589 1.195 . . . . 0.0 112.222 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.24 95.69 30.13 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.89 -2.48 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.904 3.069 . . . . 0.0 111.163 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.48 121.08 14.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.565 0.746 . . . . 0.0 109.022 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -83.07 136.11 34.6 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.615 0.366 . . . . 0.0 111.187 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 p -135.69 143.98 45.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.325 0.65 . . . . 0.0 110.81 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.03 131.32 25.01 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -125.47 155.43 40.52 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.333 0.253 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 180.0 -178.54 48.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.69 148.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.132 0.573 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.66 143.01 9.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.18 24.25 3.53 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.337 0.655 . . . . 0.0 111.145 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.42 178.42 36.13 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 122.978 0.323 . . . . 0.0 112.319 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.44 4.08 6.63 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.745 3.63 . . . . 0.0 112.059 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -65.99 145.86 55.38 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.044 0.537 . . . . 0.0 111.396 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -135.25 55.13 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.847 0.859 . . . . 0.0 109.108 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -94.73 51.31 1.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.895 0.878 . . . . 0.0 110.189 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.79 40.35 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.986 0.914 . . . . 0.0 112.237 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -131.87 134.58 45.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.97 0.908 . . . . 0.0 109.19 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -74.07 -4.34 34.93 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -81.26 -7.97 59.66 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -140.71 24.99 2.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.771 0.828 . . . . 0.0 110.294 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.37 3.48 0.12 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.367 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -79.57 55.2 1.92 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.182 1.491 . . . . 0.0 110.757 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.1 m -135.37 29.62 3.3 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.938 0.895 . . . . 0.0 110.255 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.0 pt -74.88 144.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.151 0.581 . . . . 0.0 111.107 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.707 ' H ' ' HD2' ' A' ' 120' ' ' PRO . 61.0 mt -133.61 -45.71 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.447 -0.787 . . . . 0.0 112.356 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.707 ' HD2' ' H ' ' A' ' 119' ' ' ILE . 87.9 Cg_endo -77.29 -8.18 17.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.75 1.633 . . . . 0.0 111.834 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.94 24.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.665 0.386 . . . . 0.0 111.753 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.87 -26.61 1.53 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.476 0.311 . . . . 0.0 110.771 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -87.48 -9.83 53.49 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.26 -52.62 8.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.892 0.877 . . . . 0.0 108.689 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -71.69 -19.68 62.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.097 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.7 -60.72 2.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.5 -26.02 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -172.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.22 -42.13 6.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.377 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -77.04 -21.26 54.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.224 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.18 -46.69 8.61 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.723 0.692 . . . . 0.0 111.111 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -84.63 5.03 29.6 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.493 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.3 m -138.83 -5.02 1.53 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.58 19.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.493 1.042 . . . . 0.0 112.571 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -82.87 49.79 1.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.322 -0.861 . . . . 0.0 111.557 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.92 8.0 3.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.923 0.489 . . . . 0.0 110.491 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -145.52 156.92 44.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.287 1.035 . . . . 0.0 109.547 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -76.2 104.53 6.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.55 178.8 33.8 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.04 136.87 25.86 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -146.2 32.75 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.928 0.364 . . . . 0.0 111.331 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 m 57.1 40.71 28.2 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.841 0.456 . . . . 0.0 111.901 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.98 -19.0 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -146.88 162.08 34.72 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.718 0.807 . . . . 0.0 109.287 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.02 3.82 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.46 3.44 . . . . 0.0 114.43 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.02 -5.76 28.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.69 0.677 . . . . 0.0 111.659 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.36 14.69 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.45 0.7 . . . . 0.0 111.042 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -133.43 44.33 2.81 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.78 -57.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.18 128.2 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.641 0.734 . . . . 0.0 109.653 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.13 31.77 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.54 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -132.61 130.93 40.86 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.581 0.353 . . . . 0.0 110.741 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.72 154.15 40.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.956 0.503 . . . . 0.0 111.227 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.506 ' H ' ' HD2' ' A' ' 154' ' ' PRO . 75.7 mm-40 -132.01 -59.21 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.457 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 153' ' ' GLU . 83.3 Cg_endo -74.06 149.01 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.52 2.146 . . . . 0.0 111.144 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -138.49 25.01 2.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.8 tp -135.33 131.41 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 122.089 -0.382 . . . . 0.0 111.328 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.5 tp -147.99 46.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.628 0.771 . . . . 0.0 109.565 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.36 137.14 55.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 C-N-CA 123.003 0.521 . . . . 0.0 110.084 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 167.29 -3.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.981 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -98.23 143.06 29.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 117.966 0.883 . . . . 0.0 111.209 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 175.18 154.29 11.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.68 143.97 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.274 0.629 . . . . 0.0 110.215 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -136.16 141.22 44.06 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.919 0.488 . . . . 0.0 110.954 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -145.74 137.82 25.4 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.249 0.619 . . . . 0.0 110.031 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -141.19 135.24 30.58 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.921 0.488 . . . . 0.0 110.713 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -136.04 126.15 26.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.338 0.655 . . . . 0.0 109.666 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.7 tt -141.96 144.97 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.784 0.434 . . . . 0.0 110.959 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.3 m -135.37 110.79 9.09 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 109.214 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.78 62.14 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.983 0.513 . . . . 0.0 110.314 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -135.31 144.74 46.91 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.886 0.474 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.3 ttm -152.8 135.92 9.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.257 0.623 . . . . 0.0 109.36 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.36 154.39 40.79 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.572 2.848 . . . . 0.0 111.339 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.1 m -137.07 85.38 2.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -135.54 24.88 3.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.894 0.478 . . . . 0.0 111.29 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.9 m -88.43 135.03 33.67 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.687 0.395 . . . . 0.0 111.066 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.29 161.41 20.79 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -140.64 121.67 14.64 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.204 0.601 . . . . 0.0 109.987 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -143.48 139.63 29.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.993 0.517 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.03 157.24 20.45 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.88 170.67 19.39 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.448 3.432 . . . . 0.0 111.249 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -135.57 150.14 49.62 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.362 0.665 . . . . 0.0 110.48 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.9 p -85.58 147.75 26.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.886 0.474 . . . . 0.0 111.129 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.48 176.72 54.6 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.69 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 65.9 tttm -147.25 -49.4 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.926 . . . . 0.0 112.362 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.69 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 97.9 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.138 1.892 . . . . 0.0 111.119 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 112.581 0.185 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -135.79 84.76 2.11 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.044 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.81 148.81 48.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.262 0.625 . . . . 0.0 110.711 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.81 156.21 49.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.15 0.58 . . . . 0.0 111.235 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 62.64 116.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.541 1.536 . . . . 0.0 113.201 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.26 27.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.712 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -71.32 153.65 42.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.992 0.425 . . . . 0.0 111.597 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -82.49 163.66 21.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.008 0.523 . . . . 0.0 111.099 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -124.15 154.14 68.36 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.361 0.664 . . . . 0.0 110.481 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.16 172.37 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.001 3.134 . . . . 0.0 112.055 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -79.18 24.32 0.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.617 0.767 . . . . 0.0 111.772 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.73 119.75 17.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -140.49 157.08 69.04 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 122.355 0.262 . . . . 0.0 110.945 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.57 167.09 3.04 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.082 3.188 . . . . 0.0 112.275 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -134.51 42.1 0.75 Allowed Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 87.4 Cg_endo -72.01 -3.75 13.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.278 2.652 . . . . 0.0 112.276 -177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.61 93.68 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.7 p -159.52 164.74 34.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.45 1.1 . . . . 0.0 109.637 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -55.4 104.92 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.613 0.765 . . . . 0.0 110.193 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -113.01 13.64 19.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.703 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t 60.49 170.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 113.552 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t 46.67 44.88 14.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.282 1.433 . . . . 0.0 112.728 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.86 147.04 97.82 Favored Pre-proline 0 CA--C 1.531 0.222 0 O-C-N 122.028 -0.42 . . . . 0.0 110.744 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.08 142.31 34.19 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.932 3.088 . . . . 0.0 111.052 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.45 -8.9 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.939 3.092 . . . . 0.0 112.823 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -135.26 24.22 3.51 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -136.03 25.36 3.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.764 0.316 . . . . 0.0 110.796 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.522 HD11 ' H ' ' A' ' 29' ' ' LYS . 6.7 tp -137.42 148.46 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.914 0.486 . . . . 0.0 110.572 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' H ' HD11 ' A' ' 28' ' ' ILE . 21.1 tptm -96.21 15.0 22.18 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.644 0.778 . . . . 0.0 112.301 -173.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 m -135.38 32.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 O-C-N 121.895 -0.503 . . . . 0.0 111.096 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -78.91 155.12 29.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.476 0.31 . . . . 0.0 110.582 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.1 p -135.52 144.05 46.1 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.834 0.453 . . . . 0.0 111.192 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -135.96 16.55 3.28 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.167 0.587 . . . . 0.0 111.425 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -142.15 141.52 32.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.204 0.602 . . . . 0.0 109.79 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 tp -135.2 126.29 27.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -100.7 143.02 31.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.534 0.333 . . . . 0.0 110.695 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.73 102.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.23 164.5 18.15 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.31 72.63 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.019 -0.878 . . . . 0.0 113.77 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -53.59 117.51 12.33 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 118.548 1.174 . . . . 0.0 111.09 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.97 -9.49 25.16 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.373 2.715 . . . . 0.0 112.413 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -135.09 67.84 1.48 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.78 0.832 . . . . 0.0 110.856 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.52 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.608 0.763 . . . . 0.0 112.323 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 42' ' ' LEU . 12.1 tpt -147.87 22.81 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.128 0.571 . . . . 0.0 110.902 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 47' ' ' TRP . 29.0 tptt -145.43 78.63 1.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.35 -20.46 66.12 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.06 -0.4 . . . . 0.0 111.745 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.494 ' CE2' ' HE3' ' A' ' 45' ' ' LYS . 63.9 p-90 -92.09 1.7 57.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.95 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.83 -28.51 28.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.39 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.49 -40.39 85.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.49 65.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.229 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -92.06 -3.41 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.214 0.461 . . . . 0.0 112.142 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.16 -2.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 O-C-N 121.996 -0.44 . . . . 0.0 111.75 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tp -124.95 -6.41 7.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 98.5 mttt -96.01 -29.75 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.286 -0.864 . . . . 0.0 113.284 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.51 -18.66 47.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.427 2.085 . . . . 0.0 114.117 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.66 8.53 3.32 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.75 150.12 28.17 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.597 0.635 . . . . 0.0 110.427 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -87.94 40.06 0.92 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.686 0.394 . . . . 0.0 111.642 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.92 141.34 16.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 O-C-N 122.052 -0.405 . . . . 0.0 109.995 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -135.29 7.83 3.38 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 124.25 25.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.206 0.457 . . . . 0.0 110.789 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.09 130.54 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 123.737 0.815 . . . . 0.0 109.337 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.78 131.73 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.81 119.5 22.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -86.64 104.08 15.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -84.5 18.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.273 0.629 . . . . 0.0 112.049 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.6 3.79 3.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.425 0.29 . . . . 0.0 111.588 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -141.18 14.08 2.22 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.95 0.5 . . . . 0.0 111.036 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.1 pttt 44.5 40.7 4.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.727 1.211 . . . . 0.0 112.89 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -127.25 138.5 53.1 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.113 0.565 . . . . 0.0 109.918 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.77 147.0 48.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.752 0.31 . . . . 0.0 111.187 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.86 144.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.5 156.69 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.09 139.39 44.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.58 154.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 126.284 1.834 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.2 15.41 17.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 t -155.91 137.63 14.26 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.055 0.542 . . . . 0.0 110.35 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -68.06 -11.4 58.95 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -81.39 -17.37 49.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.797 -0.564 . . . . 0.0 110.706 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -90.98 -23.13 20.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.02 -22.09 56.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -82.51 -21.59 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -78.04 -20.47 52.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.074 -0.391 . . . . 0.0 110.559 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.8 t -81.58 -40.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.458 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.8 -18.36 60.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.243 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -82.29 -19.2 39.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.999 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -79.09 -26.01 43.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -84.15 -8.85 58.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.952 0.501 . . . . 0.0 111.409 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -127.24 12.19 7.05 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' HZ2' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -134.94 10.06 3.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.397 0.544 . . . . 0.0 112.459 174.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -122.77 -20.02 6.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.531 0.605 . . . . 0.0 111.353 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.93 9.73 5.85 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.038 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.3 43.78 2.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.851 1.326 . . . . 0.0 112.26 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.36 119.78 26.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.52 -8.28 12.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.8 3.0 . . . . 0.0 111.404 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.04 138.96 50.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.996 0.519 . . . . 0.0 111.113 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -95.29 84.68 4.09 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.1 p -79.58 122.64 26.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.464 0.705 . . . . 0.0 110.872 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -140.61 118.3 11.65 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.121 0.568 . . . . 0.0 110.281 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -86.83 155.29 20.34 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.673 0.389 . . . . 0.0 111.359 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.78 -171.74 37.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -135.95 136.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.381 0.672 . . . . 0.0 110.338 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.07 135.99 13.33 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -106.52 44.7 1.03 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.678 0.791 . . . . 0.0 110.515 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.23 -167.99 52.76 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.4 -5.53 17.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.024 3.149 . . . . 0.0 112.237 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.33 134.78 34.9 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.666 0.387 . . . . 0.0 110.653 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.064 0.546 . . . . 0.0 110.022 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.7 m -135.05 26.81 3.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.365 0.666 . . . . 0.0 110.41 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.19 133.04 44.9 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.59 0.356 . . . . 0.0 110.875 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -135.93 147.31 48.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.486 0.714 . . . . 0.0 109.552 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -72.72 -4.09 29.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -93.66 5.83 50.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.375 0.534 . . . . 0.0 110.001 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -136.44 24.98 3.19 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.282 0.633 . . . . 0.0 111.067 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.11 -5.98 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.74 -1.033 . . . . 0.0 115.32 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -84.2 58.61 4.87 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.558 1.679 . . . . 0.0 110.691 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -135.21 149.01 49.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.258 0.623 . . . . 0.0 110.486 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.0 pt -116.68 24.89 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.479 0.712 . . . . 0.0 110.681 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.19 145.15 97.41 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 123.05 0.54 . . . . 0.0 109.944 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 122' ' ' HIS . 52.1 Cg_exo -57.75 177.56 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.844 3.029 . . . . 0.0 112.801 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -71.67 24.11 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' ' 120' ' ' PRO . 46.1 t-80 -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.603 -0.685 . . . . 0.0 110.909 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -87.08 -8.04 57.45 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 tp -103.66 -39.32 6.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.593 0.757 . . . . 0.0 109.262 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -70.61 -26.58 63.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.74 -45.55 9.22 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 117.915 0.325 . . . . 0.0 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.23 -10.95 59.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.923 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -106.7 -24.44 12.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.451 0.569 . . . . 0.0 111.275 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.03 -16.71 59.9 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.267 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -85.15 -55.56 3.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -86.6 11.67 12.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 t -137.37 -21.97 1.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.57 19.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.855 1.207 . . . . 0.0 114.117 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 t -101.95 37.55 1.83 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.313 0.96 . . . . 0.0 110.888 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.32 19.69 3.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -152.79 -41.32 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -136.41 13.01 3.25 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.86 15.08 66.43 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.425 0.557 . . . . 0.0 112.865 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.35 -176.58 41.92 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.74 0.77 . . . . 0.0 112.542 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 25.2 m 64.26 107.85 0.03 OUTLIER 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.895 1.278 . . . . 0.0 111.831 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t 60.74 31.7 20.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.989 0.915 . . . . 0.0 112.18 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.13 -29.77 24.54 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.643 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -152.23 165.44 17.49 Favored Pre-proline 0 C--N 1.34 0.158 0 CA-C-N 117.96 0.88 . . . . 0.0 110.052 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.6 -1.97 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.259 3.306 . . . . 0.0 114.622 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.52 -10.01 59.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.63 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.228 -0.065 0 C-N-CA 123.06 0.544 . . . . 0.0 112.455 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.2 p -135.53 -8.75 2.19 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 122.237 -0.29 . . . . 0.0 111.089 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.32 -31.05 14.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.03 64.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 23.1 m -122.26 19.86 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.229 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -135.58 141.54 45.17 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.85 77.51 2.77 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.974 -174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -141.73 122.09 8.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 166.82 27.53 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.613 2.875 . . . . 0.0 111.632 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.38 35.12 2.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 110.306 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.439 HG13 ' H ' ' A' ' 158' ' ' VAL . 10.4 tp -78.17 145.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.493 0.317 . . . . 0.0 110.162 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.0 pt -123.45 20.5 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.744 0.417 . . . . 0.0 111.616 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.439 ' H ' HG13 ' A' ' 156' ' ' ILE . 35.9 m -138.62 151.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.915 0.886 . . . . 0.0 109.564 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -73.66 158.84 52.69 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -135.09 104.89 6.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.7 39.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.76 147.18 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.116 0.567 . . . . 0.0 110.493 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 79.1 p -80.74 159.4 25.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.024 0.53 . . . . 0.0 111.018 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.7 p -129.08 150.38 50.5 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.27 0.628 . . . . 0.0 110.333 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -135.29 117.93 15.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.122 0.569 . . . . 0.0 110.076 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.89 149.86 26.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.873 0.469 . . . . 0.0 110.292 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 34.7 pt -131.63 146.65 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.177 0.591 . . . . 0.0 110.304 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -135.54 151.95 50.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.286 0.634 . . . . 0.0 110.531 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -133.28 140.47 47.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 109.574 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.38 147.21 38.19 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.558 0.343 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 47.8 tpp -146.57 64.12 9.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.197 0.599 . . . . 0.0 109.567 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.65 165.02 33.82 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.783 2.989 . . . . 0.0 111.187 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.6 t -135.59 149.42 49.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.271 0.628 . . . . 0.0 110.342 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -135.29 26.47 3.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.195 0.598 . . . . 0.0 110.293 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.4 t -77.52 104.53 8.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.51 0.324 . . . . 0.0 110.146 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.87 -175.43 50.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -135.48 141.65 45.38 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 123.315 0.646 . . . . 0.0 110.296 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -137.72 147.2 44.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.137 0.575 . . . . 0.0 110.093 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.79 167.24 39.73 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.92 163.22 38.98 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.087 3.191 . . . . 0.0 111.197 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -81.54 125.99 31.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.2 p -59.2 147.14 36.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.037 0.535 . . . . 0.0 111.463 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.11 174.66 43.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.74 159.03 84.1 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.904 0.482 . . . . 0.0 110.782 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.006 3.138 . . . . 0.0 112.413 178.595 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.471 0.187 0 N-CA-C 112.772 0.258 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.67 136.98 41.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.916 0.486 . . . . 0.0 110.416 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -135.95 142.42 44.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 110.294 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.74 143.24 50.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 109.945 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.08 66.25 8.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.29 148.47 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.587 0.755 . . . . 0.0 110.022 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -109.67 139.47 44.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.841 0.456 . . . . 0.0 110.756 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -135.3 145.23 47.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.699 0.799 . . . . 0.0 109.224 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -70.98 146.58 93.1 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.146 0.179 . . . . 0.0 111.42 -175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.58 176.23 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 124.43 3.42 . . . . 0.0 110.634 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -131.62 24.36 4.73 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.927 0.491 . . . . 0.0 110.797 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -139.01 68.09 1.38 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.929 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -134.28 155.81 79.55 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.821 0.848 . . . . 0.0 110.291 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.77 171.38 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.901 3.067 . . . . 0.0 110.647 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.91 152.49 44.92 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 122.948 0.499 . . . . 0.0 110.957 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.28 -175.66 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.255 3.303 . . . . 0.0 110.104 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.76 93.79 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -142.57 141.9 32.09 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.865 0.866 . . . . 0.0 109.297 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.45 101.32 0.96 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.176 0.512 . . . . 0.0 110.636 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -135.59 156.59 48.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.849 0.859 . . . . 0.0 109.834 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -77.0 108.19 9.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.635 0.374 . . . . 0.0 111.271 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.1 m 63.3 99.79 0.03 OUTLIER 'General case' 0 C--N 1.339 0.118 0 C-N-CA 125.081 1.352 . . . . 0.0 112.055 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' CB ' ' CD ' ' A' ' 24' ' ' PRO . 4.0 mm? -85.93 -72.59 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 23' ' ' LEU . 25.2 Cg_endo -86.42 165.67 9.37 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.136 2.557 . . . . 0.0 111.047 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.96 -46.08 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.004 2.47 . . . . 0.0 111.796 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -155.42 24.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -103.85 47.81 0.87 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.143 0.497 . . . . 0.0 110.513 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD13 ' H ' ' A' ' 29' ' ' LYS . 6.2 tp -140.32 151.48 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.03 0.532 . . . . 0.0 110.227 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' H ' HD13 ' A' ' 28' ' ' ILE . 35.7 mmtp -118.54 27.39 8.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.305 0.642 . . . . 0.0 111.526 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.534 ' H ' HG13 ' A' ' 28' ' ' ILE . 31.7 t -126.78 -24.25 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.62 25.12 0.59 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.525 0.602 . . . . 0.0 112.482 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.5 t -66.99 129.62 40.47 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 121.871 -0.518 . . . . 0.0 111.169 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -135.58 104.41 5.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.618 0.767 . . . . 0.0 109.103 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 p -135.56 166.0 24.23 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.63 129.0 49.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -97.33 139.75 32.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.687 0.28 . . . . 0.0 111.666 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.2 mm -125.87 139.3 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.422 1.089 . . . . 0.0 108.544 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.7 163.58 29.35 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.98 79.36 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.53 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.78 124.59 51.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.091 0.945 . . . . 0.0 111.294 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -82.57 -3.61 11.37 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.434 2.756 . . . . 0.0 110.867 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.78 153.68 43.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 110.453 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.13 46.08 0.99 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.499 0.72 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.2 mmt 54.3 54.92 8.79 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.114 0.966 . . . . 0.0 111.982 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.2 118.07 25.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -70.49 -16.98 62.96 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -84.88 -6.46 59.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.017 -0.427 . . . . 0.0 111.468 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.6 -23.11 19.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.527 0.603 . . . . 0.0 110.141 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.58 -28.21 56.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.15 -21.27 46.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.292 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -79.46 -12.4 59.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.924 0.329 . . . . 0.0 111.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.85 -2.84 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.114 -0.367 . . . . 0.0 111.596 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.87 13.39 24.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.794 0.838 . . . . 0.0 109.857 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.5 tttt -78.17 -38.82 1.67 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.11 170.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.87 118.76 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.678 2.252 . . . . 0.0 112.332 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 50.29 22.99 1.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.075 1.35 . . . . 0.0 113.661 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.49 162.27 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.0 110.453 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -135.07 59.41 1.73 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.789 0.436 . . . . 0.0 110.515 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.92 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 O-C-N 121.904 -0.497 . . . . 0.0 109.691 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -134.78 11.13 3.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 m -135.35 122.0 20.83 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.8 t -135.2 128.1 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.396 0.678 . . . . 0.0 109.229 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.91 104.37 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.14 112.72 25.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.637 0.375 . . . . 0.0 110.187 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -85.94 105.37 16.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.145 0.498 . . . . 0.0 109.777 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -71.59 162.86 28.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.986 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m 61.51 11.09 3.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -148.76 22.24 1.0 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.103 0.41 . . . . 0.0 111.666 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 35.08 45.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.103 1.761 . . . . 0.0 114.744 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -128.97 143.66 50.94 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.91 152.88 39.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.063 0.459 . . . . 0.0 111.437 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -122.56 131.86 54.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.2 151.47 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.37 139.53 44.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.347 0.594 . . . . 0.0 111.733 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.72 153.38 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 125.597 1.559 . . . . 0.0 109.496 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -89.96 9.53 27.48 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -152.57 137.09 16.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.312 0.645 . . . . 0.0 109.792 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -78.74 -4.01 47.11 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -88.04 -23.4 23.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.959 0.345 . . . . 0.0 110.334 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.68 -18.28 33.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.26 72.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.62 -22.45 61.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.393 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -80.06 -17.42 52.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.393 0.542 . . . . 0.0 111.501 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.46 -38.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.456 0.571 . . . . 0.0 110.002 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.55 -17.71 61.16 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.194 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -83.46 -15.3 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.892 -0.505 . . . . 0.0 110.072 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.05 -28.01 39.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.61 -7.0 59.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.124 0.57 . . . . 0.0 110.591 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.37 10.45 9.23 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -135.28 6.55 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.28 0.491 . . . . 0.0 112.119 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.48 -24.32 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.828 -0.545 . . . . 0.0 110.784 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.48 4.93 3.16 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 118.938 -0.923 . . . . 0.0 114.967 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.64 24.85 3.41 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.956 1.378 . . . . 0.0 112.976 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.56 135.21 43.75 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -6.36 12.19 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 124.094 3.196 . . . . 0.0 112.173 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.96 140.67 30.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -92.19 89.97 7.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.0 p -95.25 129.8 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.964 0.505 . . . . 0.0 111.099 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -146.38 148.43 32.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.901 0.48 . . . . 0.0 110.678 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.47 146.34 48.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.178 0.591 . . . . 0.0 111.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.36 16.83 5.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.994 0.807 . . . . 0.0 111.293 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.85 137.57 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 117.364 0.582 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.9 134.6 12.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -135.16 107.15 7.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.299 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.5 -177.33 51.09 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.82 161.88 44.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.92 3.08 . . . . 0.0 110.677 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -78.64 141.11 38.26 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.627 0.371 . . . . 0.0 110.65 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -135.42 134.79 40.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.395 0.678 . . . . 0.0 109.801 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.6 m -129.3 24.48 5.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.8 m 53.23 50.53 17.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.709 0.803 . . . . 0.0 112.033 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.32 145.33 47.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.041 0.537 . . . . 0.0 109.936 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -80.3 -3.15 48.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -70.51 -7.67 45.38 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.91 -0.494 . . . . 0.0 110.32 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -135.33 12.43 3.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 109.782 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.75 -21.37 50.91 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -94.76 24.94 4.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.726 172.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 t -135.61 -179.14 5.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.73 1.212 . . . . 0.0 109.577 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.0 mt -50.85 127.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.324 0.65 . . . . 0.0 110.148 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt -89.63 165.2 26.29 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.584 0.754 . . . . 0.0 111.619 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.11 -169.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 124.849 3.7 . . . . 0.0 112.815 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -73.63 43.31 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.836 0.854 . . . . 0.0 112.43 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -85.19 -7.91 58.83 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.807 -0.558 . . . . 0.0 110.042 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -77.01 -4.11 42.48 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.0 tp -71.21 -45.71 62.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.663 0.785 . . . . 0.0 109.733 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.6 p -84.99 -22.28 29.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.613 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -81.4 -48.58 11.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.234 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.97 -4.61 54.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.68 -29.25 8.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.135 0.88 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -76.64 -21.28 55.7 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.143 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.31 -50.61 7.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -91.26 14.93 13.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -135.91 -21.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.32 30.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.196 0.907 . . . . 0.0 113.372 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.7 t -77.21 50.12 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.784 0.72 . . . . 0.0 110.671 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.47 126.08 16.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.872 0.869 . . . . 0.0 108.941 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.96 -174.52 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.872 0.469 . . . . 0.0 111.703 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -73.85 43.0 0.15 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.27 1.028 . . . . 0.0 112.227 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.08 -154.5 7.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.816 0.722 . . . . 0.0 111.834 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.08 -8.42 75.91 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.771 -0.461 . . . . 0.0 112.486 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.1 m -135.57 -17.28 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.426 0.613 . . . . 0.0 111.798 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -148.43 24.17 1.01 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.8 0.44 . . . . 0.0 111.107 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.41 -34.49 7.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.469 -0.629 . . . . 0.0 113.538 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -149.93 164.35 21.1 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.924 . . . . 0.0 110.124 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.81 6.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 124.916 3.744 . . . . 0.0 115.162 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.18 -12.4 58.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.684 0.674 . . . . 0.0 110.595 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.54 19.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.499 0.72 . . . . 0.0 111.846 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.8 p -119.06 20.56 12.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.276 0.23 . . . . 0.0 111.328 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.46 -25.33 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.812 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.06 81.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 117.962 0.881 . . . . 0.0 109.696 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.7 m -112.8 22.46 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 123.668 0.787 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -87.35 -43.79 11.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -143.51 156.81 44.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.121 0.568 . . . . 0.0 110.575 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -143.01 58.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.95 161.02 47.51 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.691 2.928 . . . . 0.0 111.318 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.87 104.47 16.63 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 153.32 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 110.157 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.52 145.42 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-O 120.702 0.287 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.6 m -135.17 24.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.338 0.655 . . . . 0.0 110.764 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -71.37 -11.58 71.81 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -131.08 29.62 4.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.109 0.964 . . . . 0.0 109.351 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -70.13 174.21 37.76 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.74 139.04 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 123.138 0.575 . . . . 0.0 110.23 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.3 m -104.72 144.48 31.67 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.159 0.583 . . . . 0.0 110.433 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.0 t -135.62 144.07 45.91 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.108 0.563 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.98 46.16 1.35 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.342 0.657 . . . . 0.0 110.356 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.81 143.48 45.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.5 0.72 . . . . 0.0 110.03 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.22 138.71 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 123.509 0.724 . . . . 0.0 109.365 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -70.29 137.96 51.16 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.801 0.44 . . . . 0.0 110.944 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.3 149.02 49.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.329 0.652 . . . . 0.0 110.218 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -135.15 151.11 50.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.508 0.723 . . . . 0.0 110.135 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.3 ttm -144.39 137.23 13.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.96 169.9 21.07 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 111.343 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.8 p -133.39 152.01 51.88 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.371 0.669 . . . . 0.0 110.303 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -122.53 24.67 9.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.308 0.643 . . . . 0.0 111.267 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.3 t -135.48 134.03 39.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.234 0.614 . . . . 0.0 110.116 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 177.56 -163.97 32.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.36 141.42 58.57 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.1 0.45 . . . . 0.0 110.267 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -85.82 155.39 21.01 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.942 0.497 . . . . 0.0 111.769 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.58 26.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.44 151.89 65.32 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.756 2.971 . . . . 0.0 112.486 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -140.3 146.82 39.02 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.386 0.675 . . . . 0.0 110.23 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t -135.94 141.62 44.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.927 0.491 . . . . 0.0 110.613 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 173.45 173.6 39.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.97 140.37 35.04 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 122.841 0.456 . . . . 0.0 109.787 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.719 2.946 . . . . 0.0 112.568 177.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 CA--C 1.528 0.206 0 N-CA-C 113.125 0.394 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -135.48 24.61 3.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.002 0.521 . . . . 0.0 111.012 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -88.12 146.14 25.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.229 0.612 . . . . 0.0 110.287 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.18 24.28 3.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.939 0.495 . . . . 0.0 111.905 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -91.63 106.05 18.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.84 25.0 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.203 0.601 . . . . 0.0 110.93 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 t -76.44 109.12 9.9 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.528 0.331 . . . . 0.0 110.267 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -136.66 129.8 31.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.322 0.649 . . . . 0.0 109.677 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -140.84 147.34 47.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 122.953 0.501 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.12 161.91 37.66 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.812 3.008 . . . . 0.0 111.18 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -135.68 24.92 3.4 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.403 0.681 . . . . 0.0 110.204 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -136.06 161.13 36.56 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.943 0.897 . . . . 0.0 110.534 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.06 148.09 67.58 Favored Pre-proline 0 CA--C 1.529 0.159 0 C-N-CA 123.026 0.53 . . . . 0.0 110.088 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.01 6.42 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.403 3.402 . . . . 0.0 113.228 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.0 149.25 70.38 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 118.588 0.631 . . . . 0.0 111.707 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.28 -167.17 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.809 3.672 . . . . 0.0 110.423 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.9 t -50.68 -53.09 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.129 0.572 . . . . 0.0 110.855 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.8 m -146.27 157.59 43.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.854 0.862 . . . . 0.0 109.479 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -86.82 53.45 2.83 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.81 0.444 . . . . 0.0 110.505 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 p30 46.81 31.58 1.5 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.912 1.285 . . . . 0.0 113.002 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 t -135.59 151.08 49.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.246 0.619 . . . . 0.0 110.883 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 m 60.36 55.04 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.115 0.966 . . . . 0.0 111.19 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.32 155.47 63.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.37 164.36 34.44 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.825 3.016 . . . . 0.0 110.905 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.96 -8.14 22.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.756 2.97 . . . . 0.0 111.517 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.78 134.1 33.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.054 0.542 . . . . 0.0 109.702 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -74.14 155.02 38.85 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.852 0.461 . . . . 0.0 111.513 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.52 159.91 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' H ' HD12 ' A' ' 28' ' ' ILE . 55.9 mtpt -86.68 16.13 5.02 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 28' ' ' ILE . 22.1 m -135.8 29.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 122.835 0.454 . . . . 0.0 110.734 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -135.66 133.36 38.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.027 0.531 . . . . 0.0 110.515 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.7 t -137.62 125.75 22.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.322 0.649 . . . . 0.0 109.329 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.97 139.43 39.17 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.8 p -135.75 152.57 51.26 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.26 1.024 . . . . 0.0 109.644 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.6 tp -135.47 112.19 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.43 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -86.56 135.91 33.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.854 0.862 . . . . 0.0 110.302 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.42 143.05 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.23 166.59 36.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.86 66.76 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.176 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.3 m -52.93 134.83 47.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.789 0.794 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -83.93 -12.25 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.198 3.265 . . . . 0.0 111.362 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.87 166.23 20.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.031 0.932 . . . . 0.0 111.105 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.9 44.56 0.66 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.258 0.623 . . . . 0.0 111.511 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.6 mtt 49.34 55.27 9.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.232 1.013 . . . . 0.0 112.194 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.59 132.98 54.54 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.218 0.607 . . . . 0.0 109.443 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -70.74 -10.1 58.72 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -99.64 -11.88 20.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.983 0.356 . . . . 0.0 111.952 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -96.19 -22.93 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.81 -39.67 63.93 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.81 -17.41 61.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.932 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -81.99 -14.38 56.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.616 0.644 . . . . 0.0 111.842 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.4 m -110.26 -4.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 118.227 0.467 . . . . 0.0 111.78 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -126.14 6.17 7.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -171.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 1.1 tmmt? -101.32 -38.61 0.22 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.929 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 61.9 Cg_exo -55.16 131.78 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.261 1.974 . . . . 0.0 111.182 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 p90 46.83 27.48 0.7 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 113.047 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.65 170.46 15.97 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.909 0.883 . . . . 0.0 110.274 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -135.07 55.13 1.9 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 110.957 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.08 130.14 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -123.35 4.16 9.11 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -140.84 121.34 14.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -135.75 120.22 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 136.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.31 110.77 9.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -83.55 104.38 13.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -84.21 25.81 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.0 p -131.86 3.85 4.13 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.3 0.56 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.998 0.363 . . . . 0.0 111.928 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.3 pttt 45.93 47.12 12.48 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.692 1.197 . . . . 0.0 112.37 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -124.94 129.94 51.36 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.275 0.63 . . . . 0.0 110.277 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.21 147.53 49.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.317 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.3 136.6 35.04 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.666 0.386 . . . . 0.0 110.082 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.57 159.7 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 122.323 0.249 . . . . 0.0 110.739 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.55 132.0 34.6 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.945 0.402 . . . . 0.0 111.513 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -101.1 154.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 124.383 1.073 . . . . 0.0 109.23 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -81.1 -4.62 55.9 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.1 t -147.01 139.08 24.51 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.726 0.41 . . . . 0.0 110.712 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -78.69 -5.84 54.17 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -90.0 -22.05 22.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.64 -15.36 45.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.28 -42.11 60.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.3 -22.49 66.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -81.25 -22.49 38.69 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.103 -0.373 . . . . 0.0 111.093 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.53 -38.65 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.88 -18.39 63.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.912 173.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -77.73 -23.12 49.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.302 0.501 . . . . 0.0 109.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -72.78 -49.64 29.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.877 -0.514 . . . . 0.0 109.614 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -89.47 10.16 23.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -135.65 6.57 3.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.356 0.526 . . . . 0.0 112.284 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -136.96 7.16 2.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.539 0.608 . . . . 0.0 112.396 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.12 -18.95 15.33 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.6 0.636 . . . . 0.0 110.909 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.58 4.55 4.1 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.337 0.97 . . . . 0.0 115.172 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.8 35.14 2.88 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.009 1.405 . . . . 0.0 112.745 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.83 127.94 23.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -84.85 -10.44 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.087 3.191 . . . . 0.0 112.61 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.37 134.97 44.22 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -111.64 136.88 50.24 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -141.65 145.2 34.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.042 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -143.34 126.78 16.79 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.29 0.636 . . . . 0.0 110.257 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -85.84 156.74 20.43 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.14 -164.97 14.72 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.13 136.76 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.988 0.515 . . . . 0.0 110.452 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.92 130.43 10.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -135.77 151.89 50.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.473 0.709 . . . . 0.0 110.381 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.76 174.76 35.48 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.33 161.06 46.33 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.777 2.985 . . . . 0.0 110.994 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -69.69 133.27 47.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.783 0.433 . . . . 0.0 110.127 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -86.12 104.52 15.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 110.695 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.8 m -135.07 28.53 3.46 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.692 0.797 . . . . 0.0 110.321 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 74.8 m -74.23 148.21 41.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.056 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.91 154.06 42.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -68.42 -9.66 49.98 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.214 -0.304 . . . . 0.0 111.777 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.68 -2.26 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.036 0.38 . . . . 0.0 110.314 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -142.55 24.25 1.91 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -154.46 -0.6 0.16 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.971 -0.905 . . . . 0.0 113.964 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -80.02 55.15 2.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.105 1.453 . . . . 0.0 110.055 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.8 t -138.74 151.08 46.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.083 0.953 . . . . 0.0 109.847 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.9 pt -93.9 28.21 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 122.952 0.501 . . . . 0.0 111.646 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 9.5 tp -84.52 -25.15 0.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.09 -0.957 . . . . 0.0 113.551 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 31.8 Cg_exo -63.96 176.26 2.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.46 2.107 . . . . 0.0 111.828 174.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -74.15 24.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.833 0.453 . . . . 0.0 111.507 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.439 ' H ' ' C ' ' A' ' 120' ' ' PRO . 7.8 m-70 -91.29 -7.6 50.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.17 -9.21 59.71 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.82 -46.88 11.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.992 0.917 . . . . 0.0 109.503 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -77.68 -16.07 58.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.968 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.96 -43.94 12.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.103 -0.373 . . . . 0.0 111.401 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.21 -12.09 53.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.59 -24.32 11.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.679 0.672 . . . . 0.0 111.189 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -74.81 -22.68 58.6 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.544 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -90.35 -52.73 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.952 -0.467 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -83.16 7.23 16.68 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -143.94 -4.32 0.84 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.78 23.18 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.16 0.891 . . . . 0.0 111.851 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.7 t -84.9 32.86 0.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.624 -0.672 . . . . 0.0 111.374 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.07 20.6 3.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.023 0.529 . . . . 0.0 110.241 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -135.92 147.25 48.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.756 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -65.91 104.8 1.17 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.51 65.42 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.947 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 61.71 -148.26 47.6 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 118.18 0.99 . . . . 0.0 110.787 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.4 m 70.77 114.93 0.05 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.021 0.928 . . . . 0.0 111.507 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.6 t 59.22 31.01 20.87 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.62 -18.59 44.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -149.68 160.02 34.94 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 108.959 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.66 -10.83 10.07 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.661 2.908 . . . . 0.0 113.682 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.13 -36.63 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.786 0.434 . . . . 0.0 111.24 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -8.32 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 O-C-N 122.045 -0.409 . . . . 0.0 110.682 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -83.09 24.02 0.81 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.093 0.473 . . . . 0.0 109.86 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.99 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.57 -44.51 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 117.559 0.679 . . . . 0.0 109.896 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.4 m 43.63 24.5 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.204 1.802 . . . . 0.0 114.221 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -72.55 159.26 34.19 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.119 -0.363 . . . . 0.0 110.133 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -73.24 -75.09 0.15 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.272 0.229 . . . . 0.0 111.586 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -159.52 123.96 2.14 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.92 -176.61 3.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.064 3.176 . . . . 0.0 110.865 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.31 148.18 42.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 tt -64.81 134.85 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -175.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.8 tp -135.8 104.87 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.675 0.79 . . . . 0.0 109.328 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.44 24.34 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.828 0.451 . . . . 0.0 111.322 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 67.61 -166.5 42.62 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 145.9 47.84 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.389 0.676 . . . . 0.0 110.264 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -179.31 172.14 44.1 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.92 144.74 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.289 0.636 . . . . 0.0 110.222 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.7 t -92.94 133.0 36.55 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.724 0.409 . . . . 0.0 110.412 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.6 m -135.84 146.45 47.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.267 0.627 . . . . 0.0 110.502 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -135.16 142.01 46.04 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.351 0.661 . . . . 0.0 110.164 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.95 143.26 32.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.734 0.414 . . . . 0.0 110.751 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.2 161.84 39.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.438 0.695 . . . . 0.0 111.016 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.0 m -75.82 147.84 38.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.951 0.5 . . . . 0.0 110.745 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -135.01 142.07 46.34 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.104 0.561 . . . . 0.0 110.334 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -86.74 55.13 3.42 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.333 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.404 ' N ' ' HD2' ' A' ' 172' ' ' PRO . 16.0 tpt -70.53 -42.73 15.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.453 -0.784 . . . . 0.0 112.891 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 171' ' ' MET . 93.7 Cg_endo -76.25 158.87 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.958 1.772 . . . . 0.0 110.948 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 67.0 p -135.68 151.74 50.5 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 123.375 0.67 . . . . 0.0 110.367 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.57 104.98 6.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.868 0.467 . . . . 0.0 110.129 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.8 p -135.96 151.58 50.09 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.458 0.703 . . . . 0.0 110.591 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 176.18 -1.82 0.03 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.106 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 23.2 tpp85 -76.56 113.95 14.75 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.189 0.995 . . . . 0.0 110.024 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -135.94 148.44 48.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.417 0.687 . . . . 0.0 109.786 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.42 166.75 50.64 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.07 161.34 45.0 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.003 3.136 . . . . 0.0 111.219 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -135.88 55.21 1.87 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.293 0.637 . . . . 0.0 109.64 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.8 m -73.68 104.85 4.75 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.9 0.48 . . . . 0.0 110.322 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.24 175.48 36.7 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.3 mptm? -89.99 -35.65 0.4 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.184 -0.912 . . . . 0.0 112.601 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 65.2 Cg_exo . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.093 2.529 . . . . 0.0 112.545 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.471 0.204 0 CA-C-O 120.6 0.167 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.44 39.99 1.02 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.209 0.604 . . . . 0.0 110.849 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -135.37 132.43 37.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.225 0.61 . . . . 0.0 110.148 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.69 148.6 30.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.843 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -135.27 125.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.967 0.507 . . . . 0.0 109.862 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.71 32.83 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.888 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 m -78.2 55.14 1.47 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.313 0.645 . . . . 0.0 111.032 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -67.49 140.79 57.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.023 0.529 . . . . 0.0 110.293 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.35 152.18 45.63 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.196 0.598 . . . . 0.0 109.927 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.76 158.53 52.99 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.615 2.877 . . . . 0.0 111.547 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -135.96 145.98 46.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.539 0.736 . . . . 0.0 110.099 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -72.56 141.69 48.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -147.59 157.89 43.98 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 122.986 0.514 . . . . 0.0 110.243 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.01 172.04 13.63 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.681 2.921 . . . . 0.0 112.358 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -62.94 149.46 90.17 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -84.88 174.37 7.5 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.056 3.171 . . . . 0.0 113.612 -172.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.3 -17.39 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 109.652 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 m -148.92 -174.81 4.73 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.065 1.346 . . . . 0.0 109.186 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -82.52 48.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.114 0.565 . . . . 0.0 111.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -119.78 152.1 37.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.412 0.685 . . . . 0.0 109.842 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -127.96 24.67 6.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.3 m -102.47 44.96 0.98 Allowed 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 9.3 mp -103.07 16.24 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 23' ' ' LEU . 84.7 Cg_exo -49.49 147.49 12.64 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 122.368 1.882 . . . . 0.0 111.532 172.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.83 113.19 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.861 3.041 . . . . 0.0 113.582 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.515 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 14.1 t70 -152.0 154.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.161 0.984 . . . . 0.0 108.594 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -82.26 0.74 40.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.6 tp -154.62 139.03 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.118 0.872 . . . . 0.0 111.815 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 26' ' ' ASP . 32.1 mmtp -138.57 43.48 2.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.552 0.741 . . . . 0.0 110.769 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.66 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.085 0.554 . . . . 0.0 109.733 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.95 140.21 29.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.819 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.6 m -131.32 24.99 4.85 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.464 0.706 . . . . 0.0 110.774 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -99.56 133.71 43.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 m -135.23 142.54 46.01 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.022 0.529 . . . . 0.0 109.646 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.32 127.91 41.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.55 141.21 38.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.056 0.542 . . . . 0.0 110.475 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.9 mm -123.04 147.68 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.337 1.055 . . . . 0.0 108.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.03 164.21 36.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.534 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.55 27.04 70.3 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.96 128.87 85.38 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.338 0.569 . . . . 0.0 112.146 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.9 -1.81 11.44 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.934 3.089 . . . . 0.0 111.166 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.88 162.4 29.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.067 0.547 . . . . 0.0 110.97 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -80.1 38.14 0.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.03 0.932 . . . . 0.0 112.169 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.1 mtt 56.92 44.67 22.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.0 113.125 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.14 137.88 46.43 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.186 0.594 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -72.93 -12.07 60.82 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -84.12 -7.37 59.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.149 -0.344 . . . . 0.0 110.943 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -93.56 -24.29 18.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.881 0.309 . . . . 0.0 110.312 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.87 -28.72 55.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.99 -21.37 47.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -81.34 -14.55 57.16 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.245 0.475 . . . . 0.0 111.701 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.1 -4.47 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.252 0.478 . . . . 0.0 111.459 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.2 8.29 23.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.672 0.789 . . . . 0.0 110.371 170.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 59.3 tptt -72.59 -44.8 9.6 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.8 Cg_endo -84.12 -20.65 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.266 1.978 . . . . 0.0 114.546 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -142.98 24.51 1.83 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.46 165.69 27.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.905 -0.497 . . . . 0.0 111.105 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.32 55.36 1.22 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.358 0.663 . . . . 0.0 109.548 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.9 140.58 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.075 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -131.44 -0.12 4.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -143.55 134.41 25.33 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.751 -0.593 . . . . 0.0 110.734 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.0 t -137.96 130.05 39.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.421 0.688 . . . . 0.0 109.829 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 111.11 14.08 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.3 0.24 . . . . 0.0 110.37 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -88.99 88.7 7.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -76.87 24.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.559 0.744 . . . . 0.0 112.474 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.7 p -128.24 5.96 5.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -144.16 14.99 1.68 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.972 0.509 . . . . 0.0 110.606 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 52.88 31.44 10.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.325 1.05 . . . . 0.0 112.185 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -133.69 149.82 51.53 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 122.965 0.506 . . . . 0.0 110.817 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.73 158.2 43.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.12 0.568 . . . . 0.0 110.114 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -130.15 138.72 50.78 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.82 153.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.313 0.101 . . . . 0.0 110.736 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -125.23 130.39 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.081 0.467 . . . . 0.0 111.727 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.11 150.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.705 1.602 . . . . 0.0 108.565 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -109.03 24.15 13.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -145.43 121.84 10.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.14 0.976 . . . . 0.0 108.73 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -78.85 -9.14 59.38 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.478 -0.139 . . . . 0.0 111.094 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -84.89 -24.42 28.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -88.68 -14.43 37.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.59 -42.78 64.19 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -74.08 -16.2 61.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.185 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -83.31 -17.89 40.9 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.069 -0.394 . . . . 0.0 110.78 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.3 t -73.69 -47.43 44.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.05 -16.88 63.8 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.757 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.48 -44.86 66.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.72 -26.14 30.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.789 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -81.78 0.11 40.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.114 0.415 . . . . 0.0 111.025 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.17 5.37 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.094 0.406 . . . . 0.0 111.968 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -143.27 24.1 1.8 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.91 -8.74 14.48 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.62 -0.675 . . . . 0.0 111.182 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.51 2.55 4.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.082 -0.843 . . . . 0.0 114.708 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.75 26.14 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.735 1.268 . . . . 0.0 112.482 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt -131.22 96.51 21.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.86 -0.78 11.04 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.998 3.132 . . . . 0.0 111.346 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.41 125.06 23.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.52 0.728 . . . . 0.0 109.268 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -89.75 126.68 35.76 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.469 0.308 . . . . 0.0 110.797 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 m -136.4 137.9 40.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.402 0.681 . . . . 0.0 110.247 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -141.37 144.64 34.63 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.113 0.965 . . . . 0.0 109.087 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -102.65 130.48 49.57 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.545 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.5 156.7 21.19 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.2 138.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.459 0.704 . . . . 0.0 110.205 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 127.36 7.9 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -89.36 136.15 33.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.751 0.421 . . . . 0.0 110.851 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.29 179.01 53.62 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 108' ' ' ASP . 46.4 Cg_exo -59.95 170.98 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.671 3.581 . . . . 0.0 112.385 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.25 24.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.011 0.525 . . . . 0.0 111.402 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 106' ' ' PRO . 18.0 m-20 -135.41 26.18 3.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.314 1.046 . . . . 0.0 109.751 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.3 t -85.75 45.16 1.17 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.657 0.783 . . . . 0.0 110.651 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.66 109.38 10.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.368 0.667 . . . . 0.0 109.482 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.75 133.4 32.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.606 0.762 . . . . 0.0 109.591 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.04 -10.22 59.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.38 -0.2 . . . . 0.0 111.191 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -100.96 17.41 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -136.52 24.24 3.17 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.02 0.928 . . . . 0.0 109.806 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.89 -12.72 0.03 OUTLIER Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.097 -0.835 . . . . 0.0 113.9 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -128.94 24.69 5.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.895 1.347 . . . . 0.0 110.059 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 81.2 p -142.7 161.72 37.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.211 1.004 . . . . 0.0 110.141 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -120.84 90.59 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.4 pt -140.44 42.78 0.52 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.695 0.798 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 71.9 Cg_endo -67.98 -8.08 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.397 2.731 . . . . 0.0 112.51 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 12.1 tpt -134.89 25.18 3.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.1 0.56 . . . . 0.0 110.221 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -135.15 -16.29 1.91 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.078 -0.388 . . . . 0.0 111.337 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -82.15 -19.66 39.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 173.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 32.0 tp -92.28 -25.62 18.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.414 0.686 . . . . 0.0 110.027 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.0 m -84.51 -21.47 30.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.2 -40.84 11.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.167 -0.333 . . . . 0.0 110.783 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.47 45.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -106.43 -25.2 11.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.682 0.674 . . . . 0.0 111.437 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -76.78 -24.84 52.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.773 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.06 -49.09 9.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.863 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -95.96 11.3 34.45 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -135.13 -16.85 1.88 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.824 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.69 21.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.408 1.003 . . . . 0.0 113.307 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 m -132.55 2.74 3.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 111.187 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.74 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.809 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -148.54 168.9 21.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.46 1.504 . . . . 0.0 108.373 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -129.61 27.81 5.21 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.501 0.321 . . . . 0.0 111.012 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.48 -12.65 77.86 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.666 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.95 -177.48 25.05 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 117.803 0.801 . . . . 0.0 111.802 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 p -77.81 -69.58 0.53 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 122.288 -0.537 . . . . 0.0 110.957 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 28.81 1.77 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.0 110.228 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.87 85.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.385 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.453 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 37.3 tp60 -162.3 -42.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.687 1.244 . . . . 0.0 113.258 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.453 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 39.5 Cg_exo -63.07 2.05 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.902 2.401 . . . . 0.0 114.741 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 3.41 7.0 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.872 0.76 . . . . 0.0 111.891 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.61 9.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.412 0.685 . . . . 0.0 111.789 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -135.64 24.13 3.4 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.97 0.908 . . . . 0.0 108.8 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.03 29.93 0.12 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.781 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mm -44.28 -38.73 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.665 1.186 . . . . 0.0 112.635 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.7 m 45.74 22.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.941 1.697 . . . . 0.0 114.448 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -145.62 139.85 26.94 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.932 0.787 . . . . 0.0 111.736 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -138.45 37.83 2.26 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.588 0.755 . . . . 0.0 109.213 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -74.53 140.85 75.73 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.63 161.85 11.54 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.715 2.943 . . . . 0.0 112.998 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -133.83 147.62 51.23 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.949 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.72 51.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.5 mm -82.86 126.15 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.73 55.59 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.377 0.671 . . . . 0.0 110.282 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.13 176.65 17.03 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.69 140.64 48.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.79 0.436 . . . . 0.0 110.559 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.02 -174.71 43.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 p -135.72 138.11 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.142 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.5 t -84.47 140.85 31.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.505 0.322 . . . . 0.0 110.402 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.0 t -135.48 137.51 42.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.884 0.474 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -88.44 53.51 2.75 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.197 0.599 . . . . 0.0 110.286 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.64 50.12 1.28 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.428 0.691 . . . . 0.0 110.863 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 66.8 mt -74.66 135.35 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.152 0.581 . . . . 0.0 109.566 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 34.5 t -135.53 148.07 49.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.153 0.581 . . . . 0.0 110.482 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -135.23 125.77 26.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.428 0.691 . . . . 0.0 109.14 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.494 ' HB3' ' HZ1' ' A' ' 170' ' ' LYS . 0.6 OUTLIER -96.7 24.44 6.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 45.9 ttp 44.93 56.63 14.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.845 0.858 . . . . 0.0 111.786 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.69 158.67 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.356 2.704 . . . . 0.0 110.871 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.1 t -136.78 150.24 48.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.277 0.631 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -135.53 125.75 26.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 0.0 110.037 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 78.5 p -137.03 147.64 46.32 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.2 0.6 . . . . 0.0 110.734 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.9 171.13 54.57 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -135.51 119.88 17.94 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.15 0.58 . . . . 0.0 109.806 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -135.84 106.56 6.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.076 0.551 . . . . 0.0 109.779 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.74 165.54 54.31 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.69 162.44 42.11 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.917 3.078 . . . . 0.0 110.922 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -135.37 144.82 46.82 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.39 0.676 . . . . 0.0 110.027 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.8 m -72.67 135.93 45.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.591 0.356 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.63 174.44 54.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.31 159.79 38.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.225 0.61 . . . . 0.0 110.242 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo . . . . . 0 C--O 1.252 1.191 0 C-N-CA 123.978 3.119 . . . . 0.0 112.354 178.299 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.472 0.245 0 N-CA-C 112.549 0.173 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.19 30.58 0.76 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.592 0.757 . . . . 0.0 111.716 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.28 24.67 1.1 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.285 0.634 . . . . 0.0 111.733 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.48 147.3 44.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.982 0.513 . . . . 0.0 110.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -105.34 154.83 19.75 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.138 0.575 . . . . 0.0 111.464 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.51 142.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.958 0.503 . . . . 0.0 110.066 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -135.22 138.09 43.24 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.121 0.568 . . . . 0.0 109.866 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 63.87 146.45 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.164 1.386 . . . . 0.0 112.57 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.08 155.18 34.83 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.922 0.489 . . . . 0.0 110.4 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.44 169.87 21.28 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.713 2.942 . . . . 0.0 110.536 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -97.93 25.95 5.58 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.417 0.687 . . . . 0.0 111.693 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -69.23 152.82 44.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.595 0.358 . . . . 0.0 111.049 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -140.47 162.39 49.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.435 0.694 . . . . 0.0 110.372 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.98 158.2 14.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.932 3.088 . . . . 0.0 112.987 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -134.29 156.48 78.95 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.284 1.033 . . . . 0.0 109.291 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.57 177.67 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.892 3.062 . . . . 0.0 110.83 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -46.18 127.23 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.085 0.554 . . . . 0.0 109.965 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.5 t -86.86 174.14 8.95 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.888 0.875 . . . . 0.0 112.327 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.57 44.17 1.05 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 0.0 111.255 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 57.79 32.0 21.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.902 0.881 . . . . 0.0 113.068 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 t -135.74 18.19 3.3 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -139.61 21.98 2.52 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.945 -0.472 . . . . 0.0 112.025 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.31 149.83 27.71 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 117.898 0.317 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.41 163.74 24.4 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.331 3.354 . . . . 0.0 112.097 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.6 9.54 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.734 3.623 . . . . 0.0 111.843 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.92 167.36 6.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.967 0.907 . . . . 0.0 110.92 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -51.95 146.89 7.8 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 120.865 0.364 . . . . 0.0 110.751 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 pt -68.54 144.29 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 120.795 0.331 . . . . 0.0 111.563 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' H ' ' HA3' ' A' ' 148' ' ' GLY . 96.4 mttt -106.61 26.5 9.88 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.406 0.683 . . . . 0.0 111.357 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 149' ' ' ILE . 25.5 t -80.61 117.18 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -130.67 135.85 48.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.675 0.39 . . . . 0.0 110.545 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -114.06 25.62 10.99 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.225 0.61 . . . . 0.0 111.866 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -128.29 110.01 11.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.268 0.627 . . . . 0.0 109.371 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m -137.86 144.75 41.56 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.827 0.451 . . . . 0.0 110.239 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.21 123.28 48.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -93.98 140.5 29.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.974 0.509 . . . . 0.0 111.008 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.3 137.08 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.001 0.921 . . . . 0.0 108.878 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.66 166.83 31.41 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.85 20.23 74.18 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.629 -0.54 . . . . 0.0 112.023 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.04 124.74 46.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.763 0.782 . . . . 0.0 111.646 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.26 -4.95 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.374 2.716 . . . . 0.0 110.656 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.85 149.54 39.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.113 0.565 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -84.74 52.44 2.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.992 0.517 . . . . 0.0 110.168 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 55.28 55.66 7.25 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.051 0.94 . . . . 0.0 112.05 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.08 111.84 17.03 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.6 -13.7 62.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -88.61 -6.45 57.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.97 -0.456 . . . . 0.0 111.042 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -92.77 -20.03 21.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.209 0.459 . . . . 0.0 109.971 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.24 -28.41 53.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.79 45.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.019 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.43 -15.99 58.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.961 0.346 . . . . 0.0 111.557 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.79 -4.28 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.222 0.465 . . . . 0.0 111.482 172.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.52 12.05 26.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.665 0.786 . . . . 0.0 109.804 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.2 tttp -75.15 -39.29 3.17 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 95.1 Cg_endo -75.03 125.73 9.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.564 1.51 . . . . 0.0 111.576 -174.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 t80 51.63 23.93 2.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.124 1.37 . . . . 0.0 113.093 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.94 160.03 42.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.462 0.705 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.03 55.85 1.87 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.491 0.316 . . . . 0.0 111.597 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.53 139.0 21.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 O-C-N 121.958 -0.464 . . . . 0.0 109.813 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -131.71 4.17 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.4 m -135.59 124.22 23.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.01 0.368 . . . . 0.0 110.334 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.14 115.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -111.62 104.58 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 104.81 14.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -81.05 104.2 11.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.064 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -85.67 24.34 1.24 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.44 0.696 . . . . 0.0 112.06 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -130.09 7.58 5.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -147.72 19.19 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.153 0.581 . . . . 0.0 110.235 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 37.51 38.03 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.704 1.602 . . . . 0.0 113.658 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -138.06 159.77 41.15 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.985 0.914 . . . . 0.0 109.769 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.67 159.29 42.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.979 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.45 135.31 47.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.12 154.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -135.21 139.04 44.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 0.0 111.357 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.63 150.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.48 1.512 . . . . 0.0 109.33 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -90.15 15.14 10.8 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -154.09 138.09 16.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.157 0.583 . . . . 0.0 109.886 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.24 -8.15 59.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.58 -28.87 24.56 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.41 -14.15 55.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.71 65.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.05 -13.69 60.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.146 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.72 -16.6 41.14 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.452 0.569 . . . . 0.0 111.213 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.64 -41.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -17.76 61.79 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.188 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -70.23 -40.29 74.58 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -62.56 -40.9 98.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -84.18 11.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.444 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -130.31 12.98 5.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.382 0.273 . . . . 0.0 111.234 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -135.78 3.63 2.99 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.57 -8.96 22.47 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.771 0.714 . . . . 0.0 111.981 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.88 -8.02 0.63 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.109 0.861 . . . . 0.0 114.552 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.55 72.84 1.42 Allowed 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.36 1.08 . . . . 0.0 109.929 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.52 119.67 30.49 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.135 0.574 . . . . 0.0 110.375 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.54 -11.72 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.67 2.913 . . . . 0.0 111.287 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.86 149.67 49.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.451 0.701 . . . . 0.0 111.115 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -103.7 98.52 8.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.6 t -117.52 147.94 42.32 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.089 0.556 . . . . 0.0 111.751 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.82 145.43 46.45 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.548 1.139 . . . . 0.0 108.869 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -127.9 152.19 48.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.93 146.68 14.16 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.98 136.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.004 0.522 . . . . 0.0 110.77 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.23 131.33 10.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -99.13 138.15 36.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.796 0.438 . . . . 0.0 110.985 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.12 175.21 49.86 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.55 164.97 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.058 3.172 . . . . 0.0 110.768 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.2 tpp85 -77.62 144.18 37.67 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.882 0.473 . . . . 0.0 110.111 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.89 40.07 0.38 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.297 0.639 . . . . 0.0 111.459 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.3 t -135.48 35.76 2.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.537 0.735 . . . . 0.0 109.921 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 98.0 m -72.16 155.7 39.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.885 0.474 . . . . 0.0 111.137 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -128.78 173.58 10.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.863 0.865 . . . . 0.0 110.065 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -67.46 -5.66 15.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -87.1 2.57 49.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.871 0.76 . . . . 0.0 109.747 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -135.63 22.99 3.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.291 1.037 . . . . 0.0 109.263 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.84 -15.71 1.7 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.52 0.581 . . . . 0.0 111.716 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -95.58 49.26 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -135.37 172.08 13.52 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.031 0.932 . . . . 0.0 110.594 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.44 144.99 4.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 123.249 0.62 . . . . 0.0 110.166 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt -58.49 149.96 58.15 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 123.226 0.61 . . . . 0.0 111.503 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.57 4.39 5.07 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.195 3.263 . . . . 0.0 112.441 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.61 11.51 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.234 0.47 . . . . 0.0 112.186 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -135.8 3.79 3.0 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.185 0.594 . . . . 0.0 110.418 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -91.38 -20.1 22.18 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.187 0.195 . . . . 0.0 110.842 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.32 -12.65 37.11 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 m -74.83 -47.34 31.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.12 -68.4 0.56 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.605 0.241 . . . . 0.0 111.039 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.73 -17.27 56.1 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.26 -16.95 13.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.986 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.49 -13.92 53.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.365 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -91.64 -32.99 15.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.371 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.84 9.22 25.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.535 0.607 . . . . 0.0 111.705 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -126.52 -11.21 6.23 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.938 -0.553 . . . . 0.0 112.05 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.426 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.2 t -127.27 24.97 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.6 t -74.59 55.48 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.227 -0.921 . . . . 0.0 109.85 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.04 156.15 47.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.095 0.958 . . . . 0.0 110.448 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -86.2 49.59 1.82 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.904 0.482 . . . . 0.0 111.079 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -135.93 55.56 1.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.725 0.81 . . . . 0.0 109.515 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.14 152.87 21.18 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.79 -16.2 71.01 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.488 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 76.7 p -145.71 12.71 1.31 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.221 1.01 . . . . 0.0 111.624 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 t -135.95 24.37 3.32 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.408 0.549 . . . . 0.0 112.15 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.47 81.34 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' C ' ' H ' ' A' ' 145' ' ' LEU . 8.6 tp-100 -146.45 149.18 36.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.32 14.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.434 3.423 . . . . 0.0 115.307 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.426 HD21 ' CG2' ' A' ' 133' ' ' VAL . 4.6 pp -67.57 -8.57 35.24 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.902 0.774 . . . . 0.0 111.693 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.27 7.92 2.46 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 123.968 0.907 . . . . 0.0 111.005 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.8 m -134.79 30.46 3.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 29' ' ' LYS . . . -139.04 -56.76 0.05 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.943 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.463 HG13 ' CG2' ' A' ' 30' ' ' VAL . 2.3 pp -135.72 -12.22 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.91 0.855 . . . . 0.0 112.759 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.9 m 34.97 43.15 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.416 0.687 . . . . 0.0 112.091 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.437 ' H ' ' CD1' ' A' ' 149' ' ' ILE . 15.7 m-30 -72.86 144.63 47.36 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.306 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.38 165.01 26.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.214 1.406 . . . . 0.0 109.098 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 57.24 71.82 1.04 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.34 168.23 21.6 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.436 3.424 . . . . 0.0 112.078 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -135.08 125.93 27.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.674 0.79 . . . . 0.0 109.268 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.8 tt -69.13 146.5 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.591 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.3 pt -90.09 27.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.2 147.62 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 117.96 0.345 . . . . 0.0 110.755 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.65 3.21 0.05 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.594 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.69 126.33 29.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.867 0.833 . . . . 0.0 110.795 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 166.23 168.95 29.19 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.52 139.78 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 C-N-CA 123.008 0.523 . . . . 0.0 110.327 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 79.2 p -139.29 24.57 2.5 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.027 0.531 . . . . 0.0 111.294 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -79.0 133.83 36.82 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.345 0.258 . . . . 0.0 110.975 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.47 30.21 3.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.716 0.806 . . . . 0.0 110.219 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.27 134.49 52.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.735 0.414 . . . . 0.0 110.958 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.4 147.51 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.01 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.0 m -132.27 114.57 14.58 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.133 0.573 . . . . 0.0 109.519 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -135.67 26.8 3.37 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.977 0.511 . . . . 0.0 111.561 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -71.49 129.6 39.18 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.597 0.359 . . . . 0.0 110.09 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.72 155.99 34.22 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.5 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.46 164.4 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.865 3.043 . . . . 0.0 110.84 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 45.7 p -130.36 136.46 49.11 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 122.833 0.453 . . . . 0.0 110.626 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -135.58 55.2 1.88 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.679 0.792 . . . . 0.0 109.667 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.2 p -121.01 155.54 34.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.328 0.651 . . . . 0.0 111.344 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.22 161.32 28.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -135.79 141.3 44.75 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 123.32 0.648 . . . . 0.0 110.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -135.91 159.86 40.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.657 0.783 . . . . 0.0 110.671 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.8 164.87 36.49 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.39 175.14 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.659 3.572 . . . . 0.0 111.418 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -135.08 143.65 46.77 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.782 0.833 . . . . 0.0 109.411 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -132.91 155.66 48.66 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 122.953 0.501 . . . . 0.0 111.131 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.15 -176.8 38.89 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.635 ' H ' ' CD ' ' A' ' 185' ' ' PRO . 87.8 tttt -141.48 -36.9 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.996 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 184' ' ' LYS . 57.9 Cg_exo . . . . . 0 C--O 1.251 1.125 0 C-N-CA 123.032 2.488 . . . . 0.0 112.325 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.477 0.53 0 N-CA-C 112.261 0.062 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -135.51 126.74 28.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.056 0.542 . . . . 0.0 109.915 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -89.81 126.11 35.57 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.756 0.422 . . . . 0.0 110.159 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -135.84 111.32 9.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.1 t30 64.76 156.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 112.388 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -75.5 149.28 7.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.137 0.575 . . . . 0.0 110.608 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.4 p -134.96 149.87 50.28 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.408 0.683 . . . . 0.0 110.432 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -113.1 147.73 36.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.181 0.592 . . . . 0.0 110.682 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.45 155.03 41.94 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.408 0.683 . . . . 0.0 110.102 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.9 167.55 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.843 . . . . 0.0 110.895 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -78.62 162.69 26.07 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.534 0.333 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -124.19 45.81 2.41 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.214 0.606 . . . . 0.0 110.128 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -135.45 65.53 62.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 123.311 0.644 . . . . 0.0 110.125 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.04 161.71 43.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.69 2.926 . . . . 0.0 110.605 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.703 ' H ' ' HD2' ' A' ' 16' ' ' PRO . 28.8 ttpp -149.08 -45.81 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.958 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.703 ' HD2' ' H ' ' A' ' 15' ' ' LYS . 69.3 Cg_endo -78.91 -5.3 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.159 1.906 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.1 t -131.39 124.02 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.3 m -139.71 147.49 40.99 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 122.99 0.516 . . . . 0.0 110.855 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -91.57 104.6 17.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.619 0.723 . . . . 0.0 110.563 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.65 156.57 48.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.492 1.117 . . . . 0.0 108.881 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.1 m -78.29 54.99 1.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.421 0.288 . . . . 0.0 111.365 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -135.1 25.71 3.56 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.341 0.657 . . . . 0.0 111.489 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.38 136.6 83.92 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.1 160.86 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.805 3.003 . . . . 0.0 111.868 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.72 2.81 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.297 3.331 . . . . 0.0 112.126 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -135.05 160.45 38.28 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.142 0.577 . . . . 0.0 110.825 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.8 m80 57.1 35.49 26.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.038 0.935 . . . . 0.0 111.454 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 149' ' ' ILE . 2.2 tp -135.97 129.08 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.289 0.636 . . . . 0.0 110.415 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -136.04 27.2 3.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.77 0.428 . . . . 0.0 112.085 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.34 46.49 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.746 0.418 . . . . 0.0 111.057 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -54.22 128.87 32.91 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.592 0.357 . . . . 0.0 110.408 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.9 m -135.69 50.63 2.09 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.074 0.549 . . . . 0.0 111.052 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -133.98 143.39 48.12 Favored 'General case' 0 C--N 1.337 0.042 0 C-N-CA 123.068 0.547 . . . . 0.0 110.304 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 t -135.7 170.19 16.37 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.613 0.765 . . . . 0.0 109.677 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.45 142.16 51.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.425 0.557 . . . . 0.0 112.256 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.24 143.34 50.72 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -122.74 150.49 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.87 171.0 34.87 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.865 -0.522 . . . . 0.0 112.143 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.58 73.96 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.34 128.49 59.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 117.464 0.632 . . . . 0.0 111.883 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -87.67 -7.54 6.46 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.267 3.311 . . . . 0.0 111.457 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.56 156.35 30.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.329 1.051 . . . . 0.0 111.953 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.19 57.97 4.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.938 0.895 . . . . 0.0 112.226 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 38.5 ttm 53.54 55.74 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.654 0.782 . . . . 0.0 112.083 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -126.92 108.44 10.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.252 0.621 . . . . 0.0 109.563 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.97 -17.7 65.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.95 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -85.64 -3.06 58.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.202 -0.311 . . . . 0.0 111.2 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -94.43 -23.7 17.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.466 0.575 . . . . 0.0 109.973 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.81 -35.89 75.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 170.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.3 60.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.555 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -78.22 -11.67 59.94 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.707 -0.621 . . . . 0.0 110.703 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.88 -1.27 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.58 12.29 14.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.767 0.827 . . . . 0.0 110.595 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.8 tttt -109.69 -32.28 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 59.0 Cg_exo -57.04 -21.17 40.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.492 2.128 . . . . 0.0 114.259 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.6 5.8 1.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.0 174.14 11.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.462 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.52 55.52 1.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.176 0.591 . . . . 0.0 110.662 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.74 139.7 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -115.39 -2.02 12.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -172.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.1 m -141.64 131.21 23.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.432 0.56 . . . . 0.0 110.58 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -143.19 125.19 12.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.205 0.602 . . . . 0.0 109.865 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.59 139.96 45.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.985 0.514 . . . . 0.0 110.055 173.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -109.29 138.6 45.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.82 0.848 . . . . 0.0 111.219 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -102.08 105.24 15.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -79.92 24.56 0.4 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.837 0.855 . . . . 0.0 113.253 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.2 m -133.16 6.5 3.89 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.847 0.294 . . . . 0.0 111.63 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -152.73 11.47 0.5 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.718 0.235 . . . . 0.0 111.228 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 47.44 47.03 17.36 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -128.44 150.64 50.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.121 0.569 . . . . 0.0 110.312 -173.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.34 155.42 50.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.306 0.574 . . . . 0.0 111.742 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -127.3 127.16 43.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.39 150.75 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.465 0.174 . . . . 0.0 111.188 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.47 131.32 43.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.95 0.405 . . . . 0.0 111.617 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -106.36 157.57 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 124.759 1.224 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -86.96 -2.02 58.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -153.42 150.21 28.58 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.082 -0.386 . . . . 0.0 110.366 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -70.26 -12.63 61.73 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.358 -0.214 . . . . 0.0 111.414 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -77.85 -16.92 57.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.924 -0.485 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.64 -14.92 36.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.145 -0.347 . . . . 0.0 110.219 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.55 -40.41 35.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -73.48 -25.56 60.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -79.1 -22.59 45.01 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.317 0.508 . . . . 0.0 111.203 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.9 t -74.75 -42.65 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.27 -16.08 62.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.452 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -78.86 -24.63 44.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.29 0.496 . . . . 0.0 110.412 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -99.14 -17.32 18.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.107 -0.371 . . . . 0.0 110.671 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.96 0.26 57.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.018 -0.426 . . . . 0.0 110.077 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.34 -2.58 2.48 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -144.14 20.47 1.75 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.092 0.86 . . . . 0.0 113.007 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -135.99 55.59 1.85 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.1 -2.82 72.3 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.476 -0.624 . . . . 0.0 112.798 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 50.86 74.76 0.21 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.91 0.884 . . . . 0.0 112.085 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.8 151.86 40.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.846 0.458 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.24 -6.82 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.895 3.064 . . . . 0.0 112.231 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.64 128.62 36.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.878 0.308 . . . . 0.0 110.281 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -89.32 100.36 13.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.1 m -104.95 135.39 46.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.754 0.422 . . . . 0.0 111.059 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -141.27 149.25 41.06 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.646 0.779 . . . . 0.0 109.933 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -103.85 140.62 37.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.98 151.51 22.22 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.31 151.64 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.488 0.715 . . . . 0.0 111.094 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.58 148.53 17.81 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -123.13 25.34 8.51 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.915 0.486 . . . . 0.0 111.168 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.11 -177.56 38.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.235 0.445 . . . . 0.0 112.426 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.94 170.22 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.784 3.656 . . . . 0.0 112.761 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -126.86 128.23 46.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.476 0.71 . . . . 0.0 109.286 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.3 44.01 2.6 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.046 0.539 . . . . 0.0 110.877 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 27.6 p -81.95 24.85 0.6 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.036 0.534 . . . . 0.0 111.402 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.36 168.59 18.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 110.974 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.01 159.2 14.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.905 0.482 . . . . 0.0 110.257 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -65.97 -6.07 11.47 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -80.35 -3.0 47.82 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.249 -0.282 . . . . 0.0 110.323 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -135.82 4.33 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.831 0.852 . . . . 0.0 110.057 171.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.92 -11.38 37.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -81.22 55.49 2.56 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.321 0.648 . . . . 0.0 110.417 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -135.29 141.26 45.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.492 0.717 . . . . 0.0 110.272 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.0 mt -89.64 139.18 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.913 0.485 . . . . 0.0 109.877 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.12 136.43 13.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.66 1.81 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.682 2.922 . . . . 0.0 112.497 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.8 ttt -84.51 -4.14 58.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.913 -0.492 . . . . 0.0 111.221 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -135.68 10.46 3.4 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.549 0.339 . . . . 0.0 111.403 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -74.62 -10.34 59.44 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.4 -23.78 32.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.3 m -89.94 -15.6 31.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -77.51 -50.4 12.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.613 0.365 . . . . 0.0 110.065 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.24 -15.28 41.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -91.3 -41.47 10.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.672 0.669 . . . . 0.0 110.876 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -68.77 -28.85 67.15 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.405 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.457 ' HE2' HD13 ' A' ' 157' ' ' ILE . 58.9 tttm -70.9 -62.53 1.36 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -98.1 21.58 10.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 -10.46 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.48 3.42 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.2 0.909 . . . . 0.0 112.744 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.9 m -87.79 31.13 0.78 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.244 -0.91 . . . . 0.0 111.2 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.47 24.9 6.62 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.177 0.991 . . . . 0.0 109.42 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -135.36 169.17 17.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.855 1.262 . . . . 0.0 109.144 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -76.21 24.22 0.14 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.04 137.35 2.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.02 152.78 20.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.0 m 55.24 36.45 27.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.576 0.703 . . . . 0.0 109.274 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.8 m -147.66 14.34 1.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.852 1.261 . . . . 0.0 109.042 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.21 -106.45 2.99 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 82.3 mt-30 -152.29 -42.24 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.58 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 50.2 Cg_exo -60.47 -20.51 64.16 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.849 2.366 . . . . 0.0 115.653 -171.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.97 1.2 1.64 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.07 -4.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 39.3 p -133.72 11.71 4.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.88 -71.74 1.31 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.593 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -108.55 -5.33 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.1 m 45.96 18.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.967 1.707 . . . . 0.0 114.877 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.6 154.02 17.52 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 118.438 0.563 . . . . 0.0 110.183 171.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -127.94 78.97 1.87 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.067 0.46 . . . . 0.0 110.559 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -137.65 61.48 30.55 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 109.889 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.72 167.94 25.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.287 3.325 . . . . 0.0 112.377 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -103.88 146.38 28.74 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.887 0.875 . . . . 0.0 109.623 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.8 tt -80.23 132.91 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 112.088 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.457 HD13 ' HE2' ' A' ' 130' ' ' LYS . 32.8 mm -135.5 127.04 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.484 1.114 . . . . 0.0 108.112 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.44 150.75 29.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.178 0.591 . . . . 0.0 110.628 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 174.47 0.66 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.827 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.04 149.48 35.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.006 0.903 . . . . 0.0 111.327 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 175.9 177.04 44.62 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.75 138.7 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.074 0.55 . . . . 0.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.8 m -135.62 28.98 3.27 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.098 0.559 . . . . 0.0 111.279 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.0 p -73.62 145.01 45.7 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.565 0.346 . . . . 0.0 111.024 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -135.92 142.63 44.67 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.384 0.674 . . . . 0.0 110.205 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.37 147.67 49.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.354 0.661 . . . . 0.0 110.361 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.4 tp -135.52 144.02 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.108 0.563 . . . . 0.0 110.421 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 81.0 p -135.63 156.1 49.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.669 0.788 . . . . 0.0 110.237 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.858 0.463 . . . . 0.0 110.28 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.55 152.17 51.03 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.8 ptm -145.86 154.5 51.41 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 122.961 0.504 . . . . 0.0 110.425 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.79 167.6 26.12 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.622 2.881 . . . . 0.0 110.805 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.8 p -130.96 29.37 4.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.203 0.601 . . . . 0.0 110.885 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.56 105.34 4.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.774 0.429 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -135.9 147.23 48.07 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.265 0.626 . . . . 0.0 110.61 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.18 170.81 43.78 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -135.78 129.54 32.68 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.074 0.55 . . . . 0.0 110.316 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -137.08 104.65 5.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.06 157.81 51.53 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.02 -12.25 19.58 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.844 3.03 . . . . 0.0 111.597 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 23.3 tpp85 -139.67 139.15 36.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.287 0.635 . . . . 0.0 110.091 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.1 m -135.09 48.32 2.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.621 0.768 . . . . 0.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.39 176.92 49.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 88.6 tttt -151.02 -49.61 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.132 -0.937 . . . . 0.0 112.152 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.667 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 94.6 Cg_endo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 122.208 1.939 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.473 0.271 0 N-CA-C 112.761 0.254 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.82 55.22 2.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.836 0.854 . . . . 0.0 110.175 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -123.11 24.82 8.74 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.8 0.84 . . . . 0.0 110.771 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 pp -93.05 160.11 15.01 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.065 0.546 . . . . 0.0 111.652 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -135.83 24.89 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.312 0.645 . . . . 0.0 111.268 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.59 149.08 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 122.741 0.416 . . . . 0.0 111.233 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 t -135.67 140.35 44.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.419 0.688 . . . . 0.0 110.104 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.36 154.56 50.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.095 0.558 . . . . 0.0 111.046 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 47.1 79.26 0.35 Allowed Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 112.73 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -81.05 -26.99 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.147 2.565 . . . . 0.0 113.54 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -158.08 34.45 0.25 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -138.09 141.09 40.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.682 1.128 . . . . 0.0 112.646 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -155.07 140.92 12.76 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.6 178.93 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.456 3.438 . . . . 0.0 114.139 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 63.87 155.92 0.12 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.397 1.479 . . . . 0.0 112.926 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.85 -11.0 28.79 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.745 2.963 . . . . 0.0 111.948 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.24 149.37 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.7 p -77.22 170.89 15.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.988 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -83.83 108.57 16.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.767 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -37.31 150.15 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.137 1.375 . . . . 0.0 113.245 171.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.2 p 54.66 21.82 3.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.406 1.882 . . . . 0.0 113.429 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.9 m -135.95 30.81 3.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.603 0.761 . . . . 0.0 109.285 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 156.28 81.59 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.324 0.65 . . . . 0.0 109.97 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.55 165.65 30.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.656 2.904 . . . . 0.0 111.092 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.89 -10.14 16.45 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.282 3.321 . . . . 0.0 114.067 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -69.35 137.82 53.22 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.143 0.429 . . . . 0.0 111.08 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -79.55 136.76 36.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.726 0.41 . . . . 0.0 110.554 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 pp -135.55 -177.78 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.48 0.712 . . . . 0.0 110.609 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -83.25 51.34 1.95 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.41 136.68 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 122.899 0.48 . . . . 0.0 109.752 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -86.16 55.74 3.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.312 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.1 p -63.92 155.39 30.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.297 0.639 . . . . 0.0 112.207 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -67.36 135.38 53.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.883 0.873 . . . . 0.0 110.05 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.6 p -135.8 157.39 46.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.092 0.557 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.45 131.01 54.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.289 0.636 . . . . 0.0 109.366 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -115.26 142.91 46.04 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.202 0.601 . . . . 0.0 110.804 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.93 141.81 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.835 0.854 . . . . 0.0 109.085 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.09 29.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.03 75.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.582 -0.565 . . . . 0.0 111.931 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 m -55.85 124.54 58.4 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.85 0.825 . . . . 0.0 110.87 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.5 -2.83 13.08 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.324 2.683 . . . . 0.0 111.076 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.54 157.91 34.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.32 0.648 . . . . 0.0 110.133 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -85.09 47.85 1.47 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.51 55.92 6.81 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.915 0.886 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -126.87 116.65 21.16 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.31 -12.58 61.78 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -83.78 -11.43 57.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.085 -0.384 . . . . 0.0 110.896 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -95.73 -18.53 20.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.392 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.49 -26.79 51.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.96 -22.63 42.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.94 -14.75 59.83 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.112 -0.368 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 -2.64 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 118.243 0.474 . . . . 0.0 111.783 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.33 14.3 22.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.6 0.76 . . . . 0.0 109.837 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 64.9 tttp -88.56 -37.23 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.937 169.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 49.8 Cg_exo -59.4 116.91 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.252 1.968 . . . . 0.0 111.111 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 51.67 23.89 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.398 1.079 . . . . 0.0 113.178 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 159.45 44.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.116 0.416 . . . . 0.0 110.9 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -135.34 59.18 1.73 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.894 0.477 . . . . 0.0 111.301 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -70.15 142.59 15.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 O-C-N 121.856 -0.527 . . . . 0.0 109.996 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -132.45 6.62 4.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.0 m -135.51 119.75 17.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.213 0.46 . . . . 0.0 110.472 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.16 123.91 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.284 0.633 . . . . 0.0 109.406 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 104.66 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.22 117.62 34.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -135.09 155.95 49.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.806 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 60.24 177.21 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.137 1.375 . . . . 0.0 112.349 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -70.22 78.54 0.52 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.509 0.723 . . . . 0.0 111.141 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 50.09 32.27 5.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.915 1.686 . . . . 0.0 114.833 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -135.56 4.17 3.09 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -139.47 55.26 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.226 0.921 . . . . 0.0 111.294 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.01 137.21 36.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.052 0.454 . . . . 0.0 110.228 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -135.5 133.49 38.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.552 0.741 . . . . 0.0 109.939 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.66 152.34 31.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.549 0.214 . . . . 0.0 111.137 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -135.74 142.45 45.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.241 0.544 . . . . 0.0 111.93 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.75 151.02 22.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.479 1.511 . . . . 0.0 109.174 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -87.77 11.12 16.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.3 t -149.7 136.06 19.07 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.821 0.448 . . . . 0.0 109.839 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -72.59 -17.7 61.67 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 122.401 -0.187 . . . . 0.0 110.585 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -82.53 -22.06 35.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.23 -19.07 37.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.72 66.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.21 -14.51 60.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.93 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.5 -19.86 37.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.238 0.472 . . . . 0.0 111.002 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.77 -44.06 46.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.27 -18.57 63.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -75.28 -28.54 59.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.53 0.604 . . . . 0.0 109.593 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -72.14 -28.91 63.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.4 5.55 51.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.529 0.332 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.7 17.26 5.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.896 0.478 . . . . 0.0 110.577 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -129.56 -6.52 4.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.654 0.382 . . . . 0.0 111.209 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -97.84 -6.61 32.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.472 0.578 . . . . 0.0 112.041 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 5.32 3.91 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.176 0.893 . . . . 0.0 114.093 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.02 50.11 0.52 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.392 1.096 . . . . 0.0 109.874 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.82 127.99 53.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 122.712 0.405 . . . . 0.0 111.395 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.03 0.71 8.8 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.4 3.4 . . . . 0.0 112.238 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.47 150.66 50.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.85 104.25 16.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 p -121.76 133.73 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.481 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -137.31 145.0 42.89 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 123.459 0.704 . . . . 0.0 110.16 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -133.1 157.4 45.38 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.041 0.537 . . . . 0.0 110.026 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.91 -176.07 40.57 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.546 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.55 143.33 36.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 125.049 1.34 . . . . 0.0 109.951 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.15 140.97 18.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -130.95 55.22 1.86 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.691 0.796 . . . . 0.0 109.688 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.38 156.67 19.65 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.52 -22.04 9.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.615 2.876 . . . . 0.0 112.34 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -149.51 156.8 42.57 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.736 0.414 . . . . 0.0 111.165 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -102.34 24.88 9.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.371 0.668 . . . . 0.0 110.774 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.53 25.25 12.01 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.448 0.699 . . . . 0.0 111.227 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 75.7 m -77.2 150.15 35.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 110.643 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.53 141.95 50.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -70.89 -10.26 59.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -97.51 6.02 48.74 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.511 0.596 . . . . 0.0 110.448 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -147.33 28.42 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.536 0.735 . . . . 0.0 109.841 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.95 -11.56 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.277 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -84.47 55.51 3.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.449 1.624 . . . . 0.0 109.979 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -133.41 149.07 51.82 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.607 0.763 . . . . 0.0 110.388 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -74.26 147.68 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 121' ' ' MET . 26.5 mt 63.79 126.33 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.592 1.557 . . . . 0.0 111.243 -172.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.79 -7.32 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.305 2.67 . . . . 0.0 112.889 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.493 ' H ' HG22 ' A' ' 119' ' ' ILE . 5.4 mpp? -85.81 25.87 1.05 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.385 0.539 . . . . 0.0 111.388 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -72.2 -20.71 61.53 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -92.47 10.15 31.36 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.227 -0.296 . . . . 0.0 110.949 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.55 -32.61 12.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 t -84.86 -27.68 26.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.7 -59.68 2.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.557 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.69 -24.77 41.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.82 -27.54 10.68 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 113.142 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -85.08 -18.77 33.27 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.6 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -87.37 -55.26 3.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.539 0.609 . . . . 0.0 109.738 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -87.3 4.49 42.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 m -139.58 -5.56 1.37 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 172.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.43 21.18 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.052 1.297 . . . . 0.0 112.092 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 t -100.63 30.14 4.11 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.371 -0.831 . . . . 0.0 111.384 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.57 24.36 8.57 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 110.218 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' GLY . 25.7 tt0 -140.43 156.51 46.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.354 1.062 . . . . 0.0 108.834 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -74.87 24.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.32 0.648 . . . . 0.0 112.082 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' GLN . . . 166.06 160.67 13.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.17 -169.2 42.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.1 m 68.63 112.0 0.04 OUTLIER 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.331 1.053 . . . . 0.0 112.366 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.7 t 59.36 24.93 13.53 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.345 1.058 . . . . 0.0 112.606 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.44 -9.1 82.28 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -156.82 147.24 16.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.26 7.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.445 3.43 . . . . 0.0 115.67 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.72 6.0 5.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.031 0.832 . . . . 0.0 111.663 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.08 17.57 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.125 0.57 . . . . 0.0 111.645 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -135.12 40.41 2.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.01 0.924 . . . . 0.0 109.136 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.84 -53.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.51 128.23 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.814 0.816 . . . . 0.0 110.395 171.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.38 24.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.758 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -127.56 125.33 40.12 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.689 0.796 . . . . 0.0 109.546 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -146.41 153.38 40.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.612 0.365 . . . . 0.0 111.345 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.25 153.87 38.21 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.603 0.761 . . . . 0.0 109.053 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.45 137.82 37.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.863 2.375 . . . . 0.0 110.874 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.97 149.82 31.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.134 0.573 . . . . 0.0 110.386 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 19.0 tt -135.67 148.52 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.036 0.535 . . . . 0.0 110.316 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.2 28.79 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.12 151.96 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 122.618 0.367 . . . . 0.0 110.569 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -175.4 177.43 47.29 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -135.72 149.98 49.39 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.122 0.569 . . . . 0.0 110.999 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.2 177.63 52.3 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.55 142.7 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.16 0.584 . . . . 0.0 110.35 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.8 p -135.71 152.61 51.34 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.369 0.668 . . . . 0.0 110.719 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.6 t -135.74 143.32 45.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.128 0.571 . . . . 0.0 110.376 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -95.09 134.53 37.69 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.047 0.539 . . . . 0.0 110.459 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.71 134.97 39.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.109 0.564 . . . . 0.0 110.139 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.03 142.55 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.108 0.563 . . . . 0.0 110.149 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 76.7 p -83.82 145.88 28.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.819 0.447 . . . . 0.0 110.824 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -135.71 145.84 47.1 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.83 0.452 . . . . 0.0 111.025 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.19 148.26 48.04 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.73 0.812 . . . . 0.0 109.934 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.67 152.63 65.81 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.075 0.55 . . . . 0.0 110.403 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.05 156.89 38.48 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.811 3.007 . . . . 0.0 111.541 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 p -135.5 144.83 46.57 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.524 0.729 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -135.55 130.77 35.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.739 0.416 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 59.6 m -136.0 143.63 44.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.511 0.724 . . . . 0.0 110.266 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -71.53 161.47 54.21 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -135.92 145.8 46.66 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.104 0.562 . . . . 0.0 111.07 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.65 125.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.273 0.629 . . . . 0.0 109.379 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.2 155.06 48.62 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.06 160.06 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.945 3.097 . . . . 0.0 111.022 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -138.73 146.73 41.82 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.288 0.635 . . . . 0.0 110.345 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.0 m -135.74 124.33 23.65 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.822 0.449 . . . . 0.0 110.388 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.3 173.4 54.27 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -139.73 152.0 67.28 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.41 0.684 . . . . 0.0 109.912 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.793 2.995 . . . . 0.0 111.068 178.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.471 0.154 0 N-CA-C 112.546 0.171 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -135.38 147.14 48.95 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.253 0.621 . . . . 0.0 110.352 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -135.7 133.66 38.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.098 0.559 . . . . 0.0 110.122 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -81.58 147.83 29.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.799 0.44 . . . . 0.0 111.373 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -80.56 104.04 10.82 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.08 141.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.106 0.562 . . . . 0.0 110.3 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -94.14 106.41 18.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -66.78 130.8 44.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.022 0.439 . . . . 0.0 111.112 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -153.03 153.39 29.64 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.117 0.567 . . . . 0.0 109.971 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.87 160.88 46.63 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.518 2.812 . . . . 0.0 110.586 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -135.21 136.08 41.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.606 0.362 . . . . 0.0 110.831 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.69 139.01 43.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.79 133.19 84.49 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 110.154 -0.314 . . . . 0.0 110.154 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.28 163.94 29.61 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.791 2.994 . . . . 0.0 110.762 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -82.56 -49.11 0.83 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.685 175.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.81 177.33 8.84 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.771 2.314 . . . . 0.0 109.919 171.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -126.02 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.2 m -154.27 -1.63 0.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -158.73 123.62 4.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.101 0.864 . . . . 0.0 111.447 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -154.4 151.54 29.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.384 0.674 . . . . 0.0 109.596 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.3 m -92.05 19.22 6.99 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 m -140.25 81.9 1.83 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.5 mt -125.55 138.73 32.43 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.929 0.492 . . . . 0.0 110.829 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.05 164.85 19.71 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.15 3.233 . . . . 0.0 111.237 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.57 -0.83 4.85 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.452 3.435 . . . . 0.0 113.783 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.24 146.57 43.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.214 0.605 . . . . 0.0 112.427 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -73.31 163.05 28.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.989 0.915 . . . . 0.0 109.736 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.74 142.78 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.617 0.367 . . . . 0.0 110.783 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -127.73 24.11 6.15 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.05 91.88 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.46 143.16 25.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.949 0.499 . . . . 0.0 109.719 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -107.82 104.48 13.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.713 0.292 . . . . 0.0 110.33 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.2 ptm85 -142.69 160.41 40.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.288 0.635 . . . . 0.0 110.93 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.6 p -135.04 135.07 41.03 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.191 0.596 . . . . 0.0 109.822 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.66 126.05 53.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -112.4 140.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.752 0.821 . . . . 0.0 110.312 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mm -125.45 144.66 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.42 176.97 37.91 Favored Glycine 0 CA--C 1.524 0.651 0 O-C-N 121.863 -0.523 . . . . 0.0 112.206 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.78 19.7 73.55 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 m -62.55 130.0 93.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 117.563 0.682 . . . . 0.0 111.242 -173.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.76 -10.35 6.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.13 3.22 . . . . 0.0 111.307 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 45' ' ' LYS . 4.0 pp -82.03 156.08 24.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.684 1.193 . . . . 0.0 111.666 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -80.7 55.93 2.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.736 0.815 . . . . 0.0 112.109 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.1 mtm 50.73 55.34 9.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.14 0.976 . . . . 0.0 112.495 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 88.5 tttt -115.55 106.06 13.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.64 -15.71 63.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -84.17 -7.5 59.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.158 -0.339 . . . . 0.0 110.827 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -96.85 -20.74 17.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.405 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.72 -29.28 62.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.84 50.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.235 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -76.63 -13.11 60.09 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.792 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.96 -2.6 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -118.22 18.28 13.79 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.688 0.795 . . . . 0.0 110.291 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.3 ttmt -105.71 -35.51 0.19 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.442 -0.79 . . . . 0.0 113.035 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.1 Cg_exo -58.97 -23.97 70.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.645 2.23 . . . . 0.0 114.161 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -143.82 13.71 1.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.78 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.121 0.569 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -134.56 57.86 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.483 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.32 138.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -130.65 9.31 5.02 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -135.44 113.64 11.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.42 128.14 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.13 131.49 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mt -107.78 122.68 47.26 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -118.19 161.71 19.44 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 62.1 24.9 14.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.24 1.816 . . . . 0.0 112.783 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 m 52.6 26.44 4.35 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.841 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -141.05 -174.79 4.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.29 1.436 . . . . 0.0 109.122 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.58 30.65 0.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -87.95 81.36 7.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.379 0.991 . . . . 0.0 108.728 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.16 138.73 32.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.424 0.631 . . . . 0.0 112.242 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -136.02 131.67 35.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.952 0.901 . . . . 0.0 108.866 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -133.0 151.66 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 111.617 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -135.47 142.28 45.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.421 0.629 . . . . 0.0 111.597 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.22 152.77 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 125.103 1.361 . . . . 0.0 109.156 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -98.33 24.14 7.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.6 t -149.99 138.57 20.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.959 0.504 . . . . 0.0 110.09 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -38.48 73.82 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -76.35 -15.94 59.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.241 -0.287 . . . . 0.0 111.587 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -86.28 -18.78 31.13 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.873 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.91 -22.56 42.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.94 -19.26 37.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.292 -0.255 . . . . 0.0 111.366 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -78.39 -43.38 26.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.466 0.575 . . . . 0.0 110.157 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -14.97 60.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.002 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -71.55 -43.3 66.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.764 0.711 . . . . 0.0 109.144 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -76.04 -12.4 60.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.419 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -92.35 -1.26 57.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.1 -0.375 . . . . 0.0 110.325 170.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -112.36 3.19 16.84 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.797 0.439 . . . . 0.0 111.429 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -135.02 1.69 3.01 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.15 55.17 1.77 Allowed 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.2 -0.28 20.65 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.804 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.02 3.02 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.912 0.856 . . . . 0.0 111.798 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -89.15 153.58 49.0 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 122.859 0.463 . . . . 0.0 109.776 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.53 -11.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.688 2.925 . . . . 0.0 112.062 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.08 153.14 21.5 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.786 0.435 . . . . 0.0 111.755 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -125.41 137.44 54.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 109.025 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -135.46 141.98 45.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -137.53 147.49 45.21 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.224 1.01 . . . . 0.0 109.552 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -135.13 160.49 38.2 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.12 175.08 33.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.36 148.83 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.122 0.969 . . . . 0.0 109.952 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -164.5 142.02 7.49 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -94.28 19.09 9.9 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.929 0.492 . . . . 0.0 111.496 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.9 175.93 21.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.328 0.489 . . . . 0.0 112.455 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.73 174.71 12.35 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.419 3.413 . . . . 0.0 110.771 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -64.71 151.35 45.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 122.746 0.418 . . . . 0.0 110.59 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.88 54.83 1.39 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.008 0.523 . . . . 0.0 111.015 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 68.2 m 56.07 55.93 6.39 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.248 0.619 . . . . 0.0 111.601 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.01 104.9 2.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.869 0.366 . . . . 0.0 110.444 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -135.71 172.61 12.76 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.51 1.124 . . . . 0.0 109.178 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -65.62 -7.28 14.26 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.082 -0.386 . . . . 0.0 111.579 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -73.98 0.26 14.12 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -135.12 16.73 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.578 1.151 . . . . 0.0 108.874 170.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.62 -18.29 18.94 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -131.34 24.35 4.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.286 0.635 . . . . 0.0 110.226 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.24 36.35 2.31 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.536 0.735 . . . . 0.0 110.657 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.08 133.48 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.814 0.446 . . . . 0.0 110.548 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 35.9 mm -131.49 133.98 25.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 46.8 Cg_exo -61.04 -13.38 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.633 2.888 . . . . 0.0 115.797 -171.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.88 23.85 3.34 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -91.11 -12.4 35.69 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 121.641 -0.662 . . . . 0.0 110.911 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -88.59 -6.22 57.67 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.6 tp -101.41 -27.62 13.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.709 0.804 . . . . 0.0 109.601 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -80.98 -21.68 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.29 -44.44 10.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 0.0 111.199 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.58 -13.94 59.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.46 -17.31 11.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.903 0.774 . . . . 0.0 111.747 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.405 ' HB3' ' HZ3' ' A' ' 129' ' ' LYS . 8.0 ttpm? -70.97 -25.65 62.81 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.867 169.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.89 -63.43 1.32 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.296 0.238 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -80.7 8.48 7.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -143.91 -17.69 0.59 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.6 24.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.914 1.234 . . . . 0.0 113.693 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.5 m -103.92 26.61 8.47 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.179 -0.951 . . . . 0.0 111.665 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.07 24.02 3.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.788 0.435 . . . . 0.0 111.218 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -148.14 -74.99 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.274 -0.266 . . . . 0.0 111.265 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -140.5 158.1 44.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.853 0.861 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.67 157.39 50.53 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.57 171.63 27.09 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 123.372 0.511 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 34.7 p -87.13 -5.55 58.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.206 0.602 . . . . 0.0 110.564 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.9 m -89.43 13.52 13.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.504 0.322 . . . . 0.0 110.167 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.51 -12.4 81.88 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -141.69 158.26 63.23 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.976 0.51 . . . . 0.0 110.135 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.15 14.47 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.297 3.332 . . . . 0.0 112.927 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.49 -6.0 27.71 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.899 0.772 . . . . 0.0 111.148 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -75.13 -1.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -137.62 34.03 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.47 1.108 . . . . 0.0 109.403 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.43 -16.99 0.38 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.475 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.03 -55.71 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.16 0 CA-C-N 118.623 1.212 . . . . 0.0 112.353 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.2 m 30.31 49.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.663 1.585 . . . . 0.0 114.495 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.79 153.67 34.71 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.798 -0.564 . . . . 0.0 109.578 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.03 24.94 6.32 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.29 146.86 62.65 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 121.985 -0.447 . . . . 0.0 110.429 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.13 17.3 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.756 3.638 . . . . 0.0 112.687 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.75 146.89 53.03 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.693 0.397 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.2 pt -129.44 157.1 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.456 0.702 . . . . 0.0 110.828 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.488 ' H ' ' CD1' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -78.23 24.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.914 0.886 . . . . 0.0 113.003 -176.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.99 140.31 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.475 0.71 . . . . 0.0 110.069 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 75.52 -174.48 52.35 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.38 146.15 48.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.375 0.67 . . . . 0.0 110.259 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.39 9.2 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.811 -0.438 . . . . 0.0 112.664 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.36 134.49 28.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.81 0.805 . . . . 0.0 110.297 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.5 m -135.44 150.48 49.86 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.2 m -135.04 142.94 46.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.941 0.496 . . . . 0.0 110.725 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.25 158.85 20.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.337 0.655 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -127.67 147.68 50.38 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.27 0.628 . . . . 0.0 110.443 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.45 149.34 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.379 0.672 . . . . 0.0 110.295 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -135.13 155.94 49.84 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.395 0.678 . . . . 0.0 110.615 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -135.21 143.76 46.56 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.254 0.621 . . . . 0.0 110.087 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -135.16 150.81 50.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.272 0.629 . . . . 0.0 110.626 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -148.37 154.47 41.9 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.27 0.628 . . . . 0.0 110.162 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.13 167.78 25.16 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.563 2.842 . . . . 0.0 110.881 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 64.0 m -111.73 133.9 53.66 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.064 0.545 . . . . 0.0 109.98 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.42 137.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.716 0.407 . . . . 0.0 110.878 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.3 p -135.73 147.72 48.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.164 0.586 . . . . 0.0 110.659 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.9 166.1 54.73 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -135.44 27.1 3.43 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.397 0.679 . . . . 0.0 111.235 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -135.28 144.21 46.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.463 0.705 . . . . 0.0 109.616 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.81 163.89 51.74 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.29 171.99 16.94 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.399 3.399 . . . . 0.0 111.277 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -135.27 140.24 45.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.648 0.779 . . . . 0.0 109.42 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.4 m -114.0 129.26 56.62 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.816 0.446 . . . . 0.0 110.741 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.74 -179.27 52.86 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -147.15 136.18 11.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.529 2.82 . . . . 0.0 111.283 179.595 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.527 0.158 0 N-CA-C 113.117 0.391 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -137.48 54.98 1.81 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.797 0.439 . . . . 0.0 110.732 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.71 151.9 50.62 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.814 0.446 . . . . 0.0 111.288 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.35 24.44 3.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.401 0.68 . . . . 0.0 111.206 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -78.86 162.82 25.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.198 0.599 . . . . 0.0 111.682 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.48 138.51 53.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.594 0.757 . . . . 0.0 109.384 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.0 m -135.2 55.41 1.89 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.187 0.595 . . . . 0.0 110.553 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.35 152.12 45.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.615 0.366 . . . . 0.0 110.9 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -75.24 152.77 86.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.418 0.287 . . . . 0.0 110.506 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.53 174.38 12.9 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.051 3.167 . . . . 0.0 110.65 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -92.18 24.65 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.866 0.466 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -85.05 152.61 23.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.76 0.424 . . . . 0.0 110.39 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -112.22 156.42 42.04 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 122.895 0.478 . . . . 0.0 110.78 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.63 167.28 6.85 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.094 3.196 . . . . 0.0 113.039 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -132.03 157.26 78.7 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.174 0.99 . . . . 0.0 108.887 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.26 161.07 35.69 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.293 2.662 . . . . 0.0 112.38 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.14 141.22 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.236 0.614 . . . . 0.0 111.523 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 t 63.88 14.18 8.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.683 1.593 . . . . 0.0 115.191 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -147.89 39.19 0.93 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.56 -0.712 . . . . 0.0 111.313 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -130.67 152.06 50.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.338 0.655 . . . . 0.0 109.875 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.9 m -130.05 26.66 5.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.828 0.451 . . . . 0.0 111.919 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 m -133.21 55.82 1.88 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.56 133.38 46.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.65 154.51 34.91 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.573 2.849 . . . . 0.0 110.59 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.52 17.29 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.67 3.58 . . . . 0.0 112.128 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -131.02 158.37 40.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.3 t60 58.99 46.93 12.84 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.163 1.385 . . . . 0.0 112.559 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.517 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.9 tp -135.61 142.98 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -100.57 8.86 43.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.517 ' H ' HG13 ' A' ' 28' ' ' ILE . 13.7 m -135.62 104.72 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.322 0.649 . . . . 0.0 110.055 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -141.44 125.27 17.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.557 0.343 . . . . 0.0 111.027 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -144.86 51.23 1.24 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.869 0.868 . . . . 0.0 109.568 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -73.95 146.08 44.18 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 122.658 0.383 . . . . 0.0 111.458 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.5 m -134.91 143.87 47.18 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.118 0.967 . . . . 0.0 108.533 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -110.9 141.58 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -133.39 144.61 49.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.991 0.516 . . . . 0.0 110.634 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.87 155.04 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.705 0.802 . . . . 0.0 108.935 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.22 170.22 36.23 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.0 77.35 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.119 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 m -47.97 114.34 3.26 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.682 0.793 . . . . 0.0 111.714 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.21 -8.17 10.84 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.533 2.822 . . . . 0.0 113.058 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.93 -18.2 31.37 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.974 0.806 . . . . 0.0 111.182 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 33.71 49.98 0.28 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.032 1.333 . . . . 0.0 112.608 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.3 tpp -135.58 -75.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -150.94 166.76 29.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.286 0.565 . . . . 0.0 111.675 -169.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.37 -4.77 31.97 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.683 0.793 . . . . 0.0 112.31 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -83.84 -8.86 59.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.03 -0.419 . . . . 0.0 111.57 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.95 -30.13 19.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.73 -26.41 59.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.1 -19.43 36.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.33 -13.37 59.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.044 0.383 . . . . 0.0 110.798 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.5 -5.5 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.32 12.77 20.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.243 0.617 . . . . 0.0 110.991 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 16.8 tppt? -91.45 -39.69 0.38 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.327 -0.844 . . . . 0.0 113.215 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 93.7 Cg_endo -78.72 -20.01 10.84 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.794 1.663 . . . . 0.0 113.43 -173.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -136.25 17.23 3.19 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.751 0.705 . . . . 0.0 112.694 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.25 170.23 22.35 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.994 -0.442 . . . . 0.0 110.952 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.9 55.9 1.17 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.602 0.761 . . . . 0.0 109.722 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.76 138.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.105 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -131.27 7.28 4.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -145.89 127.83 15.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -141.35 128.18 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 123.33 0.652 . . . . 0.0 109.629 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.4 138.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 122.912 0.485 . . . . 0.0 109.972 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mt -107.86 104.79 14.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.031 0.932 . . . . 0.0 109.739 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -80.91 94.0 6.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.0 m120 63.21 127.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.774 1.23 . . . . 0.0 110.473 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -76.06 22.0 0.16 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -146.69 25.48 1.18 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.966 0.507 . . . . 0.0 110.52 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -135.45 -88.38 0.34 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.125 -0.359 . . . . 0.0 111.695 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -137.42 159.25 42.47 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 123.16 0.584 . . . . 0.0 111.708 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.6 143.86 45.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.57 0.748 . . . . 0.0 109.181 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.34 133.18 56.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -135.71 151.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -135.16 135.64 41.24 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.716 0.406 . . . . 0.0 111.003 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -109.17 152.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 124.675 1.19 . . . . 0.0 110.011 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -82.2 -1.4 48.98 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.4 m -144.78 127.42 16.14 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.751 0.82 . . . . 0.0 109.222 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -8.99 58.14 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.214 -0.304 . . . . 0.0 111.755 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -87.29 -14.85 39.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.095 0.407 . . . . 0.0 110.225 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -88.61 -17.71 29.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.24 -41.01 70.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -69.94 -20.32 63.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -86.39 -9.54 56.12 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.115 -0.366 . . . . 0.0 111.581 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.63 -49.38 19.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -25.44 67.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -71.16 -44.89 64.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -77.42 -26.63 51.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.553 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.87 -0.63 52.04 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.244 -0.285 . . . . 0.0 110.436 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -125.96 8.14 7.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.734 0.243 . . . . 0.0 111.575 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -135.42 15.29 3.45 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.68 49.83 2.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.337 0.517 . . . . 0.0 110.73 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.34 10.04 81.7 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.445 -0.642 . . . . 0.0 112.63 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.75 98.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.916 1.286 . . . . 0.0 111.78 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.28 154.32 93.06 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -10.98 29.78 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.601 2.868 . . . . 0.0 112.109 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.26 119.71 23.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.82 104.54 14.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -111.73 139.2 47.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.986 0.422 . . . . 0.0 111.455 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -146.14 159.17 43.66 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.482 1.113 . . . . 0.0 109.427 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -127.62 156.27 42.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.06 -175.04 14.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.21 141.22 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.127 0.464 . . . . 0.0 110.837 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.87 1.99 61.21 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.627 0.632 . . . . 0.0 113.932 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.76 31.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.429 1.114 . . . . 0.0 112.056 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.91 163.08 54.47 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.25 125.83 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.58 2.854 . . . . 0.0 111.875 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -149.64 22.95 0.9 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.448 0.299 . . . . 0.0 110.998 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -148.36 48.81 1.04 Allowed 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.113 -0.367 . . . . 0.0 110.527 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 34.7 t -135.18 55.41 1.89 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.702 0.401 . . . . 0.0 110.463 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 83.2 m -121.05 21.18 11.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.691 0.396 . . . . 0.0 111.343 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.15 149.53 32.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.178 0.591 . . . . 0.0 109.484 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -68.55 -15.74 63.64 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.79 6.56 41.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.135 -0.353 . . . . 0.0 111.1 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -135.19 24.23 3.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 109.606 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.55 -12.65 0.19 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.032 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -98.89 24.08 8.12 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.669 1.234 . . . . 0.0 110.941 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.9 t -147.72 143.7 27.77 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.426 0.69 . . . . 0.0 109.683 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.88 103.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -143.99 39.16 0.26 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.514 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 43.7 Cg_endo -60.39 -35.97 88.92 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.142 2.561 . . . . 0.0 112.627 -169.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.17 14.26 3.04 Favored 'General case' 0 C--N 1.337 0.046 0 CA-C-N 118.117 0.417 . . . . 0.0 111.022 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -82.87 -18.15 41.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.148 -0.345 . . . . 0.0 111.054 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -97.88 -2.41 40.81 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 tp -109.8 -27.11 9.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -80.67 -26.58 37.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.45 -42.13 13.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.763 0.256 . . . . 0.0 111.539 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.36 -10.45 59.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.142 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -104.78 -20.69 13.52 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.912 0.778 . . . . 0.0 110.937 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.18 -13.82 58.22 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.012 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.12 -61.61 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -78.32 -0.42 28.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -138.97 -2.53 1.68 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.75 24.35 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.749 1.159 . . . . 0.0 111.208 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.5 p -72.84 55.06 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.755 -0.591 . . . . 0.0 111.828 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 137.68 42.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.195 0.598 . . . . 0.0 110.487 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 53.13 27.5 5.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.973 . . . . 0.0 112.432 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 78.4 m95 54.26 24.98 5.4 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.05 0.94 . . . . 0.0 112.759 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.01 170.38 54.66 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 176.18 147.0 6.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.4 m 58.2 7.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.325 1.45 . . . . 0.0 113.197 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.9 p -160.21 19.83 0.15 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.768 -0.583 . . . . 0.0 111.375 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -93.46 -21.89 28.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.206 -0.775 . . . . 0.0 114.001 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -149.09 160.77 34.23 Favored Pre-proline 0 C--O 1.227 -0.096 0 CA-C-N 118.515 1.158 . . . . 0.0 110.187 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.51 -1.27 0.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.28 3.32 . . . . 0.0 114.415 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.54 -8.14 56.0 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.809 0.732 . . . . 0.0 110.712 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.61 9.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.028 0.531 . . . . 0.0 110.553 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.1 p -128.31 31.51 5.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.05 0.54 . . . . 0.0 109.964 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.22 -26.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.55 65.24 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 121.556 0.693 . . . . 0.0 110.229 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.9 m -135.98 18.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -138.14 40.1 2.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -135.19 151.46 50.67 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 154' ' ' PRO . 25.5 tt0 -154.73 43.74 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 111.061 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 153' ' ' GLU . 60.9 Cg_endo -77.89 -18.46 13.15 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 48.28 52.44 13.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.638 0.775 . . . . 0.0 111.81 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 8.4 tt -133.97 141.09 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.86 109.09 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 m -83.93 68.02 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 121.343 0.592 . . . . 0.0 110.545 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.04 -163.09 12.32 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.57 104.6 3.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.131 0.466 . . . . 0.0 110.299 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -85.55 -169.62 46.17 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.363 0.506 . . . . 0.0 111.921 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -135.36 141.25 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.829 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.1 m -135.36 36.55 2.96 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.092 0.557 . . . . 0.0 111.15 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.0 m -82.25 40.18 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.323 0.649 . . . . 0.0 111.46 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -135.73 155.73 49.93 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.809 0.844 . . . . 0.0 110.637 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.32 146.35 48.37 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.008 0.523 . . . . 0.0 110.761 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.97 139.28 47.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.747 0.819 . . . . 0.0 108.852 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 m -61.82 138.33 58.33 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.774 0.429 . . . . 0.0 111.108 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.82 40.26 0.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.558 0.743 . . . . 0.0 111.221 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.67 110.16 8.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 109.868 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 15.3 tpt -150.5 135.79 10.12 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.13 168.73 23.27 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.315 2.676 . . . . 0.0 111.066 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.5 p -127.54 32.4 5.01 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.474 0.71 . . . . 0.0 110.598 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -82.79 55.67 3.12 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.513 0.725 . . . . 0.0 110.88 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.6 m -134.7 128.48 33.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.198 0.599 . . . . 0.0 110.225 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.78 178.14 53.92 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -135.35 25.05 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.449 0.7 . . . . 0.0 111.068 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.66 154.66 51.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.708 0.803 . . . . 0.0 109.856 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.99 174.63 37.63 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.32 160.42 48.82 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 124.144 3.229 . . . . 0.0 111.427 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.51 151.63 50.54 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.034 0.933 . . . . 0.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.3 t -135.51 138.7 43.35 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.881 0.473 . . . . 0.0 110.541 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.47 176.76 41.42 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 37.9 mtmm -85.47 -41.91 0.63 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.165 -0.922 . . . . 0.0 113.074 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 85.0 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.204 1.936 . . . . 0.0 111.093 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.472 0.239 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -135.43 153.02 51.92 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.395 0.678 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.09 158.28 44.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.381 0.673 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.3 55.43 2.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.229 0.612 . . . . 0.0 110.666 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 55.08 34.8 23.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.104 0.961 . . . . 0.0 111.698 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.17 132.48 33.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 122.842 0.457 . . . . 0.0 109.847 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -66.73 120.99 14.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.15 156.63 46.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.194 0.598 . . . . 0.0 110.758 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 47.64 59.48 16.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.04 0.936 . . . . 0.0 112.272 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.87 171.36 12.4 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.669 2.913 . . . . 0.0 111.098 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.49 150.98 39.62 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.09 0.556 . . . . 0.0 110.824 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -133.01 45.65 2.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.993 0.517 . . . . 0.0 111.706 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -135.42 158.93 73.46 Favored Pre-proline 0 CA--C 1.529 0.173 0 C-N-CA 122.736 0.414 . . . . 0.0 110.192 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -55.6 151.81 36.88 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.218 3.279 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -152.06 47.66 0.42 Allowed Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.616 0.766 . . . . 0.0 110.993 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.6 -14.37 44.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.498 2.799 . . . . 0.0 113.375 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.27 -50.73 5.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.324 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.6 t -158.91 -65.45 0.08 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.026 0.375 . . . . 0.0 111.217 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -146.09 48.35 1.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.225 1.01 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.03 -48.43 64.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.945 0.898 . . . . 0.0 112.481 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 76.9 p 51.18 26.09 2.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.041 0.937 . . . . 0.0 113.124 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 m 65.36 101.2 0.04 OUTLIER 'General case' 0 C--N 1.339 0.109 0 C-N-CA 125.086 1.354 . . . . 0.0 111.696 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.45 157.94 52.32 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.127 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.56 148.08 87.12 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.653 2.235 . . . . 0.0 109.62 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.9 12.79 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.589 3.526 . . . . 0.0 113.278 -173.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -135.08 142.0 46.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 63.46 140.22 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.715 2.006 . . . . 0.0 114.994 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.7 tp -75.65 137.71 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.52 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -113.32 24.69 12.01 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.053 0.541 . . . . 0.0 112.138 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.16 -3.69 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.209 0.604 . . . . 0.0 109.722 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -141.34 32.72 1.69 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.868 0.867 . . . . 0.0 110.038 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 t -135.38 159.4 41.69 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.88 0.472 . . . . 0.0 111.256 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -111.85 129.39 56.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.404 1.082 . . . . 0.0 109.163 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -135.65 154.44 51.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.5 tp -121.32 115.46 23.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -89.02 135.96 33.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.218 1.007 . . . . 0.0 110.445 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.8 mm -127.48 104.69 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.56 164.07 13.03 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.225 0.347 . . . . 0.0 113.232 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 -47.74 3.0 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.99 1.281 . . . . 0.0 112.596 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' LEU . 27.6 m 37.64 48.64 1.35 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.375 1.47 . . . . 0.0 114.741 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.81 1.95 4.01 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.829 2.352 . . . . 0.0 110.159 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 40' ' ' VAL . 16.2 tp -79.44 43.49 0.55 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.874 1.67 . . . . 0.0 110.775 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 56.88 24.13 8.94 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.974 1.31 . . . . 0.0 112.57 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.3 ptt? 34.35 55.21 0.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.324 1.45 . . . . 0.0 113.575 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -128.68 129.32 45.64 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.96 -13.88 62.28 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -82.77 -14.67 54.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.284 0.493 . . . . 0.0 110.594 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -95.42 -24.81 16.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.191 -0.318 . . . . 0.0 110.347 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.71 -26.59 62.55 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 -20.36 36.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -79.44 -6.56 57.13 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.109 -0.369 . . . . 0.0 111.168 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.83 -3.25 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.17 -0.331 . . . . 0.0 111.889 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -113.44 15.68 19.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.532 0.733 . . . . 0.0 110.202 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttm -101.62 -40.06 0.21 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.566 169.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 32.5 Cg_exo -61.55 114.61 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.233 1.955 . . . . 0.0 110.344 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.81 30.88 5.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.55 0.74 . . . . 0.0 112.008 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.46 161.97 40.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.028 0.531 . . . . 0.0 110.883 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -138.7 85.74 2.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.672 0.389 . . . . 0.0 111.025 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.6 140.42 25.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -135.17 8.15 3.43 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.0 m -135.7 119.6 17.4 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.59 128.52 33.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.149 0.579 . . . . 0.0 110.122 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.39 143.77 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 171.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -125.4 137.86 54.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.626 1.17 . . . . 0.0 110.838 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -112.03 98.43 7.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -83.15 43.21 0.85 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.037 0.535 . . . . 0.0 111.765 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.02 -7.04 2.35 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.636 0.374 . . . . 0.0 110.914 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -153.21 35.03 0.47 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.735 0.414 . . . . 0.0 110.63 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 33.99 55.59 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.803 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -125.83 141.57 51.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.323 0.649 . . . . 0.0 111.029 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.98 154.28 47.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.293 0.568 . . . . 0.0 111.227 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -135.24 132.76 38.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.73 38.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.688 0.28 . . . . 0.0 111.379 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -135.42 129.97 34.1 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.117 0.484 . . . . 0.0 110.885 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.96 148.13 9.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.127 1.371 . . . . 0.0 108.984 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.17 24.26 11.75 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.4 t -148.72 132.16 16.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.848 0.859 . . . . 0.0 108.813 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -78.19 -14.63 59.38 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.137 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.58 -25.45 24.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -87.47 -16.37 34.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -47.84 67.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.11 -14.37 59.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.76 -11.37 48.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.477 0.581 . . . . 0.0 111.09 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.14 -41.5 17.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.08 -21.91 64.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.884 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -77.17 -26.2 52.71 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.707 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -68.56 -42.25 78.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -83.34 10.24 9.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.367 -0.208 . . . . 0.0 111.342 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -116.35 1.27 13.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.262 0.625 . . . . 0.0 109.716 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -135.58 18.57 3.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.875 0.47 . . . . 0.0 111.406 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -134.75 48.04 2.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.178 0.513 . . . . 0.0 110.957 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.88 -13.63 12.91 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.614 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.18 33.84 18.9 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.056 0.928 . . . . 0.0 113.413 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.663 ' H ' ' CD ' ' A' ' 95' ' ' PRO . 80.4 mt -136.21 -28.23 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.663 ' CD ' ' H ' ' A' ' 94' ' ' LEU . 76.9 Cg_exo -55.35 -31.64 78.05 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.075 1.85 . . . . 0.0 113.246 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt -143.2 143.22 31.68 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.422 0.689 . . . . 0.0 109.892 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -94.85 97.07 9.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.0 p -114.41 138.03 51.09 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -173.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -146.05 146.21 30.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.277 1.031 . . . . 0.0 109.127 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -135.08 160.52 38.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 110.917 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 165.7 37.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.13 142.28 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.743 0.817 . . . . 0.0 109.692 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.73 121.2 5.69 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.54 24.26 1.74 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.294 0.638 . . . . 0.0 111.136 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.59 178.94 52.73 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.54 161.92 41.14 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.02 3.147 . . . . 0.0 111.514 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -87.44 125.16 34.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.244 0.617 . . . . 0.0 110.477 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 52.58 30.68 8.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.236 1.014 . . . . 0.0 112.752 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 12.6 t -135.77 36.52 2.87 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.93 0.492 . . . . 0.0 110.114 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.63 141.67 45.1 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.21 0.604 . . . . 0.0 110.221 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -78.03 150.83 33.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.717 0.407 . . . . 0.0 110.042 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -70.18 -6.95 37.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -85.68 0.24 53.29 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.44 0.563 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -135.81 12.49 3.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.838 0.855 . . . . 0.0 109.953 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.45 -11.41 7.33 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -135.01 24.07 3.57 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.176 0.59 . . . . 0.0 110.0 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.4 m -139.99 137.89 35.06 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.934 0.894 . . . . 0.0 109.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.2 tt -90.06 130.98 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.714 0.293 . . . . 0.0 110.496 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.27 151.08 57.39 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 123.509 0.724 . . . . 0.0 109.928 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.19 176.92 8.5 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.557 2.838 . . . . 0.0 110.618 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.65 27.63 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.343 0.657 . . . . 0.0 112.483 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -15.43 51.75 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.711 -0.618 . . . . 0.0 111.294 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -85.43 -6.76 59.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.02 -42.8 9.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.53 0.732 . . . . 0.0 109.6 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -76.29 -16.74 59.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.56 -51.2 6.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.737 -0.602 . . . . 0.0 110.398 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.26 -8.68 58.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -112.81 -15.86 12.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.759 0.709 . . . . 0.0 111.487 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HZ1' ' HB2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -72.78 -20.99 61.07 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.142 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.54 -54.28 4.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.509 0.324 . . . . 0.0 110.561 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -82.91 6.14 19.53 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -147.37 0.68 0.7 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.53 15.25 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.269 0.94 . . . . 0.0 111.133 174.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.8 m -135.0 24.74 3.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.991 0.517 . . . . 0.0 109.911 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.5 151.24 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.057 0.943 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.81 20.79 1.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -141.91 24.27 2.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.458 0.703 . . . . 0.0 110.413 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.56 -159.74 35.75 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.479 0.562 . . . . 0.0 112.135 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.68 -154.28 2.37 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.091 0.853 . . . . 0.0 111.747 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.7 m -103.77 70.6 1.02 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 t 60.71 32.03 20.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.707 0.803 . . . . 0.0 111.829 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.27 79.6 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.959 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.7 -44.38 0.5 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 118.361 1.081 . . . . 0.0 113.305 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -90.53 -19.57 1.07 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.544 2.163 . . . . 0.0 113.43 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.65 -7.66 59.15 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -171.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.8 m -74.85 -0.8 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 CA-C-N 117.877 0.308 . . . . 0.0 111.241 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 t -147.67 23.22 1.12 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.367 1.067 . . . . 0.0 108.41 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.5 34.15 0.3 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.605 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.7 mm -49.0 -29.21 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 117.582 0.691 . . . . 0.0 111.956 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.3 m 44.2 29.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.55 1.54 . . . . 0.0 114.242 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -135.27 150.17 49.98 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.053 0.388 . . . . 0.0 110.555 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -133.47 24.63 4.09 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.569 0.748 . . . . 0.0 109.327 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -153.84 141.21 13.48 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.929 0.892 . . . . 0.0 108.689 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -67.78 158.35 57.65 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.169 2.579 . . . . 0.0 111.236 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.23 141.94 32.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.57 0.348 . . . . 0.0 110.856 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.58 129.8 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.014 0.526 . . . . 0.0 110.056 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 pp -135.43 151.44 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.641 0.776 . . . . 0.0 110.366 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.0 m -135.89 146.27 29.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.087 0.555 . . . . 0.0 110.866 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -85.29 -150.06 12.62 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 67.51 143.65 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.182 1.393 . . . . 0.0 113.315 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.53 177.01 45.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.21 130.44 51.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 122.75 0.42 . . . . 0.0 110.287 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.4 m -135.65 105.82 6.33 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.617 0.767 . . . . 0.0 109.125 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 t -135.76 151.09 49.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.854 0.461 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -135.41 152.18 51.16 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.849 0.859 . . . . 0.0 110.175 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.33 153.57 51.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.847 0.459 . . . . 0.0 111.36 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 tt -135.37 149.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.858 0.863 . . . . 0.0 109.632 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.7 p -135.11 152.77 51.94 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.866 0.466 . . . . 0.0 111.291 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 62.58 118.74 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.715 1.606 . . . . 0.0 113.091 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -135.45 33.34 3.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.493 0.717 . . . . 0.0 109.936 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.8 ptm -151.66 154.28 32.98 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 123.407 0.683 . . . . 0.0 110.119 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -71.41 148.43 54.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.391 2.727 . . . . 0.0 110.664 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.2 p -135.89 25.04 3.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.281 0.633 . . . . 0.0 111.168 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -102.14 24.74 9.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.187 0.595 . . . . 0.0 111.725 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 35.4 t -81.26 136.44 35.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.632 0.373 . . . . 0.0 110.829 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 174.98 160.81 23.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -142.96 152.11 41.64 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.208 0.603 . . . . 0.0 111.016 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 131.18 57.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.365 0.666 . . . . 0.0 109.488 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.64 158.61 48.94 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.34 159.91 42.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.954 3.103 . . . . 0.0 110.931 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -135.38 112.72 10.57 Favored 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.611 0.764 . . . . 0.0 109.475 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 65.2 p -135.96 131.11 34.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.509 . . . . 0.0 110.798 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.34 173.73 51.82 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 29.1 mtpp -85.53 -34.73 0.51 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.869 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 54.7 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.104 2.536 . . . . 0.0 112.451 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.527 0.155 0 N-CA-C 112.554 0.175 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.69 154.4 21.0 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.795 0.438 . . . . 0.0 110.806 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.81 144.74 52.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.568 0.347 . . . . 0.0 110.744 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.79 27.1 6.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.442 0.697 . . . . 0.0 111.544 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -80.6 44.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.26 1.024 . . . . 0.0 111.438 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.8 p -67.0 145.5 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.185 0.594 . . . . 0.0 110.783 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 t -75.18 148.91 39.17 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.985 0.514 . . . . 0.0 111.075 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -90.44 105.0 17.52 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.828 0.451 . . . . 0.0 109.852 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -148.09 156.01 43.56 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.041 0.537 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.66 158.57 56.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.342 2.695 . . . . 0.0 110.237 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -139.55 46.47 1.89 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.732 0.413 . . . . 0.0 110.594 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -64.69 140.29 58.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.517 0.327 . . . . 0.0 110.127 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -123.4 150.06 59.72 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.912 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 -172.13 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 124.34 3.36 . . . . 0.0 110.535 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.31 166.22 0.11 Allowed Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.04 1.336 . . . . 0.0 112.881 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.05 -176.87 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.727 3.618 . . . . 0.0 113.811 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.91 148.48 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.941 0.896 . . . . 0.0 112.018 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 m -71.22 65.47 0.4 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.628 1.171 . . . . 0.0 111.77 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 72.81 29.81 1.85 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.754 1.622 . . . . 0.0 114.703 172.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.5 104.58 7.05 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 m -87.87 25.59 1.5 Allowed 'General case' 0 C--O 1.231 0.088 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' CD ' ' A' ' 24' ' ' PRO . 35.2 p -140.84 87.77 2.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.153 0.981 . . . . 0.0 109.362 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 6.9 mp -108.72 39.1 0.11 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.346 1.058 . . . . 0.0 112.114 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 23' ' ' LEU . 62.2 Cg_endo -76.73 172.18 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.938 2.425 . . . . 0.0 109.391 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.3 160.82 21.86 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.584 2.189 . . . . 0.0 110.548 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 59.25 24.48 12.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.952 0.901 . . . . 0.0 112.415 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -136.27 129.15 31.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.587 0.755 . . . . 0.0 109.039 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 tp -148.54 138.77 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.563 0.345 . . . . 0.0 110.685 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -137.86 22.87 2.86 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.97 125.32 18.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 119.757 1.162 . . . . 0.0 109.24 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.43 163.78 22.53 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.293 0.637 . . . . 0.0 111.74 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -130.47 145.81 51.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.952 0.901 . . . . 0.0 109.053 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -126.57 29.5 5.72 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 m -132.31 104.62 6.84 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -101.89 140.5 36.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -130.12 137.75 50.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.34 0.656 . . . . 0.0 110.124 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -120.33 113.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.83 160.7 16.92 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.31 17.98 74.71 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.639 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.44 130.15 34.12 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.388 1.094 . . . . 0.0 110.789 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.52 -0.6 10.54 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.43 2.753 . . . . 0.0 111.425 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.68 152.41 33.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.371 0.605 . . . . 0.0 111.44 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -97.28 55.36 1.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.1 ttt 62.96 70.14 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.564 1.145 . . . . 0.0 112.198 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.35 88.75 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.09 -11.58 20.87 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.613 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -82.91 -12.41 57.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.082 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -93.88 -22.59 18.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 118.938 -1.105 . . . . 0.0 110.55 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.65 -25.51 59.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.11 -18.07 38.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -76.47 -10.39 59.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.057 -0.402 . . . . 0.0 110.595 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.5 -4.69 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.44 17.52 19.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.45 0.7 . . . . 0.0 110.519 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' H ' ' CD ' ' A' ' 55' ' ' PRO . 88.6 tttt -114.13 -35.95 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 60.4 Cg_exo -56.91 -31.73 90.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.402 2.068 . . . . 0.0 113.648 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.18 22.78 2.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.856 0.298 . . . . 0.0 111.642 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.96 176.81 11.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.626 0.37 . . . . 0.0 110.733 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.49 76.05 1.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.003 0.43 . . . . 0.0 110.505 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.03 140.57 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -131.86 7.16 4.37 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -142.8 125.85 16.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.977 0.511 . . . . 0.0 109.729 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.75 127.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 122.965 0.506 . . . . 0.0 109.759 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.14 135.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -128.67 143.29 50.91 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.068 0.547 . . . . 0.0 111.639 -176.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -123.26 104.68 9.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.27 1.028 . . . . 0.0 108.371 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -83.52 24.67 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -120.38 -3.5 9.94 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.232 -0.292 . . . . 0.0 111.725 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtm-85 -144.97 8.54 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.889 0.476 . . . . 0.0 111.304 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 51.76 42.45 29.9 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.23 0.612 . . . . 0.0 111.221 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -111.27 145.61 38.47 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.735 0.814 . . . . 0.0 110.113 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.64 43.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -125.03 127.18 46.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.9 151.1 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.476 0.125 . . . . 0.0 110.692 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.58 136.39 41.04 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.41 155.53 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 124.48 1.112 . . . . 0.0 110.567 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -93.71 10.58 32.33 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.2 t -151.33 134.88 16.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.13 0.572 . . . . 0.0 109.913 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.55 -16.13 58.84 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.45 -25.35 33.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -83.91 -13.74 52.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.77 67.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -71.12 -18.88 62.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.777 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -82.01 -18.9 41.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.46 0.573 . . . . 0.0 111.6 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.47 -44.16 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 118.565 0.621 . . . . 0.0 109.809 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.26 -23.02 64.73 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.42 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -83.16 -10.42 58.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.884 -0.51 . . . . 0.0 110.77 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.0 -27.9 24.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -94.82 4.92 53.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.267 -0.271 . . . . 0.0 111.245 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -134.8 6.03 3.41 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -149.44 15.01 0.88 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -135.37 55.16 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.84 0.745 . . . . 0.0 110.931 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.27 83.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.201 -0.777 . . . . 0.0 113.394 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.1 74.08 0.26 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.995 0.897 . . . . 0.0 111.625 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.96 159.62 13.14 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.068 0.547 . . . . 0.0 111.265 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 -9.4 9.06 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.483 3.455 . . . . 0.0 114.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.95 128.57 36.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.587 0.63 . . . . 0.0 110.552 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -90.59 71.52 6.83 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.56 0.744 . . . . 0.0 109.083 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.6 m -74.89 129.86 38.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.146 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -135.68 149.11 49.17 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.387 1.075 . . . . 0.0 109.022 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -128.34 150.77 49.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.983 0.42 . . . . 0.0 111.575 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.51 -164.35 28.6 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.9 138.2 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.187 0.493 . . . . 0.0 110.394 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.21 12.52 37.71 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.429 0.538 . . . . 0.0 112.539 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -50.9 130.75 25.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.576 0.75 . . . . 0.0 111.428 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.37 -177.95 17.92 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.17 157.02 60.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.608 2.872 . . . . 0.0 110.556 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 88.2 mtm-85 50.84 55.01 10.2 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.541 0.736 . . . . 0.0 111.198 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -52.44 125.89 17.64 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.61 0.764 . . . . 0.0 111.312 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.9 m 54.91 27.69 9.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 0.0 113.4 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.5 m -121.74 11.37 10.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.897 0.317 . . . . 0.0 111.288 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -147.73 151.66 36.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 108.877 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -73.1 -2.57 21.93 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.252 -0.28 . . . . 0.0 111.414 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.68 5.94 41.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.913 0.485 . . . . 0.0 110.284 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -136.84 33.86 2.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.007 0.923 . . . . 0.0 109.779 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 176.03 -14.14 0.03 OUTLIER Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.09 -0.839 . . . . 0.0 113.693 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -135.17 25.03 3.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.867 1.334 . . . . 0.0 111.214 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.5 m -135.57 148.83 49.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.886 0.875 . . . . 0.0 109.536 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.4 tt -135.5 145.67 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 122.644 0.377 . . . . 0.0 111.018 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.93 157.95 75.98 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.016 0.926 . . . . 0.0 109.415 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.05 166.66 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.434 2.756 . . . . 0.0 111.012 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -124.85 25.66 7.31 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.823 0.449 . . . . 0.0 111.48 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -83.59 -9.87 58.63 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.813 -0.554 . . . . 0.0 111.217 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -88.8 3.25 51.74 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.407 0.283 . . . . 0.0 110.589 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.66 -50.4 5.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.741 0.816 . . . . 0.0 108.887 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.6 m -77.65 -19.9 54.66 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.197 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.35 -45.82 12.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.043 -0.411 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.5 -19.12 39.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.273 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.87 -20.8 17.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.693 0.679 . . . . 0.0 110.997 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -67.36 -35.17 78.83 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.667 170.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.6 -77.66 0.1 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.145 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -89.15 18.71 4.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.5 t -138.89 -4.31 1.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.67 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 t -136.44 24.22 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.294 0.952 . . . . 0.0 111.27 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.8 p -73.64 24.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.133 -0.979 . . . . 0.0 112.952 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.06 24.13 3.56 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.958 -0.464 . . . . 0.0 111.087 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -147.0 144.07 28.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.668 0.787 . . . . 0.0 109.355 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -72.79 104.71 4.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.98 -179.8 49.5 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -81.81 -153.98 12.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 67.4 104.56 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.227 1.411 . . . . 0.0 113.371 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m 54.47 30.11 12.33 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.4 -33.27 53.53 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -140.78 167.05 18.85 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 146' ' ' VAL . 50.3 Cg_exo -58.29 5.56 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.462 1 C-N-CA 125.437 4.091 . . . . 0.0 116.332 -175.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.25 22.89 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.56 1.073 . . . . 0.0 111.769 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 144' ' ' PRO . 34.8 m -69.73 1.48 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.785 0.834 . . . . 0.0 111.171 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.6 p -127.68 24.83 6.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.4 -21.85 4.27 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mm -102.72 0.93 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.45 0.625 . . . . 0.0 111.028 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.47 4.85 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 122.074 -0.391 . . . . 0.0 111.952 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -157.57 156.32 31.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.277 0.489 . . . . 0.0 110.71 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.86 31.66 0.61 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.823 0.849 . . . . 0.0 112.991 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 154' ' ' PRO . 26.4 tp10 -74.81 -38.67 3.18 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 153' ' ' GLU . 86.7 Cg_endo -77.09 160.31 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.991 1.794 . . . . 0.0 111.823 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.63 131.44 34.16 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.286 0.635 . . . . 0.0 109.886 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.3 tt -91.91 132.05 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.404 ' H ' HD11 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -135.37 129.79 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.706 0.802 . . . . 0.0 109.174 175.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.43 137.31 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.064 0 C-N-CA 122.583 0.353 . . . . 0.0 110.673 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.4 0.03 85.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.62 104.31 7.06 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.14 0.576 . . . . 0.0 110.022 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -91.35 -4.55 68.25 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.08 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.1 p -85.93 140.72 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.0 0.9 . . . . 0.0 110.715 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.5 m -135.51 156.45 48.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.508 0.723 . . . . 0.0 110.45 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 79.8 p -134.44 149.53 50.76 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.258 0.623 . . . . 0.0 110.541 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -80.62 141.54 34.89 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.819 0.447 . . . . 0.0 110.884 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.48 25.82 3.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.414 0.686 . . . . 0.0 110.752 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.3 tt -80.77 142.12 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.091 0.556 . . . . 0.0 111.109 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.7 t -137.18 145.63 43.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.491 0.717 . . . . 0.0 109.991 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -135.29 135.17 40.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.974 0.509 . . . . 0.0 110.368 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.59 159.89 40.44 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.577 0.751 . . . . 0.0 110.381 178.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.0 128.4 9.31 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 163.77 37.9 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.865 3.043 . . . . 0.0 112.66 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -135.85 145.55 46.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.118 0.567 . . . . 0.0 110.459 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -136.31 143.48 44.18 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.055 0.542 . . . . 0.0 110.602 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.3 p -135.39 24.75 3.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.207 0.603 . . . . 0.0 111.106 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.15 -1.59 90.51 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.417 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -74.77 104.52 5.44 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.714 0.757 . . . . 0.0 109.837 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.72 136.5 54.49 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.874 0.87 . . . . 0.0 109.333 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.49 144.51 33.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.75 153.49 33.69 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.701 2.934 . . . . 0.0 111.247 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -145.4 131.55 19.41 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.301 0.64 . . . . 0.0 109.449 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.4 p -135.86 147.07 48.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.876 0.47 . . . . 0.0 111.151 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.15 177.01 54.48 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.3 157.86 71.82 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.26 0.624 . . . . 0.0 110.102 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 124.009 3.139 . . . . 0.0 112.428 178.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo . . . . . 0 N--CA 1.472 0.218 0 N-CA-C 112.76 0.254 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -135.6 142.69 45.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.11 0.564 . . . . 0.0 110.264 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -135.7 149.14 49.15 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.039 0.536 . . . . 0.0 110.81 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.1 152.98 52.16 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.699 0.8 . . . . 0.0 110.279 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -69.15 152.42 45.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.918 0.487 . . . . 0.0 110.311 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.77 139.61 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 122.826 0.451 . . . . 0.0 111.107 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 m -75.05 144.31 43.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.981 0.512 . . . . 0.0 111.518 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -135.65 144.31 45.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.613 0.765 . . . . 0.0 109.195 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -71.52 143.09 87.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 122.426 -0.171 . . . . 0.0 110.642 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.9 168.63 21.88 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.06 3.173 . . . . 0.0 111.354 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -92.64 158.23 16.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.332 0.653 . . . . 0.0 110.082 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -63.76 149.47 46.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.352 0.261 . . . . 0.0 110.737 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -126.37 155.0 74.86 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.593 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 167.09 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.638 2.892 . . . . 0.0 110.701 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.75 153.99 76.11 Favored Pre-proline 0 CA--C 1.528 0.134 0 C-N-CA 123.133 0.573 . . . . 0.0 110.4 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.9 174.82 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.833 3.022 . . . . 0.0 110.561 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.24 116.08 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.3 t -135.87 136.55 40.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.043 0.537 . . . . 0.0 109.821 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -75.05 120.78 21.04 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.509 0.671 . . . . 0.0 111.497 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 63.17 57.69 1.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.262 . . . . 0.0 112.779 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.9 p -135.04 -170.27 2.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.678 0.791 . . . . 0.0 110.254 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -99.02 55.95 1.03 Allowed 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.893 0.877 . . . . 0.0 111.042 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' H ' ' A' ' 23' ' ' LEU . 1.5 mm? -66.75 135.99 94.5 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 122.591 0.357 . . . . 0.0 110.386 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.56 112.46 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.515 2.81 . . . . 0.0 109.577 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.9 149.05 25.68 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.127 2.552 . . . . 0.0 112.247 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.09 -4.56 2.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.971 0.508 . . . . 0.0 111.041 171.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -157.66 104.09 1.95 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' CD1' ' H ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -140.36 133.54 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -132.62 20.21 4.27 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.597 ' H ' ' CD1' ' A' ' 28' ' ' ILE . 7.0 m -135.49 39.78 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.196 0.999 . . . . 0.0 109.69 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.89 121.94 15.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.093 0.557 . . . . 0.0 110.223 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.7 t -79.23 131.03 36.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -135.11 -4.29 2.42 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.297 0.239 . . . . 0.0 111.283 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -142.36 136.67 29.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.82 133.62 47.05 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.59 145.22 46.7 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.307 0.575 . . . . 0.0 111.521 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.91 153.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.007 0.923 . . . . 0.0 109.361 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.29 164.47 30.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.25 19.97 79.29 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.35 -0.694 . . . . 0.0 112.724 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -48.63 129.72 13.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.114 0.957 . . . . 0.0 111.175 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -85.0 5.57 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.309 3.339 . . . . 0.0 111.458 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.98 159.63 24.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 112.291 -170.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.06 63.55 6.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.559 0.744 . . . . 0.0 109.764 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.5 ptm 51.31 104.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.126 2.17 . . . . 0.0 114.475 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HZ1' ' HB2' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -143.75 102.43 3.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.26 -19.33 65.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -85.21 -7.08 59.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.139 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -98.14 -21.57 16.67 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.306 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.09 -28.87 62.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.07 -22.26 45.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.521 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.22 -14.14 60.5 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.181 -0.324 . . . . 0.0 111.202 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.19 -0.67 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.194 -0.316 . . . . 0.0 111.783 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.1 10.89 28.0 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.421 0.688 . . . . 0.0 109.585 170.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 25.3 ttmm -78.77 -33.89 0.93 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.622 171.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.0 Cg_exo -57.7 115.04 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.444 2.096 . . . . 0.0 111.951 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 51.22 24.27 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.703 1.201 . . . . 0.0 113.455 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.8 157.29 41.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.124 0.57 . . . . 0.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -132.46 56.47 1.83 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.123 0.569 . . . . 0.0 110.298 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.42 139.04 15.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -129.3 3.37 5.16 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -135.05 121.25 20.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.051 -0.405 . . . . 0.0 110.288 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.98 129.17 43.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.497 0.719 . . . . 0.0 109.925 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.65 141.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 tt -134.23 121.72 21.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.214 . . . . 0.0 110.476 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -100.87 104.4 15.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.068 0.547 . . . . 0.0 109.976 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -86.94 24.49 1.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.056 0.542 . . . . 0.0 111.812 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -127.37 2.61 6.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.735 0.414 . . . . 0.0 110.649 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -136.12 7.74 3.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.2 32.5 10.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.07 0.948 . . . . 0.0 111.446 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -134.39 152.62 51.91 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.409 0.683 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.76 156.3 49.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.548 0.739 . . . . 0.0 110.235 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.85 134.39 49.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.78 151.45 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -135.1 139.37 44.64 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.453 0.644 . . . . 0.0 112.018 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.71 161.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 125.988 1.715 . . . . 0.0 109.172 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -108.27 22.59 15.72 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -152.59 137.48 17.14 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.201 0.6 . . . . 0.0 109.734 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.97 -9.59 58.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.316 -0.24 . . . . 0.0 111.502 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -86.84 -18.02 31.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -88.12 -22.1 24.29 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.24 43.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.09 -21.86 33.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.35 -0.219 . . . . 0.0 110.657 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.59 -19.47 38.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.014 -0.429 . . . . 0.0 110.871 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.76 -43.16 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.93 -17.0 62.7 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.075 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -74.46 -28.45 61.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.463 0.574 . . . . 0.0 109.532 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -76.1 -28.29 57.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.973 -0.454 . . . . 0.0 109.827 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -93.09 6.94 46.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.409 0.284 . . . . 0.0 111.013 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.02 16.28 3.51 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.381 0.272 . . . . 0.0 111.313 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -135.72 -8.02 2.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 -23.12 15.15 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.04 0.836 . . . . 0.0 110.786 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.21 1.16 0.63 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.832 1.206 . . . . 0.0 115.614 172.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.55 45.1 1.94 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.064 1.432 . . . . 0.0 112.159 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.81 142.69 28.19 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.52 -11.66 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.311 3.341 . . . . 0.0 112.821 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -86.51 146.13 26.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.973 0.351 . . . . 0.0 110.799 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.13 104.59 10.97 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.4 m -103.49 134.7 46.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.313 0.645 . . . . 0.0 111.327 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -136.81 153.45 50.81 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.335 1.054 . . . . 0.0 108.925 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -123.4 144.8 49.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.934 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.22 148.62 17.24 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 104' ' ' PHE . 12.4 p -92.88 138.24 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.082 0.553 . . . . 0.0 110.694 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.06 5.59 82.37 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.62 0.629 . . . . 0.0 112.788 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.488 ' H ' HG22 ' A' ' 102' ' ' VAL . 67.0 t80 -116.46 144.49 44.25 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.642 0.721 . . . . 0.0 110.484 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.7 178.35 42.74 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.03 0.347 . . . . 0.0 112.592 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.86 175.72 9.98 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.396 3.398 . . . . 0.0 111.151 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -131.9 153.48 50.21 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 123.731 0.812 . . . . 0.0 110.475 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -134.99 51.8 2.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 110.226 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 15.9 t -135.33 42.56 2.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.272 0.629 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 48.7 t -135.88 147.97 48.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.74 0.816 . . . . 0.0 109.95 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.55 142.03 58.55 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -69.25 -9.31 52.51 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -83.61 -1.86 54.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.632 0.651 . . . . 0.0 110.465 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.91 3.65 2.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.692 0.797 . . . . 0.0 110.253 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.66 -19.5 24.73 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -93.55 32.51 1.38 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.12 0.568 . . . . 0.0 110.011 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.7 t -136.13 146.62 47.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.981 0.912 . . . . 0.0 109.478 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mp -85.9 84.33 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.411 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.3 pt -139.62 46.5 1.06 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 177.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 92.1 Cg_endo -69.47 -2.4 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.582 2.855 . . . . 0.0 112.626 -174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 mtt -121.87 20.36 10.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.783 0.433 . . . . 0.0 111.004 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -135.01 -8.82 2.33 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -89.71 -4.52 57.68 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.248 0.476 . . . . 0.0 109.938 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -92.5 -45.54 8.08 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.397 1.079 . . . . 0.0 109.303 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -80.83 -23.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.59 -48.57 8.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.018 0.372 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.95 -14.13 56.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.166 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -98.37 -41.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.612 0.642 . . . . 0.0 110.891 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -76.34 -16.16 59.81 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -93.71 -52.42 4.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.982 -0.449 . . . . 0.0 110.523 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -83.49 3.8 30.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.16 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -135.85 -4.24 2.24 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 25.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.734 1.152 . . . . 0.0 112.263 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.4 p -72.46 55.71 0.35 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.937 -0.477 . . . . 0.0 111.638 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 53.89 46.41 25.72 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 111.161 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -82.0 49.76 1.44 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.588 0.755 . . . . 0.0 111.062 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 75.3 m95 54.5 35.2 22.79 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -173.47 45.31 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.57 -170.64 50.54 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 t -132.71 45.28 2.77 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.0 m 53.21 34.21 17.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.383 -172.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.96 -49.61 0.08 OUTLIER Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.01 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 62.06 170.53 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 119.166 1.483 . . . . 0.0 112.414 -175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.32 -9.9 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.744 3.629 . . . . 0.0 115.702 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -64.03 -61.39 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.91 0.777 . . . . 0.0 109.477 174.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.3 20.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.596 . . . . 0.0 111.445 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 145' ' ' LEU . 17.3 m -101.47 30.84 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 -25.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 146' ' ' VAL . 5.1 pt -100.92 46.9 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.645 0.778 . . . . 0.0 111.213 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.37 36.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.155 0.582 . . . . 0.0 112.347 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 149' ' ' ILE . 55.4 t80 -75.29 175.08 8.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.161 0.984 . . . . 0.0 110.173 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -50.33 139.0 15.88 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 111.593 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -67.18 134.86 93.55 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.142 0.577 . . . . 0.0 110.22 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.49 179.91 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.994 3.13 . . . . 0.0 111.236 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.77 149.11 47.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.213 0.605 . . . . 0.0 110.468 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.9 pt -65.62 153.68 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.395 0.678 . . . . 0.0 111.681 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.88 107.96 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.46 26.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.647 0.779 . . . . 0.0 110.411 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -172.52 177.76 44.95 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -135.61 29.76 3.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.339 0.656 . . . . 0.0 111.189 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -68.17 149.64 50.27 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.69 158.56 39.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.855 0.862 . . . . 0.0 110.284 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.4 t -99.71 131.3 45.78 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.641 0.376 . . . . 0.0 110.389 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.0 p -88.68 154.64 20.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.03 0.532 . . . . 0.0 111.428 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -135.17 154.13 51.73 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.502 0.721 . . . . 0.0 110.475 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.16 32.79 3.13 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.057 0.543 . . . . 0.0 111.022 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 15.8 tt -135.38 128.78 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.011 0.524 . . . . 0.0 110.125 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.0 p -146.55 22.15 1.31 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.061 0.544 . . . . 0.0 111.141 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -90.56 54.99 2.87 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.394 0.677 . . . . 0.0 110.406 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -135.5 130.78 35.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.642 0.777 . . . . 0.0 109.692 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.36 157.88 33.66 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.216 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.19 158.98 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.542 2.828 . . . . 0.0 110.678 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 p -134.44 144.27 48.04 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 122.787 0.435 . . . . 0.0 111.177 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -135.63 152.42 51.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.001 0.92 . . . . 0.0 109.586 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.7 p -131.11 24.12 4.9 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.521 0.328 . . . . 0.0 111.812 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 62.38 -153.43 43.07 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -108.42 157.45 18.4 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.794 0.838 . . . . 0.0 109.492 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -79.65 49.49 1.04 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.35 0.66 . . . . 0.0 111.789 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.22 -179.96 52.51 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.01 168.65 23.37 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.286 3.324 . . . . 0.0 111.028 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -120.34 141.21 50.26 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.516 0.727 . . . . 0.0 109.94 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.2 m 53.64 38.84 29.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.419 0.688 . . . . 0.0 111.888 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.23 164.22 47.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 75.1 mmtt -88.23 -33.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.368 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 64.3 Cg_exo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.078 2.519 . . . . 0.0 112.485 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.471 0.18 0 N-CA-C 112.472 0.143 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -135.6 141.83 45.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.168 0.587 . . . . 0.0 110.191 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.81 136.98 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.72 0.408 . . . . 0.0 110.973 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -83.75 58.74 4.79 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.166 0.586 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -70.34 121.0 16.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.841 0.456 . . . . 0.0 110.147 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.18 152.24 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.588 0.755 . . . . 0.0 110.225 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -135.58 154.06 51.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.257 0.623 . . . . 0.0 110.543 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -134.99 39.47 2.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.384 0.674 . . . . 0.0 109.668 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -64.05 140.68 97.94 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.824 0.449 . . . . 0.0 109.912 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 151.92 42.57 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.633 2.889 . . . . 0.0 113.387 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -135.73 154.02 51.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.744 0.817 . . . . 0.0 110.195 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.59 148.76 38.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.602 0.239 . . . . 0.0 110.709 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.73 79.8 62.91 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.286 0.634 . . . . 0.0 110.114 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.26 160.28 48.31 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.52 2.813 . . . . 0.0 110.814 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -76.03 135.4 70.4 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 122.967 0.507 . . . . 0.0 110.543 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.87 161.94 32.78 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.592 2.862 . . . . 0.0 111.76 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.65 -41.12 18.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.2 m -146.59 -46.38 0.19 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.207 0.603 . . . . 0.0 110.237 171.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -149.92 12.82 0.78 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -146.12 147.4 31.51 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -118.97 171.71 8.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.249 0.62 . . . . 0.0 112.026 -172.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t 50.8 55.37 9.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.842 1.257 . . . . 0.0 111.506 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.74 152.76 66.75 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.586 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.73 165.58 31.61 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.094 3.196 . . . . 0.0 110.624 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.63 -8.25 22.82 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.654 2.903 . . . . 0.0 111.749 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -80.69 142.54 33.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -82.4 21.76 0.92 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG13 ' H ' ' A' ' 30' ' ' VAL . 7.3 tp -146.06 144.14 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -122.97 24.59 8.91 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.26 0.624 . . . . 0.0 110.562 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.513 ' H ' HG13 ' A' ' 28' ' ' ILE . 2.7 t -135.49 22.8 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.643 0.777 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -145.54 37.2 1.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.038 0.535 . . . . 0.0 110.226 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.5 m -126.76 119.87 27.98 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.649 0.261 . . . . 0.0 111.662 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -100.13 78.06 2.04 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 t -135.33 162.78 31.63 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.61 130.58 55.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.673 1.189 . . . . 0.0 108.521 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -107.28 143.27 35.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.21 0.604 . . . . 0.0 110.602 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.0 mm -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.91 0.884 . . . . 0.0 108.876 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.56 31.45 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.32 23.25 74.94 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.1 m -53.04 123.8 34.9 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 117.527 0.663 . . . . 0.0 112.013 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.26 -4.26 13.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.734 2.956 . . . . 0.0 111.07 171.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' MET . 2.7 mm? -70.85 162.7 28.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.145 0.578 . . . . 0.0 110.5 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.22 32.79 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.537 0.735 . . . . 0.0 111.347 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' LEU . 63.7 mtm 57.41 47.98 15.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.154 0.981 . . . . 0.0 112.251 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -128.55 133.71 48.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.811 0.844 . . . . 0.0 109.134 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.02 -6.77 47.69 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -85.11 -15.77 42.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.029 -0.419 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -89.53 -26.19 21.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.96 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.01 -29.9 65.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.1 -17.66 58.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.796 -0.565 . . . . 0.0 110.422 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.21 -4.44 58.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.19 -4.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.14 0.26 5.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 39.6 ttpt -88.04 -38.78 0.47 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.28 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.7 Cg_exo -59.33 135.46 65.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.481 2.121 . . . . 0.0 111.997 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 51.48 28.23 4.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.168 0.987 . . . . 0.0 113.078 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.87 167.95 21.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.152 0.581 . . . . 0.0 110.683 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.08 40.91 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.662 0.385 . . . . 0.0 111.251 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.84 136.93 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -129.85 -3.43 4.64 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -137.1 136.45 38.33 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.074 -0.391 . . . . 0.0 111.047 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.46 115.03 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.91 104.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.22 110.57 23.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -76.52 104.3 6.96 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -82.46 24.17 0.71 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.861 0.864 . . . . 0.0 111.134 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -135.14 5.47 3.28 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.233 0.613 . . . . 0.0 110.319 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -140.38 -0.67 1.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.239 0.615 . . . . 0.0 110.859 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 51.46 34.9 12.98 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.897 0.879 . . . . 0.0 111.774 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -135.4 151.86 50.86 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 123.599 0.76 . . . . 0.0 109.46 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.25 154.0 51.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -117.26 125.18 50.7 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.009 1.324 . . . . 0.0 107.711 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.03 148.58 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 120.486 0.184 . . . . 0.0 110.56 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -130.2 135.76 48.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.927 0.394 . . . . 0.0 111.942 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.92 148.55 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.275 1.43 . . . . 0.0 109.32 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -82.54 -3.18 55.53 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.2 m -143.3 132.91 23.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -72.58 -18.02 61.65 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.385 . . . . 0.0 110.808 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -74.81 -14.28 60.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.99 -0.444 . . . . 0.0 109.983 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -93.1 -8.6 42.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.04 -43.31 44.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 -17.93 60.64 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.489 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.72 -16.2 54.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.196 0.453 . . . . 0.0 110.388 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -85.47 -23.74 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 O-C-N 121.938 -0.476 . . . . 0.0 110.526 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.74 -23.93 53.02 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.014 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.69 -15.51 57.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.42 -45.42 31.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -76.84 -0.27 23.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.337 -0.227 . . . . 0.0 111.387 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -112.35 -4.76 14.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.984 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.44 22.51 3.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.701 0.682 . . . . 0.0 112.574 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -135.23 55.18 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.285 0.493 . . . . 0.0 111.278 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.83 82.83 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.473 -0.626 . . . . 0.0 113.254 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.63 60.51 3.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.836 0.818 . . . . 0.0 111.72 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.79 151.43 15.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.089 0.556 . . . . 0.0 110.857 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.47 -0.93 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.102 3.201 . . . . 0.0 113.113 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.5 mt -63.63 138.11 58.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.494 0.588 . . . . 0.0 110.318 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -105.51 121.4 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.7 p -135.34 145.05 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 111.997 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -143.23 148.41 36.39 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 109.405 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 -128.41 158.75 37.44 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.863 0.363 . . . . 0.0 111.888 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.4 168.94 25.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 104' ' ' PHE . 12.6 p -133.69 144.5 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.059 0.544 . . . . 0.0 110.541 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 4.36 69.66 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.163 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.403 ' H ' HG21 ' A' ' 102' ' ' VAL . 64.5 t80 -70.75 131.23 43.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.974 0.887 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.52 171.2 51.88 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.48 164.25 36.32 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.971 3.114 . . . . 0.0 110.998 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -90.52 151.78 21.21 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 110.799 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 133.61 38.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.7 0.4 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.5 m -134.11 38.49 3.16 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.031 0.933 . . . . 0.0 109.01 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 75.2 m -123.66 169.16 11.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.109 0.964 . . . . 0.0 110.846 -174.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.74 155.88 21.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.202 0.601 . . . . 0.0 109.949 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.74 -5.93 18.51 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -94.75 2.36 55.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.777 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -139.57 17.84 2.54 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.082 0.953 . . . . 0.0 110.306 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.3 -6.67 0.17 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.085 -0.842 . . . . 0.0 114.046 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -84.8 55.78 3.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.033 1.416 . . . . 0.0 110.001 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.4 m -130.97 151.67 51.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.606 0.762 . . . . 0.0 110.52 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.1 pt -119.12 31.64 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.383 0.673 . . . . 0.0 111.149 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 tp -135.75 49.93 3.88 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 123.247 0.619 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.29 -14.2 34.17 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 111.783 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -81.19 15.89 1.76 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.925 0.329 . . . . 0.0 111.763 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -135.33 1.73 2.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.545 0.738 . . . . 0.0 109.957 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -86.02 -13.42 47.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.118 -0.364 . . . . 0.0 110.581 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.402 ' C ' HD11 ' A' ' 124' ' ' LEU . 3.9 pp -101.0 -12.89 18.52 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.606 0.185 . . . . 0.0 110.722 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 50.4 p -88.98 -22.07 23.2 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.87 -41.12 12.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -16.27 50.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -113.33 -15.63 12.64 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.013 0.824 . . . . 0.0 112.019 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.98 -20.66 48.58 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.649 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.56 -63.23 1.34 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -79.81 -1.14 37.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.4 m -139.91 6.3 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.1 t -137.77 20.51 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.19 1.359 . . . . 0.0 110.384 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.4 t -106.12 52.69 0.72 Allowed 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.49 172.03 13.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.04 0.936 . . . . 0.0 110.679 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -58.63 151.63 20.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.243 0.617 . . . . 0.0 110.791 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -64.1 147.96 50.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.22 0.608 . . . . 0.0 111.646 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.06 -15.29 0.59 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.376 -0.689 . . . . 0.0 111.376 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.62 161.87 10.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.725 0.679 . . . . 0.0 112.365 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.677 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 90.2 m 68.45 102.38 0.05 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m 54.6 43.45 30.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.39 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.534 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.442 ' H ' ' HD2' ' A' ' 144' ' ' PRO . 64.5 tt0 -164.81 -51.86 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 120.234 2.017 . . . . 0.0 115.884 175.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.677 ' CD ' ' H ' ' A' ' 140' ' ' THR . 22.9 Cg_endo -85.93 -5.79 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.696 2.931 . . . . 0.0 115.753 -166.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.71 -2.62 15.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.098 1.317 . . . . 0.0 111.959 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.84 0.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 123.186 0.594 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -142.14 24.68 1.96 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.511 1.124 . . . . 0.0 108.487 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.55 43.57 0.12 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mm -42.45 -41.34 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.561 1.145 . . . . 0.0 112.278 174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.8 m 44.66 29.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.407 1.483 . . . . 0.0 113.452 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -139.97 149.28 43.07 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.352 0.661 . . . . 0.0 109.625 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.05 35.92 3.05 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -141.27 137.37 16.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.98 168.15 22.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.332 2.688 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.97 55.43 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 110.394 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 tt -110.41 146.25 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.31 0.644 . . . . 0.0 109.613 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.13 56.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.988 0.515 . . . . 0.0 110.716 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.21 146.49 30.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.84 0.456 . . . . 0.0 110.482 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.52 176.67 38.99 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -135.55 149.99 49.6 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.976 0.51 . . . . 0.0 110.996 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -79.88 -174.08 46.34 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.48 156.18 41.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.682 0.793 . . . . 0.0 109.961 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -133.14 148.46 52.1 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.856 0.462 . . . . 0.0 111.144 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.5 t -135.97 152.56 51.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.573 0.749 . . . . 0.0 110.131 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -135.25 151.95 51.07 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 123.226 0.61 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.36 144.79 46.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.202 0.601 . . . . 0.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 58.7 mt -135.15 141.72 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.6 m -60.89 142.07 56.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.858 0.463 . . . . 0.0 110.907 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -135.37 151.37 50.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.028 0.531 . . . . 0.0 111.178 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.5 145.06 43.83 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.055 0.542 . . . . 0.0 110.322 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 93.0 mtp -113.81 153.14 46.06 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.278 0.631 . . . . 0.0 110.171 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -70.64 165.17 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.641 2.894 . . . . 0.0 111.445 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.0 p -135.1 157.91 45.71 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 123.722 0.809 . . . . 0.0 110.168 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -133.24 140.08 47.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.968 0.507 . . . . 0.0 110.509 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.8 m -135.46 146.51 48.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.335 0.654 . . . . 0.0 110.55 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -74.2 -178.66 39.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -135.34 146.43 48.41 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.199 0.6 . . . . 0.0 110.706 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -135.78 160.44 38.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.393 0.677 . . . . 0.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -176.4 173.51 46.33 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.3 155.07 36.98 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.187 3.258 . . . . 0.0 112.548 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -135.93 136.31 40.34 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.399 0.68 . . . . 0.0 109.976 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -135.47 142.67 45.57 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.149 0.579 . . . . 0.0 110.573 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.2 169.44 37.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -141.28 152.98 65.73 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.55 0.74 . . . . 0.0 109.932 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--O 1.252 1.208 0 C-N-CA 123.817 3.011 . . . . 0.0 111.068 178.574 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 CA--C 1.527 0.156 0 N-CA-C 112.585 0.186 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -135.11 24.81 3.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.253 0.621 . . . . 0.0 111.071 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -98.35 24.57 7.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.359 0.664 . . . . 0.0 111.443 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.85 142.81 46.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.917 0.487 . . . . 0.0 109.763 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -135.5 113.59 11.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.75 0.42 . . . . 0.0 110.129 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -135.42 135.7 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.581 0.752 . . . . 0.0 109.015 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.3 t -135.67 135.39 40.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.508 0.323 . . . . 0.0 111.012 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -140.28 147.65 40.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.892 0.877 . . . . 0.0 109.555 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.65 140.89 29.08 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 122.407 0.283 . . . . 0.0 110.242 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.09 163.8 30.26 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.869 3.046 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -138.69 147.09 42.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.345 0.658 . . . . 0.0 110.236 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -135.6 128.6 31.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.689 0.396 . . . . 0.0 110.408 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -147.96 58.86 4.16 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.96 0.504 . . . . 0.0 110.102 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -67.34 148.29 79.51 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.173 2.582 . . . . 0.0 110.949 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -151.32 117.76 3.25 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.281 0.632 . . . . 0.0 109.488 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.24 172.39 4.24 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.573 3.515 . . . . 0.0 114.035 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.13 159.29 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.433 ' H ' HG13 ' A' ' 150' ' ' VAL . 29.7 m 65.24 30.71 11.16 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.71 87.87 2.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.92 142.71 50.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.159 0.584 . . . . 0.0 111.919 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.4 p -135.42 48.62 2.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.917 0.887 . . . . 0.0 109.642 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p 52.41 43.55 30.81 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.758 1.223 . . . . 0.0 111.689 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pp -94.95 157.37 36.75 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.96 0.904 . . . . 0.0 110.46 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.77 152.15 74.15 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.218 2.612 . . . . 0.0 112.491 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.55 20.28 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.478 4.119 . . . . 0.0 112.34 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.98 161.63 8.08 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.777 0.431 . . . . 0.0 111.327 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -60.68 -42.37 96.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 29' ' ' LYS . 6.2 tp -153.2 161.58 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.826 0.739 . . . . 0.0 112.29 -176.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' H ' HD13 ' A' ' 28' ' ' ILE . 22.2 tptm 66.65 43.19 2.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 122.669 1.223 . . . . 0.0 108.21 178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.9 m -89.77 104.88 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.115 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -146.11 151.35 37.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.355 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.6 t -90.49 141.94 28.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -130.12 136.1 48.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.069 0.547 . . . . 0.0 109.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -135.78 108.85 7.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -85.52 104.57 15.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -82.34 140.32 33.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.348 0.659 . . . . 0.0 110.313 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.1 129.8 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.01 166.53 26.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.081 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.74 75.59 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.415 -0.658 . . . . 0.0 112.195 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -53.57 125.34 44.77 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 117.996 0.898 . . . . 0.0 111.186 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.31 -2.68 12.15 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.444 2.763 . . . . 0.0 111.364 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.32 154.53 27.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.923 0.489 . . . . 0.0 111.017 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -84.43 53.66 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.28 0.632 . . . . 0.0 110.38 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.2 ttt 56.48 64.74 1.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.387 1.075 . . . . 0.0 112.708 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -131.13 107.94 9.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.84 -13.08 58.89 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 112.011 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -81.84 -12.23 58.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 122.244 -0.285 . . . . 0.0 111.077 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -93.32 -22.73 18.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.518 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 -27.88 60.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.57 -23.74 42.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.911 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.64 -6.93 58.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.007 0.367 . . . . 0.0 111.638 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.58 -4.62 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 118.153 0.433 . . . . 0.0 111.243 171.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -109.52 15.36 23.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.08 0.952 . . . . 0.0 109.247 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.7 ttmt -75.53 -34.77 1.64 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 82.4 Cg_endo -73.55 124.27 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 CA-C-N 121.356 1.52 . . . . 0.0 111.068 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 51.53 23.06 1.71 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.98 1.312 . . . . 0.0 113.062 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.83 154.58 35.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.964 0.506 . . . . 0.0 110.546 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.51 64.68 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.91 128.61 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -103.71 -3.76 24.62 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -168.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -142.24 131.15 22.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.053 0.388 . . . . 0.0 110.904 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.15 129.86 38.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.26 139.54 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 110.7 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -122.73 120.31 33.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.133 1.373 . . . . 0.0 108.387 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -138.74 157.17 46.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.837 0.455 . . . . 0.0 111.337 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 65.5 151.49 0.05 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.857 1.263 . . . . 0.0 113.13 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -82.79 25.08 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.267 0.627 . . . . 0.0 111.216 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.72 24.4 7.75 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.813 0.845 . . . . 0.0 110.702 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 53.48 49.49 19.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.146 0.978 . . . . 0.0 112.599 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -96.57 104.75 16.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.93 148.33 44.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.114 0.483 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -135.52 145.11 46.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.397 0.679 . . . . 0.0 109.375 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.92 155.5 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.21 135.68 41.17 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.969 0.414 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.15 148.66 15.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 124.519 1.128 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.46 19.18 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.8 t -151.25 141.25 22.07 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.795 0.438 . . . . 0.0 110.198 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -74.46 -22.7 58.97 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -82.35 -14.74 54.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.62 -20.67 23.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.66 53.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.19 -15.8 35.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.262 -0.274 . . . . 0.0 110.732 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.38 -22.87 38.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.272 0.487 . . . . 0.0 110.607 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.53 -46.19 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.42 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.55 -19.77 65.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.614 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -75.89 -40.77 53.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.382 0.992 . . . . 0.0 109.659 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -76.33 -13.44 60.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -117.28 15.1 14.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -128.2 3.89 5.79 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -142.36 -8.19 0.88 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -153.0 24.75 0.56 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.241 0.928 . . . . 0.0 112.035 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 15.69 0.04 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.964 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.98 3.8 16.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.648 1.224 . . . . 0.0 111.791 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.7 -54.78 0.19 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.715 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.5 -23.52 14.87 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.355 2.036 . . . . 0.0 112.867 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -137.84 149.12 46.05 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.13 0.423 . . . . 0.0 111.219 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -106.09 102.7 12.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.3 p -98.15 130.79 44.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.246 0.618 . . . . 0.0 111.276 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -143.94 136.86 27.34 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.973 0.909 . . . . 0.0 109.028 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -118.58 126.91 52.99 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.096 0.407 . . . . 0.0 111.175 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.64 145.48 18.36 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.42 148.37 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.933 0.893 . . . . 0.0 109.529 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.76 121.57 5.82 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -138.98 27.3 2.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.543 0.737 . . . . 0.0 111.074 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.91 157.47 53.35 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 122.1 -0.375 . . . . 0.0 112.883 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.53 169.52 22.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 124.252 3.301 . . . . 0.0 110.527 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -74.61 141.55 44.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.483 0.313 . . . . 0.0 110.382 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -135.92 145.3 46.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 110.857 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.9 t 54.27 38.06 28.6 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.805 0.842 . . . . 0.0 111.928 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.65 104.33 11.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -142.1 151.83 42.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.416 0.687 . . . . 0.0 109.804 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -72.79 -4.67 33.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.71 -0.57 34.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.22 0.463 . . . . 0.0 109.802 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -135.25 24.11 3.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 109.802 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.86 -1.25 1.0 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.498 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -110.26 47.92 0.93 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.858 0.829 . . . . 0.0 109.473 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -135.03 153.59 52.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.704 0.801 . . . . 0.0 110.297 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.69 30.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.374 0.669 . . . . 0.0 112.367 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mt -73.3 133.84 80.56 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.2 -13.49 38.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.418 2.745 . . . . 0.0 113.746 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.5 ptm -83.97 8.26 15.76 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -95.06 -17.37 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.185 -0.322 . . . . 0.0 111.149 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.13 -4.13 58.79 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.96 -32.49 13.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.108 0.563 . . . . 0.0 109.582 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.5 t -82.59 -19.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.049 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.94 -47.06 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.911 -0.493 . . . . 0.0 110.968 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -76.48 -13.79 60.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.49 -9.6 11.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.818 0.736 . . . . 0.0 112.264 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -73.33 -18.25 61.21 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 166.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -87.51 -60.13 2.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.318 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -80.4 9.96 5.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -147.16 -6.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.65 17.17 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 119.619 1.099 . . . . 0.0 112.036 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 m -81.01 35.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.403 -0.811 . . . . 0.0 111.247 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 24.47 3.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.45 0.7 . . . . 0.0 110.223 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -138.55 147.33 42.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.777 0.831 . . . . 0.0 109.653 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -81.72 42.79 0.72 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.307 0.643 . . . . 0.0 111.05 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.99 -169.9 36.72 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.69 157.68 27.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.1 p 48.74 24.55 0.83 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.008 1.323 . . . . 0.0 112.913 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -154.92 24.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.34 0.656 . . . . 0.0 111.024 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.34 -12.11 16.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.507 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -146.37 164.98 21.65 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 118.622 1.211 . . . . 0.0 110.053 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.49 -12.18 16.33 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.363 2.708 . . . . 0.0 113.311 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.48 -6.43 46.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.12 0.418 . . . . 0.0 112.123 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -77.55 25.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -135.41 -15.43 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.208 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.43 -11.34 17.84 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 118.797 -1.002 . . . . 0.0 113.221 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.1 mm -66.79 60.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-O 122.312 1.053 . . . . 0.0 109.067 167.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.433 HG13 ' H ' ' A' ' 18' ' ' SER . 1.4 m -128.63 5.11 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.947 1.299 . . . . 0.0 109.775 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -115.87 154.95 28.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.654 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.61 59.46 4.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 112.24 -175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.17 69.64 29.98 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.31 179.37 6.56 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.154 3.236 . . . . 0.0 111.281 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -135.18 161.63 34.82 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.878 0.871 . . . . 0.0 110.069 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.82 146.0 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 122.87 0.468 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.1 mm -122.99 123.34 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.6 154.01 34.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 123.043 0.537 . . . . 0.0 111.397 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 84.71 141.52 5.32 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.933 0.778 . . . . 0.0 111.768 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.56 141.8 24.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.326 0.651 . . . . 0.0 109.755 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -73.82 172.09 51.45 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.67 140.52 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.041 0.536 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.8 m -135.97 55.02 1.88 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.436 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.9 t -135.19 130.19 34.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.583 0.353 . . . . 0.0 110.857 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -135.9 151.72 50.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 124.137 0.975 . . . . 0.0 109.868 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.27 124.03 23.86 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.68 0.392 . . . . 0.0 110.546 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.2 tp -141.91 144.68 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.447 0.699 . . . . 0.0 109.816 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.6 t -135.88 136.9 40.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.897 0.479 . . . . 0.0 110.408 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -135.91 133.76 38.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.18 0.592 . . . . 0.0 110.013 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -135.84 144.35 45.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.338 0.655 . . . . 0.0 110.089 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 92.9 mtp -135.76 152.07 75.32 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 123.352 0.661 . . . . 0.0 109.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.45 160.1 49.52 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.657 2.905 . . . . 0.0 111.081 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.3 t -138.47 149.0 44.98 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 110.51 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.67 149.75 49.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.425 0.69 . . . . 0.0 110.516 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 60.0 m -135.17 132.21 37.7 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.931 0.493 . . . . 0.0 110.624 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 166.85 160.12 13.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -141.09 129.11 21.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.796 0.438 . . . . 0.0 110.477 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -135.87 149.7 49.11 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.452 0.701 . . . . 0.0 110.533 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.47 179.04 38.99 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.29 158.45 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.362 3.375 . . . . 0.0 112.485 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -135.8 143.04 44.97 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.482 0.713 . . . . 0.0 109.897 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.8 m -133.47 124.94 27.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.837 0.455 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.37 168.55 29.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.628 ' H ' ' CD ' ' A' ' 185' ' ' PRO . 40.6 ttmt -151.04 -38.05 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.655 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.628 ' CD ' ' H ' ' A' ' 184' ' ' LYS . 53.9 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 123.016 2.477 . . . . 0.0 112.303 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.471 0.176 0 N-CA-C 112.519 0.161 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.75 148.02 31.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.825 0.45 . . . . 0.0 110.974 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.72 140.24 44.24 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.07 24.6 4.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.599 0.76 . . . . 0.0 110.606 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.64 143.48 34.63 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.913 0.485 . . . . 0.0 110.705 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.49 138.7 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.187 0.595 . . . . 0.0 110.198 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.9 p -135.84 31.38 3.03 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.423 0.689 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -80.98 55.02 2.34 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.407 0.683 . . . . 0.0 110.963 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.72 150.62 37.17 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 123.204 0.602 . . . . 0.0 110.194 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.23 152.24 55.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.444 2.763 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -145.63 143.16 29.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.13 0.572 . . . . 0.0 110.257 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -135.85 140.2 43.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.951 0.501 . . . . 0.0 110.648 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -152.03 73.89 7.73 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.129 0.572 . . . . 0.0 109.781 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -67.58 152.51 78.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.407 2.738 . . . . 0.0 110.623 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -138.56 152.8 71.71 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.591 0.756 . . . . 0.0 109.982 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.29 170.16 16.5 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.242 3.294 . . . . 0.0 112.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -75.3 158.17 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.658 0.783 . . . . 0.0 109.816 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.473 ' H ' HG13 ' A' ' 150' ' ' VAL . 35.2 m 61.82 42.5 10.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.173 0.989 . . . . 0.0 112.639 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.59 43.77 2.58 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.181 0.593 . . . . 0.0 109.541 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.82 52.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.926 1.691 . . . . 0.0 114.623 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.2 m -135.92 8.3 3.25 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -162.03 24.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.63 136.46 12.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 119.55 1.068 . . . . 0.0 113.277 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.82 156.46 18.17 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 124.08 3.187 . . . . 0.0 110.497 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.99 134.24 14.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.619 2.879 . . . . 0.0 111.959 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -142.75 148.27 36.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.86 1.264 . . . . 0.0 108.12 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 53.05 29.64 8.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.564 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.49 151.55 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.328 1.051 . . . . 0.0 110.244 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.64 12.96 3.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.64 42.93 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 122.762 0.425 . . . . 0.0 111.457 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -135.74 146.87 48.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.234 0.214 . . . . 0.0 110.817 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 p -65.09 145.17 56.65 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.353 0.661 . . . . 0.0 111.815 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -126.07 -7.59 6.56 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -155.53 154.04 31.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.057 0.39 . . . . 0.0 111.042 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.2 tp -117.97 126.0 51.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.995 0.518 . . . . 0.0 109.668 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.53 146.21 32.14 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.398 0.679 . . . . 0.0 110.444 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mm -128.02 135.01 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.22 165.87 13.66 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.77 15.43 80.75 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.289 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' N ' ' CD ' ' A' ' 41' ' ' PRO . 34.0 m -70.19 -14.22 0.25 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -176.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 40' ' ' VAL . 70.2 Cg_exo -56.99 -2.81 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.259 1.973 . . . . 0.0 114.612 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.89 -14.91 60.71 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.337 0.971 . . . . 0.0 112.68 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -148.59 -12.54 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.2 mtt 51.6 28.85 4.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -135.81 142.77 44.9 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.193 0.451 . . . . 0.0 110.79 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.66 -6.63 42.43 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -86.74 -10.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.296 -0.252 . . . . 0.0 111.067 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.69 -27.09 18.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.86 -30.09 65.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.02 -19.38 44.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.458 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -76.54 -15.51 59.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.058 -0.401 . . . . 0.0 111.155 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.75 -3.34 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.61 10.65 22.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.384 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.8 pttt -88.61 -28.04 0.35 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.582 170.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 27.2 Cg_exo -65.14 117.88 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.782 1.655 . . . . 0.0 110.945 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 50.27 24.37 1.47 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.405 1.082 . . . . 0.0 113.191 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.5 155.38 43.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.956 0.502 . . . . 0.0 110.497 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -133.73 60.63 1.7 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.976 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -70.12 141.53 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -129.75 5.82 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -135.8 119.36 17.02 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 118.064 0.393 . . . . 0.0 110.457 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.89 127.66 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.531 0.732 . . . . 0.0 109.526 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.55 139.62 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 122.847 0.459 . . . . 0.0 110.048 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.5 mt -114.94 122.66 46.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.541 0.737 . . . . 0.0 109.036 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -123.02 173.02 8.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.087 0.955 . . . . 0.0 111.064 -171.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 55.59 55.6 7.07 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.799 0.84 . . . . 0.0 111.258 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t 55.68 43.16 28.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.078 0.551 . . . . 0.0 110.924 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? 55.48 44.16 27.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.195 0.998 . . . . 0.0 111.248 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -124.3 0.97 8.41 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 111.052 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -146.48 142.89 28.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 149.13 48.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.14 134.43 45.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.298 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.34 149.78 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -135.14 135.63 41.27 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.013 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.16 157.35 14.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 124.782 1.233 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -102.85 9.06 39.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -146.41 138.51 24.96 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.057 0.543 . . . . 0.0 109.973 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.62 -13.62 60.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -85.27 -23.0 28.37 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.2 -18.08 37.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.29 -45.49 59.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.85 -20.51 62.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.005 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -82.01 -16.79 49.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.408 0.549 . . . . 0.0 111.338 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.6 -25.5 8.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-N 118.566 0.621 . . . . 0.0 110.25 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.21 -22.18 55.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.913 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -76.08 -22.26 55.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -79.88 -23.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -83.53 -4.0 58.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.7 3.76 11.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.7 0.4 . . . . 0.0 111.049 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -135.77 17.9 3.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -86.36 -1.31 57.42 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.481 -0.762 . . . . 0.0 111.573 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.49 -15.0 0.45 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.798 1.19 . . . . 0.0 115.548 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.42 12.39 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.486 1.643 . . . . 0.0 113.483 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 35.09 53.05 1.59 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.694 1.198 . . . . 0.0 113.751 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.9 -11.93 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.425 2.75 . . . . 0.0 111.275 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -133.82 133.93 42.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.411 1.084 . . . . 0.0 108.312 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -100.01 98.47 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.3 m -93.49 129.36 39.72 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.96 0.504 . . . . 0.0 111.198 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -145.69 142.13 28.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.31 0.644 . . . . 0.0 109.91 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -97.04 150.21 21.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.941 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.83 160.46 14.04 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.07 139.69 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 124.014 0.926 . . . . 0.0 110.097 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.15 126.03 7.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -135.71 148.2 48.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.446 0.698 . . . . 0.0 110.01 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.52 152.88 48.48 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.31 123.24 9.4 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.576 2.85 . . . . 0.0 110.433 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -135.72 151.4 50.12 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.991 0.916 . . . . 0.0 109.426 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -135.26 43.83 2.63 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.001 0.52 . . . . 0.0 110.105 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 20.7 t -135.38 55.21 1.89 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.163 0.585 . . . . 0.0 109.936 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 26.4 p -135.56 149.76 49.52 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.149 0.579 . . . . 0.0 110.884 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -135.87 152.71 51.32 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.526 0.731 . . . . 0.0 110.16 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -68.21 -16.92 64.17 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.3 6.79 46.88 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.03 -0.418 . . . . 0.0 110.102 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -135.66 24.5 3.4 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.074 0.949 . . . . 0.0 109.705 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -151.91 -11.97 0.08 OUTLIER Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.457 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.2 24.88 4.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.713 1.256 . . . . 0.0 110.671 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -135.58 158.46 44.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.914 0.886 . . . . 0.0 110.063 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -68.94 148.38 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 122.4 0.28 . . . . 0.0 110.61 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -137.29 136.95 21.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.47 170.11 21.0 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.708 2.939 . . . . 0.0 111.283 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.55 13.27 0.49 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -87.27 -8.8 56.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.959 -0.463 . . . . 0.0 110.448 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -81.9 -9.13 59.68 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -88.18 -40.31 13.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.2 p -75.21 -17.76 60.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.995 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.69 -19.34 14.36 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.593 0.633 . . . . 0.0 112.141 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.87 -12.07 45.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.89 0.768 . . . . 0.0 110.814 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.74 -21.72 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.78 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -74.33 -21.36 59.73 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.794 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.452 ' HE3' ' CE2' ' A' ' 131' ' ' TRP . 38.8 ttpt -91.2 -60.04 2.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.415 -0.178 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.452 ' CE2' ' HE3' ' A' ' 130' ' ' LYS . 8.6 m95 -77.26 0.89 20.32 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 m -142.12 -5.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 135' ' ' ALA . 2.4 t -137.86 23.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.949 1.25 . . . . 0.0 112.083 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -75.11 38.02 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.407 -0.808 . . . . 0.0 111.523 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.48 24.22 3.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.597 0.759 . . . . 0.0 110.07 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -141.77 140.22 33.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.748 0.819 . . . . 0.0 109.438 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -84.83 52.63 2.47 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.842 0.457 . . . . 0.0 111.824 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.95 -7.37 0.39 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.292 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 68.51 -166.39 45.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.12 0.96 . . . . 0.0 111.212 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.0 p 67.33 116.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.848 1.659 . . . . 0.0 112.51 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.1 m 61.4 27.61 17.18 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.6 1.16 . . . . 0.0 112.893 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.56 -16.48 68.41 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 145' ' ' LEU . 61.2 tt0 -155.56 151.71 22.86 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.05 10.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.992 3.128 . . . . 0.0 115.236 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 143' ' ' GLN . 4.5 pp -73.99 -0.1 15.23 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.277 0.944 . . . . 0.0 110.966 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.45 22.34 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.109 0.564 . . . . 0.0 112.071 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 10.2 5.12 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.301 0.24 . . . . 0.0 111.57 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.04 -19.46 0.32 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.3 mm -80.0 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-O 121.753 0.787 . . . . 0.0 109.322 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 18' ' ' SER . 35.4 m -129.37 24.72 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.185 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.1 151.25 23.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.07 0.548 . . . . 0.0 110.516 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -94.94 44.41 1.1 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.442 0.697 . . . . 0.0 111.968 -175.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -128.57 146.69 61.03 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.447 0.299 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.63 -178.73 4.85 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.448 3.432 . . . . 0.0 111.257 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.54 136.11 44.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.423 0.689 . . . . 0.0 109.684 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.6 tt -135.97 147.38 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.39 119.38 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.308 0.643 . . . . 0.0 110.637 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.2 30.91 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 122.919 0.488 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -172.17 -175.7 40.47 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.876 -0.515 . . . . 0.0 112.446 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.18 24.94 2.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.401 0.68 . . . . 0.0 111.426 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 77.17 169.34 31.56 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.255 0.455 . . . . 0.0 112.758 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.94 162.79 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.148 0.979 . . . . 0.0 109.748 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.0 m -55.52 138.54 46.33 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.716 0.406 . . . . 0.0 110.759 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.0 p -135.48 157.06 47.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.939 0.496 . . . . 0.0 111.656 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -135.68 162.44 32.74 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.21 1.004 . . . . 0.0 110.147 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.84 130.6 42.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 9.8 tp -135.78 144.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.437 0.295 . . . . 0.0 110.803 -176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.8 t -135.97 150.13 49.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.293 0.637 . . . . 0.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -135.6 138.03 42.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.961 0.904 . . . . 0.0 109.177 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -74.46 113.22 11.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.9 tpp -73.19 136.33 79.13 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.99 162.1 43.46 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.049 2.5 . . . . 0.0 110.606 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.3 p -130.35 24.1 5.17 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.999 0.519 . . . . 0.0 110.614 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -110.51 39.4 2.21 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.709 0.804 . . . . 0.0 110.488 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.9 t -135.23 150.4 50.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.504 0.721 . . . . 0.0 109.495 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 142.99 44.74 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -83.88 104.92 14.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -133.7 55.27 1.91 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.305 0.642 . . . . 0.0 110.179 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.73 178.16 36.84 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.52 154.57 68.51 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.689 2.926 . . . . 0.0 110.564 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.402 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -135.88 24.46 3.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.692 0.397 . . . . 0.0 112.07 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.0 p -94.49 127.1 40.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.976 0.51 . . . . 0.0 110.394 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.22 167.23 54.57 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -73.71 137.78 77.05 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.885 0.474 . . . . 0.0 109.976 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.252 1.189 0 C-N-CA 123.643 2.896 . . . . 0.0 110.939 175.415 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 CA--C 1.527 0.163 0 N-CA-C 112.505 0.156 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -135.54 147.02 48.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.181 0.593 . . . . 0.0 110.438 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.15 27.17 3.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.999 0.52 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.7 tp -135.47 54.96 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.613 0.765 . . . . 0.0 108.958 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -85.08 55.78 3.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.526 0.73 . . . . 0.0 110.664 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.68 139.63 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.031 0.533 . . . . 0.0 110.612 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 t -135.79 146.89 48.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.366 0.666 . . . . 0.0 110.362 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -92.67 135.23 34.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -71.26 151.47 94.42 Favored Pre-proline 0 N--CA 1.454 -0.238 0 C-N-CA 122.347 0.259 . . . . 0.0 110.379 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 153.25 66.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.365 2.71 . . . . 0.0 110.722 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -143.69 158.41 43.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.125 0.57 . . . . 0.0 110.305 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.43 146.63 43.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.805 0.442 . . . . 0.0 110.451 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -135.35 149.6 70.17 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 122.287 0.235 . . . . 0.0 111.591 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.95 -176.6 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 124.845 3.697 . . . . 0.0 110.8 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -64.07 154.97 80.56 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -70.61 156.9 60.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.069 2.512 . . . . 0.0 110.595 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.37 -21.15 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 122.739 0.416 . . . . 0.0 110.337 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 t -152.87 179.68 8.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.991 0.916 . . . . 0.0 109.129 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -104.59 24.41 11.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.312 0.645 . . . . 0.0 110.854 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.35 146.84 24.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -127.9 24.5 6.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.857 0.463 . . . . 0.0 111.294 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -133.05 48.51 2.4 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.613 0.765 . . . . 0.0 109.076 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.78 127.96 91.2 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.41 157.14 36.91 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.484 2.789 . . . . 0.0 112.271 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.12 -3.93 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.497 3.465 . . . . 0.0 111.538 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -73.19 110.44 7.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 111.741 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 49.87 21.01 0.63 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.622 1.969 . . . . 0.0 114.825 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.5 pt -135.75 162.26 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' H ' ' CD2' ' A' ' 124' ' ' LEU . 48.3 tptt -106.53 32.49 4.47 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 121.244 0.545 . . . . 0.0 110.914 -170.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.21 46.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.287 0.635 . . . . 0.0 110.514 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -59.14 144.15 46.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.85 0.46 . . . . 0.0 110.979 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -136.5 141.44 43.45 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.012 0.525 . . . . 0.0 110.617 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -119.01 128.16 54.12 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.1 p -88.43 124.73 34.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.948 0.499 . . . . 0.0 110.253 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.5 tp -102.85 122.08 43.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -114.21 131.09 56.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.352 0.261 . . . . 0.0 110.748 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -104.3 143.42 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.9 163.56 27.99 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.72 18.28 70.07 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -54.21 138.38 57.35 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.78 0.79 . . . . 0.0 110.982 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.11 -15.39 20.53 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.166 2.577 . . . . 0.0 110.969 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.16 123.46 14.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -106.98 24.6 12.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.506 0.322 . . . . 0.0 110.463 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.3 ttp -139.31 24.21 2.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -147.08 85.84 1.62 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.7 -14.51 52.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 110.717 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -83.11 -8.21 59.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.883 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -94.99 -21.16 18.79 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.411 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.76 -26.79 60.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.32 -21.4 39.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.45 -13.16 60.37 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.088 -0.383 . . . . 0.0 110.739 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.52 -3.05 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.9 12.01 25.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.478 0.711 . . . . 0.0 110.371 170.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttp -95.22 -31.77 0.27 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 71.9 Cg_exo -54.63 -33.96 81.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.629 2.219 . . . . 0.0 114.728 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -139.38 17.06 2.57 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.463 0.574 . . . . 0.0 112.444 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.31 172.82 17.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.703 0.401 . . . . 0.0 110.088 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.76 55.61 1.89 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.016 0.526 . . . . 0.0 110.071 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.23 140.77 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.558 0.743 . . . . 0.0 110.215 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -120.26 3.52 10.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.7 m -139.16 126.86 21.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.341 0.518 . . . . 0.0 110.866 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.13 128.16 21.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 123.435 0.694 . . . . 0.0 109.348 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.63 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 109.732 173.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.42 147.37 46.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.292 1.037 . . . . 0.0 110.383 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -134.47 135.37 42.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.128 0.571 . . . . 0.0 109.906 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -80.87 41.3 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.682 0.793 . . . . 0.0 111.27 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -128.89 105.12 8.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 55.36 26.87 9.2 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.659 0.784 . . . . 0.0 111.448 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 49.46 54.65 10.63 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.348 1.059 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -88.53 141.31 28.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.527 0.331 . . . . 0.0 110.766 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.45 148.6 49.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.717 0.407 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -135.17 131.35 36.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.42 151.27 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.811 0.444 . . . . 0.0 110.028 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -137.33 136.82 38.3 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.42 164.64 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.664 1.585 . . . . 0.0 109.677 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.2 16.88 25.0 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.613 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -151.94 137.12 17.44 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.674 0.79 . . . . 0.0 109.018 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -12.68 61.33 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -87.13 -15.53 38.15 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -83.71 -21.03 32.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.56 54.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.0 -21.19 63.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.214 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -89.45 -9.61 49.51 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.953 -0.467 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 t -87.41 -25.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.794 -0.566 . . . . 0.0 109.919 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.82 -27.88 60.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -81.44 -14.78 56.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.698 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.19 -43.92 66.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -85.02 -1.44 56.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.465 -0.147 . . . . 0.0 111.346 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.35 -0.61 26.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.424 0.29 . . . . 0.0 110.811 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.492 ' HZ1' ' HB3' ' A' ' 90' ' ' LYS . 9.0 mtpm? -131.89 11.9 4.75 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 176.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.6 -5.37 59.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.423 0.556 . . . . 0.0 110.736 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.91 -3.1 10.43 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.684 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.63 4.54 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.238 1.519 . . . . 0.0 113.542 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.3 mp 38.45 55.56 4.79 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 112.057 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.68 -15.83 26.97 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.221 2.614 . . . . 0.0 112.175 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.4 mt -136.86 146.06 45.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.532 0.733 . . . . 0.0 110.752 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -107.03 130.8 54.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -135.04 140.55 45.68 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.847 0.459 . . . . 0.0 111.338 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -138.84 147.47 42.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.147 0.979 . . . . 0.0 109.232 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -121.66 157.5 30.71 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.774 0.321 . . . . 0.0 111.227 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.51 -178.85 31.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.86 137.59 48.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.115 0.566 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.72 127.59 8.8 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.33 147.53 38.27 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.627 0.371 . . . . 0.0 110.923 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.33 -134.73 2.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.97 -174.58 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.495 2.797 . . . . 0.0 110.154 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -51.3 141.2 15.49 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.733 0.413 . . . . 0.0 110.404 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.96 136.04 56.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.0 0.52 . . . . 0.0 111.521 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 16.0 t -112.9 26.9 10.08 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.594 0.758 . . . . 0.0 110.496 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 78.5 m -73.11 148.33 44.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.957 0.503 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -135.69 158.73 43.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.348 0.659 . . . . 0.0 109.822 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.64 15.47 18.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -79.5 -7.15 58.26 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.608 0.64 . . . . 0.0 110.419 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -138.29 7.77 2.64 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.531 0.733 . . . . 0.0 110.03 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.87 -15.56 42.08 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -94.22 24.44 4.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.977 0.511 . . . . 0.0 110.25 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -135.62 151.58 50.39 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.047 0.939 . . . . 0.0 109.704 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -85.04 21.08 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.981 0.419 . . . . 0.0 111.07 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.429 ' N ' ' HD3' ' A' ' 120' ' ' PRO . 24.8 pt -141.47 56.75 6.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.644 0.778 . . . . 0.0 111.509 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 119' ' ' ILE . 51.5 Cg_exo -58.76 -21.52 56.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.366 2.044 . . . . 0.0 112.442 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 46.3 ttp -85.27 49.48 1.76 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.629 0.771 . . . . 0.0 110.216 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -135.43 -41.5 0.71 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.524 0.33 . . . . 0.0 111.039 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -79.78 -14.44 58.71 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.774 0.261 . . . . 0.0 110.337 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.483 ' CD2' ' H ' ' A' ' 29' ' ' LYS . 55.7 tp -88.78 -26.94 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -78.39 -20.76 50.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.28 -47.6 7.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.173 -0.33 . . . . 0.0 110.932 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.93 -14.56 58.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.56 -22.32 13.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.415 0.552 . . . . 0.0 111.321 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.98 -28.71 63.6 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.36 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.508 ' HZ1' ' HB3' ' A' ' 130' ' ' LYS . 4.2 mmmp? -84.04 -57.38 3.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.703 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.2 7.14 26.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -171.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.3 m -143.14 -0.53 1.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.0 t -135.28 14.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.563 1.074 . . . . 0.0 112.12 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.9 m -90.35 24.13 2.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.817 -0.552 . . . . 0.0 109.773 169.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.75 43.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.569 1.148 . . . . 0.0 109.347 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -86.3 33.35 0.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -135.79 26.35 3.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.58 165.9 33.13 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.877 -0.514 . . . . 0.0 112.659 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.18 163.45 15.11 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.107 0.86 . . . . 0.0 112.686 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.6 t -98.29 -30.08 12.8 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.725 -0.28 . . . . 0.0 111.464 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -151.79 22.69 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.703 0.401 . . . . 0.0 111.334 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.61 -9.41 68.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.352 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 59.9 tt0 -163.78 -39.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 118.45 1.125 . . . . 0.0 113.335 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 46.0 Cg_exo -61.65 11.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.98 3.12 . . . . 0.0 115.878 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.2 14.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.112 0.869 . . . . 0.0 112.019 177.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 144' ' ' PRO . 33.2 m -78.22 6.84 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.684 0.794 . . . . 0.0 111.59 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -136.03 30.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.627 1.171 . . . . 0.0 108.213 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.91 29.04 0.07 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 149' ' ' ILE . 16.5 mm -44.16 -43.63 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 118.13 0.965 . . . . 0.0 111.632 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m 46.93 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.295 1.438 . . . . 0.0 113.914 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -111.78 149.68 31.37 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 118.221 0.464 . . . . 0.0 110.688 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -131.81 32.54 4.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.211 0.604 . . . . 0.0 111.196 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.32 146.72 59.21 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 122.514 0.325 . . . . 0.0 110.802 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.71 170.57 19.62 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.289 3.326 . . . . 0.0 111.685 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -135.64 163.48 30.04 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.729 0.812 . . . . 0.0 110.245 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 tp -121.59 30.98 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.353 0.597 . . . . 0.0 110.441 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.73 121.1 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 157.82 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 123.497 0.719 . . . . 0.0 110.598 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -157.82 -167.76 19.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.36 144.9 50.86 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.057 0.543 . . . . 0.0 110.793 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -78.77 -168.49 34.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.43 132.36 66.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.333 0.653 . . . . 0.0 109.632 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.5 p -91.06 152.45 20.64 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.236 0.615 . . . . 0.0 111.25 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.2 t -73.66 134.71 43.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.511 0.324 . . . . 0.0 110.446 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -136.02 154.37 51.08 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 110.602 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 53.54 44.51 29.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.504 0.721 . . . . 0.0 111.727 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 9.0 tp -64.73 145.45 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.874 0.469 . . . . 0.0 110.601 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.7 m -64.96 146.82 54.47 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.126 0.571 . . . . 0.0 111.406 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -135.37 142.86 45.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.358 0.663 . . . . 0.0 109.915 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -135.22 154.92 51.43 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.355 0.662 . . . . 0.0 110.452 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.3 mmm -122.44 152.46 61.25 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 123.195 0.598 . . . . 0.0 110.115 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.07 170.92 17.82 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.802 3.001 . . . . 0.0 111.259 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 66.4 m -121.71 144.46 48.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.629 0.772 . . . . 0.0 109.485 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.13 145.77 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.809 0.444 . . . . 0.0 110.855 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.3 t -135.31 151.72 50.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.477 0.711 . . . . 0.0 109.854 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.94 158.29 29.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.64 152.76 51.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.449 0.7 . . . . 0.0 110.962 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -77.85 154.39 31.83 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.967 0.507 . . . . 0.0 110.19 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -166.73 -46.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.082 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.56 161.94 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.546 2.831 . . . . 0.0 112.192 175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -126.2 130.76 51.59 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.316 0.647 . . . . 0.0 109.964 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 29.1 t -140.53 148.47 41.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.159 0.584 . . . . 0.0 110.427 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.39 178.61 44.44 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -145.09 140.91 16.59 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.153 0.581 . . . . 0.0 109.636 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.833 3.022 . . . . 0.0 112.492 177.844 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.5 tp -85.49 105.92 16.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.42 141.71 35.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.636 0.774 . . . . 0.0 110.448 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mm -127.74 109.44 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.26 161.55 12.92 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 122.18 -0.325 . . . . 0.0 112.483 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.88 73.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.303 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.7 m -54.09 120.78 26.57 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.185 0.993 . . . . 0.0 111.062 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 26.9 Cg_exo -67.03 -12.84 37.67 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.595 2.863 . . . . 0.0 112.539 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 42' ' ' LEU . 2.8 mm? -84.67 157.96 20.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.325 0.65 . . . . 0.0 110.988 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -79.71 53.99 1.72 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.9 mtm 53.47 55.74 8.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.448 1.099 . . . . 0.0 112.551 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.19 104.27 13.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.69 -17.0 63.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -82.7 -11.88 58.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.053 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.25 -16.59 22.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.642 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 49' ' ' LEU . 3.7 mm? -78.09 -25.98 47.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.49 -21.3 38.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 171.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.217 -0.302 . . . . 0.0 111.233 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.28 -6.39 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.967 0.348 . . . . 0.0 111.657 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.93 17.01 21.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.65 0.78 . . . . 0.0 110.003 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -76.14 -45.33 3.71 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.107 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.37 136.49 11.25 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.198 1.932 . . . . 0.0 111.672 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 50.1 24.24 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.027 1.331 . . . . 0.0 113.783 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.14 33.62 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.719 0.407 . . . . 0.0 110.816 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -133.53 59.72 1.73 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.325 0.65 . . . . 0.0 110.331 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.31 138.48 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -133.31 4.61 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 t -151.06 137.84 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.113 0.415 . . . . 0.0 110.484 173.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.3 t -136.81 133.2 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.578 0.751 . . . . 0.0 109.468 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.03 138.87 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.484 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -126.47 117.78 23.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.108 1.363 . . . . 0.0 108.545 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -135.78 162.71 32.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.217 0.607 . . . . 0.0 111.425 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.1 t30 65.58 149.93 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.812 1.245 . . . . 0.0 112.81 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -81.74 25.01 0.57 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.169 0.588 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -127.9 24.63 6.04 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.532 0.733 . . . . 0.0 111.147 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 54.64 55.17 8.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.055 0.942 . . . . 0.0 112.002 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -104.79 120.31 41.07 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.89 153.12 51.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 112.073 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.24 147.89 49.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.45 150.63 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.21 130.35 56.89 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.738 0.415 . . . . 0.0 110.182 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.09 149.16 18.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 C-N-CA 124.056 0.942 . . . . 0.0 109.823 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -97.12 14.92 24.12 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -154.99 139.96 17.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.158 0.583 . . . . 0.0 109.848 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -84.9 -6.55 59.34 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.735 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -90.46 -28.76 18.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.34 -17.87 40.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -46.05 73.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -74.94 -11.82 60.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.352 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.66 -22.26 40.65 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.683 0.674 . . . . 0.0 110.685 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -77.76 -45.28 28.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.04 -17.72 64.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.557 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -69.66 -53.87 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.639 -0.663 . . . . 0.0 109.37 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -80.04 -45.03 19.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.738 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -89.6 9.37 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -139.46 6.88 2.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.6 0.636 . . . . 0.0 112.512 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -143.63 14.99 1.78 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.15 7.82 40.77 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.414 1.006 . . . . 0.0 112.052 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.2 4.26 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.519 0.581 . . . . 0.0 113.983 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.61 55.27 1.88 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.959 0.879 . . . . 0.0 109.318 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 94' ' ' LEU . 6.3 mp -61.84 115.73 17.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.075 0.95 . . . . 0.0 110.728 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.08 -17.26 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.234 2.623 . . . . 0.0 110.802 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.7 mt -135.77 146.11 47.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.276 1.03 . . . . 0.0 109.916 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.59 88.04 6.16 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.7 p -93.87 125.75 38.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.844 0.458 . . . . 0.0 111.664 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -140.54 145.21 36.51 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 124.243 1.017 . . . . 0.0 108.743 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -135.68 157.97 45.56 Favored 'General case' 0 C--O 1.229 0.019 0 CA-C-N 118.337 0.517 . . . . 0.0 112.195 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 157.33 29.41 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.11 140.06 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 123.506 0.723 . . . . 0.0 110.551 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 173.101 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.446 HG12 ' H ' ' A' ' 121' ' ' MET . 16.9 tt . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 42.7 Cg_exo -61.45 -16.77 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.314 2.676 . . . . 0.0 113.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.446 ' H ' HG12 ' A' ' 119' ' ' ILE . 1.7 mpt? -79.82 21.02 0.56 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.009 0.524 . . . . 0.0 112.079 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -130.01 -15.55 3.78 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.651 0.38 . . . . 0.0 110.465 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.58 -11.32 59.67 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.37 -25.7 51.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.1 m -79.18 -49.47 12.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.516 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.46 -17.37 34.42 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.658 -0.817 . . . . 0.0 113.12 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.4 -21.65 17.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.17 0.896 . . . . 0.0 112.365 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 -26.02 15.91 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.417 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -84.65 -23.94 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.857 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -81.54 -49.78 10.16 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.689 0.677 . . . . 0.0 110.627 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -94.9 4.87 53.31 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.1 m -135.86 -4.92 2.2 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.54 0.609 . . . . 0.0 112.418 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 14.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.142 0.883 . . . . 0.0 111.595 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 t -147.52 55.62 1.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.609 -0.682 . . . . 0.0 111.23 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.29 -42.15 0.97 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.437 0.295 . . . . 0.0 110.731 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -139.36 16.87 2.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.136 0.574 . . . . 0.0 110.434 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -146.42 156.86 43.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.707 0.803 . . . . 0.0 110.086 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.91 149.08 39.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.07 156.61 53.57 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 66.46 116.69 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.828 1.251 . . . . 0.0 112.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.412 ' HA ' HG11 ' A' ' 146' ' ' VAL . 23.7 m 64.98 30.8 11.68 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.611 1.164 . . . . 0.0 112.791 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.15 -13.33 52.85 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -146.38 160.67 41.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.108 0.963 . . . . 0.0 109.354 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.94 0.64 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.449 3.433 . . . . 0.0 114.644 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.44 6.58 6.7 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.726 0.693 . . . . 0.0 112.419 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 141' ' ' SER . 30.5 m -85.36 19.91 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.7 m -128.6 27.66 5.5 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.34 -48.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 118.101 0.951 . . . . 0.0 111.516 -178.396 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.5 tp -114.81 127.69 55.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -105.95 143.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.36 0.664 . . . . 0.0 110.257 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.43 143.33 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.845 0.858 . . . . 0.0 110.173 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.03 172.64 42.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.93 64.79 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -59.29 138.52 88.59 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 117.368 0.584 . . . . 0.0 111.599 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.84 -11.1 10.29 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.881 3.054 . . . . 0.0 111.526 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 45' ' ' LYS . 2.0 pp -84.39 161.02 20.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.467 0.707 . . . . 0.0 111.234 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -81.52 55.44 2.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.8 ptt? 46.61 55.16 7.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.918 1.287 . . . . 0.0 112.812 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' H ' HD13 ' A' ' 42' ' ' LEU . 54.8 mtmt -111.24 119.28 38.37 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.354 0.662 . . . . 0.0 109.292 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -70.47 -15.88 62.86 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.976 -0.102 . . . . 0.0 111.143 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -93.85 -9.89 35.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.314 -0.241 . . . . 0.0 111.484 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.01 -17.2 15.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -78.38 -28.2 46.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.2 -21.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.49 -19.16 61.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.176 0.444 . . . . 0.0 110.98 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.96 -6.52 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 117.945 0.339 . . . . 0.0 111.586 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.92 20.07 18.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.785 0.834 . . . . 0.0 110.067 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 23.7 tptm -88.34 -49.43 0.42 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.426 170.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 98.2 Cg_endo -77.08 141.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.089 1.859 . . . . 0.0 110.643 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 48.96 34.5 5.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.781 0.833 . . . . 0.0 112.369 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.89 156.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.083 -0.386 . . . . 0.0 111.378 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.37 54.92 1.92 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.422 0.689 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.88 138.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -117.79 -7.4 10.98 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -146.52 134.11 20.98 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.025 -0.422 . . . . 0.0 110.573 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.1 117.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.37 131.39 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.013 0.435 . . . . 0.0 111.578 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.32 132.9 41.32 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.503 1.121 . . . . 0.0 109.27 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.69 160.09 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.133 0.573 . . . . 0.0 111.688 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.2 t30 64.66 153.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.054 1.342 . . . . 0.0 112.719 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -78.82 32.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.504 0.722 . . . . 0.0 111.144 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -134.75 24.48 3.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.64 0.776 . . . . 0.0 110.289 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 45.91 48.21 12.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 114.001 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -106.61 146.54 30.58 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.24 39.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 111.656 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -131.16 129.78 42.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.17 151.7 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.437 0.161 . . . . 0.0 110.986 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.78 137.62 51.63 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.893 0.378 . . . . 0.0 111.168 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 m -108.77 156.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.624 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.64 6.08 29.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -155.54 137.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.126 0.57 . . . . 0.0 109.801 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.19 -13.35 61.9 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.287 -0.258 . . . . 0.0 111.628 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -88.13 -14.65 38.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -92.01 -11.55 35.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.64 -44.47 61.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.0 -15.27 61.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -83.03 -19.15 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 122.03 -0.419 . . . . 0.0 110.873 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.6 t -75.21 -37.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.65 -21.74 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.894 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.19 -19.8 53.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -85.66 -23.37 27.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -77.93 -8.89 58.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -122.51 3.42 9.64 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -139.82 24.09 2.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.712 0.687 . . . . 0.0 112.835 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -135.45 49.88 2.15 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.667 -0.645 . . . . 0.0 111.016 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.7 4.3 87.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.481 -0.621 . . . . 0.0 113.088 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.91 55.78 8.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.827 0.814 . . . . 0.0 111.679 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -56.48 153.49 20.28 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.287 0.635 . . . . 0.0 110.973 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.63 -2.14 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.925 3.083 . . . . 0.0 112.088 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.88 114.69 5.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -85.31 127.62 34.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.887 0.375 . . . . 0.0 110.734 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 t -137.43 137.48 38.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.326 0.65 . . . . 0.0 109.89 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -147.94 146.41 28.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.187 0.595 . . . . 0.0 110.484 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -106.72 155.89 19.21 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.612 0.365 . . . . 0.0 111.221 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.13 35.58 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.72 148.98 27.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 175.417 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.817 0.342 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.17 -1.87 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.872 3.048 . . . . 0.0 113.413 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.12 21.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.835 0.743 . . . . 0.0 112.399 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -97.45 -10.51 25.27 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.796 -0.565 . . . . 0.0 110.105 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -79.84 -7.71 58.86 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.36 -41.59 13.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.161 0.984 . . . . 0.0 109.673 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 p -76.92 -25.46 52.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.845 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.04 -46.71 11.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.7 0.227 . . . . 0.0 111.531 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 -9.36 57.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.72 -36.78 8.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.45 -24.4 62.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.996 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -87.26 -57.05 3.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.047 -0.408 . . . . 0.0 111.244 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -83.04 5.5 22.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -139.12 -8.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.803 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.81 24.37 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.538 1.063 . . . . 0.0 112.064 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -123.85 34.28 5.11 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.87 -0.519 . . . . 0.0 111.036 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.56 25.3 3.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.083 0.553 . . . . 0.0 111.324 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.14 25.07 3.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.813 0.445 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.5 m95 53.56 38.8 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.238 0.615 . . . . 0.0 111.839 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.47 -160.65 19.42 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -167.13 159.74 33.2 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 117.168 0.484 . . . . 0.0 111.964 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 77.0 p 51.38 24.44 2.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.629 1.572 . . . . 0.0 114.089 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -156.53 24.12 0.34 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.953 0.342 . . . . 0.0 111.789 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.92 -10.96 27.33 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.485 -0.62 . . . . 0.0 114.134 -172.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -145.86 160.4 43.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.197 0.998 . . . . 0.0 110.232 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -60.65 -3.52 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.129 3.219 . . . . 0.0 113.788 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -75.12 -2.71 28.87 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.375 0.534 . . . . 0.0 111.836 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 m -84.77 8.85 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.524 0.329 . . . . 0.0 111.237 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.1 p -129.63 38.07 3.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.19 0.996 . . . . 0.0 108.45 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.04 -59.09 0.02 OUTLIER Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 117.543 0.671 . . . . 0.0 109.962 179.303 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.562 0.22 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.76 108.55 12.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -86.78 139.63 30.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.371 0.668 . . . . 0.0 110.023 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.04 142.38 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.36 171.07 40.55 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.186 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.38 23.7 68.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -56.36 126.01 67.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 117.321 0.561 . . . . 0.0 111.799 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.25 -2.68 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.576 2.85 . . . . 0.0 110.82 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.19 159.98 33.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.221 0.608 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -79.11 38.59 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.799 0.839 . . . . 0.0 111.74 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp 57.48 54.26 6.68 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.9 0.88 . . . . 0.0 111.98 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.13 131.89 37.39 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.668 0.787 . . . . 0.0 109.185 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.8 -8.0 55.1 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -85.15 -17.94 35.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.156 -0.34 . . . . 0.0 110.946 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -87.13 -22.51 25.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.868 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.44 -37.23 77.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.36 -18.85 62.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.829 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -88.2 -4.22 58.76 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.857 -0.527 . . . . 0.0 111.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.46 -2.01 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 118.124 0.42 . . . . 0.0 111.672 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -131.27 6.68 4.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -171.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 3.2 mmpt? -96.52 -29.36 0.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 97.6 Cg_endo -74.74 134.98 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 121.779 1.671 . . . . 0.0 109.968 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 50.3 36.77 13.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.419 0.688 . . . . 0.0 111.612 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.69 165.38 29.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.658 0.783 . . . . 0.0 110.577 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -135.13 49.79 2.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 110.761 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.99 137.04 22.3 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.269 0.627 . . . . 0.0 109.915 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -125.45 1.97 7.67 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 m -138.53 138.73 38.28 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.629 0.65 . . . . 0.0 111.524 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.2 t -135.75 130.92 50.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 123.502 0.721 . . . . 0.0 109.368 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.87 137.84 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.96 142.11 51.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.741 0.816 . . . . 0.0 110.49 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -129.18 129.09 44.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.855 0.862 . . . . 0.0 109.057 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -78.39 43.46 0.46 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.137 0.975 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -135.44 104.91 6.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.7 0.8 . . . . 0.0 109.186 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 52.08 36.58 19.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.928 0.891 . . . . 0.0 111.919 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 53.8 55.77 8.03 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.435 0.694 . . . . 0.0 112.038 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -96.67 129.46 44.06 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.73 152.13 50.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.959 0.504 . . . . 0.0 110.974 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -135.67 136.86 41.26 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.24 155.36 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.595 0.236 . . . . 0.0 110.395 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.92 136.04 47.08 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.993 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -122.26 156.98 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 126.366 1.866 . . . . 0.0 108.192 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -117.94 17.91 14.07 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -143.44 122.94 13.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.757 0.823 . . . . 0.0 109.052 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 ttt-85 -70.26 -20.41 63.06 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.18 0.446 . . . . 0.0 110.679 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -75.75 -21.57 57.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.041 -0.412 . . . . 0.0 110.162 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.59 -11.76 19.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.0 64.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.95 -21.2 51.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.371 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -78.06 -20.57 52.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.972 -0.455 . . . . 0.0 110.855 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.97 -40.67 22.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 O-C-N 121.77 -0.581 . . . . 0.0 110.345 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.24 -21.72 62.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.468 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -81.65 -18.08 45.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.81 -0.557 . . . . 0.0 110.533 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.42 -26.5 32.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -91.8 2.64 56.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -119.84 -0.84 10.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.454 0.302 . . . . 0.0 111.49 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.32 16.18 3.44 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.96 49.05 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 110.595 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.34 9.04 85.91 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.343 -0.698 . . . . 0.0 112.892 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.73 81.18 0.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.083 0.953 . . . . 0.0 111.408 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.37 151.17 60.77 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.15 0.58 . . . . 0.0 111.107 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.27 -9.39 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.787 2.991 . . . . 0.0 111.468 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.9 tt -73.87 124.05 25.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.412 ' N ' HD23 ' A' ' 96' ' ' LEU . 25.8 tpt180 -85.15 136.72 33.42 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 122.368 0.267 . . . . 0.0 111.167 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 p -135.47 142.19 45.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.234 0.614 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.49 137.95 27.27 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.788 0.835 . . . . 0.0 109.061 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -135.2 155.57 50.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 0.0 111.677 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.36 176.49 45.32 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.319 0.4 . . . . 0.0 112.421 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.48 131.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.25 1.02 . . . . 0.0 109.921 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 120.194 0.045 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -56.59 -22.16 42.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.609 2.206 . . . . 0.0 113.248 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 41.4 ttp -80.08 36.34 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.023 0.529 . . . . 0.0 110.737 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -135.65 -36.95 0.76 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.393 0.677 . . . . 0.0 110.429 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -85.96 -13.49 47.53 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.579 0.172 . . . . 0.0 110.716 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.57 -24.97 14.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.209 0.604 . . . . 0.0 109.449 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.2 m -77.47 -26.04 51.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -91.0 -40.16 11.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.288 -0.258 . . . . 0.0 110.886 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.49 -9.41 59.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -112.5 -17.23 12.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.36 -24.47 62.98 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 170.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.57 -52.5 5.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -86.69 16.41 4.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.6 t -143.24 -20.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' ALA . 20.4 m -140.16 33.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.384 0.993 . . . . 0.0 113.058 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.7 p -72.81 22.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.521 -0.737 . . . . 0.0 111.887 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.53 36.52 2.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.44 1.096 . . . . 0.0 109.202 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -133.4 162.3 32.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.231 1.012 . . . . 0.0 109.449 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -75.73 44.64 0.3 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.433 0.693 . . . . 0.0 111.936 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.9 1.02 90.14 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.368 0.508 . . . . 0.0 112.597 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 167.02 54.86 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.765 0.783 . . . . 0.0 111.925 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.8 t -140.01 22.34 2.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.811 0.845 . . . . 0.0 109.353 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -135.3 20.02 3.4 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 109.786 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.25 -5.1 83.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -137.69 160.33 65.39 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.029 0.532 . . . . 0.0 110.133 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.77 20.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 125.27 3.98 . . . . 0.0 115.157 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 149' ' ' ILE . 3.4 pp -83.33 1.62 40.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.14 0.882 . . . . 0.0 111.201 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.87 21.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.564 -0.71 . . . . 0.0 112.328 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -135.71 24.55 3.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.843 0.354 . . . . 0.0 111.796 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.96 -9.51 0.03 OUTLIER Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.593 -0.692 . . . . 0.0 112.915 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.475 HG13 HD13 ' A' ' 145' ' ' LEU . 29.5 mm . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 121.889 0.852 . . . . 0.0 109.548 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.0 tp -122.55 125.46 45.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.127 0.489 . . . . 0.0 110.406 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -109.04 141.58 40.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.902 0.881 . . . . 0.0 109.653 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.99 145.1 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 109.177 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.12 40.09 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.479 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.34 24.31 65.45 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.756 -0.537 . . . . 0.0 111.756 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.18 130.14 89.09 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.427 0.614 . . . . 0.0 111.574 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.45 -2.94 12.27 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.459 2.772 . . . . 0.0 110.86 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.45 156.95 37.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.229 0.612 . . . . 0.0 110.413 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -80.5 43.16 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.409 0.684 . . . . 0.0 111.155 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 88.3 mtp 52.52 55.13 9.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.093 0.957 . . . . 0.0 112.277 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -130.83 125.97 35.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.01 -8.38 52.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -80.86 -15.65 55.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.047 -0.408 . . . . 0.0 110.974 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.02 -24.3 17.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.577 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.86 -26.28 60.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.3 -19.13 36.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.15 -8.47 59.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.953 -0.467 . . . . 0.0 110.806 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.17 -4.21 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -112.46 14.13 20.25 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.332 0.653 . . . . 0.0 111.045 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.514 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 56.3 tttp -117.71 -19.13 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 92.4 Cg_endo -78.16 -21.54 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 121.932 1.726 . . . . 0.0 112.307 -177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.84 16.41 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.129 0.571 . . . . 0.0 111.201 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.07 -175.78 5.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.439 1.096 . . . . 0.0 108.526 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -145.63 104.22 3.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.001 -0.437 . . . . 0.0 110.09 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.38 139.86 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.103 0.561 . . . . 0.0 110.123 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.57 2.72 6.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.201 0.2 . . . . 0.0 111.429 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 t -135.88 119.7 17.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.905 -0.497 . . . . 0.0 110.268 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.7 t -140.38 127.12 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.656 0.782 . . . . 0.0 109.671 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 136.18 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 122.751 0.42 . . . . 0.0 110.133 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.19 145.19 39.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.569 1.148 . . . . 0.0 110.311 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -135.15 138.21 43.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.079 0.552 . . . . 0.0 110.108 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.9 50.45 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -128.18 98.77 5.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 54.9 25.36 6.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.628 0.771 . . . . 0.0 111.693 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.08 60.96 3.28 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.206 1.002 . . . . 0.0 110.946 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.99 151.36 34.3 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.258 0.623 . . . . 0.0 111.122 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.18 160.15 40.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.647 0.779 . . . . 0.0 110.987 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -126.45 137.09 53.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.66 151.25 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-O 121.015 0.436 . . . . 0.0 111.464 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -135.0 134.79 40.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.8 156.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 125.212 1.405 . . . . 0.0 109.1 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -104.51 21.22 17.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.524 0.202 . . . . 0.0 111.216 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -142.71 115.35 8.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.934 0.893 . . . . 0.0 108.955 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -72.96 -20.05 61.12 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -89.79 -16.96 29.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.269 -0.27 . . . . 0.0 110.636 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.31 -18.62 28.11 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.15 84.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -70.48 -20.8 62.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -83.73 -14.09 52.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.99 0.359 . . . . 0.0 111.456 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -75.23 -50.2 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.27 -20.89 65.72 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.664 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -67.81 -46.42 71.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -84.07 -23.73 30.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.913 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.28 -2.86 43.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.095 0.407 . . . . 0.0 111.341 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -131.22 9.13 4.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -135.23 12.61 3.55 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -103.23 -11.84 17.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.043 0.838 . . . . 0.0 111.323 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.81 5.91 4.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.856 0.741 . . . . 0.0 114.392 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.71 29.61 3.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.589 1.195 . . . . 0.0 112.222 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.24 95.69 30.13 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.89 -2.48 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.904 3.069 . . . . 0.0 111.163 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.48 121.08 14.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.565 0.746 . . . . 0.0 109.022 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -83.07 136.11 34.6 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.615 0.366 . . . . 0.0 111.187 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 p -135.69 143.98 45.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.325 0.65 . . . . 0.0 110.81 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.03 131.32 25.01 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -125.47 155.43 40.52 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.333 0.253 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 180.0 -178.54 48.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.69 148.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.132 0.573 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 175.784 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 118.447 -0.787 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.29 -8.18 17.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.75 1.633 . . . . 0.0 111.834 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.94 24.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.665 0.386 . . . . 0.0 111.753 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.87 -26.61 1.53 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.476 0.311 . . . . 0.0 110.771 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -87.48 -9.83 53.49 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.26 -52.62 8.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.892 0.877 . . . . 0.0 108.689 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -71.69 -19.68 62.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.097 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.7 -60.72 2.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.5 -26.02 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -172.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.22 -42.13 6.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.377 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -77.04 -21.26 54.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.224 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.18 -46.69 8.61 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.723 0.692 . . . . 0.0 111.111 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -84.63 5.03 29.6 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.493 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.3 m -138.83 -5.02 1.53 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.58 19.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.493 1.042 . . . . 0.0 112.571 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -82.87 49.79 1.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.322 -0.861 . . . . 0.0 111.557 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.92 8.0 3.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.923 0.489 . . . . 0.0 110.491 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -145.52 156.92 44.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.287 1.035 . . . . 0.0 109.547 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -76.2 104.53 6.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.55 178.8 33.8 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.04 136.87 25.86 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -146.2 32.75 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.928 0.364 . . . . 0.0 111.331 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG11 ' A' ' 146' ' ' VAL . 21.1 m 57.1 40.71 28.2 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.841 0.456 . . . . 0.0 111.901 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.98 -19.0 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -146.88 162.08 34.72 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.718 0.807 . . . . 0.0 109.287 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.02 3.82 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.46 3.44 . . . . 0.0 114.43 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.02 -5.76 28.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.69 0.677 . . . . 0.0 111.659 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 141' ' ' SER . 22.8 m -89.36 14.69 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.45 0.7 . . . . 0.0 111.042 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -133.43 44.33 2.81 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.78 -57.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.641 0.734 . . . . 0.0 109.653 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 HG11 ' A' ' 84' ' ' VAL . 58.6 tp -135.2 126.29 27.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -100.7 143.02 31.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.534 0.333 . . . . 0.0 110.695 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.73 102.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.23 164.5 18.15 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.31 72.63 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.019 -0.878 . . . . 0.0 113.77 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -53.59 117.51 12.33 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 118.548 1.174 . . . . 0.0 111.09 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.97 -9.49 25.16 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.373 2.715 . . . . 0.0 112.413 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -135.09 67.84 1.48 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.78 0.832 . . . . 0.0 110.856 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.52 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.608 0.763 . . . . 0.0 112.323 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 42' ' ' LEU . 12.1 tpt -147.87 22.81 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.128 0.571 . . . . 0.0 110.902 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 47' ' ' TRP . 29.0 tptt -145.43 78.63 1.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.35 -20.46 66.12 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.06 -0.4 . . . . 0.0 111.745 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.494 ' CE2' ' HE3' ' A' ' 45' ' ' LYS . 63.9 p-90 -92.09 1.7 57.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.95 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.83 -28.51 28.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.39 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.49 -40.39 85.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.49 65.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.229 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -92.06 -3.41 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.214 0.461 . . . . 0.0 112.142 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.16 -2.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 O-C-N 121.996 -0.44 . . . . 0.0 111.75 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tp -124.95 -6.41 7.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 98.5 mttt -96.01 -29.75 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.286 -0.864 . . . . 0.0 113.284 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.51 -18.66 47.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.427 2.085 . . . . 0.0 114.117 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.66 8.53 3.32 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.75 150.12 28.17 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.597 0.635 . . . . 0.0 110.427 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -87.94 40.06 0.92 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.686 0.394 . . . . 0.0 111.642 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.92 141.34 16.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 O-C-N 122.052 -0.405 . . . . 0.0 109.995 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -135.29 7.83 3.38 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 124.25 25.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.206 0.457 . . . . 0.0 110.789 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.09 130.54 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 123.737 0.815 . . . . 0.0 109.337 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.78 131.73 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.81 119.5 22.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -86.64 104.08 15.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -84.5 18.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.273 0.629 . . . . 0.0 112.049 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.6 3.79 3.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.425 0.29 . . . . 0.0 111.588 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -141.18 14.08 2.22 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.95 0.5 . . . . 0.0 111.036 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.1 pttt 44.5 40.7 4.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.727 1.211 . . . . 0.0 112.89 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -127.25 138.5 53.1 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.113 0.565 . . . . 0.0 109.918 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.77 147.0 48.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.752 0.31 . . . . 0.0 111.187 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.86 144.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.5 156.69 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.09 139.39 44.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.58 154.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 126.284 1.834 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.2 15.41 17.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 t -155.91 137.63 14.26 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.055 0.542 . . . . 0.0 110.35 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -68.06 -11.4 58.95 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -81.39 -17.37 49.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.797 -0.564 . . . . 0.0 110.706 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -90.98 -23.13 20.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.02 -22.09 56.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -82.51 -21.59 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -78.04 -20.47 52.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.074 -0.391 . . . . 0.0 110.559 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 35' ' ' LEU . 71.8 t -81.58 -40.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.458 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.8 -18.36 60.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.243 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -82.29 -19.2 39.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.999 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -79.09 -26.01 43.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -84.15 -8.85 58.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.952 0.501 . . . . 0.0 111.409 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -127.24 12.19 7.05 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.94 10.06 3.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.397 0.544 . . . . 0.0 112.459 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -122.77 -20.02 6.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.531 0.605 . . . . 0.0 111.353 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.93 9.73 5.85 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.038 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.3 43.78 2.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.851 1.326 . . . . 0.0 112.26 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.36 119.78 26.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.52 -8.28 12.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.8 3.0 . . . . 0.0 111.404 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.04 138.96 50.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.996 0.519 . . . . 0.0 111.113 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -95.29 84.68 4.09 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.1 p -79.58 122.64 26.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.464 0.705 . . . . 0.0 110.872 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -140.61 118.3 11.65 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.121 0.568 . . . . 0.0 110.281 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -86.83 155.29 20.34 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.673 0.389 . . . . 0.0 111.359 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.78 -171.74 37.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -135.95 136.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.381 0.672 . . . . 0.0 110.338 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 174.676 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 17.6 tt . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 52.1 Cg_exo -57.75 177.56 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.844 3.029 . . . . 0.0 112.801 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -71.67 24.11 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.603 -0.685 . . . . 0.0 110.909 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -87.08 -8.04 57.45 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 tp -103.66 -39.32 6.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.593 0.757 . . . . 0.0 109.262 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -70.61 -26.58 63.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.74 -45.55 9.22 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 117.915 0.325 . . . . 0.0 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.23 -10.95 59.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.923 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -106.7 -24.44 12.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.451 0.569 . . . . 0.0 111.275 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.03 -16.71 59.9 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.267 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 94.8 mttt -85.15 -55.56 3.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -86.6 11.67 12.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 t -137.37 -21.97 1.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.57 19.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.855 1.207 . . . . 0.0 114.117 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 13.0 t -101.95 37.55 1.83 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.313 0.96 . . . . 0.0 110.888 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.32 19.69 3.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -152.79 -41.32 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -136.41 13.01 3.25 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.86 15.08 66.43 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.425 0.557 . . . . 0.0 112.865 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.35 -176.58 41.92 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.74 0.77 . . . . 0.0 112.542 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 25.2 m 64.26 107.85 0.03 OUTLIER 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.895 1.278 . . . . 0.0 111.831 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t 60.74 31.7 20.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.989 0.915 . . . . 0.0 112.18 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.13 -29.77 24.54 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.643 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -152.23 165.44 17.49 Favored Pre-proline 0 C--N 1.34 0.158 0 CA-C-N 117.96 0.88 . . . . 0.0 110.052 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.6 -1.97 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.259 3.306 . . . . 0.0 114.622 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.52 -10.01 59.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.63 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.228 -0.065 0 C-N-CA 123.06 0.544 . . . . 0.0 112.455 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.2 p -135.53 -8.75 2.19 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 122.237 -0.29 . . . . 0.0 111.089 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.32 -31.05 14.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 149' ' ' ILE . 4.3 mp . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.63 129.0 49.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -97.33 139.75 32.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.687 0.28 . . . . 0.0 111.666 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.2 mm -125.87 139.3 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.422 1.089 . . . . 0.0 108.544 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.7 163.58 29.35 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.98 79.36 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.53 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.78 124.59 51.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.091 0.945 . . . . 0.0 111.294 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -82.57 -3.61 11.37 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.434 2.756 . . . . 0.0 110.867 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.78 153.68 43.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 110.453 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.13 46.08 0.99 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.499 0.72 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.2 mmt 54.3 54.92 8.79 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.114 0.966 . . . . 0.0 111.982 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.2 118.07 25.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -70.49 -16.98 62.96 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -84.88 -6.46 59.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.017 -0.427 . . . . 0.0 111.468 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.6 -23.11 19.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.527 0.603 . . . . 0.0 110.141 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.58 -28.21 56.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.15 -21.27 46.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.292 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -79.46 -12.4 59.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.924 0.329 . . . . 0.0 111.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.85 -2.84 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.114 -0.367 . . . . 0.0 111.596 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.87 13.39 24.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.794 0.838 . . . . 0.0 109.857 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.5 tttt -78.17 -38.82 1.67 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.11 170.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.87 118.76 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.678 2.252 . . . . 0.0 112.332 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 50.29 22.99 1.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.075 1.35 . . . . 0.0 113.661 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.49 162.27 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.0 110.453 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -135.07 59.41 1.73 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.789 0.436 . . . . 0.0 110.515 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.92 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 O-C-N 121.904 -0.497 . . . . 0.0 109.691 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -134.78 11.13 3.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 m -135.35 122.0 20.83 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.8 t -135.2 128.1 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.396 0.678 . . . . 0.0 109.229 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.91 104.37 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.14 112.72 25.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.637 0.375 . . . . 0.0 110.187 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -85.94 105.37 16.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.145 0.498 . . . . 0.0 109.777 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -71.59 162.86 28.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.986 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m 61.51 11.09 3.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -148.76 22.24 1.0 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.103 0.41 . . . . 0.0 111.666 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 35.08 45.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.103 1.761 . . . . 0.0 114.744 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -128.97 143.66 50.94 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.91 152.88 39.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.063 0.459 . . . . 0.0 111.437 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -122.56 131.86 54.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.2 151.47 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.37 139.53 44.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.347 0.594 . . . . 0.0 111.733 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.72 153.38 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 125.597 1.559 . . . . 0.0 109.496 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -89.96 9.53 27.48 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -152.57 137.09 16.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.312 0.645 . . . . 0.0 109.792 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -78.74 -4.01 47.11 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -88.04 -23.4 23.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.959 0.345 . . . . 0.0 110.334 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.68 -18.28 33.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.26 72.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.62 -22.45 61.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.393 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -80.06 -17.42 52.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.393 0.542 . . . . 0.0 111.501 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.46 -38.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.456 0.571 . . . . 0.0 110.002 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.55 -17.71 61.16 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.194 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -83.46 -15.3 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.892 -0.505 . . . . 0.0 110.072 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.05 -28.01 39.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.61 -7.0 59.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.124 0.57 . . . . 0.0 110.591 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.37 10.45 9.23 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -135.28 6.55 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.28 0.491 . . . . 0.0 112.119 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.48 -24.32 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.828 -0.545 . . . . 0.0 110.784 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.48 4.93 3.16 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 118.938 -0.923 . . . . 0.0 114.967 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.64 24.85 3.41 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.956 1.378 . . . . 0.0 112.976 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.56 135.21 43.75 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -6.36 12.19 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 124.094 3.196 . . . . 0.0 112.173 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.96 140.67 30.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -92.19 89.97 7.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.0 p -95.25 129.8 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.964 0.505 . . . . 0.0 111.099 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -146.38 148.43 32.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.901 0.48 . . . . 0.0 110.678 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.47 146.34 48.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.178 0.591 . . . . 0.0 111.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.36 16.83 5.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.994 0.807 . . . . 0.0 111.293 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.85 137.57 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 117.364 0.582 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 173.949 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.11 -169.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 124.849 3.7 . . . . 0.0 112.815 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -73.63 43.31 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.836 0.854 . . . . 0.0 112.43 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -85.19 -7.91 58.83 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.807 -0.558 . . . . 0.0 110.042 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -77.01 -4.11 42.48 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.0 tp -71.21 -45.71 62.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.663 0.785 . . . . 0.0 109.733 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.6 p -84.99 -22.28 29.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.613 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -81.4 -48.58 11.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.234 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.97 -4.61 54.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.68 -29.25 8.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.135 0.88 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -76.64 -21.28 55.7 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.143 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 130' ' ' LYS . 3.8 ttmp? -85.31 -50.61 7.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -91.26 14.93 13.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -135.91 -21.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.32 30.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.196 0.907 . . . . 0.0 113.372 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.7 t -77.21 50.12 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.784 0.72 . . . . 0.0 110.671 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.47 126.08 16.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.872 0.869 . . . . 0.0 108.941 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.96 -174.52 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.872 0.469 . . . . 0.0 111.703 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -73.85 43.0 0.15 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.27 1.028 . . . . 0.0 112.227 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.08 -154.5 7.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.816 0.722 . . . . 0.0 111.834 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.08 -8.42 75.91 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.771 -0.461 . . . . 0.0 112.486 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.1 m -135.57 -17.28 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.426 0.613 . . . . 0.0 111.798 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -148.43 24.17 1.01 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.8 0.44 . . . . 0.0 111.107 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.41 -34.49 7.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.469 -0.629 . . . . 0.0 113.538 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -149.93 164.35 21.1 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.924 . . . . 0.0 110.124 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.81 6.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 124.916 3.744 . . . . 0.0 115.162 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.18 -12.4 58.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.684 0.674 . . . . 0.0 110.595 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.54 19.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.499 0.72 . . . . 0.0 111.846 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.8 p -119.06 20.56 12.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.276 0.23 . . . . 0.0 111.328 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.46 -25.33 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.812 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-N 117.962 0.881 . . . . 0.0 109.696 -178.937 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.6 tp -135.47 112.19 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.43 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -86.56 135.91 33.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.854 0.862 . . . . 0.0 110.302 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.42 143.05 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.23 166.59 36.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.86 66.76 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.176 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.3 m -52.93 134.83 47.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.789 0.794 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -83.93 -12.25 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.198 3.265 . . . . 0.0 111.362 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.87 166.23 20.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.031 0.932 . . . . 0.0 111.105 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.9 44.56 0.66 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.258 0.623 . . . . 0.0 111.511 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.6 mtt 49.34 55.27 9.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.232 1.013 . . . . 0.0 112.194 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.59 132.98 54.54 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.218 0.607 . . . . 0.0 109.443 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -70.74 -10.1 58.72 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -99.64 -11.88 20.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.983 0.356 . . . . 0.0 111.952 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -96.19 -22.93 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.81 -39.67 63.93 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.81 -17.41 61.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.932 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -81.99 -14.38 56.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.616 0.644 . . . . 0.0 111.842 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.4 m -110.26 -4.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 118.227 0.467 . . . . 0.0 111.78 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -126.14 6.17 7.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -171.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 1.1 tmmt? -101.32 -38.61 0.22 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.929 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 61.9 Cg_exo -55.16 131.78 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.261 1.974 . . . . 0.0 111.182 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 p90 46.83 27.48 0.7 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 113.047 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.65 170.46 15.97 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.909 0.883 . . . . 0.0 110.274 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -135.07 55.13 1.9 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 110.957 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.08 130.14 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -123.35 4.16 9.11 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -140.84 121.34 14.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -135.75 120.22 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 136.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.31 110.77 9.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -83.55 104.38 13.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -84.21 25.81 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.0 p -131.86 3.85 4.13 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.3 0.56 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.998 0.363 . . . . 0.0 111.928 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.3 pttt 45.93 47.12 12.48 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.692 1.197 . . . . 0.0 112.37 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -124.94 129.94 51.36 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.275 0.63 . . . . 0.0 110.277 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.21 147.53 49.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.317 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.3 136.6 35.04 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.666 0.386 . . . . 0.0 110.082 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.57 159.7 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 122.323 0.249 . . . . 0.0 110.739 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.55 132.0 34.6 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.945 0.402 . . . . 0.0 111.513 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -101.1 154.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 124.383 1.073 . . . . 0.0 109.23 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -81.1 -4.62 55.9 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.1 t -147.01 139.08 24.51 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.726 0.41 . . . . 0.0 110.712 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -78.69 -5.84 54.17 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -90.0 -22.05 22.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.64 -15.36 45.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.28 -42.11 60.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.3 -22.49 66.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -81.25 -22.49 38.69 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.103 -0.373 . . . . 0.0 111.093 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.53 -38.65 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.88 -18.39 63.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.912 173.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -77.73 -23.12 49.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.302 0.501 . . . . 0.0 109.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -72.78 -49.64 29.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.877 -0.514 . . . . 0.0 109.614 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -89.47 10.16 23.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -135.65 6.57 3.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.356 0.526 . . . . 0.0 112.284 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -136.96 7.16 2.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.539 0.608 . . . . 0.0 112.396 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.12 -18.95 15.33 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.6 0.636 . . . . 0.0 110.909 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.58 4.55 4.1 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.337 0.97 . . . . 0.0 115.172 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.8 35.14 2.88 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.009 1.405 . . . . 0.0 112.745 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.83 127.94 23.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -84.85 -10.44 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.087 3.191 . . . . 0.0 112.61 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.6 tt -73.37 134.97 44.22 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 96' ' ' LEU . 82.2 mmt-85 -111.64 136.88 50.24 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -141.65 145.2 34.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.042 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -143.34 126.78 16.79 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.29 0.636 . . . . 0.0 110.257 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -85.84 156.74 20.43 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.14 -164.97 14.72 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.13 136.76 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.988 0.515 . . . . 0.0 110.452 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 174.55 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 9.5 tp . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 118.09 -0.957 . . . . 0.0 113.551 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 31.8 Cg_exo -63.96 176.26 2.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.46 2.107 . . . . 0.0 111.828 174.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -74.15 24.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.833 0.453 . . . . 0.0 111.507 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -91.29 -7.6 50.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.17 -9.21 59.71 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.82 -46.88 11.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.992 0.917 . . . . 0.0 109.503 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -77.68 -16.07 58.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.968 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.96 -43.94 12.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.103 -0.373 . . . . 0.0 111.401 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.21 -12.09 53.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.59 -24.32 11.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.679 0.672 . . . . 0.0 111.189 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -74.81 -22.68 58.6 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.544 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -90.35 -52.73 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.952 -0.467 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -83.16 7.23 16.68 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -143.94 -4.32 0.84 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.78 23.18 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.16 0.891 . . . . 0.0 111.851 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.7 t -84.9 32.86 0.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.624 -0.672 . . . . 0.0 111.374 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.07 20.6 3.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.023 0.529 . . . . 0.0 110.241 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -135.92 147.25 48.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.756 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -65.91 104.8 1.17 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.51 65.42 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.947 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 61.71 -148.26 47.6 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 118.18 0.99 . . . . 0.0 110.787 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.4 m 70.77 114.93 0.05 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.021 0.928 . . . . 0.0 111.507 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.6 t 59.22 31.01 20.87 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.62 -18.59 44.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -149.68 160.02 34.94 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 108.959 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.66 -10.83 10.07 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.661 2.908 . . . . 0.0 113.682 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.13 -36.63 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.786 0.434 . . . . 0.0 111.24 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -8.32 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 O-C-N 122.045 -0.409 . . . . 0.0 110.682 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -83.09 24.02 0.81 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.093 0.473 . . . . 0.0 109.86 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.99 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 CA--C 1.527 0.087 0 CA-C-N 117.559 0.679 . . . . 0.0 109.896 174.426 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.32 127.91 41.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.55 141.21 38.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.056 0.542 . . . . 0.0 110.475 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.9 mm -123.04 147.68 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.337 1.055 . . . . 0.0 108.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.03 164.21 36.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.534 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.55 27.04 70.3 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.96 128.87 85.38 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.338 0.569 . . . . 0.0 112.146 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.9 -1.81 11.44 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.934 3.089 . . . . 0.0 111.166 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.88 162.4 29.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.067 0.547 . . . . 0.0 110.97 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -80.1 38.14 0.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.03 0.932 . . . . 0.0 112.169 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.1 mtt 56.92 44.67 22.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.0 113.125 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.14 137.88 46.43 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.186 0.594 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -72.93 -12.07 60.82 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -84.12 -7.37 59.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.149 -0.344 . . . . 0.0 110.943 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -93.56 -24.29 18.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.881 0.309 . . . . 0.0 110.312 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.87 -28.72 55.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.99 -21.37 47.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -81.34 -14.55 57.16 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.245 0.475 . . . . 0.0 111.701 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.1 -4.47 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.252 0.478 . . . . 0.0 111.459 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.2 8.29 23.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.672 0.789 . . . . 0.0 110.371 170.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 59.3 tptt -72.59 -44.8 9.6 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.8 Cg_endo -84.12 -20.65 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.266 1.978 . . . . 0.0 114.546 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -142.98 24.51 1.83 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.46 165.69 27.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.905 -0.497 . . . . 0.0 111.105 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.32 55.36 1.22 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.358 0.663 . . . . 0.0 109.548 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.9 140.58 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.075 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -131.44 -0.12 4.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -143.55 134.41 25.33 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.751 -0.593 . . . . 0.0 110.734 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.0 t -137.96 130.05 39.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.421 0.688 . . . . 0.0 109.829 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 111.11 14.08 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.3 0.24 . . . . 0.0 110.37 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -88.99 88.7 7.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -76.87 24.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.559 0.744 . . . . 0.0 112.474 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.7 p -128.24 5.96 5.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -144.16 14.99 1.68 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.972 0.509 . . . . 0.0 110.606 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 52.88 31.44 10.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.325 1.05 . . . . 0.0 112.185 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -133.69 149.82 51.53 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 122.965 0.506 . . . . 0.0 110.817 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.73 158.2 43.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.12 0.568 . . . . 0.0 110.114 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -130.15 138.72 50.78 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.82 153.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.313 0.101 . . . . 0.0 110.736 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -125.23 130.39 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.081 0.467 . . . . 0.0 111.727 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.11 150.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.705 1.602 . . . . 0.0 108.565 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -109.03 24.15 13.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -145.43 121.84 10.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.14 0.976 . . . . 0.0 108.73 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -78.85 -9.14 59.38 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.478 -0.139 . . . . 0.0 111.094 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -84.89 -24.42 28.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -88.68 -14.43 37.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.59 -42.78 64.19 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -74.08 -16.2 61.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.185 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -83.31 -17.89 40.9 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.069 -0.394 . . . . 0.0 110.78 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.3 t -73.69 -47.43 44.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.05 -16.88 63.8 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.757 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.48 -44.86 66.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.72 -26.14 30.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.789 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -81.78 0.11 40.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.114 0.415 . . . . 0.0 111.025 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.17 5.37 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.094 0.406 . . . . 0.0 111.968 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -143.27 24.1 1.8 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.91 -8.74 14.48 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.62 -0.675 . . . . 0.0 111.182 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.51 2.55 4.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.082 -0.843 . . . . 0.0 114.708 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.75 26.14 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.735 1.268 . . . . 0.0 112.482 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt -131.22 96.51 21.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.86 -0.78 11.04 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.998 3.132 . . . . 0.0 111.346 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.41 125.06 23.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.52 0.728 . . . . 0.0 109.268 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -89.75 126.68 35.76 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.469 0.308 . . . . 0.0 110.797 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 m -136.4 137.9 40.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.402 0.681 . . . . 0.0 110.247 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -141.37 144.64 34.63 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.113 0.965 . . . . 0.0 109.087 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -102.65 130.48 49.57 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.545 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.5 156.7 21.19 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.2 138.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.459 0.704 . . . . 0.0 110.205 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 174.331 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.4 pt . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 71.9 Cg_endo -67.98 -8.08 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.397 2.731 . . . . 0.0 112.51 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 12.1 tpt -134.89 25.18 3.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.1 0.56 . . . . 0.0 110.221 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -135.15 -16.29 1.91 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.078 -0.388 . . . . 0.0 111.337 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -82.15 -19.66 39.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 173.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 32.0 tp -92.28 -25.62 18.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.414 0.686 . . . . 0.0 110.027 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.0 m -84.51 -21.47 30.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.2 -40.84 11.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.167 -0.333 . . . . 0.0 110.783 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.47 45.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -106.43 -25.2 11.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.682 0.674 . . . . 0.0 111.437 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -76.78 -24.84 52.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.773 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.06 -49.09 9.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.863 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -95.96 11.3 34.45 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -135.13 -16.85 1.88 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.824 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.69 21.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.408 1.003 . . . . 0.0 113.307 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 m -132.55 2.74 3.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 111.187 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.74 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.809 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -148.54 168.9 21.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.46 1.504 . . . . 0.0 108.373 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -129.61 27.81 5.21 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.501 0.321 . . . . 0.0 111.012 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.48 -12.65 77.86 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.666 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.95 -177.48 25.05 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 117.803 0.801 . . . . 0.0 111.802 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 p -77.81 -69.58 0.53 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 122.288 -0.537 . . . . 0.0 110.957 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 28.81 1.77 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.0 110.228 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.87 85.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.385 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.516 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 37.3 tp60 -162.3 -42.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.687 1.244 . . . . 0.0 113.258 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.516 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 39.5 Cg_exo -63.07 2.05 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.902 2.401 . . . . 0.0 114.741 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 3.41 7.0 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.872 0.76 . . . . 0.0 111.891 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.61 9.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.412 0.685 . . . . 0.0 111.789 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -135.64 24.13 3.4 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.97 0.908 . . . . 0.0 108.8 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.03 29.93 0.12 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.781 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 124.665 1.186 . . . . 0.0 112.635 177.532 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.232 0.182 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.21 123.28 48.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -93.98 140.5 29.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.974 0.509 . . . . 0.0 111.008 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.3 137.08 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.001 0.921 . . . . 0.0 108.878 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.66 166.83 31.41 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.85 20.23 74.18 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.629 -0.54 . . . . 0.0 112.023 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.04 124.74 46.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.763 0.782 . . . . 0.0 111.646 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.26 -4.95 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.374 2.716 . . . . 0.0 110.656 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.85 149.54 39.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.113 0.565 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -84.74 52.44 2.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.992 0.517 . . . . 0.0 110.168 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 55.28 55.66 7.25 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.051 0.94 . . . . 0.0 112.05 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.08 111.84 17.03 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.6 -13.7 62.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -88.61 -6.45 57.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.97 -0.456 . . . . 0.0 111.042 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -92.77 -20.03 21.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.209 0.459 . . . . 0.0 109.971 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.24 -28.41 53.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.79 45.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.019 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.43 -15.99 58.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.961 0.346 . . . . 0.0 111.557 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.79 -4.28 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.222 0.465 . . . . 0.0 111.482 172.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.52 12.05 26.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.665 0.786 . . . . 0.0 109.804 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 65.2 tttp -75.15 -39.29 3.17 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 95.1 Cg_endo -75.03 125.73 9.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.564 1.51 . . . . 0.0 111.576 -174.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 t80 51.63 23.93 2.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.124 1.37 . . . . 0.0 113.093 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.94 160.03 42.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.462 0.705 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.03 55.85 1.87 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.491 0.316 . . . . 0.0 111.597 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.53 139.0 21.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 O-C-N 121.958 -0.464 . . . . 0.0 109.813 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -131.71 4.17 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.4 m -135.59 124.22 23.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.01 0.368 . . . . 0.0 110.334 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.14 115.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.6 mp -111.62 104.58 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 104.81 14.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -81.05 104.2 11.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.064 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -85.67 24.34 1.24 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.44 0.696 . . . . 0.0 112.06 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -130.09 7.58 5.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -147.72 19.19 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.153 0.581 . . . . 0.0 110.235 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 37.51 38.03 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.704 1.602 . . . . 0.0 113.658 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -138.06 159.77 41.15 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.985 0.914 . . . . 0.0 109.769 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.67 159.29 42.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.979 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.45 135.31 47.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.12 154.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -135.21 139.04 44.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 0.0 111.357 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.63 150.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.48 1.512 . . . . 0.0 109.33 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -90.15 15.14 10.8 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -154.09 138.09 16.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.157 0.583 . . . . 0.0 109.886 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.24 -8.15 59.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.58 -28.87 24.56 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.41 -14.15 55.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.71 65.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.05 -13.69 60.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.146 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.72 -16.6 41.14 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.452 0.569 . . . . 0.0 111.213 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.64 -41.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -17.76 61.79 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.188 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -70.23 -40.29 74.58 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -62.56 -40.9 98.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -84.18 11.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.444 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -130.31 12.98 5.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.382 0.273 . . . . 0.0 111.234 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -135.78 3.63 2.99 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.57 -8.96 22.47 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.771 0.714 . . . . 0.0 111.981 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.88 -8.02 0.63 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.109 0.861 . . . . 0.0 114.552 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.55 72.84 1.42 Allowed 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.36 1.08 . . . . 0.0 109.929 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 94' ' ' LEU . 7.3 mp -56.52 119.67 30.49 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.135 0.574 . . . . 0.0 110.375 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.54 -11.72 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.67 2.913 . . . . 0.0 111.287 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.86 149.67 49.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.451 0.701 . . . . 0.0 111.115 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -103.7 98.52 8.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.6 t -117.52 147.94 42.32 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.089 0.556 . . . . 0.0 111.751 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.82 145.43 46.45 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.548 1.139 . . . . 0.0 108.869 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -127.9 152.19 48.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.93 146.68 14.16 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.98 136.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.004 0.522 . . . . 0.0 110.77 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.266 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.57 4.39 5.07 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.195 3.263 . . . . 0.0 112.441 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.61 11.51 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.234 0.47 . . . . 0.0 112.186 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -135.8 3.79 3.0 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.185 0.594 . . . . 0.0 110.418 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -91.38 -20.1 22.18 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.187 0.195 . . . . 0.0 110.842 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.4 pp -90.32 -12.65 37.11 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 m -74.83 -47.34 31.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.12 -68.4 0.56 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.605 0.241 . . . . 0.0 111.039 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.73 -17.27 56.1 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.26 -16.95 13.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.986 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.49 -13.92 53.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.365 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -91.64 -32.99 15.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.371 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.84 9.22 25.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.535 0.607 . . . . 0.0 111.705 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -126.52 -11.21 6.23 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.938 -0.553 . . . . 0.0 112.05 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.2 t -127.27 24.97 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.6 t -74.59 55.48 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.227 -0.921 . . . . 0.0 109.85 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.04 156.15 47.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.095 0.958 . . . . 0.0 110.448 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -86.2 49.59 1.82 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.904 0.482 . . . . 0.0 111.079 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -135.93 55.56 1.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.725 0.81 . . . . 0.0 109.515 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.14 152.87 21.18 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.79 -16.2 71.01 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.488 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 76.7 p -145.71 12.71 1.31 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.221 1.01 . . . . 0.0 111.624 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 t -135.95 24.37 3.32 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.408 0.549 . . . . 0.0 112.15 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.416 ' H ' HG13 ' A' ' 133' ' ' VAL . . . -79.61 0.47 81.34 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -146.45 149.18 36.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.32 14.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.434 3.423 . . . . 0.0 115.307 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 133' ' ' VAL . 4.6 pp -67.57 -8.57 35.24 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.902 0.774 . . . . 0.0 111.693 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.27 7.92 2.46 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 123.968 0.907 . . . . 0.0 111.005 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.8 m -134.79 30.46 3.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.04 -56.76 0.05 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.943 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.516 -0.344 0 CA-C-N 117.91 0.855 . . . . 0.0 112.759 -178.411 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.45 142.16 51.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.425 0.557 . . . . 0.0 112.256 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.24 143.34 50.72 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 mm -122.74 150.49 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.87 171.0 34.87 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.865 -0.522 . . . . 0.0 112.143 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.58 73.96 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 ' H ' ' A' ' 40' ' ' VAL . 2.0 m -54.34 128.49 59.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 117.464 0.632 . . . . 0.0 111.883 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -87.67 -7.54 6.46 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.267 3.311 . . . . 0.0 111.457 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.56 156.35 30.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.329 1.051 . . . . 0.0 111.953 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.19 57.97 4.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.938 0.895 . . . . 0.0 112.226 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 38.5 ttm 53.54 55.74 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.654 0.782 . . . . 0.0 112.083 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -126.92 108.44 10.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.252 0.621 . . . . 0.0 109.563 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.97 -17.7 65.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.95 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -85.64 -3.06 58.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.202 -0.311 . . . . 0.0 111.2 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -94.43 -23.7 17.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.466 0.575 . . . . 0.0 109.973 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.81 -35.89 75.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 170.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.3 60.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.555 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -78.22 -11.67 59.94 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.707 -0.621 . . . . 0.0 110.703 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.88 -1.27 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.58 12.29 14.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.767 0.827 . . . . 0.0 110.595 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.487 ' H ' ' HD3' ' A' ' 55' ' ' PRO . 88.8 tttt -109.69 -32.28 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 59.0 Cg_exo -57.04 -21.17 40.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.492 2.128 . . . . 0.0 114.259 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.6 5.8 1.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.0 174.14 11.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.462 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.52 55.52 1.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.176 0.591 . . . . 0.0 110.662 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.74 139.7 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -115.39 -2.02 12.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -172.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.1 m -141.64 131.21 23.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.432 0.56 . . . . 0.0 110.58 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -143.19 125.19 12.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.205 0.602 . . . . 0.0 109.865 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.59 139.96 45.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.985 0.514 . . . . 0.0 110.055 173.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -109.29 138.6 45.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.82 0.848 . . . . 0.0 111.219 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -102.08 105.24 15.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -79.92 24.56 0.4 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.837 0.855 . . . . 0.0 113.253 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.2 m -133.16 6.5 3.89 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.847 0.294 . . . . 0.0 111.63 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -152.73 11.47 0.5 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.718 0.235 . . . . 0.0 111.228 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 47.44 47.03 17.36 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -128.44 150.64 50.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.121 0.569 . . . . 0.0 110.312 -173.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -135.34 155.42 50.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.306 0.574 . . . . 0.0 111.742 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -127.3 127.16 43.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.39 150.75 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.465 0.174 . . . . 0.0 111.188 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.47 131.32 43.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.95 0.405 . . . . 0.0 111.617 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -106.36 157.57 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 124.759 1.224 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -86.96 -2.02 58.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -153.42 150.21 28.58 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.082 -0.386 . . . . 0.0 110.366 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -70.26 -12.63 61.73 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.358 -0.214 . . . . 0.0 111.414 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -77.85 -16.92 57.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.924 -0.485 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.64 -14.92 36.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.145 -0.347 . . . . 0.0 110.219 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.55 -40.41 35.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -73.48 -25.56 60.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -79.1 -22.59 45.01 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.317 0.508 . . . . 0.0 111.203 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.9 t -74.75 -42.65 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.27 -16.08 62.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.452 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -78.86 -24.63 44.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.29 0.496 . . . . 0.0 110.412 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -99.14 -17.32 18.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.107 -0.371 . . . . 0.0 110.671 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.96 0.26 57.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.018 -0.426 . . . . 0.0 110.077 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.34 -2.58 2.48 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -144.14 20.47 1.75 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.092 0.86 . . . . 0.0 113.007 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -135.99 55.59 1.85 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.1 -2.82 72.3 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.476 -0.624 . . . . 0.0 112.798 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 50.86 74.76 0.21 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.91 0.884 . . . . 0.0 112.085 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.8 151.86 40.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.846 0.458 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.24 -6.82 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.895 3.064 . . . . 0.0 112.231 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.64 128.62 36.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.878 0.308 . . . . 0.0 110.281 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -89.32 100.36 13.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.1 m -104.95 135.39 46.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.754 0.422 . . . . 0.0 111.059 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -141.27 149.25 41.06 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.646 0.779 . . . . 0.0 109.933 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -103.85 140.62 37.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.98 151.51 22.22 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.31 151.64 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.488 0.715 . . . . 0.0 111.094 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.569 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.955 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.66 1.81 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.682 2.922 . . . . 0.0 112.497 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.8 ttt -84.51 -4.14 58.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.913 -0.492 . . . . 0.0 111.221 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -135.68 10.46 3.4 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.549 0.339 . . . . 0.0 111.403 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -74.62 -10.34 59.44 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 149' ' ' ILE . 3.6 pp -83.4 -23.78 32.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.3 m -89.94 -15.6 31.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -77.51 -50.4 12.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.613 0.365 . . . . 0.0 110.065 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.24 -15.28 41.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -91.3 -41.47 10.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.672 0.669 . . . . 0.0 110.876 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -68.77 -28.85 67.15 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.405 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -70.9 -62.53 1.36 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -98.1 21.58 10.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 -10.46 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.48 3.42 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.2 0.909 . . . . 0.0 112.744 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.9 m -87.79 31.13 0.78 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.244 -0.91 . . . . 0.0 111.2 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.47 24.9 6.62 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.177 0.991 . . . . 0.0 109.42 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -135.36 169.17 17.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.855 1.262 . . . . 0.0 109.144 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -76.21 24.22 0.14 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.04 137.35 2.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.02 152.78 20.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.0 m 55.24 36.45 27.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.576 0.703 . . . . 0.0 109.274 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.8 m -147.66 14.34 1.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.852 1.261 . . . . 0.0 109.042 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.21 -106.45 2.99 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 82.3 mt-30 -152.29 -42.24 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 50.2 Cg_exo -60.47 -20.51 64.16 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.849 2.366 . . . . 0.0 115.653 -171.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.4 pt? -140.97 1.2 1.64 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.07 -4.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 39.3 p -133.72 11.71 4.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.88 -71.74 1.31 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.378 0.132 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.45 131.01 54.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.289 0.636 . . . . 0.0 109.366 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -115.26 142.91 46.04 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.202 0.601 . . . . 0.0 110.804 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.93 141.81 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.835 0.854 . . . . 0.0 109.085 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.09 29.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.03 75.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.582 -0.565 . . . . 0.0 111.931 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 m -55.85 124.54 58.4 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.85 0.825 . . . . 0.0 110.87 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.5 -2.83 13.08 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.324 2.683 . . . . 0.0 111.076 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.54 157.91 34.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.32 0.648 . . . . 0.0 110.133 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -85.09 47.85 1.47 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.51 55.92 6.81 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.915 0.886 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -126.87 116.65 21.16 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.31 -12.58 61.78 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -83.78 -11.43 57.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.085 -0.384 . . . . 0.0 110.896 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -95.73 -18.53 20.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.392 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 49' ' ' LEU . 3.9 mm? -77.49 -26.79 51.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.96 -22.63 42.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.94 -14.75 59.83 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.112 -0.368 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 -2.64 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 118.243 0.474 . . . . 0.0 111.783 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.33 14.3 22.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.6 0.76 . . . . 0.0 109.837 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 64.9 tttp -88.56 -37.23 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.937 169.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 49.8 Cg_exo -59.4 116.91 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.252 1.968 . . . . 0.0 111.111 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 51.67 23.89 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.398 1.079 . . . . 0.0 113.178 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 159.45 44.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.116 0.416 . . . . 0.0 110.9 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -135.34 59.18 1.73 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.894 0.477 . . . . 0.0 111.301 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -70.15 142.59 15.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 O-C-N 121.856 -0.527 . . . . 0.0 109.996 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -132.45 6.62 4.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.0 m -135.51 119.75 17.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.213 0.46 . . . . 0.0 110.472 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.16 123.91 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.284 0.633 . . . . 0.0 109.406 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 104.66 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.22 117.62 34.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -135.09 155.95 49.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.806 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 60.24 177.21 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.137 1.375 . . . . 0.0 112.349 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -70.22 78.54 0.52 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.509 0.723 . . . . 0.0 111.141 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 50.09 32.27 5.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.915 1.686 . . . . 0.0 114.833 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -135.56 4.17 3.09 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -139.47 55.26 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.226 0.921 . . . . 0.0 111.294 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.01 137.21 36.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.052 0.454 . . . . 0.0 110.228 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -135.5 133.49 38.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.552 0.741 . . . . 0.0 109.939 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.66 152.34 31.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.549 0.214 . . . . 0.0 111.137 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -135.74 142.45 45.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.241 0.544 . . . . 0.0 111.93 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.75 151.02 22.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.479 1.511 . . . . 0.0 109.174 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -87.77 11.12 16.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.3 t -149.7 136.06 19.07 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.821 0.448 . . . . 0.0 109.839 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -72.59 -17.7 61.67 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 122.401 -0.187 . . . . 0.0 110.585 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -82.53 -22.06 35.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.23 -19.07 37.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.72 66.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.21 -14.51 60.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.93 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.5 -19.86 37.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.238 0.472 . . . . 0.0 111.002 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.77 -44.06 46.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.27 -18.57 63.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -75.28 -28.54 59.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.53 0.604 . . . . 0.0 109.593 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -72.14 -28.91 63.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.4 5.55 51.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.529 0.332 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.7 17.26 5.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.896 0.478 . . . . 0.0 110.577 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -129.56 -6.52 4.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.654 0.382 . . . . 0.0 111.209 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -97.84 -6.61 32.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.472 0.578 . . . . 0.0 112.041 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 5.32 3.91 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.176 0.893 . . . . 0.0 114.093 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.02 50.11 0.52 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.392 1.096 . . . . 0.0 109.874 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 94' ' ' LEU . 1.9 pt? -53.82 127.99 53.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 122.712 0.405 . . . . 0.0 111.395 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.03 0.71 8.8 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.4 3.4 . . . . 0.0 112.238 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.47 150.66 50.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.85 104.25 16.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 p -121.76 133.73 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.481 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -137.31 145.0 42.89 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 123.459 0.704 . . . . 0.0 110.16 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -133.1 157.4 45.38 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.041 0.537 . . . . 0.0 110.026 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.91 -176.07 40.57 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.546 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.55 143.33 36.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 125.049 1.34 . . . . 0.0 109.951 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 175.119 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 121' ' ' MET . 26.5 mt . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.564 0.221 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.79 -7.32 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.305 2.67 . . . . 0.0 112.889 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.506 ' H ' HG22 ' A' ' 119' ' ' ILE . 5.4 mpp? -85.81 25.87 1.05 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.385 0.539 . . . . 0.0 111.388 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -72.2 -20.71 61.53 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -92.47 10.15 31.36 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.227 -0.296 . . . . 0.0 110.949 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.55 -32.61 12.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 t -84.86 -27.68 26.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.7 -59.68 2.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.557 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.69 -24.77 41.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.82 -27.54 10.68 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 113.142 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -85.08 -18.77 33.27 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.6 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -87.37 -55.26 3.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.539 0.609 . . . . 0.0 109.738 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -87.3 4.49 42.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 m -139.58 -5.56 1.37 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 172.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.43 21.18 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.052 1.297 . . . . 0.0 112.092 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 t -100.63 30.14 4.11 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.371 -0.831 . . . . 0.0 111.384 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.57 24.36 8.57 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 110.218 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -140.43 156.51 46.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.354 1.062 . . . . 0.0 108.834 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -74.87 24.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.32 0.648 . . . . 0.0 112.082 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.06 160.67 13.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.17 -169.2 42.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.1 m 68.63 112.0 0.04 OUTLIER 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.331 1.053 . . . . 0.0 112.366 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.7 t 59.36 24.93 13.53 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.345 1.058 . . . . 0.0 112.606 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.44 -9.1 82.28 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -156.82 147.24 16.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.26 7.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.445 3.43 . . . . 0.0 115.67 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.72 6.0 5.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.031 0.832 . . . . 0.0 111.663 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.08 17.57 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.125 0.57 . . . . 0.0 111.645 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -135.12 40.41 2.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.01 0.924 . . . . 0.0 109.136 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.84 -53.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.814 0.816 . . . . 0.0 110.395 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.66 126.05 53.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -112.4 140.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.752 0.821 . . . . 0.0 110.312 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mm -125.45 144.66 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.42 176.97 37.91 Favored Glycine 0 CA--C 1.524 0.651 0 O-C-N 121.863 -0.523 . . . . 0.0 112.206 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.78 19.7 73.55 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 40' ' ' VAL . 1.2 m -62.55 130.0 93.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 117.563 0.682 . . . . 0.0 111.242 -173.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.76 -10.35 6.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.13 3.22 . . . . 0.0 111.307 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 4.0 pp -82.03 156.08 24.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.684 1.193 . . . . 0.0 111.666 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -80.7 55.93 2.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.736 0.815 . . . . 0.0 112.109 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.1 mtm 50.73 55.34 9.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.14 0.976 . . . . 0.0 112.495 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 88.5 tttt -115.55 106.06 13.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.64 -15.71 63.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -84.17 -7.5 59.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.158 -0.339 . . . . 0.0 110.827 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -96.85 -20.74 17.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.405 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.72 -29.28 62.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.84 50.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.235 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -76.63 -13.11 60.09 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.792 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.96 -2.6 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -118.22 18.28 13.79 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.688 0.795 . . . . 0.0 110.291 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.3 ttmt -105.71 -35.51 0.19 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.442 -0.79 . . . . 0.0 113.035 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.1 Cg_exo -58.97 -23.97 70.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.645 2.23 . . . . 0.0 114.161 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -143.82 13.71 1.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.78 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.121 0.569 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -134.56 57.86 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.483 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.32 138.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -130.65 9.31 5.02 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -135.44 113.64 11.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.42 128.14 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.13 131.49 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mt -107.78 122.68 47.26 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -118.19 161.71 19.44 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 62.1 24.9 14.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.24 1.816 . . . . 0.0 112.783 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 m 52.6 26.44 4.35 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.841 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -141.05 -174.79 4.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.29 1.436 . . . . 0.0 109.122 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.58 30.65 0.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -87.95 81.36 7.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.379 0.991 . . . . 0.0 108.728 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.16 138.73 32.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.424 0.631 . . . . 0.0 112.242 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -136.02 131.67 35.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.952 0.901 . . . . 0.0 108.866 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -133.0 151.66 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 111.617 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -135.47 142.28 45.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.421 0.629 . . . . 0.0 111.597 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.22 152.77 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 125.103 1.361 . . . . 0.0 109.156 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -98.33 24.14 7.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.6 t -149.99 138.57 20.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.959 0.504 . . . . 0.0 110.09 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -38.48 73.82 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -76.35 -15.94 59.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.241 -0.287 . . . . 0.0 111.587 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -86.28 -18.78 31.13 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.873 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.91 -22.56 42.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.94 -19.26 37.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.292 -0.255 . . . . 0.0 111.366 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -78.39 -43.38 26.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.466 0.575 . . . . 0.0 110.157 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' LEU . 3.1 mm? -75.37 -14.97 60.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.002 177.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -71.55 -43.3 66.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.764 0.711 . . . . 0.0 109.144 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -76.04 -12.4 60.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.419 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -92.35 -1.26 57.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.1 -0.375 . . . . 0.0 110.325 170.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -112.36 3.19 16.84 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.797 0.439 . . . . 0.0 111.429 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -135.02 1.69 3.01 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.15 55.17 1.77 Allowed 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.2 -0.28 20.65 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.804 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.02 3.02 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.912 0.856 . . . . 0.0 111.798 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -89.15 153.58 49.0 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 122.859 0.463 . . . . 0.0 109.776 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.53 -11.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.688 2.925 . . . . 0.0 112.062 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.08 153.14 21.5 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.786 0.435 . . . . 0.0 111.755 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -125.41 137.44 54.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 109.025 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -135.46 141.98 45.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -137.53 147.49 45.21 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.224 1.01 . . . . 0.0 109.552 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -135.13 160.49 38.2 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.12 175.08 33.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.36 148.83 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.122 0.969 . . . . 0.0 109.952 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.093 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 35.9 mm . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 46.8 Cg_exo -61.04 -13.38 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.633 2.888 . . . . 0.0 115.797 -171.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.88 23.85 3.34 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -91.11 -12.4 35.69 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 121.641 -0.662 . . . . 0.0 110.911 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -88.59 -6.22 57.67 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.6 tp -101.41 -27.62 13.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.709 0.804 . . . . 0.0 109.601 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -80.98 -21.68 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.29 -44.44 10.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 0.0 111.199 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.58 -13.94 59.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.46 -17.31 11.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.903 0.774 . . . . 0.0 111.747 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -70.97 -25.65 62.81 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.867 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.89 -63.43 1.32 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.296 0.238 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -80.7 8.48 7.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -143.91 -17.69 0.59 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.421 ' CG2' HD21 ' A' ' 145' ' ' LEU . 1.5 t -135.6 24.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.914 1.234 . . . . 0.0 113.693 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.5 m -103.92 26.61 8.47 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.179 -0.951 . . . . 0.0 111.665 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.07 24.02 3.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.788 0.435 . . . . 0.0 111.218 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -148.14 -74.99 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.274 -0.266 . . . . 0.0 111.265 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -140.5 158.1 44.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.853 0.861 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.67 157.39 50.53 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.57 171.63 27.09 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 123.372 0.511 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 34.7 p -87.13 -5.55 58.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.206 0.602 . . . . 0.0 110.564 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.9 m -89.43 13.52 13.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.504 0.322 . . . . 0.0 110.167 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.51 -12.4 81.88 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -141.69 158.26 63.23 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.976 0.51 . . . . 0.0 110.135 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.15 14.47 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.297 3.332 . . . . 0.0 112.927 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 133' ' ' VAL . 2.9 pp -69.49 -6.0 27.71 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.899 0.772 . . . . 0.0 111.148 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -75.13 -1.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -137.62 34.03 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.47 1.108 . . . . 0.0 109.403 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.43 -16.99 0.38 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.475 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.623 1.212 . . . . 0.0 112.353 178.017 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.231 0.086 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -110.9 141.58 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -133.39 144.61 49.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.991 0.516 . . . . 0.0 110.634 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.87 155.04 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.705 0.802 . . . . 0.0 108.935 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.22 170.22 36.23 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.0 77.35 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.119 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 m -47.97 114.34 3.26 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.682 0.793 . . . . 0.0 111.714 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.21 -8.17 10.84 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.533 2.822 . . . . 0.0 113.058 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.93 -18.2 31.37 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.974 0.806 . . . . 0.0 111.182 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 33.71 49.98 0.28 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.032 1.333 . . . . 0.0 112.608 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.3 tpp -135.58 -75.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -150.94 166.76 29.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.286 0.565 . . . . 0.0 111.675 -169.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.37 -4.77 31.97 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.683 0.793 . . . . 0.0 112.31 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -83.84 -8.86 59.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.03 -0.419 . . . . 0.0 111.57 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.95 -30.13 19.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.73 -26.41 59.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.1 -19.43 36.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.33 -13.37 59.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.044 0.383 . . . . 0.0 110.798 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.5 -5.5 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.32 12.77 20.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.243 0.617 . . . . 0.0 110.991 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 16.8 tppt? -91.45 -39.69 0.38 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.327 -0.844 . . . . 0.0 113.215 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 93.7 Cg_endo -78.72 -20.01 10.84 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.794 1.663 . . . . 0.0 113.43 -173.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -136.25 17.23 3.19 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.751 0.705 . . . . 0.0 112.694 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.25 170.23 22.35 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.994 -0.442 . . . . 0.0 110.952 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.9 55.9 1.17 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.602 0.761 . . . . 0.0 109.722 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.76 138.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.105 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -131.27 7.28 4.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -145.89 127.83 15.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -141.35 128.18 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 123.33 0.652 . . . . 0.0 109.629 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.4 138.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 122.912 0.485 . . . . 0.0 109.972 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mt -107.86 104.79 14.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.031 0.932 . . . . 0.0 109.739 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -80.91 94.0 6.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.0 m120 63.21 127.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.774 1.23 . . . . 0.0 110.473 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -76.06 22.0 0.16 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -146.69 25.48 1.18 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.966 0.507 . . . . 0.0 110.52 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -135.45 -88.38 0.34 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.125 -0.359 . . . . 0.0 111.695 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -137.42 159.25 42.47 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 123.16 0.584 . . . . 0.0 111.708 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.6 143.86 45.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.57 0.748 . . . . 0.0 109.181 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.34 133.18 56.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -135.71 151.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -135.16 135.64 41.24 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.716 0.406 . . . . 0.0 111.003 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -109.17 152.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 124.675 1.19 . . . . 0.0 110.011 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -82.2 -1.4 48.98 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.4 m -144.78 127.42 16.14 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.751 0.82 . . . . 0.0 109.222 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -8.99 58.14 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.214 -0.304 . . . . 0.0 111.755 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -87.29 -14.85 39.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.095 0.407 . . . . 0.0 110.225 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -88.61 -17.71 29.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.24 -41.01 70.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -69.94 -20.32 63.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -86.39 -9.54 56.12 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.115 -0.366 . . . . 0.0 111.581 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.63 -49.38 19.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -25.44 67.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -71.16 -44.89 64.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -77.42 -26.63 51.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.553 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.87 -0.63 52.04 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.244 -0.285 . . . . 0.0 110.436 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -125.96 8.14 7.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.734 0.243 . . . . 0.0 111.575 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -135.42 15.29 3.45 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.68 49.83 2.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.337 0.517 . . . . 0.0 110.73 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.34 10.04 81.7 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.445 -0.642 . . . . 0.0 112.63 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.75 98.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.916 1.286 . . . . 0.0 111.78 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.28 154.32 93.06 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -10.98 29.78 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.601 2.868 . . . . 0.0 112.109 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 96' ' ' LEU . 23.9 mt -80.26 119.71 23.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.82 104.54 14.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -111.73 139.2 47.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.986 0.422 . . . . 0.0 111.455 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -146.14 159.17 43.66 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.482 1.113 . . . . 0.0 109.427 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -127.62 156.27 42.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.06 -175.04 14.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.21 141.22 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.127 0.464 . . . . 0.0 110.837 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 123.627 0.632 . . . . 0.0 113.932 -176.371 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.514 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 43.7 Cg_endo -60.39 -35.97 88.92 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.142 2.561 . . . . 0.0 112.627 -169.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.17 14.26 3.04 Favored 'General case' 0 C--N 1.337 0.046 0 CA-C-N 118.117 0.417 . . . . 0.0 111.022 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -82.87 -18.15 41.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.148 -0.345 . . . . 0.0 111.054 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -97.88 -2.41 40.81 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 tp -109.8 -27.11 9.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -80.67 -26.58 37.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.45 -42.13 13.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.763 0.256 . . . . 0.0 111.539 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.36 -10.45 59.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.142 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -104.78 -20.69 13.52 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.912 0.778 . . . . 0.0 110.937 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.18 -13.82 58.22 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.012 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.12 -61.61 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -78.32 -0.42 28.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -138.97 -2.53 1.68 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.75 24.35 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.749 1.159 . . . . 0.0 111.208 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.5 p -72.84 55.06 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.755 -0.591 . . . . 0.0 111.828 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 137.68 42.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.195 0.598 . . . . 0.0 110.487 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 53.13 27.5 5.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.973 . . . . 0.0 112.432 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 78.4 m95 54.26 24.98 5.4 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.05 0.94 . . . . 0.0 112.759 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.01 170.38 54.66 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 176.18 147.0 6.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.4 m 58.2 7.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.325 1.45 . . . . 0.0 113.197 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.9 p -160.21 19.83 0.15 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.768 -0.583 . . . . 0.0 111.375 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -93.46 -21.89 28.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.206 -0.775 . . . . 0.0 114.001 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -149.09 160.77 34.23 Favored Pre-proline 0 C--O 1.227 -0.096 0 CA-C-N 118.515 1.158 . . . . 0.0 110.187 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.51 -1.27 0.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.28 3.32 . . . . 0.0 114.415 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.54 -8.14 56.0 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.809 0.732 . . . . 0.0 110.712 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.61 9.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.028 0.531 . . . . 0.0 110.553 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.1 p -128.31 31.51 5.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.05 0.54 . . . . 0.0 109.964 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.22 -26.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.556 0.693 . . . . 0.0 110.229 173.561 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.124 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.5 tp -121.32 115.46 23.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -89.02 135.96 33.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.218 1.007 . . . . 0.0 110.445 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.8 mm -127.48 104.69 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.56 164.07 13.03 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.225 0.347 . . . . 0.0 113.232 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 -47.74 3.0 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.99 1.281 . . . . 0.0 112.596 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m 37.64 48.64 1.35 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.375 1.47 . . . . 0.0 114.741 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.81 1.95 4.01 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.829 2.352 . . . . 0.0 110.159 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.44 43.49 0.55 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.874 1.67 . . . . 0.0 110.775 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 56.88 24.13 8.94 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.974 1.31 . . . . 0.0 112.57 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.3 ptt? 34.35 55.21 0.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.324 1.45 . . . . 0.0 113.575 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -128.68 129.32 45.64 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.96 -13.88 62.28 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -82.77 -14.67 54.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.284 0.493 . . . . 0.0 110.594 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -95.42 -24.81 16.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.191 -0.318 . . . . 0.0 110.347 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.71 -26.59 62.55 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 -20.36 36.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -79.44 -6.56 57.13 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.109 -0.369 . . . . 0.0 111.168 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.83 -3.25 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.17 -0.331 . . . . 0.0 111.889 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -113.44 15.68 19.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.532 0.733 . . . . 0.0 110.202 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttm -101.62 -40.06 0.21 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.566 169.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 32.5 Cg_exo -61.55 114.61 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.233 1.955 . . . . 0.0 110.344 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.81 30.88 5.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.55 0.74 . . . . 0.0 112.008 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.46 161.97 40.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.028 0.531 . . . . 0.0 110.883 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -138.7 85.74 2.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.672 0.389 . . . . 0.0 111.025 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.6 140.42 25.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -135.17 8.15 3.43 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.0 m -135.7 119.6 17.4 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.59 128.52 33.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.149 0.579 . . . . 0.0 110.122 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.39 143.77 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 171.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -125.4 137.86 54.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.626 1.17 . . . . 0.0 110.838 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -112.03 98.43 7.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -83.15 43.21 0.85 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.037 0.535 . . . . 0.0 111.765 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.02 -7.04 2.35 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.636 0.374 . . . . 0.0 110.914 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -153.21 35.03 0.47 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.735 0.414 . . . . 0.0 110.63 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 33.99 55.59 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.803 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -125.83 141.57 51.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.323 0.649 . . . . 0.0 111.029 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.98 154.28 47.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.293 0.568 . . . . 0.0 111.227 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -135.24 132.76 38.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.73 38.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.688 0.28 . . . . 0.0 111.379 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -135.42 129.97 34.1 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.117 0.484 . . . . 0.0 110.885 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.96 148.13 9.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.127 1.371 . . . . 0.0 108.984 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.17 24.26 11.75 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.4 t -148.72 132.16 16.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.848 0.859 . . . . 0.0 108.813 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -78.19 -14.63 59.38 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.137 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.58 -25.45 24.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -87.47 -16.37 34.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -47.84 67.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.11 -14.37 59.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.76 -11.37 48.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.477 0.581 . . . . 0.0 111.09 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.14 -41.5 17.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.08 -21.91 64.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.884 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -77.17 -26.2 52.71 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.707 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -68.56 -42.25 78.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -83.34 10.24 9.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.367 -0.208 . . . . 0.0 111.342 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -116.35 1.27 13.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.262 0.625 . . . . 0.0 109.716 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -135.58 18.57 3.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.875 0.47 . . . . 0.0 111.406 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -134.75 48.04 2.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.178 0.513 . . . . 0.0 110.957 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.88 -13.63 12.91 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.614 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.18 33.84 18.9 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.056 0.928 . . . . 0.0 113.413 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.722 ' H ' ' CD ' ' A' ' 95' ' ' PRO . 80.4 mt -136.21 -28.23 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.722 ' CD ' ' H ' ' A' ' 94' ' ' LEU . 76.9 Cg_exo -55.35 -31.64 78.05 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.075 1.85 . . . . 0.0 113.246 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt -143.2 143.22 31.68 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.422 0.689 . . . . 0.0 109.892 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -94.85 97.07 9.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.0 p -114.41 138.03 51.09 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -173.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -146.05 146.21 30.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.277 1.031 . . . . 0.0 109.127 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -135.08 160.52 38.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 110.917 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 165.7 37.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.13 142.28 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.743 0.817 . . . . 0.0 109.692 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 177.199 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.19 176.92 8.5 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.557 2.838 . . . . 0.0 110.618 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.65 27.63 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.343 0.657 . . . . 0.0 112.483 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -15.43 51.75 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.711 -0.618 . . . . 0.0 111.294 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -85.43 -6.76 59.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.02 -42.8 9.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.53 0.732 . . . . 0.0 109.6 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -76.29 -16.74 59.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.56 -51.2 6.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.737 -0.602 . . . . 0.0 110.398 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.26 -8.68 58.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -112.81 -15.86 12.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.759 0.709 . . . . 0.0 111.487 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -20.99 61.07 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.54 -54.28 4.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.509 0.324 . . . . 0.0 110.561 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -82.91 6.14 19.53 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -147.37 0.68 0.7 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.53 15.25 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.269 0.94 . . . . 0.0 111.133 174.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.8 m -135.0 24.74 3.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.991 0.517 . . . . 0.0 109.911 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.5 151.24 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.057 0.943 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.81 20.79 1.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -141.91 24.27 2.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.458 0.703 . . . . 0.0 110.413 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.56 -159.74 35.75 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.479 0.562 . . . . 0.0 112.135 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.68 -154.28 2.37 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.091 0.853 . . . . 0.0 111.747 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.7 m -103.77 70.6 1.02 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 t 60.71 32.03 20.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.707 0.803 . . . . 0.0 111.829 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.27 79.6 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.959 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.7 -44.38 0.5 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 118.361 1.081 . . . . 0.0 113.305 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -90.53 -19.57 1.07 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.544 2.163 . . . . 0.0 113.43 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.65 -7.66 59.15 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -171.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.8 m -74.85 -0.8 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 CA-C-N 117.877 0.308 . . . . 0.0 111.241 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 t -147.67 23.22 1.12 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.367 1.067 . . . . 0.0 108.41 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.5 34.15 0.3 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.605 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.7 mm . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 117.582 0.691 . . . . 0.0 111.956 173.645 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 m . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -101.89 140.5 36.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -130.12 137.75 50.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.34 0.656 . . . . 0.0 110.124 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 5.8 mm -120.33 113.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.83 160.7 16.92 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.31 17.98 74.71 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.639 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.44 130.15 34.12 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.388 1.094 . . . . 0.0 110.789 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.52 -0.6 10.54 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.43 2.753 . . . . 0.0 111.425 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.68 152.41 33.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.371 0.605 . . . . 0.0 111.44 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -97.28 55.36 1.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.1 ttt 62.96 70.14 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.564 1.145 . . . . 0.0 112.198 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.35 88.75 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.09 -11.58 20.87 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.613 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -82.91 -12.41 57.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.082 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -93.88 -22.59 18.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 118.938 -1.105 . . . . 0.0 110.55 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.65 -25.51 59.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.11 -18.07 38.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -76.47 -10.39 59.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.057 -0.402 . . . . 0.0 110.595 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.5 -4.69 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.44 17.52 19.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.45 0.7 . . . . 0.0 110.519 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 55' ' ' PRO . 88.6 tttt -114.13 -35.95 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 60.4 Cg_exo -56.91 -31.73 90.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.402 2.068 . . . . 0.0 113.648 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.18 22.78 2.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.856 0.298 . . . . 0.0 111.642 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.96 176.81 11.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.626 0.37 . . . . 0.0 110.733 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.49 76.05 1.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.003 0.43 . . . . 0.0 110.505 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.03 140.57 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -131.86 7.16 4.37 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -142.8 125.85 16.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.977 0.511 . . . . 0.0 109.729 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.75 127.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 122.965 0.506 . . . . 0.0 109.759 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.14 135.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mt -128.67 143.29 50.91 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.068 0.547 . . . . 0.0 111.639 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -123.26 104.68 9.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.27 1.028 . . . . 0.0 108.371 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -83.52 24.67 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -120.38 -3.5 9.94 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.232 -0.292 . . . . 0.0 111.725 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtm-85 -144.97 8.54 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.889 0.476 . . . . 0.0 111.304 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 51.76 42.45 29.9 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.23 0.612 . . . . 0.0 111.221 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -111.27 145.61 38.47 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.735 0.814 . . . . 0.0 110.113 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -140.83 150.64 43.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -125.03 127.18 46.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.9 151.1 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.476 0.125 . . . . 0.0 110.692 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.58 136.39 41.04 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.41 155.53 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 124.48 1.112 . . . . 0.0 110.567 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -93.71 10.58 32.33 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.2 t -151.33 134.88 16.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.13 0.572 . . . . 0.0 109.913 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.55 -16.13 58.84 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.45 -25.35 33.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -83.91 -13.74 52.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.77 67.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -71.12 -18.88 62.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.777 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -82.01 -18.9 41.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.46 0.573 . . . . 0.0 111.6 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.47 -44.16 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 118.565 0.621 . . . . 0.0 109.809 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.26 -23.02 64.73 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.42 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -83.16 -10.42 58.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.884 -0.51 . . . . 0.0 110.77 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.0 -27.9 24.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -94.82 4.92 53.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.267 -0.271 . . . . 0.0 111.245 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -134.8 6.03 3.41 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -149.44 15.01 0.88 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -135.37 55.16 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.84 0.745 . . . . 0.0 110.931 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.27 83.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.201 -0.777 . . . . 0.0 113.394 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.1 74.08 0.26 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.995 0.897 . . . . 0.0 111.625 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.96 159.62 13.14 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.068 0.547 . . . . 0.0 111.265 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 -9.4 9.06 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.483 3.455 . . . . 0.0 114.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.95 128.57 36.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.587 0.63 . . . . 0.0 110.552 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -90.59 71.52 6.83 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.56 0.744 . . . . 0.0 109.083 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.6 m -74.89 129.86 38.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.146 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -135.68 149.11 49.17 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.387 1.075 . . . . 0.0 109.022 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -128.34 150.77 49.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.983 0.42 . . . . 0.0 111.575 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.51 -164.35 28.6 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.9 138.2 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.187 0.493 . . . . 0.0 110.394 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 C-N-CA 123.429 0.538 . . . . 0.0 112.539 -179.66 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.05 166.66 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.434 2.756 . . . . 0.0 111.012 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -124.85 25.66 7.31 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.823 0.449 . . . . 0.0 111.48 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -83.59 -9.87 58.63 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.813 -0.554 . . . . 0.0 111.217 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -88.8 3.25 51.74 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.407 0.283 . . . . 0.0 110.589 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.66 -50.4 5.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.741 0.816 . . . . 0.0 108.887 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.6 m -77.65 -19.9 54.66 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.197 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.35 -45.82 12.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.043 -0.411 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.5 -19.12 39.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.273 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.87 -20.8 17.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.693 0.679 . . . . 0.0 110.997 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -67.36 -35.17 78.83 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.667 170.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.6 -77.66 0.1 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.145 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -89.15 18.71 4.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.5 t -138.89 -4.31 1.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.67 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 t -136.44 24.22 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.294 0.952 . . . . 0.0 111.27 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.8 p -73.64 24.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.133 -0.979 . . . . 0.0 112.952 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.06 24.13 3.56 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.958 -0.464 . . . . 0.0 111.087 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -147.0 144.07 28.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.668 0.787 . . . . 0.0 109.355 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -72.79 104.71 4.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.98 -179.8 49.5 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -81.81 -153.98 12.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 67.4 104.56 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.227 1.411 . . . . 0.0 113.371 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m 54.47 30.11 12.33 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.4 -33.27 53.53 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -140.78 167.05 18.85 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.29 5.56 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.462 1 C-N-CA 125.437 4.091 . . . . 0.0 116.332 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.25 22.89 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.56 1.073 . . . . 0.0 111.769 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.73 1.48 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.785 0.834 . . . . 0.0 111.171 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.6 p -127.68 24.83 6.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.4 -21.85 4.27 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mm . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 117.45 0.625 . . . . 0.0 111.028 174.253 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.82 133.62 47.05 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.59 145.22 46.7 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.307 0.575 . . . . 0.0 111.521 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.91 153.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.007 0.923 . . . . 0.0 109.361 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.29 164.47 30.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.25 19.97 79.29 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.35 -0.694 . . . . 0.0 112.724 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -48.63 129.72 13.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.114 0.957 . . . . 0.0 111.175 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -85.0 5.57 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.309 3.339 . . . . 0.0 111.458 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.98 159.63 24.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 112.291 -170.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.06 63.55 6.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.559 0.744 . . . . 0.0 109.764 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.5 ptm 51.31 104.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.126 2.17 . . . . 0.0 114.475 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.75 102.43 3.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.26 -19.33 65.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -85.21 -7.08 59.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.139 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -98.14 -21.57 16.67 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.306 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.09 -28.87 62.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.07 -22.26 45.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.521 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.22 -14.14 60.5 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.181 -0.324 . . . . 0.0 111.202 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.19 -0.67 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.194 -0.316 . . . . 0.0 111.783 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.1 10.89 28.0 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.421 0.688 . . . . 0.0 109.585 170.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 25.3 ttmm -78.77 -33.89 0.93 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.622 171.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.0 Cg_exo -57.7 115.04 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.444 2.096 . . . . 0.0 111.951 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 51.22 24.27 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.703 1.201 . . . . 0.0 113.455 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.8 157.29 41.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.124 0.57 . . . . 0.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -132.46 56.47 1.83 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.123 0.569 . . . . 0.0 110.298 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.42 139.04 15.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -129.3 3.37 5.16 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -135.05 121.25 20.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.051 -0.405 . . . . 0.0 110.288 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.98 129.17 43.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.497 0.719 . . . . 0.0 109.925 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.65 141.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 1.6 tt -134.23 121.72 21.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.214 . . . . 0.0 110.476 -169.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -100.87 104.4 15.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.068 0.547 . . . . 0.0 109.976 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -86.94 24.49 1.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.056 0.542 . . . . 0.0 111.812 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -127.37 2.61 6.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.735 0.414 . . . . 0.0 110.649 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -136.12 7.74 3.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.2 32.5 10.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.07 0.948 . . . . 0.0 111.446 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -134.39 152.62 51.91 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.409 0.683 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . . . -135.76 156.3 49.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.548 0.739 . . . . 0.0 110.235 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.85 134.39 49.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.78 151.45 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -135.1 139.37 44.64 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.453 0.644 . . . . 0.0 112.018 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.71 161.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 125.988 1.715 . . . . 0.0 109.172 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -108.27 22.59 15.72 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -152.59 137.48 17.14 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.201 0.6 . . . . 0.0 109.734 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.97 -9.59 58.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.316 -0.24 . . . . 0.0 111.502 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -86.84 -18.02 31.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -88.12 -22.1 24.29 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.24 43.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.09 -21.86 33.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.35 -0.219 . . . . 0.0 110.657 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.59 -19.47 38.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.014 -0.429 . . . . 0.0 110.871 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.76 -43.16 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.93 -17.0 62.7 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.075 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -74.46 -28.45 61.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.463 0.574 . . . . 0.0 109.532 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -76.1 -28.29 57.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.973 -0.454 . . . . 0.0 109.827 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -93.09 6.94 46.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.409 0.284 . . . . 0.0 111.013 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.02 16.28 3.51 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.381 0.272 . . . . 0.0 111.313 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -135.72 -8.02 2.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 -23.12 15.15 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.04 0.836 . . . . 0.0 110.786 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.21 1.16 0.63 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.832 1.206 . . . . 0.0 115.614 172.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.55 45.1 1.94 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.064 1.432 . . . . 0.0 112.159 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.81 142.69 28.19 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.52 -11.66 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.311 3.341 . . . . 0.0 112.821 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -86.51 146.13 26.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.973 0.351 . . . . 0.0 110.799 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.13 104.59 10.97 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.4 m -103.49 134.7 46.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.313 0.645 . . . . 0.0 111.327 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -136.81 153.45 50.81 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.335 1.054 . . . . 0.0 108.925 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -123.4 144.8 49.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.934 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.22 148.62 17.24 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.88 138.24 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.082 0.553 . . . . 0.0 110.694 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.92 0 C-N-CA 123.62 0.629 . . . . 0.0 112.788 -178.274 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.411 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.3 pt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 92.1 Cg_endo -69.47 -2.4 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.582 2.855 . . . . 0.0 112.626 -174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 mtt -121.87 20.36 10.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.783 0.433 . . . . 0.0 111.004 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -135.01 -8.82 2.33 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -89.71 -4.52 57.68 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.248 0.476 . . . . 0.0 109.938 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -92.5 -45.54 8.08 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.397 1.079 . . . . 0.0 109.303 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -80.83 -23.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.59 -48.57 8.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.018 0.372 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.95 -14.13 56.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.166 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -98.37 -41.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.612 0.642 . . . . 0.0 110.891 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -76.34 -16.16 59.81 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -93.71 -52.42 4.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.982 -0.449 . . . . 0.0 110.523 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -83.49 3.8 30.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.16 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -135.85 -4.24 2.24 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 25.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.734 1.152 . . . . 0.0 112.263 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.4 p -72.46 55.71 0.35 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.937 -0.477 . . . . 0.0 111.638 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 53.89 46.41 25.72 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 111.161 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -82.0 49.76 1.44 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.588 0.755 . . . . 0.0 111.062 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 75.3 m95 54.5 35.2 22.79 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -173.47 45.31 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.57 -170.64 50.54 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 t -132.71 45.28 2.77 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.0 m 53.21 34.21 17.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.383 -172.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.96 -49.61 0.08 OUTLIER Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.01 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 145' ' ' LEU . 57.0 mt-30 62.06 170.53 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 119.166 1.483 . . . . 0.0 112.414 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.32 -9.9 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.744 3.629 . . . . 0.0 115.702 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -64.03 -61.39 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.91 0.777 . . . . 0.0 109.477 174.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.3 20.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.596 . . . . 0.0 111.445 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.3 m -101.47 30.84 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 -25.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 146' ' ' VAL . 5.1 pt . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 123.645 0.778 . . . . 0.0 111.213 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.61 130.58 55.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.673 1.189 . . . . 0.0 108.521 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -107.28 143.27 35.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.21 0.604 . . . . 0.0 110.602 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.0 mm -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.91 0.884 . . . . 0.0 108.876 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.56 31.45 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.32 23.25 74.94 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.1 m -53.04 123.8 34.9 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 117.527 0.663 . . . . 0.0 112.013 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.26 -4.26 13.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.734 2.956 . . . . 0.0 111.07 171.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.85 162.7 28.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.145 0.578 . . . . 0.0 110.5 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.22 32.79 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.537 0.735 . . . . 0.0 111.347 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.7 mtm 57.41 47.98 15.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.154 0.981 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -128.55 133.71 48.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.811 0.844 . . . . 0.0 109.134 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.02 -6.77 47.69 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -85.11 -15.77 42.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.029 -0.419 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -89.53 -26.19 21.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.96 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.01 -29.9 65.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.1 -17.66 58.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.796 -0.565 . . . . 0.0 110.422 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.21 -4.44 58.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.19 -4.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.14 0.26 5.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 39.6 ttpt -88.04 -38.78 0.47 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.28 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.7 Cg_exo -59.33 135.46 65.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.481 2.121 . . . . 0.0 111.997 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 51.48 28.23 4.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.168 0.987 . . . . 0.0 113.078 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.87 167.95 21.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.152 0.581 . . . . 0.0 110.683 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.08 40.91 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.662 0.385 . . . . 0.0 111.251 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.84 136.93 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -129.85 -3.43 4.64 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -137.1 136.45 38.33 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.074 -0.391 . . . . 0.0 111.047 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.46 115.03 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -113.91 104.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.22 110.57 23.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -76.52 104.3 6.96 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -82.46 24.17 0.71 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.861 0.864 . . . . 0.0 111.134 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -135.14 5.47 3.28 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.233 0.613 . . . . 0.0 110.319 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -140.38 -0.67 1.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.239 0.615 . . . . 0.0 110.859 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 51.46 34.9 12.98 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.897 0.879 . . . . 0.0 111.774 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -135.4 151.86 50.86 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 123.599 0.76 . . . . 0.0 109.46 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.25 154.0 51.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -117.26 125.18 50.7 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.009 1.324 . . . . 0.0 107.711 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.03 148.58 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 120.486 0.184 . . . . 0.0 110.56 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -130.2 135.76 48.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.927 0.394 . . . . 0.0 111.942 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.92 148.55 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.275 1.43 . . . . 0.0 109.32 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -82.54 -3.18 55.53 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.2 m -143.3 132.91 23.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -72.58 -18.02 61.65 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.385 . . . . 0.0 110.808 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -74.81 -14.28 60.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.99 -0.444 . . . . 0.0 109.983 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -93.1 -8.6 42.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.04 -43.31 44.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 -17.93 60.64 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.489 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.72 -16.2 54.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.196 0.453 . . . . 0.0 110.388 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -85.47 -23.74 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 O-C-N 121.938 -0.476 . . . . 0.0 110.526 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.74 -23.93 53.02 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.014 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.69 -15.51 57.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.42 -45.42 31.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -76.84 -0.27 23.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.337 -0.227 . . . . 0.0 111.387 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -112.35 -4.76 14.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.984 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.44 22.51 3.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.701 0.682 . . . . 0.0 112.574 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -135.23 55.18 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.285 0.493 . . . . 0.0 111.278 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.83 82.83 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.473 -0.626 . . . . 0.0 113.254 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.63 60.51 3.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.836 0.818 . . . . 0.0 111.72 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.79 151.43 15.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.089 0.556 . . . . 0.0 110.857 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.47 -0.93 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.102 3.201 . . . . 0.0 113.113 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.5 mt -63.63 138.11 58.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.494 0.588 . . . . 0.0 110.318 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -105.51 121.4 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.7 p -135.34 145.05 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 111.997 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -143.23 148.41 36.39 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 109.405 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 -128.41 158.75 37.44 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.863 0.363 . . . . 0.0 111.888 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.4 168.94 25.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 p -133.69 144.5 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.059 0.544 . . . . 0.0 110.541 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.163 -177.795 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.29 -14.2 34.17 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 111.783 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -81.19 15.89 1.76 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.925 0.329 . . . . 0.0 111.763 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -135.33 1.73 2.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.545 0.738 . . . . 0.0 109.957 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -86.02 -13.42 47.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.118 -0.364 . . . . 0.0 110.581 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.9 pp -101.0 -12.89 18.52 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.606 0.185 . . . . 0.0 110.722 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 50.4 p -88.98 -22.07 23.2 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.87 -41.12 12.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -16.27 50.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -113.33 -15.63 12.64 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.013 0.824 . . . . 0.0 112.019 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.98 -20.66 48.58 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.649 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.56 -63.23 1.34 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -79.81 -1.14 37.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.4 m -139.91 6.3 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 145' ' ' LEU . 5.1 t -137.77 20.51 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.19 1.359 . . . . 0.0 110.384 170.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.4 t -106.12 52.69 0.72 Allowed 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.49 172.03 13.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.04 0.936 . . . . 0.0 110.679 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -58.63 151.63 20.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.243 0.617 . . . . 0.0 110.791 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -64.1 147.96 50.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.22 0.608 . . . . 0.0 111.646 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.06 -15.29 0.59 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.376 -0.689 . . . . 0.0 111.376 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 144' ' ' PRO . . . 75.62 161.87 10.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.725 0.679 . . . . 0.0 112.365 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.668 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 90.2 m 68.45 102.38 0.05 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m 54.6 43.45 30.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.39 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.534 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 144' ' ' PRO . 64.5 tt0 -164.81 -51.86 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 120.234 2.017 . . . . 0.0 115.884 175.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 140' ' ' THR . 22.9 Cg_endo -85.93 -5.79 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.696 2.931 . . . . 0.0 115.753 -166.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.478 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -70.71 -2.62 15.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.098 1.317 . . . . 0.0 111.959 -176.056 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.406 ' N ' HD12 ' A' ' 145' ' ' LEU . 32.3 m -75.84 0.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 123.186 0.594 . . . . 0.0 110.926 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -142.14 24.68 1.96 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.511 1.124 . . . . 0.0 108.487 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.55 43.57 0.12 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.561 1.145 . . . . 0.0 112.278 174.522 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -85.52 104.57 15.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -82.34 140.32 33.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.348 0.659 . . . . 0.0 110.313 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.1 129.8 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.01 166.53 26.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.081 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.74 75.59 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.415 -0.658 . . . . 0.0 112.195 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -53.57 125.34 44.77 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 117.996 0.898 . . . . 0.0 111.186 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.31 -2.68 12.15 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.444 2.763 . . . . 0.0 111.364 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.32 154.53 27.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.923 0.489 . . . . 0.0 111.017 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -84.43 53.66 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.28 0.632 . . . . 0.0 110.38 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.2 ttt 56.48 64.74 1.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.387 1.075 . . . . 0.0 112.708 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -131.13 107.94 9.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.84 -13.08 58.89 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 112.011 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -81.84 -12.23 58.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 122.244 -0.285 . . . . 0.0 111.077 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -93.32 -22.73 18.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.518 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 -27.88 60.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.57 -23.74 42.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.911 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.64 -6.93 58.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.007 0.367 . . . . 0.0 111.638 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.58 -4.62 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 118.153 0.433 . . . . 0.0 111.243 171.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -109.52 15.36 23.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.08 0.952 . . . . 0.0 109.247 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 40.7 ttmt -75.53 -34.77 1.64 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 82.4 Cg_endo -73.55 124.27 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 CA-C-N 121.356 1.52 . . . . 0.0 111.068 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 51.53 23.06 1.71 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.98 1.312 . . . . 0.0 113.062 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.83 154.58 35.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.964 0.506 . . . . 0.0 110.546 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.51 64.68 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.91 128.61 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -103.71 -3.76 24.62 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -168.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -142.24 131.15 22.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.053 0.388 . . . . 0.0 110.904 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.15 129.86 38.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.26 139.54 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 110.7 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -122.73 120.31 33.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.133 1.373 . . . . 0.0 108.387 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -138.74 157.17 46.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.837 0.455 . . . . 0.0 111.337 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 65.5 151.49 0.05 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.857 1.263 . . . . 0.0 113.13 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -82.79 25.08 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.267 0.627 . . . . 0.0 111.216 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.72 24.4 7.75 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.813 0.845 . . . . 0.0 110.702 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 53.48 49.49 19.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.146 0.978 . . . . 0.0 112.599 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -96.57 104.75 16.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.93 148.33 44.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.114 0.483 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -135.52 145.11 46.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.397 0.679 . . . . 0.0 109.375 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.92 155.5 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.21 135.68 41.17 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.969 0.414 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.15 148.66 15.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 124.519 1.128 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.46 19.18 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.8 t -151.25 141.25 22.07 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.795 0.438 . . . . 0.0 110.198 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -74.46 -22.7 58.97 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -82.35 -14.74 54.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.62 -20.67 23.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.66 53.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.19 -15.8 35.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.262 -0.274 . . . . 0.0 110.732 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.38 -22.87 38.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.272 0.487 . . . . 0.0 110.607 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.53 -46.19 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.42 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.8 mm? -67.55 -19.77 65.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.614 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -75.89 -40.77 53.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.382 0.992 . . . . 0.0 109.659 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -76.33 -13.44 60.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -117.28 15.1 14.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -128.2 3.89 5.79 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -142.36 -8.19 0.88 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -153.0 24.75 0.56 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.241 0.928 . . . . 0.0 112.035 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 15.69 0.04 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.964 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.98 3.8 16.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.648 1.224 . . . . 0.0 111.791 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 95' ' ' PRO . 3.1 mm? -98.7 -54.78 0.19 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.715 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 94' ' ' LEU . 86.0 Cg_endo -74.5 -23.52 14.87 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.355 2.036 . . . . 0.0 112.867 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 96' ' ' LEU . 36.4 mt -137.84 149.12 46.05 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.13 0.423 . . . . 0.0 111.219 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -106.09 102.7 12.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.3 p -98.15 130.79 44.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.246 0.618 . . . . 0.0 111.276 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -143.94 136.86 27.34 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.973 0.909 . . . . 0.0 109.028 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -118.58 126.91 52.99 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.096 0.407 . . . . 0.0 111.175 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.64 145.48 18.36 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.42 148.37 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.933 0.893 . . . . 0.0 109.529 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 176.013 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.2 -13.49 38.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.418 2.745 . . . . 0.0 113.746 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.5 ptm -83.97 8.26 15.76 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -95.06 -17.37 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.185 -0.322 . . . . 0.0 111.149 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.13 -4.13 58.79 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.96 -32.49 13.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.108 0.563 . . . . 0.0 109.582 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.5 t -82.59 -19.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.049 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.94 -47.06 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.911 -0.493 . . . . 0.0 110.968 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -76.48 -13.79 60.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.49 -9.6 11.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.818 0.736 . . . . 0.0 112.264 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -73.33 -18.25 61.21 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 166.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.403 ' HE3' ' CH2' ' A' ' 131' ' ' TRP . 64.3 tttp -87.51 -60.13 2.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.318 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.403 ' CH2' ' HE3' ' A' ' 130' ' ' LYS . 11.8 m95 -80.4 9.96 5.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -147.16 -6.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.65 17.17 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 119.619 1.099 . . . . 0.0 112.036 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 m -81.01 35.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.403 -0.811 . . . . 0.0 111.247 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 24.47 3.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.45 0.7 . . . . 0.0 110.223 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -138.55 147.33 42.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.777 0.831 . . . . 0.0 109.653 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -81.72 42.79 0.72 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.307 0.643 . . . . 0.0 111.05 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.99 -169.9 36.72 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.69 157.68 27.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.1 p 48.74 24.55 0.83 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.008 1.323 . . . . 0.0 112.913 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -154.92 24.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.34 0.656 . . . . 0.0 111.024 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.34 -12.11 16.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.507 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -146.37 164.98 21.65 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 118.622 1.211 . . . . 0.0 110.053 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.49 -12.18 16.33 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.363 2.708 . . . . 0.0 113.311 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.48 -6.43 46.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.12 0.418 . . . . 0.0 112.123 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -77.55 25.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -135.41 -15.43 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.208 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.43 -11.34 17.84 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 118.797 -1.002 . . . . 0.0 113.221 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--N 1.34 0.183 0 CA-C-O 122.312 1.053 . . . . 0.0 109.067 167.409 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.412 0.149 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.2 tp -117.97 126.0 51.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.995 0.518 . . . . 0.0 109.668 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.53 146.21 32.14 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.398 0.679 . . . . 0.0 110.444 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mm -128.02 135.01 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.22 165.87 13.66 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.77 15.43 80.75 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.289 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' N ' ' CD ' ' A' ' 41' ' ' PRO . 34.0 m -70.19 -14.22 0.25 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 40' ' ' VAL . 70.2 Cg_exo -56.99 -2.81 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.259 1.973 . . . . 0.0 114.612 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.89 -14.91 60.71 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.337 0.971 . . . . 0.0 112.68 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -148.59 -12.54 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.2 mtt 51.6 28.85 4.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -135.81 142.77 44.9 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.193 0.451 . . . . 0.0 110.79 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.66 -6.63 42.43 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -86.74 -10.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.296 -0.252 . . . . 0.0 111.067 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.69 -27.09 18.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.86 -30.09 65.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.02 -19.38 44.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.458 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -76.54 -15.51 59.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.058 -0.401 . . . . 0.0 111.155 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.75 -3.34 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.61 10.65 22.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.384 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.8 pttt -88.61 -28.04 0.35 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.582 170.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 27.2 Cg_exo -65.14 117.88 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.782 1.655 . . . . 0.0 110.945 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 50.27 24.37 1.47 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.405 1.082 . . . . 0.0 113.191 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.5 155.38 43.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.956 0.502 . . . . 0.0 110.497 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -133.73 60.63 1.7 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.976 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -70.12 141.53 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -129.75 5.82 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -135.8 119.36 17.02 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 118.064 0.393 . . . . 0.0 110.457 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.89 127.66 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.531 0.732 . . . . 0.0 109.526 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.55 139.62 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 122.847 0.459 . . . . 0.0 110.048 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.5 mt -114.94 122.66 46.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.541 0.737 . . . . 0.0 109.036 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -123.02 173.02 8.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.087 0.955 . . . . 0.0 111.064 -171.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 55.59 55.6 7.07 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.799 0.84 . . . . 0.0 111.258 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t 55.68 43.16 28.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.078 0.551 . . . . 0.0 110.924 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? 55.48 44.16 27.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.195 0.998 . . . . 0.0 111.248 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -124.3 0.97 8.41 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 111.052 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -146.48 142.89 28.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 149.13 48.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.14 134.43 45.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.298 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.34 149.78 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -135.14 135.63 41.27 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.013 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.16 157.35 14.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 124.782 1.233 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -102.85 9.06 39.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -146.41 138.51 24.96 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.057 0.543 . . . . 0.0 109.973 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -76.62 -13.62 60.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -85.27 -23.0 28.37 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.2 -18.08 37.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.29 -45.49 59.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.85 -20.51 62.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.005 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -82.01 -16.79 49.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.408 0.549 . . . . 0.0 111.338 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.6 -25.5 8.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-N 118.566 0.621 . . . . 0.0 110.25 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.21 -22.18 55.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.913 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -76.08 -22.26 55.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -79.88 -23.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -83.53 -4.0 58.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.7 3.76 11.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.7 0.4 . . . . 0.0 111.049 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -135.77 17.9 3.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -86.36 -1.31 57.42 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.481 -0.762 . . . . 0.0 111.573 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.49 -15.0 0.45 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.798 1.19 . . . . 0.0 115.548 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.42 12.39 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.486 1.643 . . . . 0.0 113.483 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 35.09 53.05 1.59 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.694 1.198 . . . . 0.0 113.751 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.9 -11.93 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.425 2.75 . . . . 0.0 111.275 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -133.82 133.93 42.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.411 1.084 . . . . 0.0 108.312 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -100.01 98.47 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.3 m -93.49 129.36 39.72 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.96 0.504 . . . . 0.0 111.198 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -145.69 142.13 28.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.31 0.644 . . . . 0.0 109.91 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -97.04 150.21 21.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.941 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.83 160.46 14.04 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.07 139.69 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 124.014 0.926 . . . . 0.0 110.097 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 176.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.47 170.11 21.0 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.708 2.939 . . . . 0.0 111.283 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.55 13.27 0.49 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -87.27 -8.8 56.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.959 -0.463 . . . . 0.0 110.448 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -81.9 -9.13 59.68 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 149' ' ' ILE . 8.4 tp -88.18 -40.31 13.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.2 p -75.21 -17.76 60.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.995 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.69 -19.34 14.36 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.593 0.633 . . . . 0.0 112.141 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.87 -12.07 45.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.89 0.768 . . . . 0.0 110.814 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.74 -21.72 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.78 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -74.33 -21.36 59.73 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.794 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 131' ' ' TRP . 38.8 ttpt -91.2 -60.04 2.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.415 -0.178 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.457 ' CE2' ' HE3' ' A' ' 130' ' ' LYS . 8.6 m95 -77.26 0.89 20.32 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 m -142.12 -5.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.86 23.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.949 1.25 . . . . 0.0 112.083 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -75.11 38.02 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.407 -0.808 . . . . 0.0 111.523 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.48 24.22 3.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.597 0.759 . . . . 0.0 110.07 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -141.77 140.22 33.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.748 0.819 . . . . 0.0 109.438 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -84.83 52.63 2.47 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.842 0.457 . . . . 0.0 111.824 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.95 -7.37 0.39 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.292 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 68.51 -166.39 45.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.12 0.96 . . . . 0.0 111.212 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.0 p 67.33 116.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.848 1.659 . . . . 0.0 112.51 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.1 m 61.4 27.61 17.18 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.6 1.16 . . . . 0.0 112.893 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.56 -16.48 68.41 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -155.56 151.71 22.86 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.05 10.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.992 3.128 . . . . 0.0 115.236 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.99 -0.1 15.23 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.277 0.944 . . . . 0.0 110.966 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.45 22.34 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.109 0.564 . . . . 0.0 112.071 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 10.2 5.12 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.301 0.24 . . . . 0.0 111.57 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.04 -19.46 0.32 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 124' ' ' LEU . 18.3 mm . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 121.753 0.787 . . . . 0.0 109.322 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.5 tp -102.85 122.08 43.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -114.21 131.09 56.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.352 0.261 . . . . 0.0 110.748 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -104.3 143.42 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.9 163.56 27.99 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.72 18.28 70.07 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -54.21 138.38 57.35 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.78 0.79 . . . . 0.0 110.982 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.11 -15.39 20.53 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.166 2.577 . . . . 0.0 110.969 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.16 123.46 14.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -106.98 24.6 12.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.506 0.322 . . . . 0.0 110.463 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.3 ttp -139.31 24.21 2.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -147.08 85.84 1.62 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.7 -14.51 52.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 110.717 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -83.11 -8.21 59.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.883 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -94.99 -21.16 18.79 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.411 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.76 -26.79 60.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.32 -21.4 39.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.45 -13.16 60.37 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.088 -0.383 . . . . 0.0 110.739 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.52 -3.05 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.9 12.01 25.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.478 0.711 . . . . 0.0 110.371 170.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttp -95.22 -31.77 0.27 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 71.9 Cg_exo -54.63 -33.96 81.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.629 2.219 . . . . 0.0 114.728 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -139.38 17.06 2.57 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.463 0.574 . . . . 0.0 112.444 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.31 172.82 17.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.703 0.401 . . . . 0.0 110.088 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.76 55.61 1.89 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.016 0.526 . . . . 0.0 110.071 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.23 140.77 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.558 0.743 . . . . 0.0 110.215 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -120.26 3.52 10.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.7 m -139.16 126.86 21.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.341 0.518 . . . . 0.0 110.866 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.13 128.16 21.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 123.435 0.694 . . . . 0.0 109.348 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.63 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 109.732 173.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.42 147.37 46.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.292 1.037 . . . . 0.0 110.383 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -134.47 135.37 42.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.128 0.571 . . . . 0.0 109.906 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -80.87 41.3 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.682 0.793 . . . . 0.0 111.27 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -128.89 105.12 8.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 55.36 26.87 9.2 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.659 0.784 . . . . 0.0 111.448 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 49.46 54.65 10.63 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.348 1.059 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -88.53 141.31 28.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.527 0.331 . . . . 0.0 110.766 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.45 148.6 49.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.717 0.407 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -135.17 131.35 36.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.42 151.27 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.811 0.444 . . . . 0.0 110.028 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -137.33 136.82 38.3 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.42 164.64 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.664 1.585 . . . . 0.0 109.677 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.2 16.88 25.0 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.613 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -151.94 137.12 17.44 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.674 0.79 . . . . 0.0 109.018 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -12.68 61.33 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -87.13 -15.53 38.15 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -83.71 -21.03 32.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.56 54.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.0 -21.19 63.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.214 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -89.45 -9.61 49.51 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.953 -0.467 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 t -87.41 -25.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.794 -0.566 . . . . 0.0 109.919 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.7 mm? -74.82 -27.88 60.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -81.44 -14.78 56.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.698 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.19 -43.92 66.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -85.02 -1.44 56.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.465 -0.147 . . . . 0.0 111.346 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.35 -0.61 26.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.424 0.29 . . . . 0.0 110.811 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -131.89 11.9 4.75 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.6 -5.37 59.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.423 0.556 . . . . 0.0 110.736 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.91 -3.1 10.43 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.684 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.63 4.54 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.238 1.519 . . . . 0.0 113.542 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 94' ' ' LEU . 8.3 mp 38.45 55.56 4.79 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 112.057 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.68 -15.83 26.97 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.221 2.614 . . . . 0.0 112.175 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.4 mt -136.86 146.06 45.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.532 0.733 . . . . 0.0 110.752 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -107.03 130.8 54.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -135.04 140.55 45.68 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.847 0.459 . . . . 0.0 111.338 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -138.84 147.47 42.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.147 0.979 . . . . 0.0 109.232 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -121.66 157.5 30.71 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.774 0.321 . . . . 0.0 111.227 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.51 -178.85 31.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.86 137.59 48.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.115 0.566 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.153 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.457 ' N ' ' HD3' ' A' ' 120' ' ' PRO . 24.8 pt . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 119.584 -0.246 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 119' ' ' ILE . 51.5 Cg_exo -58.76 -21.52 56.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.366 2.044 . . . . 0.0 112.442 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 46.3 ttp -85.27 49.48 1.76 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.629 0.771 . . . . 0.0 110.216 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -135.43 -41.5 0.71 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.524 0.33 . . . . 0.0 111.039 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -79.78 -14.44 58.71 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.774 0.261 . . . . 0.0 110.337 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 tp -88.78 -26.94 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -78.39 -20.76 50.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.28 -47.6 7.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.173 -0.33 . . . . 0.0 110.932 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.93 -14.56 58.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.56 -22.32 13.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.415 0.552 . . . . 0.0 111.321 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.98 -28.71 63.6 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.36 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -84.04 -57.38 3.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.703 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.2 7.14 26.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -171.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.3 m -143.14 -0.53 1.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.0 t -135.28 14.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.563 1.074 . . . . 0.0 112.12 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.9 m -90.35 24.13 2.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.817 -0.552 . . . . 0.0 109.773 169.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.75 43.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.569 1.148 . . . . 0.0 109.347 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -86.3 33.35 0.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -135.79 26.35 3.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.58 165.9 33.13 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.877 -0.514 . . . . 0.0 112.659 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA2' HD23 ' A' ' 145' ' ' LEU . . . 76.18 163.45 15.11 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.107 0.86 . . . . 0.0 112.686 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.6 t -98.29 -30.08 12.8 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.725 -0.28 . . . . 0.0 111.464 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -151.79 22.69 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.703 0.401 . . . . 0.0 111.334 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.61 -9.41 68.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.352 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.602 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 59.9 tt0 -163.78 -39.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 118.45 1.125 . . . . 0.0 113.335 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 46.0 Cg_exo -61.65 11.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.98 3.12 . . . . 0.0 115.878 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.606 HD21 ' CG2' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.2 14.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.112 0.869 . . . . 0.0 112.019 177.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.22 6.84 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.684 0.794 . . . . 0.0 111.59 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -136.03 30.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.627 1.171 . . . . 0.0 108.213 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.91 29.04 0.07 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.5 mm . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 118.13 0.965 . . . . 0.0 111.632 175.888 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 N--CA 1.471 0.164 0 N-CA-C 112.477 0.145 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -135.51 143.8 45.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.164 0.586 . . . . 0.0 110.419 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -93.42 55.07 2.18 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.105 0.562 . . . . 0.0 110.023 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.3 145.89 54.67 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.708 0.403 . . . . 0.0 111.604 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -83.41 136.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.848 0.459 . . . . 0.0 110.101 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.51 24.38 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.268 0.627 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -81.57 151.74 27.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.976 0.51 . . . . 0.0 110.648 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -135.31 126.89 28.85 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.912 0.485 . . . . 0.0 109.785 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -147.94 119.07 4.43 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.12 165.6 32.14 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.398 2.732 . . . . 0.0 111.602 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -68.51 151.61 46.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.024 0.53 . . . . 0.0 110.813 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -69.97 139.66 52.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.529 0.204 . . . . 0.0 110.46 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -139.37 163.66 44.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.0 109.923 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.77 159.69 4.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.964 3.109 . . . . 0.0 112.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -118.9 159.32 45.07 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.683 0.793 . . . . 0.0 110.346 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.79 172.71 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.586 2.857 . . . . 0.0 110.728 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 t -78.49 57.09 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 121.342 0.591 . . . . 0.0 110.799 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -164.06 24.94 0.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.231 0.612 . . . . 0.0 111.24 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -129.82 86.44 2.41 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.767 -0.583 . . . . 0.0 110.955 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.67 33.29 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.437 1.495 . . . . 0.0 112.652 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -135.87 24.42 3.35 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.732 -0.605 . . . . 0.0 111.953 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -138.34 24.25 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.82 134.86 71.54 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 122.441 0.296 . . . . 0.0 111.141 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.18 162.5 34.01 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.289 3.326 . . . . 0.0 110.53 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.9 -2.48 12.6 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.944 3.096 . . . . 0.0 112.198 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.44 154.02 51.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.181 0.592 . . . . 0.0 111.399 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 53.78 46.73 25.21 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.819 0.848 . . . . 0.0 112.002 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.8 tp -135.32 141.77 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.455 0.702 . . . . 0.0 110.113 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -142.92 26.81 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.5 t -85.14 125.94 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 O-C-N 121.698 -0.627 . . . . 0.0 109.572 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 54.5 27.1 7.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.369 1.067 . . . . 0.0 113.003 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.0 m -137.74 112.04 8.6 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -80.05 -15.64 56.76 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.4 p 53.42 -174.5 0.03 OUTLIER 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.428 1.491 . . . . 0.0 112.654 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.5 tp -85.49 105.92 16.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.42 141.71 35.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.636 0.774 . . . . 0.0 110.448 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mm -127.74 109.44 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.26 161.55 12.92 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 122.18 -0.325 . . . . 0.0 112.483 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.88 73.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.303 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.7 m -54.09 120.78 26.57 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.185 0.993 . . . . 0.0 111.062 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 26.9 Cg_exo -67.03 -12.84 37.67 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.595 2.863 . . . . 0.0 112.539 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 42' ' ' LEU . 2.8 mm? -84.67 157.96 20.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.325 0.65 . . . . 0.0 110.988 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -79.71 53.99 1.72 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.9 mtm 53.47 55.74 8.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.448 1.099 . . . . 0.0 112.551 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.19 104.27 13.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.69 -17.0 63.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -82.7 -11.88 58.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.053 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.25 -16.59 22.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.642 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 49' ' ' LEU . 3.7 mm? -78.09 -25.98 47.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.49 -21.3 38.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 171.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.217 -0.302 . . . . 0.0 111.233 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.28 -6.39 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.967 0.348 . . . . 0.0 111.657 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.93 17.01 21.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.65 0.78 . . . . 0.0 110.003 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -76.14 -45.33 3.71 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.107 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.37 136.49 11.25 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.198 1.932 . . . . 0.0 111.672 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 50.1 24.24 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.027 1.331 . . . . 0.0 113.783 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.14 33.62 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.719 0.407 . . . . 0.0 110.816 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -133.53 59.72 1.73 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.325 0.65 . . . . 0.0 110.331 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.31 138.48 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -133.31 4.61 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 t -151.06 137.84 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.113 0.415 . . . . 0.0 110.484 173.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.3 t -136.81 133.2 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.578 0.751 . . . . 0.0 109.468 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.03 138.87 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.484 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -126.47 117.78 23.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.108 1.363 . . . . 0.0 108.545 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -135.78 162.71 32.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.217 0.607 . . . . 0.0 111.425 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.1 t30 65.58 149.93 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.812 1.245 . . . . 0.0 112.81 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -81.74 25.01 0.57 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.169 0.588 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -127.9 24.63 6.04 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.532 0.733 . . . . 0.0 111.147 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 54.64 55.17 8.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.055 0.942 . . . . 0.0 112.002 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -104.79 120.31 41.07 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.89 153.12 51.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 112.073 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.24 147.89 49.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.45 150.63 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.21 130.35 56.89 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.738 0.415 . . . . 0.0 110.182 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.09 149.16 18.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 C-N-CA 124.056 0.942 . . . . 0.0 109.823 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -97.12 14.92 24.12 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -154.99 139.96 17.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.158 0.583 . . . . 0.0 109.848 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -84.9 -6.55 59.34 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.735 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -90.46 -28.76 18.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.34 -17.87 40.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -46.05 73.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -74.94 -11.82 60.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.352 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.66 -22.26 40.65 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.683 0.674 . . . . 0.0 110.685 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -77.76 -45.28 28.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.04 -17.72 64.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.557 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -69.66 -53.87 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.639 -0.663 . . . . 0.0 109.37 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -80.04 -45.03 19.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.738 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -89.6 9.37 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -139.46 6.88 2.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.6 0.636 . . . . 0.0 112.512 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -143.63 14.99 1.78 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.15 7.82 40.77 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.414 1.006 . . . . 0.0 112.052 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.2 4.26 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.519 0.581 . . . . 0.0 113.983 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.61 55.27 1.88 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.959 0.879 . . . . 0.0 109.318 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 94' ' ' LEU . 6.3 mp -61.84 115.73 17.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.075 0.95 . . . . 0.0 110.728 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.08 -17.26 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.234 2.623 . . . . 0.0 110.802 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.7 mt -135.77 146.11 47.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.276 1.03 . . . . 0.0 109.916 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.59 88.04 6.16 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.7 p -93.87 125.75 38.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.844 0.458 . . . . 0.0 111.664 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -140.54 145.21 36.51 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 124.243 1.017 . . . . 0.0 108.743 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -135.68 157.97 45.56 Favored 'General case' 0 C--O 1.229 0.019 0 CA-C-N 118.337 0.517 . . . . 0.0 112.195 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 157.33 29.41 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.11 140.06 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 123.506 0.723 . . . . 0.0 110.551 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.1 144.21 16.76 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -92.11 19.79 6.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.154 0.582 . . . . 0.0 111.645 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 63.47 74.54 0.43 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -54.53 150.05 36.49 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.077 3.185 . . . . 0.0 113.077 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -135.57 150.12 49.61 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.029 0.932 . . . . 0.0 109.719 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 46.32 40.43 7.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.173 0.989 . . . . 0.0 112.257 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 27.0 p -79.18 39.67 0.39 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.864 0.866 . . . . 0.0 111.542 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 74.5 m -80.62 55.63 2.4 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.941 0.896 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -132.36 157.41 44.56 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.799 0.84 . . . . 0.0 110.147 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -69.17 -5.91 25.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -80.93 1.32 31.52 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -135.14 23.09 3.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.632 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.59 -15.1 1.63 Allowed Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.721 -0.488 . . . . 0.0 112.084 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -129.55 24.67 5.43 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.656 0.728 . . . . 0.0 110.498 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.9 m -135.48 132.55 37.49 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.355 0.662 . . . . 0.0 109.857 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.43 149.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.629 0.372 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.446 HG12 ' H ' ' A' ' 121' ' ' MET . 16.9 tt -146.94 138.15 13.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 42.7 Cg_exo -61.45 -16.77 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.314 2.676 . . . . 0.0 113.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.446 ' H ' HG12 ' A' ' 119' ' ' ILE . 1.7 mpt? -79.82 21.02 0.56 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.009 0.524 . . . . 0.0 112.079 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -130.01 -15.55 3.78 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.651 0.38 . . . . 0.0 110.465 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.58 -11.32 59.67 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.37 -25.7 51.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.1 m -79.18 -49.47 12.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.516 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.46 -17.37 34.42 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.658 -0.817 . . . . 0.0 113.12 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.4 -21.65 17.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.17 0.896 . . . . 0.0 112.365 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 -26.02 15.91 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.417 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -84.65 -23.94 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.857 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -81.54 -49.78 10.16 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.689 0.677 . . . . 0.0 110.627 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -94.9 4.87 53.31 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.1 m -135.86 -4.92 2.2 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.54 0.609 . . . . 0.0 112.418 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 14.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.142 0.883 . . . . 0.0 111.595 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 t -147.52 55.62 1.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.609 -0.682 . . . . 0.0 111.23 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.29 -42.15 0.97 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.437 0.295 . . . . 0.0 110.731 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -139.36 16.87 2.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.136 0.574 . . . . 0.0 110.434 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -146.42 156.86 43.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.707 0.803 . . . . 0.0 110.086 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.91 149.08 39.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.07 156.61 53.57 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 66.46 116.69 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.828 1.251 . . . . 0.0 112.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.412 ' HA ' HG11 ' A' ' 146' ' ' VAL . 23.7 m 64.98 30.8 11.68 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.611 1.164 . . . . 0.0 112.791 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.15 -13.33 52.85 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -146.38 160.67 41.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.108 0.963 . . . . 0.0 109.354 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.94 0.64 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.449 3.433 . . . . 0.0 114.644 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.44 6.58 6.7 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.726 0.693 . . . . 0.0 112.419 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 141' ' ' SER . 30.5 m -85.36 19.91 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.7 m -128.6 27.66 5.5 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.34 -48.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.642 HG22 ' H ' ' A' ' 151' ' ' PHE . 1.6 mp -58.08 -40.94 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.101 0.951 . . . . 0.0 111.516 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.8 m 43.83 20.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.183 1.793 . . . . 0.0 115.151 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.642 ' H ' HG22 ' A' ' 149' ' ' ILE . 29.1 m-85 -117.27 131.41 56.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.798 0.839 . . . . 0.0 109.594 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.66 55.39 1.87 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.09 0.472 . . . . 0.0 110.232 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.73 151.45 45.66 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.29 0.69 8.73 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.167 3.245 . . . . 0.0 112.232 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.28 138.1 43.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.976 0.353 . . . . 0.0 111.188 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 156' ' ' ILE . 0.1 OUTLIER -134.17 164.93 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.789 0.836 . . . . 0.0 109.359 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.63 104.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 110.761 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.7 t -142.09 135.64 28.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 124.13 0.972 . . . . 0.0 109.432 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 172.29 169.31 34.84 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.34 149.95 49.85 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.956 0.902 . . . . 0.0 109.554 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -70.07 146.73 43.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.82 139.45 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.447 0.699 . . . . 0.0 109.686 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -135.67 139.21 43.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.008 0.523 . . . . 0.0 110.289 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.7 m -135.16 26.66 3.53 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.348 0.659 . . . . 0.0 110.596 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.17 141.66 47.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.917 0.487 . . . . 0.0 110.636 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.56 129.23 32.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 109.988 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.62 156.58 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 34.7 t -135.35 137.68 42.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.078 0.551 . . . . 0.0 109.95 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -85.4 143.29 28.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.74 0.416 . . . . 0.0 110.671 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -135.47 155.61 50.25 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.474 0.71 . . . . 0.0 110.61 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 61.5 ttp -141.55 142.91 27.69 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.926 0.49 . . . . 0.0 109.741 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.11 163.7 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.585 2.857 . . . . 0.0 112.776 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t -108.39 154.72 21.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.351 0.661 . . . . 0.0 110.334 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -135.17 128.52 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.949 0.5 . . . . 0.0 110.355 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 82.6 p -138.25 155.42 48.64 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.464 0.706 . . . . 0.0 110.708 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -133.78 163.12 24.49 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -135.36 111.2 9.38 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 123.087 0.555 . . . . 0.0 110.034 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -118.99 105.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.458 0.703 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.6 165.64 54.41 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.26 160.76 18.4 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.185 3.257 . . . . 0.0 112.64 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -135.69 136.61 41.01 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.742 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.1 t -135.74 144.57 45.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.903 0.481 . . . . 0.0 110.538 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.06 -178.22 46.84 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -146.84 161.32 37.83 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.192 0.597 . . . . 0.0 110.474 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.847 3.031 . . . . 0.0 111.71 174.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.471 0.188 0 N-CA-C 112.751 0.25 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -135.63 151.62 50.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.129 0.571 . . . . 0.0 110.634 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -135.7 146.21 47.5 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.091 0.556 . . . . 0.0 110.072 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.84 145.03 51.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.469 0.708 . . . . 0.0 110.323 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.16 28.86 3.41 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.311 0.644 . . . . 0.0 111.171 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.37 24.48 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.247 0.619 . . . . 0.0 110.783 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 t -92.72 51.63 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.102 0.561 . . . . 0.0 109.947 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -135.92 134.24 38.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.36 0.664 . . . . 0.0 109.881 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -145.52 151.68 47.56 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 123.019 0.528 . . . . 0.0 110.709 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.43 167.79 25.9 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.721 2.948 . . . . 0.0 110.807 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -76.88 150.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.348 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -91.97 -13.76 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.167 0.187 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -155.01 148.86 18.88 Favored Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.132 1.373 . . . . 0.0 108.397 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.62 147.3 57.06 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.961 2.44 . . . . 0.0 109.732 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.39 152.27 56.73 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.046 0.539 . . . . 0.0 109.962 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.94 177.58 7.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.814 3.009 . . . . 0.0 110.182 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.74 98.9 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -154.29 151.89 29.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.172 0.589 . . . . 0.0 110.499 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.82 104.63 10.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.96 151.9 44.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.619 0.767 . . . . 0.0 111.104 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.9 m -78.31 34.44 0.21 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.613 0.765 . . . . 0.0 112.464 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m -135.78 29.03 3.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.83 127.68 83.4 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 123.102 0.561 . . . . 0.0 110.555 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.3 160.1 36.12 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.821 3.014 . . . . 0.0 111.373 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.94 11.6 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.835 3.69 . . . . 0.0 111.792 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -60.77 153.6 23.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -56.98 137.63 55.32 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.342 0.657 . . . . 0.0 111.187 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.579 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.2 tp -135.99 149.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 123.101 0.561 . . . . 0.0 110.738 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' H ' HD12 ' A' ' 28' ' ' ILE . 97.5 mttt -119.73 24.74 10.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.202 0.601 . . . . 0.0 111.842 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.579 ' H ' HG13 ' A' ' 28' ' ' ILE . 44.3 t -109.06 -4.07 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.485 0.714 . . . . 0.0 109.543 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -141.42 152.49 44.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.401 0.681 . . . . 0.0 110.076 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.7 t -133.5 132.67 41.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -101.62 143.21 31.87 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.873 0.469 . . . . 0.0 111.338 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -106.02 160.68 15.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.055 0.942 . . . . 0.0 109.773 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.5 tp -114.81 127.69 55.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -105.95 143.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.36 0.664 . . . . 0.0 110.257 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.43 143.33 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.845 0.858 . . . . 0.0 110.173 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.03 172.64 42.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.93 64.79 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -59.29 138.52 88.59 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 117.368 0.584 . . . . 0.0 111.599 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.84 -11.1 10.29 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.881 3.054 . . . . 0.0 111.526 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 45' ' ' LYS . 2.0 pp -84.39 161.02 20.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.467 0.707 . . . . 0.0 111.234 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -81.52 55.44 2.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.8 ptt? 46.61 55.16 7.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.918 1.287 . . . . 0.0 112.812 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' H ' HD13 ' A' ' 42' ' ' LEU . 54.8 mtmt -111.24 119.28 38.37 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.354 0.662 . . . . 0.0 109.292 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -70.47 -15.88 62.86 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.976 -0.102 . . . . 0.0 111.143 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -93.85 -9.89 35.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.314 -0.241 . . . . 0.0 111.484 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.01 -17.2 15.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -78.38 -28.2 46.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.2 -21.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.49 -19.16 61.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.176 0.444 . . . . 0.0 110.98 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.96 -6.52 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 117.945 0.339 . . . . 0.0 111.586 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.92 20.07 18.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.785 0.834 . . . . 0.0 110.067 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 23.7 tptm -88.34 -49.43 0.42 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.426 170.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 98.2 Cg_endo -77.08 141.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.089 1.859 . . . . 0.0 110.643 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 48.96 34.5 5.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.781 0.833 . . . . 0.0 112.369 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.89 156.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.083 -0.386 . . . . 0.0 111.378 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.37 54.92 1.92 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.422 0.689 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.88 138.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -117.79 -7.4 10.98 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -146.52 134.11 20.98 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.025 -0.422 . . . . 0.0 110.573 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.1 117.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.37 131.39 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.013 0.435 . . . . 0.0 111.578 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.32 132.9 41.32 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.503 1.121 . . . . 0.0 109.27 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.69 160.09 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.133 0.573 . . . . 0.0 111.688 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.2 t30 64.66 153.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.054 1.342 . . . . 0.0 112.719 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -78.82 32.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.504 0.722 . . . . 0.0 111.144 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -134.75 24.48 3.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.64 0.776 . . . . 0.0 110.289 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 45.91 48.21 12.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 114.001 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -106.61 146.54 30.58 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.24 39.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 111.656 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -131.16 129.78 42.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.17 151.7 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.437 0.161 . . . . 0.0 110.986 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.78 137.62 51.63 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.893 0.378 . . . . 0.0 111.168 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 m -108.77 156.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.624 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.64 6.08 29.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -155.54 137.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.126 0.57 . . . . 0.0 109.801 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.19 -13.35 61.9 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.287 -0.258 . . . . 0.0 111.628 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -88.13 -14.65 38.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -92.01 -11.55 35.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.64 -44.47 61.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.0 -15.27 61.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -83.03 -19.15 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 122.03 -0.419 . . . . 0.0 110.873 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.6 t -75.21 -37.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.65 -21.74 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.894 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.19 -19.8 53.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -85.66 -23.37 27.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -77.93 -8.89 58.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -122.51 3.42 9.64 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -139.82 24.09 2.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.712 0.687 . . . . 0.0 112.835 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -135.45 49.88 2.15 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.667 -0.645 . . . . 0.0 111.016 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.7 4.3 87.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.481 -0.621 . . . . 0.0 113.088 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.91 55.78 8.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.827 0.814 . . . . 0.0 111.679 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -56.48 153.49 20.28 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.287 0.635 . . . . 0.0 110.973 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.63 -2.14 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.925 3.083 . . . . 0.0 112.088 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.88 114.69 5.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -85.31 127.62 34.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.887 0.375 . . . . 0.0 110.734 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 t -137.43 137.48 38.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.326 0.65 . . . . 0.0 109.89 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -147.94 146.41 28.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.187 0.595 . . . . 0.0 110.484 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -106.72 155.89 19.21 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.612 0.365 . . . . 0.0 111.221 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.13 35.58 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.72 148.98 27.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.53 143.2 10.2 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -75.53 152.25 37.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.532 0.333 . . . . 0.0 110.994 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.0 -175.49 15.95 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.324 0.488 . . . . 0.0 112.392 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.59 170.55 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.191 3.261 . . . . 0.0 111.245 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -119.79 31.09 6.71 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.322 0.649 . . . . 0.0 111.721 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.88 33.37 0.38 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.473 0.709 . . . . 0.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 68.1 m -86.5 40.73 0.9 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.806 0.842 . . . . 0.0 110.956 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.8 t -87.72 24.44 1.73 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.903 0.481 . . . . 0.0 111.443 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -144.01 144.28 31.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.558 0.743 . . . . 0.0 109.084 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -70.15 -19.93 63.18 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -88.28 7.65 31.17 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -135.56 24.25 3.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.389 1.076 . . . . 0.0 109.009 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -125.91 -34.31 0.65 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -135.91 21.75 3.29 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.69 0.745 . . . . 0.0 111.788 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -135.76 24.5 3.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.053 0.541 . . . . 0.0 110.772 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 tt -140.71 152.3 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.504 0.722 . . . . 0.0 109.481 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 mp 63.34 129.67 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.271 1.428 . . . . 0.0 111.639 -173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.17 -1.87 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.872 3.048 . . . . 0.0 113.413 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.12 21.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.835 0.743 . . . . 0.0 112.399 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -97.45 -10.51 25.27 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.796 -0.565 . . . . 0.0 110.105 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -79.84 -7.71 58.86 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.36 -41.59 13.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.161 0.984 . . . . 0.0 109.673 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 p -76.92 -25.46 52.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.845 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.04 -46.71 11.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.7 0.227 . . . . 0.0 111.531 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 -9.36 57.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.72 -36.78 8.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.45 -24.4 62.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.996 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -87.26 -57.05 3.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.047 -0.408 . . . . 0.0 111.244 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -83.04 5.5 22.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -139.12 -8.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.803 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.81 24.37 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.538 1.063 . . . . 0.0 112.064 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -123.85 34.28 5.11 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.87 -0.519 . . . . 0.0 111.036 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.56 25.3 3.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.083 0.553 . . . . 0.0 111.324 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.14 25.07 3.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.813 0.445 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.5 m95 53.56 38.8 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.238 0.615 . . . . 0.0 111.839 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.47 -160.65 19.42 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -167.13 159.74 33.2 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 117.168 0.484 . . . . 0.0 111.964 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 77.0 p 51.38 24.44 2.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.629 1.572 . . . . 0.0 114.089 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -156.53 24.12 0.34 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.953 0.342 . . . . 0.0 111.789 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.92 -10.96 27.33 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.485 -0.62 . . . . 0.0 114.134 -172.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -145.86 160.4 43.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.197 0.998 . . . . 0.0 110.232 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -60.65 -3.52 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.129 3.219 . . . . 0.0 113.788 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -75.12 -2.71 28.87 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.375 0.534 . . . . 0.0 111.836 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 m -84.77 8.85 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.524 0.329 . . . . 0.0 111.237 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.1 p -129.63 38.07 3.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.19 0.996 . . . . 0.0 108.45 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.04 -59.09 0.02 OUTLIER Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 151' ' ' PHE . 1.8 mp -58.97 -53.25 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 117.543 0.671 . . . . 0.0 109.962 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.3 m 35.86 33.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 126.069 1.748 . . . . 0.0 114.521 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.496 ' H ' HG22 ' A' ' 149' ' ' ILE . 55.4 t80 -135.15 155.12 51.24 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.007 -0.433 . . . . 0.0 111.184 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.62 161.22 28.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.499 0.72 . . . . 0.0 111.278 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -137.44 152.15 72.56 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 122.789 0.435 . . . . 0.0 111.269 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.07 -19.58 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.514 2.81 . . . . 0.0 111.126 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.2 t70 53.1 55.37 8.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.192 0.997 . . . . 0.0 112.21 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.0 pt -113.41 11.53 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.5 tp 46.38 55.79 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 112.824 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.8 t -117.37 135.09 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 C-N-CA 123.287 0.635 . . . . 0.0 109.385 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -173.62 -12.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.34 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -135.8 141.14 44.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.262 1.031 . . . . 0.0 110.366 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -179.76 9.42 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.074 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.54 144.89 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 118.119 0.96 . . . . 0.0 110.935 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.8 p -135.69 155.62 50.11 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.738 0.815 . . . . 0.0 110.411 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.6 t -135.65 146.6 48.0 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.892 0.477 . . . . 0.0 110.853 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -135.4 154.25 51.53 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.84 0.856 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.36 36.66 3.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.281 0.633 . . . . 0.0 110.757 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 37.0 pt -82.51 38.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.803 0.841 . . . . 0.0 111.497 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 77.3 p -133.53 30.15 3.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.691 0.796 . . . . 0.0 111.193 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 162.79 27.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.91 0.484 . . . . 0.0 111.68 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -135.25 146.86 49.01 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.605 0.762 . . . . 0.0 109.905 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -139.95 154.34 70.47 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.322 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.51 172.45 15.05 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.901 3.068 . . . . 0.0 111.339 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.4 p -130.89 153.87 48.69 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.551 0.741 . . . . 0.0 110.37 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -66.36 130.35 42.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.796 0.438 . . . . 0.0 111.15 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.3 p -135.43 22.64 3.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.661 0.784 . . . . 0.0 110.428 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -85.68 -132.23 2.83 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 49.27 29.77 2.83 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.481 1.513 . . . . 0.0 113.458 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -135.99 145.51 46.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.66 0.784 . . . . 0.0 109.584 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.47 173.1 45.29 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.22 171.0 18.52 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 124.491 3.461 . . . . 0.0 111.353 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -135.21 134.2 39.81 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.514 0.725 . . . . 0.0 109.709 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.0 m -73.75 140.12 45.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.731 0.412 . . . . 0.0 111.078 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.56 171.53 40.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 41.1 ttmt -87.45 -44.48 0.51 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.736 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 85.2 Cg_endo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.233 1.955 . . . . 0.0 111.207 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo . . . . . 0 C--O 1.231 0.143 0 N-CA-C 112.445 0.133 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -135.82 39.51 2.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.172 0.589 . . . . 0.0 111.084 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -65.76 145.11 56.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.867 0.365 . . . . 0.0 111.322 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 pp -135.93 164.7 27.36 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.355 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -81.91 148.3 28.82 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.85 0.46 . . . . 0.0 110.412 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.72 31.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 111.146 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.7 t -69.91 145.33 52.04 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.772 0.429 . . . . 0.0 110.79 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -75.93 153.05 36.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.98 0.512 . . . . 0.0 110.961 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.97 159.31 53.62 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 123.084 0.554 . . . . 0.0 110.591 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.95 164.4 12.12 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.004 3.136 . . . . 0.0 112.277 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -119.7 24.7 10.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.163 0.585 . . . . 0.0 110.889 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -143.63 139.85 29.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.454 0.702 . . . . 0.0 109.983 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -134.53 91.99 20.9 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 123.282 0.633 . . . . 0.0 109.324 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.45 136.87 77.14 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.911 3.074 . . . . 0.0 112.393 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -163.45 162.38 17.33 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.179 0.992 . . . . 0.0 109.141 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.86 158.96 53.88 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.499 2.132 . . . . 0.0 110.176 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.25 104.93 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.7 p -141.21 149.3 41.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.27 0.628 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -38.23 122.91 1.1 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.818 1.247 . . . . 0.0 111.687 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -47.88 104.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.341 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.9 m -142.43 -2.49 1.1 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.848 0.459 . . . . 0.0 111.35 169.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -148.1 24.05 1.05 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.52 146.38 53.47 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 121.475 -0.766 . . . . 0.0 111.601 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.52 168.36 24.62 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.904 3.736 . . . . 0.0 110.591 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.04 18.85 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.485 3.457 . . . . 0.0 112.404 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.02 175.37 5.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.688 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -52.52 154.31 2.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.05 1.34 . . . . 0.0 113.149 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 119.45 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -82.44 35.59 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -172.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 12.73 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.77 55.89 1.26 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.055 0.942 . . . . 0.0 108.613 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.4 t -62.11 109.04 1.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.942 0.497 . . . . 0.0 111.124 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.16 54.26 1.94 Allowed 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.6 m -76.11 135.44 39.84 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.446 -171.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.76 108.55 12.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -86.78 139.63 30.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.371 0.668 . . . . 0.0 110.023 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.04 142.38 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.36 171.07 40.55 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.186 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.38 23.7 68.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -56.36 126.01 67.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 117.321 0.561 . . . . 0.0 111.799 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.25 -2.68 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.576 2.85 . . . . 0.0 110.82 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.19 159.98 33.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.221 0.608 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -79.11 38.59 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.799 0.839 . . . . 0.0 111.74 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp 57.48 54.26 6.68 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.9 0.88 . . . . 0.0 111.98 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.13 131.89 37.39 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.668 0.787 . . . . 0.0 109.185 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.8 -8.0 55.1 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -85.15 -17.94 35.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.156 -0.34 . . . . 0.0 110.946 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -87.13 -22.51 25.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.868 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.44 -37.23 77.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.36 -18.85 62.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.829 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -88.2 -4.22 58.76 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.857 -0.527 . . . . 0.0 111.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.46 -2.01 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 118.124 0.42 . . . . 0.0 111.672 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -131.27 6.68 4.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -171.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 3.2 mmpt? -96.52 -29.36 0.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 97.6 Cg_endo -74.74 134.98 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 121.779 1.671 . . . . 0.0 109.968 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 50.3 36.77 13.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.419 0.688 . . . . 0.0 111.612 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.69 165.38 29.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.658 0.783 . . . . 0.0 110.577 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -135.13 49.79 2.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 110.761 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.99 137.04 22.3 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.269 0.627 . . . . 0.0 109.915 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -125.45 1.97 7.67 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 m -138.53 138.73 38.28 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.629 0.65 . . . . 0.0 111.524 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.2 t -135.75 130.92 50.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 123.502 0.721 . . . . 0.0 109.368 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.87 137.84 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.96 142.11 51.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.741 0.816 . . . . 0.0 110.49 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -129.18 129.09 44.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.855 0.862 . . . . 0.0 109.057 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -78.39 43.46 0.46 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.137 0.975 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -135.44 104.91 6.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.7 0.8 . . . . 0.0 109.186 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 52.08 36.58 19.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.928 0.891 . . . . 0.0 111.919 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 53.8 55.77 8.03 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.435 0.694 . . . . 0.0 112.038 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -96.67 129.46 44.06 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.73 152.13 50.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.959 0.504 . . . . 0.0 110.974 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -135.67 136.86 41.26 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.24 155.36 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.595 0.236 . . . . 0.0 110.395 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.92 136.04 47.08 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.993 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -122.26 156.98 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 126.366 1.866 . . . . 0.0 108.192 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -117.94 17.91 14.07 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -143.44 122.94 13.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.757 0.823 . . . . 0.0 109.052 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 ttt-85 -70.26 -20.41 63.06 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.18 0.446 . . . . 0.0 110.679 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -75.75 -21.57 57.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.041 -0.412 . . . . 0.0 110.162 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.59 -11.76 19.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.0 64.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.95 -21.2 51.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.371 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -78.06 -20.57 52.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.972 -0.455 . . . . 0.0 110.855 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.97 -40.67 22.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 O-C-N 121.77 -0.581 . . . . 0.0 110.345 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.24 -21.72 62.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.468 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -81.65 -18.08 45.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.81 -0.557 . . . . 0.0 110.533 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.42 -26.5 32.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -91.8 2.64 56.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -119.84 -0.84 10.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.454 0.302 . . . . 0.0 111.49 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.32 16.18 3.44 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.96 49.05 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 110.595 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.34 9.04 85.91 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.343 -0.698 . . . . 0.0 112.892 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.73 81.18 0.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.083 0.953 . . . . 0.0 111.408 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.37 151.17 60.77 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.15 0.58 . . . . 0.0 111.107 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.27 -9.39 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.787 2.991 . . . . 0.0 111.468 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.9 tt -73.87 124.05 25.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.412 ' N ' HD23 ' A' ' 96' ' ' LEU . 25.8 tpt180 -85.15 136.72 33.42 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 122.368 0.267 . . . . 0.0 111.167 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 p -135.47 142.19 45.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.234 0.614 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.49 137.95 27.27 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.788 0.835 . . . . 0.0 109.061 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -135.2 155.57 50.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 0.0 111.677 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.36 176.49 45.32 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.319 0.4 . . . . 0.0 112.421 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.48 131.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.25 1.02 . . . . 0.0 109.921 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.24 135.98 14.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -135.69 142.52 45.11 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.008 0.523 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.4 -172.22 48.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.75 171.02 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.657 3.571 . . . . 0.0 112.726 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -57.83 144.21 39.54 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.106 0.562 . . . . 0.0 110.98 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -108.25 24.39 13.07 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.45 0.7 . . . . 0.0 112.001 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -99.73 24.37 8.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.866 0.467 . . . . 0.0 111.383 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.4 m -76.79 154.17 34.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.991 0.517 . . . . 0.0 110.395 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -78.21 146.52 34.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -74.95 3.74 7.75 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -78.75 -8.6 58.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.252 0.478 . . . . 0.0 109.945 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -135.22 4.64 3.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.855 0.862 . . . . 0.0 110.055 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.95 -12.77 45.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.84 134.21 56.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.429 0.614 . . . . 0.0 110.782 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.3 p -143.34 149.64 38.04 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.249 0.62 . . . . 0.0 110.296 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.5 tp -92.37 108.58 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm 62.57 140.96 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 111.089 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -56.59 -22.16 42.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.609 2.206 . . . . 0.0 113.248 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 41.4 ttp -80.08 36.34 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.023 0.529 . . . . 0.0 110.737 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -135.65 -36.95 0.76 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.393 0.677 . . . . 0.0 110.429 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -85.96 -13.49 47.53 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.579 0.172 . . . . 0.0 110.716 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.57 -24.97 14.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.209 0.604 . . . . 0.0 109.449 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.2 m -77.47 -26.04 51.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -91.0 -40.16 11.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.288 -0.258 . . . . 0.0 110.886 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.49 -9.41 59.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -112.5 -17.23 12.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.36 -24.47 62.98 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 170.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.57 -52.5 5.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -86.69 16.41 4.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.6 t -143.24 -20.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' ALA . 20.4 m -140.16 33.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.384 0.993 . . . . 0.0 113.058 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.7 p -72.81 22.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.521 -0.737 . . . . 0.0 111.887 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.53 36.52 2.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.44 1.096 . . . . 0.0 109.202 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -133.4 162.3 32.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.231 1.012 . . . . 0.0 109.449 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -75.73 44.64 0.3 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.433 0.693 . . . . 0.0 111.936 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.9 1.02 90.14 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.368 0.508 . . . . 0.0 112.597 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 167.02 54.86 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.765 0.783 . . . . 0.0 111.925 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.8 t -140.01 22.34 2.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.811 0.845 . . . . 0.0 109.353 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -135.3 20.02 3.4 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 109.786 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.25 -5.1 83.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -137.69 160.33 65.39 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.029 0.532 . . . . 0.0 110.133 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.77 20.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 125.27 3.98 . . . . 0.0 115.157 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 149' ' ' ILE . 3.4 pp -83.33 1.62 40.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.14 0.882 . . . . 0.0 111.201 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.87 21.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.564 -0.71 . . . . 0.0 112.328 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -135.71 24.55 3.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.843 0.354 . . . . 0.0 111.796 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.96 -9.51 0.03 OUTLIER Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.593 -0.692 . . . . 0.0 112.915 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.475 HG13 HD13 ' A' ' 145' ' ' LEU . 29.5 mm -86.39 42.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.889 0.852 . . . . 0.0 109.548 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.14 24.71 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.184 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.12 161.79 28.36 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.39 55.7 1.87 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.107 0.563 . . . . 0.0 109.72 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.9 151.93 71.99 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 122.964 0.506 . . . . 0.0 110.527 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.42 5.82 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.075 3.183 . . . . 0.0 112.339 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -80.9 55.31 2.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.294 0.637 . . . . 0.0 110.902 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.3 pt -80.31 158.13 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.296 0.638 . . . . 0.0 110.808 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.3 pt -77.59 29.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.21 26.14 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.893 0.477 . . . . 0.0 110.715 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 79.78 -173.97 55.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -135.37 142.33 45.7 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.155 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.42 179.15 45.01 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.1 150.82 29.95 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 C-N-CA 123.324 0.65 . . . . 0.0 110.455 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.6 m -135.4 148.57 49.4 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.286 0.635 . . . . 0.0 110.521 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.2 m -135.16 145.51 47.84 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.454 0.701 . . . . 0.0 110.202 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -135.32 34.6 3.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.063 0.545 . . . . 0.0 110.433 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.98 107.98 10.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.631 0.372 . . . . 0.0 110.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.2 tp -135.81 143.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.182 0.593 . . . . 0.0 110.279 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.6 t -135.83 136.68 40.83 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.226 0.611 . . . . 0.0 110.0 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -135.5 138.01 42.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.19 0.596 . . . . 0.0 109.976 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -136.06 152.39 50.84 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.171 0.589 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.4 ttm -147.58 136.81 11.75 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.86 146.37 47.67 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.178 2.585 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 62.7 p -135.98 24.63 3.32 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.471 0.708 . . . . 0.0 110.687 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.92 24.59 11.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.43 0.692 . . . . 0.0 111.703 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.9 p -99.37 130.41 45.64 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.045 0.538 . . . . 0.0 110.572 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 167.3 -177.03 42.01 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -135.55 119.43 17.36 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 123.336 0.654 . . . . 0.0 109.752 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -135.85 27.05 3.31 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.241 0.616 . . . . 0.0 111.541 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.44 157.24 51.93 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.07 168.09 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 124.312 3.341 . . . . 0.0 111.333 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -82.55 154.64 24.91 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.168 0.587 . . . . 0.0 110.25 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.6 m -132.78 132.11 41.86 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.882 0.473 . . . . 0.0 110.356 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 169.91 176.62 39.72 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 0.4 OUTLIER -82.88 -50.77 0.72 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.433 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 96.3 Cg_endo . . . . . 0 C--O 1.25 1.115 0 C-N-CA 122.429 2.086 . . . . 0.0 111.07 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.47 0.137 0 N-CA-C 112.52 0.161 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -135.16 26.71 3.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.151 0.581 . . . . 0.0 110.731 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.29 133.29 40.08 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.588 0.355 . . . . 0.0 110.529 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.22 104.75 16.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -81.21 138.92 35.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.973 0.509 . . . . 0.0 110.777 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.36 135.18 56.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.421 0.688 . . . . 0.0 109.85 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.9 m -134.61 27.73 3.66 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.287 0.635 . . . . 0.0 110.873 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -135.49 147.3 48.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.436 0.695 . . . . 0.0 110.105 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -78.69 119.83 78.74 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.13 169.74 21.51 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.453 2.769 . . . . 0.0 111.492 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -135.4 140.16 44.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.288 0.635 . . . . 0.0 110.093 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -136.73 127.76 27.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.055 0.542 . . . . 0.0 110.054 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -146.79 80.2 9.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.39 -9.77 13.64 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.763 2.976 . . . . 0.0 111.36 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -93.38 140.84 23.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.608 0.763 . . . . 0.0 110.46 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.29 -174.4 0.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.768 2.979 . . . . 0.0 110.316 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -56.93 135.27 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -78.64 177.26 8.75 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.494 0.717 . . . . 0.0 110.771 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -119.87 96.09 5.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.645 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 57.55 46.47 17.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -79.64 -174.81 4.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.489 0.715 . . . . 0.0 111.133 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -109.37 63.84 0.61 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.483 1.113 . . . . 0.0 108.621 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.724 HD22 ' H ' ' A' ' 23' ' ' LEU . 1.1 mm? -61.76 155.18 62.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.386 0.674 . . . . 0.0 110.831 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.05 161.94 10.02 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 111.728 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.39 126.75 17.56 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.864 2.376 . . . . 0.0 109.756 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -150.16 166.7 29.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.578 0.751 . . . . 0.0 109.785 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.85 55.64 0.54 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.719 0.808 . . . . 0.0 110.08 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -61.48 138.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.684 1.194 . . . . 0.0 109.474 -176.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' N ' HD13 ' A' ' 28' ' ' ILE . 22.5 ptmt -114.15 31.22 6.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.45 -9.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 122.774 0.43 . . . . 0.0 110.465 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.26 149.27 32.54 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.532 0.733 . . . . 0.0 109.884 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -82.62 124.71 30.42 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -69.04 144.43 54.03 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.041 0.536 . . . . 0.0 111.315 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.6 p -99.5 159.91 14.67 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.846 0.859 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.0 tp -122.55 125.46 45.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.127 0.489 . . . . 0.0 110.406 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -109.04 141.58 40.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.902 0.881 . . . . 0.0 109.653 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.99 145.1 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 109.177 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.12 40.09 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.479 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.34 24.31 65.45 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.756 -0.537 . . . . 0.0 111.756 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.18 130.14 89.09 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.427 0.614 . . . . 0.0 111.574 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.45 -2.94 12.27 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.459 2.772 . . . . 0.0 110.86 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.45 156.95 37.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.229 0.612 . . . . 0.0 110.413 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -80.5 43.16 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.409 0.684 . . . . 0.0 111.155 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 88.3 mtp 52.52 55.13 9.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.093 0.957 . . . . 0.0 112.277 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -130.83 125.97 35.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.01 -8.38 52.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -80.86 -15.65 55.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.047 -0.408 . . . . 0.0 110.974 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.02 -24.3 17.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.577 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.86 -26.28 60.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.3 -19.13 36.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.15 -8.47 59.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.953 -0.467 . . . . 0.0 110.806 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.17 -4.21 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -112.46 14.13 20.25 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.332 0.653 . . . . 0.0 111.045 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.514 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 56.3 tttp -117.71 -19.13 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 92.4 Cg_endo -78.16 -21.54 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 121.932 1.726 . . . . 0.0 112.307 -177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.84 16.41 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.129 0.571 . . . . 0.0 111.201 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.07 -175.78 5.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.439 1.096 . . . . 0.0 108.526 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -145.63 104.22 3.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.001 -0.437 . . . . 0.0 110.09 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.38 139.86 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.103 0.561 . . . . 0.0 110.123 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.57 2.72 6.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.201 0.2 . . . . 0.0 111.429 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 t -135.88 119.7 17.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.905 -0.497 . . . . 0.0 110.268 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.7 t -140.38 127.12 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.656 0.782 . . . . 0.0 109.671 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 136.18 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 122.751 0.42 . . . . 0.0 110.133 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.19 145.19 39.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.569 1.148 . . . . 0.0 110.311 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -135.15 138.21 43.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.079 0.552 . . . . 0.0 110.108 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.9 50.45 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -128.18 98.77 5.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 54.9 25.36 6.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.628 0.771 . . . . 0.0 111.693 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.08 60.96 3.28 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.206 1.002 . . . . 0.0 110.946 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.99 151.36 34.3 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.258 0.623 . . . . 0.0 111.122 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.18 160.15 40.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.647 0.779 . . . . 0.0 110.987 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -126.45 137.09 53.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.66 151.25 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-O 121.015 0.436 . . . . 0.0 111.464 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -135.0 134.79 40.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.8 156.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 125.212 1.405 . . . . 0.0 109.1 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -104.51 21.22 17.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.524 0.202 . . . . 0.0 111.216 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -142.71 115.35 8.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.934 0.893 . . . . 0.0 108.955 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -72.96 -20.05 61.12 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -89.79 -16.96 29.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.269 -0.27 . . . . 0.0 110.636 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.31 -18.62 28.11 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.15 84.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -70.48 -20.8 62.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -83.73 -14.09 52.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.99 0.359 . . . . 0.0 111.456 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -75.23 -50.2 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.27 -20.89 65.72 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.664 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -67.81 -46.42 71.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -84.07 -23.73 30.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.913 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.28 -2.86 43.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.095 0.407 . . . . 0.0 111.341 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -131.22 9.13 4.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -135.23 12.61 3.55 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -103.23 -11.84 17.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.043 0.838 . . . . 0.0 111.323 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.81 5.91 4.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.856 0.741 . . . . 0.0 114.392 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.71 29.61 3.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.589 1.195 . . . . 0.0 112.222 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.24 95.69 30.13 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.89 -2.48 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.904 3.069 . . . . 0.0 111.163 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.48 121.08 14.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.565 0.746 . . . . 0.0 109.022 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -83.07 136.11 34.6 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.615 0.366 . . . . 0.0 111.187 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 p -135.69 143.98 45.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.325 0.65 . . . . 0.0 110.81 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.03 131.32 25.01 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -125.47 155.43 40.52 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.333 0.253 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 180.0 -178.54 48.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.69 148.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.132 0.573 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.66 143.01 9.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.18 24.25 3.53 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.337 0.655 . . . . 0.0 111.145 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.42 178.42 36.13 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 122.978 0.323 . . . . 0.0 112.319 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.44 4.08 6.63 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.745 3.63 . . . . 0.0 112.059 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -65.99 145.86 55.38 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.044 0.537 . . . . 0.0 111.396 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -135.25 55.13 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.847 0.859 . . . . 0.0 109.108 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -94.73 51.31 1.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.895 0.878 . . . . 0.0 110.189 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.79 40.35 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.986 0.914 . . . . 0.0 112.237 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -131.87 134.58 45.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.97 0.908 . . . . 0.0 109.19 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -74.07 -4.34 34.93 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -81.26 -7.97 59.66 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -140.71 24.99 2.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.771 0.828 . . . . 0.0 110.294 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.37 3.48 0.12 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.367 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -79.57 55.2 1.92 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.182 1.491 . . . . 0.0 110.757 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.1 m -135.37 29.62 3.3 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.938 0.895 . . . . 0.0 110.255 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.0 pt -74.88 144.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.151 0.581 . . . . 0.0 111.107 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.783 ' H ' ' HD2' ' A' ' 120' ' ' PRO . 61.0 mt -133.61 -45.71 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.447 -0.787 . . . . 0.0 112.356 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.783 ' HD2' ' H ' ' A' ' 119' ' ' ILE . 87.9 Cg_endo -77.29 -8.18 17.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.75 1.633 . . . . 0.0 111.834 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.94 24.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.665 0.386 . . . . 0.0 111.753 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.87 -26.61 1.53 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.476 0.311 . . . . 0.0 110.771 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -87.48 -9.83 53.49 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.26 -52.62 8.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.892 0.877 . . . . 0.0 108.689 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -71.69 -19.68 62.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.097 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.7 -60.72 2.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.5 -26.02 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -172.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.22 -42.13 6.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.377 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -77.04 -21.26 54.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.224 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.18 -46.69 8.61 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.723 0.692 . . . . 0.0 111.111 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -84.63 5.03 29.6 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.493 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.3 m -138.83 -5.02 1.53 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.58 19.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.493 1.042 . . . . 0.0 112.571 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -82.87 49.79 1.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.322 -0.861 . . . . 0.0 111.557 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.92 8.0 3.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.923 0.489 . . . . 0.0 110.491 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -145.52 156.92 44.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.287 1.035 . . . . 0.0 109.547 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -76.2 104.53 6.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.55 178.8 33.8 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.04 136.87 25.86 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -146.2 32.75 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.928 0.364 . . . . 0.0 111.331 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG11 ' A' ' 146' ' ' VAL . 21.1 m 57.1 40.71 28.2 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.841 0.456 . . . . 0.0 111.901 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.98 -19.0 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -146.88 162.08 34.72 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.718 0.807 . . . . 0.0 109.287 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.02 3.82 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.46 3.44 . . . . 0.0 114.43 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.02 -5.76 28.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.69 0.677 . . . . 0.0 111.659 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 141' ' ' SER . 22.8 m -89.36 14.69 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.45 0.7 . . . . 0.0 111.042 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -133.43 44.33 2.81 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.78 -57.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.18 128.2 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.641 0.734 . . . . 0.0 109.653 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.13 31.77 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.54 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -132.61 130.93 40.86 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.581 0.353 . . . . 0.0 110.741 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.72 154.15 40.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.956 0.503 . . . . 0.0 111.227 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.569 ' H ' ' HD2' ' A' ' 154' ' ' PRO . 75.7 mm-40 -132.01 -59.21 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.457 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.569 ' HD2' ' H ' ' A' ' 153' ' ' GLU . 83.3 Cg_endo -74.06 149.01 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.52 2.146 . . . . 0.0 111.144 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -138.49 25.01 2.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.8 tp -135.33 131.41 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 122.089 -0.382 . . . . 0.0 111.328 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.5 tp -147.99 46.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.628 0.771 . . . . 0.0 109.565 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.36 137.14 55.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 C-N-CA 123.003 0.521 . . . . 0.0 110.084 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 167.29 -3.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.981 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -98.23 143.06 29.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 117.966 0.883 . . . . 0.0 111.209 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 175.18 154.29 11.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.68 143.97 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.274 0.629 . . . . 0.0 110.215 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -136.16 141.22 44.06 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.919 0.488 . . . . 0.0 110.954 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -145.74 137.82 25.4 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.249 0.619 . . . . 0.0 110.031 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -141.19 135.24 30.58 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.921 0.488 . . . . 0.0 110.713 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -136.04 126.15 26.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.338 0.655 . . . . 0.0 109.666 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.7 tt -141.96 144.97 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.784 0.434 . . . . 0.0 110.959 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.3 m -135.37 110.79 9.09 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 109.214 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.78 62.14 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.983 0.513 . . . . 0.0 110.314 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -135.31 144.74 46.91 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.886 0.474 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.3 ttm -152.8 135.92 9.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.257 0.623 . . . . 0.0 109.36 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.36 154.39 40.79 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.572 2.848 . . . . 0.0 111.339 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.1 m -137.07 85.38 2.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -135.54 24.88 3.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.894 0.478 . . . . 0.0 111.29 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.9 m -88.43 135.03 33.67 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.687 0.395 . . . . 0.0 111.066 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.29 161.41 20.79 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -140.64 121.67 14.64 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.204 0.601 . . . . 0.0 109.987 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -143.48 139.63 29.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.993 0.517 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.03 157.24 20.45 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.88 170.67 19.39 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.448 3.432 . . . . 0.0 111.249 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -135.57 150.14 49.62 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.362 0.665 . . . . 0.0 110.48 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.9 p -85.58 147.75 26.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.886 0.474 . . . . 0.0 111.129 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.48 176.72 54.6 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 65.9 tttm -147.25 -49.4 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.926 . . . . 0.0 112.362 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.763 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 97.9 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.138 1.892 . . . . 0.0 111.119 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 112.581 0.185 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -135.79 84.76 2.11 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.044 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.81 148.81 48.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.262 0.625 . . . . 0.0 110.711 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -135.81 156.21 49.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.15 0.58 . . . . 0.0 111.235 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 62.64 116.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.541 1.536 . . . . 0.0 113.201 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.26 27.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.712 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -71.32 153.65 42.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.992 0.425 . . . . 0.0 111.597 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -82.49 163.66 21.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.008 0.523 . . . . 0.0 111.099 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -124.15 154.14 68.36 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.361 0.664 . . . . 0.0 110.481 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.16 172.37 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.001 3.134 . . . . 0.0 112.055 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -79.18 24.32 0.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.617 0.767 . . . . 0.0 111.772 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.73 119.75 17.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -140.49 157.08 69.04 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 122.355 0.262 . . . . 0.0 110.945 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.57 167.09 3.04 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.082 3.188 . . . . 0.0 112.275 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -134.51 42.1 0.75 Allowed Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 87.4 Cg_endo -72.01 -3.75 13.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.278 2.652 . . . . 0.0 112.276 -177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.61 93.68 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.7 p -159.52 164.74 34.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.45 1.1 . . . . 0.0 109.637 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -55.4 104.92 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.613 0.765 . . . . 0.0 110.193 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -113.01 13.64 19.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.703 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t 60.49 170.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 113.552 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t 46.67 44.88 14.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.282 1.433 . . . . 0.0 112.728 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' A' ' 148' ' ' GLY . 94.5 mt -68.86 147.04 97.82 Favored Pre-proline 0 CA--C 1.531 0.222 0 O-C-N 122.028 -0.42 . . . . 0.0 110.744 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.08 142.31 34.19 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.932 3.088 . . . . 0.0 111.052 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.45 -8.9 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.939 3.092 . . . . 0.0 112.823 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -135.26 24.22 3.51 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -136.03 25.36 3.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.764 0.316 . . . . 0.0 110.796 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 29' ' ' LYS . 6.7 tp -137.42 148.46 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.914 0.486 . . . . 0.0 110.572 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' H ' HD12 ' A' ' 28' ' ' ILE . 21.1 tptm -96.21 15.0 22.18 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.644 0.778 . . . . 0.0 112.301 -173.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' H ' HG13 ' A' ' 28' ' ' ILE . 24.6 m -135.38 32.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 O-C-N 121.895 -0.503 . . . . 0.0 111.096 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -78.91 155.12 29.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.476 0.31 . . . . 0.0 110.582 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.1 p -135.52 144.05 46.1 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.834 0.453 . . . . 0.0 111.192 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -135.96 16.55 3.28 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.167 0.587 . . . . 0.0 111.425 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -142.15 141.52 32.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.204 0.602 . . . . 0.0 109.79 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 HG11 ' A' ' 84' ' ' VAL . 58.6 tp -135.2 126.29 27.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -100.7 143.02 31.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.534 0.333 . . . . 0.0 110.695 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.73 102.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.23 164.5 18.15 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.31 72.63 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.019 -0.878 . . . . 0.0 113.77 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -53.59 117.51 12.33 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 118.548 1.174 . . . . 0.0 111.09 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.97 -9.49 25.16 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.373 2.715 . . . . 0.0 112.413 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -135.09 67.84 1.48 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.78 0.832 . . . . 0.0 110.856 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.52 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.608 0.763 . . . . 0.0 112.323 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 42' ' ' LEU . 12.1 tpt -147.87 22.81 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.128 0.571 . . . . 0.0 110.902 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 47' ' ' TRP . 29.0 tptt -145.43 78.63 1.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.35 -20.46 66.12 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.06 -0.4 . . . . 0.0 111.745 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.494 ' CE2' ' HE3' ' A' ' 45' ' ' LYS . 63.9 p-90 -92.09 1.7 57.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.95 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.83 -28.51 28.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.39 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.49 -40.39 85.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.49 65.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.229 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -92.06 -3.41 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.214 0.461 . . . . 0.0 112.142 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.16 -2.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 O-C-N 121.996 -0.44 . . . . 0.0 111.75 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tp -124.95 -6.41 7.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 98.5 mttt -96.01 -29.75 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.286 -0.864 . . . . 0.0 113.284 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.51 -18.66 47.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.427 2.085 . . . . 0.0 114.117 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.66 8.53 3.32 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.75 150.12 28.17 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.597 0.635 . . . . 0.0 110.427 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -87.94 40.06 0.92 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.686 0.394 . . . . 0.0 111.642 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.92 141.34 16.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 O-C-N 122.052 -0.405 . . . . 0.0 109.995 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -135.29 7.83 3.38 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 124.25 25.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.206 0.457 . . . . 0.0 110.789 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.09 130.54 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 123.737 0.815 . . . . 0.0 109.337 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.78 131.73 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.81 119.5 22.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -86.64 104.08 15.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -84.5 18.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.273 0.629 . . . . 0.0 112.049 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.6 3.79 3.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.425 0.29 . . . . 0.0 111.588 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -141.18 14.08 2.22 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.95 0.5 . . . . 0.0 111.036 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.1 pttt 44.5 40.7 4.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.727 1.211 . . . . 0.0 112.89 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -127.25 138.5 53.1 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.113 0.565 . . . . 0.0 109.918 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.77 147.0 48.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.752 0.31 . . . . 0.0 111.187 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.86 144.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.5 156.69 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.09 139.39 44.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.58 154.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 126.284 1.834 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.2 15.41 17.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 t -155.91 137.63 14.26 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.055 0.542 . . . . 0.0 110.35 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -68.06 -11.4 58.95 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -81.39 -17.37 49.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.797 -0.564 . . . . 0.0 110.706 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -90.98 -23.13 20.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.02 -22.09 56.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -82.51 -21.59 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -78.04 -20.47 52.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.074 -0.391 . . . . 0.0 110.559 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 35' ' ' LEU . 71.8 t -81.58 -40.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.458 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.8 -18.36 60.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.243 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -82.29 -19.2 39.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.999 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -79.09 -26.01 43.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -84.15 -8.85 58.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.952 0.501 . . . . 0.0 111.409 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -127.24 12.19 7.05 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.94 10.06 3.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.397 0.544 . . . . 0.0 112.459 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -122.77 -20.02 6.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.531 0.605 . . . . 0.0 111.353 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.93 9.73 5.85 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.038 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.3 43.78 2.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.851 1.326 . . . . 0.0 112.26 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.36 119.78 26.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.52 -8.28 12.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.8 3.0 . . . . 0.0 111.404 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.04 138.96 50.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.996 0.519 . . . . 0.0 111.113 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -95.29 84.68 4.09 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.1 p -79.58 122.64 26.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.464 0.705 . . . . 0.0 110.872 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -140.61 118.3 11.65 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.121 0.568 . . . . 0.0 110.281 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -86.83 155.29 20.34 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.673 0.389 . . . . 0.0 111.359 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.78 -171.74 37.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -135.95 136.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.381 0.672 . . . . 0.0 110.338 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.07 135.99 13.33 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -106.52 44.7 1.03 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.678 0.791 . . . . 0.0 110.515 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.23 -167.99 52.76 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.4 -5.53 17.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.024 3.149 . . . . 0.0 112.237 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.33 134.78 34.9 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.666 0.387 . . . . 0.0 110.653 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.064 0.546 . . . . 0.0 110.022 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.7 m -135.05 26.81 3.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.365 0.666 . . . . 0.0 110.41 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.19 133.04 44.9 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.59 0.356 . . . . 0.0 110.875 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -135.93 147.31 48.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.486 0.714 . . . . 0.0 109.552 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -72.72 -4.09 29.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -93.66 5.83 50.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.375 0.534 . . . . 0.0 110.001 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -136.44 24.98 3.19 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.282 0.633 . . . . 0.0 111.067 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.11 -5.98 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.74 -1.033 . . . . 0.0 115.32 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -84.2 58.61 4.87 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.558 1.679 . . . . 0.0 110.691 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -135.21 149.01 49.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.258 0.623 . . . . 0.0 110.486 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.0 pt -116.68 24.89 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.479 0.712 . . . . 0.0 110.681 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 17.6 tt -68.19 145.15 97.41 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 123.05 0.54 . . . . 0.0 109.944 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 52.1 Cg_exo -57.75 177.56 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.844 3.029 . . . . 0.0 112.801 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -71.67 24.11 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.603 -0.685 . . . . 0.0 110.909 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -87.08 -8.04 57.45 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 tp -103.66 -39.32 6.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.593 0.757 . . . . 0.0 109.262 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -70.61 -26.58 63.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.74 -45.55 9.22 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 117.915 0.325 . . . . 0.0 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.23 -10.95 59.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.923 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -106.7 -24.44 12.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.451 0.569 . . . . 0.0 111.275 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.03 -16.71 59.9 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.267 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 94.8 mttt -85.15 -55.56 3.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -86.6 11.67 12.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 t -137.37 -21.97 1.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.57 19.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.855 1.207 . . . . 0.0 114.117 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 13.0 t -101.95 37.55 1.83 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.313 0.96 . . . . 0.0 110.888 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.32 19.69 3.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -152.79 -41.32 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -136.41 13.01 3.25 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.86 15.08 66.43 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.425 0.557 . . . . 0.0 112.865 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.35 -176.58 41.92 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.74 0.77 . . . . 0.0 112.542 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 25.2 m 64.26 107.85 0.03 OUTLIER 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.895 1.278 . . . . 0.0 111.831 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t 60.74 31.7 20.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.989 0.915 . . . . 0.0 112.18 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.13 -29.77 24.54 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.643 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -152.23 165.44 17.49 Favored Pre-proline 0 C--N 1.34 0.158 0 CA-C-N 117.96 0.88 . . . . 0.0 110.052 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.6 -1.97 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.259 3.306 . . . . 0.0 114.622 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.52 -10.01 59.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.63 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.228 -0.065 0 C-N-CA 123.06 0.544 . . . . 0.0 112.455 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.2 p -135.53 -8.75 2.19 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 122.237 -0.29 . . . . 0.0 111.089 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -88.32 -31.05 14.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 149' ' ' ILE . 4.3 mp -81.03 64.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 23.1 m -122.26 19.86 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.229 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -135.58 141.54 45.17 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.85 77.51 2.77 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.974 -174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -141.73 122.09 8.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 166.82 27.53 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.613 2.875 . . . . 0.0 111.632 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.38 35.12 2.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 110.306 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 158' ' ' VAL . 10.4 tp -78.17 145.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.493 0.317 . . . . 0.0 110.162 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.0 pt -123.45 20.5 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.744 0.417 . . . . 0.0 111.616 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.448 ' H ' HG13 ' A' ' 156' ' ' ILE . 35.9 m -138.62 151.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.915 0.886 . . . . 0.0 109.564 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -73.66 158.84 52.69 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -135.09 104.89 6.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.7 39.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.76 147.18 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.116 0.567 . . . . 0.0 110.493 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 79.1 p -80.74 159.4 25.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.024 0.53 . . . . 0.0 111.018 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.7 p -129.08 150.38 50.5 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.27 0.628 . . . . 0.0 110.333 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -135.29 117.93 15.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.122 0.569 . . . . 0.0 110.076 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.89 149.86 26.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.873 0.469 . . . . 0.0 110.292 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 34.7 pt -131.63 146.65 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.177 0.591 . . . . 0.0 110.304 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -135.54 151.95 50.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.286 0.634 . . . . 0.0 110.531 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -133.28 140.47 47.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 109.574 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.38 147.21 38.19 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.558 0.343 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 47.8 tpp -146.57 64.12 9.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.197 0.599 . . . . 0.0 109.567 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.65 165.02 33.82 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.783 2.989 . . . . 0.0 111.187 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.6 t -135.59 149.42 49.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.271 0.628 . . . . 0.0 110.342 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -135.29 26.47 3.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.195 0.598 . . . . 0.0 110.293 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.4 t -77.52 104.53 8.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.51 0.324 . . . . 0.0 110.146 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.87 -175.43 50.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -135.48 141.65 45.38 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 123.315 0.646 . . . . 0.0 110.296 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -137.72 147.2 44.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.137 0.575 . . . . 0.0 110.093 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.79 167.24 39.73 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.92 163.22 38.98 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.087 3.191 . . . . 0.0 111.197 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -81.54 125.99 31.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.2 p -59.2 147.14 36.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.037 0.535 . . . . 0.0 111.463 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.11 174.66 43.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.74 159.03 84.1 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.904 0.482 . . . . 0.0 110.782 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.006 3.138 . . . . 0.0 112.413 178.595 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.471 0.187 0 N-CA-C 112.772 0.258 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.67 136.98 41.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.916 0.486 . . . . 0.0 110.416 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -135.95 142.42 44.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 110.294 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.74 143.24 50.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 109.945 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.08 66.25 8.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.29 148.47 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.587 0.755 . . . . 0.0 110.022 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -109.67 139.47 44.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.841 0.456 . . . . 0.0 110.756 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -135.3 145.23 47.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.699 0.799 . . . . 0.0 109.224 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -70.98 146.58 93.1 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.146 0.179 . . . . 0.0 111.42 -175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.58 176.23 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 124.43 3.42 . . . . 0.0 110.634 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -131.62 24.36 4.73 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.927 0.491 . . . . 0.0 110.797 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -139.01 68.09 1.38 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.929 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -134.28 155.81 79.55 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.821 0.848 . . . . 0.0 110.291 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.77 171.38 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.901 3.067 . . . . 0.0 110.647 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.91 152.49 44.92 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 122.948 0.499 . . . . 0.0 110.957 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.28 -175.66 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.255 3.303 . . . . 0.0 110.104 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.76 93.79 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -142.57 141.9 32.09 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.865 0.866 . . . . 0.0 109.297 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.45 101.32 0.96 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.176 0.512 . . . . 0.0 110.636 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -135.59 156.59 48.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.849 0.859 . . . . 0.0 109.834 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -77.0 108.19 9.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.635 0.374 . . . . 0.0 111.271 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.1 m 63.3 99.79 0.03 OUTLIER 'General case' 0 C--N 1.339 0.118 0 C-N-CA 125.081 1.352 . . . . 0.0 112.055 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' HB2' ' HD3' ' A' ' 24' ' ' PRO . 4.0 mm? -85.93 -72.59 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 23' ' ' LEU . 25.2 Cg_endo -86.42 165.67 9.37 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.136 2.557 . . . . 0.0 111.047 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.96 -46.08 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.004 2.47 . . . . 0.0 111.796 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -155.42 24.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -103.85 47.81 0.87 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.143 0.497 . . . . 0.0 110.513 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.551 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.2 tp -140.32 151.48 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.03 0.532 . . . . 0.0 110.227 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' H ' HD12 ' A' ' 28' ' ' ILE . 35.7 mmtp -118.54 27.39 8.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.305 0.642 . . . . 0.0 111.526 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 28' ' ' ILE . 31.7 t -126.78 -24.25 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.62 25.12 0.59 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.525 0.602 . . . . 0.0 112.482 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.5 t -66.99 129.62 40.47 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 121.871 -0.518 . . . . 0.0 111.169 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -135.58 104.41 5.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.618 0.767 . . . . 0.0 109.103 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 p -135.56 166.0 24.23 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.63 129.0 49.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -97.33 139.75 32.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.687 0.28 . . . . 0.0 111.666 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.2 mm -125.87 139.3 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.422 1.089 . . . . 0.0 108.544 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.7 163.58 29.35 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.98 79.36 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.53 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.78 124.59 51.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.091 0.945 . . . . 0.0 111.294 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -82.57 -3.61 11.37 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.434 2.756 . . . . 0.0 110.867 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.78 153.68 43.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 110.453 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.13 46.08 0.99 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.499 0.72 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.2 mmt 54.3 54.92 8.79 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.114 0.966 . . . . 0.0 111.982 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.2 118.07 25.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -70.49 -16.98 62.96 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -84.88 -6.46 59.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.017 -0.427 . . . . 0.0 111.468 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.6 -23.11 19.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.527 0.603 . . . . 0.0 110.141 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.58 -28.21 56.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.15 -21.27 46.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.292 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -79.46 -12.4 59.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.924 0.329 . . . . 0.0 111.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.85 -2.84 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.114 -0.367 . . . . 0.0 111.596 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.87 13.39 24.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.794 0.838 . . . . 0.0 109.857 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.5 tttt -78.17 -38.82 1.67 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.11 170.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.87 118.76 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.678 2.252 . . . . 0.0 112.332 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 50.29 22.99 1.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.075 1.35 . . . . 0.0 113.661 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.49 162.27 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.0 110.453 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -135.07 59.41 1.73 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.789 0.436 . . . . 0.0 110.515 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.92 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 O-C-N 121.904 -0.497 . . . . 0.0 109.691 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -134.78 11.13 3.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 m -135.35 122.0 20.83 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.8 t -135.2 128.1 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.396 0.678 . . . . 0.0 109.229 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.91 104.37 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.14 112.72 25.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.637 0.375 . . . . 0.0 110.187 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -85.94 105.37 16.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.145 0.498 . . . . 0.0 109.777 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -71.59 162.86 28.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.986 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m 61.51 11.09 3.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -148.76 22.24 1.0 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.103 0.41 . . . . 0.0 111.666 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 35.08 45.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.103 1.761 . . . . 0.0 114.744 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -128.97 143.66 50.94 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.91 152.88 39.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.063 0.459 . . . . 0.0 111.437 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -122.56 131.86 54.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.2 151.47 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.37 139.53 44.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.347 0.594 . . . . 0.0 111.733 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.72 153.38 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 125.597 1.559 . . . . 0.0 109.496 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -89.96 9.53 27.48 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -152.57 137.09 16.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.312 0.645 . . . . 0.0 109.792 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -78.74 -4.01 47.11 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -88.04 -23.4 23.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.959 0.345 . . . . 0.0 110.334 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.68 -18.28 33.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.26 72.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.62 -22.45 61.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.393 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -80.06 -17.42 52.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.393 0.542 . . . . 0.0 111.501 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.46 -38.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.456 0.571 . . . . 0.0 110.002 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.55 -17.71 61.16 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.194 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -83.46 -15.3 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.892 -0.505 . . . . 0.0 110.072 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.05 -28.01 39.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.61 -7.0 59.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.124 0.57 . . . . 0.0 110.591 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.37 10.45 9.23 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -135.28 6.55 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.28 0.491 . . . . 0.0 112.119 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.48 -24.32 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.828 -0.545 . . . . 0.0 110.784 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.48 4.93 3.16 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 118.938 -0.923 . . . . 0.0 114.967 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.64 24.85 3.41 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.956 1.378 . . . . 0.0 112.976 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.56 135.21 43.75 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -6.36 12.19 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 124.094 3.196 . . . . 0.0 112.173 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.96 140.67 30.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -92.19 89.97 7.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.0 p -95.25 129.8 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.964 0.505 . . . . 0.0 111.099 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -146.38 148.43 32.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.901 0.48 . . . . 0.0 110.678 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.47 146.34 48.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.178 0.591 . . . . 0.0 111.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.36 16.83 5.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.994 0.807 . . . . 0.0 111.293 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.85 137.57 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 117.364 0.582 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.9 134.6 12.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -135.16 107.15 7.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.299 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.5 -177.33 51.09 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.82 161.88 44.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.92 3.08 . . . . 0.0 110.677 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -78.64 141.11 38.26 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.627 0.371 . . . . 0.0 110.65 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -135.42 134.79 40.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.395 0.678 . . . . 0.0 109.801 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.6 m -129.3 24.48 5.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.8 m 53.23 50.53 17.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.709 0.803 . . . . 0.0 112.033 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.32 145.33 47.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.041 0.537 . . . . 0.0 109.936 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -80.3 -3.15 48.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -70.51 -7.67 45.38 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.91 -0.494 . . . . 0.0 110.32 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -135.33 12.43 3.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 109.782 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.75 -21.37 50.91 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -94.76 24.94 4.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.726 172.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 t -135.61 -179.14 5.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.73 1.212 . . . . 0.0 109.577 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.0 mt -50.85 127.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.324 0.65 . . . . 0.0 110.148 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt -89.63 165.2 26.29 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.584 0.754 . . . . 0.0 111.619 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.11 -169.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 124.849 3.7 . . . . 0.0 112.815 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -73.63 43.31 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.836 0.854 . . . . 0.0 112.43 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -85.19 -7.91 58.83 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.807 -0.558 . . . . 0.0 110.042 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -77.01 -4.11 42.48 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.0 tp -71.21 -45.71 62.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.663 0.785 . . . . 0.0 109.733 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.6 p -84.99 -22.28 29.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.613 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -81.4 -48.58 11.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.234 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.97 -4.61 54.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.68 -29.25 8.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.135 0.88 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -76.64 -21.28 55.7 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.143 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 130' ' ' LYS . 3.8 ttmp? -85.31 -50.61 7.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -91.26 14.93 13.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -135.91 -21.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.32 30.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.196 0.907 . . . . 0.0 113.372 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.7 t -77.21 50.12 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.784 0.72 . . . . 0.0 110.671 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.47 126.08 16.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.872 0.869 . . . . 0.0 108.941 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.96 -174.52 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.872 0.469 . . . . 0.0 111.703 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -73.85 43.0 0.15 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.27 1.028 . . . . 0.0 112.227 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.08 -154.5 7.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.816 0.722 . . . . 0.0 111.834 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.08 -8.42 75.91 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.771 -0.461 . . . . 0.0 112.486 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.1 m -135.57 -17.28 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.426 0.613 . . . . 0.0 111.798 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -148.43 24.17 1.01 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.8 0.44 . . . . 0.0 111.107 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.41 -34.49 7.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.469 -0.629 . . . . 0.0 113.538 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -149.93 164.35 21.1 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.924 . . . . 0.0 110.124 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.81 6.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 124.916 3.744 . . . . 0.0 115.162 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.18 -12.4 58.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.684 0.674 . . . . 0.0 110.595 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.54 19.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.499 0.72 . . . . 0.0 111.846 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.8 p -119.06 20.56 12.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.276 0.23 . . . . 0.0 111.328 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.46 -25.33 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.812 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.06 81.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 117.962 0.881 . . . . 0.0 109.696 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.7 m -112.8 22.46 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 123.668 0.787 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -87.35 -43.79 11.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -143.51 156.81 44.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.121 0.568 . . . . 0.0 110.575 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -143.01 58.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.95 161.02 47.51 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.691 2.928 . . . . 0.0 111.318 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.87 104.47 16.63 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 153.32 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 110.157 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.52 145.42 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-O 120.702 0.287 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.6 m -135.17 24.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.338 0.655 . . . . 0.0 110.764 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -71.37 -11.58 71.81 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -131.08 29.62 4.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.109 0.964 . . . . 0.0 109.351 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -70.13 174.21 37.76 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.74 139.04 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 123.138 0.575 . . . . 0.0 110.23 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.3 m -104.72 144.48 31.67 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.159 0.583 . . . . 0.0 110.433 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.0 t -135.62 144.07 45.91 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.108 0.563 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.98 46.16 1.35 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.342 0.657 . . . . 0.0 110.356 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.81 143.48 45.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.5 0.72 . . . . 0.0 110.03 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.22 138.71 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 123.509 0.724 . . . . 0.0 109.365 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -70.29 137.96 51.16 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.801 0.44 . . . . 0.0 110.944 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.3 149.02 49.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.329 0.652 . . . . 0.0 110.218 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -135.15 151.11 50.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.508 0.723 . . . . 0.0 110.135 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.3 ttm -144.39 137.23 13.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.96 169.9 21.07 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 111.343 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.8 p -133.39 152.01 51.88 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.371 0.669 . . . . 0.0 110.303 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -122.53 24.67 9.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.308 0.643 . . . . 0.0 111.267 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.3 t -135.48 134.03 39.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.234 0.614 . . . . 0.0 110.116 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 177.56 -163.97 32.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.36 141.42 58.57 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.1 0.45 . . . . 0.0 110.267 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -85.82 155.39 21.01 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.942 0.497 . . . . 0.0 111.769 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.58 26.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.44 151.89 65.32 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.756 2.971 . . . . 0.0 112.486 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -140.3 146.82 39.02 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.386 0.675 . . . . 0.0 110.23 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t -135.94 141.62 44.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.927 0.491 . . . . 0.0 110.613 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 173.45 173.6 39.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.97 140.37 35.04 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 122.841 0.456 . . . . 0.0 109.787 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.719 2.946 . . . . 0.0 112.568 177.693 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 CA--C 1.528 0.206 0 N-CA-C 113.125 0.394 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -135.48 24.61 3.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.002 0.521 . . . . 0.0 111.012 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -88.12 146.14 25.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.229 0.612 . . . . 0.0 110.287 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 4' ' ' LEU . 1.7 pt? -135.18 24.28 3.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.939 0.495 . . . . 0.0 111.905 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -91.63 106.05 18.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.84 25.0 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.203 0.601 . . . . 0.0 110.93 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 t -76.44 109.12 9.9 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.528 0.331 . . . . 0.0 110.267 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -136.66 129.8 31.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.322 0.649 . . . . 0.0 109.677 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -140.84 147.34 47.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 122.953 0.501 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.12 161.91 37.66 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.812 3.008 . . . . 0.0 111.18 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -135.68 24.92 3.4 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.403 0.681 . . . . 0.0 110.204 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -136.06 161.13 36.56 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.943 0.897 . . . . 0.0 110.534 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.06 148.09 67.58 Favored Pre-proline 0 CA--C 1.529 0.159 0 C-N-CA 123.026 0.53 . . . . 0.0 110.088 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.01 6.42 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.403 3.402 . . . . 0.0 113.228 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.0 149.25 70.38 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 118.588 0.631 . . . . 0.0 111.707 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.28 -167.17 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.809 3.672 . . . . 0.0 110.423 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG21 ' HB ' ' A' ' 146' ' ' VAL . 46.9 t -50.68 -53.09 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.129 0.572 . . . . 0.0 110.855 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.8 m -146.27 157.59 43.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.854 0.862 . . . . 0.0 109.479 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -86.82 53.45 2.83 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.81 0.444 . . . . 0.0 110.505 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 p30 46.81 31.58 1.5 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.912 1.285 . . . . 0.0 113.002 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 t -135.59 151.08 49.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.246 0.619 . . . . 0.0 110.883 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 m 60.36 55.04 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.115 0.966 . . . . 0.0 111.19 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.32 155.47 63.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.37 164.36 34.44 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.825 3.016 . . . . 0.0 110.905 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.96 -8.14 22.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.756 2.97 . . . . 0.0 111.517 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.78 134.1 33.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.054 0.542 . . . . 0.0 109.702 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -74.14 155.02 38.85 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.852 0.461 . . . . 0.0 111.513 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.62 HD13 ' H ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.52 159.91 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.62 ' H ' HD13 ' A' ' 28' ' ' ILE . 55.9 mtpt -86.68 16.13 5.02 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.491 ' H ' HG23 ' A' ' 28' ' ' ILE . 22.1 m -135.8 29.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 122.835 0.454 . . . . 0.0 110.734 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -135.66 133.36 38.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.027 0.531 . . . . 0.0 110.515 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.7 t -137.62 125.75 22.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.322 0.649 . . . . 0.0 109.329 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.97 139.43 39.17 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.8 p -135.75 152.57 51.26 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.26 1.024 . . . . 0.0 109.644 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.6 tp -135.47 112.19 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.43 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -86.56 135.91 33.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.854 0.862 . . . . 0.0 110.302 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.42 143.05 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.23 166.59 36.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.86 66.76 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.176 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.3 m -52.93 134.83 47.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.789 0.794 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -83.93 -12.25 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.198 3.265 . . . . 0.0 111.362 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.87 166.23 20.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.031 0.932 . . . . 0.0 111.105 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.9 44.56 0.66 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.258 0.623 . . . . 0.0 111.511 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.6 mtt 49.34 55.27 9.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.232 1.013 . . . . 0.0 112.194 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.59 132.98 54.54 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.218 0.607 . . . . 0.0 109.443 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -70.74 -10.1 58.72 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -99.64 -11.88 20.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.983 0.356 . . . . 0.0 111.952 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -96.19 -22.93 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.81 -39.67 63.93 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.81 -17.41 61.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.932 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -81.99 -14.38 56.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.616 0.644 . . . . 0.0 111.842 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.4 m -110.26 -4.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 118.227 0.467 . . . . 0.0 111.78 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -126.14 6.17 7.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -171.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 1.1 tmmt? -101.32 -38.61 0.22 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.929 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 61.9 Cg_exo -55.16 131.78 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.261 1.974 . . . . 0.0 111.182 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 p90 46.83 27.48 0.7 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 113.047 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.65 170.46 15.97 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.909 0.883 . . . . 0.0 110.274 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -135.07 55.13 1.9 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 110.957 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.08 130.14 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -123.35 4.16 9.11 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -140.84 121.34 14.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -135.75 120.22 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 136.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.31 110.77 9.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -83.55 104.38 13.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -84.21 25.81 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.0 p -131.86 3.85 4.13 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.3 0.56 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.998 0.363 . . . . 0.0 111.928 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.3 pttt 45.93 47.12 12.48 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.692 1.197 . . . . 0.0 112.37 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -124.94 129.94 51.36 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.275 0.63 . . . . 0.0 110.277 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.21 147.53 49.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.317 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.3 136.6 35.04 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.666 0.386 . . . . 0.0 110.082 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.57 159.7 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 122.323 0.249 . . . . 0.0 110.739 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.55 132.0 34.6 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.945 0.402 . . . . 0.0 111.513 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -101.1 154.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 124.383 1.073 . . . . 0.0 109.23 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -81.1 -4.62 55.9 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.1 t -147.01 139.08 24.51 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.726 0.41 . . . . 0.0 110.712 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -78.69 -5.84 54.17 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -90.0 -22.05 22.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.64 -15.36 45.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.28 -42.11 60.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.3 -22.49 66.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -81.25 -22.49 38.69 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.103 -0.373 . . . . 0.0 111.093 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.53 -38.65 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.88 -18.39 63.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.912 173.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -77.73 -23.12 49.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.302 0.501 . . . . 0.0 109.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -72.78 -49.64 29.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.877 -0.514 . . . . 0.0 109.614 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -89.47 10.16 23.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -135.65 6.57 3.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.356 0.526 . . . . 0.0 112.284 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -136.96 7.16 2.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.539 0.608 . . . . 0.0 112.396 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.12 -18.95 15.33 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.6 0.636 . . . . 0.0 110.909 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.58 4.55 4.1 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.337 0.97 . . . . 0.0 115.172 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.8 35.14 2.88 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.009 1.405 . . . . 0.0 112.745 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.83 127.94 23.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -84.85 -10.44 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.087 3.191 . . . . 0.0 112.61 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.6 tt -73.37 134.97 44.22 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 96' ' ' LEU . 82.2 mmt-85 -111.64 136.88 50.24 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -141.65 145.2 34.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.042 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -143.34 126.78 16.79 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.29 0.636 . . . . 0.0 110.257 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -85.84 156.74 20.43 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.14 -164.97 14.72 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.13 136.76 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.988 0.515 . . . . 0.0 110.452 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.92 130.43 10.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -135.77 151.89 50.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.473 0.709 . . . . 0.0 110.381 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.76 174.76 35.48 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.33 161.06 46.33 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.777 2.985 . . . . 0.0 110.994 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -69.69 133.27 47.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.783 0.433 . . . . 0.0 110.127 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -86.12 104.52 15.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 110.695 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.8 m -135.07 28.53 3.46 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.692 0.797 . . . . 0.0 110.321 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 74.8 m -74.23 148.21 41.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.056 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.91 154.06 42.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -68.42 -9.66 49.98 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.214 -0.304 . . . . 0.0 111.777 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.68 -2.26 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.036 0.38 . . . . 0.0 110.314 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -142.55 24.25 1.91 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -154.46 -0.6 0.16 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.971 -0.905 . . . . 0.0 113.964 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -80.02 55.15 2.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.105 1.453 . . . . 0.0 110.055 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.8 t -138.74 151.08 46.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.083 0.953 . . . . 0.0 109.847 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.9 pt -93.9 28.21 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 122.952 0.501 . . . . 0.0 111.646 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 9.5 tp -84.52 -25.15 0.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.09 -0.957 . . . . 0.0 113.551 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 31.8 Cg_exo -63.96 176.26 2.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.46 2.107 . . . . 0.0 111.828 174.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -74.15 24.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.833 0.453 . . . . 0.0 111.507 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -91.29 -7.6 50.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.17 -9.21 59.71 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.82 -46.88 11.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.992 0.917 . . . . 0.0 109.503 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -77.68 -16.07 58.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.968 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.96 -43.94 12.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.103 -0.373 . . . . 0.0 111.401 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.21 -12.09 53.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.59 -24.32 11.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.679 0.672 . . . . 0.0 111.189 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -74.81 -22.68 58.6 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.544 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -90.35 -52.73 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.952 -0.467 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -83.16 7.23 16.68 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -143.94 -4.32 0.84 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.78 23.18 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.16 0.891 . . . . 0.0 111.851 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.7 t -84.9 32.86 0.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.624 -0.672 . . . . 0.0 111.374 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.07 20.6 3.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.023 0.529 . . . . 0.0 110.241 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -135.92 147.25 48.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.756 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -65.91 104.8 1.17 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.51 65.42 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.947 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 61.71 -148.26 47.6 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 118.18 0.99 . . . . 0.0 110.787 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.4 m 70.77 114.93 0.05 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.021 0.928 . . . . 0.0 111.507 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.6 t 59.22 31.01 20.87 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.62 -18.59 44.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -149.68 160.02 34.94 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 108.959 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.66 -10.83 10.07 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.661 2.908 . . . . 0.0 113.682 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.13 -36.63 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.786 0.434 . . . . 0.0 111.24 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' HB ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -84.98 -8.32 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 O-C-N 122.045 -0.409 . . . . 0.0 110.682 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -83.09 24.02 0.81 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.093 0.473 . . . . 0.0 109.86 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.99 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.57 -44.51 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 117.559 0.679 . . . . 0.0 109.896 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.4 m 43.63 24.5 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.204 1.802 . . . . 0.0 114.221 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -72.55 159.26 34.19 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.119 -0.363 . . . . 0.0 110.133 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -73.24 -75.09 0.15 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.272 0.229 . . . . 0.0 111.586 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -159.52 123.96 2.14 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.92 -176.61 3.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.064 3.176 . . . . 0.0 110.865 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.31 148.18 42.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 tt -64.81 134.85 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -175.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.8 tp -135.8 104.87 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.675 0.79 . . . . 0.0 109.328 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.44 24.34 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.828 0.451 . . . . 0.0 111.322 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 67.61 -166.5 42.62 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 145.9 47.84 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.389 0.676 . . . . 0.0 110.264 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -179.31 172.14 44.1 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.92 144.74 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.289 0.636 . . . . 0.0 110.222 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.7 t -92.94 133.0 36.55 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.724 0.409 . . . . 0.0 110.412 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.6 m -135.84 146.45 47.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.267 0.627 . . . . 0.0 110.502 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -135.16 142.01 46.04 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.351 0.661 . . . . 0.0 110.164 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.95 143.26 32.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.734 0.414 . . . . 0.0 110.751 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.2 161.84 39.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.438 0.695 . . . . 0.0 111.016 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.0 m -75.82 147.84 38.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.951 0.5 . . . . 0.0 110.745 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -135.01 142.07 46.34 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.104 0.561 . . . . 0.0 110.334 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -86.74 55.13 3.42 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.333 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 172' ' ' PRO . 16.0 tpt -70.53 -42.73 15.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.453 -0.784 . . . . 0.0 112.891 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 171' ' ' MET . 93.7 Cg_endo -76.25 158.87 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.958 1.772 . . . . 0.0 110.948 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 67.0 p -135.68 151.74 50.5 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 123.375 0.67 . . . . 0.0 110.367 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.57 104.98 6.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.868 0.467 . . . . 0.0 110.129 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.8 p -135.96 151.58 50.09 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.458 0.703 . . . . 0.0 110.591 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 176.18 -1.82 0.03 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.106 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 23.2 tpp85 -76.56 113.95 14.75 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.189 0.995 . . . . 0.0 110.024 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -135.94 148.44 48.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.417 0.687 . . . . 0.0 109.786 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.42 166.75 50.64 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.07 161.34 45.0 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.003 3.136 . . . . 0.0 111.219 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -135.88 55.21 1.87 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.293 0.637 . . . . 0.0 109.64 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.8 m -73.68 104.85 4.75 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.9 0.48 . . . . 0.0 110.322 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.24 175.48 36.7 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.3 mptm? -89.99 -35.65 0.4 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.184 -0.912 . . . . 0.0 112.601 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 65.2 Cg_exo . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.093 2.529 . . . . 0.0 112.545 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.471 0.204 0 CA-C-O 120.6 0.167 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.44 39.99 1.02 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.209 0.604 . . . . 0.0 110.849 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -135.37 132.43 37.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.225 0.61 . . . . 0.0 110.148 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.69 148.6 30.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.843 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -135.27 125.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.967 0.507 . . . . 0.0 109.862 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.71 32.83 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.888 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 m -78.2 55.14 1.47 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.313 0.645 . . . . 0.0 111.032 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -67.49 140.79 57.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.023 0.529 . . . . 0.0 110.293 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.35 152.18 45.63 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.196 0.598 . . . . 0.0 109.927 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.76 158.53 52.99 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.615 2.877 . . . . 0.0 111.547 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -135.96 145.98 46.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.539 0.736 . . . . 0.0 110.099 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -72.56 141.69 48.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 6.6 ppt_? -147.59 157.89 43.98 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 122.986 0.514 . . . . 0.0 110.243 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 72.0 Cg_endo -70.01 172.04 13.63 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.681 2.921 . . . . 0.0 112.358 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -62.94 149.46 90.17 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -84.88 174.37 7.5 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.056 3.171 . . . . 0.0 113.612 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.3 -17.39 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 109.652 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 m -148.92 -174.81 4.73 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.065 1.346 . . . . 0.0 109.186 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -82.52 48.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.114 0.565 . . . . 0.0 111.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -119.78 152.1 37.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.412 0.685 . . . . 0.0 109.842 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -127.96 24.67 6.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.3 m -102.47 44.96 0.98 Allowed 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 9.3 mp -103.07 16.24 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 23' ' ' LEU . 84.7 Cg_exo -49.49 147.49 12.64 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 122.368 1.882 . . . . 0.0 111.532 172.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 77.9 Cg_exo -51.83 113.19 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.861 3.041 . . . . 0.0 113.582 -173.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 14.1 t70 -152.0 154.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.161 0.984 . . . . 0.0 108.594 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -82.26 0.74 40.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.6 tp -154.62 139.03 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.118 0.872 . . . . 0.0 111.815 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 26' ' ' ASP . 32.1 mmtp -138.57 43.48 2.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.552 0.741 . . . . 0.0 110.769 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.66 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.085 0.554 . . . . 0.0 109.733 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.95 140.21 29.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.819 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.6 m -131.32 24.99 4.85 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.464 0.706 . . . . 0.0 110.774 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -99.56 133.71 43.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 m -135.23 142.54 46.01 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.022 0.529 . . . . 0.0 109.646 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.32 127.91 41.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.55 141.21 38.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.056 0.542 . . . . 0.0 110.475 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.9 mm -123.04 147.68 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.337 1.055 . . . . 0.0 108.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.03 164.21 36.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.534 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.55 27.04 70.3 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.96 128.87 85.38 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.338 0.569 . . . . 0.0 112.146 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.9 -1.81 11.44 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.934 3.089 . . . . 0.0 111.166 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.88 162.4 29.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.067 0.547 . . . . 0.0 110.97 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -80.1 38.14 0.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.03 0.932 . . . . 0.0 112.169 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.1 mtt 56.92 44.67 22.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.0 113.125 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.14 137.88 46.43 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.186 0.594 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -72.93 -12.07 60.82 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -84.12 -7.37 59.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.149 -0.344 . . . . 0.0 110.943 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -93.56 -24.29 18.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.881 0.309 . . . . 0.0 110.312 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.87 -28.72 55.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.99 -21.37 47.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -81.34 -14.55 57.16 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.245 0.475 . . . . 0.0 111.701 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.1 -4.47 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.252 0.478 . . . . 0.0 111.459 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.2 8.29 23.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.672 0.789 . . . . 0.0 110.371 170.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 59.3 tptt -72.59 -44.8 9.6 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.8 Cg_endo -84.12 -20.65 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.266 1.978 . . . . 0.0 114.546 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -142.98 24.51 1.83 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.46 165.69 27.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.905 -0.497 . . . . 0.0 111.105 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.32 55.36 1.22 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.358 0.663 . . . . 0.0 109.548 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.9 140.58 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.075 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -131.44 -0.12 4.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -143.55 134.41 25.33 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.751 -0.593 . . . . 0.0 110.734 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.0 t -137.96 130.05 39.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.421 0.688 . . . . 0.0 109.829 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 111.11 14.08 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.3 0.24 . . . . 0.0 110.37 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -88.99 88.7 7.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -76.87 24.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.559 0.744 . . . . 0.0 112.474 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.7 p -128.24 5.96 5.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -144.16 14.99 1.68 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.972 0.509 . . . . 0.0 110.606 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 52.88 31.44 10.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.325 1.05 . . . . 0.0 112.185 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -133.69 149.82 51.53 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 122.965 0.506 . . . . 0.0 110.817 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.73 158.2 43.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.12 0.568 . . . . 0.0 110.114 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -130.15 138.72 50.78 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.82 153.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.313 0.101 . . . . 0.0 110.736 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -125.23 130.39 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.081 0.467 . . . . 0.0 111.727 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.11 150.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.705 1.602 . . . . 0.0 108.565 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -109.03 24.15 13.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -145.43 121.84 10.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.14 0.976 . . . . 0.0 108.73 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -78.85 -9.14 59.38 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.478 -0.139 . . . . 0.0 111.094 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -84.89 -24.42 28.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -88.68 -14.43 37.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.59 -42.78 64.19 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -74.08 -16.2 61.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.185 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -83.31 -17.89 40.9 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.069 -0.394 . . . . 0.0 110.78 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.3 t -73.69 -47.43 44.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.05 -16.88 63.8 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.757 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.48 -44.86 66.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.72 -26.14 30.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.789 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -81.78 0.11 40.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.114 0.415 . . . . 0.0 111.025 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.17 5.37 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.094 0.406 . . . . 0.0 111.968 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -143.27 24.1 1.8 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.91 -8.74 14.48 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.62 -0.675 . . . . 0.0 111.182 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.51 2.55 4.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.082 -0.843 . . . . 0.0 114.708 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.75 26.14 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.735 1.268 . . . . 0.0 112.482 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt -131.22 96.51 21.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.86 -0.78 11.04 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.998 3.132 . . . . 0.0 111.346 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.41 125.06 23.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.52 0.728 . . . . 0.0 109.268 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -89.75 126.68 35.76 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.469 0.308 . . . . 0.0 110.797 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 m -136.4 137.9 40.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.402 0.681 . . . . 0.0 110.247 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -141.37 144.64 34.63 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.113 0.965 . . . . 0.0 109.087 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -102.65 130.48 49.57 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.545 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.5 156.7 21.19 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.2 138.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.459 0.704 . . . . 0.0 110.205 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 127.36 7.9 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -89.36 136.15 33.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.751 0.421 . . . . 0.0 110.851 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.29 179.01 53.62 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.95 170.98 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.671 3.581 . . . . 0.0 112.385 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.25 24.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.011 0.525 . . . . 0.0 111.402 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -135.41 26.18 3.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.314 1.046 . . . . 0.0 109.751 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.3 t -85.75 45.16 1.17 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.657 0.783 . . . . 0.0 110.651 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.66 109.38 10.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.368 0.667 . . . . 0.0 109.482 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.75 133.4 32.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.606 0.762 . . . . 0.0 109.591 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.04 -10.22 59.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.38 -0.2 . . . . 0.0 111.191 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -100.96 17.41 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -136.52 24.24 3.17 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.02 0.928 . . . . 0.0 109.806 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.89 -12.72 0.03 OUTLIER Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.097 -0.835 . . . . 0.0 113.9 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -128.94 24.69 5.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.895 1.347 . . . . 0.0 110.059 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 81.2 p -142.7 161.72 37.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.211 1.004 . . . . 0.0 110.141 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -120.84 90.59 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.4 pt -140.44 42.78 0.52 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.695 0.798 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 71.9 Cg_endo -67.98 -8.08 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.397 2.731 . . . . 0.0 112.51 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 12.1 tpt -134.89 25.18 3.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.1 0.56 . . . . 0.0 110.221 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -135.15 -16.29 1.91 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.078 -0.388 . . . . 0.0 111.337 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -82.15 -19.66 39.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 173.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 32.0 tp -92.28 -25.62 18.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.414 0.686 . . . . 0.0 110.027 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.0 m -84.51 -21.47 30.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.2 -40.84 11.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.167 -0.333 . . . . 0.0 110.783 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.47 45.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -106.43 -25.2 11.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.682 0.674 . . . . 0.0 111.437 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -76.78 -24.84 52.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.773 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.06 -49.09 9.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.863 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -95.96 11.3 34.45 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -135.13 -16.85 1.88 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.824 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.69 21.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.408 1.003 . . . . 0.0 113.307 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 m -132.55 2.74 3.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 111.187 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.74 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.809 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -148.54 168.9 21.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.46 1.504 . . . . 0.0 108.373 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -129.61 27.81 5.21 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.501 0.321 . . . . 0.0 111.012 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.48 -12.65 77.86 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.666 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.95 -177.48 25.05 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 117.803 0.801 . . . . 0.0 111.802 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 p -77.81 -69.58 0.53 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 122.288 -0.537 . . . . 0.0 110.957 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 28.81 1.77 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.0 110.228 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.87 85.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.385 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.516 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 37.3 tp60 -162.3 -42.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.687 1.244 . . . . 0.0 113.258 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.516 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 39.5 Cg_exo -63.07 2.05 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.902 2.401 . . . . 0.0 114.741 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 3.41 7.0 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.872 0.76 . . . . 0.0 111.891 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.61 9.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.412 0.685 . . . . 0.0 111.789 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -135.64 24.13 3.4 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.97 0.908 . . . . 0.0 108.8 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.03 29.93 0.12 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.781 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mm -44.28 -38.73 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.665 1.186 . . . . 0.0 112.635 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.7 m 45.74 22.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.941 1.697 . . . . 0.0 114.448 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -145.62 139.85 26.94 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.932 0.787 . . . . 0.0 111.736 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -138.45 37.83 2.26 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.588 0.755 . . . . 0.0 109.213 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 40.5 tt0 -74.53 140.85 75.73 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 50.8 Cg_exo -57.63 161.85 11.54 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.715 2.943 . . . . 0.0 112.998 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -133.83 147.62 51.23 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.949 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.72 51.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.5 mm -82.86 126.15 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.73 55.59 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.377 0.671 . . . . 0.0 110.282 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.13 176.65 17.03 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.69 140.64 48.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.79 0.436 . . . . 0.0 110.559 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.02 -174.71 43.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 p -135.72 138.11 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.142 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.5 t -84.47 140.85 31.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.505 0.322 . . . . 0.0 110.402 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.0 t -135.48 137.51 42.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.884 0.474 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -88.44 53.51 2.75 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.197 0.599 . . . . 0.0 110.286 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.64 50.12 1.28 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.428 0.691 . . . . 0.0 110.863 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 66.8 mt -74.66 135.35 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.152 0.581 . . . . 0.0 109.566 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 34.5 t -135.53 148.07 49.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.153 0.581 . . . . 0.0 110.482 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -135.23 125.77 26.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.428 0.691 . . . . 0.0 109.14 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.7 24.44 6.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 45.9 ttp 44.93 56.63 14.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.845 0.858 . . . . 0.0 111.786 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.69 158.67 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.356 2.704 . . . . 0.0 110.871 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.1 t -136.78 150.24 48.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.277 0.631 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -135.53 125.75 26.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 0.0 110.037 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 78.5 p -137.03 147.64 46.32 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.2 0.6 . . . . 0.0 110.734 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.9 171.13 54.57 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -135.51 119.88 17.94 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.15 0.58 . . . . 0.0 109.806 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -135.84 106.56 6.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.076 0.551 . . . . 0.0 109.779 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.74 165.54 54.31 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.69 162.44 42.11 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.917 3.078 . . . . 0.0 110.922 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -135.37 144.82 46.82 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.39 0.676 . . . . 0.0 110.027 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.8 m -72.67 135.93 45.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.591 0.356 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.63 174.44 54.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.31 159.79 38.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.225 0.61 . . . . 0.0 110.242 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo . . . . . 0 C--O 1.252 1.191 0 C-N-CA 123.978 3.119 . . . . 0.0 112.354 178.299 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.472 0.245 0 N-CA-C 112.549 0.173 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.19 30.58 0.76 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.592 0.757 . . . . 0.0 111.716 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.28 24.67 1.1 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.285 0.634 . . . . 0.0 111.733 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.48 147.3 44.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.982 0.513 . . . . 0.0 110.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -105.34 154.83 19.75 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.138 0.575 . . . . 0.0 111.464 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.51 142.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.958 0.503 . . . . 0.0 110.066 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -135.22 138.09 43.24 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.121 0.568 . . . . 0.0 109.866 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 63.87 146.45 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.164 1.386 . . . . 0.0 112.57 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.08 155.18 34.83 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.922 0.489 . . . . 0.0 110.4 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.44 169.87 21.28 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.713 2.942 . . . . 0.0 110.536 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -97.93 25.95 5.58 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.417 0.687 . . . . 0.0 111.693 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -69.23 152.82 44.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.595 0.358 . . . . 0.0 111.049 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -140.47 162.39 49.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.435 0.694 . . . . 0.0 110.372 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.98 158.2 14.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.932 3.088 . . . . 0.0 112.987 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -134.29 156.48 78.95 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.284 1.033 . . . . 0.0 109.291 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.57 177.67 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.892 3.062 . . . . 0.0 110.83 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -46.18 127.23 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.085 0.554 . . . . 0.0 109.965 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.5 t -86.86 174.14 8.95 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.888 0.875 . . . . 0.0 112.327 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.57 44.17 1.05 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 0.0 111.255 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 57.79 32.0 21.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.902 0.881 . . . . 0.0 113.068 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 t -135.74 18.19 3.3 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -139.61 21.98 2.52 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.945 -0.472 . . . . 0.0 112.025 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.31 149.83 27.71 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 117.898 0.317 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.41 163.74 24.4 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.331 3.354 . . . . 0.0 112.097 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.6 9.54 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.734 3.623 . . . . 0.0 111.843 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.92 167.36 6.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.967 0.907 . . . . 0.0 110.92 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -51.95 146.89 7.8 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 120.865 0.364 . . . . 0.0 110.751 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 pt -68.54 144.29 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 120.795 0.331 . . . . 0.0 111.563 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' H ' ' HA3' ' A' ' 148' ' ' GLY . 96.4 mttt -106.61 26.5 9.88 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.406 0.683 . . . . 0.0 111.357 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 145' ' ' LEU . 25.5 t -80.61 117.18 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -130.67 135.85 48.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.675 0.39 . . . . 0.0 110.545 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -114.06 25.62 10.99 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.225 0.61 . . . . 0.0 111.866 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -128.29 110.01 11.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.268 0.627 . . . . 0.0 109.371 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m -137.86 144.75 41.56 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.827 0.451 . . . . 0.0 110.239 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.21 123.28 48.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -93.98 140.5 29.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.974 0.509 . . . . 0.0 111.008 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.3 137.08 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.001 0.921 . . . . 0.0 108.878 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.66 166.83 31.41 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.85 20.23 74.18 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.629 -0.54 . . . . 0.0 112.023 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.04 124.74 46.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.763 0.782 . . . . 0.0 111.646 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.26 -4.95 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.374 2.716 . . . . 0.0 110.656 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.85 149.54 39.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.113 0.565 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -84.74 52.44 2.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.992 0.517 . . . . 0.0 110.168 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 55.28 55.66 7.25 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.051 0.94 . . . . 0.0 112.05 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.08 111.84 17.03 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.6 -13.7 62.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -88.61 -6.45 57.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.97 -0.456 . . . . 0.0 111.042 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -92.77 -20.03 21.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.209 0.459 . . . . 0.0 109.971 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.24 -28.41 53.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.79 45.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.019 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.43 -15.99 58.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.961 0.346 . . . . 0.0 111.557 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.79 -4.28 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.222 0.465 . . . . 0.0 111.482 172.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.52 12.05 26.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.665 0.786 . . . . 0.0 109.804 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 65.2 tttp -75.15 -39.29 3.17 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 95.1 Cg_endo -75.03 125.73 9.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.564 1.51 . . . . 0.0 111.576 -174.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 t80 51.63 23.93 2.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.124 1.37 . . . . 0.0 113.093 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.94 160.03 42.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.462 0.705 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.03 55.85 1.87 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.491 0.316 . . . . 0.0 111.597 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.53 139.0 21.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 O-C-N 121.958 -0.464 . . . . 0.0 109.813 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -131.71 4.17 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.4 m -135.59 124.22 23.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.01 0.368 . . . . 0.0 110.334 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.14 115.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.6 mp -111.62 104.58 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 104.81 14.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -81.05 104.2 11.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.064 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -85.67 24.34 1.24 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.44 0.696 . . . . 0.0 112.06 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -130.09 7.58 5.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -147.72 19.19 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.153 0.581 . . . . 0.0 110.235 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 37.51 38.03 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.704 1.602 . . . . 0.0 113.658 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -138.06 159.77 41.15 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.985 0.914 . . . . 0.0 109.769 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.67 159.29 42.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.979 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.45 135.31 47.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.12 154.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -135.21 139.04 44.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 0.0 111.357 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.63 150.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.48 1.512 . . . . 0.0 109.33 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -90.15 15.14 10.8 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -154.09 138.09 16.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.157 0.583 . . . . 0.0 109.886 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.24 -8.15 59.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.58 -28.87 24.56 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.41 -14.15 55.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.71 65.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.05 -13.69 60.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.146 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.72 -16.6 41.14 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.452 0.569 . . . . 0.0 111.213 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.64 -41.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -17.76 61.79 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.188 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -70.23 -40.29 74.58 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -62.56 -40.9 98.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -84.18 11.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.444 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -130.31 12.98 5.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.382 0.273 . . . . 0.0 111.234 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -135.78 3.63 2.99 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.57 -8.96 22.47 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.771 0.714 . . . . 0.0 111.981 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.88 -8.02 0.63 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.109 0.861 . . . . 0.0 114.552 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.55 72.84 1.42 Allowed 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.36 1.08 . . . . 0.0 109.929 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 94' ' ' LEU . 7.3 mp -56.52 119.67 30.49 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.135 0.574 . . . . 0.0 110.375 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.54 -11.72 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.67 2.913 . . . . 0.0 111.287 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.86 149.67 49.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.451 0.701 . . . . 0.0 111.115 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -103.7 98.52 8.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.6 t -117.52 147.94 42.32 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.089 0.556 . . . . 0.0 111.751 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.82 145.43 46.45 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.548 1.139 . . . . 0.0 108.869 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -127.9 152.19 48.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.93 146.68 14.16 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.98 136.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.004 0.522 . . . . 0.0 110.77 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.23 131.33 10.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -99.13 138.15 36.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.796 0.438 . . . . 0.0 110.985 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.12 175.21 49.86 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.55 164.97 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.058 3.172 . . . . 0.0 110.768 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.2 tpp85 -77.62 144.18 37.67 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.882 0.473 . . . . 0.0 110.111 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.89 40.07 0.38 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.297 0.639 . . . . 0.0 111.459 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.3 t -135.48 35.76 2.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.537 0.735 . . . . 0.0 109.921 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 98.0 m -72.16 155.7 39.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.885 0.474 . . . . 0.0 111.137 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -128.78 173.58 10.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.863 0.865 . . . . 0.0 110.065 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -67.46 -5.66 15.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -87.1 2.57 49.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.871 0.76 . . . . 0.0 109.747 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -135.63 22.99 3.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.291 1.037 . . . . 0.0 109.263 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.84 -15.71 1.7 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.52 0.581 . . . . 0.0 111.716 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -95.58 49.26 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -135.37 172.08 13.52 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.031 0.932 . . . . 0.0 110.594 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.44 144.99 4.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 123.249 0.62 . . . . 0.0 110.166 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt -58.49 149.96 58.15 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 123.226 0.61 . . . . 0.0 111.503 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.57 4.39 5.07 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.195 3.263 . . . . 0.0 112.441 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.61 11.51 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.234 0.47 . . . . 0.0 112.186 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -135.8 3.79 3.0 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.185 0.594 . . . . 0.0 110.418 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -91.38 -20.1 22.18 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.187 0.195 . . . . 0.0 110.842 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.4 pp -90.32 -12.65 37.11 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 m -74.83 -47.34 31.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.12 -68.4 0.56 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.605 0.241 . . . . 0.0 111.039 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.73 -17.27 56.1 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.26 -16.95 13.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.986 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.49 -13.92 53.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.365 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -91.64 -32.99 15.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.371 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.84 9.22 25.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.535 0.607 . . . . 0.0 111.705 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -126.52 -11.21 6.23 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.938 -0.553 . . . . 0.0 112.05 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.2 t -127.27 24.97 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.6 t -74.59 55.48 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.227 -0.921 . . . . 0.0 109.85 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.04 156.15 47.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.095 0.958 . . . . 0.0 110.448 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -86.2 49.59 1.82 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.904 0.482 . . . . 0.0 111.079 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -135.93 55.56 1.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.725 0.81 . . . . 0.0 109.515 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.14 152.87 21.18 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.79 -16.2 71.01 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.488 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 76.7 p -145.71 12.71 1.31 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.221 1.01 . . . . 0.0 111.624 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 t -135.95 24.37 3.32 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.408 0.549 . . . . 0.0 112.15 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.416 ' H ' HG13 ' A' ' 133' ' ' VAL . . . -79.61 0.47 81.34 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -146.45 149.18 36.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.32 14.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.434 3.423 . . . . 0.0 115.307 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 30' ' ' VAL . 4.6 pp -67.57 -8.57 35.24 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.902 0.774 . . . . 0.0 111.693 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.27 7.92 2.46 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 123.968 0.907 . . . . 0.0 111.005 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.8 m -134.79 30.46 3.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.552 ' HA3' ' H ' ' A' ' 29' ' ' LYS . . . -139.04 -56.76 0.05 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.943 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.493 ' CG1' HG21 ' A' ' 30' ' ' VAL . 2.3 pp -135.72 -12.22 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.91 0.855 . . . . 0.0 112.759 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.9 m 34.97 43.15 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.416 0.687 . . . . 0.0 112.091 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.468 ' H ' HD12 ' A' ' 149' ' ' ILE . 15.7 m-30 -72.86 144.63 47.36 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.306 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.38 165.01 26.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.214 1.406 . . . . 0.0 109.098 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 57.24 71.82 1.04 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.34 168.23 21.6 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.436 3.424 . . . . 0.0 112.078 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -135.08 125.93 27.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.674 0.79 . . . . 0.0 109.268 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.8 tt -69.13 146.5 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.591 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.3 pt -90.09 27.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.2 147.62 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 117.96 0.345 . . . . 0.0 110.755 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.65 3.21 0.05 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.594 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.69 126.33 29.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.867 0.833 . . . . 0.0 110.795 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 166.23 168.95 29.19 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.52 139.78 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 C-N-CA 123.008 0.523 . . . . 0.0 110.327 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 79.2 p -139.29 24.57 2.5 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.027 0.531 . . . . 0.0 111.294 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -79.0 133.83 36.82 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.345 0.258 . . . . 0.0 110.975 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.47 30.21 3.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.716 0.806 . . . . 0.0 110.219 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.27 134.49 52.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.735 0.414 . . . . 0.0 110.958 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.4 147.51 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.01 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.0 m -132.27 114.57 14.58 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.133 0.573 . . . . 0.0 109.519 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -135.67 26.8 3.37 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.977 0.511 . . . . 0.0 111.561 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -71.49 129.6 39.18 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.597 0.359 . . . . 0.0 110.09 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.72 155.99 34.22 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.5 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.46 164.4 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.865 3.043 . . . . 0.0 110.84 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 45.7 p -130.36 136.46 49.11 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 122.833 0.453 . . . . 0.0 110.626 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -135.58 55.2 1.88 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.679 0.792 . . . . 0.0 109.667 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.2 p -121.01 155.54 34.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.328 0.651 . . . . 0.0 111.344 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.22 161.32 28.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -135.79 141.3 44.75 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 123.32 0.648 . . . . 0.0 110.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -135.91 159.86 40.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.657 0.783 . . . . 0.0 110.671 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.8 164.87 36.49 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.39 175.14 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.659 3.572 . . . . 0.0 111.418 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -135.08 143.65 46.77 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.782 0.833 . . . . 0.0 109.411 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -132.91 155.66 48.66 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 122.953 0.501 . . . . 0.0 111.131 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.15 -176.8 38.89 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.693 ' H ' ' CD ' ' A' ' 185' ' ' PRO . 87.8 tttt -141.48 -36.9 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.996 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.693 ' CD ' ' H ' ' A' ' 184' ' ' LYS . 57.9 Cg_exo . . . . . 0 C--O 1.251 1.125 0 C-N-CA 123.032 2.488 . . . . 0.0 112.325 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.477 0.53 0 N-CA-C 112.261 0.062 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -135.51 126.74 28.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.056 0.542 . . . . 0.0 109.915 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -89.81 126.11 35.57 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.756 0.422 . . . . 0.0 110.159 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -135.84 111.32 9.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.1 t30 64.76 156.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 112.388 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -75.5 149.28 7.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.137 0.575 . . . . 0.0 110.608 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.4 p -134.96 149.87 50.28 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.408 0.683 . . . . 0.0 110.432 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -113.1 147.73 36.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.181 0.592 . . . . 0.0 110.682 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.45 155.03 41.94 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.408 0.683 . . . . 0.0 110.102 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.9 167.55 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.843 . . . . 0.0 110.895 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -78.62 162.69 26.07 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.534 0.333 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -124.19 45.81 2.41 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.214 0.606 . . . . 0.0 110.128 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -135.45 65.53 62.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 123.311 0.644 . . . . 0.0 110.125 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.04 161.71 43.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.69 2.926 . . . . 0.0 110.605 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.773 ' H ' ' HD2' ' A' ' 16' ' ' PRO . 28.8 ttpp -149.08 -45.81 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.958 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.773 ' HD2' ' H ' ' A' ' 15' ' ' LYS . 69.3 Cg_endo -78.91 -5.3 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.159 1.906 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 140' ' ' THR . 92.1 t -131.39 124.02 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.3 m -139.71 147.49 40.99 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 122.99 0.516 . . . . 0.0 110.855 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -91.57 104.6 17.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.619 0.723 . . . . 0.0 110.563 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.65 156.57 48.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.492 1.117 . . . . 0.0 108.881 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.1 m -78.29 54.99 1.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.421 0.288 . . . . 0.0 111.365 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -135.1 25.71 3.56 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.341 0.657 . . . . 0.0 111.489 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.38 136.6 83.92 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.1 160.86 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.805 3.003 . . . . 0.0 111.868 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.72 2.81 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.297 3.331 . . . . 0.0 112.126 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -135.05 160.45 38.28 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.142 0.577 . . . . 0.0 110.825 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.8 m80 57.1 35.49 26.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.038 0.935 . . . . 0.0 111.454 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 149' ' ' ILE . 2.2 tp -135.97 129.08 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.289 0.636 . . . . 0.0 110.415 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -136.04 27.2 3.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.77 0.428 . . . . 0.0 112.085 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.34 46.49 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.746 0.418 . . . . 0.0 111.057 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -54.22 128.87 32.91 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.592 0.357 . . . . 0.0 110.408 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.9 m -135.69 50.63 2.09 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.074 0.549 . . . . 0.0 111.052 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -133.98 143.39 48.12 Favored 'General case' 0 C--N 1.337 0.042 0 C-N-CA 123.068 0.547 . . . . 0.0 110.304 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 t -135.7 170.19 16.37 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.613 0.765 . . . . 0.0 109.677 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.45 142.16 51.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.425 0.557 . . . . 0.0 112.256 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.24 143.34 50.72 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 mm -122.74 150.49 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.87 171.0 34.87 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.865 -0.522 . . . . 0.0 112.143 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.58 73.96 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 ' H ' ' A' ' 40' ' ' VAL . 2.0 m -54.34 128.49 59.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 117.464 0.632 . . . . 0.0 111.883 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -87.67 -7.54 6.46 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.267 3.311 . . . . 0.0 111.457 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.56 156.35 30.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.329 1.051 . . . . 0.0 111.953 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.19 57.97 4.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.938 0.895 . . . . 0.0 112.226 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 38.5 ttm 53.54 55.74 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.654 0.782 . . . . 0.0 112.083 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -126.92 108.44 10.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.252 0.621 . . . . 0.0 109.563 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.97 -17.7 65.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.95 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -85.64 -3.06 58.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.202 -0.311 . . . . 0.0 111.2 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -94.43 -23.7 17.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.466 0.575 . . . . 0.0 109.973 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.81 -35.89 75.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 170.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.3 60.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.555 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -78.22 -11.67 59.94 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.707 -0.621 . . . . 0.0 110.703 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.88 -1.27 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.58 12.29 14.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.767 0.827 . . . . 0.0 110.595 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.487 ' H ' ' HD3' ' A' ' 55' ' ' PRO . 88.8 tttt -109.69 -32.28 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 59.0 Cg_exo -57.04 -21.17 40.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.492 2.128 . . . . 0.0 114.259 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.6 5.8 1.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.0 174.14 11.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.462 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.52 55.52 1.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.176 0.591 . . . . 0.0 110.662 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.74 139.7 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -115.39 -2.02 12.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -172.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.1 m -141.64 131.21 23.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.432 0.56 . . . . 0.0 110.58 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -143.19 125.19 12.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.205 0.602 . . . . 0.0 109.865 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.59 139.96 45.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.985 0.514 . . . . 0.0 110.055 173.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -109.29 138.6 45.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.82 0.848 . . . . 0.0 111.219 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -102.08 105.24 15.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -79.92 24.56 0.4 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.837 0.855 . . . . 0.0 113.253 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.2 m -133.16 6.5 3.89 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.847 0.294 . . . . 0.0 111.63 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -152.73 11.47 0.5 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.718 0.235 . . . . 0.0 111.228 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 47.44 47.03 17.36 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -128.44 150.64 50.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.121 0.569 . . . . 0.0 110.312 -173.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -135.34 155.42 50.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.306 0.574 . . . . 0.0 111.742 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -127.3 127.16 43.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.39 150.75 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.465 0.174 . . . . 0.0 111.188 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.47 131.32 43.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.95 0.405 . . . . 0.0 111.617 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -106.36 157.57 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 124.759 1.224 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -86.96 -2.02 58.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -153.42 150.21 28.58 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.082 -0.386 . . . . 0.0 110.366 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -70.26 -12.63 61.73 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.358 -0.214 . . . . 0.0 111.414 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -77.85 -16.92 57.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.924 -0.485 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.64 -14.92 36.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.145 -0.347 . . . . 0.0 110.219 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.55 -40.41 35.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -73.48 -25.56 60.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -79.1 -22.59 45.01 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.317 0.508 . . . . 0.0 111.203 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.9 t -74.75 -42.65 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.27 -16.08 62.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.452 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -78.86 -24.63 44.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.29 0.496 . . . . 0.0 110.412 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -99.14 -17.32 18.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.107 -0.371 . . . . 0.0 110.671 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.96 0.26 57.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.018 -0.426 . . . . 0.0 110.077 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.34 -2.58 2.48 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -144.14 20.47 1.75 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.092 0.86 . . . . 0.0 113.007 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -135.99 55.59 1.85 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.1 -2.82 72.3 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.476 -0.624 . . . . 0.0 112.798 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 50.86 74.76 0.21 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.91 0.884 . . . . 0.0 112.085 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.8 151.86 40.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.846 0.458 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.24 -6.82 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.895 3.064 . . . . 0.0 112.231 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.64 128.62 36.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.878 0.308 . . . . 0.0 110.281 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -89.32 100.36 13.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.1 m -104.95 135.39 46.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.754 0.422 . . . . 0.0 111.059 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -141.27 149.25 41.06 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.646 0.779 . . . . 0.0 109.933 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -103.85 140.62 37.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.98 151.51 22.22 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.31 151.64 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.488 0.715 . . . . 0.0 111.094 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.58 148.53 17.81 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -123.13 25.34 8.51 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.915 0.486 . . . . 0.0 111.168 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.11 -177.56 38.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.235 0.445 . . . . 0.0 112.426 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.94 170.22 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.784 3.656 . . . . 0.0 112.761 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -126.86 128.23 46.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.476 0.71 . . . . 0.0 109.286 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.3 44.01 2.6 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.046 0.539 . . . . 0.0 110.877 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 27.6 p -81.95 24.85 0.6 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.036 0.534 . . . . 0.0 111.402 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.36 168.59 18.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 110.974 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.01 159.2 14.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.905 0.482 . . . . 0.0 110.257 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -65.97 -6.07 11.47 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -80.35 -3.0 47.82 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.249 -0.282 . . . . 0.0 110.323 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -135.82 4.33 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.831 0.852 . . . . 0.0 110.057 171.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.92 -11.38 37.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -81.22 55.49 2.56 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.321 0.648 . . . . 0.0 110.417 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -135.29 141.26 45.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.492 0.717 . . . . 0.0 110.272 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.0 mt -89.64 139.18 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.913 0.485 . . . . 0.0 109.877 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.12 136.43 13.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.66 1.81 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.682 2.922 . . . . 0.0 112.497 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.8 ttt -84.51 -4.14 58.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.913 -0.492 . . . . 0.0 111.221 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -135.68 10.46 3.4 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.549 0.339 . . . . 0.0 111.403 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -74.62 -10.34 59.44 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 149' ' ' ILE . 3.6 pp -83.4 -23.78 32.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.3 m -89.94 -15.6 31.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -77.51 -50.4 12.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.613 0.365 . . . . 0.0 110.065 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.24 -15.28 41.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -91.3 -41.47 10.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.672 0.669 . . . . 0.0 110.876 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -68.77 -28.85 67.15 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.405 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' A' ' 157' ' ' ILE . 58.9 tttm -70.9 -62.53 1.36 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -98.1 21.58 10.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 -10.46 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.48 3.42 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.2 0.909 . . . . 0.0 112.744 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.9 m -87.79 31.13 0.78 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.244 -0.91 . . . . 0.0 111.2 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.47 24.9 6.62 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.177 0.991 . . . . 0.0 109.42 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -135.36 169.17 17.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.855 1.262 . . . . 0.0 109.144 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -76.21 24.22 0.14 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.04 137.35 2.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.02 152.78 20.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.517 HG22 HG21 ' A' ' 17' ' ' VAL . 17.0 m 55.24 36.45 27.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.576 0.703 . . . . 0.0 109.274 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.8 m -147.66 14.34 1.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.852 1.261 . . . . 0.0 109.042 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.21 -106.45 2.99 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 82.3 mt-30 -152.29 -42.24 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 50.2 Cg_exo -60.47 -20.51 64.16 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.849 2.366 . . . . 0.0 115.653 -171.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.4 pt? -140.97 1.2 1.64 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.07 -4.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 39.3 p -133.72 11.71 4.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 28' ' ' ILE . . . -84.88 -71.74 1.31 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -108.55 -5.33 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.1 m 45.96 18.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.967 1.707 . . . . 0.0 114.877 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.6 154.02 17.52 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 118.438 0.563 . . . . 0.0 110.183 171.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' HA ' HG21 ' A' ' 140' ' ' THR . 33.7 tt0 -127.94 78.97 1.87 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.067 0.46 . . . . 0.0 110.559 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -137.65 61.48 30.55 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 109.889 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.72 167.94 25.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.287 3.325 . . . . 0.0 112.377 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -103.88 146.38 28.74 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.887 0.875 . . . . 0.0 109.623 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.8 tt -80.23 132.91 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 112.088 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.468 HD11 ' HE2' ' A' ' 130' ' ' LYS . 32.8 mm -135.5 127.04 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.484 1.114 . . . . 0.0 108.112 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.44 150.75 29.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.178 0.591 . . . . 0.0 110.628 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 174.47 0.66 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.827 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.04 149.48 35.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.006 0.903 . . . . 0.0 111.327 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 175.9 177.04 44.62 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.75 138.7 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.074 0.55 . . . . 0.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.8 m -135.62 28.98 3.27 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.098 0.559 . . . . 0.0 111.279 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.0 p -73.62 145.01 45.7 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.565 0.346 . . . . 0.0 111.024 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -135.92 142.63 44.67 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.384 0.674 . . . . 0.0 110.205 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.37 147.67 49.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.354 0.661 . . . . 0.0 110.361 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.4 tp -135.52 144.02 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.108 0.563 . . . . 0.0 110.421 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 81.0 p -135.63 156.1 49.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.669 0.788 . . . . 0.0 110.237 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.858 0.463 . . . . 0.0 110.28 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.55 152.17 51.03 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.8 ptm -145.86 154.5 51.41 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 122.961 0.504 . . . . 0.0 110.425 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.79 167.6 26.12 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.622 2.881 . . . . 0.0 110.805 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.8 p -130.96 29.37 4.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.203 0.601 . . . . 0.0 110.885 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.56 105.34 4.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.774 0.429 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -135.9 147.23 48.07 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.265 0.626 . . . . 0.0 110.61 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.18 170.81 43.78 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -135.78 129.54 32.68 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.074 0.55 . . . . 0.0 110.316 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -137.08 104.65 5.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.06 157.81 51.53 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.02 -12.25 19.58 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.844 3.03 . . . . 0.0 111.597 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 23.3 tpp85 -139.67 139.15 36.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.287 0.635 . . . . 0.0 110.091 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.1 m -135.09 48.32 2.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.621 0.768 . . . . 0.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.39 176.92 49.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.741 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 88.6 tttt -151.02 -49.61 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.132 -0.937 . . . . 0.0 112.152 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.741 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 94.6 Cg_endo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 122.208 1.939 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.473 0.271 0 N-CA-C 112.761 0.254 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.82 55.22 2.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.836 0.854 . . . . 0.0 110.175 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -123.11 24.82 8.74 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.8 0.84 . . . . 0.0 110.771 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 pp -93.05 160.11 15.01 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.065 0.546 . . . . 0.0 111.652 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -135.83 24.89 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.312 0.645 . . . . 0.0 111.268 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.59 149.08 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 122.741 0.416 . . . . 0.0 111.233 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 t -135.67 140.35 44.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.419 0.688 . . . . 0.0 110.104 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.36 154.56 50.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.095 0.558 . . . . 0.0 111.046 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 47.1 79.26 0.35 Allowed Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 112.73 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -81.05 -26.99 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.147 2.565 . . . . 0.0 113.54 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -158.08 34.45 0.25 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -138.09 141.09 40.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.682 1.128 . . . . 0.0 112.646 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.6 tmm_? -155.07 140.92 12.76 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 13' ' ' ARG . 53.1 Cg_exo -57.6 178.93 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.456 3.438 . . . . 0.0 114.139 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 63.87 155.92 0.12 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.397 1.479 . . . . 0.0 112.926 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.85 -11.0 28.79 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.745 2.963 . . . . 0.0 111.948 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.24 149.37 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.7 p -77.22 170.89 15.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.988 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -83.83 108.57 16.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.767 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -37.31 150.15 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.137 1.375 . . . . 0.0 113.245 171.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.2 p 54.66 21.82 3.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.406 1.882 . . . . 0.0 113.429 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.9 m -135.95 30.81 3.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.603 0.761 . . . . 0.0 109.285 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 156.28 81.59 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.324 0.65 . . . . 0.0 109.97 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.55 165.65 30.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.656 2.904 . . . . 0.0 111.092 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.89 -10.14 16.45 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.282 3.321 . . . . 0.0 114.067 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -69.35 137.82 53.22 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.143 0.429 . . . . 0.0 111.08 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -79.55 136.76 36.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.726 0.41 . . . . 0.0 110.554 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.497 HD13 HG22 ' A' ' 149' ' ' ILE . 2.2 pp -135.55 -177.78 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.48 0.712 . . . . 0.0 110.609 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -83.25 51.34 1.95 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.41 136.68 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 122.899 0.48 . . . . 0.0 109.752 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -86.16 55.74 3.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.312 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.1 p -63.92 155.39 30.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.297 0.639 . . . . 0.0 112.207 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -67.36 135.38 53.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.883 0.873 . . . . 0.0 110.05 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.6 p -135.8 157.39 46.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.092 0.557 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.45 131.01 54.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.289 0.636 . . . . 0.0 109.366 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -115.26 142.91 46.04 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.202 0.601 . . . . 0.0 110.804 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.93 141.81 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.835 0.854 . . . . 0.0 109.085 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.09 29.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.03 75.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.582 -0.565 . . . . 0.0 111.931 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 m -55.85 124.54 58.4 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.85 0.825 . . . . 0.0 110.87 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.5 -2.83 13.08 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.324 2.683 . . . . 0.0 111.076 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.54 157.91 34.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.32 0.648 . . . . 0.0 110.133 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -85.09 47.85 1.47 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.51 55.92 6.81 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.915 0.886 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -126.87 116.65 21.16 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.31 -12.58 61.78 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -83.78 -11.43 57.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.085 -0.384 . . . . 0.0 110.896 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -95.73 -18.53 20.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.392 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 49' ' ' LEU . 3.9 mm? -77.49 -26.79 51.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.96 -22.63 42.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.94 -14.75 59.83 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.112 -0.368 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 -2.64 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 118.243 0.474 . . . . 0.0 111.783 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.33 14.3 22.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.6 0.76 . . . . 0.0 109.837 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 64.9 tttp -88.56 -37.23 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.937 169.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 49.8 Cg_exo -59.4 116.91 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.252 1.968 . . . . 0.0 111.111 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 51.67 23.89 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.398 1.079 . . . . 0.0 113.178 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 159.45 44.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.116 0.416 . . . . 0.0 110.9 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -135.34 59.18 1.73 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.894 0.477 . . . . 0.0 111.301 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -70.15 142.59 15.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 O-C-N 121.856 -0.527 . . . . 0.0 109.996 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -132.45 6.62 4.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.0 m -135.51 119.75 17.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.213 0.46 . . . . 0.0 110.472 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.16 123.91 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.284 0.633 . . . . 0.0 109.406 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 104.66 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.22 117.62 34.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -135.09 155.95 49.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.806 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 60.24 177.21 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.137 1.375 . . . . 0.0 112.349 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -70.22 78.54 0.52 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.509 0.723 . . . . 0.0 111.141 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 50.09 32.27 5.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.915 1.686 . . . . 0.0 114.833 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -135.56 4.17 3.09 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -139.47 55.26 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.226 0.921 . . . . 0.0 111.294 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.01 137.21 36.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.052 0.454 . . . . 0.0 110.228 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -135.5 133.49 38.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.552 0.741 . . . . 0.0 109.939 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.66 152.34 31.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.549 0.214 . . . . 0.0 111.137 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -135.74 142.45 45.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.241 0.544 . . . . 0.0 111.93 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.75 151.02 22.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.479 1.511 . . . . 0.0 109.174 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -87.77 11.12 16.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.3 t -149.7 136.06 19.07 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.821 0.448 . . . . 0.0 109.839 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -72.59 -17.7 61.67 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 122.401 -0.187 . . . . 0.0 110.585 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -82.53 -22.06 35.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.23 -19.07 37.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.72 66.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.21 -14.51 60.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.93 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.5 -19.86 37.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.238 0.472 . . . . 0.0 111.002 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.77 -44.06 46.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.27 -18.57 63.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -75.28 -28.54 59.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.53 0.604 . . . . 0.0 109.593 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -72.14 -28.91 63.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.4 5.55 51.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.529 0.332 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.7 17.26 5.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.896 0.478 . . . . 0.0 110.577 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -129.56 -6.52 4.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.654 0.382 . . . . 0.0 111.209 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -97.84 -6.61 32.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.472 0.578 . . . . 0.0 112.041 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 5.32 3.91 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.176 0.893 . . . . 0.0 114.093 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.02 50.11 0.52 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.392 1.096 . . . . 0.0 109.874 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 94' ' ' LEU . 1.9 pt? -53.82 127.99 53.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 122.712 0.405 . . . . 0.0 111.395 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.03 0.71 8.8 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.4 3.4 . . . . 0.0 112.238 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.47 150.66 50.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.85 104.25 16.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 p -121.76 133.73 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.481 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -137.31 145.0 42.89 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 123.459 0.704 . . . . 0.0 110.16 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -133.1 157.4 45.38 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.041 0.537 . . . . 0.0 110.026 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.91 -176.07 40.57 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.546 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.55 143.33 36.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 125.049 1.34 . . . . 0.0 109.951 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.15 140.97 18.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -130.95 55.22 1.86 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.691 0.796 . . . . 0.0 109.688 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.38 156.67 19.65 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.52 -22.04 9.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.615 2.876 . . . . 0.0 112.34 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -149.51 156.8 42.57 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.736 0.414 . . . . 0.0 111.165 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -102.34 24.88 9.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.371 0.668 . . . . 0.0 110.774 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.53 25.25 12.01 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.448 0.699 . . . . 0.0 111.227 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 75.7 m -77.2 150.15 35.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 110.643 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.53 141.95 50.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -70.89 -10.26 59.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -97.51 6.02 48.74 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.511 0.596 . . . . 0.0 110.448 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -147.33 28.42 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.536 0.735 . . . . 0.0 109.841 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.95 -11.56 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.277 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -84.47 55.51 3.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.449 1.624 . . . . 0.0 109.979 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -133.41 149.07 51.82 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.607 0.763 . . . . 0.0 110.388 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -74.26 147.68 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 121' ' ' MET . 26.5 mt 63.79 126.33 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.592 1.557 . . . . 0.0 111.243 -172.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.79 -7.32 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.305 2.67 . . . . 0.0 112.889 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.506 ' H ' HG22 ' A' ' 119' ' ' ILE . 5.4 mpp? -85.81 25.87 1.05 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.385 0.539 . . . . 0.0 111.388 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -72.2 -20.71 61.53 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -92.47 10.15 31.36 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.227 -0.296 . . . . 0.0 110.949 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.55 -32.61 12.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 t -84.86 -27.68 26.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.7 -59.68 2.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.557 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.69 -24.77 41.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.82 -27.54 10.68 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 113.142 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -85.08 -18.77 33.27 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.6 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -87.37 -55.26 3.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.539 0.609 . . . . 0.0 109.738 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -87.3 4.49 42.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 m -139.58 -5.56 1.37 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 172.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.43 21.18 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.052 1.297 . . . . 0.0 112.092 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 t -100.63 30.14 4.11 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.371 -0.831 . . . . 0.0 111.384 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.57 24.36 8.57 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 110.218 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -140.43 156.51 46.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.354 1.062 . . . . 0.0 108.834 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -74.87 24.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.32 0.648 . . . . 0.0 112.082 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.06 160.67 13.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.17 -169.2 42.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.1 m 68.63 112.0 0.04 OUTLIER 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.331 1.053 . . . . 0.0 112.366 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.7 t 59.36 24.93 13.53 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.345 1.058 . . . . 0.0 112.606 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.44 -9.1 82.28 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -156.82 147.24 16.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.26 7.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.445 3.43 . . . . 0.0 115.67 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.72 6.0 5.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.031 0.832 . . . . 0.0 111.663 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.08 17.57 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.125 0.57 . . . . 0.0 111.645 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -135.12 40.41 2.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.01 0.924 . . . . 0.0 109.136 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.84 -53.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -115.51 128.23 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.814 0.816 . . . . 0.0 110.395 171.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.38 24.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.758 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -127.56 125.33 40.12 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.689 0.796 . . . . 0.0 109.546 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -146.41 153.38 40.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.612 0.365 . . . . 0.0 111.345 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.25 153.87 38.21 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.603 0.761 . . . . 0.0 109.053 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.45 137.82 37.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.863 2.375 . . . . 0.0 110.874 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.97 149.82 31.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.134 0.573 . . . . 0.0 110.386 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 19.0 tt -135.67 148.52 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.036 0.535 . . . . 0.0 110.316 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.2 28.79 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.12 151.96 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 122.618 0.367 . . . . 0.0 110.569 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -175.4 177.43 47.29 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -135.72 149.98 49.39 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.122 0.569 . . . . 0.0 110.999 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.2 177.63 52.3 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.55 142.7 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.16 0.584 . . . . 0.0 110.35 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.8 p -135.71 152.61 51.34 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.369 0.668 . . . . 0.0 110.719 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.6 t -135.74 143.32 45.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.128 0.571 . . . . 0.0 110.376 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -95.09 134.53 37.69 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.047 0.539 . . . . 0.0 110.459 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.71 134.97 39.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.109 0.564 . . . . 0.0 110.139 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.03 142.55 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.108 0.563 . . . . 0.0 110.149 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 76.7 p -83.82 145.88 28.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.819 0.447 . . . . 0.0 110.824 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -135.71 145.84 47.1 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.83 0.452 . . . . 0.0 111.025 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.19 148.26 48.04 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.73 0.812 . . . . 0.0 109.934 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.67 152.63 65.81 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.075 0.55 . . . . 0.0 110.403 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.05 156.89 38.48 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.811 3.007 . . . . 0.0 111.541 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 p -135.5 144.83 46.57 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.524 0.729 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -135.55 130.77 35.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.739 0.416 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 59.6 m -136.0 143.63 44.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.511 0.724 . . . . 0.0 110.266 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -71.53 161.47 54.21 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -135.92 145.8 46.66 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.104 0.562 . . . . 0.0 111.07 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.65 125.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.273 0.629 . . . . 0.0 109.379 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.2 155.06 48.62 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.06 160.06 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.945 3.097 . . . . 0.0 111.022 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -138.73 146.73 41.82 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.288 0.635 . . . . 0.0 110.345 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.0 m -135.74 124.33 23.65 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.822 0.449 . . . . 0.0 110.388 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.3 173.4 54.27 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -139.73 152.0 67.28 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.41 0.684 . . . . 0.0 109.912 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.793 2.995 . . . . 0.0 111.068 178.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.471 0.154 0 N-CA-C 112.546 0.171 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -135.38 147.14 48.95 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.253 0.621 . . . . 0.0 110.352 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -135.7 133.66 38.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.098 0.559 . . . . 0.0 110.122 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 4' ' ' LEU . 1.9 pt? -81.58 147.83 29.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.799 0.44 . . . . 0.0 111.373 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -80.56 104.04 10.82 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.08 141.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.106 0.562 . . . . 0.0 110.3 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -94.14 106.41 18.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -66.78 130.8 44.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.022 0.439 . . . . 0.0 111.112 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -153.03 153.39 29.64 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.117 0.567 . . . . 0.0 109.971 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.87 160.88 46.63 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.518 2.812 . . . . 0.0 110.586 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -135.21 136.08 41.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.606 0.362 . . . . 0.0 110.831 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.69 139.01 43.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.79 133.19 84.49 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 110.154 -0.314 . . . . 0.0 110.154 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.28 163.94 29.61 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.791 2.994 . . . . 0.0 110.762 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 65.4 mttp -82.56 -49.11 0.83 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.685 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 61.0 Cg_endo -78.81 177.33 8.84 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.771 2.314 . . . . 0.0 109.919 171.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -126.02 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.2 m -154.27 -1.63 0.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -158.73 123.62 4.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.101 0.864 . . . . 0.0 111.447 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -154.4 151.54 29.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.384 0.674 . . . . 0.0 109.596 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.3 m -92.05 19.22 6.99 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 m -140.25 81.9 1.83 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.5 mt -125.55 138.73 32.43 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.929 0.492 . . . . 0.0 110.829 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.05 164.85 19.71 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.15 3.233 . . . . 0.0 111.237 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.57 -0.83 4.85 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.452 3.435 . . . . 0.0 113.783 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.24 146.57 43.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.214 0.605 . . . . 0.0 112.427 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -73.31 163.05 28.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.989 0.915 . . . . 0.0 109.736 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.74 142.78 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.617 0.367 . . . . 0.0 110.783 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -127.73 24.11 6.15 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.05 91.88 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.46 143.16 25.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.949 0.499 . . . . 0.0 109.719 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -107.82 104.48 13.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.713 0.292 . . . . 0.0 110.33 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.2 ptm85 -142.69 160.41 40.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.288 0.635 . . . . 0.0 110.93 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.6 p -135.04 135.07 41.03 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.191 0.596 . . . . 0.0 109.822 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.66 126.05 53.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -112.4 140.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.752 0.821 . . . . 0.0 110.312 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mm -125.45 144.66 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.42 176.97 37.91 Favored Glycine 0 CA--C 1.524 0.651 0 O-C-N 121.863 -0.523 . . . . 0.0 112.206 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.78 19.7 73.55 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 40' ' ' VAL . 1.2 m -62.55 130.0 93.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 117.563 0.682 . . . . 0.0 111.242 -173.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.76 -10.35 6.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.13 3.22 . . . . 0.0 111.307 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 4.0 pp -82.03 156.08 24.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.684 1.193 . . . . 0.0 111.666 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -80.7 55.93 2.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.736 0.815 . . . . 0.0 112.109 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.1 mtm 50.73 55.34 9.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.14 0.976 . . . . 0.0 112.495 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 88.5 tttt -115.55 106.06 13.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.64 -15.71 63.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -84.17 -7.5 59.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.158 -0.339 . . . . 0.0 110.827 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -96.85 -20.74 17.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.405 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.72 -29.28 62.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.84 50.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.235 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -76.63 -13.11 60.09 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.792 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.96 -2.6 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -118.22 18.28 13.79 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.688 0.795 . . . . 0.0 110.291 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.3 ttmt -105.71 -35.51 0.19 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.442 -0.79 . . . . 0.0 113.035 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.1 Cg_exo -58.97 -23.97 70.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.645 2.23 . . . . 0.0 114.161 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -143.82 13.71 1.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.78 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.121 0.569 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -134.56 57.86 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.483 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.32 138.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -130.65 9.31 5.02 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -135.44 113.64 11.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.42 128.14 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.13 131.49 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mt -107.78 122.68 47.26 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -118.19 161.71 19.44 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 62.1 24.9 14.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.24 1.816 . . . . 0.0 112.783 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 m 52.6 26.44 4.35 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.841 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -141.05 -174.79 4.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.29 1.436 . . . . 0.0 109.122 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.58 30.65 0.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -87.95 81.36 7.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.379 0.991 . . . . 0.0 108.728 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.16 138.73 32.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.424 0.631 . . . . 0.0 112.242 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -136.02 131.67 35.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.952 0.901 . . . . 0.0 108.866 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -133.0 151.66 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 111.617 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -135.47 142.28 45.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.421 0.629 . . . . 0.0 111.597 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.22 152.77 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 125.103 1.361 . . . . 0.0 109.156 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -98.33 24.14 7.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.6 t -149.99 138.57 20.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.959 0.504 . . . . 0.0 110.09 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -38.48 73.82 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -76.35 -15.94 59.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.241 -0.287 . . . . 0.0 111.587 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -86.28 -18.78 31.13 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.873 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.91 -22.56 42.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.94 -19.26 37.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.292 -0.255 . . . . 0.0 111.366 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -78.39 -43.38 26.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.466 0.575 . . . . 0.0 110.157 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' LEU . 3.1 mm? -75.37 -14.97 60.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.002 177.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -71.55 -43.3 66.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.764 0.711 . . . . 0.0 109.144 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -76.04 -12.4 60.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.419 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -92.35 -1.26 57.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.1 -0.375 . . . . 0.0 110.325 170.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -112.36 3.19 16.84 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.797 0.439 . . . . 0.0 111.429 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -135.02 1.69 3.01 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.15 55.17 1.77 Allowed 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.2 -0.28 20.65 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.804 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.02 3.02 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.912 0.856 . . . . 0.0 111.798 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -89.15 153.58 49.0 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 122.859 0.463 . . . . 0.0 109.776 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.53 -11.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.688 2.925 . . . . 0.0 112.062 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.08 153.14 21.5 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.786 0.435 . . . . 0.0 111.755 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -125.41 137.44 54.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 109.025 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -135.46 141.98 45.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -137.53 147.49 45.21 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.224 1.01 . . . . 0.0 109.552 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -135.13 160.49 38.2 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.12 175.08 33.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.36 148.83 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.122 0.969 . . . . 0.0 109.952 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -164.5 142.02 7.49 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -94.28 19.09 9.9 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.929 0.492 . . . . 0.0 111.496 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.9 175.93 21.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.328 0.489 . . . . 0.0 112.455 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.73 174.71 12.35 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.419 3.413 . . . . 0.0 110.771 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -64.71 151.35 45.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 122.746 0.418 . . . . 0.0 110.59 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.88 54.83 1.39 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.008 0.523 . . . . 0.0 111.015 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 68.2 m 56.07 55.93 6.39 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.248 0.619 . . . . 0.0 111.601 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.01 104.9 2.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.869 0.366 . . . . 0.0 110.444 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -135.71 172.61 12.76 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.51 1.124 . . . . 0.0 109.178 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -65.62 -7.28 14.26 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.082 -0.386 . . . . 0.0 111.579 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -73.98 0.26 14.12 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -135.12 16.73 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.578 1.151 . . . . 0.0 108.874 170.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.62 -18.29 18.94 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -131.34 24.35 4.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.286 0.635 . . . . 0.0 110.226 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.24 36.35 2.31 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.536 0.735 . . . . 0.0 110.657 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.08 133.48 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.814 0.446 . . . . 0.0 110.548 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 35.9 mm -131.49 133.98 25.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 46.8 Cg_exo -61.04 -13.38 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.633 2.888 . . . . 0.0 115.797 -171.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.88 23.85 3.34 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -91.11 -12.4 35.69 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 121.641 -0.662 . . . . 0.0 110.911 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -88.59 -6.22 57.67 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.6 tp -101.41 -27.62 13.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.709 0.804 . . . . 0.0 109.601 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -80.98 -21.68 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.29 -44.44 10.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 0.0 111.199 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.58 -13.94 59.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.46 -17.31 11.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.903 0.774 . . . . 0.0 111.747 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -70.97 -25.65 62.81 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.867 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.89 -63.43 1.32 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.296 0.238 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -80.7 8.48 7.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -143.91 -17.69 0.59 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.421 ' CG2' HD21 ' A' ' 145' ' ' LEU . 1.5 t -135.6 24.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.914 1.234 . . . . 0.0 113.693 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.5 m -103.92 26.61 8.47 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.179 -0.951 . . . . 0.0 111.665 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.07 24.02 3.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.788 0.435 . . . . 0.0 111.218 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -148.14 -74.99 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.274 -0.266 . . . . 0.0 111.265 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -140.5 158.1 44.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.853 0.861 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.67 157.39 50.53 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.57 171.63 27.09 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 123.372 0.511 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 34.7 p -87.13 -5.55 58.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.206 0.602 . . . . 0.0 110.564 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.9 m -89.43 13.52 13.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.504 0.322 . . . . 0.0 110.167 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.51 -12.4 81.88 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -141.69 158.26 63.23 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.976 0.51 . . . . 0.0 110.135 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.15 14.47 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.297 3.332 . . . . 0.0 112.927 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 133' ' ' VAL . 2.9 pp -69.49 -6.0 27.71 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.899 0.772 . . . . 0.0 111.148 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -75.13 -1.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -137.62 34.03 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.47 1.108 . . . . 0.0 109.403 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.43 -16.99 0.38 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.475 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.03 -55.71 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.16 0 CA-C-N 118.623 1.212 . . . . 0.0 112.353 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.2 m 30.31 49.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.663 1.585 . . . . 0.0 114.495 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.79 153.67 34.71 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.798 -0.564 . . . . 0.0 109.578 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.03 24.94 6.32 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.29 146.86 62.65 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 121.985 -0.447 . . . . 0.0 110.429 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.13 17.3 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.756 3.638 . . . . 0.0 112.687 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.75 146.89 53.03 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.693 0.397 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.2 pt -129.44 157.1 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.456 0.702 . . . . 0.0 110.828 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -78.23 24.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.914 0.886 . . . . 0.0 113.003 -176.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.99 140.31 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.475 0.71 . . . . 0.0 110.069 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 75.52 -174.48 52.35 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.38 146.15 48.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.375 0.67 . . . . 0.0 110.259 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.39 9.2 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.811 -0.438 . . . . 0.0 112.664 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.36 134.49 28.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.81 0.805 . . . . 0.0 110.297 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.5 m -135.44 150.48 49.86 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.2 m -135.04 142.94 46.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.941 0.496 . . . . 0.0 110.725 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.25 158.85 20.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.337 0.655 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -127.67 147.68 50.38 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.27 0.628 . . . . 0.0 110.443 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.45 149.34 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.379 0.672 . . . . 0.0 110.295 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -135.13 155.94 49.84 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.395 0.678 . . . . 0.0 110.615 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -135.21 143.76 46.56 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.254 0.621 . . . . 0.0 110.087 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -135.16 150.81 50.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.272 0.629 . . . . 0.0 110.626 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -148.37 154.47 41.9 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.27 0.628 . . . . 0.0 110.162 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.13 167.78 25.16 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.563 2.842 . . . . 0.0 110.881 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 64.0 m -111.73 133.9 53.66 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.064 0.545 . . . . 0.0 109.98 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.42 137.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.716 0.407 . . . . 0.0 110.878 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.3 p -135.73 147.72 48.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.164 0.586 . . . . 0.0 110.659 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.9 166.1 54.73 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -135.44 27.1 3.43 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.397 0.679 . . . . 0.0 111.235 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -135.28 144.21 46.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.463 0.705 . . . . 0.0 109.616 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.81 163.89 51.74 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.29 171.99 16.94 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.399 3.399 . . . . 0.0 111.277 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -135.27 140.24 45.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.648 0.779 . . . . 0.0 109.42 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.4 m -114.0 129.26 56.62 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.816 0.446 . . . . 0.0 110.741 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.74 -179.27 52.86 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -147.15 136.18 11.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.529 2.82 . . . . 0.0 111.283 179.595 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.527 0.158 0 N-CA-C 113.117 0.391 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -137.48 54.98 1.81 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.797 0.439 . . . . 0.0 110.732 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.71 151.9 50.62 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.814 0.446 . . . . 0.0 111.288 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -135.35 24.44 3.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.401 0.68 . . . . 0.0 111.206 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -78.86 162.82 25.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.198 0.599 . . . . 0.0 111.682 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.48 138.51 53.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.594 0.757 . . . . 0.0 109.384 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.0 m -135.2 55.41 1.89 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.187 0.595 . . . . 0.0 110.553 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.35 152.12 45.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.615 0.366 . . . . 0.0 110.9 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -75.24 152.77 86.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.418 0.287 . . . . 0.0 110.506 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.53 174.38 12.9 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.051 3.167 . . . . 0.0 110.65 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -92.18 24.65 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.866 0.466 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -85.05 152.61 23.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.76 0.424 . . . . 0.0 110.39 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -112.22 156.42 42.04 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 122.895 0.478 . . . . 0.0 110.78 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.63 167.28 6.85 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.094 3.196 . . . . 0.0 113.039 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -132.03 157.26 78.7 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.174 0.99 . . . . 0.0 108.887 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.26 161.07 35.69 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.293 2.662 . . . . 0.0 112.38 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.14 141.22 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.236 0.614 . . . . 0.0 111.523 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.499 ' H ' HG12 ' A' ' 150' ' ' VAL . 6.3 t 63.88 14.18 8.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.683 1.593 . . . . 0.0 115.191 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -147.89 39.19 0.93 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.56 -0.712 . . . . 0.0 111.313 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -130.67 152.06 50.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.338 0.655 . . . . 0.0 109.875 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.9 m -130.05 26.66 5.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.828 0.451 . . . . 0.0 111.919 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 m -133.21 55.82 1.88 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.56 133.38 46.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.65 154.51 34.91 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.573 2.849 . . . . 0.0 110.59 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.52 17.29 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.67 3.58 . . . . 0.0 112.128 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -131.02 158.37 40.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.3 t60 58.99 46.93 12.84 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.163 1.385 . . . . 0.0 112.559 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.9 tp -135.61 142.98 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -100.57 8.86 43.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.541 ' H ' HG13 ' A' ' 28' ' ' ILE . 13.7 m -135.62 104.72 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.322 0.649 . . . . 0.0 110.055 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -141.44 125.27 17.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.557 0.343 . . . . 0.0 111.027 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -144.86 51.23 1.24 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.869 0.868 . . . . 0.0 109.568 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -73.95 146.08 44.18 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 122.658 0.383 . . . . 0.0 111.458 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.5 m -134.91 143.87 47.18 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.118 0.967 . . . . 0.0 108.533 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -110.9 141.58 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -133.39 144.61 49.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.991 0.516 . . . . 0.0 110.634 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.87 155.04 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.705 0.802 . . . . 0.0 108.935 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.22 170.22 36.23 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.0 77.35 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.119 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 m -47.97 114.34 3.26 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.682 0.793 . . . . 0.0 111.714 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.21 -8.17 10.84 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.533 2.822 . . . . 0.0 113.058 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.93 -18.2 31.37 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.974 0.806 . . . . 0.0 111.182 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 33.71 49.98 0.28 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.032 1.333 . . . . 0.0 112.608 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.3 tpp -135.58 -75.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -150.94 166.76 29.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.286 0.565 . . . . 0.0 111.675 -169.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.37 -4.77 31.97 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.683 0.793 . . . . 0.0 112.31 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -83.84 -8.86 59.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.03 -0.419 . . . . 0.0 111.57 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.95 -30.13 19.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.73 -26.41 59.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.1 -19.43 36.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.33 -13.37 59.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.044 0.383 . . . . 0.0 110.798 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.5 -5.5 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.32 12.77 20.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.243 0.617 . . . . 0.0 110.991 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 16.8 tppt? -91.45 -39.69 0.38 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.327 -0.844 . . . . 0.0 113.215 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 93.7 Cg_endo -78.72 -20.01 10.84 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.794 1.663 . . . . 0.0 113.43 -173.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -136.25 17.23 3.19 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.751 0.705 . . . . 0.0 112.694 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.25 170.23 22.35 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.994 -0.442 . . . . 0.0 110.952 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.9 55.9 1.17 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.602 0.761 . . . . 0.0 109.722 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.76 138.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.105 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -131.27 7.28 4.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -145.89 127.83 15.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -141.35 128.18 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 123.33 0.652 . . . . 0.0 109.629 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.4 138.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 122.912 0.485 . . . . 0.0 109.972 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mt -107.86 104.79 14.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.031 0.932 . . . . 0.0 109.739 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -80.91 94.0 6.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.0 m120 63.21 127.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.774 1.23 . . . . 0.0 110.473 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -76.06 22.0 0.16 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -146.69 25.48 1.18 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.966 0.507 . . . . 0.0 110.52 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -135.45 -88.38 0.34 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.125 -0.359 . . . . 0.0 111.695 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -137.42 159.25 42.47 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 123.16 0.584 . . . . 0.0 111.708 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.6 143.86 45.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.57 0.748 . . . . 0.0 109.181 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.34 133.18 56.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -135.71 151.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -135.16 135.64 41.24 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.716 0.406 . . . . 0.0 111.003 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -109.17 152.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 124.675 1.19 . . . . 0.0 110.011 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -82.2 -1.4 48.98 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.4 m -144.78 127.42 16.14 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.751 0.82 . . . . 0.0 109.222 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -8.99 58.14 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.214 -0.304 . . . . 0.0 111.755 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -87.29 -14.85 39.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.095 0.407 . . . . 0.0 110.225 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -88.61 -17.71 29.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.24 -41.01 70.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -69.94 -20.32 63.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -86.39 -9.54 56.12 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.115 -0.366 . . . . 0.0 111.581 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.63 -49.38 19.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -25.44 67.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -71.16 -44.89 64.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -77.42 -26.63 51.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.553 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.87 -0.63 52.04 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.244 -0.285 . . . . 0.0 110.436 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -125.96 8.14 7.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.734 0.243 . . . . 0.0 111.575 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -135.42 15.29 3.45 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.68 49.83 2.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.337 0.517 . . . . 0.0 110.73 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.34 10.04 81.7 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.445 -0.642 . . . . 0.0 112.63 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.75 98.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.916 1.286 . . . . 0.0 111.78 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.28 154.32 93.06 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -10.98 29.78 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.601 2.868 . . . . 0.0 112.109 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 96' ' ' LEU . 23.9 mt -80.26 119.71 23.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.82 104.54 14.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -111.73 139.2 47.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.986 0.422 . . . . 0.0 111.455 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -146.14 159.17 43.66 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.482 1.113 . . . . 0.0 109.427 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -127.62 156.27 42.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.06 -175.04 14.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.21 141.22 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.127 0.464 . . . . 0.0 110.837 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.87 1.99 61.21 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.627 0.632 . . . . 0.0 113.932 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.76 31.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.429 1.114 . . . . 0.0 112.056 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.91 163.08 54.47 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.25 125.83 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.58 2.854 . . . . 0.0 111.875 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -149.64 22.95 0.9 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.448 0.299 . . . . 0.0 110.998 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -148.36 48.81 1.04 Allowed 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.113 -0.367 . . . . 0.0 110.527 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 34.7 t -135.18 55.41 1.89 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.702 0.401 . . . . 0.0 110.463 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 83.2 m -121.05 21.18 11.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.691 0.396 . . . . 0.0 111.343 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.15 149.53 32.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.178 0.591 . . . . 0.0 109.484 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -68.55 -15.74 63.64 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.79 6.56 41.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.135 -0.353 . . . . 0.0 111.1 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -135.19 24.23 3.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 109.606 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.55 -12.65 0.19 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.032 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -98.89 24.08 8.12 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.669 1.234 . . . . 0.0 110.941 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.9 t -147.72 143.7 27.77 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.426 0.69 . . . . 0.0 109.683 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.88 103.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -143.99 39.16 0.26 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.514 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 43.7 Cg_endo -60.39 -35.97 88.92 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.142 2.561 . . . . 0.0 112.627 -169.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.17 14.26 3.04 Favored 'General case' 0 C--N 1.337 0.046 0 CA-C-N 118.117 0.417 . . . . 0.0 111.022 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -82.87 -18.15 41.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.148 -0.345 . . . . 0.0 111.054 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -97.88 -2.41 40.81 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 tp -109.8 -27.11 9.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -80.67 -26.58 37.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.45 -42.13 13.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.763 0.256 . . . . 0.0 111.539 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.36 -10.45 59.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.142 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -104.78 -20.69 13.52 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.912 0.778 . . . . 0.0 110.937 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.18 -13.82 58.22 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.012 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.12 -61.61 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -78.32 -0.42 28.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -138.97 -2.53 1.68 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.75 24.35 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.749 1.159 . . . . 0.0 111.208 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.5 p -72.84 55.06 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.755 -0.591 . . . . 0.0 111.828 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 137.68 42.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.195 0.598 . . . . 0.0 110.487 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 53.13 27.5 5.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.973 . . . . 0.0 112.432 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 78.4 m95 54.26 24.98 5.4 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.05 0.94 . . . . 0.0 112.759 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.01 170.38 54.66 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 176.18 147.0 6.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.4 m 58.2 7.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.325 1.45 . . . . 0.0 113.197 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.9 p -160.21 19.83 0.15 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.768 -0.583 . . . . 0.0 111.375 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -93.46 -21.89 28.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.206 -0.775 . . . . 0.0 114.001 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -149.09 160.77 34.23 Favored Pre-proline 0 C--O 1.227 -0.096 0 CA-C-N 118.515 1.158 . . . . 0.0 110.187 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.51 -1.27 0.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.28 3.32 . . . . 0.0 114.415 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.54 -8.14 56.0 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.809 0.732 . . . . 0.0 110.712 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.61 9.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.028 0.531 . . . . 0.0 110.553 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.1 p -128.31 31.51 5.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.05 0.54 . . . . 0.0 109.964 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.22 -26.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.55 65.24 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 121.556 0.693 . . . . 0.0 110.229 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 18' ' ' SER . 19.9 m -135.98 18.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -138.14 40.1 2.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -135.19 151.46 50.67 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 154' ' ' PRO . 25.5 tt0 -154.73 43.74 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 111.061 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 153' ' ' GLU . 60.9 Cg_endo -77.89 -18.46 13.15 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 48.28 52.44 13.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.638 0.775 . . . . 0.0 111.81 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 8.4 tt -133.97 141.09 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.86 109.09 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 m -83.93 68.02 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 121.343 0.592 . . . . 0.0 110.545 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.04 -163.09 12.32 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.57 104.6 3.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.131 0.466 . . . . 0.0 110.299 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -85.55 -169.62 46.17 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.363 0.506 . . . . 0.0 111.921 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -135.36 141.25 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.829 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.1 m -135.36 36.55 2.96 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.092 0.557 . . . . 0.0 111.15 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.0 m -82.25 40.18 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.323 0.649 . . . . 0.0 111.46 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -135.73 155.73 49.93 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.809 0.844 . . . . 0.0 110.637 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.32 146.35 48.37 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.008 0.523 . . . . 0.0 110.761 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.97 139.28 47.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.747 0.819 . . . . 0.0 108.852 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 m -61.82 138.33 58.33 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.774 0.429 . . . . 0.0 111.108 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.82 40.26 0.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.558 0.743 . . . . 0.0 111.221 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.67 110.16 8.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 109.868 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 15.3 tpt -150.5 135.79 10.12 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.13 168.73 23.27 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.315 2.676 . . . . 0.0 111.066 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.5 p -127.54 32.4 5.01 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.474 0.71 . . . . 0.0 110.598 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -82.79 55.67 3.12 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.513 0.725 . . . . 0.0 110.88 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.6 m -134.7 128.48 33.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.198 0.599 . . . . 0.0 110.225 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.78 178.14 53.92 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -135.35 25.05 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.449 0.7 . . . . 0.0 111.068 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.66 154.66 51.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.708 0.803 . . . . 0.0 109.856 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.99 174.63 37.63 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.32 160.42 48.82 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 124.144 3.229 . . . . 0.0 111.427 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.51 151.63 50.54 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.034 0.933 . . . . 0.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.3 t -135.51 138.7 43.35 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.881 0.473 . . . . 0.0 110.541 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.47 176.76 41.42 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 37.9 mtmm -85.47 -41.91 0.63 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.165 -0.922 . . . . 0.0 113.074 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 85.0 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.204 1.936 . . . . 0.0 111.093 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.472 0.239 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -135.43 153.02 51.92 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.395 0.678 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.09 158.28 44.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.381 0.673 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.3 55.43 2.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.229 0.612 . . . . 0.0 110.666 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 55.08 34.8 23.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.104 0.961 . . . . 0.0 111.698 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.17 132.48 33.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 122.842 0.457 . . . . 0.0 109.847 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -66.73 120.99 14.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.15 156.63 46.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.194 0.598 . . . . 0.0 110.758 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 47.64 59.48 16.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.04 0.936 . . . . 0.0 112.272 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.87 171.36 12.4 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.669 2.913 . . . . 0.0 111.098 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.49 150.98 39.62 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.09 0.556 . . . . 0.0 110.824 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -133.01 45.65 2.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.993 0.517 . . . . 0.0 111.706 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -135.42 158.93 73.46 Favored Pre-proline 0 CA--C 1.529 0.173 0 C-N-CA 122.736 0.414 . . . . 0.0 110.192 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -55.6 151.81 36.88 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.218 3.279 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -152.06 47.66 0.42 Allowed Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.616 0.766 . . . . 0.0 110.993 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.6 -14.37 44.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.498 2.799 . . . . 0.0 113.375 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.27 -50.73 5.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.324 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.6 t -158.91 -65.45 0.08 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.026 0.375 . . . . 0.0 111.217 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -146.09 48.35 1.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.225 1.01 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.03 -48.43 64.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.945 0.898 . . . . 0.0 112.481 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 76.9 p 51.18 26.09 2.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.041 0.937 . . . . 0.0 113.124 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 m 65.36 101.2 0.04 OUTLIER 'General case' 0 C--N 1.339 0.109 0 C-N-CA 125.086 1.354 . . . . 0.0 111.696 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' HD22 ' A' ' 23' ' ' LEU . 2.5 mm? -87.45 157.94 52.32 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.127 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.56 148.08 87.12 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.653 2.235 . . . . 0.0 109.62 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.9 12.79 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.589 3.526 . . . . 0.0 113.278 -173.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -135.08 142.0 46.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 63.46 140.22 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.715 2.006 . . . . 0.0 114.994 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.7 tp -75.65 137.71 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.52 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -113.32 24.69 12.01 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.053 0.541 . . . . 0.0 112.138 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' H ' HG13 ' A' ' 28' ' ' ILE . 55.4 t -106.16 -3.69 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.209 0.604 . . . . 0.0 109.722 174.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -141.34 32.72 1.69 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.868 0.867 . . . . 0.0 110.038 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 t -135.38 159.4 41.69 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.88 0.472 . . . . 0.0 111.256 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -111.85 129.39 56.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.404 1.082 . . . . 0.0 109.163 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -135.65 154.44 51.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.5 tp -121.32 115.46 23.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -89.02 135.96 33.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.218 1.007 . . . . 0.0 110.445 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.8 mm -127.48 104.69 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.56 164.07 13.03 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.225 0.347 . . . . 0.0 113.232 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 -47.74 3.0 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.99 1.281 . . . . 0.0 112.596 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m 37.64 48.64 1.35 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.375 1.47 . . . . 0.0 114.741 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.81 1.95 4.01 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.829 2.352 . . . . 0.0 110.159 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.44 43.49 0.55 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.874 1.67 . . . . 0.0 110.775 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 56.88 24.13 8.94 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.974 1.31 . . . . 0.0 112.57 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.3 ptt? 34.35 55.21 0.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.324 1.45 . . . . 0.0 113.575 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -128.68 129.32 45.64 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.96 -13.88 62.28 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -82.77 -14.67 54.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.284 0.493 . . . . 0.0 110.594 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -95.42 -24.81 16.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.191 -0.318 . . . . 0.0 110.347 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.71 -26.59 62.55 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 -20.36 36.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -79.44 -6.56 57.13 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.109 -0.369 . . . . 0.0 111.168 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.83 -3.25 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.17 -0.331 . . . . 0.0 111.889 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -113.44 15.68 19.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.532 0.733 . . . . 0.0 110.202 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttm -101.62 -40.06 0.21 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.566 169.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 32.5 Cg_exo -61.55 114.61 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.233 1.955 . . . . 0.0 110.344 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.81 30.88 5.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.55 0.74 . . . . 0.0 112.008 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.46 161.97 40.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.028 0.531 . . . . 0.0 110.883 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -138.7 85.74 2.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.672 0.389 . . . . 0.0 111.025 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.6 140.42 25.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -135.17 8.15 3.43 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.0 m -135.7 119.6 17.4 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.59 128.52 33.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.149 0.579 . . . . 0.0 110.122 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.39 143.77 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 171.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -125.4 137.86 54.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.626 1.17 . . . . 0.0 110.838 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -112.03 98.43 7.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -83.15 43.21 0.85 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.037 0.535 . . . . 0.0 111.765 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.02 -7.04 2.35 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.636 0.374 . . . . 0.0 110.914 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -153.21 35.03 0.47 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.735 0.414 . . . . 0.0 110.63 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 33.99 55.59 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.803 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -125.83 141.57 51.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.323 0.649 . . . . 0.0 111.029 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.98 154.28 47.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.293 0.568 . . . . 0.0 111.227 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -135.24 132.76 38.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.73 38.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.688 0.28 . . . . 0.0 111.379 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -135.42 129.97 34.1 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.117 0.484 . . . . 0.0 110.885 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.96 148.13 9.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.127 1.371 . . . . 0.0 108.984 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.17 24.26 11.75 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.4 t -148.72 132.16 16.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.848 0.859 . . . . 0.0 108.813 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -78.19 -14.63 59.38 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.137 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.58 -25.45 24.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -87.47 -16.37 34.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -47.84 67.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.11 -14.37 59.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.76 -11.37 48.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.477 0.581 . . . . 0.0 111.09 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.14 -41.5 17.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.08 -21.91 64.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.884 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -77.17 -26.2 52.71 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.707 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -68.56 -42.25 78.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -83.34 10.24 9.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.367 -0.208 . . . . 0.0 111.342 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -116.35 1.27 13.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.262 0.625 . . . . 0.0 109.716 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -135.58 18.57 3.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.875 0.47 . . . . 0.0 111.406 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -134.75 48.04 2.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.178 0.513 . . . . 0.0 110.957 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.88 -13.63 12.91 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.614 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.18 33.84 18.9 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.056 0.928 . . . . 0.0 113.413 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.722 ' H ' ' CD ' ' A' ' 95' ' ' PRO . 80.4 mt -136.21 -28.23 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.722 ' CD ' ' H ' ' A' ' 94' ' ' LEU . 76.9 Cg_exo -55.35 -31.64 78.05 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.075 1.85 . . . . 0.0 113.246 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt -143.2 143.22 31.68 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.422 0.689 . . . . 0.0 109.892 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -94.85 97.07 9.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.0 p -114.41 138.03 51.09 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -173.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -146.05 146.21 30.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.277 1.031 . . . . 0.0 109.127 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -135.08 160.52 38.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 110.917 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 165.7 37.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.13 142.28 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.743 0.817 . . . . 0.0 109.692 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.73 121.2 5.69 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.54 24.26 1.74 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.294 0.638 . . . . 0.0 111.136 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.59 178.94 52.73 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.54 161.92 41.14 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.02 3.147 . . . . 0.0 111.514 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -87.44 125.16 34.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.244 0.617 . . . . 0.0 110.477 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 52.58 30.68 8.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.236 1.014 . . . . 0.0 112.752 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 12.6 t -135.77 36.52 2.87 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.93 0.492 . . . . 0.0 110.114 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.63 141.67 45.1 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.21 0.604 . . . . 0.0 110.221 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -78.03 150.83 33.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.717 0.407 . . . . 0.0 110.042 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -70.18 -6.95 37.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -85.68 0.24 53.29 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.44 0.563 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -135.81 12.49 3.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.838 0.855 . . . . 0.0 109.953 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.45 -11.41 7.33 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -135.01 24.07 3.57 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.176 0.59 . . . . 0.0 110.0 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.4 m -139.99 137.89 35.06 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.934 0.894 . . . . 0.0 109.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.2 tt -90.06 130.98 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.714 0.293 . . . . 0.0 110.496 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -142.27 151.08 57.39 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 123.509 0.724 . . . . 0.0 109.928 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.19 176.92 8.5 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.557 2.838 . . . . 0.0 110.618 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.65 27.63 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.343 0.657 . . . . 0.0 112.483 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -15.43 51.75 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.711 -0.618 . . . . 0.0 111.294 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -85.43 -6.76 59.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.02 -42.8 9.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.53 0.732 . . . . 0.0 109.6 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -76.29 -16.74 59.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.56 -51.2 6.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.737 -0.602 . . . . 0.0 110.398 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.26 -8.68 58.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -112.81 -15.86 12.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.759 0.709 . . . . 0.0 111.487 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -20.99 61.07 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.54 -54.28 4.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.509 0.324 . . . . 0.0 110.561 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -82.91 6.14 19.53 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -147.37 0.68 0.7 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.53 15.25 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.269 0.94 . . . . 0.0 111.133 174.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.8 m -135.0 24.74 3.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.991 0.517 . . . . 0.0 109.911 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.5 151.24 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.057 0.943 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.81 20.79 1.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -141.91 24.27 2.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.458 0.703 . . . . 0.0 110.413 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.56 -159.74 35.75 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.479 0.562 . . . . 0.0 112.135 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.68 -154.28 2.37 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.091 0.853 . . . . 0.0 111.747 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.7 m -103.77 70.6 1.02 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 t 60.71 32.03 20.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.707 0.803 . . . . 0.0 111.829 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.27 79.6 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.959 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.7 -44.38 0.5 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 118.361 1.081 . . . . 0.0 113.305 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -90.53 -19.57 1.07 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.544 2.163 . . . . 0.0 113.43 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.65 -7.66 59.15 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -171.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.8 m -74.85 -0.8 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 CA-C-N 117.877 0.308 . . . . 0.0 111.241 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 t -147.67 23.22 1.12 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.367 1.067 . . . . 0.0 108.41 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.5 34.15 0.3 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.605 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.7 mm -49.0 -29.21 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 117.582 0.691 . . . . 0.0 111.956 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.3 m 44.2 29.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.55 1.54 . . . . 0.0 114.242 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -135.27 150.17 49.98 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.053 0.388 . . . . 0.0 110.555 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -133.47 24.63 4.09 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.569 0.748 . . . . 0.0 109.327 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -153.84 141.21 13.48 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.929 0.892 . . . . 0.0 108.689 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -67.78 158.35 57.65 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.169 2.579 . . . . 0.0 111.236 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.23 141.94 32.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.57 0.348 . . . . 0.0 110.856 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.58 129.8 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.014 0.526 . . . . 0.0 110.056 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 pp -135.43 151.44 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.641 0.776 . . . . 0.0 110.366 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.0 m -135.89 146.27 29.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.087 0.555 . . . . 0.0 110.866 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -85.29 -150.06 12.62 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 67.51 143.65 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.182 1.393 . . . . 0.0 113.315 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.53 177.01 45.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.21 130.44 51.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 122.75 0.42 . . . . 0.0 110.287 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.4 m -135.65 105.82 6.33 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.617 0.767 . . . . 0.0 109.125 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 t -135.76 151.09 49.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.854 0.461 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -135.41 152.18 51.16 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.849 0.859 . . . . 0.0 110.175 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.33 153.57 51.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.847 0.459 . . . . 0.0 111.36 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 tt -135.37 149.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.858 0.863 . . . . 0.0 109.632 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.7 p -135.11 152.77 51.94 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.866 0.466 . . . . 0.0 111.291 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 62.58 118.74 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.715 1.606 . . . . 0.0 113.091 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -135.45 33.34 3.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.493 0.717 . . . . 0.0 109.936 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.8 ptm -151.66 154.28 32.98 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 123.407 0.683 . . . . 0.0 110.119 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -71.41 148.43 54.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.391 2.727 . . . . 0.0 110.664 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.2 p -135.89 25.04 3.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.281 0.633 . . . . 0.0 111.168 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -102.14 24.74 9.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.187 0.595 . . . . 0.0 111.725 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 35.4 t -81.26 136.44 35.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.632 0.373 . . . . 0.0 110.829 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 174.98 160.81 23.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -142.96 152.11 41.64 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.208 0.603 . . . . 0.0 111.016 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 131.18 57.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.365 0.666 . . . . 0.0 109.488 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.64 158.61 48.94 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.34 159.91 42.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.954 3.103 . . . . 0.0 110.931 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -135.38 112.72 10.57 Favored 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.611 0.764 . . . . 0.0 109.475 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 65.2 p -135.96 131.11 34.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.509 . . . . 0.0 110.798 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.34 173.73 51.82 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 29.1 mtpp -85.53 -34.73 0.51 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.869 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 54.7 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.104 2.536 . . . . 0.0 112.451 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.527 0.155 0 N-CA-C 112.554 0.175 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.69 154.4 21.0 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.795 0.438 . . . . 0.0 110.806 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.81 144.74 52.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.568 0.347 . . . . 0.0 110.744 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.79 27.1 6.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.442 0.697 . . . . 0.0 111.544 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -80.6 44.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.26 1.024 . . . . 0.0 111.438 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.8 p -67.0 145.5 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.185 0.594 . . . . 0.0 110.783 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 t -75.18 148.91 39.17 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.985 0.514 . . . . 0.0 111.075 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -90.44 105.0 17.52 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.828 0.451 . . . . 0.0 109.852 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -148.09 156.01 43.56 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.041 0.537 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.66 158.57 56.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.342 2.695 . . . . 0.0 110.237 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -139.55 46.47 1.89 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.732 0.413 . . . . 0.0 110.594 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -64.69 140.29 58.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.517 0.327 . . . . 0.0 110.127 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -123.4 150.06 59.72 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.912 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 -172.13 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 124.34 3.36 . . . . 0.0 110.535 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.31 166.22 0.11 Allowed Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.04 1.336 . . . . 0.0 112.881 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.05 -176.87 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.727 3.618 . . . . 0.0 113.811 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.91 148.48 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.941 0.896 . . . . 0.0 112.018 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.429 ' H ' HG21 ' A' ' 150' ' ' VAL . 32.3 m -71.22 65.47 0.4 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.628 1.171 . . . . 0.0 111.77 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 72.81 29.81 1.85 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.754 1.622 . . . . 0.0 114.703 172.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.5 104.58 7.05 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 m -87.87 25.59 1.5 Allowed 'General case' 0 C--O 1.231 0.088 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' CD ' ' A' ' 24' ' ' PRO . 35.2 p -140.84 87.77 2.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.153 0.981 . . . . 0.0 109.362 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 6.9 mp -108.72 39.1 0.11 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.346 1.058 . . . . 0.0 112.114 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 23' ' ' LEU . 62.2 Cg_endo -76.73 172.18 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.938 2.425 . . . . 0.0 109.391 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.3 160.82 21.86 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.584 2.189 . . . . 0.0 110.548 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 59.25 24.48 12.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.952 0.901 . . . . 0.0 112.415 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -136.27 129.15 31.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.587 0.755 . . . . 0.0 109.039 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.41 ' CD1' HD23 ' A' ' 124' ' ' LEU . 5.1 tp -148.54 138.77 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.563 0.345 . . . . 0.0 110.685 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -137.86 22.87 2.86 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.97 125.32 18.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 119.757 1.162 . . . . 0.0 109.24 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.43 163.78 22.53 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.293 0.637 . . . . 0.0 111.74 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -130.47 145.81 51.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.952 0.901 . . . . 0.0 109.053 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -126.57 29.5 5.72 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 m -132.31 104.62 6.84 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -101.89 140.5 36.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -130.12 137.75 50.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.34 0.656 . . . . 0.0 110.124 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 5.8 mm -120.33 113.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.83 160.7 16.92 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.31 17.98 74.71 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.639 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.44 130.15 34.12 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.388 1.094 . . . . 0.0 110.789 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.52 -0.6 10.54 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.43 2.753 . . . . 0.0 111.425 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.68 152.41 33.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.371 0.605 . . . . 0.0 111.44 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -97.28 55.36 1.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.1 ttt 62.96 70.14 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.564 1.145 . . . . 0.0 112.198 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.35 88.75 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.09 -11.58 20.87 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.613 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -82.91 -12.41 57.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.082 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -93.88 -22.59 18.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 118.938 -1.105 . . . . 0.0 110.55 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.65 -25.51 59.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.11 -18.07 38.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -76.47 -10.39 59.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.057 -0.402 . . . . 0.0 110.595 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.5 -4.69 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.44 17.52 19.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.45 0.7 . . . . 0.0 110.519 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 55' ' ' PRO . 88.6 tttt -114.13 -35.95 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 60.4 Cg_exo -56.91 -31.73 90.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.402 2.068 . . . . 0.0 113.648 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.18 22.78 2.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.856 0.298 . . . . 0.0 111.642 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.96 176.81 11.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.626 0.37 . . . . 0.0 110.733 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.49 76.05 1.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.003 0.43 . . . . 0.0 110.505 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.03 140.57 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -131.86 7.16 4.37 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -142.8 125.85 16.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.977 0.511 . . . . 0.0 109.729 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.75 127.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 122.965 0.506 . . . . 0.0 109.759 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.14 135.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mt -128.67 143.29 50.91 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.068 0.547 . . . . 0.0 111.639 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -123.26 104.68 9.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.27 1.028 . . . . 0.0 108.371 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -83.52 24.67 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -120.38 -3.5 9.94 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.232 -0.292 . . . . 0.0 111.725 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtm-85 -144.97 8.54 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.889 0.476 . . . . 0.0 111.304 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 51.76 42.45 29.9 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.23 0.612 . . . . 0.0 111.221 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -111.27 145.61 38.47 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.735 0.814 . . . . 0.0 110.113 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -140.83 150.64 43.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -125.03 127.18 46.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.9 151.1 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.476 0.125 . . . . 0.0 110.692 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.58 136.39 41.04 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.41 155.53 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 124.48 1.112 . . . . 0.0 110.567 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -93.71 10.58 32.33 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.2 t -151.33 134.88 16.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.13 0.572 . . . . 0.0 109.913 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.55 -16.13 58.84 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.45 -25.35 33.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -83.91 -13.74 52.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.77 67.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -71.12 -18.88 62.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.777 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -82.01 -18.9 41.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.46 0.573 . . . . 0.0 111.6 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.47 -44.16 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 118.565 0.621 . . . . 0.0 109.809 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.26 -23.02 64.73 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.42 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -83.16 -10.42 58.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.884 -0.51 . . . . 0.0 110.77 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.0 -27.9 24.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -94.82 4.92 53.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.267 -0.271 . . . . 0.0 111.245 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -134.8 6.03 3.41 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -149.44 15.01 0.88 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -135.37 55.16 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.84 0.745 . . . . 0.0 110.931 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.27 83.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.201 -0.777 . . . . 0.0 113.394 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.1 74.08 0.26 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.995 0.897 . . . . 0.0 111.625 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.96 159.62 13.14 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.068 0.547 . . . . 0.0 111.265 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 -9.4 9.06 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.483 3.455 . . . . 0.0 114.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.95 128.57 36.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.587 0.63 . . . . 0.0 110.552 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -90.59 71.52 6.83 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.56 0.744 . . . . 0.0 109.083 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.6 m -74.89 129.86 38.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.146 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -135.68 149.11 49.17 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.387 1.075 . . . . 0.0 109.022 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -128.34 150.77 49.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.983 0.42 . . . . 0.0 111.575 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.51 -164.35 28.6 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.9 138.2 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.187 0.493 . . . . 0.0 110.394 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.21 12.52 37.71 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.429 0.538 . . . . 0.0 112.539 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -50.9 130.75 25.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.576 0.75 . . . . 0.0 111.428 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.37 -177.95 17.92 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.17 157.02 60.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.608 2.872 . . . . 0.0 110.556 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 88.2 mtm-85 50.84 55.01 10.2 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.541 0.736 . . . . 0.0 111.198 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -52.44 125.89 17.64 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.61 0.764 . . . . 0.0 111.312 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.9 m 54.91 27.69 9.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 0.0 113.4 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.5 m -121.74 11.37 10.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.897 0.317 . . . . 0.0 111.288 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -147.73 151.66 36.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 108.877 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -73.1 -2.57 21.93 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.252 -0.28 . . . . 0.0 111.414 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.68 5.94 41.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.913 0.485 . . . . 0.0 110.284 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -136.84 33.86 2.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.007 0.923 . . . . 0.0 109.779 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 176.03 -14.14 0.03 OUTLIER Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.09 -0.839 . . . . 0.0 113.693 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -135.17 25.03 3.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.867 1.334 . . . . 0.0 111.214 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.5 m -135.57 148.83 49.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.886 0.875 . . . . 0.0 109.536 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.4 tt -135.5 145.67 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 122.644 0.377 . . . . 0.0 111.018 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.93 157.95 75.98 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.016 0.926 . . . . 0.0 109.415 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.05 166.66 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.434 2.756 . . . . 0.0 111.012 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -124.85 25.66 7.31 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.823 0.449 . . . . 0.0 111.48 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -83.59 -9.87 58.63 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.813 -0.554 . . . . 0.0 111.217 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -88.8 3.25 51.74 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.407 0.283 . . . . 0.0 110.589 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.41 HD23 ' CD1' ' A' ' 28' ' ' ILE . 2.9 tp -90.66 -50.4 5.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.741 0.816 . . . . 0.0 108.887 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.6 m -77.65 -19.9 54.66 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.197 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.35 -45.82 12.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.043 -0.411 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.5 -19.12 39.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.273 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.87 -20.8 17.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.693 0.679 . . . . 0.0 110.997 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -67.36 -35.17 78.83 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.667 170.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.6 -77.66 0.1 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.145 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -89.15 18.71 4.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.5 t -138.89 -4.31 1.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.67 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 t -136.44 24.22 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.294 0.952 . . . . 0.0 111.27 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.8 p -73.64 24.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.133 -0.979 . . . . 0.0 112.952 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.06 24.13 3.56 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.958 -0.464 . . . . 0.0 111.087 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -147.0 144.07 28.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.668 0.787 . . . . 0.0 109.355 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -72.79 104.71 4.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.98 -179.8 49.5 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -81.81 -153.98 12.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 67.4 104.56 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.227 1.411 . . . . 0.0 113.371 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m 54.47 30.11 12.33 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.4 -33.27 53.53 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -140.78 167.05 18.85 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.29 5.56 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.462 1 C-N-CA 125.437 4.091 . . . . 0.0 116.332 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.25 22.89 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.56 1.073 . . . . 0.0 111.769 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.73 1.48 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.785 0.834 . . . . 0.0 111.171 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.6 p -127.68 24.83 6.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.4 -21.85 4.27 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mm -102.72 0.93 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.45 0.625 . . . . 0.0 111.028 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.429 HG21 ' H ' ' A' ' 18' ' ' SER . 28.3 m -135.47 4.85 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 122.074 -0.391 . . . . 0.0 111.952 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -157.57 156.32 31.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.277 0.489 . . . . 0.0 110.71 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.86 31.66 0.61 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.823 0.849 . . . . 0.0 112.991 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.435 ' N ' ' HD2' ' A' ' 154' ' ' PRO . 26.4 tp10 -74.81 -38.67 3.18 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 153' ' ' GLU . 86.7 Cg_endo -77.09 160.31 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.991 1.794 . . . . 0.0 111.823 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.63 131.44 34.16 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.286 0.635 . . . . 0.0 109.886 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.3 tt -91.91 132.05 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -135.37 129.79 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.706 0.802 . . . . 0.0 109.174 175.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.43 137.31 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.064 0 C-N-CA 122.583 0.353 . . . . 0.0 110.673 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.4 0.03 85.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.62 104.31 7.06 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.14 0.576 . . . . 0.0 110.022 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -91.35 -4.55 68.25 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.08 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.1 p -85.93 140.72 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.0 0.9 . . . . 0.0 110.715 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.5 m -135.51 156.45 48.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.508 0.723 . . . . 0.0 110.45 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 79.8 p -134.44 149.53 50.76 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.258 0.623 . . . . 0.0 110.541 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -80.62 141.54 34.89 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.819 0.447 . . . . 0.0 110.884 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.48 25.82 3.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.414 0.686 . . . . 0.0 110.752 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.3 tt -80.77 142.12 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.091 0.556 . . . . 0.0 111.109 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.7 t -137.18 145.63 43.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.491 0.717 . . . . 0.0 109.991 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -135.29 135.17 40.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.974 0.509 . . . . 0.0 110.368 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.59 159.89 40.44 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.577 0.751 . . . . 0.0 110.381 178.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.0 128.4 9.31 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 163.77 37.9 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.865 3.043 . . . . 0.0 112.66 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -135.85 145.55 46.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.118 0.567 . . . . 0.0 110.459 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -136.31 143.48 44.18 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.055 0.542 . . . . 0.0 110.602 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.3 p -135.39 24.75 3.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.207 0.603 . . . . 0.0 111.106 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.15 -1.59 90.51 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.417 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -74.77 104.52 5.44 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.714 0.757 . . . . 0.0 109.837 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.72 136.5 54.49 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.874 0.87 . . . . 0.0 109.333 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.49 144.51 33.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.75 153.49 33.69 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.701 2.934 . . . . 0.0 111.247 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -145.4 131.55 19.41 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.301 0.64 . . . . 0.0 109.449 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.4 p -135.86 147.07 48.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.876 0.47 . . . . 0.0 111.151 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.15 177.01 54.48 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.3 157.86 71.82 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.26 0.624 . . . . 0.0 110.102 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 124.009 3.139 . . . . 0.0 112.428 178.587 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo . . . . . 0 N--CA 1.472 0.218 0 N-CA-C 112.76 0.254 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -135.6 142.69 45.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.11 0.564 . . . . 0.0 110.264 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -135.7 149.14 49.15 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.039 0.536 . . . . 0.0 110.81 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.1 152.98 52.16 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.699 0.8 . . . . 0.0 110.279 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -69.15 152.42 45.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.918 0.487 . . . . 0.0 110.311 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.77 139.61 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 122.826 0.451 . . . . 0.0 111.107 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 m -75.05 144.31 43.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.981 0.512 . . . . 0.0 111.518 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -135.65 144.31 45.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.613 0.765 . . . . 0.0 109.195 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -71.52 143.09 87.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 122.426 -0.171 . . . . 0.0 110.642 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.9 168.63 21.88 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.06 3.173 . . . . 0.0 111.354 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -92.64 158.23 16.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.332 0.653 . . . . 0.0 110.082 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -63.76 149.47 46.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.352 0.261 . . . . 0.0 110.737 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -126.37 155.0 74.86 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.593 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 167.09 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.638 2.892 . . . . 0.0 110.701 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.75 153.99 76.11 Favored Pre-proline 0 CA--C 1.528 0.134 0 C-N-CA 123.133 0.573 . . . . 0.0 110.4 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.9 174.82 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.833 3.022 . . . . 0.0 110.561 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.24 116.08 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.3 t -135.87 136.55 40.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.043 0.537 . . . . 0.0 109.821 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -75.05 120.78 21.04 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.509 0.671 . . . . 0.0 111.497 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 63.17 57.69 1.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.262 . . . . 0.0 112.779 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.9 p -135.04 -170.27 2.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.678 0.791 . . . . 0.0 110.254 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -99.02 55.95 1.03 Allowed 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.893 0.877 . . . . 0.0 111.042 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.729 HD22 ' H ' ' A' ' 23' ' ' LEU . 1.5 mm? -66.75 135.99 94.5 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 122.591 0.357 . . . . 0.0 110.386 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.56 112.46 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.515 2.81 . . . . 0.0 109.577 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.9 149.05 25.68 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.127 2.552 . . . . 0.0 112.247 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.09 -4.56 2.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.971 0.508 . . . . 0.0 111.041 171.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -157.66 104.09 1.95 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CD1' ' H ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -140.36 133.54 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' N ' HD13 ' A' ' 28' ' ' ILE . 75.0 mmtt -132.62 20.21 4.27 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.616 ' H ' ' CD1' ' A' ' 28' ' ' ILE . 7.0 m -135.49 39.78 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.196 0.999 . . . . 0.0 109.69 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.89 121.94 15.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.093 0.557 . . . . 0.0 110.223 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.7 t -79.23 131.03 36.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -135.11 -4.29 2.42 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.297 0.239 . . . . 0.0 111.283 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -142.36 136.67 29.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.82 133.62 47.05 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.59 145.22 46.7 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.307 0.575 . . . . 0.0 111.521 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.91 153.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.007 0.923 . . . . 0.0 109.361 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.29 164.47 30.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.25 19.97 79.29 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.35 -0.694 . . . . 0.0 112.724 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -48.63 129.72 13.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.114 0.957 . . . . 0.0 111.175 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -85.0 5.57 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.309 3.339 . . . . 0.0 111.458 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.98 159.63 24.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 112.291 -170.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.06 63.55 6.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.559 0.744 . . . . 0.0 109.764 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.5 ptm 51.31 104.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.126 2.17 . . . . 0.0 114.475 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.75 102.43 3.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.26 -19.33 65.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -85.21 -7.08 59.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.139 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -98.14 -21.57 16.67 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.306 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.09 -28.87 62.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.07 -22.26 45.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.521 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.22 -14.14 60.5 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.181 -0.324 . . . . 0.0 111.202 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.19 -0.67 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.194 -0.316 . . . . 0.0 111.783 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.1 10.89 28.0 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.421 0.688 . . . . 0.0 109.585 170.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 25.3 ttmm -78.77 -33.89 0.93 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.622 171.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.0 Cg_exo -57.7 115.04 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.444 2.096 . . . . 0.0 111.951 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 51.22 24.27 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.703 1.201 . . . . 0.0 113.455 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.8 157.29 41.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.124 0.57 . . . . 0.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -132.46 56.47 1.83 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.123 0.569 . . . . 0.0 110.298 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.42 139.04 15.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -129.3 3.37 5.16 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -135.05 121.25 20.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.051 -0.405 . . . . 0.0 110.288 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.98 129.17 43.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.497 0.719 . . . . 0.0 109.925 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.65 141.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 1.6 tt -134.23 121.72 21.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.214 . . . . 0.0 110.476 -169.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -100.87 104.4 15.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.068 0.547 . . . . 0.0 109.976 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -86.94 24.49 1.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.056 0.542 . . . . 0.0 111.812 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -127.37 2.61 6.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.735 0.414 . . . . 0.0 110.649 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -136.12 7.74 3.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.2 32.5 10.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.07 0.948 . . . . 0.0 111.446 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -134.39 152.62 51.91 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.409 0.683 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . . . -135.76 156.3 49.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.548 0.739 . . . . 0.0 110.235 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.85 134.39 49.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.78 151.45 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -135.1 139.37 44.64 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.453 0.644 . . . . 0.0 112.018 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.71 161.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 125.988 1.715 . . . . 0.0 109.172 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -108.27 22.59 15.72 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -152.59 137.48 17.14 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.201 0.6 . . . . 0.0 109.734 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.97 -9.59 58.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.316 -0.24 . . . . 0.0 111.502 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -86.84 -18.02 31.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -88.12 -22.1 24.29 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.24 43.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.09 -21.86 33.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.35 -0.219 . . . . 0.0 110.657 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.59 -19.47 38.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.014 -0.429 . . . . 0.0 110.871 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.76 -43.16 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.93 -17.0 62.7 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.075 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -74.46 -28.45 61.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.463 0.574 . . . . 0.0 109.532 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -76.1 -28.29 57.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.973 -0.454 . . . . 0.0 109.827 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -93.09 6.94 46.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.409 0.284 . . . . 0.0 111.013 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.02 16.28 3.51 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.381 0.272 . . . . 0.0 111.313 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -135.72 -8.02 2.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 -23.12 15.15 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.04 0.836 . . . . 0.0 110.786 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.21 1.16 0.63 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.832 1.206 . . . . 0.0 115.614 172.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.55 45.1 1.94 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.064 1.432 . . . . 0.0 112.159 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.81 142.69 28.19 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.52 -11.66 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.311 3.341 . . . . 0.0 112.821 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -86.51 146.13 26.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.973 0.351 . . . . 0.0 110.799 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.13 104.59 10.97 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.4 m -103.49 134.7 46.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.313 0.645 . . . . 0.0 111.327 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -136.81 153.45 50.81 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.335 1.054 . . . . 0.0 108.925 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -123.4 144.8 49.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.934 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.22 148.62 17.24 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 104' ' ' PHE . 12.4 p -92.88 138.24 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.082 0.553 . . . . 0.0 110.694 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.06 5.59 82.37 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.62 0.629 . . . . 0.0 112.788 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.514 ' H ' HG22 ' A' ' 102' ' ' VAL . 67.0 t80 -116.46 144.49 44.25 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.642 0.721 . . . . 0.0 110.484 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.7 178.35 42.74 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.03 0.347 . . . . 0.0 112.592 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.86 175.72 9.98 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.396 3.398 . . . . 0.0 111.151 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -131.9 153.48 50.21 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 123.731 0.812 . . . . 0.0 110.475 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -134.99 51.8 2.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 110.226 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 15.9 t -135.33 42.56 2.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.272 0.629 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 48.7 t -135.88 147.97 48.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.74 0.816 . . . . 0.0 109.95 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.55 142.03 58.55 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -69.25 -9.31 52.51 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -83.61 -1.86 54.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.632 0.651 . . . . 0.0 110.465 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.91 3.65 2.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.692 0.797 . . . . 0.0 110.253 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.66 -19.5 24.73 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -93.55 32.51 1.38 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.12 0.568 . . . . 0.0 110.011 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.7 t -136.13 146.62 47.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.981 0.912 . . . . 0.0 109.478 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 118' ' ' ILE . 2.7 mp -85.9 84.33 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.411 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.3 pt -139.62 46.5 1.06 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 92.1 Cg_endo -69.47 -2.4 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.582 2.855 . . . . 0.0 112.626 -174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 mtt -121.87 20.36 10.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.783 0.433 . . . . 0.0 111.004 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -135.01 -8.82 2.33 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -89.71 -4.52 57.68 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.248 0.476 . . . . 0.0 109.938 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -92.5 -45.54 8.08 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.397 1.079 . . . . 0.0 109.303 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -80.83 -23.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.59 -48.57 8.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.018 0.372 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.95 -14.13 56.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.166 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -98.37 -41.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.612 0.642 . . . . 0.0 110.891 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -76.34 -16.16 59.81 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -93.71 -52.42 4.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.982 -0.449 . . . . 0.0 110.523 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -83.49 3.8 30.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.16 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -135.85 -4.24 2.24 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 25.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.734 1.152 . . . . 0.0 112.263 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.4 p -72.46 55.71 0.35 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.937 -0.477 . . . . 0.0 111.638 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 53.89 46.41 25.72 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 111.161 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -82.0 49.76 1.44 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.588 0.755 . . . . 0.0 111.062 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 75.3 m95 54.5 35.2 22.79 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -173.47 45.31 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.57 -170.64 50.54 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 t -132.71 45.28 2.77 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.0 m 53.21 34.21 17.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.383 -172.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.96 -49.61 0.08 OUTLIER Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.01 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 145' ' ' LEU . 57.0 mt-30 62.06 170.53 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 119.166 1.483 . . . . 0.0 112.414 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.32 -9.9 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.744 3.629 . . . . 0.0 115.702 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -64.03 -61.39 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.91 0.777 . . . . 0.0 109.477 174.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.3 20.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.596 . . . . 0.0 111.445 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.3 m -101.47 30.84 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 -25.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 146' ' ' VAL . 5.1 pt -100.92 46.9 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.645 0.778 . . . . 0.0 111.213 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.37 36.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.155 0.582 . . . . 0.0 112.347 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 149' ' ' ILE . 55.4 t80 -75.29 175.08 8.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.161 0.984 . . . . 0.0 110.173 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -50.33 139.0 15.88 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 111.593 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -67.18 134.86 93.55 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.142 0.577 . . . . 0.0 110.22 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.49 179.91 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.994 3.13 . . . . 0.0 111.236 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.77 149.11 47.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.213 0.605 . . . . 0.0 110.468 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.9 pt -65.62 153.68 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.395 0.678 . . . . 0.0 111.681 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 157' ' ' ILE . 2.1 mp -77.88 107.96 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.46 26.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.647 0.779 . . . . 0.0 110.411 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -172.52 177.76 44.95 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -135.61 29.76 3.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.339 0.656 . . . . 0.0 111.189 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -68.17 149.64 50.27 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.69 158.56 39.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.855 0.862 . . . . 0.0 110.284 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.4 t -99.71 131.3 45.78 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.641 0.376 . . . . 0.0 110.389 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.0 p -88.68 154.64 20.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.03 0.532 . . . . 0.0 111.428 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -135.17 154.13 51.73 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.502 0.721 . . . . 0.0 110.475 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.16 32.79 3.13 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.057 0.543 . . . . 0.0 111.022 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 15.8 tt -135.38 128.78 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.011 0.524 . . . . 0.0 110.125 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.0 p -146.55 22.15 1.31 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.061 0.544 . . . . 0.0 111.141 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -90.56 54.99 2.87 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.394 0.677 . . . . 0.0 110.406 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -135.5 130.78 35.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.642 0.777 . . . . 0.0 109.692 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.36 157.88 33.66 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.216 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.19 158.98 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.542 2.828 . . . . 0.0 110.678 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 p -134.44 144.27 48.04 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 122.787 0.435 . . . . 0.0 111.177 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -135.63 152.42 51.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.001 0.92 . . . . 0.0 109.586 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.7 p -131.11 24.12 4.9 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.521 0.328 . . . . 0.0 111.812 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 62.38 -153.43 43.07 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -108.42 157.45 18.4 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.794 0.838 . . . . 0.0 109.492 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -79.65 49.49 1.04 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.35 0.66 . . . . 0.0 111.789 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.22 -179.96 52.51 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.01 168.65 23.37 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.286 3.324 . . . . 0.0 111.028 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -120.34 141.21 50.26 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.516 0.727 . . . . 0.0 109.94 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.2 m 53.64 38.84 29.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.419 0.688 . . . . 0.0 111.888 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.23 164.22 47.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 75.1 mmtt -88.23 -33.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.368 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 64.3 Cg_exo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.078 2.519 . . . . 0.0 112.485 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.471 0.18 0 N-CA-C 112.472 0.143 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -135.6 141.83 45.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.168 0.587 . . . . 0.0 110.191 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.81 136.98 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.72 0.408 . . . . 0.0 110.973 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -83.75 58.74 4.79 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.166 0.586 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -70.34 121.0 16.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.841 0.456 . . . . 0.0 110.147 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.18 152.24 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.588 0.755 . . . . 0.0 110.225 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -135.58 154.06 51.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.257 0.623 . . . . 0.0 110.543 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -134.99 39.47 2.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.384 0.674 . . . . 0.0 109.668 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 19.8 t-20 -64.05 140.68 97.94 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.824 0.449 . . . . 0.0 109.912 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' ASN . 52.7 Cg_exo -56.42 151.92 42.57 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.633 2.889 . . . . 0.0 113.387 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -135.73 154.02 51.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.744 0.817 . . . . 0.0 110.195 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.59 148.76 38.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.602 0.239 . . . . 0.0 110.709 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.73 79.8 62.91 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.286 0.634 . . . . 0.0 110.114 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.26 160.28 48.31 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.52 2.813 . . . . 0.0 110.814 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -76.03 135.4 70.4 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 122.967 0.507 . . . . 0.0 110.543 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.87 161.94 32.78 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.592 2.862 . . . . 0.0 111.76 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.65 -41.12 18.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.2 m -146.59 -46.38 0.19 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.207 0.603 . . . . 0.0 110.237 171.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -149.92 12.82 0.78 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -146.12 147.4 31.51 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -118.97 171.71 8.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.249 0.62 . . . . 0.0 112.026 -172.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t 50.8 55.37 9.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.842 1.257 . . . . 0.0 111.506 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.74 152.76 66.75 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.586 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.73 165.58 31.61 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.094 3.196 . . . . 0.0 110.624 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.63 -8.25 22.82 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.654 2.903 . . . . 0.0 111.749 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -80.69 142.54 33.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -82.4 21.76 0.92 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 30' ' ' VAL . 7.3 tp -146.06 144.14 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -122.97 24.59 8.91 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.26 0.624 . . . . 0.0 110.562 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.544 ' H ' HG13 ' A' ' 28' ' ' ILE . 2.7 t -135.49 22.8 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.643 0.777 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -145.54 37.2 1.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.038 0.535 . . . . 0.0 110.226 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.5 m -126.76 119.87 27.98 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.649 0.261 . . . . 0.0 111.662 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -100.13 78.06 2.04 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 t -135.33 162.78 31.63 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.61 130.58 55.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.673 1.189 . . . . 0.0 108.521 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -107.28 143.27 35.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.21 0.604 . . . . 0.0 110.602 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.0 mm -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.91 0.884 . . . . 0.0 108.876 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.56 31.45 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.32 23.25 74.94 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.1 m -53.04 123.8 34.9 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 117.527 0.663 . . . . 0.0 112.013 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.26 -4.26 13.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.734 2.956 . . . . 0.0 111.07 171.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.85 162.7 28.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.145 0.578 . . . . 0.0 110.5 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.22 32.79 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.537 0.735 . . . . 0.0 111.347 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.7 mtm 57.41 47.98 15.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.154 0.981 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -128.55 133.71 48.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.811 0.844 . . . . 0.0 109.134 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.02 -6.77 47.69 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -85.11 -15.77 42.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.029 -0.419 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -89.53 -26.19 21.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.96 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.01 -29.9 65.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.1 -17.66 58.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.796 -0.565 . . . . 0.0 110.422 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.21 -4.44 58.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.19 -4.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.14 0.26 5.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 39.6 ttpt -88.04 -38.78 0.47 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.28 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.7 Cg_exo -59.33 135.46 65.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.481 2.121 . . . . 0.0 111.997 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 51.48 28.23 4.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.168 0.987 . . . . 0.0 113.078 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.87 167.95 21.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.152 0.581 . . . . 0.0 110.683 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.08 40.91 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.662 0.385 . . . . 0.0 111.251 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.84 136.93 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -129.85 -3.43 4.64 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -137.1 136.45 38.33 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.074 -0.391 . . . . 0.0 111.047 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.46 115.03 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -113.91 104.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.22 110.57 23.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -76.52 104.3 6.96 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -82.46 24.17 0.71 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.861 0.864 . . . . 0.0 111.134 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -135.14 5.47 3.28 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.233 0.613 . . . . 0.0 110.319 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -140.38 -0.67 1.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.239 0.615 . . . . 0.0 110.859 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 51.46 34.9 12.98 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.897 0.879 . . . . 0.0 111.774 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -135.4 151.86 50.86 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 123.599 0.76 . . . . 0.0 109.46 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.25 154.0 51.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -117.26 125.18 50.7 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.009 1.324 . . . . 0.0 107.711 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.03 148.58 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 120.486 0.184 . . . . 0.0 110.56 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -130.2 135.76 48.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.927 0.394 . . . . 0.0 111.942 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.92 148.55 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.275 1.43 . . . . 0.0 109.32 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -82.54 -3.18 55.53 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.2 m -143.3 132.91 23.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -72.58 -18.02 61.65 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.385 . . . . 0.0 110.808 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -74.81 -14.28 60.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.99 -0.444 . . . . 0.0 109.983 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -93.1 -8.6 42.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.04 -43.31 44.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 -17.93 60.64 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.489 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.72 -16.2 54.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.196 0.453 . . . . 0.0 110.388 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -85.47 -23.74 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 O-C-N 121.938 -0.476 . . . . 0.0 110.526 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.74 -23.93 53.02 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.014 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.69 -15.51 57.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.42 -45.42 31.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -76.84 -0.27 23.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.337 -0.227 . . . . 0.0 111.387 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -112.35 -4.76 14.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.984 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.44 22.51 3.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.701 0.682 . . . . 0.0 112.574 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -135.23 55.18 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.285 0.493 . . . . 0.0 111.278 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.83 82.83 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.473 -0.626 . . . . 0.0 113.254 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.63 60.51 3.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.836 0.818 . . . . 0.0 111.72 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.79 151.43 15.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.089 0.556 . . . . 0.0 110.857 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.47 -0.93 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.102 3.201 . . . . 0.0 113.113 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.5 mt -63.63 138.11 58.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.494 0.588 . . . . 0.0 110.318 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -105.51 121.4 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.7 p -135.34 145.05 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 111.997 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -143.23 148.41 36.39 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 109.405 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 -128.41 158.75 37.44 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.863 0.363 . . . . 0.0 111.888 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.4 168.94 25.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 104' ' ' PHE . 12.6 p -133.69 144.5 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.059 0.544 . . . . 0.0 110.541 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 4.36 69.66 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.163 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' H ' HG22 ' A' ' 102' ' ' VAL . 64.5 t80 -70.75 131.23 43.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.974 0.887 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.52 171.2 51.88 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.48 164.25 36.32 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.971 3.114 . . . . 0.0 110.998 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -90.52 151.78 21.21 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 110.799 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 133.61 38.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.7 0.4 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.5 m -134.11 38.49 3.16 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.031 0.933 . . . . 0.0 109.01 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 75.2 m -123.66 169.16 11.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.109 0.964 . . . . 0.0 110.846 -174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.74 155.88 21.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.202 0.601 . . . . 0.0 109.949 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.74 -5.93 18.51 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -94.75 2.36 55.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.777 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -139.57 17.84 2.54 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.082 0.953 . . . . 0.0 110.306 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.3 -6.67 0.17 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.085 -0.842 . . . . 0.0 114.046 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -84.8 55.78 3.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.033 1.416 . . . . 0.0 110.001 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.4 m -130.97 151.67 51.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.606 0.762 . . . . 0.0 110.52 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.1 pt -119.12 31.64 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.383 0.673 . . . . 0.0 111.149 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 tp -135.75 49.93 3.88 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 123.247 0.619 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.29 -14.2 34.17 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 111.783 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -81.19 15.89 1.76 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.925 0.329 . . . . 0.0 111.763 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -135.33 1.73 2.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.545 0.738 . . . . 0.0 109.957 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -86.02 -13.42 47.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.118 -0.364 . . . . 0.0 110.581 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.9 pp -101.0 -12.89 18.52 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.606 0.185 . . . . 0.0 110.722 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 50.4 p -88.98 -22.07 23.2 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.87 -41.12 12.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -16.27 50.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -113.33 -15.63 12.64 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.013 0.824 . . . . 0.0 112.019 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.98 -20.66 48.58 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.649 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.56 -63.23 1.34 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -79.81 -1.14 37.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.4 m -139.91 6.3 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 145' ' ' LEU . 5.1 t -137.77 20.51 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.19 1.359 . . . . 0.0 110.384 170.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.4 t -106.12 52.69 0.72 Allowed 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.49 172.03 13.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.04 0.936 . . . . 0.0 110.679 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -58.63 151.63 20.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.243 0.617 . . . . 0.0 110.791 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -64.1 147.96 50.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.22 0.608 . . . . 0.0 111.646 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.06 -15.29 0.59 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.376 -0.689 . . . . 0.0 111.376 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 144' ' ' PRO . . . 75.62 161.87 10.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.725 0.679 . . . . 0.0 112.365 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.668 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 90.2 m 68.45 102.38 0.05 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m 54.6 43.45 30.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.39 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.534 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 144' ' ' PRO . 64.5 tt0 -164.81 -51.86 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 120.234 2.017 . . . . 0.0 115.884 175.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 140' ' ' THR . 22.9 Cg_endo -85.93 -5.79 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.696 2.931 . . . . 0.0 115.753 -166.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.478 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -70.71 -2.62 15.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.098 1.317 . . . . 0.0 111.959 -176.056 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.406 ' N ' HD12 ' A' ' 145' ' ' LEU . 32.3 m -75.84 0.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 123.186 0.594 . . . . 0.0 110.926 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -142.14 24.68 1.96 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.511 1.124 . . . . 0.0 108.487 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.55 43.57 0.12 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mm -42.45 -41.34 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.561 1.145 . . . . 0.0 112.278 174.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.8 m 44.66 29.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.407 1.483 . . . . 0.0 113.452 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -139.97 149.28 43.07 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.352 0.661 . . . . 0.0 109.625 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.05 35.92 3.05 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -141.27 137.37 16.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.98 168.15 22.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.332 2.688 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.97 55.43 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 110.394 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 tt -110.41 146.25 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.31 0.644 . . . . 0.0 109.613 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.13 56.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.988 0.515 . . . . 0.0 110.716 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.21 146.49 30.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.84 0.456 . . . . 0.0 110.482 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.52 176.67 38.99 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -135.55 149.99 49.6 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.976 0.51 . . . . 0.0 110.996 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -79.88 -174.08 46.34 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.48 156.18 41.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.682 0.793 . . . . 0.0 109.961 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -133.14 148.46 52.1 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.856 0.462 . . . . 0.0 111.144 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.5 t -135.97 152.56 51.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.573 0.749 . . . . 0.0 110.131 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -135.25 151.95 51.07 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 123.226 0.61 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.36 144.79 46.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.202 0.601 . . . . 0.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 58.7 mt -135.15 141.72 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.6 m -60.89 142.07 56.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.858 0.463 . . . . 0.0 110.907 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -135.37 151.37 50.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.028 0.531 . . . . 0.0 111.178 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.5 145.06 43.83 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.055 0.542 . . . . 0.0 110.322 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 93.0 mtp -113.81 153.14 46.06 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.278 0.631 . . . . 0.0 110.171 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -70.64 165.17 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.641 2.894 . . . . 0.0 111.445 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.0 p -135.1 157.91 45.71 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 123.722 0.809 . . . . 0.0 110.168 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -133.24 140.08 47.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.968 0.507 . . . . 0.0 110.509 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.8 m -135.46 146.51 48.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.335 0.654 . . . . 0.0 110.55 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -74.2 -178.66 39.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -135.34 146.43 48.41 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.199 0.6 . . . . 0.0 110.706 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -135.78 160.44 38.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.393 0.677 . . . . 0.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -176.4 173.51 46.33 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.3 155.07 36.98 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.187 3.258 . . . . 0.0 112.548 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -135.93 136.31 40.34 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.399 0.68 . . . . 0.0 109.976 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -135.47 142.67 45.57 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.149 0.579 . . . . 0.0 110.573 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.2 169.44 37.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -141.28 152.98 65.73 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.55 0.74 . . . . 0.0 109.932 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--O 1.252 1.208 0 C-N-CA 123.817 3.011 . . . . 0.0 111.068 178.574 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 CA--C 1.527 0.156 0 N-CA-C 112.585 0.186 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -135.11 24.81 3.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.253 0.621 . . . . 0.0 111.071 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -98.35 24.57 7.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.359 0.664 . . . . 0.0 111.443 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.85 142.81 46.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.917 0.487 . . . . 0.0 109.763 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -135.5 113.59 11.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.75 0.42 . . . . 0.0 110.129 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -135.42 135.7 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.581 0.752 . . . . 0.0 109.015 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.3 t -135.67 135.39 40.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.508 0.323 . . . . 0.0 111.012 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -140.28 147.65 40.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.892 0.877 . . . . 0.0 109.555 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.65 140.89 29.08 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 122.407 0.283 . . . . 0.0 110.242 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.09 163.8 30.26 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.869 3.046 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -138.69 147.09 42.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.345 0.658 . . . . 0.0 110.236 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -135.6 128.6 31.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.689 0.396 . . . . 0.0 110.408 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -147.96 58.86 4.16 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.96 0.504 . . . . 0.0 110.102 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -67.34 148.29 79.51 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.173 2.582 . . . . 0.0 110.949 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 25.4 ttmm -151.32 117.76 3.25 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.281 0.632 . . . . 0.0 109.488 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 40.1 Cg_exo -62.24 172.39 4.24 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.573 3.515 . . . . 0.0 114.035 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.13 159.29 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.578 ' H ' HG12 ' A' ' 150' ' ' VAL . 29.7 m 65.24 30.71 11.16 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.71 87.87 2.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.92 142.71 50.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.159 0.584 . . . . 0.0 111.919 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.4 p -135.42 48.62 2.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.917 0.887 . . . . 0.0 109.642 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p 52.41 43.55 30.81 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.758 1.223 . . . . 0.0 111.689 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pp -94.95 157.37 36.75 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.96 0.904 . . . . 0.0 110.46 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.77 152.15 74.15 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.218 2.612 . . . . 0.0 112.491 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.55 20.28 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.478 4.119 . . . . 0.0 112.34 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.98 161.63 8.08 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.777 0.431 . . . . 0.0 111.327 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -60.68 -42.37 96.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 29' ' ' LYS . 6.2 tp -153.2 161.58 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.826 0.739 . . . . 0.0 112.29 -176.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' H ' HD12 ' A' ' 28' ' ' ILE . 22.2 tptm 66.65 43.19 2.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 122.669 1.223 . . . . 0.0 108.21 178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 30' ' ' VAL . 6.9 m -89.77 104.88 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.115 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -146.11 151.35 37.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.355 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.6 t -90.49 141.94 28.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -130.12 136.1 48.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.069 0.547 . . . . 0.0 109.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -135.78 108.85 7.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -85.52 104.57 15.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -82.34 140.32 33.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.348 0.659 . . . . 0.0 110.313 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.1 129.8 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.01 166.53 26.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.081 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.74 75.59 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.415 -0.658 . . . . 0.0 112.195 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -53.57 125.34 44.77 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 117.996 0.898 . . . . 0.0 111.186 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.31 -2.68 12.15 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.444 2.763 . . . . 0.0 111.364 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.32 154.53 27.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.923 0.489 . . . . 0.0 111.017 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -84.43 53.66 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.28 0.632 . . . . 0.0 110.38 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.2 ttt 56.48 64.74 1.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.387 1.075 . . . . 0.0 112.708 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -131.13 107.94 9.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.84 -13.08 58.89 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 112.011 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -81.84 -12.23 58.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 122.244 -0.285 . . . . 0.0 111.077 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -93.32 -22.73 18.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.518 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 -27.88 60.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.57 -23.74 42.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.911 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.64 -6.93 58.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.007 0.367 . . . . 0.0 111.638 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.58 -4.62 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 118.153 0.433 . . . . 0.0 111.243 171.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -109.52 15.36 23.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.08 0.952 . . . . 0.0 109.247 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 40.7 ttmt -75.53 -34.77 1.64 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 82.4 Cg_endo -73.55 124.27 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 CA-C-N 121.356 1.52 . . . . 0.0 111.068 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 51.53 23.06 1.71 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.98 1.312 . . . . 0.0 113.062 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.83 154.58 35.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.964 0.506 . . . . 0.0 110.546 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.51 64.68 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.91 128.61 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -103.71 -3.76 24.62 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -168.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -142.24 131.15 22.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.053 0.388 . . . . 0.0 110.904 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.15 129.86 38.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.26 139.54 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 110.7 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -122.73 120.31 33.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.133 1.373 . . . . 0.0 108.387 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -138.74 157.17 46.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.837 0.455 . . . . 0.0 111.337 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 65.5 151.49 0.05 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.857 1.263 . . . . 0.0 113.13 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -82.79 25.08 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.267 0.627 . . . . 0.0 111.216 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.72 24.4 7.75 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.813 0.845 . . . . 0.0 110.702 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 53.48 49.49 19.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.146 0.978 . . . . 0.0 112.599 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -96.57 104.75 16.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.93 148.33 44.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.114 0.483 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -135.52 145.11 46.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.397 0.679 . . . . 0.0 109.375 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.92 155.5 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.21 135.68 41.17 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.969 0.414 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.15 148.66 15.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 124.519 1.128 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.46 19.18 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.8 t -151.25 141.25 22.07 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.795 0.438 . . . . 0.0 110.198 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -74.46 -22.7 58.97 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -82.35 -14.74 54.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.62 -20.67 23.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.66 53.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.19 -15.8 35.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.262 -0.274 . . . . 0.0 110.732 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.38 -22.87 38.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.272 0.487 . . . . 0.0 110.607 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.53 -46.19 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.42 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.8 mm? -67.55 -19.77 65.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.614 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -75.89 -40.77 53.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.382 0.992 . . . . 0.0 109.659 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -76.33 -13.44 60.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -117.28 15.1 14.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -128.2 3.89 5.79 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -142.36 -8.19 0.88 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -153.0 24.75 0.56 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.241 0.928 . . . . 0.0 112.035 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 15.69 0.04 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.964 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.98 3.8 16.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.648 1.224 . . . . 0.0 111.791 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 95' ' ' PRO . 3.1 mm? -98.7 -54.78 0.19 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.715 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 94' ' ' LEU . 86.0 Cg_endo -74.5 -23.52 14.87 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.355 2.036 . . . . 0.0 112.867 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 96' ' ' LEU . 36.4 mt -137.84 149.12 46.05 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.13 0.423 . . . . 0.0 111.219 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -106.09 102.7 12.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.3 p -98.15 130.79 44.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.246 0.618 . . . . 0.0 111.276 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -143.94 136.86 27.34 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.973 0.909 . . . . 0.0 109.028 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -118.58 126.91 52.99 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.096 0.407 . . . . 0.0 111.175 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.64 145.48 18.36 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.42 148.37 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.933 0.893 . . . . 0.0 109.529 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.76 121.57 5.82 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -138.98 27.3 2.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.543 0.737 . . . . 0.0 111.074 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.91 157.47 53.35 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 122.1 -0.375 . . . . 0.0 112.883 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.53 169.52 22.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 124.252 3.301 . . . . 0.0 110.527 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -74.61 141.55 44.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.483 0.313 . . . . 0.0 110.382 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -135.92 145.3 46.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 110.857 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.9 t 54.27 38.06 28.6 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.805 0.842 . . . . 0.0 111.928 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.65 104.33 11.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -142.1 151.83 42.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.416 0.687 . . . . 0.0 109.804 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -72.79 -4.67 33.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.71 -0.57 34.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.22 0.463 . . . . 0.0 109.802 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -135.25 24.11 3.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 109.802 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.86 -1.25 1.0 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.498 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -110.26 47.92 0.93 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.858 0.829 . . . . 0.0 109.473 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -135.03 153.59 52.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.704 0.801 . . . . 0.0 110.297 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.69 30.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.374 0.669 . . . . 0.0 112.367 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mt -73.3 133.84 80.56 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.2 -13.49 38.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.418 2.745 . . . . 0.0 113.746 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.5 ptm -83.97 8.26 15.76 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -95.06 -17.37 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.185 -0.322 . . . . 0.0 111.149 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.13 -4.13 58.79 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.96 -32.49 13.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.108 0.563 . . . . 0.0 109.582 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.5 t -82.59 -19.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.049 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.94 -47.06 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.911 -0.493 . . . . 0.0 110.968 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -76.48 -13.79 60.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.49 -9.6 11.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.818 0.736 . . . . 0.0 112.264 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -73.33 -18.25 61.21 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 166.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.403 ' HE3' ' CH2' ' A' ' 131' ' ' TRP . 64.3 tttp -87.51 -60.13 2.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.318 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.403 ' CH2' ' HE3' ' A' ' 130' ' ' LYS . 11.8 m95 -80.4 9.96 5.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -147.16 -6.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.65 17.17 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 119.619 1.099 . . . . 0.0 112.036 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 m -81.01 35.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.403 -0.811 . . . . 0.0 111.247 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 24.47 3.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.45 0.7 . . . . 0.0 110.223 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -138.55 147.33 42.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.777 0.831 . . . . 0.0 109.653 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -81.72 42.79 0.72 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.307 0.643 . . . . 0.0 111.05 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.99 -169.9 36.72 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.69 157.68 27.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.1 p 48.74 24.55 0.83 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.008 1.323 . . . . 0.0 112.913 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -154.92 24.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.34 0.656 . . . . 0.0 111.024 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.34 -12.11 16.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.507 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -146.37 164.98 21.65 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 118.622 1.211 . . . . 0.0 110.053 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.49 -12.18 16.33 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.363 2.708 . . . . 0.0 113.311 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.48 -6.43 46.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.12 0.418 . . . . 0.0 112.123 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -77.55 25.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -135.41 -15.43 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.208 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.43 -11.34 17.84 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 118.797 -1.002 . . . . 0.0 113.221 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.1 mm -66.79 60.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-O 122.312 1.053 . . . . 0.0 109.067 167.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 18' ' ' SER . 1.4 m -128.63 5.11 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.947 1.299 . . . . 0.0 109.775 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -115.87 154.95 28.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.654 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.61 59.46 4.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 112.24 -175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.17 69.64 29.98 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.31 179.37 6.56 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.154 3.236 . . . . 0.0 111.281 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -135.18 161.63 34.82 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.878 0.871 . . . . 0.0 110.069 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.82 146.0 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 122.87 0.468 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.1 mm -122.99 123.34 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.6 154.01 34.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 123.043 0.537 . . . . 0.0 111.397 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 84.71 141.52 5.32 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.933 0.778 . . . . 0.0 111.768 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.56 141.8 24.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.326 0.651 . . . . 0.0 109.755 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -73.82 172.09 51.45 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.67 140.52 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.041 0.536 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.8 m -135.97 55.02 1.88 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.436 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.9 t -135.19 130.19 34.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.583 0.353 . . . . 0.0 110.857 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -135.9 151.72 50.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 124.137 0.975 . . . . 0.0 109.868 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.27 124.03 23.86 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.68 0.392 . . . . 0.0 110.546 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.2 tp -141.91 144.68 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.447 0.699 . . . . 0.0 109.816 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.6 t -135.88 136.9 40.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.897 0.479 . . . . 0.0 110.408 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -135.91 133.76 38.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.18 0.592 . . . . 0.0 110.013 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -135.84 144.35 45.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.338 0.655 . . . . 0.0 110.089 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 92.9 mtp -135.76 152.07 75.32 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 123.352 0.661 . . . . 0.0 109.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.45 160.1 49.52 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.657 2.905 . . . . 0.0 111.081 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.3 t -138.47 149.0 44.98 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 110.51 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.67 149.75 49.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.425 0.69 . . . . 0.0 110.516 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 60.0 m -135.17 132.21 37.7 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.931 0.493 . . . . 0.0 110.624 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 166.85 160.12 13.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -141.09 129.11 21.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.796 0.438 . . . . 0.0 110.477 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -135.87 149.7 49.11 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.452 0.701 . . . . 0.0 110.533 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.47 179.04 38.99 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.29 158.45 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.362 3.375 . . . . 0.0 112.485 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -135.8 143.04 44.97 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.482 0.713 . . . . 0.0 109.897 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.8 m -133.47 124.94 27.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.837 0.455 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.37 168.55 29.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.689 ' H ' ' CD ' ' A' ' 185' ' ' PRO . 40.6 ttmt -151.04 -38.05 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.655 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.689 ' CD ' ' H ' ' A' ' 184' ' ' LYS . 53.9 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 123.016 2.477 . . . . 0.0 112.303 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.471 0.176 0 N-CA-C 112.519 0.161 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.75 148.02 31.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.825 0.45 . . . . 0.0 110.974 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.72 140.24 44.24 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.07 24.6 4.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.599 0.76 . . . . 0.0 110.606 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.64 143.48 34.63 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.913 0.485 . . . . 0.0 110.705 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.49 138.7 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.187 0.595 . . . . 0.0 110.198 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.9 p -135.84 31.38 3.03 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.423 0.689 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -80.98 55.02 2.34 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.407 0.683 . . . . 0.0 110.963 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.72 150.62 37.17 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 123.204 0.602 . . . . 0.0 110.194 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.23 152.24 55.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.444 2.763 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -145.63 143.16 29.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.13 0.572 . . . . 0.0 110.257 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -135.85 140.2 43.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.951 0.501 . . . . 0.0 110.648 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -152.03 73.89 7.73 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.129 0.572 . . . . 0.0 109.781 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -67.58 152.51 78.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.407 2.738 . . . . 0.0 110.623 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -138.56 152.8 71.71 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.591 0.756 . . . . 0.0 109.982 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.29 170.16 16.5 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.242 3.294 . . . . 0.0 112.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -75.3 158.17 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.658 0.783 . . . . 0.0 109.816 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.577 ' H ' HG12 ' A' ' 150' ' ' VAL . 35.2 m 61.82 42.5 10.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.173 0.989 . . . . 0.0 112.639 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.59 43.77 2.58 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.181 0.593 . . . . 0.0 109.541 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.82 52.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.926 1.691 . . . . 0.0 114.623 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.2 m -135.92 8.3 3.25 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -162.03 24.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.63 136.46 12.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 119.55 1.068 . . . . 0.0 113.277 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.82 156.46 18.17 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 124.08 3.187 . . . . 0.0 110.497 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.99 134.24 14.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.619 2.879 . . . . 0.0 111.959 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -142.75 148.27 36.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.86 1.264 . . . . 0.0 108.12 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 53.05 29.64 8.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.564 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.49 151.55 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.328 1.051 . . . . 0.0 110.244 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.64 12.96 3.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.64 42.93 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 122.762 0.425 . . . . 0.0 111.457 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -135.74 146.87 48.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.234 0.214 . . . . 0.0 110.817 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 p -65.09 145.17 56.65 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.353 0.661 . . . . 0.0 111.815 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -126.07 -7.59 6.56 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -155.53 154.04 31.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.057 0.39 . . . . 0.0 111.042 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.2 tp -117.97 126.0 51.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.995 0.518 . . . . 0.0 109.668 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.53 146.21 32.14 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.398 0.679 . . . . 0.0 110.444 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mm -128.02 135.01 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.22 165.87 13.66 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.77 15.43 80.75 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.289 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' N ' ' CD ' ' A' ' 41' ' ' PRO . 34.0 m -70.19 -14.22 0.25 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 40' ' ' VAL . 70.2 Cg_exo -56.99 -2.81 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.259 1.973 . . . . 0.0 114.612 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.89 -14.91 60.71 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.337 0.971 . . . . 0.0 112.68 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -148.59 -12.54 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.2 mtt 51.6 28.85 4.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -135.81 142.77 44.9 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.193 0.451 . . . . 0.0 110.79 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.66 -6.63 42.43 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -86.74 -10.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.296 -0.252 . . . . 0.0 111.067 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.69 -27.09 18.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.86 -30.09 65.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.02 -19.38 44.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.458 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -76.54 -15.51 59.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.058 -0.401 . . . . 0.0 111.155 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.75 -3.34 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.61 10.65 22.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.384 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.8 pttt -88.61 -28.04 0.35 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.582 170.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 27.2 Cg_exo -65.14 117.88 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.782 1.655 . . . . 0.0 110.945 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 50.27 24.37 1.47 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.405 1.082 . . . . 0.0 113.191 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.5 155.38 43.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.956 0.502 . . . . 0.0 110.497 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -133.73 60.63 1.7 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.976 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -70.12 141.53 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -129.75 5.82 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -135.8 119.36 17.02 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 118.064 0.393 . . . . 0.0 110.457 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.89 127.66 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.531 0.732 . . . . 0.0 109.526 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.55 139.62 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 122.847 0.459 . . . . 0.0 110.048 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.5 mt -114.94 122.66 46.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.541 0.737 . . . . 0.0 109.036 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -123.02 173.02 8.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.087 0.955 . . . . 0.0 111.064 -171.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 55.59 55.6 7.07 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.799 0.84 . . . . 0.0 111.258 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t 55.68 43.16 28.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.078 0.551 . . . . 0.0 110.924 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? 55.48 44.16 27.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.195 0.998 . . . . 0.0 111.248 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -124.3 0.97 8.41 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 111.052 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -146.48 142.89 28.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 149.13 48.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.14 134.43 45.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.298 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.34 149.78 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -135.14 135.63 41.27 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.013 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.16 157.35 14.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 124.782 1.233 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -102.85 9.06 39.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -146.41 138.51 24.96 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.057 0.543 . . . . 0.0 109.973 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -76.62 -13.62 60.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -85.27 -23.0 28.37 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.2 -18.08 37.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.29 -45.49 59.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.85 -20.51 62.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.005 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -82.01 -16.79 49.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.408 0.549 . . . . 0.0 111.338 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.6 -25.5 8.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-N 118.566 0.621 . . . . 0.0 110.25 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.21 -22.18 55.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.913 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -76.08 -22.26 55.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -79.88 -23.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -83.53 -4.0 58.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.7 3.76 11.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.7 0.4 . . . . 0.0 111.049 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -135.77 17.9 3.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -86.36 -1.31 57.42 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.481 -0.762 . . . . 0.0 111.573 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.49 -15.0 0.45 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.798 1.19 . . . . 0.0 115.548 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.42 12.39 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.486 1.643 . . . . 0.0 113.483 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 35.09 53.05 1.59 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.694 1.198 . . . . 0.0 113.751 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.9 -11.93 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.425 2.75 . . . . 0.0 111.275 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -133.82 133.93 42.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.411 1.084 . . . . 0.0 108.312 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -100.01 98.47 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.3 m -93.49 129.36 39.72 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.96 0.504 . . . . 0.0 111.198 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -145.69 142.13 28.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.31 0.644 . . . . 0.0 109.91 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -97.04 150.21 21.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.941 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.83 160.46 14.04 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.07 139.69 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 124.014 0.926 . . . . 0.0 110.097 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.15 126.03 7.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -135.71 148.2 48.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.446 0.698 . . . . 0.0 110.01 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.52 152.88 48.48 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.31 123.24 9.4 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.576 2.85 . . . . 0.0 110.433 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -135.72 151.4 50.12 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.991 0.916 . . . . 0.0 109.426 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -135.26 43.83 2.63 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.001 0.52 . . . . 0.0 110.105 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 20.7 t -135.38 55.21 1.89 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.163 0.585 . . . . 0.0 109.936 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 26.4 p -135.56 149.76 49.52 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.149 0.579 . . . . 0.0 110.884 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -135.87 152.71 51.32 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.526 0.731 . . . . 0.0 110.16 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -68.21 -16.92 64.17 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.3 6.79 46.88 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.03 -0.418 . . . . 0.0 110.102 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -135.66 24.5 3.4 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.074 0.949 . . . . 0.0 109.705 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -151.91 -11.97 0.08 OUTLIER Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.457 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.2 24.88 4.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.713 1.256 . . . . 0.0 110.671 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -135.58 158.46 44.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.914 0.886 . . . . 0.0 110.063 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -68.94 148.38 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 122.4 0.28 . . . . 0.0 110.61 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -137.29 136.95 21.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.47 170.11 21.0 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.708 2.939 . . . . 0.0 111.283 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.55 13.27 0.49 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -87.27 -8.8 56.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.959 -0.463 . . . . 0.0 110.448 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -81.9 -9.13 59.68 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 149' ' ' ILE . 8.4 tp -88.18 -40.31 13.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.2 p -75.21 -17.76 60.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.995 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.69 -19.34 14.36 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.593 0.633 . . . . 0.0 112.141 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.87 -12.07 45.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.89 0.768 . . . . 0.0 110.814 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.74 -21.72 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.78 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -74.33 -21.36 59.73 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.794 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 131' ' ' TRP . 38.8 ttpt -91.2 -60.04 2.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.415 -0.178 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.457 ' CE2' ' HE3' ' A' ' 130' ' ' LYS . 8.6 m95 -77.26 0.89 20.32 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 m -142.12 -5.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.86 23.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.949 1.25 . . . . 0.0 112.083 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -75.11 38.02 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.407 -0.808 . . . . 0.0 111.523 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.48 24.22 3.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.597 0.759 . . . . 0.0 110.07 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -141.77 140.22 33.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.748 0.819 . . . . 0.0 109.438 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -84.83 52.63 2.47 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.842 0.457 . . . . 0.0 111.824 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.95 -7.37 0.39 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.292 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 68.51 -166.39 45.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.12 0.96 . . . . 0.0 111.212 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.0 p 67.33 116.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.848 1.659 . . . . 0.0 112.51 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.1 m 61.4 27.61 17.18 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.6 1.16 . . . . 0.0 112.893 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.56 -16.48 68.41 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -155.56 151.71 22.86 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.05 10.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.992 3.128 . . . . 0.0 115.236 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.99 -0.1 15.23 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.277 0.944 . . . . 0.0 110.966 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.45 22.34 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.109 0.564 . . . . 0.0 112.071 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 10.2 5.12 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.301 0.24 . . . . 0.0 111.57 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.04 -19.46 0.32 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 124' ' ' LEU . 18.3 mm -80.0 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-O 121.753 0.787 . . . . 0.0 109.322 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 18' ' ' SER . 35.4 m -129.37 24.72 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.185 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.1 151.25 23.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.07 0.548 . . . . 0.0 110.516 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -94.94 44.41 1.1 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.442 0.697 . . . . 0.0 111.968 -175.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -128.57 146.69 61.03 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.447 0.299 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.63 -178.73 4.85 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.448 3.432 . . . . 0.0 111.257 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.54 136.11 44.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.423 0.689 . . . . 0.0 109.684 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.6 tt -135.97 147.38 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.39 119.38 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.308 0.643 . . . . 0.0 110.637 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.2 30.91 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 122.919 0.488 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -172.17 -175.7 40.47 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.876 -0.515 . . . . 0.0 112.446 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.18 24.94 2.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.401 0.68 . . . . 0.0 111.426 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 77.17 169.34 31.56 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.255 0.455 . . . . 0.0 112.758 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.94 162.79 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.148 0.979 . . . . 0.0 109.748 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.0 m -55.52 138.54 46.33 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.716 0.406 . . . . 0.0 110.759 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.0 p -135.48 157.06 47.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.939 0.496 . . . . 0.0 111.656 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -135.68 162.44 32.74 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.21 1.004 . . . . 0.0 110.147 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.84 130.6 42.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 9.8 tp -135.78 144.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.437 0.295 . . . . 0.0 110.803 -176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.8 t -135.97 150.13 49.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.293 0.637 . . . . 0.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -135.6 138.03 42.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.961 0.904 . . . . 0.0 109.177 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -74.46 113.22 11.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.9 tpp -73.19 136.33 79.13 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.99 162.1 43.46 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.049 2.5 . . . . 0.0 110.606 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.3 p -130.35 24.1 5.17 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.999 0.519 . . . . 0.0 110.614 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -110.51 39.4 2.21 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.709 0.804 . . . . 0.0 110.488 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.9 t -135.23 150.4 50.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.504 0.721 . . . . 0.0 109.495 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 142.99 44.74 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -83.88 104.92 14.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -133.7 55.27 1.91 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.305 0.642 . . . . 0.0 110.179 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.73 178.16 36.84 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.52 154.57 68.51 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.689 2.926 . . . . 0.0 110.564 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -135.88 24.46 3.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.692 0.397 . . . . 0.0 112.07 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.0 p -94.49 127.1 40.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.976 0.51 . . . . 0.0 110.394 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.22 167.23 54.57 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -73.71 137.78 77.05 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.885 0.474 . . . . 0.0 109.976 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.252 1.189 0 C-N-CA 123.643 2.896 . . . . 0.0 110.939 175.415 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 CA--C 1.527 0.163 0 N-CA-C 112.505 0.156 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -135.54 147.02 48.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.181 0.593 . . . . 0.0 110.438 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.15 27.17 3.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.999 0.52 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.7 tp -135.47 54.96 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.613 0.765 . . . . 0.0 108.958 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -85.08 55.78 3.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.526 0.73 . . . . 0.0 110.664 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.68 139.63 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.031 0.533 . . . . 0.0 110.612 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 t -135.79 146.89 48.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.366 0.666 . . . . 0.0 110.362 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -92.67 135.23 34.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -71.26 151.47 94.42 Favored Pre-proline 0 N--CA 1.454 -0.238 0 C-N-CA 122.347 0.259 . . . . 0.0 110.379 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 153.25 66.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.365 2.71 . . . . 0.0 110.722 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -143.69 158.41 43.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.125 0.57 . . . . 0.0 110.305 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.43 146.63 43.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.805 0.442 . . . . 0.0 110.451 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -135.35 149.6 70.17 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 122.287 0.235 . . . . 0.0 111.591 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.95 -176.6 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 124.845 3.697 . . . . 0.0 110.8 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -64.07 154.97 80.56 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -70.61 156.9 60.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.069 2.512 . . . . 0.0 110.595 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.37 -21.15 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 122.739 0.416 . . . . 0.0 110.337 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 t -152.87 179.68 8.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.991 0.916 . . . . 0.0 109.129 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -104.59 24.41 11.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.312 0.645 . . . . 0.0 110.854 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.35 146.84 24.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -127.9 24.5 6.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.857 0.463 . . . . 0.0 111.294 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -133.05 48.51 2.4 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.613 0.765 . . . . 0.0 109.076 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.78 127.96 91.2 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.41 157.14 36.91 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.484 2.789 . . . . 0.0 112.271 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.12 -3.93 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.497 3.465 . . . . 0.0 111.538 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -73.19 110.44 7.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 111.741 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 49.87 21.01 0.63 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.622 1.969 . . . . 0.0 114.825 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 28' ' ' ILE . 26.5 pt -135.75 162.26 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.482 ' H ' ' CD2' ' A' ' 124' ' ' LEU . 48.3 tptt -106.53 32.49 4.47 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 121.244 0.545 . . . . 0.0 110.914 -170.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.21 46.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.287 0.635 . . . . 0.0 110.514 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -59.14 144.15 46.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.85 0.46 . . . . 0.0 110.979 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -136.5 141.44 43.45 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.012 0.525 . . . . 0.0 110.617 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -119.01 128.16 54.12 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.1 p -88.43 124.73 34.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.948 0.499 . . . . 0.0 110.253 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.5 tp -102.85 122.08 43.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -114.21 131.09 56.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.352 0.261 . . . . 0.0 110.748 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -104.3 143.42 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.9 163.56 27.99 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.72 18.28 70.07 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -54.21 138.38 57.35 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.78 0.79 . . . . 0.0 110.982 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.11 -15.39 20.53 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.166 2.577 . . . . 0.0 110.969 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.16 123.46 14.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -106.98 24.6 12.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.506 0.322 . . . . 0.0 110.463 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.3 ttp -139.31 24.21 2.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -147.08 85.84 1.62 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.7 -14.51 52.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 110.717 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -83.11 -8.21 59.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.883 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -94.99 -21.16 18.79 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.411 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.76 -26.79 60.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.32 -21.4 39.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.45 -13.16 60.37 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.088 -0.383 . . . . 0.0 110.739 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.52 -3.05 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.9 12.01 25.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.478 0.711 . . . . 0.0 110.371 170.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttp -95.22 -31.77 0.27 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 71.9 Cg_exo -54.63 -33.96 81.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.629 2.219 . . . . 0.0 114.728 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -139.38 17.06 2.57 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.463 0.574 . . . . 0.0 112.444 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.31 172.82 17.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.703 0.401 . . . . 0.0 110.088 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.76 55.61 1.89 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.016 0.526 . . . . 0.0 110.071 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.23 140.77 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.558 0.743 . . . . 0.0 110.215 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -120.26 3.52 10.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.7 m -139.16 126.86 21.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.341 0.518 . . . . 0.0 110.866 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.13 128.16 21.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 123.435 0.694 . . . . 0.0 109.348 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.63 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 109.732 173.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.42 147.37 46.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.292 1.037 . . . . 0.0 110.383 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -134.47 135.37 42.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.128 0.571 . . . . 0.0 109.906 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -80.87 41.3 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.682 0.793 . . . . 0.0 111.27 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -128.89 105.12 8.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 55.36 26.87 9.2 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.659 0.784 . . . . 0.0 111.448 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 49.46 54.65 10.63 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.348 1.059 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -88.53 141.31 28.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.527 0.331 . . . . 0.0 110.766 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.45 148.6 49.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.717 0.407 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -135.17 131.35 36.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.42 151.27 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.811 0.444 . . . . 0.0 110.028 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -137.33 136.82 38.3 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.42 164.64 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.664 1.585 . . . . 0.0 109.677 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.2 16.88 25.0 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.613 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -151.94 137.12 17.44 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.674 0.79 . . . . 0.0 109.018 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -12.68 61.33 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -87.13 -15.53 38.15 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -83.71 -21.03 32.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.56 54.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.0 -21.19 63.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.214 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -89.45 -9.61 49.51 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.953 -0.467 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 t -87.41 -25.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.794 -0.566 . . . . 0.0 109.919 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.7 mm? -74.82 -27.88 60.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -81.44 -14.78 56.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.698 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.19 -43.92 66.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -85.02 -1.44 56.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.465 -0.147 . . . . 0.0 111.346 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.35 -0.61 26.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.424 0.29 . . . . 0.0 110.811 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -131.89 11.9 4.75 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.6 -5.37 59.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.423 0.556 . . . . 0.0 110.736 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.91 -3.1 10.43 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.684 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.63 4.54 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.238 1.519 . . . . 0.0 113.542 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 94' ' ' LEU . 8.3 mp 38.45 55.56 4.79 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 112.057 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.68 -15.83 26.97 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.221 2.614 . . . . 0.0 112.175 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.4 mt -136.86 146.06 45.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.532 0.733 . . . . 0.0 110.752 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -107.03 130.8 54.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -135.04 140.55 45.68 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.847 0.459 . . . . 0.0 111.338 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -138.84 147.47 42.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.147 0.979 . . . . 0.0 109.232 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -121.66 157.5 30.71 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.774 0.321 . . . . 0.0 111.227 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.51 -178.85 31.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.86 137.59 48.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.115 0.566 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.72 127.59 8.8 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.33 147.53 38.27 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.627 0.371 . . . . 0.0 110.923 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.33 -134.73 2.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.97 -174.58 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.495 2.797 . . . . 0.0 110.154 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -51.3 141.2 15.49 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.733 0.413 . . . . 0.0 110.404 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.96 136.04 56.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.0 0.52 . . . . 0.0 111.521 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 16.0 t -112.9 26.9 10.08 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.594 0.758 . . . . 0.0 110.496 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 78.5 m -73.11 148.33 44.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.957 0.503 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -135.69 158.73 43.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.348 0.659 . . . . 0.0 109.822 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.64 15.47 18.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -79.5 -7.15 58.26 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.608 0.64 . . . . 0.0 110.419 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -138.29 7.77 2.64 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.531 0.733 . . . . 0.0 110.03 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.87 -15.56 42.08 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -94.22 24.44 4.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.977 0.511 . . . . 0.0 110.25 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -135.62 151.58 50.39 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.047 0.939 . . . . 0.0 109.704 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -85.04 21.08 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.981 0.419 . . . . 0.0 111.07 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.457 ' N ' ' HD3' ' A' ' 120' ' ' PRO . 24.8 pt -141.47 56.75 6.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.644 0.778 . . . . 0.0 111.509 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 119' ' ' ILE . 51.5 Cg_exo -58.76 -21.52 56.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.366 2.044 . . . . 0.0 112.442 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 46.3 ttp -85.27 49.48 1.76 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.629 0.771 . . . . 0.0 110.216 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -135.43 -41.5 0.71 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.524 0.33 . . . . 0.0 111.039 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -79.78 -14.44 58.71 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.774 0.261 . . . . 0.0 110.337 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' CD2' ' H ' ' A' ' 29' ' ' LYS . 55.7 tp -88.78 -26.94 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -78.39 -20.76 50.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.28 -47.6 7.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.173 -0.33 . . . . 0.0 110.932 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.93 -14.56 58.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.56 -22.32 13.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.415 0.552 . . . . 0.0 111.321 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.98 -28.71 63.6 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.36 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -84.04 -57.38 3.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.703 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.2 7.14 26.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -171.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.3 m -143.14 -0.53 1.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.0 t -135.28 14.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.563 1.074 . . . . 0.0 112.12 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.9 m -90.35 24.13 2.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.817 -0.552 . . . . 0.0 109.773 169.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.75 43.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.569 1.148 . . . . 0.0 109.347 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -86.3 33.35 0.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -135.79 26.35 3.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.58 165.9 33.13 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.877 -0.514 . . . . 0.0 112.659 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA2' HD23 ' A' ' 145' ' ' LEU . . . 76.18 163.45 15.11 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.107 0.86 . . . . 0.0 112.686 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.6 t -98.29 -30.08 12.8 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.725 -0.28 . . . . 0.0 111.464 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -151.79 22.69 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.703 0.401 . . . . 0.0 111.334 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.61 -9.41 68.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.352 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.602 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 59.9 tt0 -163.78 -39.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 118.45 1.125 . . . . 0.0 113.335 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 46.0 Cg_exo -61.65 11.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.98 3.12 . . . . 0.0 115.878 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.606 HD21 ' CG2' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.2 14.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.112 0.869 . . . . 0.0 112.019 177.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.22 6.84 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.684 0.794 . . . . 0.0 111.59 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -136.03 30.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.627 1.171 . . . . 0.0 108.213 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.91 29.04 0.07 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.5 mm -44.16 -43.63 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 118.13 0.965 . . . . 0.0 111.632 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m 46.93 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.295 1.438 . . . . 0.0 113.914 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -111.78 149.68 31.37 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 118.221 0.464 . . . . 0.0 110.688 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -131.81 32.54 4.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.211 0.604 . . . . 0.0 111.196 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.32 146.72 59.21 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 122.514 0.325 . . . . 0.0 110.802 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.71 170.57 19.62 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.289 3.326 . . . . 0.0 111.685 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -135.64 163.48 30.04 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.729 0.812 . . . . 0.0 110.245 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 tp -121.59 30.98 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.353 0.597 . . . . 0.0 110.441 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.73 121.1 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 157.82 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 123.497 0.719 . . . . 0.0 110.598 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -157.82 -167.76 19.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.36 144.9 50.86 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.057 0.543 . . . . 0.0 110.793 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -78.77 -168.49 34.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.43 132.36 66.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.333 0.653 . . . . 0.0 109.632 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.5 p -91.06 152.45 20.64 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.236 0.615 . . . . 0.0 111.25 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.2 t -73.66 134.71 43.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.511 0.324 . . . . 0.0 110.446 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -136.02 154.37 51.08 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 110.602 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 53.54 44.51 29.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.504 0.721 . . . . 0.0 111.727 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 9.0 tp -64.73 145.45 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.874 0.469 . . . . 0.0 110.601 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.7 m -64.96 146.82 54.47 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.126 0.571 . . . . 0.0 111.406 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -135.37 142.86 45.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.358 0.663 . . . . 0.0 109.915 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -135.22 154.92 51.43 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.355 0.662 . . . . 0.0 110.452 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.3 mmm -122.44 152.46 61.25 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 123.195 0.598 . . . . 0.0 110.115 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.07 170.92 17.82 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.802 3.001 . . . . 0.0 111.259 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 66.4 m -121.71 144.46 48.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.629 0.772 . . . . 0.0 109.485 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.13 145.77 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.809 0.444 . . . . 0.0 110.855 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.3 t -135.31 151.72 50.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.477 0.711 . . . . 0.0 109.854 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.94 158.29 29.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.64 152.76 51.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.449 0.7 . . . . 0.0 110.962 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -77.85 154.39 31.83 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.967 0.507 . . . . 0.0 110.19 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.444 ' H ' ' HD2' ' A' ' 180' ' ' PRO . . . -166.73 -46.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 179' ' ' GLY . 51.7 Cg_exo -58.56 161.94 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.546 2.831 . . . . 0.0 112.192 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -126.2 130.76 51.59 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.316 0.647 . . . . 0.0 109.964 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 29.1 t -140.53 148.47 41.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.159 0.584 . . . . 0.0 110.427 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.39 178.61 44.44 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -145.09 140.91 16.59 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.153 0.581 . . . . 0.0 109.636 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.833 3.022 . . . . 0.0 112.492 177.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.5 tp -85.49 105.92 16.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.42 141.71 35.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.636 0.774 . . . . 0.0 110.448 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mm -127.74 109.44 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.26 161.55 12.92 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 122.18 -0.325 . . . . 0.0 112.483 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.88 73.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.303 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.7 m -54.09 120.78 26.57 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.185 0.993 . . . . 0.0 111.062 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 26.9 Cg_exo -67.03 -12.84 37.67 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.595 2.863 . . . . 0.0 112.539 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 42' ' ' LEU . 2.8 mm? -84.67 157.96 20.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.325 0.65 . . . . 0.0 110.988 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -79.71 53.99 1.72 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.9 mtm 53.47 55.74 8.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.448 1.099 . . . . 0.0 112.551 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.19 104.27 13.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.69 -17.0 63.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -82.7 -11.88 58.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.053 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.25 -16.59 22.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.642 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 49' ' ' LEU . 3.7 mm? -78.09 -25.98 47.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.49 -21.3 38.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 171.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.217 -0.302 . . . . 0.0 111.233 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.28 -6.39 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.967 0.348 . . . . 0.0 111.657 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.93 17.01 21.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.65 0.78 . . . . 0.0 110.003 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -76.14 -45.33 3.71 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.107 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.37 136.49 11.25 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.198 1.932 . . . . 0.0 111.672 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 50.1 24.24 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.027 1.331 . . . . 0.0 113.783 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.14 33.62 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.719 0.407 . . . . 0.0 110.816 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -133.53 59.72 1.73 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.325 0.65 . . . . 0.0 110.331 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.31 138.48 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -133.31 4.61 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 t -151.06 137.84 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.113 0.415 . . . . 0.0 110.484 173.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.3 t -136.81 133.2 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.578 0.751 . . . . 0.0 109.468 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.03 138.87 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.484 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -126.47 117.78 23.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.108 1.363 . . . . 0.0 108.545 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -135.78 162.71 32.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.217 0.607 . . . . 0.0 111.425 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.1 t30 65.58 149.93 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.812 1.245 . . . . 0.0 112.81 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -81.74 25.01 0.57 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.169 0.588 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -127.9 24.63 6.04 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.532 0.733 . . . . 0.0 111.147 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 54.64 55.17 8.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.055 0.942 . . . . 0.0 112.002 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -104.79 120.31 41.07 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.89 153.12 51.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 112.073 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.24 147.89 49.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.45 150.63 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.21 130.35 56.89 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.738 0.415 . . . . 0.0 110.182 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.09 149.16 18.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 C-N-CA 124.056 0.942 . . . . 0.0 109.823 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -97.12 14.92 24.12 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -154.99 139.96 17.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.158 0.583 . . . . 0.0 109.848 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -84.9 -6.55 59.34 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.735 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -90.46 -28.76 18.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.34 -17.87 40.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -46.05 73.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -74.94 -11.82 60.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.352 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.66 -22.26 40.65 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.683 0.674 . . . . 0.0 110.685 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -77.76 -45.28 28.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.04 -17.72 64.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.557 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -69.66 -53.87 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.639 -0.663 . . . . 0.0 109.37 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -80.04 -45.03 19.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.738 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -89.6 9.37 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -139.46 6.88 2.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.6 0.636 . . . . 0.0 112.512 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -143.63 14.99 1.78 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.15 7.82 40.77 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.414 1.006 . . . . 0.0 112.052 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.2 4.26 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.519 0.581 . . . . 0.0 113.983 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.61 55.27 1.88 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.959 0.879 . . . . 0.0 109.318 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 94' ' ' LEU . 6.3 mp -61.84 115.73 17.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.075 0.95 . . . . 0.0 110.728 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.08 -17.26 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.234 2.623 . . . . 0.0 110.802 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.7 mt -135.77 146.11 47.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.276 1.03 . . . . 0.0 109.916 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.59 88.04 6.16 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.7 p -93.87 125.75 38.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.844 0.458 . . . . 0.0 111.664 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -140.54 145.21 36.51 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 124.243 1.017 . . . . 0.0 108.743 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -135.68 157.97 45.56 Favored 'General case' 0 C--O 1.229 0.019 0 CA-C-N 118.337 0.517 . . . . 0.0 112.195 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 157.33 29.41 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.11 140.06 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 123.506 0.723 . . . . 0.0 110.551 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 173.101 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.446 HG12 ' H ' ' A' ' 121' ' ' MET . 16.9 tt . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 42.7 Cg_exo -61.45 -16.77 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.314 2.676 . . . . 0.0 113.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.446 ' H ' HG12 ' A' ' 119' ' ' ILE . 1.7 mpt? -79.82 21.02 0.56 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.009 0.524 . . . . 0.0 112.079 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -130.01 -15.55 3.78 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.651 0.38 . . . . 0.0 110.465 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.58 -11.32 59.67 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.37 -25.7 51.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.1 m -79.18 -49.47 12.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.516 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.46 -17.37 34.42 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.658 -0.817 . . . . 0.0 113.12 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.4 -21.65 17.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.17 0.896 . . . . 0.0 112.365 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 -26.02 15.91 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.417 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -84.65 -23.94 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.857 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -81.54 -49.78 10.16 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.689 0.677 . . . . 0.0 110.627 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -94.9 4.87 53.31 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.1 m -135.86 -4.92 2.2 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.54 0.609 . . . . 0.0 112.418 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 14.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.142 0.883 . . . . 0.0 111.595 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 t -147.52 55.62 1.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.609 -0.682 . . . . 0.0 111.23 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.29 -42.15 0.97 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.437 0.295 . . . . 0.0 110.731 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -139.36 16.87 2.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.136 0.574 . . . . 0.0 110.434 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -146.42 156.86 43.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.707 0.803 . . . . 0.0 110.086 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.91 149.08 39.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.07 156.61 53.57 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 66.46 116.69 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.828 1.251 . . . . 0.0 112.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.412 ' HA ' HG11 ' A' ' 146' ' ' VAL . 23.7 m 64.98 30.8 11.68 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.611 1.164 . . . . 0.0 112.791 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.15 -13.33 52.85 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -146.38 160.67 41.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.108 0.963 . . . . 0.0 109.354 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.94 0.64 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.449 3.433 . . . . 0.0 114.644 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.44 6.58 6.7 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.726 0.693 . . . . 0.0 112.419 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 141' ' ' SER . 30.5 m -85.36 19.91 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.7 m -128.6 27.66 5.5 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.34 -48.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 118.101 0.951 . . . . 0.0 111.516 -178.396 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.5 tp -114.81 127.69 55.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -105.95 143.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.36 0.664 . . . . 0.0 110.257 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.43 143.33 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.845 0.858 . . . . 0.0 110.173 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.03 172.64 42.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.93 64.79 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -59.29 138.52 88.59 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 117.368 0.584 . . . . 0.0 111.599 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.84 -11.1 10.29 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.881 3.054 . . . . 0.0 111.526 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 45' ' ' LYS . 2.0 pp -84.39 161.02 20.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.467 0.707 . . . . 0.0 111.234 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -81.52 55.44 2.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.8 ptt? 46.61 55.16 7.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.918 1.287 . . . . 0.0 112.812 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' H ' HD13 ' A' ' 42' ' ' LEU . 54.8 mtmt -111.24 119.28 38.37 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.354 0.662 . . . . 0.0 109.292 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -70.47 -15.88 62.86 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.976 -0.102 . . . . 0.0 111.143 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -93.85 -9.89 35.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.314 -0.241 . . . . 0.0 111.484 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.01 -17.2 15.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -78.38 -28.2 46.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.2 -21.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.49 -19.16 61.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.176 0.444 . . . . 0.0 110.98 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.96 -6.52 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 117.945 0.339 . . . . 0.0 111.586 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.92 20.07 18.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.785 0.834 . . . . 0.0 110.067 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 23.7 tptm -88.34 -49.43 0.42 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.426 170.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 98.2 Cg_endo -77.08 141.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.089 1.859 . . . . 0.0 110.643 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 48.96 34.5 5.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.781 0.833 . . . . 0.0 112.369 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.89 156.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.083 -0.386 . . . . 0.0 111.378 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.37 54.92 1.92 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.422 0.689 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.88 138.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -117.79 -7.4 10.98 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -146.52 134.11 20.98 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.025 -0.422 . . . . 0.0 110.573 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.1 117.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.37 131.39 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.013 0.435 . . . . 0.0 111.578 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.32 132.9 41.32 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.503 1.121 . . . . 0.0 109.27 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.69 160.09 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.133 0.573 . . . . 0.0 111.688 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.2 t30 64.66 153.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.054 1.342 . . . . 0.0 112.719 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -78.82 32.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.504 0.722 . . . . 0.0 111.144 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -134.75 24.48 3.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.64 0.776 . . . . 0.0 110.289 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 45.91 48.21 12.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 114.001 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -106.61 146.54 30.58 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.24 39.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 111.656 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -131.16 129.78 42.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.17 151.7 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.437 0.161 . . . . 0.0 110.986 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.78 137.62 51.63 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.893 0.378 . . . . 0.0 111.168 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 m -108.77 156.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.624 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.64 6.08 29.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -155.54 137.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.126 0.57 . . . . 0.0 109.801 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.19 -13.35 61.9 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.287 -0.258 . . . . 0.0 111.628 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -88.13 -14.65 38.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -92.01 -11.55 35.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.64 -44.47 61.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.0 -15.27 61.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -83.03 -19.15 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 122.03 -0.419 . . . . 0.0 110.873 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.6 t -75.21 -37.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.65 -21.74 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.894 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.19 -19.8 53.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -85.66 -23.37 27.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -77.93 -8.89 58.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -122.51 3.42 9.64 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -139.82 24.09 2.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.712 0.687 . . . . 0.0 112.835 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -135.45 49.88 2.15 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.667 -0.645 . . . . 0.0 111.016 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.7 4.3 87.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.481 -0.621 . . . . 0.0 113.088 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.91 55.78 8.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.827 0.814 . . . . 0.0 111.679 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -56.48 153.49 20.28 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.287 0.635 . . . . 0.0 110.973 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.63 -2.14 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.925 3.083 . . . . 0.0 112.088 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.88 114.69 5.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -85.31 127.62 34.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.887 0.375 . . . . 0.0 110.734 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 t -137.43 137.48 38.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.326 0.65 . . . . 0.0 109.89 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -147.94 146.41 28.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.187 0.595 . . . . 0.0 110.484 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -106.72 155.89 19.21 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.612 0.365 . . . . 0.0 111.221 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.13 35.58 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.72 148.98 27.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 175.417 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.817 0.342 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.17 -1.87 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.872 3.048 . . . . 0.0 113.413 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.12 21.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.835 0.743 . . . . 0.0 112.399 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -97.45 -10.51 25.27 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.796 -0.565 . . . . 0.0 110.105 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -79.84 -7.71 58.86 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.36 -41.59 13.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.161 0.984 . . . . 0.0 109.673 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 p -76.92 -25.46 52.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.845 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.04 -46.71 11.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.7 0.227 . . . . 0.0 111.531 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 -9.36 57.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.72 -36.78 8.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.45 -24.4 62.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.996 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -87.26 -57.05 3.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.047 -0.408 . . . . 0.0 111.244 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -83.04 5.5 22.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -139.12 -8.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.803 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.81 24.37 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.538 1.063 . . . . 0.0 112.064 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -123.85 34.28 5.11 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.87 -0.519 . . . . 0.0 111.036 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.56 25.3 3.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.083 0.553 . . . . 0.0 111.324 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.14 25.07 3.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.813 0.445 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.5 m95 53.56 38.8 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.238 0.615 . . . . 0.0 111.839 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.47 -160.65 19.42 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -167.13 159.74 33.2 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 117.168 0.484 . . . . 0.0 111.964 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 77.0 p 51.38 24.44 2.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.629 1.572 . . . . 0.0 114.089 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -156.53 24.12 0.34 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.953 0.342 . . . . 0.0 111.789 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.92 -10.96 27.33 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.485 -0.62 . . . . 0.0 114.134 -172.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -145.86 160.4 43.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.197 0.998 . . . . 0.0 110.232 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -60.65 -3.52 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.129 3.219 . . . . 0.0 113.788 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -75.12 -2.71 28.87 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.375 0.534 . . . . 0.0 111.836 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 m -84.77 8.85 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.524 0.329 . . . . 0.0 111.237 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.1 p -129.63 38.07 3.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.19 0.996 . . . . 0.0 108.45 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.04 -59.09 0.02 OUTLIER Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 117.543 0.671 . . . . 0.0 109.962 179.303 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.562 0.22 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.76 108.55 12.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -86.78 139.63 30.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.371 0.668 . . . . 0.0 110.023 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.04 142.38 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.36 171.07 40.55 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.186 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.38 23.7 68.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -56.36 126.01 67.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 117.321 0.561 . . . . 0.0 111.799 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.25 -2.68 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.576 2.85 . . . . 0.0 110.82 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.19 159.98 33.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.221 0.608 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -79.11 38.59 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.799 0.839 . . . . 0.0 111.74 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp 57.48 54.26 6.68 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.9 0.88 . . . . 0.0 111.98 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.13 131.89 37.39 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.668 0.787 . . . . 0.0 109.185 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.8 -8.0 55.1 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -85.15 -17.94 35.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.156 -0.34 . . . . 0.0 110.946 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -87.13 -22.51 25.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.868 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.44 -37.23 77.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.36 -18.85 62.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.829 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -88.2 -4.22 58.76 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.857 -0.527 . . . . 0.0 111.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.46 -2.01 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 118.124 0.42 . . . . 0.0 111.672 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -131.27 6.68 4.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -171.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 3.2 mmpt? -96.52 -29.36 0.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 97.6 Cg_endo -74.74 134.98 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 121.779 1.671 . . . . 0.0 109.968 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 50.3 36.77 13.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.419 0.688 . . . . 0.0 111.612 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.69 165.38 29.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.658 0.783 . . . . 0.0 110.577 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -135.13 49.79 2.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 110.761 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.99 137.04 22.3 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.269 0.627 . . . . 0.0 109.915 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -125.45 1.97 7.67 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 m -138.53 138.73 38.28 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.629 0.65 . . . . 0.0 111.524 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.2 t -135.75 130.92 50.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 123.502 0.721 . . . . 0.0 109.368 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.87 137.84 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.96 142.11 51.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.741 0.816 . . . . 0.0 110.49 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -129.18 129.09 44.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.855 0.862 . . . . 0.0 109.057 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -78.39 43.46 0.46 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.137 0.975 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -135.44 104.91 6.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.7 0.8 . . . . 0.0 109.186 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 52.08 36.58 19.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.928 0.891 . . . . 0.0 111.919 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 53.8 55.77 8.03 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.435 0.694 . . . . 0.0 112.038 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -96.67 129.46 44.06 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.73 152.13 50.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.959 0.504 . . . . 0.0 110.974 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -135.67 136.86 41.26 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.24 155.36 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.595 0.236 . . . . 0.0 110.395 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.92 136.04 47.08 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.993 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -122.26 156.98 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 126.366 1.866 . . . . 0.0 108.192 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -117.94 17.91 14.07 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -143.44 122.94 13.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.757 0.823 . . . . 0.0 109.052 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 ttt-85 -70.26 -20.41 63.06 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.18 0.446 . . . . 0.0 110.679 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -75.75 -21.57 57.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.041 -0.412 . . . . 0.0 110.162 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.59 -11.76 19.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.0 64.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.95 -21.2 51.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.371 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -78.06 -20.57 52.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.972 -0.455 . . . . 0.0 110.855 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.97 -40.67 22.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 O-C-N 121.77 -0.581 . . . . 0.0 110.345 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.24 -21.72 62.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.468 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -81.65 -18.08 45.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.81 -0.557 . . . . 0.0 110.533 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.42 -26.5 32.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -91.8 2.64 56.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -119.84 -0.84 10.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.454 0.302 . . . . 0.0 111.49 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.32 16.18 3.44 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.96 49.05 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 110.595 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.34 9.04 85.91 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.343 -0.698 . . . . 0.0 112.892 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.73 81.18 0.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.083 0.953 . . . . 0.0 111.408 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.37 151.17 60.77 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.15 0.58 . . . . 0.0 111.107 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.27 -9.39 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.787 2.991 . . . . 0.0 111.468 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.9 tt -73.87 124.05 25.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.412 ' N ' HD23 ' A' ' 96' ' ' LEU . 25.8 tpt180 -85.15 136.72 33.42 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 122.368 0.267 . . . . 0.0 111.167 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 p -135.47 142.19 45.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.234 0.614 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.49 137.95 27.27 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.788 0.835 . . . . 0.0 109.061 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -135.2 155.57 50.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 0.0 111.677 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.36 176.49 45.32 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.319 0.4 . . . . 0.0 112.421 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.48 131.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.25 1.02 . . . . 0.0 109.921 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 120.194 0.045 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -56.59 -22.16 42.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.609 2.206 . . . . 0.0 113.248 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 41.4 ttp -80.08 36.34 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.023 0.529 . . . . 0.0 110.737 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -135.65 -36.95 0.76 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.393 0.677 . . . . 0.0 110.429 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -85.96 -13.49 47.53 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.579 0.172 . . . . 0.0 110.716 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.57 -24.97 14.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.209 0.604 . . . . 0.0 109.449 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.2 m -77.47 -26.04 51.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -91.0 -40.16 11.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.288 -0.258 . . . . 0.0 110.886 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.49 -9.41 59.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -112.5 -17.23 12.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.36 -24.47 62.98 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 170.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.57 -52.5 5.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -86.69 16.41 4.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.6 t -143.24 -20.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' ALA . 20.4 m -140.16 33.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.384 0.993 . . . . 0.0 113.058 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.7 p -72.81 22.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.521 -0.737 . . . . 0.0 111.887 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.53 36.52 2.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.44 1.096 . . . . 0.0 109.202 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -133.4 162.3 32.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.231 1.012 . . . . 0.0 109.449 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -75.73 44.64 0.3 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.433 0.693 . . . . 0.0 111.936 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.9 1.02 90.14 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.368 0.508 . . . . 0.0 112.597 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 167.02 54.86 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.765 0.783 . . . . 0.0 111.925 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.8 t -140.01 22.34 2.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.811 0.845 . . . . 0.0 109.353 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -135.3 20.02 3.4 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 109.786 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.25 -5.1 83.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -137.69 160.33 65.39 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.029 0.532 . . . . 0.0 110.133 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.77 20.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 125.27 3.98 . . . . 0.0 115.157 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 149' ' ' ILE . 3.4 pp -83.33 1.62 40.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.14 0.882 . . . . 0.0 111.201 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.87 21.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.564 -0.71 . . . . 0.0 112.328 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -135.71 24.55 3.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.843 0.354 . . . . 0.0 111.796 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.96 -9.51 0.03 OUTLIER Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.593 -0.692 . . . . 0.0 112.915 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.475 HG13 HD13 ' A' ' 145' ' ' LEU . 29.5 mm . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 121.889 0.852 . . . . 0.0 109.548 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.0 tp -122.55 125.46 45.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.127 0.489 . . . . 0.0 110.406 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -109.04 141.58 40.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.902 0.881 . . . . 0.0 109.653 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.99 145.1 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 109.177 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.12 40.09 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.479 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.34 24.31 65.45 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.756 -0.537 . . . . 0.0 111.756 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.18 130.14 89.09 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.427 0.614 . . . . 0.0 111.574 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.45 -2.94 12.27 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.459 2.772 . . . . 0.0 110.86 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.45 156.95 37.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.229 0.612 . . . . 0.0 110.413 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -80.5 43.16 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.409 0.684 . . . . 0.0 111.155 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 88.3 mtp 52.52 55.13 9.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.093 0.957 . . . . 0.0 112.277 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -130.83 125.97 35.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.01 -8.38 52.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -80.86 -15.65 55.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.047 -0.408 . . . . 0.0 110.974 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.02 -24.3 17.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.577 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.86 -26.28 60.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.3 -19.13 36.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.15 -8.47 59.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.953 -0.467 . . . . 0.0 110.806 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.17 -4.21 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -112.46 14.13 20.25 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.332 0.653 . . . . 0.0 111.045 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.514 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 56.3 tttp -117.71 -19.13 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 92.4 Cg_endo -78.16 -21.54 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 121.932 1.726 . . . . 0.0 112.307 -177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.84 16.41 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.129 0.571 . . . . 0.0 111.201 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.07 -175.78 5.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.439 1.096 . . . . 0.0 108.526 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -145.63 104.22 3.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.001 -0.437 . . . . 0.0 110.09 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.38 139.86 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.103 0.561 . . . . 0.0 110.123 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.57 2.72 6.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.201 0.2 . . . . 0.0 111.429 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 t -135.88 119.7 17.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.905 -0.497 . . . . 0.0 110.268 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.7 t -140.38 127.12 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.656 0.782 . . . . 0.0 109.671 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 136.18 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 122.751 0.42 . . . . 0.0 110.133 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.19 145.19 39.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.569 1.148 . . . . 0.0 110.311 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -135.15 138.21 43.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.079 0.552 . . . . 0.0 110.108 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.9 50.45 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -128.18 98.77 5.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 54.9 25.36 6.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.628 0.771 . . . . 0.0 111.693 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.08 60.96 3.28 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.206 1.002 . . . . 0.0 110.946 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.99 151.36 34.3 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.258 0.623 . . . . 0.0 111.122 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.18 160.15 40.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.647 0.779 . . . . 0.0 110.987 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -126.45 137.09 53.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.66 151.25 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-O 121.015 0.436 . . . . 0.0 111.464 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -135.0 134.79 40.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.8 156.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 125.212 1.405 . . . . 0.0 109.1 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -104.51 21.22 17.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.524 0.202 . . . . 0.0 111.216 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -142.71 115.35 8.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.934 0.893 . . . . 0.0 108.955 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -72.96 -20.05 61.12 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -89.79 -16.96 29.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.269 -0.27 . . . . 0.0 110.636 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.31 -18.62 28.11 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.15 84.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -70.48 -20.8 62.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -83.73 -14.09 52.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.99 0.359 . . . . 0.0 111.456 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -75.23 -50.2 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.27 -20.89 65.72 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.664 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -67.81 -46.42 71.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -84.07 -23.73 30.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.913 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.28 -2.86 43.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.095 0.407 . . . . 0.0 111.341 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -131.22 9.13 4.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -135.23 12.61 3.55 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -103.23 -11.84 17.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.043 0.838 . . . . 0.0 111.323 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.81 5.91 4.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.856 0.741 . . . . 0.0 114.392 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.71 29.61 3.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.589 1.195 . . . . 0.0 112.222 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.24 95.69 30.13 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.89 -2.48 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.904 3.069 . . . . 0.0 111.163 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.48 121.08 14.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.565 0.746 . . . . 0.0 109.022 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -83.07 136.11 34.6 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.615 0.366 . . . . 0.0 111.187 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 p -135.69 143.98 45.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.325 0.65 . . . . 0.0 110.81 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.03 131.32 25.01 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -125.47 155.43 40.52 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.333 0.253 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 180.0 -178.54 48.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.69 148.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.132 0.573 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 175.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 118.447 -0.787 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.29 -8.18 17.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.75 1.633 . . . . 0.0 111.834 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.94 24.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.665 0.386 . . . . 0.0 111.753 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.87 -26.61 1.53 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.476 0.311 . . . . 0.0 110.771 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -87.48 -9.83 53.49 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.26 -52.62 8.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.892 0.877 . . . . 0.0 108.689 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -71.69 -19.68 62.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.097 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.7 -60.72 2.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.5 -26.02 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -172.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.22 -42.13 6.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.377 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -77.04 -21.26 54.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.224 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.18 -46.69 8.61 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.723 0.692 . . . . 0.0 111.111 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -84.63 5.03 29.6 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.493 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.3 m -138.83 -5.02 1.53 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.58 19.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.493 1.042 . . . . 0.0 112.571 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -82.87 49.79 1.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.322 -0.861 . . . . 0.0 111.557 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.92 8.0 3.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.923 0.489 . . . . 0.0 110.491 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -145.52 156.92 44.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.287 1.035 . . . . 0.0 109.547 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -76.2 104.53 6.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.55 178.8 33.8 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.04 136.87 25.86 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -146.2 32.75 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.928 0.364 . . . . 0.0 111.331 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG11 ' A' ' 146' ' ' VAL . 21.1 m 57.1 40.71 28.2 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.841 0.456 . . . . 0.0 111.901 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.98 -19.0 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -146.88 162.08 34.72 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.718 0.807 . . . . 0.0 109.287 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.02 3.82 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.46 3.44 . . . . 0.0 114.43 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.02 -5.76 28.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.69 0.677 . . . . 0.0 111.659 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 141' ' ' SER . 22.8 m -89.36 14.69 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.45 0.7 . . . . 0.0 111.042 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -133.43 44.33 2.81 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.78 -57.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.641 0.734 . . . . 0.0 109.653 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 HG11 ' A' ' 84' ' ' VAL . 58.6 tp -135.2 126.29 27.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -100.7 143.02 31.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.534 0.333 . . . . 0.0 110.695 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.73 102.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.23 164.5 18.15 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.31 72.63 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.019 -0.878 . . . . 0.0 113.77 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -53.59 117.51 12.33 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 118.548 1.174 . . . . 0.0 111.09 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.97 -9.49 25.16 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.373 2.715 . . . . 0.0 112.413 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -135.09 67.84 1.48 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.78 0.832 . . . . 0.0 110.856 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.52 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.608 0.763 . . . . 0.0 112.323 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 42' ' ' LEU . 12.1 tpt -147.87 22.81 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.128 0.571 . . . . 0.0 110.902 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 47' ' ' TRP . 29.0 tptt -145.43 78.63 1.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.35 -20.46 66.12 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.06 -0.4 . . . . 0.0 111.745 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.494 ' CE2' ' HE3' ' A' ' 45' ' ' LYS . 63.9 p-90 -92.09 1.7 57.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.95 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.83 -28.51 28.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.39 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.49 -40.39 85.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.49 65.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.229 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -92.06 -3.41 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.214 0.461 . . . . 0.0 112.142 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.16 -2.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 O-C-N 121.996 -0.44 . . . . 0.0 111.75 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tp -124.95 -6.41 7.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 98.5 mttt -96.01 -29.75 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.286 -0.864 . . . . 0.0 113.284 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.51 -18.66 47.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.427 2.085 . . . . 0.0 114.117 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.66 8.53 3.32 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.75 150.12 28.17 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.597 0.635 . . . . 0.0 110.427 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -87.94 40.06 0.92 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.686 0.394 . . . . 0.0 111.642 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.92 141.34 16.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 O-C-N 122.052 -0.405 . . . . 0.0 109.995 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -135.29 7.83 3.38 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 124.25 25.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.206 0.457 . . . . 0.0 110.789 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.09 130.54 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 123.737 0.815 . . . . 0.0 109.337 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.78 131.73 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.81 119.5 22.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -86.64 104.08 15.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -84.5 18.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.273 0.629 . . . . 0.0 112.049 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.6 3.79 3.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.425 0.29 . . . . 0.0 111.588 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -141.18 14.08 2.22 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.95 0.5 . . . . 0.0 111.036 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.1 pttt 44.5 40.7 4.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.727 1.211 . . . . 0.0 112.89 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -127.25 138.5 53.1 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.113 0.565 . . . . 0.0 109.918 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.77 147.0 48.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.752 0.31 . . . . 0.0 111.187 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.86 144.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.5 156.69 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.09 139.39 44.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.58 154.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 126.284 1.834 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.2 15.41 17.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 t -155.91 137.63 14.26 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.055 0.542 . . . . 0.0 110.35 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -68.06 -11.4 58.95 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -81.39 -17.37 49.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.797 -0.564 . . . . 0.0 110.706 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -90.98 -23.13 20.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.02 -22.09 56.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -82.51 -21.59 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -78.04 -20.47 52.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.074 -0.391 . . . . 0.0 110.559 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 35' ' ' LEU . 71.8 t -81.58 -40.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.458 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.8 -18.36 60.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.243 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -82.29 -19.2 39.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.999 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -79.09 -26.01 43.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -84.15 -8.85 58.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.952 0.501 . . . . 0.0 111.409 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -127.24 12.19 7.05 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.94 10.06 3.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.397 0.544 . . . . 0.0 112.459 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -122.77 -20.02 6.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.531 0.605 . . . . 0.0 111.353 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.93 9.73 5.85 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.038 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.3 43.78 2.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.851 1.326 . . . . 0.0 112.26 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.36 119.78 26.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.52 -8.28 12.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.8 3.0 . . . . 0.0 111.404 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.04 138.96 50.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.996 0.519 . . . . 0.0 111.113 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -95.29 84.68 4.09 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.1 p -79.58 122.64 26.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.464 0.705 . . . . 0.0 110.872 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -140.61 118.3 11.65 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.121 0.568 . . . . 0.0 110.281 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -86.83 155.29 20.34 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.673 0.389 . . . . 0.0 111.359 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.78 -171.74 37.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -135.95 136.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.381 0.672 . . . . 0.0 110.338 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 174.676 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 17.6 tt . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 52.1 Cg_exo -57.75 177.56 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.844 3.029 . . . . 0.0 112.801 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -71.67 24.11 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.603 -0.685 . . . . 0.0 110.909 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -87.08 -8.04 57.45 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 tp -103.66 -39.32 6.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.593 0.757 . . . . 0.0 109.262 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -70.61 -26.58 63.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.74 -45.55 9.22 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 117.915 0.325 . . . . 0.0 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.23 -10.95 59.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.923 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -106.7 -24.44 12.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.451 0.569 . . . . 0.0 111.275 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.03 -16.71 59.9 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.267 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 94.8 mttt -85.15 -55.56 3.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -86.6 11.67 12.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 t -137.37 -21.97 1.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.57 19.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.855 1.207 . . . . 0.0 114.117 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 13.0 t -101.95 37.55 1.83 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.313 0.96 . . . . 0.0 110.888 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.32 19.69 3.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -152.79 -41.32 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -136.41 13.01 3.25 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.86 15.08 66.43 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.425 0.557 . . . . 0.0 112.865 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.35 -176.58 41.92 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.74 0.77 . . . . 0.0 112.542 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 25.2 m 64.26 107.85 0.03 OUTLIER 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.895 1.278 . . . . 0.0 111.831 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t 60.74 31.7 20.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.989 0.915 . . . . 0.0 112.18 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.13 -29.77 24.54 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.643 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -152.23 165.44 17.49 Favored Pre-proline 0 C--N 1.34 0.158 0 CA-C-N 117.96 0.88 . . . . 0.0 110.052 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.6 -1.97 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.259 3.306 . . . . 0.0 114.622 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.52 -10.01 59.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.63 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.228 -0.065 0 C-N-CA 123.06 0.544 . . . . 0.0 112.455 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.2 p -135.53 -8.75 2.19 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 122.237 -0.29 . . . . 0.0 111.089 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.32 -31.05 14.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 149' ' ' ILE . 4.3 mp . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.63 129.0 49.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -97.33 139.75 32.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.687 0.28 . . . . 0.0 111.666 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.2 mm -125.87 139.3 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.422 1.089 . . . . 0.0 108.544 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.7 163.58 29.35 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.98 79.36 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.53 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.78 124.59 51.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.091 0.945 . . . . 0.0 111.294 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -82.57 -3.61 11.37 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.434 2.756 . . . . 0.0 110.867 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.78 153.68 43.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 110.453 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.13 46.08 0.99 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.499 0.72 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.2 mmt 54.3 54.92 8.79 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.114 0.966 . . . . 0.0 111.982 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.2 118.07 25.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -70.49 -16.98 62.96 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -84.88 -6.46 59.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.017 -0.427 . . . . 0.0 111.468 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.6 -23.11 19.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.527 0.603 . . . . 0.0 110.141 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.58 -28.21 56.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.15 -21.27 46.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.292 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -79.46 -12.4 59.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.924 0.329 . . . . 0.0 111.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.85 -2.84 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.114 -0.367 . . . . 0.0 111.596 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.87 13.39 24.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.794 0.838 . . . . 0.0 109.857 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.5 tttt -78.17 -38.82 1.67 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.11 170.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.87 118.76 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.678 2.252 . . . . 0.0 112.332 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 50.29 22.99 1.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.075 1.35 . . . . 0.0 113.661 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.49 162.27 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.0 110.453 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -135.07 59.41 1.73 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.789 0.436 . . . . 0.0 110.515 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.92 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 O-C-N 121.904 -0.497 . . . . 0.0 109.691 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -134.78 11.13 3.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 m -135.35 122.0 20.83 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.8 t -135.2 128.1 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.396 0.678 . . . . 0.0 109.229 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.91 104.37 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.14 112.72 25.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.637 0.375 . . . . 0.0 110.187 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -85.94 105.37 16.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.145 0.498 . . . . 0.0 109.777 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -71.59 162.86 28.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.986 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m 61.51 11.09 3.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -148.76 22.24 1.0 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.103 0.41 . . . . 0.0 111.666 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 35.08 45.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.103 1.761 . . . . 0.0 114.744 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -128.97 143.66 50.94 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.91 152.88 39.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.063 0.459 . . . . 0.0 111.437 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -122.56 131.86 54.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.2 151.47 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.37 139.53 44.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.347 0.594 . . . . 0.0 111.733 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.72 153.38 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 125.597 1.559 . . . . 0.0 109.496 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -89.96 9.53 27.48 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -152.57 137.09 16.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.312 0.645 . . . . 0.0 109.792 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -78.74 -4.01 47.11 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -88.04 -23.4 23.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.959 0.345 . . . . 0.0 110.334 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.68 -18.28 33.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.26 72.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.62 -22.45 61.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.393 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -80.06 -17.42 52.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.393 0.542 . . . . 0.0 111.501 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.46 -38.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.456 0.571 . . . . 0.0 110.002 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.55 -17.71 61.16 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.194 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -83.46 -15.3 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.892 -0.505 . . . . 0.0 110.072 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.05 -28.01 39.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.61 -7.0 59.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.124 0.57 . . . . 0.0 110.591 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.37 10.45 9.23 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -135.28 6.55 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.28 0.491 . . . . 0.0 112.119 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.48 -24.32 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.828 -0.545 . . . . 0.0 110.784 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.48 4.93 3.16 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 118.938 -0.923 . . . . 0.0 114.967 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.64 24.85 3.41 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.956 1.378 . . . . 0.0 112.976 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.56 135.21 43.75 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -6.36 12.19 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 124.094 3.196 . . . . 0.0 112.173 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.96 140.67 30.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -92.19 89.97 7.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.0 p -95.25 129.8 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.964 0.505 . . . . 0.0 111.099 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -146.38 148.43 32.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.901 0.48 . . . . 0.0 110.678 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.47 146.34 48.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.178 0.591 . . . . 0.0 111.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.36 16.83 5.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.994 0.807 . . . . 0.0 111.293 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.85 137.57 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 117.364 0.582 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 173.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.11 -169.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 124.849 3.7 . . . . 0.0 112.815 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -73.63 43.31 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.836 0.854 . . . . 0.0 112.43 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -85.19 -7.91 58.83 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.807 -0.558 . . . . 0.0 110.042 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -77.01 -4.11 42.48 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.0 tp -71.21 -45.71 62.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.663 0.785 . . . . 0.0 109.733 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.6 p -84.99 -22.28 29.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.613 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -81.4 -48.58 11.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.234 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.97 -4.61 54.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.68 -29.25 8.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.135 0.88 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -76.64 -21.28 55.7 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.143 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 130' ' ' LYS . 3.8 ttmp? -85.31 -50.61 7.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -91.26 14.93 13.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -135.91 -21.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.32 30.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.196 0.907 . . . . 0.0 113.372 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.7 t -77.21 50.12 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.784 0.72 . . . . 0.0 110.671 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.47 126.08 16.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.872 0.869 . . . . 0.0 108.941 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.96 -174.52 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.872 0.469 . . . . 0.0 111.703 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -73.85 43.0 0.15 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.27 1.028 . . . . 0.0 112.227 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.08 -154.5 7.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.816 0.722 . . . . 0.0 111.834 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.08 -8.42 75.91 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.771 -0.461 . . . . 0.0 112.486 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.1 m -135.57 -17.28 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.426 0.613 . . . . 0.0 111.798 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -148.43 24.17 1.01 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.8 0.44 . . . . 0.0 111.107 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.41 -34.49 7.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.469 -0.629 . . . . 0.0 113.538 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -149.93 164.35 21.1 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.924 . . . . 0.0 110.124 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.81 6.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 124.916 3.744 . . . . 0.0 115.162 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.18 -12.4 58.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.684 0.674 . . . . 0.0 110.595 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.54 19.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.499 0.72 . . . . 0.0 111.846 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.8 p -119.06 20.56 12.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.276 0.23 . . . . 0.0 111.328 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.46 -25.33 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.812 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-N 117.962 0.881 . . . . 0.0 109.696 -178.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.6 tp -135.47 112.19 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.43 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -86.56 135.91 33.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.854 0.862 . . . . 0.0 110.302 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.42 143.05 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.23 166.59 36.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.86 66.76 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.176 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.3 m -52.93 134.83 47.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.789 0.794 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -83.93 -12.25 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.198 3.265 . . . . 0.0 111.362 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.87 166.23 20.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.031 0.932 . . . . 0.0 111.105 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.9 44.56 0.66 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.258 0.623 . . . . 0.0 111.511 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.6 mtt 49.34 55.27 9.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.232 1.013 . . . . 0.0 112.194 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.59 132.98 54.54 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.218 0.607 . . . . 0.0 109.443 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -70.74 -10.1 58.72 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -99.64 -11.88 20.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.983 0.356 . . . . 0.0 111.952 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -96.19 -22.93 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.81 -39.67 63.93 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.81 -17.41 61.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.932 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -81.99 -14.38 56.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.616 0.644 . . . . 0.0 111.842 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.4 m -110.26 -4.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 118.227 0.467 . . . . 0.0 111.78 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -126.14 6.17 7.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -171.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 1.1 tmmt? -101.32 -38.61 0.22 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.929 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 61.9 Cg_exo -55.16 131.78 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.261 1.974 . . . . 0.0 111.182 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 p90 46.83 27.48 0.7 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 113.047 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.65 170.46 15.97 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.909 0.883 . . . . 0.0 110.274 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -135.07 55.13 1.9 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 110.957 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.08 130.14 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -123.35 4.16 9.11 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -140.84 121.34 14.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -135.75 120.22 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 136.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.31 110.77 9.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -83.55 104.38 13.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -84.21 25.81 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.0 p -131.86 3.85 4.13 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.3 0.56 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.998 0.363 . . . . 0.0 111.928 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.3 pttt 45.93 47.12 12.48 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.692 1.197 . . . . 0.0 112.37 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -124.94 129.94 51.36 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.275 0.63 . . . . 0.0 110.277 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.21 147.53 49.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.317 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.3 136.6 35.04 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.666 0.386 . . . . 0.0 110.082 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.57 159.7 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 122.323 0.249 . . . . 0.0 110.739 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.55 132.0 34.6 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.945 0.402 . . . . 0.0 111.513 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -101.1 154.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 124.383 1.073 . . . . 0.0 109.23 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -81.1 -4.62 55.9 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.1 t -147.01 139.08 24.51 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.726 0.41 . . . . 0.0 110.712 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -78.69 -5.84 54.17 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -90.0 -22.05 22.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.64 -15.36 45.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.28 -42.11 60.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.3 -22.49 66.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -81.25 -22.49 38.69 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.103 -0.373 . . . . 0.0 111.093 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.53 -38.65 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.88 -18.39 63.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.912 173.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -77.73 -23.12 49.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.302 0.501 . . . . 0.0 109.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -72.78 -49.64 29.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.877 -0.514 . . . . 0.0 109.614 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -89.47 10.16 23.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -135.65 6.57 3.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.356 0.526 . . . . 0.0 112.284 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -136.96 7.16 2.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.539 0.608 . . . . 0.0 112.396 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.12 -18.95 15.33 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.6 0.636 . . . . 0.0 110.909 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.58 4.55 4.1 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.337 0.97 . . . . 0.0 115.172 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.8 35.14 2.88 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.009 1.405 . . . . 0.0 112.745 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.83 127.94 23.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -84.85 -10.44 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.087 3.191 . . . . 0.0 112.61 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.6 tt -73.37 134.97 44.22 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 96' ' ' LEU . 82.2 mmt-85 -111.64 136.88 50.24 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -141.65 145.2 34.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.042 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -143.34 126.78 16.79 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.29 0.636 . . . . 0.0 110.257 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -85.84 156.74 20.43 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.14 -164.97 14.72 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.13 136.76 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.988 0.515 . . . . 0.0 110.452 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 174.55 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 9.5 tp . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 118.09 -0.957 . . . . 0.0 113.551 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 31.8 Cg_exo -63.96 176.26 2.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.46 2.107 . . . . 0.0 111.828 174.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -74.15 24.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.833 0.453 . . . . 0.0 111.507 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -91.29 -7.6 50.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.17 -9.21 59.71 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.82 -46.88 11.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.992 0.917 . . . . 0.0 109.503 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -77.68 -16.07 58.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.968 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.96 -43.94 12.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.103 -0.373 . . . . 0.0 111.401 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.21 -12.09 53.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.59 -24.32 11.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.679 0.672 . . . . 0.0 111.189 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -74.81 -22.68 58.6 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.544 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -90.35 -52.73 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.952 -0.467 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -83.16 7.23 16.68 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -143.94 -4.32 0.84 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.78 23.18 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.16 0.891 . . . . 0.0 111.851 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.7 t -84.9 32.86 0.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.624 -0.672 . . . . 0.0 111.374 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.07 20.6 3.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.023 0.529 . . . . 0.0 110.241 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -135.92 147.25 48.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.756 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -65.91 104.8 1.17 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.51 65.42 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.947 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 61.71 -148.26 47.6 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 118.18 0.99 . . . . 0.0 110.787 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.4 m 70.77 114.93 0.05 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.021 0.928 . . . . 0.0 111.507 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.6 t 59.22 31.01 20.87 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.62 -18.59 44.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -149.68 160.02 34.94 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 108.959 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.66 -10.83 10.07 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.661 2.908 . . . . 0.0 113.682 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.13 -36.63 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.786 0.434 . . . . 0.0 111.24 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -8.32 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 O-C-N 122.045 -0.409 . . . . 0.0 110.682 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -83.09 24.02 0.81 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.093 0.473 . . . . 0.0 109.86 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.99 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 CA--C 1.527 0.087 0 CA-C-N 117.559 0.679 . . . . 0.0 109.896 174.426 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.32 127.91 41.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.55 141.21 38.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.056 0.542 . . . . 0.0 110.475 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.9 mm -123.04 147.68 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.337 1.055 . . . . 0.0 108.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.03 164.21 36.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.534 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.55 27.04 70.3 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.96 128.87 85.38 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.338 0.569 . . . . 0.0 112.146 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.9 -1.81 11.44 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.934 3.089 . . . . 0.0 111.166 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.88 162.4 29.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.067 0.547 . . . . 0.0 110.97 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -80.1 38.14 0.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.03 0.932 . . . . 0.0 112.169 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.1 mtt 56.92 44.67 22.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.0 113.125 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.14 137.88 46.43 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.186 0.594 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -72.93 -12.07 60.82 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -84.12 -7.37 59.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.149 -0.344 . . . . 0.0 110.943 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -93.56 -24.29 18.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.881 0.309 . . . . 0.0 110.312 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.87 -28.72 55.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.99 -21.37 47.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -81.34 -14.55 57.16 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.245 0.475 . . . . 0.0 111.701 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.1 -4.47 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.252 0.478 . . . . 0.0 111.459 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.2 8.29 23.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.672 0.789 . . . . 0.0 110.371 170.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 59.3 tptt -72.59 -44.8 9.6 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.8 Cg_endo -84.12 -20.65 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.266 1.978 . . . . 0.0 114.546 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -142.98 24.51 1.83 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.46 165.69 27.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.905 -0.497 . . . . 0.0 111.105 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.32 55.36 1.22 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.358 0.663 . . . . 0.0 109.548 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.9 140.58 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.075 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -131.44 -0.12 4.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -143.55 134.41 25.33 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.751 -0.593 . . . . 0.0 110.734 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.0 t -137.96 130.05 39.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.421 0.688 . . . . 0.0 109.829 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 111.11 14.08 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.3 0.24 . . . . 0.0 110.37 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -88.99 88.7 7.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -76.87 24.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.559 0.744 . . . . 0.0 112.474 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.7 p -128.24 5.96 5.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -144.16 14.99 1.68 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.972 0.509 . . . . 0.0 110.606 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 52.88 31.44 10.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.325 1.05 . . . . 0.0 112.185 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -133.69 149.82 51.53 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 122.965 0.506 . . . . 0.0 110.817 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.73 158.2 43.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.12 0.568 . . . . 0.0 110.114 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -130.15 138.72 50.78 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.82 153.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.313 0.101 . . . . 0.0 110.736 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -125.23 130.39 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.081 0.467 . . . . 0.0 111.727 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.11 150.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.705 1.602 . . . . 0.0 108.565 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -109.03 24.15 13.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -145.43 121.84 10.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.14 0.976 . . . . 0.0 108.73 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -78.85 -9.14 59.38 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.478 -0.139 . . . . 0.0 111.094 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -84.89 -24.42 28.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -88.68 -14.43 37.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.59 -42.78 64.19 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -74.08 -16.2 61.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.185 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -83.31 -17.89 40.9 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.069 -0.394 . . . . 0.0 110.78 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.3 t -73.69 -47.43 44.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.05 -16.88 63.8 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.757 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.48 -44.86 66.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.72 -26.14 30.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.789 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -81.78 0.11 40.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.114 0.415 . . . . 0.0 111.025 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.17 5.37 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.094 0.406 . . . . 0.0 111.968 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -143.27 24.1 1.8 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.91 -8.74 14.48 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.62 -0.675 . . . . 0.0 111.182 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.51 2.55 4.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.082 -0.843 . . . . 0.0 114.708 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.75 26.14 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.735 1.268 . . . . 0.0 112.482 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt -131.22 96.51 21.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.86 -0.78 11.04 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.998 3.132 . . . . 0.0 111.346 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.41 125.06 23.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.52 0.728 . . . . 0.0 109.268 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -89.75 126.68 35.76 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.469 0.308 . . . . 0.0 110.797 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 m -136.4 137.9 40.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.402 0.681 . . . . 0.0 110.247 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -141.37 144.64 34.63 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.113 0.965 . . . . 0.0 109.087 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -102.65 130.48 49.57 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.545 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.5 156.7 21.19 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.2 138.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.459 0.704 . . . . 0.0 110.205 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 174.331 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.4 pt . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 71.9 Cg_endo -67.98 -8.08 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.397 2.731 . . . . 0.0 112.51 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 12.1 tpt -134.89 25.18 3.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.1 0.56 . . . . 0.0 110.221 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -135.15 -16.29 1.91 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.078 -0.388 . . . . 0.0 111.337 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -82.15 -19.66 39.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 173.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 32.0 tp -92.28 -25.62 18.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.414 0.686 . . . . 0.0 110.027 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.0 m -84.51 -21.47 30.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.2 -40.84 11.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.167 -0.333 . . . . 0.0 110.783 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.47 45.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -106.43 -25.2 11.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.682 0.674 . . . . 0.0 111.437 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -76.78 -24.84 52.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.773 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.06 -49.09 9.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.863 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -95.96 11.3 34.45 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -135.13 -16.85 1.88 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.824 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.69 21.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.408 1.003 . . . . 0.0 113.307 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 m -132.55 2.74 3.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 111.187 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.74 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.809 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -148.54 168.9 21.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.46 1.504 . . . . 0.0 108.373 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -129.61 27.81 5.21 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.501 0.321 . . . . 0.0 111.012 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.48 -12.65 77.86 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.666 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.95 -177.48 25.05 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 117.803 0.801 . . . . 0.0 111.802 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 p -77.81 -69.58 0.53 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 122.288 -0.537 . . . . 0.0 110.957 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 28.81 1.77 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.0 110.228 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.87 85.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.385 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.516 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 37.3 tp60 -162.3 -42.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.687 1.244 . . . . 0.0 113.258 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.516 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 39.5 Cg_exo -63.07 2.05 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.902 2.401 . . . . 0.0 114.741 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 3.41 7.0 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.872 0.76 . . . . 0.0 111.891 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.61 9.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.412 0.685 . . . . 0.0 111.789 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -135.64 24.13 3.4 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.97 0.908 . . . . 0.0 108.8 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.03 29.93 0.12 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.781 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 124.665 1.186 . . . . 0.0 112.635 177.532 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.232 0.182 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.21 123.28 48.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -93.98 140.5 29.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.974 0.509 . . . . 0.0 111.008 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.3 137.08 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.001 0.921 . . . . 0.0 108.878 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.66 166.83 31.41 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.85 20.23 74.18 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.629 -0.54 . . . . 0.0 112.023 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.04 124.74 46.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.763 0.782 . . . . 0.0 111.646 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.26 -4.95 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.374 2.716 . . . . 0.0 110.656 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.85 149.54 39.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.113 0.565 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -84.74 52.44 2.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.992 0.517 . . . . 0.0 110.168 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 55.28 55.66 7.25 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.051 0.94 . . . . 0.0 112.05 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.08 111.84 17.03 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.6 -13.7 62.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -88.61 -6.45 57.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.97 -0.456 . . . . 0.0 111.042 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -92.77 -20.03 21.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.209 0.459 . . . . 0.0 109.971 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.24 -28.41 53.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.79 45.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.019 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.43 -15.99 58.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.961 0.346 . . . . 0.0 111.557 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.79 -4.28 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.222 0.465 . . . . 0.0 111.482 172.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.52 12.05 26.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.665 0.786 . . . . 0.0 109.804 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 65.2 tttp -75.15 -39.29 3.17 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 95.1 Cg_endo -75.03 125.73 9.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.564 1.51 . . . . 0.0 111.576 -174.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 t80 51.63 23.93 2.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.124 1.37 . . . . 0.0 113.093 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.94 160.03 42.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.462 0.705 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.03 55.85 1.87 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.491 0.316 . . . . 0.0 111.597 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.53 139.0 21.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 O-C-N 121.958 -0.464 . . . . 0.0 109.813 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -131.71 4.17 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.4 m -135.59 124.22 23.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.01 0.368 . . . . 0.0 110.334 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.14 115.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.6 mp -111.62 104.58 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 104.81 14.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -81.05 104.2 11.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.064 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -85.67 24.34 1.24 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.44 0.696 . . . . 0.0 112.06 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -130.09 7.58 5.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -147.72 19.19 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.153 0.581 . . . . 0.0 110.235 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 37.51 38.03 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.704 1.602 . . . . 0.0 113.658 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -138.06 159.77 41.15 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.985 0.914 . . . . 0.0 109.769 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.67 159.29 42.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.979 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.45 135.31 47.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.12 154.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -135.21 139.04 44.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 0.0 111.357 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.63 150.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.48 1.512 . . . . 0.0 109.33 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -90.15 15.14 10.8 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -154.09 138.09 16.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.157 0.583 . . . . 0.0 109.886 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.24 -8.15 59.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.58 -28.87 24.56 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.41 -14.15 55.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.71 65.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.05 -13.69 60.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.146 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.72 -16.6 41.14 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.452 0.569 . . . . 0.0 111.213 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.64 -41.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -17.76 61.79 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.188 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -70.23 -40.29 74.58 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -62.56 -40.9 98.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -84.18 11.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.444 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -130.31 12.98 5.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.382 0.273 . . . . 0.0 111.234 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -135.78 3.63 2.99 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.57 -8.96 22.47 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.771 0.714 . . . . 0.0 111.981 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.88 -8.02 0.63 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.109 0.861 . . . . 0.0 114.552 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.55 72.84 1.42 Allowed 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.36 1.08 . . . . 0.0 109.929 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 94' ' ' LEU . 7.3 mp -56.52 119.67 30.49 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.135 0.574 . . . . 0.0 110.375 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.54 -11.72 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.67 2.913 . . . . 0.0 111.287 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.86 149.67 49.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.451 0.701 . . . . 0.0 111.115 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -103.7 98.52 8.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.6 t -117.52 147.94 42.32 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.089 0.556 . . . . 0.0 111.751 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.82 145.43 46.45 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.548 1.139 . . . . 0.0 108.869 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -127.9 152.19 48.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.93 146.68 14.16 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.98 136.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.004 0.522 . . . . 0.0 110.77 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.266 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.57 4.39 5.07 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.195 3.263 . . . . 0.0 112.441 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.61 11.51 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.234 0.47 . . . . 0.0 112.186 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -135.8 3.79 3.0 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.185 0.594 . . . . 0.0 110.418 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -91.38 -20.1 22.18 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.187 0.195 . . . . 0.0 110.842 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.4 pp -90.32 -12.65 37.11 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 m -74.83 -47.34 31.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.12 -68.4 0.56 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.605 0.241 . . . . 0.0 111.039 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.73 -17.27 56.1 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.26 -16.95 13.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.986 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.49 -13.92 53.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.365 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -91.64 -32.99 15.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.371 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.84 9.22 25.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.535 0.607 . . . . 0.0 111.705 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -126.52 -11.21 6.23 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.938 -0.553 . . . . 0.0 112.05 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.2 t -127.27 24.97 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.6 t -74.59 55.48 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.227 -0.921 . . . . 0.0 109.85 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.04 156.15 47.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.095 0.958 . . . . 0.0 110.448 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -86.2 49.59 1.82 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.904 0.482 . . . . 0.0 111.079 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -135.93 55.56 1.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.725 0.81 . . . . 0.0 109.515 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.14 152.87 21.18 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.79 -16.2 71.01 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.488 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 76.7 p -145.71 12.71 1.31 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.221 1.01 . . . . 0.0 111.624 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 t -135.95 24.37 3.32 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.408 0.549 . . . . 0.0 112.15 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.416 ' H ' HG13 ' A' ' 133' ' ' VAL . . . -79.61 0.47 81.34 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -146.45 149.18 36.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.32 14.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.434 3.423 . . . . 0.0 115.307 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 133' ' ' VAL . 4.6 pp -67.57 -8.57 35.24 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.902 0.774 . . . . 0.0 111.693 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.27 7.92 2.46 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 123.968 0.907 . . . . 0.0 111.005 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.8 m -134.79 30.46 3.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.04 -56.76 0.05 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.943 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.516 -0.344 0 CA-C-N 117.91 0.855 . . . . 0.0 112.759 -178.411 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.45 142.16 51.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.425 0.557 . . . . 0.0 112.256 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.24 143.34 50.72 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 mm -122.74 150.49 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.87 171.0 34.87 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.865 -0.522 . . . . 0.0 112.143 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.58 73.96 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 ' H ' ' A' ' 40' ' ' VAL . 2.0 m -54.34 128.49 59.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 117.464 0.632 . . . . 0.0 111.883 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -87.67 -7.54 6.46 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.267 3.311 . . . . 0.0 111.457 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.56 156.35 30.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.329 1.051 . . . . 0.0 111.953 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.19 57.97 4.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.938 0.895 . . . . 0.0 112.226 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 38.5 ttm 53.54 55.74 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.654 0.782 . . . . 0.0 112.083 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -126.92 108.44 10.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.252 0.621 . . . . 0.0 109.563 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.97 -17.7 65.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.95 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -85.64 -3.06 58.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.202 -0.311 . . . . 0.0 111.2 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -94.43 -23.7 17.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.466 0.575 . . . . 0.0 109.973 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.81 -35.89 75.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 170.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.3 60.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.555 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -78.22 -11.67 59.94 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.707 -0.621 . . . . 0.0 110.703 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.88 -1.27 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.58 12.29 14.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.767 0.827 . . . . 0.0 110.595 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.487 ' H ' ' HD3' ' A' ' 55' ' ' PRO . 88.8 tttt -109.69 -32.28 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 59.0 Cg_exo -57.04 -21.17 40.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.492 2.128 . . . . 0.0 114.259 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.6 5.8 1.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.0 174.14 11.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.462 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.52 55.52 1.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.176 0.591 . . . . 0.0 110.662 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.74 139.7 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -115.39 -2.02 12.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -172.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.1 m -141.64 131.21 23.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.432 0.56 . . . . 0.0 110.58 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -143.19 125.19 12.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.205 0.602 . . . . 0.0 109.865 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.59 139.96 45.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.985 0.514 . . . . 0.0 110.055 173.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -109.29 138.6 45.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.82 0.848 . . . . 0.0 111.219 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -102.08 105.24 15.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -79.92 24.56 0.4 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.837 0.855 . . . . 0.0 113.253 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.2 m -133.16 6.5 3.89 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.847 0.294 . . . . 0.0 111.63 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -152.73 11.47 0.5 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.718 0.235 . . . . 0.0 111.228 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 47.44 47.03 17.36 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -128.44 150.64 50.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.121 0.569 . . . . 0.0 110.312 -173.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -135.34 155.42 50.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.306 0.574 . . . . 0.0 111.742 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -127.3 127.16 43.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.39 150.75 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.465 0.174 . . . . 0.0 111.188 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.47 131.32 43.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.95 0.405 . . . . 0.0 111.617 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -106.36 157.57 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 124.759 1.224 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -86.96 -2.02 58.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -153.42 150.21 28.58 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.082 -0.386 . . . . 0.0 110.366 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -70.26 -12.63 61.73 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.358 -0.214 . . . . 0.0 111.414 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -77.85 -16.92 57.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.924 -0.485 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.64 -14.92 36.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.145 -0.347 . . . . 0.0 110.219 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.55 -40.41 35.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -73.48 -25.56 60.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -79.1 -22.59 45.01 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.317 0.508 . . . . 0.0 111.203 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.9 t -74.75 -42.65 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.27 -16.08 62.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.452 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -78.86 -24.63 44.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.29 0.496 . . . . 0.0 110.412 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -99.14 -17.32 18.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.107 -0.371 . . . . 0.0 110.671 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.96 0.26 57.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.018 -0.426 . . . . 0.0 110.077 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.34 -2.58 2.48 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -144.14 20.47 1.75 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.092 0.86 . . . . 0.0 113.007 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -135.99 55.59 1.85 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.1 -2.82 72.3 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.476 -0.624 . . . . 0.0 112.798 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 50.86 74.76 0.21 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.91 0.884 . . . . 0.0 112.085 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.8 151.86 40.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.846 0.458 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.24 -6.82 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.895 3.064 . . . . 0.0 112.231 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.64 128.62 36.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.878 0.308 . . . . 0.0 110.281 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -89.32 100.36 13.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.1 m -104.95 135.39 46.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.754 0.422 . . . . 0.0 111.059 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -141.27 149.25 41.06 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.646 0.779 . . . . 0.0 109.933 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -103.85 140.62 37.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.98 151.51 22.22 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.31 151.64 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.488 0.715 . . . . 0.0 111.094 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.569 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.66 1.81 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.682 2.922 . . . . 0.0 112.497 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.8 ttt -84.51 -4.14 58.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.913 -0.492 . . . . 0.0 111.221 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -135.68 10.46 3.4 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.549 0.339 . . . . 0.0 111.403 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -74.62 -10.34 59.44 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 149' ' ' ILE . 3.6 pp -83.4 -23.78 32.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.3 m -89.94 -15.6 31.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -77.51 -50.4 12.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.613 0.365 . . . . 0.0 110.065 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.24 -15.28 41.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -91.3 -41.47 10.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.672 0.669 . . . . 0.0 110.876 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -68.77 -28.85 67.15 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.405 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -70.9 -62.53 1.36 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -98.1 21.58 10.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 -10.46 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.48 3.42 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.2 0.909 . . . . 0.0 112.744 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.9 m -87.79 31.13 0.78 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.244 -0.91 . . . . 0.0 111.2 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.47 24.9 6.62 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.177 0.991 . . . . 0.0 109.42 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -135.36 169.17 17.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.855 1.262 . . . . 0.0 109.144 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -76.21 24.22 0.14 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.04 137.35 2.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.02 152.78 20.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.0 m 55.24 36.45 27.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.576 0.703 . . . . 0.0 109.274 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.8 m -147.66 14.34 1.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.852 1.261 . . . . 0.0 109.042 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.21 -106.45 2.99 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 82.3 mt-30 -152.29 -42.24 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 50.2 Cg_exo -60.47 -20.51 64.16 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.849 2.366 . . . . 0.0 115.653 -171.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.4 pt? -140.97 1.2 1.64 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.07 -4.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 39.3 p -133.72 11.71 4.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.88 -71.74 1.31 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.378 0.132 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.45 131.01 54.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.289 0.636 . . . . 0.0 109.366 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -115.26 142.91 46.04 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.202 0.601 . . . . 0.0 110.804 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.93 141.81 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.835 0.854 . . . . 0.0 109.085 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.09 29.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.03 75.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.582 -0.565 . . . . 0.0 111.931 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 m -55.85 124.54 58.4 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.85 0.825 . . . . 0.0 110.87 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.5 -2.83 13.08 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.324 2.683 . . . . 0.0 111.076 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.54 157.91 34.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.32 0.648 . . . . 0.0 110.133 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -85.09 47.85 1.47 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.51 55.92 6.81 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.915 0.886 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -126.87 116.65 21.16 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.31 -12.58 61.78 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -83.78 -11.43 57.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.085 -0.384 . . . . 0.0 110.896 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -95.73 -18.53 20.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.392 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 49' ' ' LEU . 3.9 mm? -77.49 -26.79 51.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.96 -22.63 42.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.94 -14.75 59.83 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.112 -0.368 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 -2.64 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 118.243 0.474 . . . . 0.0 111.783 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.33 14.3 22.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.6 0.76 . . . . 0.0 109.837 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 64.9 tttp -88.56 -37.23 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.937 169.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 49.8 Cg_exo -59.4 116.91 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.252 1.968 . . . . 0.0 111.111 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 51.67 23.89 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.398 1.079 . . . . 0.0 113.178 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 159.45 44.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.116 0.416 . . . . 0.0 110.9 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -135.34 59.18 1.73 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.894 0.477 . . . . 0.0 111.301 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -70.15 142.59 15.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 O-C-N 121.856 -0.527 . . . . 0.0 109.996 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -132.45 6.62 4.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.0 m -135.51 119.75 17.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.213 0.46 . . . . 0.0 110.472 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.16 123.91 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.284 0.633 . . . . 0.0 109.406 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 104.66 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.22 117.62 34.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -135.09 155.95 49.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.806 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 60.24 177.21 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.137 1.375 . . . . 0.0 112.349 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -70.22 78.54 0.52 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.509 0.723 . . . . 0.0 111.141 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 50.09 32.27 5.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.915 1.686 . . . . 0.0 114.833 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -135.56 4.17 3.09 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -139.47 55.26 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.226 0.921 . . . . 0.0 111.294 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.01 137.21 36.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.052 0.454 . . . . 0.0 110.228 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -135.5 133.49 38.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.552 0.741 . . . . 0.0 109.939 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.66 152.34 31.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.549 0.214 . . . . 0.0 111.137 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -135.74 142.45 45.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.241 0.544 . . . . 0.0 111.93 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.75 151.02 22.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.479 1.511 . . . . 0.0 109.174 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -87.77 11.12 16.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.3 t -149.7 136.06 19.07 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.821 0.448 . . . . 0.0 109.839 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -72.59 -17.7 61.67 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 122.401 -0.187 . . . . 0.0 110.585 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -82.53 -22.06 35.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.23 -19.07 37.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.72 66.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.21 -14.51 60.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.93 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.5 -19.86 37.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.238 0.472 . . . . 0.0 111.002 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.77 -44.06 46.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.27 -18.57 63.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -75.28 -28.54 59.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.53 0.604 . . . . 0.0 109.593 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -72.14 -28.91 63.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.4 5.55 51.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.529 0.332 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.7 17.26 5.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.896 0.478 . . . . 0.0 110.577 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -129.56 -6.52 4.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.654 0.382 . . . . 0.0 111.209 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -97.84 -6.61 32.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.472 0.578 . . . . 0.0 112.041 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 5.32 3.91 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.176 0.893 . . . . 0.0 114.093 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.02 50.11 0.52 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.392 1.096 . . . . 0.0 109.874 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 94' ' ' LEU . 1.9 pt? -53.82 127.99 53.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 122.712 0.405 . . . . 0.0 111.395 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.03 0.71 8.8 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.4 3.4 . . . . 0.0 112.238 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.47 150.66 50.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.85 104.25 16.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 p -121.76 133.73 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.481 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -137.31 145.0 42.89 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 123.459 0.704 . . . . 0.0 110.16 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -133.1 157.4 45.38 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.041 0.537 . . . . 0.0 110.026 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.91 -176.07 40.57 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.546 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.55 143.33 36.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 125.049 1.34 . . . . 0.0 109.951 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 175.119 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 121' ' ' MET . 26.5 mt . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.564 0.221 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.79 -7.32 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.305 2.67 . . . . 0.0 112.889 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.506 ' H ' HG22 ' A' ' 119' ' ' ILE . 5.4 mpp? -85.81 25.87 1.05 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.385 0.539 . . . . 0.0 111.388 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -72.2 -20.71 61.53 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -92.47 10.15 31.36 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.227 -0.296 . . . . 0.0 110.949 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.55 -32.61 12.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 t -84.86 -27.68 26.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.7 -59.68 2.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.557 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.69 -24.77 41.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.82 -27.54 10.68 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 113.142 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -85.08 -18.77 33.27 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.6 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -87.37 -55.26 3.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.539 0.609 . . . . 0.0 109.738 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -87.3 4.49 42.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 m -139.58 -5.56 1.37 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 172.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.43 21.18 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.052 1.297 . . . . 0.0 112.092 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 t -100.63 30.14 4.11 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.371 -0.831 . . . . 0.0 111.384 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.57 24.36 8.57 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 110.218 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -140.43 156.51 46.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.354 1.062 . . . . 0.0 108.834 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -74.87 24.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.32 0.648 . . . . 0.0 112.082 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.06 160.67 13.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.17 -169.2 42.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.1 m 68.63 112.0 0.04 OUTLIER 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.331 1.053 . . . . 0.0 112.366 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.7 t 59.36 24.93 13.53 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.345 1.058 . . . . 0.0 112.606 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.44 -9.1 82.28 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -156.82 147.24 16.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.26 7.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.445 3.43 . . . . 0.0 115.67 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.72 6.0 5.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.031 0.832 . . . . 0.0 111.663 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.08 17.57 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.125 0.57 . . . . 0.0 111.645 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -135.12 40.41 2.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.01 0.924 . . . . 0.0 109.136 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.84 -53.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.814 0.816 . . . . 0.0 110.395 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.66 126.05 53.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -112.4 140.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.752 0.821 . . . . 0.0 110.312 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mm -125.45 144.66 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.42 176.97 37.91 Favored Glycine 0 CA--C 1.524 0.651 0 O-C-N 121.863 -0.523 . . . . 0.0 112.206 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.78 19.7 73.55 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 40' ' ' VAL . 1.2 m -62.55 130.0 93.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 117.563 0.682 . . . . 0.0 111.242 -173.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.76 -10.35 6.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.13 3.22 . . . . 0.0 111.307 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 4.0 pp -82.03 156.08 24.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.684 1.193 . . . . 0.0 111.666 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -80.7 55.93 2.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.736 0.815 . . . . 0.0 112.109 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.1 mtm 50.73 55.34 9.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.14 0.976 . . . . 0.0 112.495 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 88.5 tttt -115.55 106.06 13.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.64 -15.71 63.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -84.17 -7.5 59.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.158 -0.339 . . . . 0.0 110.827 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -96.85 -20.74 17.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.405 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.72 -29.28 62.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.84 50.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.235 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -76.63 -13.11 60.09 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.792 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.96 -2.6 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -118.22 18.28 13.79 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.688 0.795 . . . . 0.0 110.291 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.3 ttmt -105.71 -35.51 0.19 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.442 -0.79 . . . . 0.0 113.035 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.1 Cg_exo -58.97 -23.97 70.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.645 2.23 . . . . 0.0 114.161 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -143.82 13.71 1.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.78 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.121 0.569 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -134.56 57.86 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.483 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.32 138.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -130.65 9.31 5.02 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -135.44 113.64 11.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.42 128.14 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.13 131.49 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mt -107.78 122.68 47.26 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -118.19 161.71 19.44 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 62.1 24.9 14.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.24 1.816 . . . . 0.0 112.783 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 m 52.6 26.44 4.35 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.841 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -141.05 -174.79 4.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.29 1.436 . . . . 0.0 109.122 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.58 30.65 0.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -87.95 81.36 7.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.379 0.991 . . . . 0.0 108.728 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.16 138.73 32.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.424 0.631 . . . . 0.0 112.242 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -136.02 131.67 35.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.952 0.901 . . . . 0.0 108.866 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -133.0 151.66 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 111.617 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -135.47 142.28 45.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.421 0.629 . . . . 0.0 111.597 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.22 152.77 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 125.103 1.361 . . . . 0.0 109.156 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -98.33 24.14 7.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.6 t -149.99 138.57 20.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.959 0.504 . . . . 0.0 110.09 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -38.48 73.82 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -76.35 -15.94 59.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.241 -0.287 . . . . 0.0 111.587 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -86.28 -18.78 31.13 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.873 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.91 -22.56 42.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.94 -19.26 37.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.292 -0.255 . . . . 0.0 111.366 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -78.39 -43.38 26.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.466 0.575 . . . . 0.0 110.157 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' LEU . 3.1 mm? -75.37 -14.97 60.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.002 177.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -71.55 -43.3 66.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.764 0.711 . . . . 0.0 109.144 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -76.04 -12.4 60.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.419 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -92.35 -1.26 57.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.1 -0.375 . . . . 0.0 110.325 170.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -112.36 3.19 16.84 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.797 0.439 . . . . 0.0 111.429 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -135.02 1.69 3.01 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.15 55.17 1.77 Allowed 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.2 -0.28 20.65 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.804 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.02 3.02 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.912 0.856 . . . . 0.0 111.798 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -89.15 153.58 49.0 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 122.859 0.463 . . . . 0.0 109.776 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.53 -11.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.688 2.925 . . . . 0.0 112.062 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.08 153.14 21.5 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.786 0.435 . . . . 0.0 111.755 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -125.41 137.44 54.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 109.025 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -135.46 141.98 45.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -137.53 147.49 45.21 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.224 1.01 . . . . 0.0 109.552 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -135.13 160.49 38.2 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.12 175.08 33.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.36 148.83 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.122 0.969 . . . . 0.0 109.952 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.093 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 35.9 mm . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 46.8 Cg_exo -61.04 -13.38 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.633 2.888 . . . . 0.0 115.797 -171.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.88 23.85 3.34 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -91.11 -12.4 35.69 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 121.641 -0.662 . . . . 0.0 110.911 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -88.59 -6.22 57.67 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.6 tp -101.41 -27.62 13.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.709 0.804 . . . . 0.0 109.601 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -80.98 -21.68 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.29 -44.44 10.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 0.0 111.199 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.58 -13.94 59.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.46 -17.31 11.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.903 0.774 . . . . 0.0 111.747 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -70.97 -25.65 62.81 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.867 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.89 -63.43 1.32 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.296 0.238 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -80.7 8.48 7.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -143.91 -17.69 0.59 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.421 ' CG2' HD21 ' A' ' 145' ' ' LEU . 1.5 t -135.6 24.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.914 1.234 . . . . 0.0 113.693 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.5 m -103.92 26.61 8.47 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.179 -0.951 . . . . 0.0 111.665 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.07 24.02 3.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.788 0.435 . . . . 0.0 111.218 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -148.14 -74.99 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.274 -0.266 . . . . 0.0 111.265 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -140.5 158.1 44.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.853 0.861 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.67 157.39 50.53 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.57 171.63 27.09 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 123.372 0.511 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 34.7 p -87.13 -5.55 58.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.206 0.602 . . . . 0.0 110.564 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.9 m -89.43 13.52 13.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.504 0.322 . . . . 0.0 110.167 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.51 -12.4 81.88 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -141.69 158.26 63.23 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.976 0.51 . . . . 0.0 110.135 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.15 14.47 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.297 3.332 . . . . 0.0 112.927 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 133' ' ' VAL . 2.9 pp -69.49 -6.0 27.71 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.899 0.772 . . . . 0.0 111.148 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -75.13 -1.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -137.62 34.03 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.47 1.108 . . . . 0.0 109.403 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.43 -16.99 0.38 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.475 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.623 1.212 . . . . 0.0 112.353 178.017 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.231 0.086 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -110.9 141.58 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -133.39 144.61 49.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.991 0.516 . . . . 0.0 110.634 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.87 155.04 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.705 0.802 . . . . 0.0 108.935 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.22 170.22 36.23 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.0 77.35 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.119 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 m -47.97 114.34 3.26 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.682 0.793 . . . . 0.0 111.714 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.21 -8.17 10.84 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.533 2.822 . . . . 0.0 113.058 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.93 -18.2 31.37 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.974 0.806 . . . . 0.0 111.182 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 33.71 49.98 0.28 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.032 1.333 . . . . 0.0 112.608 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.3 tpp -135.58 -75.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -150.94 166.76 29.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.286 0.565 . . . . 0.0 111.675 -169.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.37 -4.77 31.97 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.683 0.793 . . . . 0.0 112.31 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -83.84 -8.86 59.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.03 -0.419 . . . . 0.0 111.57 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.95 -30.13 19.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.73 -26.41 59.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.1 -19.43 36.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.33 -13.37 59.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.044 0.383 . . . . 0.0 110.798 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.5 -5.5 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.32 12.77 20.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.243 0.617 . . . . 0.0 110.991 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 16.8 tppt? -91.45 -39.69 0.38 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.327 -0.844 . . . . 0.0 113.215 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 93.7 Cg_endo -78.72 -20.01 10.84 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.794 1.663 . . . . 0.0 113.43 -173.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -136.25 17.23 3.19 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.751 0.705 . . . . 0.0 112.694 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.25 170.23 22.35 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.994 -0.442 . . . . 0.0 110.952 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.9 55.9 1.17 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.602 0.761 . . . . 0.0 109.722 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.76 138.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.105 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -131.27 7.28 4.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -145.89 127.83 15.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -141.35 128.18 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 123.33 0.652 . . . . 0.0 109.629 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.4 138.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 122.912 0.485 . . . . 0.0 109.972 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mt -107.86 104.79 14.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.031 0.932 . . . . 0.0 109.739 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -80.91 94.0 6.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.0 m120 63.21 127.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.774 1.23 . . . . 0.0 110.473 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -76.06 22.0 0.16 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -146.69 25.48 1.18 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.966 0.507 . . . . 0.0 110.52 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -135.45 -88.38 0.34 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.125 -0.359 . . . . 0.0 111.695 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -137.42 159.25 42.47 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 123.16 0.584 . . . . 0.0 111.708 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.6 143.86 45.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.57 0.748 . . . . 0.0 109.181 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.34 133.18 56.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -135.71 151.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -135.16 135.64 41.24 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.716 0.406 . . . . 0.0 111.003 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -109.17 152.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 124.675 1.19 . . . . 0.0 110.011 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -82.2 -1.4 48.98 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.4 m -144.78 127.42 16.14 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.751 0.82 . . . . 0.0 109.222 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -8.99 58.14 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.214 -0.304 . . . . 0.0 111.755 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -87.29 -14.85 39.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.095 0.407 . . . . 0.0 110.225 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -88.61 -17.71 29.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.24 -41.01 70.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -69.94 -20.32 63.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -86.39 -9.54 56.12 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.115 -0.366 . . . . 0.0 111.581 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.63 -49.38 19.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -25.44 67.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -71.16 -44.89 64.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -77.42 -26.63 51.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.553 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.87 -0.63 52.04 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.244 -0.285 . . . . 0.0 110.436 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -125.96 8.14 7.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.734 0.243 . . . . 0.0 111.575 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -135.42 15.29 3.45 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.68 49.83 2.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.337 0.517 . . . . 0.0 110.73 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.34 10.04 81.7 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.445 -0.642 . . . . 0.0 112.63 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.75 98.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.916 1.286 . . . . 0.0 111.78 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.28 154.32 93.06 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -10.98 29.78 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.601 2.868 . . . . 0.0 112.109 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 96' ' ' LEU . 23.9 mt -80.26 119.71 23.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.82 104.54 14.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -111.73 139.2 47.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.986 0.422 . . . . 0.0 111.455 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -146.14 159.17 43.66 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.482 1.113 . . . . 0.0 109.427 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -127.62 156.27 42.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.06 -175.04 14.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.21 141.22 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.127 0.464 . . . . 0.0 110.837 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 123.627 0.632 . . . . 0.0 113.932 -176.371 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.514 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 43.7 Cg_endo -60.39 -35.97 88.92 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.142 2.561 . . . . 0.0 112.627 -169.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.17 14.26 3.04 Favored 'General case' 0 C--N 1.337 0.046 0 CA-C-N 118.117 0.417 . . . . 0.0 111.022 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -82.87 -18.15 41.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.148 -0.345 . . . . 0.0 111.054 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -97.88 -2.41 40.81 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 tp -109.8 -27.11 9.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -80.67 -26.58 37.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.45 -42.13 13.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.763 0.256 . . . . 0.0 111.539 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.36 -10.45 59.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.142 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -104.78 -20.69 13.52 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.912 0.778 . . . . 0.0 110.937 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.18 -13.82 58.22 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.012 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.12 -61.61 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -78.32 -0.42 28.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -138.97 -2.53 1.68 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.75 24.35 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.749 1.159 . . . . 0.0 111.208 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.5 p -72.84 55.06 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.755 -0.591 . . . . 0.0 111.828 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 137.68 42.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.195 0.598 . . . . 0.0 110.487 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 53.13 27.5 5.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.973 . . . . 0.0 112.432 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 78.4 m95 54.26 24.98 5.4 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.05 0.94 . . . . 0.0 112.759 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.01 170.38 54.66 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 176.18 147.0 6.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.4 m 58.2 7.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.325 1.45 . . . . 0.0 113.197 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.9 p -160.21 19.83 0.15 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.768 -0.583 . . . . 0.0 111.375 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -93.46 -21.89 28.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.206 -0.775 . . . . 0.0 114.001 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -149.09 160.77 34.23 Favored Pre-proline 0 C--O 1.227 -0.096 0 CA-C-N 118.515 1.158 . . . . 0.0 110.187 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.51 -1.27 0.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.28 3.32 . . . . 0.0 114.415 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.54 -8.14 56.0 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.809 0.732 . . . . 0.0 110.712 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.61 9.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.028 0.531 . . . . 0.0 110.553 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.1 p -128.31 31.51 5.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.05 0.54 . . . . 0.0 109.964 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.22 -26.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.556 0.693 . . . . 0.0 110.229 173.561 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.124 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.5 tp -121.32 115.46 23.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -89.02 135.96 33.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.218 1.007 . . . . 0.0 110.445 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.8 mm -127.48 104.69 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.56 164.07 13.03 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.225 0.347 . . . . 0.0 113.232 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 -47.74 3.0 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.99 1.281 . . . . 0.0 112.596 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m 37.64 48.64 1.35 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.375 1.47 . . . . 0.0 114.741 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.81 1.95 4.01 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.829 2.352 . . . . 0.0 110.159 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.44 43.49 0.55 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.874 1.67 . . . . 0.0 110.775 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 56.88 24.13 8.94 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.974 1.31 . . . . 0.0 112.57 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.3 ptt? 34.35 55.21 0.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.324 1.45 . . . . 0.0 113.575 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -128.68 129.32 45.64 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.96 -13.88 62.28 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -82.77 -14.67 54.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.284 0.493 . . . . 0.0 110.594 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -95.42 -24.81 16.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.191 -0.318 . . . . 0.0 110.347 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.71 -26.59 62.55 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 -20.36 36.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -79.44 -6.56 57.13 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.109 -0.369 . . . . 0.0 111.168 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.83 -3.25 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.17 -0.331 . . . . 0.0 111.889 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -113.44 15.68 19.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.532 0.733 . . . . 0.0 110.202 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttm -101.62 -40.06 0.21 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.566 169.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 32.5 Cg_exo -61.55 114.61 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.233 1.955 . . . . 0.0 110.344 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.81 30.88 5.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.55 0.74 . . . . 0.0 112.008 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.46 161.97 40.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.028 0.531 . . . . 0.0 110.883 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -138.7 85.74 2.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.672 0.389 . . . . 0.0 111.025 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.6 140.42 25.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -135.17 8.15 3.43 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.0 m -135.7 119.6 17.4 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.59 128.52 33.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.149 0.579 . . . . 0.0 110.122 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.39 143.77 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 171.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -125.4 137.86 54.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.626 1.17 . . . . 0.0 110.838 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -112.03 98.43 7.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -83.15 43.21 0.85 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.037 0.535 . . . . 0.0 111.765 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.02 -7.04 2.35 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.636 0.374 . . . . 0.0 110.914 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -153.21 35.03 0.47 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.735 0.414 . . . . 0.0 110.63 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 33.99 55.59 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.803 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -125.83 141.57 51.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.323 0.649 . . . . 0.0 111.029 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.98 154.28 47.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.293 0.568 . . . . 0.0 111.227 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -135.24 132.76 38.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.73 38.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.688 0.28 . . . . 0.0 111.379 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -135.42 129.97 34.1 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.117 0.484 . . . . 0.0 110.885 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.96 148.13 9.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.127 1.371 . . . . 0.0 108.984 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.17 24.26 11.75 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.4 t -148.72 132.16 16.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.848 0.859 . . . . 0.0 108.813 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -78.19 -14.63 59.38 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.137 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.58 -25.45 24.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -87.47 -16.37 34.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -47.84 67.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.11 -14.37 59.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.76 -11.37 48.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.477 0.581 . . . . 0.0 111.09 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.14 -41.5 17.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.08 -21.91 64.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.884 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -77.17 -26.2 52.71 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.707 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -68.56 -42.25 78.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -83.34 10.24 9.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.367 -0.208 . . . . 0.0 111.342 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -116.35 1.27 13.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.262 0.625 . . . . 0.0 109.716 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -135.58 18.57 3.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.875 0.47 . . . . 0.0 111.406 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -134.75 48.04 2.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.178 0.513 . . . . 0.0 110.957 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.88 -13.63 12.91 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.614 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.18 33.84 18.9 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.056 0.928 . . . . 0.0 113.413 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.722 ' H ' ' CD ' ' A' ' 95' ' ' PRO . 80.4 mt -136.21 -28.23 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.722 ' CD ' ' H ' ' A' ' 94' ' ' LEU . 76.9 Cg_exo -55.35 -31.64 78.05 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.075 1.85 . . . . 0.0 113.246 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt -143.2 143.22 31.68 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.422 0.689 . . . . 0.0 109.892 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -94.85 97.07 9.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.0 p -114.41 138.03 51.09 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -173.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -146.05 146.21 30.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.277 1.031 . . . . 0.0 109.127 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -135.08 160.52 38.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 110.917 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 165.7 37.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.13 142.28 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.743 0.817 . . . . 0.0 109.692 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 177.199 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.19 176.92 8.5 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.557 2.838 . . . . 0.0 110.618 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.65 27.63 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.343 0.657 . . . . 0.0 112.483 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -15.43 51.75 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.711 -0.618 . . . . 0.0 111.294 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -85.43 -6.76 59.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.02 -42.8 9.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.53 0.732 . . . . 0.0 109.6 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -76.29 -16.74 59.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.56 -51.2 6.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.737 -0.602 . . . . 0.0 110.398 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.26 -8.68 58.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -112.81 -15.86 12.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.759 0.709 . . . . 0.0 111.487 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -20.99 61.07 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.54 -54.28 4.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.509 0.324 . . . . 0.0 110.561 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -82.91 6.14 19.53 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -147.37 0.68 0.7 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.53 15.25 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.269 0.94 . . . . 0.0 111.133 174.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.8 m -135.0 24.74 3.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.991 0.517 . . . . 0.0 109.911 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.5 151.24 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.057 0.943 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.81 20.79 1.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -141.91 24.27 2.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.458 0.703 . . . . 0.0 110.413 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.56 -159.74 35.75 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.479 0.562 . . . . 0.0 112.135 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.68 -154.28 2.37 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.091 0.853 . . . . 0.0 111.747 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.7 m -103.77 70.6 1.02 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 t 60.71 32.03 20.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.707 0.803 . . . . 0.0 111.829 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.27 79.6 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.959 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.7 -44.38 0.5 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 118.361 1.081 . . . . 0.0 113.305 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -90.53 -19.57 1.07 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.544 2.163 . . . . 0.0 113.43 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.65 -7.66 59.15 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -171.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.8 m -74.85 -0.8 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 CA-C-N 117.877 0.308 . . . . 0.0 111.241 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 t -147.67 23.22 1.12 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.367 1.067 . . . . 0.0 108.41 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.5 34.15 0.3 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.605 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.7 mm . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 117.582 0.691 . . . . 0.0 111.956 173.645 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 m . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -101.89 140.5 36.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -130.12 137.75 50.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.34 0.656 . . . . 0.0 110.124 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 5.8 mm -120.33 113.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.83 160.7 16.92 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.31 17.98 74.71 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.639 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.44 130.15 34.12 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.388 1.094 . . . . 0.0 110.789 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.52 -0.6 10.54 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.43 2.753 . . . . 0.0 111.425 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.68 152.41 33.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.371 0.605 . . . . 0.0 111.44 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -97.28 55.36 1.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.1 ttt 62.96 70.14 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.564 1.145 . . . . 0.0 112.198 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.35 88.75 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.09 -11.58 20.87 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.613 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -82.91 -12.41 57.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.082 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -93.88 -22.59 18.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 118.938 -1.105 . . . . 0.0 110.55 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.65 -25.51 59.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.11 -18.07 38.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -76.47 -10.39 59.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.057 -0.402 . . . . 0.0 110.595 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.5 -4.69 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.44 17.52 19.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.45 0.7 . . . . 0.0 110.519 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 55' ' ' PRO . 88.6 tttt -114.13 -35.95 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 60.4 Cg_exo -56.91 -31.73 90.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.402 2.068 . . . . 0.0 113.648 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.18 22.78 2.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.856 0.298 . . . . 0.0 111.642 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.96 176.81 11.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.626 0.37 . . . . 0.0 110.733 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.49 76.05 1.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.003 0.43 . . . . 0.0 110.505 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.03 140.57 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -131.86 7.16 4.37 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -142.8 125.85 16.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.977 0.511 . . . . 0.0 109.729 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.75 127.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 122.965 0.506 . . . . 0.0 109.759 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.14 135.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mt -128.67 143.29 50.91 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.068 0.547 . . . . 0.0 111.639 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -123.26 104.68 9.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.27 1.028 . . . . 0.0 108.371 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -83.52 24.67 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -120.38 -3.5 9.94 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.232 -0.292 . . . . 0.0 111.725 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtm-85 -144.97 8.54 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.889 0.476 . . . . 0.0 111.304 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 51.76 42.45 29.9 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.23 0.612 . . . . 0.0 111.221 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -111.27 145.61 38.47 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.735 0.814 . . . . 0.0 110.113 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -140.83 150.64 43.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -125.03 127.18 46.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.9 151.1 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.476 0.125 . . . . 0.0 110.692 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.58 136.39 41.04 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.41 155.53 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 124.48 1.112 . . . . 0.0 110.567 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -93.71 10.58 32.33 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.2 t -151.33 134.88 16.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.13 0.572 . . . . 0.0 109.913 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.55 -16.13 58.84 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.45 -25.35 33.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -83.91 -13.74 52.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.77 67.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -71.12 -18.88 62.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.777 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -82.01 -18.9 41.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.46 0.573 . . . . 0.0 111.6 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.47 -44.16 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 118.565 0.621 . . . . 0.0 109.809 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.26 -23.02 64.73 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.42 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -83.16 -10.42 58.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.884 -0.51 . . . . 0.0 110.77 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.0 -27.9 24.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -94.82 4.92 53.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.267 -0.271 . . . . 0.0 111.245 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -134.8 6.03 3.41 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -149.44 15.01 0.88 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -135.37 55.16 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.84 0.745 . . . . 0.0 110.931 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.27 83.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.201 -0.777 . . . . 0.0 113.394 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.1 74.08 0.26 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.995 0.897 . . . . 0.0 111.625 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.96 159.62 13.14 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.068 0.547 . . . . 0.0 111.265 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 -9.4 9.06 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.483 3.455 . . . . 0.0 114.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.95 128.57 36.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.587 0.63 . . . . 0.0 110.552 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -90.59 71.52 6.83 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.56 0.744 . . . . 0.0 109.083 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.6 m -74.89 129.86 38.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.146 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -135.68 149.11 49.17 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.387 1.075 . . . . 0.0 109.022 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -128.34 150.77 49.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.983 0.42 . . . . 0.0 111.575 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.51 -164.35 28.6 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.9 138.2 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.187 0.493 . . . . 0.0 110.394 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 C-N-CA 123.429 0.538 . . . . 0.0 112.539 -179.66 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.05 166.66 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.434 2.756 . . . . 0.0 111.012 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -124.85 25.66 7.31 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.823 0.449 . . . . 0.0 111.48 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -83.59 -9.87 58.63 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.813 -0.554 . . . . 0.0 111.217 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -88.8 3.25 51.74 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.407 0.283 . . . . 0.0 110.589 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.66 -50.4 5.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.741 0.816 . . . . 0.0 108.887 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.6 m -77.65 -19.9 54.66 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.197 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.35 -45.82 12.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.043 -0.411 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.5 -19.12 39.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.273 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.87 -20.8 17.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.693 0.679 . . . . 0.0 110.997 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -67.36 -35.17 78.83 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.667 170.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.6 -77.66 0.1 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.145 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -89.15 18.71 4.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.5 t -138.89 -4.31 1.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.67 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 t -136.44 24.22 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.294 0.952 . . . . 0.0 111.27 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.8 p -73.64 24.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.133 -0.979 . . . . 0.0 112.952 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.06 24.13 3.56 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.958 -0.464 . . . . 0.0 111.087 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -147.0 144.07 28.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.668 0.787 . . . . 0.0 109.355 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -72.79 104.71 4.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.98 -179.8 49.5 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -81.81 -153.98 12.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 67.4 104.56 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.227 1.411 . . . . 0.0 113.371 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m 54.47 30.11 12.33 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.4 -33.27 53.53 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -140.78 167.05 18.85 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.29 5.56 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.462 1 C-N-CA 125.437 4.091 . . . . 0.0 116.332 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.25 22.89 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.56 1.073 . . . . 0.0 111.769 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.73 1.48 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.785 0.834 . . . . 0.0 111.171 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.6 p -127.68 24.83 6.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.4 -21.85 4.27 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mm . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 117.45 0.625 . . . . 0.0 111.028 174.253 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.82 133.62 47.05 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.59 145.22 46.7 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.307 0.575 . . . . 0.0 111.521 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.91 153.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.007 0.923 . . . . 0.0 109.361 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.29 164.47 30.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.25 19.97 79.29 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.35 -0.694 . . . . 0.0 112.724 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -48.63 129.72 13.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.114 0.957 . . . . 0.0 111.175 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -85.0 5.57 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.309 3.339 . . . . 0.0 111.458 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.98 159.63 24.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 112.291 -170.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.06 63.55 6.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.559 0.744 . . . . 0.0 109.764 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.5 ptm 51.31 104.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.126 2.17 . . . . 0.0 114.475 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.75 102.43 3.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.26 -19.33 65.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -85.21 -7.08 59.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.139 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -98.14 -21.57 16.67 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.306 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.09 -28.87 62.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.07 -22.26 45.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.521 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.22 -14.14 60.5 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.181 -0.324 . . . . 0.0 111.202 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.19 -0.67 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.194 -0.316 . . . . 0.0 111.783 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.1 10.89 28.0 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.421 0.688 . . . . 0.0 109.585 170.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 25.3 ttmm -78.77 -33.89 0.93 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.622 171.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.0 Cg_exo -57.7 115.04 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.444 2.096 . . . . 0.0 111.951 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 51.22 24.27 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.703 1.201 . . . . 0.0 113.455 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.8 157.29 41.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.124 0.57 . . . . 0.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -132.46 56.47 1.83 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.123 0.569 . . . . 0.0 110.298 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.42 139.04 15.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -129.3 3.37 5.16 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -135.05 121.25 20.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.051 -0.405 . . . . 0.0 110.288 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.98 129.17 43.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.497 0.719 . . . . 0.0 109.925 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.65 141.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 1.6 tt -134.23 121.72 21.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.214 . . . . 0.0 110.476 -169.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -100.87 104.4 15.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.068 0.547 . . . . 0.0 109.976 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -86.94 24.49 1.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.056 0.542 . . . . 0.0 111.812 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -127.37 2.61 6.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.735 0.414 . . . . 0.0 110.649 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -136.12 7.74 3.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.2 32.5 10.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.07 0.948 . . . . 0.0 111.446 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -134.39 152.62 51.91 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.409 0.683 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . . . -135.76 156.3 49.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.548 0.739 . . . . 0.0 110.235 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.85 134.39 49.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.78 151.45 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -135.1 139.37 44.64 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.453 0.644 . . . . 0.0 112.018 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.71 161.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 125.988 1.715 . . . . 0.0 109.172 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -108.27 22.59 15.72 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -152.59 137.48 17.14 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.201 0.6 . . . . 0.0 109.734 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.97 -9.59 58.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.316 -0.24 . . . . 0.0 111.502 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -86.84 -18.02 31.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -88.12 -22.1 24.29 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.24 43.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.09 -21.86 33.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.35 -0.219 . . . . 0.0 110.657 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.59 -19.47 38.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.014 -0.429 . . . . 0.0 110.871 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.76 -43.16 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.93 -17.0 62.7 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.075 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -74.46 -28.45 61.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.463 0.574 . . . . 0.0 109.532 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -76.1 -28.29 57.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.973 -0.454 . . . . 0.0 109.827 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -93.09 6.94 46.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.409 0.284 . . . . 0.0 111.013 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.02 16.28 3.51 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.381 0.272 . . . . 0.0 111.313 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -135.72 -8.02 2.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 -23.12 15.15 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.04 0.836 . . . . 0.0 110.786 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.21 1.16 0.63 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.832 1.206 . . . . 0.0 115.614 172.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.55 45.1 1.94 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.064 1.432 . . . . 0.0 112.159 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.81 142.69 28.19 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.52 -11.66 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.311 3.341 . . . . 0.0 112.821 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -86.51 146.13 26.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.973 0.351 . . . . 0.0 110.799 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.13 104.59 10.97 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.4 m -103.49 134.7 46.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.313 0.645 . . . . 0.0 111.327 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -136.81 153.45 50.81 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.335 1.054 . . . . 0.0 108.925 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -123.4 144.8 49.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.934 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.22 148.62 17.24 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.88 138.24 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.082 0.553 . . . . 0.0 110.694 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.92 0 C-N-CA 123.62 0.629 . . . . 0.0 112.788 -178.274 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.411 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.3 pt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 92.1 Cg_endo -69.47 -2.4 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.582 2.855 . . . . 0.0 112.626 -174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 mtt -121.87 20.36 10.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.783 0.433 . . . . 0.0 111.004 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -135.01 -8.82 2.33 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -89.71 -4.52 57.68 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.248 0.476 . . . . 0.0 109.938 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -92.5 -45.54 8.08 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.397 1.079 . . . . 0.0 109.303 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -80.83 -23.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.59 -48.57 8.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.018 0.372 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.95 -14.13 56.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.166 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -98.37 -41.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.612 0.642 . . . . 0.0 110.891 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -76.34 -16.16 59.81 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -93.71 -52.42 4.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.982 -0.449 . . . . 0.0 110.523 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -83.49 3.8 30.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.16 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -135.85 -4.24 2.24 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 25.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.734 1.152 . . . . 0.0 112.263 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.4 p -72.46 55.71 0.35 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.937 -0.477 . . . . 0.0 111.638 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 53.89 46.41 25.72 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 111.161 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -82.0 49.76 1.44 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.588 0.755 . . . . 0.0 111.062 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 75.3 m95 54.5 35.2 22.79 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -173.47 45.31 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.57 -170.64 50.54 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 t -132.71 45.28 2.77 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.0 m 53.21 34.21 17.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.383 -172.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.96 -49.61 0.08 OUTLIER Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.01 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 145' ' ' LEU . 57.0 mt-30 62.06 170.53 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 119.166 1.483 . . . . 0.0 112.414 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.32 -9.9 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.744 3.629 . . . . 0.0 115.702 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -64.03 -61.39 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.91 0.777 . . . . 0.0 109.477 174.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.3 20.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.596 . . . . 0.0 111.445 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.3 m -101.47 30.84 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 -25.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 146' ' ' VAL . 5.1 pt . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 123.645 0.778 . . . . 0.0 111.213 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.61 130.58 55.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.673 1.189 . . . . 0.0 108.521 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -107.28 143.27 35.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.21 0.604 . . . . 0.0 110.602 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.0 mm -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.91 0.884 . . . . 0.0 108.876 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.56 31.45 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.32 23.25 74.94 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.1 m -53.04 123.8 34.9 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 117.527 0.663 . . . . 0.0 112.013 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.26 -4.26 13.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.734 2.956 . . . . 0.0 111.07 171.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.85 162.7 28.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.145 0.578 . . . . 0.0 110.5 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.22 32.79 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.537 0.735 . . . . 0.0 111.347 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.7 mtm 57.41 47.98 15.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.154 0.981 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -128.55 133.71 48.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.811 0.844 . . . . 0.0 109.134 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.02 -6.77 47.69 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -85.11 -15.77 42.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.029 -0.419 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -89.53 -26.19 21.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.96 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.01 -29.9 65.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.1 -17.66 58.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.796 -0.565 . . . . 0.0 110.422 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.21 -4.44 58.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.19 -4.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.14 0.26 5.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 39.6 ttpt -88.04 -38.78 0.47 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.28 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.7 Cg_exo -59.33 135.46 65.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.481 2.121 . . . . 0.0 111.997 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 51.48 28.23 4.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.168 0.987 . . . . 0.0 113.078 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.87 167.95 21.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.152 0.581 . . . . 0.0 110.683 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.08 40.91 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.662 0.385 . . . . 0.0 111.251 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.84 136.93 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -129.85 -3.43 4.64 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -137.1 136.45 38.33 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.074 -0.391 . . . . 0.0 111.047 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.46 115.03 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -113.91 104.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.22 110.57 23.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -76.52 104.3 6.96 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -82.46 24.17 0.71 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.861 0.864 . . . . 0.0 111.134 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -135.14 5.47 3.28 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.233 0.613 . . . . 0.0 110.319 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -140.38 -0.67 1.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.239 0.615 . . . . 0.0 110.859 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 51.46 34.9 12.98 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.897 0.879 . . . . 0.0 111.774 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -135.4 151.86 50.86 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 123.599 0.76 . . . . 0.0 109.46 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.25 154.0 51.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -117.26 125.18 50.7 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.009 1.324 . . . . 0.0 107.711 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.03 148.58 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 120.486 0.184 . . . . 0.0 110.56 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -130.2 135.76 48.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.927 0.394 . . . . 0.0 111.942 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.92 148.55 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.275 1.43 . . . . 0.0 109.32 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -82.54 -3.18 55.53 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.2 m -143.3 132.91 23.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -72.58 -18.02 61.65 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.385 . . . . 0.0 110.808 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -74.81 -14.28 60.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.99 -0.444 . . . . 0.0 109.983 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -93.1 -8.6 42.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.04 -43.31 44.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 -17.93 60.64 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.489 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.72 -16.2 54.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.196 0.453 . . . . 0.0 110.388 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -85.47 -23.74 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 O-C-N 121.938 -0.476 . . . . 0.0 110.526 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.74 -23.93 53.02 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.014 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.69 -15.51 57.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.42 -45.42 31.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -76.84 -0.27 23.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.337 -0.227 . . . . 0.0 111.387 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -112.35 -4.76 14.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.984 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.44 22.51 3.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.701 0.682 . . . . 0.0 112.574 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -135.23 55.18 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.285 0.493 . . . . 0.0 111.278 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.83 82.83 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.473 -0.626 . . . . 0.0 113.254 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.63 60.51 3.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.836 0.818 . . . . 0.0 111.72 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.79 151.43 15.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.089 0.556 . . . . 0.0 110.857 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.47 -0.93 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.102 3.201 . . . . 0.0 113.113 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.5 mt -63.63 138.11 58.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.494 0.588 . . . . 0.0 110.318 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -105.51 121.4 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.7 p -135.34 145.05 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 111.997 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -143.23 148.41 36.39 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 109.405 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 -128.41 158.75 37.44 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.863 0.363 . . . . 0.0 111.888 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.4 168.94 25.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 p -133.69 144.5 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.059 0.544 . . . . 0.0 110.541 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.163 -177.795 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.29 -14.2 34.17 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 111.783 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -81.19 15.89 1.76 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.925 0.329 . . . . 0.0 111.763 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -135.33 1.73 2.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.545 0.738 . . . . 0.0 109.957 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -86.02 -13.42 47.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.118 -0.364 . . . . 0.0 110.581 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.9 pp -101.0 -12.89 18.52 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.606 0.185 . . . . 0.0 110.722 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 50.4 p -88.98 -22.07 23.2 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.87 -41.12 12.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -16.27 50.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -113.33 -15.63 12.64 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.013 0.824 . . . . 0.0 112.019 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.98 -20.66 48.58 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.649 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.56 -63.23 1.34 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -79.81 -1.14 37.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.4 m -139.91 6.3 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 145' ' ' LEU . 5.1 t -137.77 20.51 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.19 1.359 . . . . 0.0 110.384 170.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.4 t -106.12 52.69 0.72 Allowed 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.49 172.03 13.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.04 0.936 . . . . 0.0 110.679 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -58.63 151.63 20.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.243 0.617 . . . . 0.0 110.791 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -64.1 147.96 50.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.22 0.608 . . . . 0.0 111.646 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.06 -15.29 0.59 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.376 -0.689 . . . . 0.0 111.376 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 144' ' ' PRO . . . 75.62 161.87 10.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.725 0.679 . . . . 0.0 112.365 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.668 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 90.2 m 68.45 102.38 0.05 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m 54.6 43.45 30.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.39 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.534 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 144' ' ' PRO . 64.5 tt0 -164.81 -51.86 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 120.234 2.017 . . . . 0.0 115.884 175.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 140' ' ' THR . 22.9 Cg_endo -85.93 -5.79 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.696 2.931 . . . . 0.0 115.753 -166.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.478 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -70.71 -2.62 15.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.098 1.317 . . . . 0.0 111.959 -176.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.406 ' N ' HD12 ' A' ' 145' ' ' LEU . 32.3 m -75.84 0.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 123.186 0.594 . . . . 0.0 110.926 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -142.14 24.68 1.96 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.511 1.124 . . . . 0.0 108.487 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.55 43.57 0.12 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.561 1.145 . . . . 0.0 112.278 174.522 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -85.52 104.57 15.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -82.34 140.32 33.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.348 0.659 . . . . 0.0 110.313 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.1 129.8 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.01 166.53 26.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.081 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.74 75.59 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.415 -0.658 . . . . 0.0 112.195 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -53.57 125.34 44.77 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 117.996 0.898 . . . . 0.0 111.186 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.31 -2.68 12.15 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.444 2.763 . . . . 0.0 111.364 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.32 154.53 27.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.923 0.489 . . . . 0.0 111.017 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -84.43 53.66 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.28 0.632 . . . . 0.0 110.38 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.2 ttt 56.48 64.74 1.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.387 1.075 . . . . 0.0 112.708 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -131.13 107.94 9.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.84 -13.08 58.89 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 112.011 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -81.84 -12.23 58.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 122.244 -0.285 . . . . 0.0 111.077 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -93.32 -22.73 18.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.518 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 -27.88 60.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.57 -23.74 42.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.911 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.64 -6.93 58.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.007 0.367 . . . . 0.0 111.638 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.58 -4.62 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 118.153 0.433 . . . . 0.0 111.243 171.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -109.52 15.36 23.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.08 0.952 . . . . 0.0 109.247 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 40.7 ttmt -75.53 -34.77 1.64 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 82.4 Cg_endo -73.55 124.27 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 CA-C-N 121.356 1.52 . . . . 0.0 111.068 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 51.53 23.06 1.71 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.98 1.312 . . . . 0.0 113.062 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.83 154.58 35.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.964 0.506 . . . . 0.0 110.546 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.51 64.68 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.91 128.61 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -103.71 -3.76 24.62 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -168.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -142.24 131.15 22.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.053 0.388 . . . . 0.0 110.904 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.15 129.86 38.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.26 139.54 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 110.7 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -122.73 120.31 33.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.133 1.373 . . . . 0.0 108.387 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -138.74 157.17 46.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.837 0.455 . . . . 0.0 111.337 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 65.5 151.49 0.05 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.857 1.263 . . . . 0.0 113.13 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -82.79 25.08 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.267 0.627 . . . . 0.0 111.216 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.72 24.4 7.75 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.813 0.845 . . . . 0.0 110.702 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 53.48 49.49 19.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.146 0.978 . . . . 0.0 112.599 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -96.57 104.75 16.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.93 148.33 44.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.114 0.483 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -135.52 145.11 46.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.397 0.679 . . . . 0.0 109.375 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.92 155.5 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.21 135.68 41.17 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.969 0.414 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.15 148.66 15.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 124.519 1.128 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.46 19.18 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.8 t -151.25 141.25 22.07 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.795 0.438 . . . . 0.0 110.198 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -74.46 -22.7 58.97 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -82.35 -14.74 54.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.62 -20.67 23.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.66 53.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.19 -15.8 35.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.262 -0.274 . . . . 0.0 110.732 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.38 -22.87 38.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.272 0.487 . . . . 0.0 110.607 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.53 -46.19 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.42 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.8 mm? -67.55 -19.77 65.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.614 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -75.89 -40.77 53.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.382 0.992 . . . . 0.0 109.659 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -76.33 -13.44 60.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -117.28 15.1 14.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -128.2 3.89 5.79 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -142.36 -8.19 0.88 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -153.0 24.75 0.56 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.241 0.928 . . . . 0.0 112.035 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 15.69 0.04 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.964 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.98 3.8 16.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.648 1.224 . . . . 0.0 111.791 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 95' ' ' PRO . 3.1 mm? -98.7 -54.78 0.19 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.715 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 94' ' ' LEU . 86.0 Cg_endo -74.5 -23.52 14.87 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.355 2.036 . . . . 0.0 112.867 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 96' ' ' LEU . 36.4 mt -137.84 149.12 46.05 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.13 0.423 . . . . 0.0 111.219 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -106.09 102.7 12.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.3 p -98.15 130.79 44.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.246 0.618 . . . . 0.0 111.276 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -143.94 136.86 27.34 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.973 0.909 . . . . 0.0 109.028 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -118.58 126.91 52.99 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.096 0.407 . . . . 0.0 111.175 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.64 145.48 18.36 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.42 148.37 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.933 0.893 . . . . 0.0 109.529 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 176.013 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.2 -13.49 38.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.418 2.745 . . . . 0.0 113.746 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.5 ptm -83.97 8.26 15.76 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -95.06 -17.37 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.185 -0.322 . . . . 0.0 111.149 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.13 -4.13 58.79 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.96 -32.49 13.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.108 0.563 . . . . 0.0 109.582 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.5 t -82.59 -19.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.049 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.94 -47.06 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.911 -0.493 . . . . 0.0 110.968 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -76.48 -13.79 60.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.49 -9.6 11.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.818 0.736 . . . . 0.0 112.264 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -73.33 -18.25 61.21 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 166.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.403 ' HE3' ' CH2' ' A' ' 131' ' ' TRP . 64.3 tttp -87.51 -60.13 2.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.318 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.403 ' CH2' ' HE3' ' A' ' 130' ' ' LYS . 11.8 m95 -80.4 9.96 5.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -147.16 -6.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.65 17.17 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 119.619 1.099 . . . . 0.0 112.036 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 m -81.01 35.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.403 -0.811 . . . . 0.0 111.247 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 24.47 3.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.45 0.7 . . . . 0.0 110.223 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -138.55 147.33 42.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.777 0.831 . . . . 0.0 109.653 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -81.72 42.79 0.72 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.307 0.643 . . . . 0.0 111.05 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.99 -169.9 36.72 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.69 157.68 27.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.1 p 48.74 24.55 0.83 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.008 1.323 . . . . 0.0 112.913 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -154.92 24.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.34 0.656 . . . . 0.0 111.024 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.34 -12.11 16.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.507 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -146.37 164.98 21.65 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 118.622 1.211 . . . . 0.0 110.053 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.49 -12.18 16.33 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.363 2.708 . . . . 0.0 113.311 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.48 -6.43 46.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.12 0.418 . . . . 0.0 112.123 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -77.55 25.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -135.41 -15.43 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.208 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.43 -11.34 17.84 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 118.797 -1.002 . . . . 0.0 113.221 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--N 1.34 0.183 0 CA-C-O 122.312 1.053 . . . . 0.0 109.067 167.409 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.412 0.149 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.2 tp -117.97 126.0 51.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.995 0.518 . . . . 0.0 109.668 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.53 146.21 32.14 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.398 0.679 . . . . 0.0 110.444 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mm -128.02 135.01 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.22 165.87 13.66 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.77 15.43 80.75 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.289 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' N ' ' CD ' ' A' ' 41' ' ' PRO . 34.0 m -70.19 -14.22 0.25 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 40' ' ' VAL . 70.2 Cg_exo -56.99 -2.81 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.259 1.973 . . . . 0.0 114.612 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.89 -14.91 60.71 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.337 0.971 . . . . 0.0 112.68 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -148.59 -12.54 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.2 mtt 51.6 28.85 4.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -135.81 142.77 44.9 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.193 0.451 . . . . 0.0 110.79 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.66 -6.63 42.43 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -86.74 -10.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.296 -0.252 . . . . 0.0 111.067 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.69 -27.09 18.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.86 -30.09 65.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.02 -19.38 44.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.458 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -76.54 -15.51 59.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.058 -0.401 . . . . 0.0 111.155 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.75 -3.34 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.61 10.65 22.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.384 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.8 pttt -88.61 -28.04 0.35 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.582 170.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 27.2 Cg_exo -65.14 117.88 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.782 1.655 . . . . 0.0 110.945 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 50.27 24.37 1.47 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.405 1.082 . . . . 0.0 113.191 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.5 155.38 43.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.956 0.502 . . . . 0.0 110.497 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -133.73 60.63 1.7 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.976 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -70.12 141.53 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -129.75 5.82 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -135.8 119.36 17.02 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 118.064 0.393 . . . . 0.0 110.457 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.89 127.66 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.531 0.732 . . . . 0.0 109.526 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.55 139.62 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 122.847 0.459 . . . . 0.0 110.048 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.5 mt -114.94 122.66 46.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.541 0.737 . . . . 0.0 109.036 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -123.02 173.02 8.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.087 0.955 . . . . 0.0 111.064 -171.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 55.59 55.6 7.07 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.799 0.84 . . . . 0.0 111.258 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t 55.68 43.16 28.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.078 0.551 . . . . 0.0 110.924 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? 55.48 44.16 27.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.195 0.998 . . . . 0.0 111.248 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -124.3 0.97 8.41 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 111.052 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -146.48 142.89 28.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 149.13 48.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.14 134.43 45.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.298 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.34 149.78 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -135.14 135.63 41.27 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.013 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.16 157.35 14.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 124.782 1.233 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -102.85 9.06 39.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -146.41 138.51 24.96 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.057 0.543 . . . . 0.0 109.973 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -76.62 -13.62 60.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -85.27 -23.0 28.37 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.2 -18.08 37.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.29 -45.49 59.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.85 -20.51 62.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.005 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -82.01 -16.79 49.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.408 0.549 . . . . 0.0 111.338 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.6 -25.5 8.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-N 118.566 0.621 . . . . 0.0 110.25 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.21 -22.18 55.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.913 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -76.08 -22.26 55.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -79.88 -23.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -83.53 -4.0 58.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.7 3.76 11.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.7 0.4 . . . . 0.0 111.049 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -135.77 17.9 3.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -86.36 -1.31 57.42 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.481 -0.762 . . . . 0.0 111.573 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.49 -15.0 0.45 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.798 1.19 . . . . 0.0 115.548 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.42 12.39 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.486 1.643 . . . . 0.0 113.483 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 35.09 53.05 1.59 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.694 1.198 . . . . 0.0 113.751 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.9 -11.93 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.425 2.75 . . . . 0.0 111.275 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -133.82 133.93 42.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.411 1.084 . . . . 0.0 108.312 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -100.01 98.47 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.3 m -93.49 129.36 39.72 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.96 0.504 . . . . 0.0 111.198 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -145.69 142.13 28.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.31 0.644 . . . . 0.0 109.91 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -97.04 150.21 21.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.941 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.83 160.46 14.04 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.07 139.69 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 124.014 0.926 . . . . 0.0 110.097 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 176.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.47 170.11 21.0 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.708 2.939 . . . . 0.0 111.283 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.55 13.27 0.49 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -87.27 -8.8 56.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.959 -0.463 . . . . 0.0 110.448 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -81.9 -9.13 59.68 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 149' ' ' ILE . 8.4 tp -88.18 -40.31 13.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.2 p -75.21 -17.76 60.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.995 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.69 -19.34 14.36 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.593 0.633 . . . . 0.0 112.141 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.87 -12.07 45.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.89 0.768 . . . . 0.0 110.814 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.74 -21.72 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.78 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -74.33 -21.36 59.73 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.794 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 131' ' ' TRP . 38.8 ttpt -91.2 -60.04 2.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.415 -0.178 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.457 ' CE2' ' HE3' ' A' ' 130' ' ' LYS . 8.6 m95 -77.26 0.89 20.32 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 m -142.12 -5.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.86 23.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.949 1.25 . . . . 0.0 112.083 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -75.11 38.02 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.407 -0.808 . . . . 0.0 111.523 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.48 24.22 3.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.597 0.759 . . . . 0.0 110.07 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -141.77 140.22 33.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.748 0.819 . . . . 0.0 109.438 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -84.83 52.63 2.47 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.842 0.457 . . . . 0.0 111.824 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.95 -7.37 0.39 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.292 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 68.51 -166.39 45.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.12 0.96 . . . . 0.0 111.212 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.0 p 67.33 116.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.848 1.659 . . . . 0.0 112.51 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.1 m 61.4 27.61 17.18 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.6 1.16 . . . . 0.0 112.893 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.56 -16.48 68.41 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -155.56 151.71 22.86 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.05 10.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.992 3.128 . . . . 0.0 115.236 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.99 -0.1 15.23 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.277 0.944 . . . . 0.0 110.966 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.45 22.34 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.109 0.564 . . . . 0.0 112.071 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 10.2 5.12 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.301 0.24 . . . . 0.0 111.57 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.04 -19.46 0.32 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 124' ' ' LEU . 18.3 mm . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 121.753 0.787 . . . . 0.0 109.322 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.5 tp -102.85 122.08 43.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -114.21 131.09 56.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.352 0.261 . . . . 0.0 110.748 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -104.3 143.42 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.9 163.56 27.99 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.72 18.28 70.07 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -54.21 138.38 57.35 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.78 0.79 . . . . 0.0 110.982 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.11 -15.39 20.53 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.166 2.577 . . . . 0.0 110.969 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.16 123.46 14.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -106.98 24.6 12.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.506 0.322 . . . . 0.0 110.463 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.3 ttp -139.31 24.21 2.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -147.08 85.84 1.62 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.7 -14.51 52.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 110.717 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -83.11 -8.21 59.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.883 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -94.99 -21.16 18.79 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.411 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.76 -26.79 60.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.32 -21.4 39.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.45 -13.16 60.37 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.088 -0.383 . . . . 0.0 110.739 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.52 -3.05 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.9 12.01 25.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.478 0.711 . . . . 0.0 110.371 170.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttp -95.22 -31.77 0.27 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 71.9 Cg_exo -54.63 -33.96 81.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.629 2.219 . . . . 0.0 114.728 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -139.38 17.06 2.57 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.463 0.574 . . . . 0.0 112.444 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.31 172.82 17.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.703 0.401 . . . . 0.0 110.088 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.76 55.61 1.89 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.016 0.526 . . . . 0.0 110.071 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.23 140.77 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.558 0.743 . . . . 0.0 110.215 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -120.26 3.52 10.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.7 m -139.16 126.86 21.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.341 0.518 . . . . 0.0 110.866 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.13 128.16 21.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 123.435 0.694 . . . . 0.0 109.348 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.63 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 109.732 173.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.42 147.37 46.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.292 1.037 . . . . 0.0 110.383 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -134.47 135.37 42.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.128 0.571 . . . . 0.0 109.906 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -80.87 41.3 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.682 0.793 . . . . 0.0 111.27 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -128.89 105.12 8.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 55.36 26.87 9.2 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.659 0.784 . . . . 0.0 111.448 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 49.46 54.65 10.63 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.348 1.059 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -88.53 141.31 28.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.527 0.331 . . . . 0.0 110.766 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.45 148.6 49.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.717 0.407 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -135.17 131.35 36.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.42 151.27 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.811 0.444 . . . . 0.0 110.028 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -137.33 136.82 38.3 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.42 164.64 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.664 1.585 . . . . 0.0 109.677 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.2 16.88 25.0 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.613 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -151.94 137.12 17.44 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.674 0.79 . . . . 0.0 109.018 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -12.68 61.33 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -87.13 -15.53 38.15 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -83.71 -21.03 32.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.56 54.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.0 -21.19 63.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.214 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -89.45 -9.61 49.51 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.953 -0.467 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 t -87.41 -25.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.794 -0.566 . . . . 0.0 109.919 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.7 mm? -74.82 -27.88 60.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -81.44 -14.78 56.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.698 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.19 -43.92 66.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -85.02 -1.44 56.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.465 -0.147 . . . . 0.0 111.346 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.35 -0.61 26.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.424 0.29 . . . . 0.0 110.811 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -131.89 11.9 4.75 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.6 -5.37 59.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.423 0.556 . . . . 0.0 110.736 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.91 -3.1 10.43 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.684 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.63 4.54 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.238 1.519 . . . . 0.0 113.542 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 94' ' ' LEU . 8.3 mp 38.45 55.56 4.79 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 112.057 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.68 -15.83 26.97 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.221 2.614 . . . . 0.0 112.175 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.4 mt -136.86 146.06 45.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.532 0.733 . . . . 0.0 110.752 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -107.03 130.8 54.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -135.04 140.55 45.68 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.847 0.459 . . . . 0.0 111.338 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -138.84 147.47 42.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.147 0.979 . . . . 0.0 109.232 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -121.66 157.5 30.71 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.774 0.321 . . . . 0.0 111.227 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.51 -178.85 31.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.86 137.59 48.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.115 0.566 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.153 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.457 ' N ' ' HD3' ' A' ' 120' ' ' PRO . 24.8 pt . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 119.584 -0.246 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 119' ' ' ILE . 51.5 Cg_exo -58.76 -21.52 56.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.366 2.044 . . . . 0.0 112.442 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 46.3 ttp -85.27 49.48 1.76 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.629 0.771 . . . . 0.0 110.216 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -135.43 -41.5 0.71 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.524 0.33 . . . . 0.0 111.039 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -79.78 -14.44 58.71 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.774 0.261 . . . . 0.0 110.337 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 tp -88.78 -26.94 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -78.39 -20.76 50.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.28 -47.6 7.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.173 -0.33 . . . . 0.0 110.932 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.93 -14.56 58.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.56 -22.32 13.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.415 0.552 . . . . 0.0 111.321 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.98 -28.71 63.6 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.36 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -84.04 -57.38 3.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.703 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.2 7.14 26.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -171.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.3 m -143.14 -0.53 1.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.0 t -135.28 14.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.563 1.074 . . . . 0.0 112.12 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.9 m -90.35 24.13 2.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.817 -0.552 . . . . 0.0 109.773 169.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.75 43.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.569 1.148 . . . . 0.0 109.347 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -86.3 33.35 0.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -135.79 26.35 3.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.58 165.9 33.13 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.877 -0.514 . . . . 0.0 112.659 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA2' HD23 ' A' ' 145' ' ' LEU . . . 76.18 163.45 15.11 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.107 0.86 . . . . 0.0 112.686 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.6 t -98.29 -30.08 12.8 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.725 -0.28 . . . . 0.0 111.464 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -151.79 22.69 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.703 0.401 . . . . 0.0 111.334 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.61 -9.41 68.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.352 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.602 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 59.9 tt0 -163.78 -39.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 118.45 1.125 . . . . 0.0 113.335 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 46.0 Cg_exo -61.65 11.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.98 3.12 . . . . 0.0 115.878 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.606 HD21 ' CG2' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.2 14.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.112 0.869 . . . . 0.0 112.019 177.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.22 6.84 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.684 0.794 . . . . 0.0 111.59 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -136.03 30.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.627 1.171 . . . . 0.0 108.213 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.91 29.04 0.07 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.5 mm . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 118.13 0.965 . . . . 0.0 111.632 175.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 N--CA 1.471 0.164 0 N-CA-C 112.477 0.145 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -135.51 143.8 45.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.164 0.586 . . . . 0.0 110.419 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -93.42 55.07 2.18 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.105 0.562 . . . . 0.0 110.023 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.3 145.89 54.67 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.708 0.403 . . . . 0.0 111.604 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -83.41 136.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.848 0.459 . . . . 0.0 110.101 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.51 24.38 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.268 0.627 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -81.57 151.74 27.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.976 0.51 . . . . 0.0 110.648 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -135.31 126.89 28.85 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.912 0.485 . . . . 0.0 109.785 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -147.94 119.07 4.43 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.12 165.6 32.14 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.398 2.732 . . . . 0.0 111.602 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -68.51 151.61 46.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.024 0.53 . . . . 0.0 110.813 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -69.97 139.66 52.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.529 0.204 . . . . 0.0 110.46 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -139.37 163.66 44.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.0 109.923 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.77 159.69 4.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.964 3.109 . . . . 0.0 112.887 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -118.9 159.32 45.07 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.683 0.793 . . . . 0.0 110.346 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.79 172.71 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.586 2.857 . . . . 0.0 110.728 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 t -78.49 57.09 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 121.342 0.591 . . . . 0.0 110.799 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -164.06 24.94 0.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.231 0.612 . . . . 0.0 111.24 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -129.82 86.44 2.41 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.767 -0.583 . . . . 0.0 110.955 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.67 33.29 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.437 1.495 . . . . 0.0 112.652 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -135.87 24.42 3.35 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.732 -0.605 . . . . 0.0 111.953 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -138.34 24.25 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.82 134.86 71.54 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 122.441 0.296 . . . . 0.0 111.141 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.18 162.5 34.01 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.289 3.326 . . . . 0.0 110.53 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.9 -2.48 12.6 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.944 3.096 . . . . 0.0 112.198 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.44 154.02 51.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.181 0.592 . . . . 0.0 111.399 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 53.78 46.73 25.21 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.819 0.848 . . . . 0.0 112.002 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.8 tp -135.32 141.77 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.455 0.702 . . . . 0.0 110.113 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -142.92 26.81 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.5 t -85.14 125.94 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 O-C-N 121.698 -0.627 . . . . 0.0 109.572 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 54.5 27.1 7.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.369 1.067 . . . . 0.0 113.003 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.0 m -137.74 112.04 8.6 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -80.05 -15.64 56.76 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.4 p 53.42 -174.5 0.03 OUTLIER 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.428 1.491 . . . . 0.0 112.654 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.5 tp -85.49 105.92 16.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.42 141.71 35.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.636 0.774 . . . . 0.0 110.448 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mm -127.74 109.44 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.26 161.55 12.92 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 122.18 -0.325 . . . . 0.0 112.483 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.88 73.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.303 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.7 m -54.09 120.78 26.57 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.185 0.993 . . . . 0.0 111.062 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 26.9 Cg_exo -67.03 -12.84 37.67 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.595 2.863 . . . . 0.0 112.539 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 42' ' ' LEU . 2.8 mm? -84.67 157.96 20.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.325 0.65 . . . . 0.0 110.988 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -79.71 53.99 1.72 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.9 mtm 53.47 55.74 8.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.448 1.099 . . . . 0.0 112.551 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.19 104.27 13.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.69 -17.0 63.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 49.1 p-90 -82.7 -11.88 58.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.053 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.25 -16.59 22.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.642 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 49' ' ' LEU . 3.7 mm? -78.09 -25.98 47.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.49 -21.3 38.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 171.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.217 -0.302 . . . . 0.0 111.233 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.28 -6.39 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.967 0.348 . . . . 0.0 111.657 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.93 17.01 21.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.65 0.78 . . . . 0.0 110.003 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -76.14 -45.33 3.71 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.107 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.37 136.49 11.25 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.198 1.932 . . . . 0.0 111.672 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 50.1 24.24 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.027 1.331 . . . . 0.0 113.783 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.14 33.62 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.719 0.407 . . . . 0.0 110.816 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -133.53 59.72 1.73 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.325 0.65 . . . . 0.0 110.331 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.31 138.48 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -133.31 4.61 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 t -151.06 137.84 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.113 0.415 . . . . 0.0 110.484 173.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.3 t -136.81 133.2 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.578 0.751 . . . . 0.0 109.468 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.03 138.87 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.484 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -126.47 117.78 23.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.108 1.363 . . . . 0.0 108.545 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -135.78 162.71 32.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.217 0.607 . . . . 0.0 111.425 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.1 t30 65.58 149.93 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.812 1.245 . . . . 0.0 112.81 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -81.74 25.01 0.57 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.169 0.588 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -127.9 24.63 6.04 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.532 0.733 . . . . 0.0 111.147 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 54.64 55.17 8.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.055 0.942 . . . . 0.0 112.002 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -104.79 120.31 41.07 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.89 153.12 51.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 112.073 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.24 147.89 49.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.45 150.63 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.21 130.35 56.89 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.738 0.415 . . . . 0.0 110.182 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.09 149.16 18.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 C-N-CA 124.056 0.942 . . . . 0.0 109.823 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -97.12 14.92 24.12 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -154.99 139.96 17.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.158 0.583 . . . . 0.0 109.848 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -84.9 -6.55 59.34 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.735 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -90.46 -28.76 18.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.34 -17.87 40.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -46.05 73.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -74.94 -11.82 60.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.352 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.66 -22.26 40.65 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.683 0.674 . . . . 0.0 110.685 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -77.76 -45.28 28.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.04 -17.72 64.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.557 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -69.66 -53.87 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.639 -0.663 . . . . 0.0 109.37 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -80.04 -45.03 19.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.738 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -89.6 9.37 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -139.46 6.88 2.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.6 0.636 . . . . 0.0 112.512 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -143.63 14.99 1.78 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.15 7.82 40.77 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.414 1.006 . . . . 0.0 112.052 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.2 4.26 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.519 0.581 . . . . 0.0 113.983 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.61 55.27 1.88 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.959 0.879 . . . . 0.0 109.318 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 94' ' ' LEU . 6.3 mp -61.84 115.73 17.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.075 0.95 . . . . 0.0 110.728 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.08 -17.26 4.75 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.234 2.623 . . . . 0.0 110.802 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.7 mt -135.77 146.11 47.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.276 1.03 . . . . 0.0 109.916 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.59 88.04 6.16 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.7 p -93.87 125.75 38.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.844 0.458 . . . . 0.0 111.664 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -140.54 145.21 36.51 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 124.243 1.017 . . . . 0.0 108.743 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -135.68 157.97 45.56 Favored 'General case' 0 C--O 1.229 0.019 0 CA-C-N 118.337 0.517 . . . . 0.0 112.195 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 157.33 29.41 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.11 140.06 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 123.506 0.723 . . . . 0.0 110.551 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.1 144.21 16.76 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -92.11 19.79 6.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.154 0.582 . . . . 0.0 111.645 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 63.47 74.54 0.43 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -54.53 150.05 36.49 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.077 3.185 . . . . 0.0 113.077 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -135.57 150.12 49.61 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.029 0.932 . . . . 0.0 109.719 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 46.32 40.43 7.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.173 0.989 . . . . 0.0 112.257 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 27.0 p -79.18 39.67 0.39 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.864 0.866 . . . . 0.0 111.542 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 74.5 m -80.62 55.63 2.4 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.941 0.896 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -132.36 157.41 44.56 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.799 0.84 . . . . 0.0 110.147 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -69.17 -5.91 25.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -80.93 1.32 31.52 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -135.14 23.09 3.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.632 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.59 -15.1 1.63 Allowed Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.721 -0.488 . . . . 0.0 112.084 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -129.55 24.67 5.43 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.656 0.728 . . . . 0.0 110.498 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.9 m -135.48 132.55 37.49 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.355 0.662 . . . . 0.0 109.857 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.43 149.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.629 0.372 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.446 HG12 ' H ' ' A' ' 121' ' ' MET . 16.9 tt -146.94 138.15 13.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 42.7 Cg_exo -61.45 -16.77 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.314 2.676 . . . . 0.0 113.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.446 ' H ' HG12 ' A' ' 119' ' ' ILE . 1.7 mpt? -79.82 21.02 0.56 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.009 0.524 . . . . 0.0 112.079 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -130.01 -15.55 3.78 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.651 0.38 . . . . 0.0 110.465 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -80.58 -11.32 59.67 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.37 -25.7 51.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.1 m -79.18 -49.47 12.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.516 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.46 -17.37 34.42 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.658 -0.817 . . . . 0.0 113.12 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.4 -21.65 17.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.17 0.896 . . . . 0.0 112.365 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 -26.02 15.91 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.417 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -84.65 -23.94 29.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.857 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -81.54 -49.78 10.16 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.689 0.677 . . . . 0.0 110.627 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -94.9 4.87 53.31 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.1 m -135.86 -4.92 2.2 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.54 0.609 . . . . 0.0 112.418 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 14.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.142 0.883 . . . . 0.0 111.595 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 t -147.52 55.62 1.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.609 -0.682 . . . . 0.0 111.23 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.29 -42.15 0.97 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.437 0.295 . . . . 0.0 110.731 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -139.36 16.87 2.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.136 0.574 . . . . 0.0 110.434 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -146.42 156.86 43.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.707 0.803 . . . . 0.0 110.086 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.91 149.08 39.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.07 156.61 53.57 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 66.46 116.69 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.828 1.251 . . . . 0.0 112.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.412 ' HA ' HG11 ' A' ' 146' ' ' VAL . 23.7 m 64.98 30.8 11.68 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.611 1.164 . . . . 0.0 112.791 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.15 -13.33 52.85 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -146.38 160.67 41.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.108 0.963 . . . . 0.0 109.354 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.94 0.64 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.449 3.433 . . . . 0.0 114.644 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.44 6.58 6.7 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.726 0.693 . . . . 0.0 112.419 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 141' ' ' SER . 30.5 m -85.36 19.91 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.7 m -128.6 27.66 5.5 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.34 -48.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.642 HG22 ' H ' ' A' ' 151' ' ' PHE . 1.6 mp -58.08 -40.94 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.101 0.951 . . . . 0.0 111.516 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.8 m 43.83 20.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.183 1.793 . . . . 0.0 115.151 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.642 ' H ' HG22 ' A' ' 149' ' ' ILE . 29.1 m-85 -117.27 131.41 56.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.798 0.839 . . . . 0.0 109.594 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.66 55.39 1.87 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.09 0.472 . . . . 0.0 110.232 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.73 151.45 45.66 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.29 0.69 8.73 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.167 3.245 . . . . 0.0 112.232 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.28 138.1 43.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.976 0.353 . . . . 0.0 111.188 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 156' ' ' ILE . 0.1 OUTLIER -134.17 164.93 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.789 0.836 . . . . 0.0 109.359 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.63 104.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 110.761 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.7 t -142.09 135.64 28.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 124.13 0.972 . . . . 0.0 109.432 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 172.29 169.31 34.84 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -135.34 149.95 49.85 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.956 0.902 . . . . 0.0 109.554 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -70.07 146.73 43.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.82 139.45 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.447 0.699 . . . . 0.0 109.686 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -135.67 139.21 43.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.008 0.523 . . . . 0.0 110.289 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.7 m -135.16 26.66 3.53 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.348 0.659 . . . . 0.0 110.596 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.17 141.66 47.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.917 0.487 . . . . 0.0 110.636 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.56 129.23 32.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 109.988 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.8 pt -135.62 156.58 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.491 0.716 . . . . 0.0 110.466 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 34.7 t -135.35 137.68 42.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.078 0.551 . . . . 0.0 109.95 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -85.4 143.29 28.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.74 0.416 . . . . 0.0 110.671 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -135.47 155.61 50.25 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.474 0.71 . . . . 0.0 110.61 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 61.5 ttp -141.55 142.91 27.69 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.926 0.49 . . . . 0.0 109.741 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.11 163.7 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.585 2.857 . . . . 0.0 112.776 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t -108.39 154.72 21.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.351 0.661 . . . . 0.0 110.334 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -135.17 128.52 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.949 0.5 . . . . 0.0 110.355 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 82.6 p -138.25 155.42 48.64 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.464 0.706 . . . . 0.0 110.708 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -133.78 163.12 24.49 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -135.36 111.2 9.38 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 123.087 0.555 . . . . 0.0 110.034 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -118.99 105.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.458 0.703 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.6 165.64 54.41 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.26 160.76 18.4 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.185 3.257 . . . . 0.0 112.64 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -135.69 136.61 41.01 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.742 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.1 t -135.74 144.57 45.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.903 0.481 . . . . 0.0 110.538 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.06 -178.22 46.84 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -146.84 161.32 37.83 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.192 0.597 . . . . 0.0 110.474 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.847 3.031 . . . . 0.0 111.71 174.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.471 0.188 0 N-CA-C 112.751 0.25 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -135.63 151.62 50.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.129 0.571 . . . . 0.0 110.634 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -135.7 146.21 47.5 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.091 0.556 . . . . 0.0 110.072 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.84 145.03 51.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.469 0.708 . . . . 0.0 110.323 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.16 28.86 3.41 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.311 0.644 . . . . 0.0 111.171 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.37 24.48 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.247 0.619 . . . . 0.0 110.783 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 t -92.72 51.63 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.102 0.561 . . . . 0.0 109.947 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -135.92 134.24 38.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.36 0.664 . . . . 0.0 109.881 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -145.52 151.68 47.56 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 123.019 0.528 . . . . 0.0 110.709 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.43 167.79 25.9 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.721 2.948 . . . . 0.0 110.807 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -76.88 150.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.348 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -91.97 -13.76 30.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.167 0.187 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -155.01 148.86 18.88 Favored Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.132 1.373 . . . . 0.0 108.397 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.62 147.3 57.06 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.961 2.44 . . . . 0.0 109.732 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.39 152.27 56.73 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.046 0.539 . . . . 0.0 109.962 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.94 177.58 7.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.814 3.009 . . . . 0.0 110.182 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.74 98.9 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -154.29 151.89 29.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.172 0.589 . . . . 0.0 110.499 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.82 104.63 10.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.96 151.9 44.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.619 0.767 . . . . 0.0 111.104 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.9 m -78.31 34.44 0.21 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.613 0.765 . . . . 0.0 112.464 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m -135.78 29.03 3.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.83 127.68 83.4 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 123.102 0.561 . . . . 0.0 110.555 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.3 160.1 36.12 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.821 3.014 . . . . 0.0 111.373 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.94 11.6 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.835 3.69 . . . . 0.0 111.792 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -60.77 153.6 23.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -56.98 137.63 55.32 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.342 0.657 . . . . 0.0 111.187 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.579 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.2 tp -135.99 149.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 123.101 0.561 . . . . 0.0 110.738 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' H ' HD12 ' A' ' 28' ' ' ILE . 97.5 mttt -119.73 24.74 10.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.202 0.601 . . . . 0.0 111.842 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.579 ' H ' HG13 ' A' ' 28' ' ' ILE . 44.3 t -109.06 -4.07 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.485 0.714 . . . . 0.0 109.543 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -141.42 152.49 44.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.401 0.681 . . . . 0.0 110.076 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.7 t -133.5 132.67 41.27 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -101.62 143.21 31.87 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.873 0.469 . . . . 0.0 111.338 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -106.02 160.68 15.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.055 0.942 . . . . 0.0 109.773 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.5 tp -114.81 127.69 55.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -105.95 143.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.36 0.664 . . . . 0.0 110.257 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.43 143.33 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.845 0.858 . . . . 0.0 110.173 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.03 172.64 42.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.93 64.79 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -59.29 138.52 88.59 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 117.368 0.584 . . . . 0.0 111.599 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.84 -11.1 10.29 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.881 3.054 . . . . 0.0 111.526 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 45' ' ' LYS . 2.0 pp -84.39 161.02 20.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.467 0.707 . . . . 0.0 111.234 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -81.52 55.44 2.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.8 ptt? 46.61 55.16 7.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.918 1.287 . . . . 0.0 112.812 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' H ' HD13 ' A' ' 42' ' ' LEU . 54.8 mtmt -111.24 119.28 38.37 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.354 0.662 . . . . 0.0 109.292 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -70.47 -15.88 62.86 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.976 -0.102 . . . . 0.0 111.143 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -93.85 -9.89 35.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.314 -0.241 . . . . 0.0 111.484 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.01 -17.2 15.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -78.38 -28.2 46.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.2 -21.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.49 -19.16 61.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.176 0.444 . . . . 0.0 110.98 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.96 -6.52 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 117.945 0.339 . . . . 0.0 111.586 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.92 20.07 18.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.785 0.834 . . . . 0.0 110.067 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 23.7 tptm -88.34 -49.43 0.42 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.426 170.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 98.2 Cg_endo -77.08 141.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.089 1.859 . . . . 0.0 110.643 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 48.96 34.5 5.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.781 0.833 . . . . 0.0 112.369 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.89 156.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.083 -0.386 . . . . 0.0 111.378 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.37 54.92 1.92 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.422 0.689 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.88 138.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -117.79 -7.4 10.98 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -146.52 134.11 20.98 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.025 -0.422 . . . . 0.0 110.573 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.1 117.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.37 131.39 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.013 0.435 . . . . 0.0 111.578 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.32 132.9 41.32 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.503 1.121 . . . . 0.0 109.27 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.69 160.09 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.133 0.573 . . . . 0.0 111.688 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.2 t30 64.66 153.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.054 1.342 . . . . 0.0 112.719 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -78.82 32.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.504 0.722 . . . . 0.0 111.144 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -134.75 24.48 3.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.64 0.776 . . . . 0.0 110.289 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 45.91 48.21 12.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 114.001 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -106.61 146.54 30.58 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.24 39.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 111.656 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -131.16 129.78 42.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.17 151.7 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.437 0.161 . . . . 0.0 110.986 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -128.78 137.62 51.63 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.893 0.378 . . . . 0.0 111.168 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 m -108.77 156.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.624 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.64 6.08 29.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -155.54 137.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.126 0.57 . . . . 0.0 109.801 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.19 -13.35 61.9 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.287 -0.258 . . . . 0.0 111.628 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -88.13 -14.65 38.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -92.01 -11.55 35.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.64 -44.47 61.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.0 -15.27 61.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -83.03 -19.15 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 122.03 -0.419 . . . . 0.0 110.873 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.6 t -75.21 -37.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.65 -21.74 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.894 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.19 -19.8 53.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -85.66 -23.37 27.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -77.93 -8.89 58.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -122.51 3.42 9.64 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -139.82 24.09 2.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.712 0.687 . . . . 0.0 112.835 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -135.45 49.88 2.15 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.667 -0.645 . . . . 0.0 111.016 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.7 4.3 87.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.481 -0.621 . . . . 0.0 113.088 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.91 55.78 8.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.827 0.814 . . . . 0.0 111.679 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -56.48 153.49 20.28 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.287 0.635 . . . . 0.0 110.973 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.63 -2.14 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.925 3.083 . . . . 0.0 112.088 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.88 114.69 5.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -85.31 127.62 34.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.887 0.375 . . . . 0.0 110.734 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 t -137.43 137.48 38.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.326 0.65 . . . . 0.0 109.89 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -147.94 146.41 28.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.187 0.595 . . . . 0.0 110.484 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -106.72 155.89 19.21 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.612 0.365 . . . . 0.0 111.221 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.13 35.58 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.72 148.98 27.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.53 143.2 10.2 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -75.53 152.25 37.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.532 0.333 . . . . 0.0 110.994 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.0 -175.49 15.95 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.324 0.488 . . . . 0.0 112.392 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.59 170.55 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.191 3.261 . . . . 0.0 111.245 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -119.79 31.09 6.71 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.322 0.649 . . . . 0.0 111.721 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.88 33.37 0.38 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.473 0.709 . . . . 0.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 68.1 m -86.5 40.73 0.9 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.806 0.842 . . . . 0.0 110.956 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.8 t -87.72 24.44 1.73 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.903 0.481 . . . . 0.0 111.443 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -144.01 144.28 31.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.558 0.743 . . . . 0.0 109.084 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -70.15 -19.93 63.18 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -88.28 7.65 31.17 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -135.56 24.25 3.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.389 1.076 . . . . 0.0 109.009 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -125.91 -34.31 0.65 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -135.91 21.75 3.29 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.69 0.745 . . . . 0.0 111.788 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.4 m -135.76 24.5 3.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.053 0.541 . . . . 0.0 110.772 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 tt -140.71 152.3 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.504 0.722 . . . . 0.0 109.481 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 mp 63.34 129.67 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.271 1.428 . . . . 0.0 111.639 -173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.17 -1.87 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.872 3.048 . . . . 0.0 113.413 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -75.12 21.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.835 0.743 . . . . 0.0 112.399 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -97.45 -10.51 25.27 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.796 -0.565 . . . . 0.0 110.105 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -79.84 -7.71 58.86 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.36 -41.59 13.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.161 0.984 . . . . 0.0 109.673 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 p -76.92 -25.46 52.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.845 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.04 -46.71 11.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.7 0.227 . . . . 0.0 111.531 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 -9.36 57.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.72 -36.78 8.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.45 -24.4 62.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.996 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -87.26 -57.05 3.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.047 -0.408 . . . . 0.0 111.244 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -83.04 5.5 22.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -139.12 -8.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.803 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.81 24.37 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.538 1.063 . . . . 0.0 112.064 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -123.85 34.28 5.11 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.87 -0.519 . . . . 0.0 111.036 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.56 25.3 3.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.083 0.553 . . . . 0.0 111.324 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.14 25.07 3.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.813 0.445 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.5 m95 53.56 38.8 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.238 0.615 . . . . 0.0 111.839 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.47 -160.65 19.42 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -167.13 159.74 33.2 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 117.168 0.484 . . . . 0.0 111.964 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 77.0 p 51.38 24.44 2.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.629 1.572 . . . . 0.0 114.089 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -156.53 24.12 0.34 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.953 0.342 . . . . 0.0 111.789 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.92 -10.96 27.33 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.485 -0.62 . . . . 0.0 114.134 -172.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -145.86 160.4 43.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.197 0.998 . . . . 0.0 110.232 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -60.65 -3.52 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.129 3.219 . . . . 0.0 113.788 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -75.12 -2.71 28.87 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.375 0.534 . . . . 0.0 111.836 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 m -84.77 8.85 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.524 0.329 . . . . 0.0 111.237 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.1 p -129.63 38.07 3.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.19 0.996 . . . . 0.0 108.45 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.04 -59.09 0.02 OUTLIER Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 151' ' ' PHE . 1.8 mp -58.97 -53.25 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 117.543 0.671 . . . . 0.0 109.962 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.3 m 35.86 33.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 126.069 1.748 . . . . 0.0 114.521 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.496 ' H ' HG22 ' A' ' 149' ' ' ILE . 55.4 t80 -135.15 155.12 51.24 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.007 -0.433 . . . . 0.0 111.184 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.62 161.22 28.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.499 0.72 . . . . 0.0 111.278 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -137.44 152.15 72.56 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 122.789 0.435 . . . . 0.0 111.269 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.07 -19.58 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.514 2.81 . . . . 0.0 111.126 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.2 t70 53.1 55.37 8.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.192 0.997 . . . . 0.0 112.21 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.0 pt -113.41 11.53 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.5 tp 46.38 55.79 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.78 1.232 . . . . 0.0 112.824 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.8 t -117.37 135.09 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 C-N-CA 123.287 0.635 . . . . 0.0 109.385 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -173.62 -12.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.34 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -135.8 141.14 44.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.262 1.031 . . . . 0.0 110.366 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -179.76 9.42 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.074 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.54 144.89 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 118.119 0.96 . . . . 0.0 110.935 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.8 p -135.69 155.62 50.11 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.738 0.815 . . . . 0.0 110.411 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.6 t -135.65 146.6 48.0 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.892 0.477 . . . . 0.0 110.853 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -135.4 154.25 51.53 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.84 0.856 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.36 36.66 3.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.281 0.633 . . . . 0.0 110.757 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 37.0 pt -82.51 38.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.803 0.841 . . . . 0.0 111.497 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 77.3 p -133.53 30.15 3.84 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.691 0.796 . . . . 0.0 111.193 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 162.79 27.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.91 0.484 . . . . 0.0 111.68 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -135.25 146.86 49.01 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.605 0.762 . . . . 0.0 109.905 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -139.95 154.34 70.47 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.322 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.51 172.45 15.05 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.901 3.068 . . . . 0.0 111.339 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.4 p -130.89 153.87 48.69 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.551 0.741 . . . . 0.0 110.37 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -66.36 130.35 42.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.796 0.438 . . . . 0.0 111.15 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.3 p -135.43 22.64 3.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.661 0.784 . . . . 0.0 110.428 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -85.68 -132.23 2.83 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 49.27 29.77 2.83 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.481 1.513 . . . . 0.0 113.458 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -135.99 145.51 46.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.66 0.784 . . . . 0.0 109.584 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.47 173.1 45.29 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.22 171.0 18.52 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 124.491 3.461 . . . . 0.0 111.353 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -135.21 134.2 39.81 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.514 0.725 . . . . 0.0 109.709 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.0 m -73.75 140.12 45.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.731 0.412 . . . . 0.0 111.078 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.56 171.53 40.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 41.1 ttmt -87.45 -44.48 0.51 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.736 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 85.2 Cg_endo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.233 1.955 . . . . 0.0 111.207 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo . . . . . 0 C--O 1.231 0.143 0 N-CA-C 112.445 0.133 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -135.82 39.51 2.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.172 0.589 . . . . 0.0 111.084 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -65.76 145.11 56.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.867 0.365 . . . . 0.0 111.322 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 pp -135.93 164.7 27.36 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.355 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -81.91 148.3 28.82 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.85 0.46 . . . . 0.0 110.412 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.72 31.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 111.146 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.7 t -69.91 145.33 52.04 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.772 0.429 . . . . 0.0 110.79 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -75.93 153.05 36.93 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.98 0.512 . . . . 0.0 110.961 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.97 159.31 53.62 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 123.084 0.554 . . . . 0.0 110.591 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.95 164.4 12.12 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.004 3.136 . . . . 0.0 112.277 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -119.7 24.7 10.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.163 0.585 . . . . 0.0 110.889 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -143.63 139.85 29.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.454 0.702 . . . . 0.0 109.983 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -134.53 91.99 20.9 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 123.282 0.633 . . . . 0.0 109.324 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.45 136.87 77.14 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.911 3.074 . . . . 0.0 112.393 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -163.45 162.38 17.33 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.179 0.992 . . . . 0.0 109.141 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.86 158.96 53.88 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.499 2.132 . . . . 0.0 110.176 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.25 104.93 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.7 p -141.21 149.3 41.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.27 0.628 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -38.23 122.91 1.1 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.818 1.247 . . . . 0.0 111.687 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -47.88 104.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.341 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.9 m -142.43 -2.49 1.1 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.848 0.459 . . . . 0.0 111.35 169.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -148.1 24.05 1.05 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.52 146.38 53.47 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 121.475 -0.766 . . . . 0.0 111.601 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.52 168.36 24.62 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.904 3.736 . . . . 0.0 110.591 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.04 18.85 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.485 3.457 . . . . 0.0 112.404 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.02 175.37 5.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.688 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -52.52 154.31 2.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.05 1.34 . . . . 0.0 113.149 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 119.45 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -82.44 35.59 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -172.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 12.73 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.77 55.89 1.26 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.055 0.942 . . . . 0.0 108.613 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.4 t -62.11 109.04 1.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.942 0.497 . . . . 0.0 111.124 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.16 54.26 1.94 Allowed 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.6 m -76.11 135.44 39.84 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.446 -171.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.76 108.55 12.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -86.78 139.63 30.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.371 0.668 . . . . 0.0 110.023 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.04 142.38 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.36 171.07 40.55 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.186 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.38 23.7 68.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -56.36 126.01 67.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 117.321 0.561 . . . . 0.0 111.799 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.25 -2.68 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.576 2.85 . . . . 0.0 110.82 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.19 159.98 33.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.221 0.608 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -79.11 38.59 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.799 0.839 . . . . 0.0 111.74 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp 57.48 54.26 6.68 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.9 0.88 . . . . 0.0 111.98 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.13 131.89 37.39 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.668 0.787 . . . . 0.0 109.185 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.8 -8.0 55.1 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -85.15 -17.94 35.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.156 -0.34 . . . . 0.0 110.946 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -87.13 -22.51 25.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.868 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.44 -37.23 77.3 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.36 -18.85 62.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.829 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -88.2 -4.22 58.76 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.857 -0.527 . . . . 0.0 111.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.46 -2.01 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 118.124 0.42 . . . . 0.0 111.672 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -131.27 6.68 4.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -171.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 3.2 mmpt? -96.52 -29.36 0.26 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 97.6 Cg_endo -74.74 134.98 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 CA-C-N 121.779 1.671 . . . . 0.0 109.968 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 50.3 36.77 13.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.419 0.688 . . . . 0.0 111.612 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.69 165.38 29.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.658 0.783 . . . . 0.0 110.577 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -135.13 49.79 2.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 110.761 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.99 137.04 22.3 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.269 0.627 . . . . 0.0 109.915 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -125.45 1.97 7.67 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 m -138.53 138.73 38.28 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.629 0.65 . . . . 0.0 111.524 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.2 t -135.75 130.92 50.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 123.502 0.721 . . . . 0.0 109.368 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.87 137.84 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.96 142.11 51.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.741 0.816 . . . . 0.0 110.49 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -129.18 129.09 44.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.855 0.862 . . . . 0.0 109.057 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -78.39 43.46 0.46 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.137 0.975 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -135.44 104.91 6.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.7 0.8 . . . . 0.0 109.186 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 52.08 36.58 19.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.928 0.891 . . . . 0.0 111.919 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 53.8 55.77 8.03 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.435 0.694 . . . . 0.0 112.038 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -96.67 129.46 44.06 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.73 152.13 50.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.959 0.504 . . . . 0.0 110.974 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -135.67 136.86 41.26 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.24 155.36 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.595 0.236 . . . . 0.0 110.395 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.92 136.04 47.08 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.993 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -122.26 156.98 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 126.366 1.866 . . . . 0.0 108.192 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -117.94 17.91 14.07 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -143.44 122.94 13.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.757 0.823 . . . . 0.0 109.052 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 ttt-85 -70.26 -20.41 63.06 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.18 0.446 . . . . 0.0 110.679 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -75.75 -21.57 57.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.041 -0.412 . . . . 0.0 110.162 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.59 -11.76 19.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.0 64.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.95 -21.2 51.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.371 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -78.06 -20.57 52.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.972 -0.455 . . . . 0.0 110.855 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.97 -40.67 22.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 O-C-N 121.77 -0.581 . . . . 0.0 110.345 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.24 -21.72 62.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.468 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -81.65 -18.08 45.82 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.81 -0.557 . . . . 0.0 110.533 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.42 -26.5 32.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -91.8 2.64 56.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -119.84 -0.84 10.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.454 0.302 . . . . 0.0 111.49 171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.32 16.18 3.44 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.96 49.05 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 110.595 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.34 9.04 85.91 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.343 -0.698 . . . . 0.0 112.892 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.73 81.18 0.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.083 0.953 . . . . 0.0 111.408 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.37 151.17 60.77 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.15 0.58 . . . . 0.0 111.107 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.27 -9.39 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.787 2.991 . . . . 0.0 111.468 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.9 tt -73.87 124.05 25.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.412 ' N ' HD23 ' A' ' 96' ' ' LEU . 25.8 tpt180 -85.15 136.72 33.42 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 122.368 0.267 . . . . 0.0 111.167 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 p -135.47 142.19 45.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.234 0.614 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.49 137.95 27.27 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.788 0.835 . . . . 0.0 109.061 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -135.2 155.57 50.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 0.0 111.677 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.36 176.49 45.32 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.319 0.4 . . . . 0.0 112.421 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.48 131.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.25 1.02 . . . . 0.0 109.921 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.24 135.98 14.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -135.69 142.52 45.11 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.008 0.523 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.4 -172.22 48.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.75 171.02 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.657 3.571 . . . . 0.0 112.726 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -57.83 144.21 39.54 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.106 0.562 . . . . 0.0 110.98 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -108.25 24.39 13.07 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.45 0.7 . . . . 0.0 112.001 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -99.73 24.37 8.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.866 0.467 . . . . 0.0 111.383 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.4 m -76.79 154.17 34.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.991 0.517 . . . . 0.0 110.395 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -78.21 146.52 34.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -74.95 3.74 7.75 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -78.75 -8.6 58.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.252 0.478 . . . . 0.0 109.945 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -135.22 4.64 3.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.855 0.862 . . . . 0.0 110.055 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.95 -12.77 45.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.84 134.21 56.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.429 0.614 . . . . 0.0 110.782 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.3 p -143.34 149.64 38.04 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.249 0.62 . . . . 0.0 110.296 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.5 tp -92.37 108.58 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm 62.57 140.96 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 111.089 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -56.59 -22.16 42.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.609 2.206 . . . . 0.0 113.248 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 41.4 ttp -80.08 36.34 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.023 0.529 . . . . 0.0 110.737 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -135.65 -36.95 0.76 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.393 0.677 . . . . 0.0 110.429 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -85.96 -13.49 47.53 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.579 0.172 . . . . 0.0 110.716 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.57 -24.97 14.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.209 0.604 . . . . 0.0 109.449 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.2 m -77.47 -26.04 51.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -91.0 -40.16 11.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.288 -0.258 . . . . 0.0 110.886 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.49 -9.41 59.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -112.5 -17.23 12.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.36 -24.47 62.98 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 170.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.57 -52.5 5.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -86.69 16.41 4.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.6 t -143.24 -20.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' ALA . 20.4 m -140.16 33.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.384 0.993 . . . . 0.0 113.058 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.7 p -72.81 22.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.521 -0.737 . . . . 0.0 111.887 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 133' ' ' VAL . . . -135.53 36.52 2.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.44 1.096 . . . . 0.0 109.202 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -133.4 162.3 32.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.231 1.012 . . . . 0.0 109.449 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -75.73 44.64 0.3 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.433 0.693 . . . . 0.0 111.936 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.9 1.02 90.14 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.368 0.508 . . . . 0.0 112.597 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 167.02 54.86 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.765 0.783 . . . . 0.0 111.925 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.8 t -140.01 22.34 2.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.811 0.845 . . . . 0.0 109.353 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -135.3 20.02 3.4 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 109.786 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.25 -5.1 83.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -137.69 160.33 65.39 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.029 0.532 . . . . 0.0 110.133 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.77 20.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 125.27 3.98 . . . . 0.0 115.157 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 149' ' ' ILE . 3.4 pp -83.33 1.62 40.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.14 0.882 . . . . 0.0 111.201 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.87 21.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.564 -0.71 . . . . 0.0 112.328 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -135.71 24.55 3.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.843 0.354 . . . . 0.0 111.796 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.96 -9.51 0.03 OUTLIER Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.593 -0.692 . . . . 0.0 112.915 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.475 HG13 HD13 ' A' ' 145' ' ' LEU . 29.5 mm -86.39 42.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.889 0.852 . . . . 0.0 109.548 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.14 24.71 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.184 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.12 161.79 28.36 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.39 55.7 1.87 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.107 0.563 . . . . 0.0 109.72 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.9 151.93 71.99 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 122.964 0.506 . . . . 0.0 110.527 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.42 5.82 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.075 3.183 . . . . 0.0 112.339 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -80.9 55.31 2.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.294 0.637 . . . . 0.0 110.902 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.3 pt -80.31 158.13 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.296 0.638 . . . . 0.0 110.808 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.3 pt -77.59 29.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.21 26.14 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.893 0.477 . . . . 0.0 110.715 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 79.78 -173.97 55.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -135.37 142.33 45.7 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.368 0.667 . . . . 0.0 110.155 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.42 179.15 45.01 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.1 150.82 29.95 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 C-N-CA 123.324 0.65 . . . . 0.0 110.455 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.6 m -135.4 148.57 49.4 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.286 0.635 . . . . 0.0 110.521 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.2 m -135.16 145.51 47.84 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.454 0.701 . . . . 0.0 110.202 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -135.32 34.6 3.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.063 0.545 . . . . 0.0 110.433 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.98 107.98 10.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.631 0.372 . . . . 0.0 110.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.2 tp -135.81 143.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.182 0.593 . . . . 0.0 110.279 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.6 t -135.83 136.68 40.83 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.226 0.611 . . . . 0.0 110.0 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -135.5 138.01 42.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.19 0.596 . . . . 0.0 109.976 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -136.06 152.39 50.84 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.171 0.589 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.4 ttm -147.58 136.81 11.75 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.86 146.37 47.67 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.178 2.585 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 62.7 p -135.98 24.63 3.32 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.471 0.708 . . . . 0.0 110.687 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.92 24.59 11.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.43 0.692 . . . . 0.0 111.703 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.9 p -99.37 130.41 45.64 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.045 0.538 . . . . 0.0 110.572 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 167.3 -177.03 42.01 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -135.55 119.43 17.36 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 123.336 0.654 . . . . 0.0 109.752 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -135.85 27.05 3.31 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.241 0.616 . . . . 0.0 111.541 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.44 157.24 51.93 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.07 168.09 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 124.312 3.341 . . . . 0.0 111.333 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -82.55 154.64 24.91 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.168 0.587 . . . . 0.0 110.25 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.6 m -132.78 132.11 41.86 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.882 0.473 . . . . 0.0 110.356 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 169.91 176.62 39.72 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 0.4 OUTLIER -82.88 -50.77 0.72 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.433 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 96.3 Cg_endo . . . . . 0 C--O 1.25 1.115 0 C-N-CA 122.429 2.086 . . . . 0.0 111.07 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.47 0.137 0 N-CA-C 112.52 0.161 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -135.16 26.71 3.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.151 0.581 . . . . 0.0 110.731 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.29 133.29 40.08 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.588 0.355 . . . . 0.0 110.529 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.22 104.75 16.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -81.21 138.92 35.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.973 0.509 . . . . 0.0 110.777 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.36 135.18 56.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.421 0.688 . . . . 0.0 109.85 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.9 m -134.61 27.73 3.66 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.287 0.635 . . . . 0.0 110.873 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -135.49 147.3 48.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.436 0.695 . . . . 0.0 110.105 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -78.69 119.83 78.74 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.13 169.74 21.51 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.453 2.769 . . . . 0.0 111.492 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -135.4 140.16 44.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.288 0.635 . . . . 0.0 110.093 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -136.73 127.76 27.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.055 0.542 . . . . 0.0 110.054 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -146.79 80.2 9.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.39 -9.77 13.64 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.763 2.976 . . . . 0.0 111.36 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -93.38 140.84 23.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.608 0.763 . . . . 0.0 110.46 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.29 -174.4 0.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.768 2.979 . . . . 0.0 110.316 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -56.93 135.27 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -78.64 177.26 8.75 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.494 0.717 . . . . 0.0 110.771 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -119.87 96.09 5.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.645 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 57.55 46.47 17.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -79.64 -174.81 4.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.489 0.715 . . . . 0.0 111.133 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -109.37 63.84 0.61 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.483 1.113 . . . . 0.0 108.621 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 23' ' ' LEU . 1.1 mm? -61.76 155.18 62.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.386 0.674 . . . . 0.0 110.831 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.05 161.94 10.02 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 111.728 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.39 126.75 17.56 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.864 2.376 . . . . 0.0 109.756 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -150.16 166.7 29.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.578 0.751 . . . . 0.0 109.785 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.85 55.64 0.54 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.719 0.808 . . . . 0.0 110.08 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -61.48 138.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.684 1.194 . . . . 0.0 109.474 -176.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' N ' HD13 ' A' ' 28' ' ' ILE . 22.5 ptmt -114.15 31.22 6.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.45 -9.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 122.774 0.43 . . . . 0.0 110.465 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.26 149.27 32.54 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.532 0.733 . . . . 0.0 109.884 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -82.62 124.71 30.42 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -69.04 144.43 54.03 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.041 0.536 . . . . 0.0 111.315 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.6 p -99.5 159.91 14.67 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.846 0.859 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.0 tp -122.55 125.46 45.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.127 0.489 . . . . 0.0 110.406 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -109.04 141.58 40.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.902 0.881 . . . . 0.0 109.653 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.99 145.1 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 109.177 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.12 40.09 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.479 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.34 24.31 65.45 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.756 -0.537 . . . . 0.0 111.756 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.18 130.14 89.09 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.427 0.614 . . . . 0.0 111.574 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.45 -2.94 12.27 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.459 2.772 . . . . 0.0 110.86 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.45 156.95 37.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.229 0.612 . . . . 0.0 110.413 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -80.5 43.16 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.409 0.684 . . . . 0.0 111.155 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 88.3 mtp 52.52 55.13 9.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.093 0.957 . . . . 0.0 112.277 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -130.83 125.97 35.05 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.01 -8.38 52.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -80.86 -15.65 55.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.047 -0.408 . . . . 0.0 110.974 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.02 -24.3 17.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.577 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.86 -26.28 60.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.3 -19.13 36.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.15 -8.47 59.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.953 -0.467 . . . . 0.0 110.806 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.17 -4.21 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -112.46 14.13 20.25 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.332 0.653 . . . . 0.0 111.045 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.514 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 56.3 tttp -117.71 -19.13 0.09 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 92.4 Cg_endo -78.16 -21.54 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 121.932 1.726 . . . . 0.0 112.307 -177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.84 16.41 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.129 0.571 . . . . 0.0 111.201 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.07 -175.78 5.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.439 1.096 . . . . 0.0 108.526 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -145.63 104.22 3.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.001 -0.437 . . . . 0.0 110.09 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.38 139.86 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.103 0.561 . . . . 0.0 110.123 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.57 2.72 6.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.201 0.2 . . . . 0.0 111.429 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 t -135.88 119.7 17.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.905 -0.497 . . . . 0.0 110.268 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.7 t -140.38 127.12 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.656 0.782 . . . . 0.0 109.671 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 136.18 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 122.751 0.42 . . . . 0.0 110.133 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.19 145.19 39.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.569 1.148 . . . . 0.0 110.311 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -135.15 138.21 43.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.079 0.552 . . . . 0.0 110.108 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.9 50.45 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -128.18 98.77 5.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 54.9 25.36 6.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.628 0.771 . . . . 0.0 111.693 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.08 60.96 3.28 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.206 1.002 . . . . 0.0 110.946 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.99 151.36 34.3 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.258 0.623 . . . . 0.0 111.122 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.18 160.15 40.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.647 0.779 . . . . 0.0 110.987 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -126.45 137.09 53.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.66 151.25 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-O 121.015 0.436 . . . . 0.0 111.464 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -135.0 134.79 40.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.8 156.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 125.212 1.405 . . . . 0.0 109.1 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -104.51 21.22 17.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.524 0.202 . . . . 0.0 111.216 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -142.71 115.35 8.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.934 0.893 . . . . 0.0 108.955 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -72.96 -20.05 61.12 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -89.79 -16.96 29.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.269 -0.27 . . . . 0.0 110.636 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.31 -18.62 28.11 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.15 84.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -70.48 -20.8 62.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -83.73 -14.09 52.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.99 0.359 . . . . 0.0 111.456 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -75.23 -50.2 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.27 -20.89 65.72 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.664 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -67.81 -46.42 71.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -84.07 -23.73 30.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.913 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.28 -2.86 43.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.095 0.407 . . . . 0.0 111.341 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -131.22 9.13 4.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -135.23 12.61 3.55 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -103.23 -11.84 17.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.043 0.838 . . . . 0.0 111.323 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.81 5.91 4.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.856 0.741 . . . . 0.0 114.392 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.71 29.61 3.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.589 1.195 . . . . 0.0 112.222 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.24 95.69 30.13 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.89 -2.48 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.904 3.069 . . . . 0.0 111.163 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.48 121.08 14.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.565 0.746 . . . . 0.0 109.022 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -83.07 136.11 34.6 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.615 0.366 . . . . 0.0 111.187 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 p -135.69 143.98 45.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.325 0.65 . . . . 0.0 110.81 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.03 131.32 25.01 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -125.47 155.43 40.52 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.333 0.253 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 180.0 -178.54 48.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.69 148.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.132 0.573 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.66 143.01 9.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.18 24.25 3.53 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.337 0.655 . . . . 0.0 111.145 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.42 178.42 36.13 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 122.978 0.323 . . . . 0.0 112.319 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.44 4.08 6.63 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.745 3.63 . . . . 0.0 112.059 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -65.99 145.86 55.38 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.044 0.537 . . . . 0.0 111.396 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -135.25 55.13 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.847 0.859 . . . . 0.0 109.108 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -94.73 51.31 1.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.895 0.878 . . . . 0.0 110.189 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.79 40.35 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.986 0.914 . . . . 0.0 112.237 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -131.87 134.58 45.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.97 0.908 . . . . 0.0 109.19 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -74.07 -4.34 34.93 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -81.26 -7.97 59.66 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -140.71 24.99 2.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.771 0.828 . . . . 0.0 110.294 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.37 3.48 0.12 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.367 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -79.57 55.2 1.92 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.182 1.491 . . . . 0.0 110.757 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.1 m -135.37 29.62 3.3 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.938 0.895 . . . . 0.0 110.255 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.0 pt -74.88 144.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.151 0.581 . . . . 0.0 111.107 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.783 ' H ' ' HD2' ' A' ' 120' ' ' PRO . 61.0 mt -133.61 -45.71 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.447 -0.787 . . . . 0.0 112.356 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.783 ' HD2' ' H ' ' A' ' 119' ' ' ILE . 87.9 Cg_endo -77.29 -8.18 17.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.75 1.633 . . . . 0.0 111.834 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.94 24.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.665 0.386 . . . . 0.0 111.753 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.87 -26.61 1.53 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.476 0.311 . . . . 0.0 110.771 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -87.48 -9.83 53.49 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.26 -52.62 8.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.892 0.877 . . . . 0.0 108.689 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -71.69 -19.68 62.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.097 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.7 -60.72 2.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.5 -26.02 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -172.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.22 -42.13 6.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.377 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -77.04 -21.26 54.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.224 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.18 -46.69 8.61 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.723 0.692 . . . . 0.0 111.111 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -84.63 5.03 29.6 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.493 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.3 m -138.83 -5.02 1.53 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.58 19.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.493 1.042 . . . . 0.0 112.571 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -82.87 49.79 1.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.322 -0.861 . . . . 0.0 111.557 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.92 8.0 3.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.923 0.489 . . . . 0.0 110.491 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -145.52 156.92 44.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.287 1.035 . . . . 0.0 109.547 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -76.2 104.53 6.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.55 178.8 33.8 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.04 136.87 25.86 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -146.2 32.75 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.928 0.364 . . . . 0.0 111.331 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG11 ' A' ' 146' ' ' VAL . 21.1 m 57.1 40.71 28.2 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.841 0.456 . . . . 0.0 111.901 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.98 -19.0 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -146.88 162.08 34.72 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.718 0.807 . . . . 0.0 109.287 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.02 3.82 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.46 3.44 . . . . 0.0 114.43 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.02 -5.76 28.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.69 0.677 . . . . 0.0 111.659 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 141' ' ' SER . 22.8 m -89.36 14.69 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.45 0.7 . . . . 0.0 111.042 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -133.43 44.33 2.81 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.78 -57.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.18 128.2 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.641 0.734 . . . . 0.0 109.653 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.13 31.77 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.54 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -132.61 130.93 40.86 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.581 0.353 . . . . 0.0 110.741 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.72 154.15 40.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.956 0.503 . . . . 0.0 111.227 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.569 ' H ' ' HD2' ' A' ' 154' ' ' PRO . 75.7 mm-40 -132.01 -59.21 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.457 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.569 ' HD2' ' H ' ' A' ' 153' ' ' GLU . 83.3 Cg_endo -74.06 149.01 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.52 2.146 . . . . 0.0 111.144 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -138.49 25.01 2.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.8 tp -135.33 131.41 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 122.089 -0.382 . . . . 0.0 111.328 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.5 tp -147.99 46.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.628 0.771 . . . . 0.0 109.565 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.36 137.14 55.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 C-N-CA 123.003 0.521 . . . . 0.0 110.084 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 167.29 -3.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.981 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -98.23 143.06 29.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 117.966 0.883 . . . . 0.0 111.209 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 175.18 154.29 11.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.68 143.97 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.274 0.629 . . . . 0.0 110.215 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -136.16 141.22 44.06 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.919 0.488 . . . . 0.0 110.954 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -145.74 137.82 25.4 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.249 0.619 . . . . 0.0 110.031 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -141.19 135.24 30.58 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.921 0.488 . . . . 0.0 110.713 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -136.04 126.15 26.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.338 0.655 . . . . 0.0 109.666 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.7 tt -141.96 144.97 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.784 0.434 . . . . 0.0 110.959 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.3 m -135.37 110.79 9.09 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 109.214 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.78 62.14 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.983 0.513 . . . . 0.0 110.314 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -135.31 144.74 46.91 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.886 0.474 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.3 ttm -152.8 135.92 9.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.257 0.623 . . . . 0.0 109.36 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.36 154.39 40.79 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.572 2.848 . . . . 0.0 111.339 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.1 m -137.07 85.38 2.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -135.54 24.88 3.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.894 0.478 . . . . 0.0 111.29 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.9 m -88.43 135.03 33.67 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.687 0.395 . . . . 0.0 111.066 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.29 161.41 20.79 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -140.64 121.67 14.64 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.204 0.601 . . . . 0.0 109.987 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -143.48 139.63 29.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.993 0.517 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.03 157.24 20.45 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.88 170.67 19.39 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.448 3.432 . . . . 0.0 111.249 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -135.57 150.14 49.62 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.362 0.665 . . . . 0.0 110.48 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.9 p -85.58 147.75 26.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.886 0.474 . . . . 0.0 111.129 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.48 176.72 54.6 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 65.9 tttm -147.25 -49.4 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.926 . . . . 0.0 112.362 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.763 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 97.9 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.138 1.892 . . . . 0.0 111.119 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 112.581 0.185 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -135.79 84.76 2.11 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.044 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.81 148.81 48.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.262 0.625 . . . . 0.0 110.711 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -135.81 156.21 49.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.15 0.58 . . . . 0.0 111.235 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 62.64 116.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.541 1.536 . . . . 0.0 113.201 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.26 27.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.712 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -71.32 153.65 42.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.992 0.425 . . . . 0.0 111.597 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -82.49 163.66 21.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.008 0.523 . . . . 0.0 111.099 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -124.15 154.14 68.36 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.361 0.664 . . . . 0.0 110.481 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.16 172.37 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.001 3.134 . . . . 0.0 112.055 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -79.18 24.32 0.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.617 0.767 . . . . 0.0 111.772 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.73 119.75 17.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -140.49 157.08 69.04 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 122.355 0.262 . . . . 0.0 110.945 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.57 167.09 3.04 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.082 3.188 . . . . 0.0 112.275 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -134.51 42.1 0.75 Allowed Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 87.4 Cg_endo -72.01 -3.75 13.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.278 2.652 . . . . 0.0 112.276 -177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.61 93.68 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.7 p -159.52 164.74 34.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.45 1.1 . . . . 0.0 109.637 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -55.4 104.92 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.613 0.765 . . . . 0.0 110.193 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -113.01 13.64 19.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.703 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t 60.49 170.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 113.552 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t 46.67 44.88 14.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.282 1.433 . . . . 0.0 112.728 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' A' ' 148' ' ' GLY . 94.5 mt -68.86 147.04 97.82 Favored Pre-proline 0 CA--C 1.531 0.222 0 O-C-N 122.028 -0.42 . . . . 0.0 110.744 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.08 142.31 34.19 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.932 3.088 . . . . 0.0 111.052 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.45 -8.9 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.939 3.092 . . . . 0.0 112.823 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -135.26 24.22 3.51 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -136.03 25.36 3.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.764 0.316 . . . . 0.0 110.796 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 29' ' ' LYS . 6.7 tp -137.42 148.46 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.914 0.486 . . . . 0.0 110.572 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' H ' HD12 ' A' ' 28' ' ' ILE . 21.1 tptm -96.21 15.0 22.18 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.644 0.778 . . . . 0.0 112.301 -173.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' H ' HG13 ' A' ' 28' ' ' ILE . 24.6 m -135.38 32.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 O-C-N 121.895 -0.503 . . . . 0.0 111.096 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -78.91 155.12 29.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.476 0.31 . . . . 0.0 110.582 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.1 p -135.52 144.05 46.1 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.834 0.453 . . . . 0.0 111.192 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -135.96 16.55 3.28 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.167 0.587 . . . . 0.0 111.425 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -142.15 141.52 32.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.204 0.602 . . . . 0.0 109.79 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 HG11 ' A' ' 84' ' ' VAL . 58.6 tp -135.2 126.29 27.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -100.7 143.02 31.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.534 0.333 . . . . 0.0 110.695 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.73 102.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.23 164.5 18.15 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.31 72.63 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.019 -0.878 . . . . 0.0 113.77 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -53.59 117.51 12.33 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 118.548 1.174 . . . . 0.0 111.09 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.97 -9.49 25.16 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.373 2.715 . . . . 0.0 112.413 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -135.09 67.84 1.48 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.78 0.832 . . . . 0.0 110.856 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.52 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.608 0.763 . . . . 0.0 112.323 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 42' ' ' LEU . 12.1 tpt -147.87 22.81 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.128 0.571 . . . . 0.0 110.902 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 47' ' ' TRP . 29.0 tptt -145.43 78.63 1.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.35 -20.46 66.12 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.06 -0.4 . . . . 0.0 111.745 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.494 ' CE2' ' HE3' ' A' ' 45' ' ' LYS . 63.9 p-90 -92.09 1.7 57.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.95 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.83 -28.51 28.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.39 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.49 -40.39 85.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.49 65.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.229 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -92.06 -3.41 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.214 0.461 . . . . 0.0 112.142 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.16 -2.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 O-C-N 121.996 -0.44 . . . . 0.0 111.75 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tp -124.95 -6.41 7.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 98.5 mttt -96.01 -29.75 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.286 -0.864 . . . . 0.0 113.284 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.51 -18.66 47.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.427 2.085 . . . . 0.0 114.117 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.66 8.53 3.32 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.75 150.12 28.17 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.597 0.635 . . . . 0.0 110.427 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -87.94 40.06 0.92 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.686 0.394 . . . . 0.0 111.642 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.92 141.34 16.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 O-C-N 122.052 -0.405 . . . . 0.0 109.995 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -135.29 7.83 3.38 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 124.25 25.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.206 0.457 . . . . 0.0 110.789 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.09 130.54 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 123.737 0.815 . . . . 0.0 109.337 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.78 131.73 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.81 119.5 22.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -86.64 104.08 15.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -84.5 18.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.273 0.629 . . . . 0.0 112.049 -173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.6 3.79 3.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.425 0.29 . . . . 0.0 111.588 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -141.18 14.08 2.22 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.95 0.5 . . . . 0.0 111.036 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.1 pttt 44.5 40.7 4.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.727 1.211 . . . . 0.0 112.89 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -127.25 138.5 53.1 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.113 0.565 . . . . 0.0 109.918 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.77 147.0 48.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.752 0.31 . . . . 0.0 111.187 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.86 144.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.5 156.69 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.09 139.39 44.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.58 154.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 126.284 1.834 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.2 15.41 17.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 t -155.91 137.63 14.26 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.055 0.542 . . . . 0.0 110.35 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -68.06 -11.4 58.95 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -81.39 -17.37 49.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.797 -0.564 . . . . 0.0 110.706 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -90.98 -23.13 20.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.02 -22.09 56.16 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -82.51 -21.59 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -78.04 -20.47 52.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.074 -0.391 . . . . 0.0 110.559 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 35' ' ' LEU . 71.8 t -81.58 -40.14 17.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.458 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.8 -18.36 60.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.243 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -82.29 -19.2 39.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.999 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -79.09 -26.01 43.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -84.15 -8.85 58.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.952 0.501 . . . . 0.0 111.409 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -127.24 12.19 7.05 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.94 10.06 3.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.397 0.544 . . . . 0.0 112.459 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -122.77 -20.02 6.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.531 0.605 . . . . 0.0 111.353 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.93 9.73 5.85 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.038 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.3 43.78 2.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.851 1.326 . . . . 0.0 112.26 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.36 119.78 26.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.52 -8.28 12.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.8 3.0 . . . . 0.0 111.404 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.04 138.96 50.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.996 0.519 . . . . 0.0 111.113 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -95.29 84.68 4.09 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.1 p -79.58 122.64 26.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.464 0.705 . . . . 0.0 110.872 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -140.61 118.3 11.65 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.121 0.568 . . . . 0.0 110.281 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -86.83 155.29 20.34 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.673 0.389 . . . . 0.0 111.359 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.78 -171.74 37.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -135.95 136.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.381 0.672 . . . . 0.0 110.338 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.07 135.99 13.33 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -106.52 44.7 1.03 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.678 0.791 . . . . 0.0 110.515 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.23 -167.99 52.76 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.4 -5.53 17.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.024 3.149 . . . . 0.0 112.237 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.33 134.78 34.9 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.666 0.387 . . . . 0.0 110.653 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.064 0.546 . . . . 0.0 110.022 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.7 m -135.05 26.81 3.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.365 0.666 . . . . 0.0 110.41 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.19 133.04 44.9 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.59 0.356 . . . . 0.0 110.875 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -135.93 147.31 48.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.486 0.714 . . . . 0.0 109.552 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -72.72 -4.09 29.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -93.66 5.83 50.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.375 0.534 . . . . 0.0 110.001 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -136.44 24.98 3.19 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.282 0.633 . . . . 0.0 111.067 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.11 -5.98 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.74 -1.033 . . . . 0.0 115.32 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -84.2 58.61 4.87 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.558 1.679 . . . . 0.0 110.691 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -135.21 149.01 49.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.258 0.623 . . . . 0.0 110.486 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.0 pt -116.68 24.89 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.479 0.712 . . . . 0.0 110.681 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 17.6 tt -68.19 145.15 97.41 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 123.05 0.54 . . . . 0.0 109.944 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 52.1 Cg_exo -57.75 177.56 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.844 3.029 . . . . 0.0 112.801 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -71.67 24.11 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.603 -0.685 . . . . 0.0 110.909 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -87.08 -8.04 57.45 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 tp -103.66 -39.32 6.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.593 0.757 . . . . 0.0 109.262 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -70.61 -26.58 63.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.74 -45.55 9.22 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 117.915 0.325 . . . . 0.0 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.23 -10.95 59.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.923 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -106.7 -24.44 12.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.451 0.569 . . . . 0.0 111.275 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.03 -16.71 59.9 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.267 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 94.8 mttt -85.15 -55.56 3.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -86.6 11.67 12.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.4 t -137.37 -21.97 1.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.57 19.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.855 1.207 . . . . 0.0 114.117 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 13.0 t -101.95 37.55 1.83 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.313 0.96 . . . . 0.0 110.888 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.32 19.69 3.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -152.79 -41.32 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -136.41 13.01 3.25 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.86 15.08 66.43 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.425 0.557 . . . . 0.0 112.865 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.35 -176.58 41.92 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.74 0.77 . . . . 0.0 112.542 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 25.2 m 64.26 107.85 0.03 OUTLIER 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.895 1.278 . . . . 0.0 111.831 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t 60.74 31.7 20.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.989 0.915 . . . . 0.0 112.18 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.13 -29.77 24.54 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.643 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -152.23 165.44 17.49 Favored Pre-proline 0 C--N 1.34 0.158 0 CA-C-N 117.96 0.88 . . . . 0.0 110.052 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.6 -1.97 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.259 3.306 . . . . 0.0 114.622 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.52 -10.01 59.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.63 21.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.228 -0.065 0 C-N-CA 123.06 0.544 . . . . 0.0 112.455 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.2 p -135.53 -8.75 2.19 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 122.237 -0.29 . . . . 0.0 111.089 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -88.32 -31.05 14.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 149' ' ' ILE . 4.3 mp -81.03 64.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 23.1 m -122.26 19.86 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.229 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -135.58 141.54 45.17 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.85 77.51 2.77 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.974 -174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -141.73 122.09 8.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 166.82 27.53 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.613 2.875 . . . . 0.0 111.632 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.38 35.12 2.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 110.306 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 158' ' ' VAL . 10.4 tp -78.17 145.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.493 0.317 . . . . 0.0 110.162 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.0 pt -123.45 20.5 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.744 0.417 . . . . 0.0 111.616 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.448 ' H ' HG13 ' A' ' 156' ' ' ILE . 35.9 m -138.62 151.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.915 0.886 . . . . 0.0 109.564 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -73.66 158.84 52.69 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -135.09 104.89 6.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.7 39.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.76 147.18 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.116 0.567 . . . . 0.0 110.493 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 79.1 p -80.74 159.4 25.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.024 0.53 . . . . 0.0 111.018 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.7 p -129.08 150.38 50.5 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.27 0.628 . . . . 0.0 110.333 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -135.29 117.93 15.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.122 0.569 . . . . 0.0 110.076 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.89 149.86 26.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.873 0.469 . . . . 0.0 110.292 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 34.7 pt -131.63 146.65 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 C-N-CA 123.177 0.591 . . . . 0.0 110.304 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.7 m -135.54 151.95 50.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.286 0.634 . . . . 0.0 110.531 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -133.28 140.47 47.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 109.574 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.38 147.21 38.19 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.558 0.343 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 47.8 tpp -146.57 64.12 9.17 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.197 0.599 . . . . 0.0 109.567 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.65 165.02 33.82 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.783 2.989 . . . . 0.0 111.187 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.6 t -135.59 149.42 49.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.271 0.628 . . . . 0.0 110.342 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -135.29 26.47 3.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.195 0.598 . . . . 0.0 110.293 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.4 t -77.52 104.53 8.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.51 0.324 . . . . 0.0 110.146 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.87 -175.43 50.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -135.48 141.65 45.38 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 123.315 0.646 . . . . 0.0 110.296 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -137.72 147.2 44.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.137 0.575 . . . . 0.0 110.093 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.79 167.24 39.73 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.92 163.22 38.98 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.087 3.191 . . . . 0.0 111.197 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -81.54 125.99 31.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.2 p -59.2 147.14 36.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.037 0.535 . . . . 0.0 111.463 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.11 174.66 43.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.74 159.03 84.1 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.904 0.482 . . . . 0.0 110.782 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.006 3.138 . . . . 0.0 112.413 178.595 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.471 0.187 0 N-CA-C 112.772 0.258 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.67 136.98 41.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.916 0.486 . . . . 0.0 110.416 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -135.95 142.42 44.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 110.294 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.74 143.24 50.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 109.945 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.08 66.25 8.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.29 148.47 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.587 0.755 . . . . 0.0 110.022 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -109.67 139.47 44.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.841 0.456 . . . . 0.0 110.756 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -135.3 145.23 47.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.699 0.799 . . . . 0.0 109.224 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -70.98 146.58 93.1 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.146 0.179 . . . . 0.0 111.42 -175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.58 176.23 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 124.43 3.42 . . . . 0.0 110.634 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -131.62 24.36 4.73 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.927 0.491 . . . . 0.0 110.797 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -139.01 68.09 1.38 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.929 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -134.28 155.81 79.55 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.821 0.848 . . . . 0.0 110.291 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.77 171.38 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.901 3.067 . . . . 0.0 110.647 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.91 152.49 44.92 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 122.948 0.499 . . . . 0.0 110.957 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.28 -175.66 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.255 3.303 . . . . 0.0 110.104 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.76 93.79 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -142.57 141.9 32.09 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.865 0.866 . . . . 0.0 109.297 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.45 101.32 0.96 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.176 0.512 . . . . 0.0 110.636 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -135.59 156.59 48.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.849 0.859 . . . . 0.0 109.834 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -77.0 108.19 9.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.635 0.374 . . . . 0.0 111.271 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.1 m 63.3 99.79 0.03 OUTLIER 'General case' 0 C--N 1.339 0.118 0 C-N-CA 125.081 1.352 . . . . 0.0 112.055 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' HB2' ' HD3' ' A' ' 24' ' ' PRO . 4.0 mm? -85.93 -72.59 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 23' ' ' LEU . 25.2 Cg_endo -86.42 165.67 9.37 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.136 2.557 . . . . 0.0 111.047 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.96 -46.08 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.004 2.47 . . . . 0.0 111.796 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -155.42 24.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -103.85 47.81 0.87 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.143 0.497 . . . . 0.0 110.513 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.551 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.2 tp -140.32 151.48 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.03 0.532 . . . . 0.0 110.227 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' H ' HD12 ' A' ' 28' ' ' ILE . 35.7 mmtp -118.54 27.39 8.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.305 0.642 . . . . 0.0 111.526 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 28' ' ' ILE . 31.7 t -126.78 -24.25 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.62 25.12 0.59 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.525 0.602 . . . . 0.0 112.482 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.5 t -66.99 129.62 40.47 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 121.871 -0.518 . . . . 0.0 111.169 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -135.58 104.41 5.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.618 0.767 . . . . 0.0 109.103 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 p -135.56 166.0 24.23 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.63 129.0 49.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -97.33 139.75 32.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.687 0.28 . . . . 0.0 111.666 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.2 mm -125.87 139.3 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.422 1.089 . . . . 0.0 108.544 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.7 163.58 29.35 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.98 79.36 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.53 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.78 124.59 51.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.091 0.945 . . . . 0.0 111.294 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -82.57 -3.61 11.37 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.434 2.756 . . . . 0.0 110.867 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.78 153.68 43.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 110.453 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.13 46.08 0.99 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.499 0.72 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.2 mmt 54.3 54.92 8.79 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.114 0.966 . . . . 0.0 111.982 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.2 118.07 25.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -70.49 -16.98 62.96 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -84.88 -6.46 59.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.017 -0.427 . . . . 0.0 111.468 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.6 -23.11 19.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.527 0.603 . . . . 0.0 110.141 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.58 -28.21 56.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.15 -21.27 46.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.292 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -79.46 -12.4 59.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.924 0.329 . . . . 0.0 111.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.85 -2.84 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.114 -0.367 . . . . 0.0 111.596 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.87 13.39 24.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.794 0.838 . . . . 0.0 109.857 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 88.5 tttt -78.17 -38.82 1.67 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.11 170.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 51.0 Cg_exo -59.87 118.76 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.678 2.252 . . . . 0.0 112.332 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 50.29 22.99 1.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.075 1.35 . . . . 0.0 113.661 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.49 162.27 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.0 110.453 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -135.07 59.41 1.73 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.789 0.436 . . . . 0.0 110.515 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.92 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 O-C-N 121.904 -0.497 . . . . 0.0 109.691 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -134.78 11.13 3.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 m -135.35 122.0 20.83 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.8 t -135.2 128.1 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.396 0.678 . . . . 0.0 109.229 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.91 104.37 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.14 112.72 25.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.637 0.375 . . . . 0.0 110.187 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -85.94 105.37 16.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.145 0.498 . . . . 0.0 109.777 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -71.59 162.86 28.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.986 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m 61.51 11.09 3.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -148.76 22.24 1.0 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.103 0.41 . . . . 0.0 111.666 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 35.08 45.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.103 1.761 . . . . 0.0 114.744 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -128.97 143.66 50.94 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.91 152.88 39.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.063 0.459 . . . . 0.0 111.437 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -122.56 131.86 54.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.2 151.47 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.37 139.53 44.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.347 0.594 . . . . 0.0 111.733 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.72 153.38 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 125.597 1.559 . . . . 0.0 109.496 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -89.96 9.53 27.48 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -152.57 137.09 16.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.312 0.645 . . . . 0.0 109.792 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -78.74 -4.01 47.11 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -88.04 -23.4 23.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.959 0.345 . . . . 0.0 110.334 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.68 -18.28 33.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.26 72.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.62 -22.45 61.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.393 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -80.06 -17.42 52.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.393 0.542 . . . . 0.0 111.501 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.46 -38.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.456 0.571 . . . . 0.0 110.002 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.55 -17.71 61.16 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.194 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -83.46 -15.3 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.892 -0.505 . . . . 0.0 110.072 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.05 -28.01 39.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.61 -7.0 59.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.124 0.57 . . . . 0.0 110.591 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.37 10.45 9.23 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -135.28 6.55 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.28 0.491 . . . . 0.0 112.119 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.48 -24.32 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.828 -0.545 . . . . 0.0 110.784 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.48 4.93 3.16 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 118.938 -0.923 . . . . 0.0 114.967 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.64 24.85 3.41 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.956 1.378 . . . . 0.0 112.976 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.56 135.21 43.75 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -6.36 12.19 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 124.094 3.196 . . . . 0.0 112.173 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.96 140.67 30.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -92.19 89.97 7.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.0 p -95.25 129.8 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.964 0.505 . . . . 0.0 111.099 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -146.38 148.43 32.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.901 0.48 . . . . 0.0 110.678 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.47 146.34 48.85 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.178 0.591 . . . . 0.0 111.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.36 16.83 5.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.994 0.807 . . . . 0.0 111.293 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.85 137.57 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 117.364 0.582 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.9 134.6 12.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -135.16 107.15 7.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.299 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.5 -177.33 51.09 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.82 161.88 44.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.92 3.08 . . . . 0.0 110.677 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -78.64 141.11 38.26 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.627 0.371 . . . . 0.0 110.65 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -135.42 134.79 40.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.395 0.678 . . . . 0.0 109.801 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.6 m -129.3 24.48 5.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.8 m 53.23 50.53 17.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.709 0.803 . . . . 0.0 112.033 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.32 145.33 47.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.041 0.537 . . . . 0.0 109.936 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -80.3 -3.15 48.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -70.51 -7.67 45.38 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.91 -0.494 . . . . 0.0 110.32 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -135.33 12.43 3.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.576 0.75 . . . . 0.0 109.782 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.75 -21.37 50.91 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -94.76 24.94 4.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.726 172.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 t -135.61 -179.14 5.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.73 1.212 . . . . 0.0 109.577 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.0 mt -50.85 127.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.324 0.65 . . . . 0.0 110.148 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt -89.63 165.2 26.29 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.584 0.754 . . . . 0.0 111.619 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.11 -169.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 124.849 3.7 . . . . 0.0 112.815 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -73.63 43.31 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.836 0.854 . . . . 0.0 112.43 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -85.19 -7.91 58.83 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.807 -0.558 . . . . 0.0 110.042 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -77.01 -4.11 42.48 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.0 tp -71.21 -45.71 62.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.663 0.785 . . . . 0.0 109.733 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.6 p -84.99 -22.28 29.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.613 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -81.4 -48.58 11.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.234 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.97 -4.61 54.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.68 -29.25 8.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.135 0.88 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -76.64 -21.28 55.7 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.143 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 130' ' ' LYS . 3.8 ttmp? -85.31 -50.61 7.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -91.26 14.93 13.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -135.91 -21.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.32 30.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.196 0.907 . . . . 0.0 113.372 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.7 t -77.21 50.12 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.784 0.72 . . . . 0.0 110.671 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.47 126.08 16.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.872 0.869 . . . . 0.0 108.941 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.96 -174.52 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.872 0.469 . . . . 0.0 111.703 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -73.85 43.0 0.15 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.27 1.028 . . . . 0.0 112.227 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.08 -154.5 7.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.816 0.722 . . . . 0.0 111.834 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.08 -8.42 75.91 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.771 -0.461 . . . . 0.0 112.486 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.1 m -135.57 -17.28 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.426 0.613 . . . . 0.0 111.798 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -148.43 24.17 1.01 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.8 0.44 . . . . 0.0 111.107 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.41 -34.49 7.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.469 -0.629 . . . . 0.0 113.538 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -149.93 164.35 21.1 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.924 . . . . 0.0 110.124 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.81 6.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 124.916 3.744 . . . . 0.0 115.162 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.18 -12.4 58.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.684 0.674 . . . . 0.0 110.595 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.54 19.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.499 0.72 . . . . 0.0 111.846 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.8 p -119.06 20.56 12.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.276 0.23 . . . . 0.0 111.328 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.46 -25.33 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.812 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.06 81.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 117.962 0.881 . . . . 0.0 109.696 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.7 m -112.8 22.46 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 123.668 0.787 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -87.35 -43.79 11.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -143.51 156.81 44.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.121 0.568 . . . . 0.0 110.575 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -143.01 58.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.95 161.02 47.51 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.691 2.928 . . . . 0.0 111.318 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.87 104.47 16.63 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 153.32 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 110.157 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.52 145.42 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-O 120.702 0.287 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.6 m -135.17 24.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.338 0.655 . . . . 0.0 110.764 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -71.37 -11.58 71.81 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -131.08 29.62 4.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.109 0.964 . . . . 0.0 109.351 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -70.13 174.21 37.76 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.74 139.04 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 123.138 0.575 . . . . 0.0 110.23 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.3 m -104.72 144.48 31.67 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.159 0.583 . . . . 0.0 110.433 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.0 t -135.62 144.07 45.91 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.108 0.563 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.98 46.16 1.35 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.342 0.657 . . . . 0.0 110.356 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.81 143.48 45.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.5 0.72 . . . . 0.0 110.03 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.22 138.71 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 123.509 0.724 . . . . 0.0 109.365 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -70.29 137.96 51.16 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.801 0.44 . . . . 0.0 110.944 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.3 149.02 49.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.329 0.652 . . . . 0.0 110.218 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -135.15 151.11 50.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.508 0.723 . . . . 0.0 110.135 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.3 ttm -144.39 137.23 13.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.96 169.9 21.07 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 111.343 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.8 p -133.39 152.01 51.88 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.371 0.669 . . . . 0.0 110.303 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -122.53 24.67 9.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.308 0.643 . . . . 0.0 111.267 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.3 t -135.48 134.03 39.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.234 0.614 . . . . 0.0 110.116 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 177.56 -163.97 32.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.36 141.42 58.57 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.1 0.45 . . . . 0.0 110.267 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -85.82 155.39 21.01 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.942 0.497 . . . . 0.0 111.769 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.58 26.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.44 151.89 65.32 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.756 2.971 . . . . 0.0 112.486 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -140.3 146.82 39.02 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.386 0.675 . . . . 0.0 110.23 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.3 t -135.94 141.62 44.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.927 0.491 . . . . 0.0 110.613 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 173.45 173.6 39.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.97 140.37 35.04 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 122.841 0.456 . . . . 0.0 109.787 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.719 2.946 . . . . 0.0 112.568 177.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 CA--C 1.528 0.206 0 N-CA-C 113.125 0.394 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -135.48 24.61 3.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.002 0.521 . . . . 0.0 111.012 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -88.12 146.14 25.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.229 0.612 . . . . 0.0 110.287 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 4' ' ' LEU . 1.7 pt? -135.18 24.28 3.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.939 0.495 . . . . 0.0 111.905 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -91.63 106.05 18.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.84 25.0 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.203 0.601 . . . . 0.0 110.93 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 t -76.44 109.12 9.9 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.528 0.331 . . . . 0.0 110.267 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -136.66 129.8 31.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.322 0.649 . . . . 0.0 109.677 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -140.84 147.34 47.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 122.953 0.501 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.12 161.91 37.66 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.812 3.008 . . . . 0.0 111.18 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -135.68 24.92 3.4 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.403 0.681 . . . . 0.0 110.204 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -136.06 161.13 36.56 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.943 0.897 . . . . 0.0 110.534 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.06 148.09 67.58 Favored Pre-proline 0 CA--C 1.529 0.159 0 C-N-CA 123.026 0.53 . . . . 0.0 110.088 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.01 6.42 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.403 3.402 . . . . 0.0 113.228 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.0 149.25 70.38 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 118.588 0.631 . . . . 0.0 111.707 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.28 -167.17 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.809 3.672 . . . . 0.0 110.423 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG21 ' HB ' ' A' ' 146' ' ' VAL . 46.9 t -50.68 -53.09 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.129 0.572 . . . . 0.0 110.855 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.8 m -146.27 157.59 43.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.854 0.862 . . . . 0.0 109.479 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -86.82 53.45 2.83 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.81 0.444 . . . . 0.0 110.505 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 p30 46.81 31.58 1.5 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.912 1.285 . . . . 0.0 113.002 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 t -135.59 151.08 49.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.246 0.619 . . . . 0.0 110.883 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 m 60.36 55.04 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.115 0.966 . . . . 0.0 111.19 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.32 155.47 63.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.37 164.36 34.44 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.825 3.016 . . . . 0.0 110.905 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.96 -8.14 22.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.756 2.97 . . . . 0.0 111.517 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.78 134.1 33.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.054 0.542 . . . . 0.0 109.702 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -74.14 155.02 38.85 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.852 0.461 . . . . 0.0 111.513 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.62 HD13 ' H ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.52 159.91 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.62 ' H ' HD13 ' A' ' 28' ' ' ILE . 55.9 mtpt -86.68 16.13 5.02 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.491 ' H ' HG23 ' A' ' 28' ' ' ILE . 22.1 m -135.8 29.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 122.835 0.454 . . . . 0.0 110.734 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -135.66 133.36 38.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.027 0.531 . . . . 0.0 110.515 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.7 t -137.62 125.75 22.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.322 0.649 . . . . 0.0 109.329 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.97 139.43 39.17 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.8 p -135.75 152.57 51.26 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.26 1.024 . . . . 0.0 109.644 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.6 tp -135.47 112.19 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.43 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -86.56 135.91 33.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.854 0.862 . . . . 0.0 110.302 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.42 143.05 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.23 166.59 36.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.86 66.76 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.176 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.3 m -52.93 134.83 47.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.789 0.794 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -83.93 -12.25 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.198 3.265 . . . . 0.0 111.362 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.87 166.23 20.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.031 0.932 . . . . 0.0 111.105 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.9 44.56 0.66 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.258 0.623 . . . . 0.0 111.511 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.6 mtt 49.34 55.27 9.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.232 1.013 . . . . 0.0 112.194 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -122.59 132.98 54.54 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.218 0.607 . . . . 0.0 109.443 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -70.74 -10.1 58.72 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -99.64 -11.88 20.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.983 0.356 . . . . 0.0 111.952 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -96.19 -22.93 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.81 -39.67 63.93 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.81 -17.41 61.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.932 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -81.99 -14.38 56.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.616 0.644 . . . . 0.0 111.842 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.4 m -110.26 -4.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 118.227 0.467 . . . . 0.0 111.78 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -126.14 6.17 7.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -171.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 1.1 tmmt? -101.32 -38.61 0.22 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.929 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 61.9 Cg_exo -55.16 131.78 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.261 1.974 . . . . 0.0 111.182 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 p90 46.83 27.48 0.7 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 113.047 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.65 170.46 15.97 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.909 0.883 . . . . 0.0 110.274 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -135.07 55.13 1.9 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 110.957 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.08 130.14 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -123.35 4.16 9.11 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -140.84 121.34 14.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -135.75 120.22 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 136.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.31 110.77 9.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -83.55 104.38 13.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -84.21 25.81 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.0 p -131.86 3.85 4.13 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 25.3 0.56 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.998 0.363 . . . . 0.0 111.928 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.3 pttt 45.93 47.12 12.48 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.692 1.197 . . . . 0.0 112.37 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -124.94 129.94 51.36 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.275 0.63 . . . . 0.0 110.277 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.21 147.53 49.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.317 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.3 136.6 35.04 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.666 0.386 . . . . 0.0 110.082 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.57 159.7 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 122.323 0.249 . . . . 0.0 110.739 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.55 132.0 34.6 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.945 0.402 . . . . 0.0 111.513 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -101.1 154.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 124.383 1.073 . . . . 0.0 109.23 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -81.1 -4.62 55.9 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.1 t -147.01 139.08 24.51 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.726 0.41 . . . . 0.0 110.712 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -78.69 -5.84 54.17 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -90.0 -22.05 22.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.64 -15.36 45.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.28 -42.11 60.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.3 -22.49 66.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -81.25 -22.49 38.69 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.103 -0.373 . . . . 0.0 111.093 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.53 -38.65 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.88 -18.39 63.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.912 173.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -77.73 -23.12 49.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.302 0.501 . . . . 0.0 109.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -72.78 -49.64 29.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.877 -0.514 . . . . 0.0 109.614 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -89.47 10.16 23.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -135.65 6.57 3.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.356 0.526 . . . . 0.0 112.284 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -136.96 7.16 2.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.539 0.608 . . . . 0.0 112.396 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.12 -18.95 15.33 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.6 0.636 . . . . 0.0 110.909 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.58 4.55 4.1 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.337 0.97 . . . . 0.0 115.172 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.8 35.14 2.88 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.009 1.405 . . . . 0.0 112.745 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.83 127.94 23.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -84.85 -10.44 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.087 3.191 . . . . 0.0 112.61 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 97' ' ' ARG . 1.6 tt -73.37 134.97 44.22 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 96' ' ' LEU . 82.2 mmt-85 -111.64 136.88 50.24 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -141.65 145.2 34.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.042 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -143.34 126.78 16.79 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.29 0.636 . . . . 0.0 110.257 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -85.84 156.74 20.43 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.14 -164.97 14.72 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.13 136.76 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.988 0.515 . . . . 0.0 110.452 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.92 130.43 10.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -135.77 151.89 50.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.473 0.709 . . . . 0.0 110.381 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.76 174.76 35.48 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.33 161.06 46.33 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.777 2.985 . . . . 0.0 110.994 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -69.69 133.27 47.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.783 0.433 . . . . 0.0 110.127 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -86.12 104.52 15.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 110.695 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.8 m -135.07 28.53 3.46 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.692 0.797 . . . . 0.0 110.321 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 74.8 m -74.23 148.21 41.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.056 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.91 154.06 42.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -68.42 -9.66 49.98 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.214 -0.304 . . . . 0.0 111.777 -176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.68 -2.26 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.036 0.38 . . . . 0.0 110.314 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -142.55 24.25 1.91 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -154.46 -0.6 0.16 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.971 -0.905 . . . . 0.0 113.964 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -80.02 55.15 2.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.105 1.453 . . . . 0.0 110.055 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.8 t -138.74 151.08 46.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.083 0.953 . . . . 0.0 109.847 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.9 pt -93.9 28.21 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 122.952 0.501 . . . . 0.0 111.646 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 9.5 tp -84.52 -25.15 0.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.09 -0.957 . . . . 0.0 113.551 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 31.8 Cg_exo -63.96 176.26 2.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.46 2.107 . . . . 0.0 111.828 174.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -74.15 24.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.833 0.453 . . . . 0.0 111.507 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -91.29 -7.6 50.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.17 -9.21 59.71 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.82 -46.88 11.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.992 0.917 . . . . 0.0 109.503 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -77.68 -16.07 58.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.968 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.96 -43.94 12.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.103 -0.373 . . . . 0.0 111.401 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.21 -12.09 53.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.59 -24.32 11.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.679 0.672 . . . . 0.0 111.189 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -74.81 -22.68 58.6 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.544 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -90.35 -52.73 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.952 -0.467 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -83.16 7.23 16.68 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -143.94 -4.32 0.84 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.78 23.18 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.16 0.891 . . . . 0.0 111.851 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.7 t -84.9 32.86 0.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.624 -0.672 . . . . 0.0 111.374 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.07 20.6 3.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.023 0.529 . . . . 0.0 110.241 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -135.92 147.25 48.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.756 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -65.91 104.8 1.17 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.51 65.42 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.947 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 61.71 -148.26 47.6 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 118.18 0.99 . . . . 0.0 110.787 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.4 m 70.77 114.93 0.05 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.021 0.928 . . . . 0.0 111.507 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.6 t 59.22 31.01 20.87 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.62 -18.59 44.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -149.68 160.02 34.94 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 108.959 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.66 -10.83 10.07 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.661 2.908 . . . . 0.0 113.682 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.13 -36.63 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.786 0.434 . . . . 0.0 111.24 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' HB ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -84.98 -8.32 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 O-C-N 122.045 -0.409 . . . . 0.0 110.682 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -83.09 24.02 0.81 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.093 0.473 . . . . 0.0 109.86 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.99 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.57 -44.51 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 117.559 0.679 . . . . 0.0 109.896 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.4 m 43.63 24.5 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.204 1.802 . . . . 0.0 114.221 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -72.55 159.26 34.19 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.119 -0.363 . . . . 0.0 110.133 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -73.24 -75.09 0.15 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.272 0.229 . . . . 0.0 111.586 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -159.52 123.96 2.14 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.92 -176.61 3.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.064 3.176 . . . . 0.0 110.865 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.31 148.18 42.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 tt -64.81 134.85 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -175.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.8 tp -135.8 104.87 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.675 0.79 . . . . 0.0 109.328 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.44 24.34 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.828 0.451 . . . . 0.0 111.322 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 67.61 -166.5 42.62 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 145.9 47.84 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.389 0.676 . . . . 0.0 110.264 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -179.31 172.14 44.1 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.92 144.74 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.289 0.636 . . . . 0.0 110.222 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.7 t -92.94 133.0 36.55 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.724 0.409 . . . . 0.0 110.412 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.6 m -135.84 146.45 47.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.267 0.627 . . . . 0.0 110.502 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -135.16 142.01 46.04 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.351 0.661 . . . . 0.0 110.164 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.95 143.26 32.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.734 0.414 . . . . 0.0 110.751 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.2 161.84 39.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.438 0.695 . . . . 0.0 111.016 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.0 m -75.82 147.84 38.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.951 0.5 . . . . 0.0 110.745 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -135.01 142.07 46.34 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.104 0.561 . . . . 0.0 110.334 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -86.74 55.13 3.42 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.333 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 172' ' ' PRO . 16.0 tpt -70.53 -42.73 15.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.453 -0.784 . . . . 0.0 112.891 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 171' ' ' MET . 93.7 Cg_endo -76.25 158.87 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.958 1.772 . . . . 0.0 110.948 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 67.0 p -135.68 151.74 50.5 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 123.375 0.67 . . . . 0.0 110.367 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.57 104.98 6.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.868 0.467 . . . . 0.0 110.129 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.8 p -135.96 151.58 50.09 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.458 0.703 . . . . 0.0 110.591 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 176.18 -1.82 0.03 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.106 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 23.2 tpp85 -76.56 113.95 14.75 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.189 0.995 . . . . 0.0 110.024 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -135.94 148.44 48.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.417 0.687 . . . . 0.0 109.786 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.42 166.75 50.64 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.07 161.34 45.0 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.003 3.136 . . . . 0.0 111.219 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -135.88 55.21 1.87 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.293 0.637 . . . . 0.0 109.64 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.8 m -73.68 104.85 4.75 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.9 0.48 . . . . 0.0 110.322 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.24 175.48 36.7 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.3 mptm? -89.99 -35.65 0.4 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.184 -0.912 . . . . 0.0 112.601 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 65.2 Cg_exo . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.093 2.529 . . . . 0.0 112.545 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.471 0.204 0 CA-C-O 120.6 0.167 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.44 39.99 1.02 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.209 0.604 . . . . 0.0 110.849 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -135.37 132.43 37.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.225 0.61 . . . . 0.0 110.148 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.69 148.6 30.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.843 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -135.27 125.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.967 0.507 . . . . 0.0 109.862 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.71 32.83 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.888 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 m -78.2 55.14 1.47 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.313 0.645 . . . . 0.0 111.032 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -67.49 140.79 57.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.023 0.529 . . . . 0.0 110.293 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.35 152.18 45.63 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.196 0.598 . . . . 0.0 109.927 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.76 158.53 52.99 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.615 2.877 . . . . 0.0 111.547 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -135.96 145.98 46.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.539 0.736 . . . . 0.0 110.099 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -72.56 141.69 48.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 6.6 ppt_? -147.59 157.89 43.98 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 122.986 0.514 . . . . 0.0 110.243 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 72.0 Cg_endo -70.01 172.04 13.63 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.681 2.921 . . . . 0.0 112.358 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -62.94 149.46 90.17 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -84.88 174.37 7.5 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 124.056 3.171 . . . . 0.0 113.612 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.3 -17.39 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 109.652 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 m -148.92 -174.81 4.73 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.065 1.346 . . . . 0.0 109.186 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -82.52 48.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.114 0.565 . . . . 0.0 111.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -119.78 152.1 37.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.412 0.685 . . . . 0.0 109.842 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -127.96 24.67 6.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.3 m -102.47 44.96 0.98 Allowed 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 9.3 mp -103.07 16.24 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 23' ' ' LEU . 84.7 Cg_exo -49.49 147.49 12.64 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 122.368 1.882 . . . . 0.0 111.532 172.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 77.9 Cg_exo -51.83 113.19 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.861 3.041 . . . . 0.0 113.582 -173.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 14.1 t70 -152.0 154.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.161 0.984 . . . . 0.0 108.594 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -82.26 0.74 40.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.6 tp -154.62 139.03 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.118 0.872 . . . . 0.0 111.815 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 26' ' ' ASP . 32.1 mmtp -138.57 43.48 2.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.552 0.741 . . . . 0.0 110.769 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.66 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.085 0.554 . . . . 0.0 109.733 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.95 140.21 29.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.819 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.6 m -131.32 24.99 4.85 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.464 0.706 . . . . 0.0 110.774 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -99.56 133.71 43.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 m -135.23 142.54 46.01 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.022 0.529 . . . . 0.0 109.646 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.32 127.91 41.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.55 141.21 38.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.056 0.542 . . . . 0.0 110.475 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.9 mm -123.04 147.68 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.337 1.055 . . . . 0.0 108.899 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.03 164.21 36.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.534 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.55 27.04 70.3 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.96 128.87 85.38 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.338 0.569 . . . . 0.0 112.146 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -80.9 -1.81 11.44 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.934 3.089 . . . . 0.0 111.166 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.88 162.4 29.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.067 0.547 . . . . 0.0 110.97 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -80.1 38.14 0.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.03 0.932 . . . . 0.0 112.169 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.1 mtt 56.92 44.67 22.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.0 113.125 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.14 137.88 46.43 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.186 0.594 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -72.93 -12.07 60.82 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -84.12 -7.37 59.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.149 -0.344 . . . . 0.0 110.943 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -93.56 -24.29 18.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.881 0.309 . . . . 0.0 110.312 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.87 -28.72 55.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.99 -21.37 47.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -81.34 -14.55 57.16 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.245 0.475 . . . . 0.0 111.701 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.1 -4.47 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.252 0.478 . . . . 0.0 111.459 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.2 8.29 23.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.672 0.789 . . . . 0.0 110.371 170.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 59.3 tptt -72.59 -44.8 9.6 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.8 Cg_endo -84.12 -20.65 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.266 1.978 . . . . 0.0 114.546 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -142.98 24.51 1.83 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.46 165.69 27.82 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.905 -0.497 . . . . 0.0 111.105 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.32 55.36 1.22 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.358 0.663 . . . . 0.0 109.548 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.9 140.58 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.075 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -131.44 -0.12 4.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -143.55 134.41 25.33 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.751 -0.593 . . . . 0.0 110.734 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.0 t -137.96 130.05 39.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.421 0.688 . . . . 0.0 109.829 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 111.11 14.08 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.3 0.24 . . . . 0.0 110.37 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -88.99 88.7 7.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -76.87 24.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.559 0.744 . . . . 0.0 112.474 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.7 p -128.24 5.96 5.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -144.16 14.99 1.68 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.972 0.509 . . . . 0.0 110.606 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 52.88 31.44 10.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.325 1.05 . . . . 0.0 112.185 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -133.69 149.82 51.53 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 122.965 0.506 . . . . 0.0 110.817 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.73 158.2 43.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.12 0.568 . . . . 0.0 110.114 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -130.15 138.72 50.78 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.82 153.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.313 0.101 . . . . 0.0 110.736 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -125.23 130.39 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.081 0.467 . . . . 0.0 111.727 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.11 150.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.705 1.602 . . . . 0.0 108.565 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -109.03 24.15 13.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -145.43 121.84 10.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.14 0.976 . . . . 0.0 108.73 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -78.85 -9.14 59.38 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.478 -0.139 . . . . 0.0 111.094 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -84.89 -24.42 28.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -88.68 -14.43 37.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.59 -42.78 64.19 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -74.08 -16.2 61.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.185 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -83.31 -17.89 40.9 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.069 -0.394 . . . . 0.0 110.78 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.3 t -73.69 -47.43 44.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.05 -16.88 63.8 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.757 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.48 -44.86 66.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.72 -26.14 30.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.789 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -81.78 0.11 40.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.114 0.415 . . . . 0.0 111.025 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.17 5.37 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.094 0.406 . . . . 0.0 111.968 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -143.27 24.1 1.8 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.91 -8.74 14.48 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.62 -0.675 . . . . 0.0 111.182 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.51 2.55 4.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.082 -0.843 . . . . 0.0 114.708 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.75 26.14 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.735 1.268 . . . . 0.0 112.482 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt -131.22 96.51 21.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.86 -0.78 11.04 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.998 3.132 . . . . 0.0 111.346 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.41 125.06 23.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.52 0.728 . . . . 0.0 109.268 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -89.75 126.68 35.76 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.469 0.308 . . . . 0.0 110.797 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 m -136.4 137.9 40.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.402 0.681 . . . . 0.0 110.247 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -141.37 144.64 34.63 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.113 0.965 . . . . 0.0 109.087 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -102.65 130.48 49.57 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.545 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.5 156.7 21.19 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.2 138.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.459 0.704 . . . . 0.0 110.205 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 127.36 7.9 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -89.36 136.15 33.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.751 0.421 . . . . 0.0 110.851 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.29 179.01 53.62 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.95 170.98 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.671 3.581 . . . . 0.0 112.385 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.25 24.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.011 0.525 . . . . 0.0 111.402 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -135.41 26.18 3.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.314 1.046 . . . . 0.0 109.751 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.3 t -85.75 45.16 1.17 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.657 0.783 . . . . 0.0 110.651 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.66 109.38 10.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.368 0.667 . . . . 0.0 109.482 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.75 133.4 32.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.606 0.762 . . . . 0.0 109.591 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.04 -10.22 59.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.38 -0.2 . . . . 0.0 111.191 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -100.96 17.41 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -136.52 24.24 3.17 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.02 0.928 . . . . 0.0 109.806 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.89 -12.72 0.03 OUTLIER Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.097 -0.835 . . . . 0.0 113.9 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -128.94 24.69 5.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.895 1.347 . . . . 0.0 110.059 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 81.2 p -142.7 161.72 37.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.211 1.004 . . . . 0.0 110.141 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -120.84 90.59 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.4 pt -140.44 42.78 0.52 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.695 0.798 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 71.9 Cg_endo -67.98 -8.08 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.397 2.731 . . . . 0.0 112.51 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 12.1 tpt -134.89 25.18 3.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.1 0.56 . . . . 0.0 110.221 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -135.15 -16.29 1.91 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.078 -0.388 . . . . 0.0 111.337 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -82.15 -19.66 39.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 173.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 32.0 tp -92.28 -25.62 18.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.414 0.686 . . . . 0.0 110.027 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.0 m -84.51 -21.47 30.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.2 -40.84 11.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.167 -0.333 . . . . 0.0 110.783 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.47 45.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -106.43 -25.2 11.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.682 0.674 . . . . 0.0 111.437 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -76.78 -24.84 52.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.773 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.06 -49.09 9.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.863 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -95.96 11.3 34.45 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -135.13 -16.85 1.88 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.824 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.69 21.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.408 1.003 . . . . 0.0 113.307 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 m -132.55 2.74 3.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 111.187 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.74 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.809 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -148.54 168.9 21.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.46 1.504 . . . . 0.0 108.373 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -129.61 27.81 5.21 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.501 0.321 . . . . 0.0 111.012 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.48 -12.65 77.86 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.666 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.95 -177.48 25.05 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 117.803 0.801 . . . . 0.0 111.802 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 p -77.81 -69.58 0.53 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 122.288 -0.537 . . . . 0.0 110.957 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.3 m -141.66 28.81 1.77 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.0 110.228 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.87 85.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.385 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.516 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 37.3 tp60 -162.3 -42.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.687 1.244 . . . . 0.0 113.258 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.516 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 39.5 Cg_exo -63.07 2.05 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.902 2.401 . . . . 0.0 114.741 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 3.41 7.0 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.872 0.76 . . . . 0.0 111.891 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.61 9.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.412 0.685 . . . . 0.0 111.789 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -135.64 24.13 3.4 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.97 0.908 . . . . 0.0 108.8 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.03 29.93 0.12 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.781 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mm -44.28 -38.73 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.665 1.186 . . . . 0.0 112.635 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.7 m 45.74 22.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.941 1.697 . . . . 0.0 114.448 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -145.62 139.85 26.94 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.932 0.787 . . . . 0.0 111.736 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -138.45 37.83 2.26 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.588 0.755 . . . . 0.0 109.213 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 40.5 tt0 -74.53 140.85 75.73 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 50.8 Cg_exo -57.63 161.85 11.54 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.715 2.943 . . . . 0.0 112.998 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -133.83 147.62 51.23 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.949 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.72 51.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.5 mm -82.86 126.15 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.73 55.59 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.377 0.671 . . . . 0.0 110.282 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.13 176.65 17.03 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.69 140.64 48.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.79 0.436 . . . . 0.0 110.559 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.02 -174.71 43.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 p -135.72 138.11 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.142 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.5 t -84.47 140.85 31.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.505 0.322 . . . . 0.0 110.402 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.0 t -135.48 137.51 42.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.884 0.474 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -88.44 53.51 2.75 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.197 0.599 . . . . 0.0 110.286 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.64 50.12 1.28 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.428 0.691 . . . . 0.0 110.863 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 66.8 mt -74.66 135.35 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.152 0.581 . . . . 0.0 109.566 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 34.5 t -135.53 148.07 49.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.153 0.581 . . . . 0.0 110.482 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -135.23 125.77 26.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.428 0.691 . . . . 0.0 109.14 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.7 24.44 6.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 45.9 ttp 44.93 56.63 14.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.845 0.858 . . . . 0.0 111.786 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.69 158.67 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.356 2.704 . . . . 0.0 110.871 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.1 t -136.78 150.24 48.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.277 0.631 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -135.53 125.75 26.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 0.0 110.037 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 78.5 p -137.03 147.64 46.32 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.2 0.6 . . . . 0.0 110.734 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.9 171.13 54.57 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -135.51 119.88 17.94 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.15 0.58 . . . . 0.0 109.806 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -135.84 106.56 6.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.076 0.551 . . . . 0.0 109.779 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -75.74 165.54 54.31 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.69 162.44 42.11 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.917 3.078 . . . . 0.0 110.922 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -135.37 144.82 46.82 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.39 0.676 . . . . 0.0 110.027 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.8 m -72.67 135.93 45.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.591 0.356 . . . . 0.0 110.881 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.63 174.44 54.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.31 159.79 38.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.225 0.61 . . . . 0.0 110.242 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo . . . . . 0 C--O 1.252 1.191 0 C-N-CA 123.978 3.119 . . . . 0.0 112.354 178.299 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.472 0.245 0 N-CA-C 112.549 0.173 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.19 30.58 0.76 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.592 0.757 . . . . 0.0 111.716 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.28 24.67 1.1 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.285 0.634 . . . . 0.0 111.733 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.48 147.3 44.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.982 0.513 . . . . 0.0 110.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -105.34 154.83 19.75 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.138 0.575 . . . . 0.0 111.464 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.51 142.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.958 0.503 . . . . 0.0 110.066 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -135.22 138.09 43.24 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.121 0.568 . . . . 0.0 109.866 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 63.87 146.45 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.164 1.386 . . . . 0.0 112.57 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.08 155.18 34.83 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.922 0.489 . . . . 0.0 110.4 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.44 169.87 21.28 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.713 2.942 . . . . 0.0 110.536 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -97.93 25.95 5.58 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.417 0.687 . . . . 0.0 111.693 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -69.23 152.82 44.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.595 0.358 . . . . 0.0 111.049 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -140.47 162.39 49.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.435 0.694 . . . . 0.0 110.372 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.98 158.2 14.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.932 3.088 . . . . 0.0 112.987 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -134.29 156.48 78.95 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.284 1.033 . . . . 0.0 109.291 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.57 177.67 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.892 3.062 . . . . 0.0 110.83 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -46.18 127.23 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.085 0.554 . . . . 0.0 109.965 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.5 t -86.86 174.14 8.95 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.888 0.875 . . . . 0.0 112.327 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.57 44.17 1.05 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 0.0 111.255 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 57.79 32.0 21.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.902 0.881 . . . . 0.0 113.068 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 t -135.74 18.19 3.3 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -139.61 21.98 2.52 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.945 -0.472 . . . . 0.0 112.025 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.31 149.83 27.71 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 117.898 0.317 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.41 163.74 24.4 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.331 3.354 . . . . 0.0 112.097 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.6 9.54 2.21 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.734 3.623 . . . . 0.0 111.843 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.92 167.36 6.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.967 0.907 . . . . 0.0 110.92 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -51.95 146.89 7.8 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 120.865 0.364 . . . . 0.0 110.751 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 pt -68.54 144.29 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 120.795 0.331 . . . . 0.0 111.563 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' H ' ' HA3' ' A' ' 148' ' ' GLY . 96.4 mttt -106.61 26.5 9.88 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.406 0.683 . . . . 0.0 111.357 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 145' ' ' LEU . 25.5 t -80.61 117.18 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -130.67 135.85 48.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.675 0.39 . . . . 0.0 110.545 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -114.06 25.62 10.99 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.225 0.61 . . . . 0.0 111.866 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -128.29 110.01 11.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.268 0.627 . . . . 0.0 109.371 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m -137.86 144.75 41.56 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.827 0.451 . . . . 0.0 110.239 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.21 123.28 48.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -93.98 140.5 29.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.974 0.509 . . . . 0.0 111.008 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.3 137.08 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.001 0.921 . . . . 0.0 108.878 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.66 166.83 31.41 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.85 20.23 74.18 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.629 -0.54 . . . . 0.0 112.023 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.04 124.74 46.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 117.763 0.782 . . . . 0.0 111.646 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.26 -4.95 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.374 2.716 . . . . 0.0 110.656 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.85 149.54 39.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.113 0.565 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -84.74 52.44 2.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.992 0.517 . . . . 0.0 110.168 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 55.28 55.66 7.25 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.051 0.94 . . . . 0.0 112.05 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.08 111.84 17.03 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.6 -13.7 62.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -88.61 -6.45 57.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.97 -0.456 . . . . 0.0 111.042 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -92.77 -20.03 21.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.209 0.459 . . . . 0.0 109.971 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.24 -28.41 53.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.79 45.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.019 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.43 -15.99 58.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.961 0.346 . . . . 0.0 111.557 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.79 -4.28 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.222 0.465 . . . . 0.0 111.482 172.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.52 12.05 26.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.665 0.786 . . . . 0.0 109.804 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 65.2 tttp -75.15 -39.29 3.17 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 95.1 Cg_endo -75.03 125.73 9.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.564 1.51 . . . . 0.0 111.576 -174.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 t80 51.63 23.93 2.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.124 1.37 . . . . 0.0 113.093 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.94 160.03 42.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.462 0.705 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.03 55.85 1.87 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.491 0.316 . . . . 0.0 111.597 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.53 139.0 21.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 O-C-N 121.958 -0.464 . . . . 0.0 109.813 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -131.71 4.17 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.4 m -135.59 124.22 23.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.01 0.368 . . . . 0.0 110.334 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.14 115.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.6 mp -111.62 104.58 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 104.81 14.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -81.05 104.2 11.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.064 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -85.67 24.34 1.24 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.44 0.696 . . . . 0.0 112.06 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -130.09 7.58 5.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -147.72 19.19 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.153 0.581 . . . . 0.0 110.235 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 37.51 38.03 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.704 1.602 . . . . 0.0 113.658 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -138.06 159.77 41.15 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.985 0.914 . . . . 0.0 109.769 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.67 159.29 42.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.979 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.45 135.31 47.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.12 154.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -135.21 139.04 44.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 0.0 111.357 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.63 150.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.48 1.512 . . . . 0.0 109.33 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -90.15 15.14 10.8 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -154.09 138.09 16.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.157 0.583 . . . . 0.0 109.886 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.24 -8.15 59.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.58 -28.87 24.56 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.41 -14.15 55.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.71 65.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.05 -13.69 60.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.146 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.72 -16.6 41.14 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.452 0.569 . . . . 0.0 111.213 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.64 -41.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -17.76 61.79 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.188 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -70.23 -40.29 74.58 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -62.56 -40.9 98.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -84.18 11.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.444 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -130.31 12.98 5.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.382 0.273 . . . . 0.0 111.234 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -135.78 3.63 2.99 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.57 -8.96 22.47 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.771 0.714 . . . . 0.0 111.981 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.88 -8.02 0.63 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.109 0.861 . . . . 0.0 114.552 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.55 72.84 1.42 Allowed 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.36 1.08 . . . . 0.0 109.929 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 94' ' ' LEU . 7.3 mp -56.52 119.67 30.49 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.135 0.574 . . . . 0.0 110.375 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.54 -11.72 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.67 2.913 . . . . 0.0 111.287 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.86 149.67 49.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.451 0.701 . . . . 0.0 111.115 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -103.7 98.52 8.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.6 t -117.52 147.94 42.32 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.089 0.556 . . . . 0.0 111.751 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.82 145.43 46.45 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.548 1.139 . . . . 0.0 108.869 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -127.9 152.19 48.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.93 146.68 14.16 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.98 136.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.004 0.522 . . . . 0.0 110.77 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.23 131.33 10.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -99.13 138.15 36.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.796 0.438 . . . . 0.0 110.985 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.12 175.21 49.86 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.55 164.97 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.058 3.172 . . . . 0.0 110.768 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.2 tpp85 -77.62 144.18 37.67 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.882 0.473 . . . . 0.0 110.111 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.89 40.07 0.38 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.297 0.639 . . . . 0.0 111.459 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.3 t -135.48 35.76 2.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.537 0.735 . . . . 0.0 109.921 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 98.0 m -72.16 155.7 39.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.885 0.474 . . . . 0.0 111.137 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -128.78 173.58 10.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.863 0.865 . . . . 0.0 110.065 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -67.46 -5.66 15.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -87.1 2.57 49.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.871 0.76 . . . . 0.0 109.747 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -135.63 22.99 3.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.291 1.037 . . . . 0.0 109.263 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.84 -15.71 1.7 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.52 0.581 . . . . 0.0 111.716 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -95.58 49.26 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -135.37 172.08 13.52 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.031 0.932 . . . . 0.0 110.594 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.44 144.99 4.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 123.249 0.62 . . . . 0.0 110.166 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt -58.49 149.96 58.15 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 123.226 0.61 . . . . 0.0 111.503 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.57 4.39 5.07 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.195 3.263 . . . . 0.0 112.441 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.61 11.51 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.234 0.47 . . . . 0.0 112.186 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -135.8 3.79 3.0 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.185 0.594 . . . . 0.0 110.418 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -91.38 -20.1 22.18 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.187 0.195 . . . . 0.0 110.842 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.4 pp -90.32 -12.65 37.11 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 m -74.83 -47.34 31.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.12 -68.4 0.56 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.605 0.241 . . . . 0.0 111.039 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -78.73 -17.27 56.1 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.26 -16.95 13.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.986 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.49 -13.92 53.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.365 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -91.64 -32.99 15.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.371 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.84 9.22 25.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.535 0.607 . . . . 0.0 111.705 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -126.52 -11.21 6.23 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.938 -0.553 . . . . 0.0 112.05 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.2 t -127.27 24.97 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.6 t -74.59 55.48 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.227 -0.921 . . . . 0.0 109.85 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.04 156.15 47.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.095 0.958 . . . . 0.0 110.448 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -86.2 49.59 1.82 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.904 0.482 . . . . 0.0 111.079 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -135.93 55.56 1.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.725 0.81 . . . . 0.0 109.515 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.14 152.87 21.18 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.79 -16.2 71.01 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.488 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 76.7 p -145.71 12.71 1.31 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.221 1.01 . . . . 0.0 111.624 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 t -135.95 24.37 3.32 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.408 0.549 . . . . 0.0 112.15 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.416 ' H ' HG13 ' A' ' 133' ' ' VAL . . . -79.61 0.47 81.34 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -146.45 149.18 36.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.32 14.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.434 3.423 . . . . 0.0 115.307 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 30' ' ' VAL . 4.6 pp -67.57 -8.57 35.24 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.902 0.774 . . . . 0.0 111.693 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.27 7.92 2.46 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 123.968 0.907 . . . . 0.0 111.005 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.8 m -134.79 30.46 3.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.552 ' HA3' ' H ' ' A' ' 29' ' ' LYS . . . -139.04 -56.76 0.05 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.943 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.493 ' CG1' HG21 ' A' ' 30' ' ' VAL . 2.3 pp -135.72 -12.22 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.91 0.855 . . . . 0.0 112.759 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.9 m 34.97 43.15 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.416 0.687 . . . . 0.0 112.091 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.468 ' H ' HD12 ' A' ' 149' ' ' ILE . 15.7 m-30 -72.86 144.63 47.36 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.306 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.38 165.01 26.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.214 1.406 . . . . 0.0 109.098 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 57.24 71.82 1.04 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.34 168.23 21.6 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.436 3.424 . . . . 0.0 112.078 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -135.08 125.93 27.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.674 0.79 . . . . 0.0 109.268 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.8 tt -69.13 146.5 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.591 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.3 pt -90.09 27.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.2 147.62 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 117.96 0.345 . . . . 0.0 110.755 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.65 3.21 0.05 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.594 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.69 126.33 29.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.867 0.833 . . . . 0.0 110.795 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 166.23 168.95 29.19 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.52 139.78 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 C-N-CA 123.008 0.523 . . . . 0.0 110.327 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 79.2 p -139.29 24.57 2.5 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.027 0.531 . . . . 0.0 111.294 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -79.0 133.83 36.82 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.345 0.258 . . . . 0.0 110.975 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.47 30.21 3.22 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.716 0.806 . . . . 0.0 110.219 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.27 134.49 52.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.735 0.414 . . . . 0.0 110.958 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.4 147.51 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.01 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.0 m -132.27 114.57 14.58 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.133 0.573 . . . . 0.0 109.519 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -135.67 26.8 3.37 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.977 0.511 . . . . 0.0 111.561 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -71.49 129.6 39.18 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.597 0.359 . . . . 0.0 110.09 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.72 155.99 34.22 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.5 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.46 164.4 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.865 3.043 . . . . 0.0 110.84 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 45.7 p -130.36 136.46 49.11 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 122.833 0.453 . . . . 0.0 110.626 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -135.58 55.2 1.88 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.679 0.792 . . . . 0.0 109.667 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.2 p -121.01 155.54 34.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.328 0.651 . . . . 0.0 111.344 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.22 161.32 28.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -135.79 141.3 44.75 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 123.32 0.648 . . . . 0.0 110.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -135.91 159.86 40.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.657 0.783 . . . . 0.0 110.671 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.8 164.87 36.49 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.39 175.14 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.659 3.572 . . . . 0.0 111.418 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -135.08 143.65 46.77 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.782 0.833 . . . . 0.0 109.411 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -132.91 155.66 48.66 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 122.953 0.501 . . . . 0.0 111.131 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.15 -176.8 38.89 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.693 ' H ' ' CD ' ' A' ' 185' ' ' PRO . 87.8 tttt -141.48 -36.9 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.996 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.693 ' CD ' ' H ' ' A' ' 184' ' ' LYS . 57.9 Cg_exo . . . . . 0 C--O 1.251 1.125 0 C-N-CA 123.032 2.488 . . . . 0.0 112.325 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.477 0.53 0 N-CA-C 112.261 0.062 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -135.51 126.74 28.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.056 0.542 . . . . 0.0 109.915 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -89.81 126.11 35.57 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.756 0.422 . . . . 0.0 110.159 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -135.84 111.32 9.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.1 t30 64.76 156.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 112.388 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -75.5 149.28 7.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.137 0.575 . . . . 0.0 110.608 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.4 p -134.96 149.87 50.28 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.408 0.683 . . . . 0.0 110.432 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -113.1 147.73 36.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.181 0.592 . . . . 0.0 110.682 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.45 155.03 41.94 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.408 0.683 . . . . 0.0 110.102 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.9 167.55 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.843 . . . . 0.0 110.895 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -78.62 162.69 26.07 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.534 0.333 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -124.19 45.81 2.41 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.214 0.606 . . . . 0.0 110.128 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -135.45 65.53 62.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 123.311 0.644 . . . . 0.0 110.125 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.04 161.71 43.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.69 2.926 . . . . 0.0 110.605 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.773 ' H ' ' HD2' ' A' ' 16' ' ' PRO . 28.8 ttpp -149.08 -45.81 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.958 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.773 ' HD2' ' H ' ' A' ' 15' ' ' LYS . 69.3 Cg_endo -78.91 -5.3 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.159 1.906 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 140' ' ' THR . 92.1 t -131.39 124.02 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.3 m -139.71 147.49 40.99 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 122.99 0.516 . . . . 0.0 110.855 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -91.57 104.6 17.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.619 0.723 . . . . 0.0 110.563 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.65 156.57 48.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.492 1.117 . . . . 0.0 108.881 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.1 m -78.29 54.99 1.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.421 0.288 . . . . 0.0 111.365 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.9 p -135.1 25.71 3.56 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.341 0.657 . . . . 0.0 111.489 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.38 136.6 83.92 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.1 160.86 24.58 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.805 3.003 . . . . 0.0 111.868 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.72 2.81 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.297 3.331 . . . . 0.0 112.126 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -135.05 160.45 38.28 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.142 0.577 . . . . 0.0 110.825 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.8 m80 57.1 35.49 26.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.038 0.935 . . . . 0.0 111.454 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 149' ' ' ILE . 2.2 tp -135.97 129.08 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.289 0.636 . . . . 0.0 110.415 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -136.04 27.2 3.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.77 0.428 . . . . 0.0 112.085 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.34 46.49 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.746 0.418 . . . . 0.0 111.057 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -54.22 128.87 32.91 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.592 0.357 . . . . 0.0 110.408 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.9 m -135.69 50.63 2.09 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.074 0.549 . . . . 0.0 111.052 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -133.98 143.39 48.12 Favored 'General case' 0 C--N 1.337 0.042 0 C-N-CA 123.068 0.547 . . . . 0.0 110.304 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 t -135.7 170.19 16.37 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.613 0.765 . . . . 0.0 109.677 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.45 142.16 51.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.425 0.557 . . . . 0.0 112.256 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.24 143.34 50.72 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 mm -122.74 150.49 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.87 171.0 34.87 Favored Glycine 0 CA--C 1.524 0.619 0 O-C-N 121.865 -0.522 . . . . 0.0 112.143 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.58 73.96 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 ' H ' ' A' ' 40' ' ' VAL . 2.0 m -54.34 128.49 59.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 117.464 0.632 . . . . 0.0 111.883 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -87.67 -7.54 6.46 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.267 3.311 . . . . 0.0 111.457 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.56 156.35 30.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.329 1.051 . . . . 0.0 111.953 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.19 57.97 4.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.938 0.895 . . . . 0.0 112.226 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 38.5 ttm 53.54 55.74 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.654 0.782 . . . . 0.0 112.083 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -126.92 108.44 10.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.252 0.621 . . . . 0.0 109.563 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.97 -17.7 65.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.688 0.28 . . . . 0.0 110.95 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -85.64 -3.06 58.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.202 -0.311 . . . . 0.0 111.2 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -94.43 -23.7 17.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.466 0.575 . . . . 0.0 109.973 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.81 -35.89 75.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 170.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.3 60.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.555 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -78.22 -11.67 59.94 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.707 -0.621 . . . . 0.0 110.703 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.88 -1.27 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.58 12.29 14.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.767 0.827 . . . . 0.0 110.595 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.487 ' H ' ' HD3' ' A' ' 55' ' ' PRO . 88.8 tttt -109.69 -32.28 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 59.0 Cg_exo -57.04 -21.17 40.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.492 2.128 . . . . 0.0 114.259 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.6 5.8 1.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.0 174.14 11.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.462 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.52 55.52 1.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.176 0.591 . . . . 0.0 110.662 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.74 139.7 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -115.39 -2.02 12.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -172.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.1 m -141.64 131.21 23.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.432 0.56 . . . . 0.0 110.58 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -143.19 125.19 12.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.205 0.602 . . . . 0.0 109.865 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.59 139.96 45.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.985 0.514 . . . . 0.0 110.055 173.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -109.29 138.6 45.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.82 0.848 . . . . 0.0 111.219 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -102.08 105.24 15.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -79.92 24.56 0.4 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.837 0.855 . . . . 0.0 113.253 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.2 m -133.16 6.5 3.89 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.847 0.294 . . . . 0.0 111.63 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -152.73 11.47 0.5 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.718 0.235 . . . . 0.0 111.228 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 47.44 47.03 17.36 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -128.44 150.64 50.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.121 0.569 . . . . 0.0 110.312 -173.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -135.34 155.42 50.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.306 0.574 . . . . 0.0 111.742 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -127.3 127.16 43.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.39 150.75 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.465 0.174 . . . . 0.0 111.188 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.47 131.32 43.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.95 0.405 . . . . 0.0 111.617 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -106.36 157.57 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 124.759 1.224 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -86.96 -2.02 58.3 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 97.4 p -153.42 150.21 28.58 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.082 -0.386 . . . . 0.0 110.366 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -70.26 -12.63 61.73 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.358 -0.214 . . . . 0.0 111.414 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -77.85 -16.92 57.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.924 -0.485 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.64 -14.92 36.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.145 -0.347 . . . . 0.0 110.219 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.55 -40.41 35.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -73.48 -25.56 60.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -79.1 -22.59 45.01 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.317 0.508 . . . . 0.0 111.203 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.9 t -74.75 -42.65 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.27 -16.08 62.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.452 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -78.86 -24.63 44.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.29 0.496 . . . . 0.0 110.412 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -99.14 -17.32 18.24 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.107 -0.371 . . . . 0.0 110.671 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.96 0.26 57.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.018 -0.426 . . . . 0.0 110.077 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -135.34 -2.58 2.48 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -144.14 20.47 1.75 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.092 0.86 . . . . 0.0 113.007 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -135.99 55.59 1.85 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.1 -2.82 72.3 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.476 -0.624 . . . . 0.0 112.798 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 50.86 74.76 0.21 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.91 0.884 . . . . 0.0 112.085 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.8 151.86 40.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.846 0.458 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.24 -6.82 19.83 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.895 3.064 . . . . 0.0 112.231 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.64 128.62 36.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.878 0.308 . . . . 0.0 110.281 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -89.32 100.36 13.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.1 m -104.95 135.39 46.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.754 0.422 . . . . 0.0 111.059 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -141.27 149.25 41.06 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.646 0.779 . . . . 0.0 109.933 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -103.85 140.62 37.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.98 151.51 22.22 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.4 p -98.31 151.64 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.488 0.715 . . . . 0.0 111.094 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.58 148.53 17.81 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -123.13 25.34 8.51 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.915 0.486 . . . . 0.0 111.168 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.11 -177.56 38.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.235 0.445 . . . . 0.0 112.426 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.94 170.22 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.784 3.656 . . . . 0.0 112.761 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -126.86 128.23 46.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.476 0.71 . . . . 0.0 109.286 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.3 44.01 2.6 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.046 0.539 . . . . 0.0 110.877 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 27.6 p -81.95 24.85 0.6 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.036 0.534 . . . . 0.0 111.402 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.36 168.59 18.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 110.974 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.01 159.2 14.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.905 0.482 . . . . 0.0 110.257 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -65.97 -6.07 11.47 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -80.35 -3.0 47.82 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.249 -0.282 . . . . 0.0 110.323 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -135.82 4.33 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.831 0.852 . . . . 0.0 110.057 171.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.92 -11.38 37.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -81.22 55.49 2.56 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.321 0.648 . . . . 0.0 110.417 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -135.29 141.26 45.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.492 0.717 . . . . 0.0 110.272 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.0 mt -89.64 139.18 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.913 0.485 . . . . 0.0 109.877 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.12 136.43 13.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.66 1.81 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.682 2.922 . . . . 0.0 112.497 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.8 ttt -84.51 -4.14 58.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.913 -0.492 . . . . 0.0 111.221 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -135.68 10.46 3.4 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.549 0.339 . . . . 0.0 111.403 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -74.62 -10.34 59.44 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 149' ' ' ILE . 3.6 pp -83.4 -23.78 32.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.3 m -89.94 -15.6 31.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -77.51 -50.4 12.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.613 0.365 . . . . 0.0 110.065 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.24 -15.28 41.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -91.3 -41.47 10.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.672 0.669 . . . . 0.0 110.876 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -68.77 -28.85 67.15 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.405 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' A' ' 157' ' ' ILE . 58.9 tttm -70.9 -62.53 1.36 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -98.1 21.58 10.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 -10.46 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.48 3.42 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.2 0.909 . . . . 0.0 112.744 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.9 m -87.79 31.13 0.78 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.244 -0.91 . . . . 0.0 111.2 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.47 24.9 6.62 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.177 0.991 . . . . 0.0 109.42 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -135.36 169.17 17.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.855 1.262 . . . . 0.0 109.144 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -76.21 24.22 0.14 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.04 137.35 2.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.02 152.78 20.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.517 HG22 HG21 ' A' ' 17' ' ' VAL . 17.0 m 55.24 36.45 27.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.576 0.703 . . . . 0.0 109.274 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.8 m -147.66 14.34 1.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.852 1.261 . . . . 0.0 109.042 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.21 -106.45 2.99 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 82.3 mt-30 -152.29 -42.24 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 50.2 Cg_exo -60.47 -20.51 64.16 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.849 2.366 . . . . 0.0 115.653 -171.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.4 pt? -140.97 1.2 1.64 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.07 -4.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 39.3 p -133.72 11.71 4.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 28' ' ' ILE . . . -84.88 -71.74 1.31 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -108.55 -5.33 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.1 m 45.96 18.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.967 1.707 . . . . 0.0 114.877 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.6 154.02 17.52 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 118.438 0.563 . . . . 0.0 110.183 171.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' HA ' HG21 ' A' ' 140' ' ' THR . 33.7 tt0 -127.94 78.97 1.87 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.067 0.46 . . . . 0.0 110.559 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -137.65 61.48 30.55 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 109.889 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.72 167.94 25.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.287 3.325 . . . . 0.0 112.377 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -103.88 146.38 28.74 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.887 0.875 . . . . 0.0 109.623 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.8 tt -80.23 132.91 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 112.088 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.468 HD11 ' HE2' ' A' ' 130' ' ' LYS . 32.8 mm -135.5 127.04 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.484 1.114 . . . . 0.0 108.112 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.44 150.75 29.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.178 0.591 . . . . 0.0 110.628 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 174.47 0.66 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.827 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.04 149.48 35.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.006 0.903 . . . . 0.0 111.327 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 175.9 177.04 44.62 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.75 138.7 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.074 0.55 . . . . 0.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.8 m -135.62 28.98 3.27 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.098 0.559 . . . . 0.0 111.279 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.0 p -73.62 145.01 45.7 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.565 0.346 . . . . 0.0 111.024 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -135.92 142.63 44.67 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.384 0.674 . . . . 0.0 110.205 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.37 147.67 49.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.354 0.661 . . . . 0.0 110.361 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.4 tp -135.52 144.02 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.108 0.563 . . . . 0.0 110.421 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 81.0 p -135.63 156.1 49.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.669 0.788 . . . . 0.0 110.237 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.858 0.463 . . . . 0.0 110.28 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -135.55 152.17 51.03 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.145 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.8 ptm -145.86 154.5 51.41 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 122.961 0.504 . . . . 0.0 110.425 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.79 167.6 26.12 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.622 2.881 . . . . 0.0 110.805 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.8 p -130.96 29.37 4.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.203 0.601 . . . . 0.0 110.885 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.56 105.34 4.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.774 0.429 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -135.9 147.23 48.07 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.265 0.626 . . . . 0.0 110.61 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.18 170.81 43.78 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -135.78 129.54 32.68 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.074 0.55 . . . . 0.0 110.316 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -137.08 104.65 5.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.06 157.81 51.53 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.02 -12.25 19.58 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.844 3.03 . . . . 0.0 111.597 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 23.3 tpp85 -139.67 139.15 36.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.287 0.635 . . . . 0.0 110.091 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.1 m -135.09 48.32 2.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.621 0.768 . . . . 0.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.39 176.92 49.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.741 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 88.6 tttt -151.02 -49.61 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.132 -0.937 . . . . 0.0 112.152 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.741 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 94.6 Cg_endo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 122.208 1.939 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.473 0.271 0 N-CA-C 112.761 0.254 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.82 55.22 2.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.836 0.854 . . . . 0.0 110.175 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -123.11 24.82 8.74 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.8 0.84 . . . . 0.0 110.771 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 pp -93.05 160.11 15.01 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.065 0.546 . . . . 0.0 111.652 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -135.83 24.89 3.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.312 0.645 . . . . 0.0 111.268 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.59 149.08 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 122.741 0.416 . . . . 0.0 111.233 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 t -135.67 140.35 44.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.419 0.688 . . . . 0.0 110.104 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.36 154.56 50.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.095 0.558 . . . . 0.0 111.046 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 47.1 79.26 0.35 Allowed Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 112.73 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -81.05 -26.99 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.147 2.565 . . . . 0.0 113.54 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -158.08 34.45 0.25 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -138.09 141.09 40.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.682 1.128 . . . . 0.0 112.646 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.6 tmm_? -155.07 140.92 12.76 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 13' ' ' ARG . 53.1 Cg_exo -57.6 178.93 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.456 3.438 . . . . 0.0 114.139 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 63.87 155.92 0.12 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.397 1.479 . . . . 0.0 112.926 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.85 -11.0 28.79 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.745 2.963 . . . . 0.0 111.948 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.24 149.37 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.7 p -77.22 170.89 15.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.988 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -83.83 108.57 16.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.767 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -37.31 150.15 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.137 1.375 . . . . 0.0 113.245 171.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.2 p 54.66 21.82 3.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.406 1.882 . . . . 0.0 113.429 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.9 m -135.95 30.81 3.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.603 0.761 . . . . 0.0 109.285 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 156.28 81.59 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.324 0.65 . . . . 0.0 109.97 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.55 165.65 30.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.656 2.904 . . . . 0.0 111.092 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.89 -10.14 16.45 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.282 3.321 . . . . 0.0 114.067 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -69.35 137.82 53.22 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.143 0.429 . . . . 0.0 111.08 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -79.55 136.76 36.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.726 0.41 . . . . 0.0 110.554 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.497 HD13 HG22 ' A' ' 149' ' ' ILE . 2.2 pp -135.55 -177.78 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.48 0.712 . . . . 0.0 110.609 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -83.25 51.34 1.95 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.41 136.68 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 122.899 0.48 . . . . 0.0 109.752 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -86.16 55.74 3.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.537 0.735 . . . . 0.0 110.312 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.1 p -63.92 155.39 30.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.297 0.639 . . . . 0.0 112.207 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -67.36 135.38 53.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.883 0.873 . . . . 0.0 110.05 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.6 p -135.8 157.39 46.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.092 0.557 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.45 131.01 54.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.289 0.636 . . . . 0.0 109.366 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -115.26 142.91 46.04 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.202 0.601 . . . . 0.0 110.804 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.93 141.81 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.835 0.854 . . . . 0.0 109.085 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.09 29.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.03 75.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.582 -0.565 . . . . 0.0 111.931 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 m -55.85 124.54 58.4 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.85 0.825 . . . . 0.0 110.87 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.5 -2.83 13.08 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.324 2.683 . . . . 0.0 111.076 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.54 157.91 34.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.32 0.648 . . . . 0.0 110.133 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -85.09 47.85 1.47 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.51 55.92 6.81 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.915 0.886 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -126.87 116.65 21.16 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.31 -12.58 61.78 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -83.78 -11.43 57.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.085 -0.384 . . . . 0.0 110.896 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -95.73 -18.53 20.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.392 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 49' ' ' LEU . 3.9 mm? -77.49 -26.79 51.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.96 -22.63 42.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.94 -14.75 59.83 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.112 -0.368 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 -2.64 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 118.243 0.474 . . . . 0.0 111.783 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.33 14.3 22.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.6 0.76 . . . . 0.0 109.837 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 64.9 tttp -88.56 -37.23 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.937 169.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 49.8 Cg_exo -59.4 116.91 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.252 1.968 . . . . 0.0 111.111 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 51.67 23.89 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.398 1.079 . . . . 0.0 113.178 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 159.45 44.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.116 0.416 . . . . 0.0 110.9 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -135.34 59.18 1.73 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.894 0.477 . . . . 0.0 111.301 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -70.15 142.59 15.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 O-C-N 121.856 -0.527 . . . . 0.0 109.996 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -132.45 6.62 4.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.0 m -135.51 119.75 17.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.213 0.46 . . . . 0.0 110.472 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.16 123.91 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.284 0.633 . . . . 0.0 109.406 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 104.66 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.22 117.62 34.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -135.09 155.95 49.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.806 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 60.24 177.21 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.137 1.375 . . . . 0.0 112.349 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -70.22 78.54 0.52 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.509 0.723 . . . . 0.0 111.141 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 50.09 32.27 5.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.915 1.686 . . . . 0.0 114.833 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -135.56 4.17 3.09 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -139.47 55.26 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.226 0.921 . . . . 0.0 111.294 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.01 137.21 36.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.052 0.454 . . . . 0.0 110.228 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -135.5 133.49 38.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.552 0.741 . . . . 0.0 109.939 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.66 152.34 31.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.549 0.214 . . . . 0.0 111.137 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -135.74 142.45 45.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.241 0.544 . . . . 0.0 111.93 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.75 151.02 22.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.479 1.511 . . . . 0.0 109.174 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -87.77 11.12 16.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.3 t -149.7 136.06 19.07 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.821 0.448 . . . . 0.0 109.839 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -72.59 -17.7 61.67 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 122.401 -0.187 . . . . 0.0 110.585 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -82.53 -22.06 35.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.23 -19.07 37.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.72 66.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.21 -14.51 60.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.93 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.5 -19.86 37.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.238 0.472 . . . . 0.0 111.002 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.77 -44.06 46.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.27 -18.57 63.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -75.28 -28.54 59.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.53 0.604 . . . . 0.0 109.593 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -72.14 -28.91 63.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.4 5.55 51.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.529 0.332 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.7 17.26 5.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.896 0.478 . . . . 0.0 110.577 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -129.56 -6.52 4.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.654 0.382 . . . . 0.0 111.209 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -97.84 -6.61 32.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.472 0.578 . . . . 0.0 112.041 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 5.32 3.91 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.176 0.893 . . . . 0.0 114.093 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.02 50.11 0.52 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.392 1.096 . . . . 0.0 109.874 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 94' ' ' LEU . 1.9 pt? -53.82 127.99 53.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 122.712 0.405 . . . . 0.0 111.395 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.03 0.71 8.8 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.4 3.4 . . . . 0.0 112.238 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.47 150.66 50.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.85 104.25 16.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 p -121.76 133.73 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.481 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -137.31 145.0 42.89 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 123.459 0.704 . . . . 0.0 110.16 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -133.1 157.4 45.38 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.041 0.537 . . . . 0.0 110.026 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.91 -176.07 40.57 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.546 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.55 143.33 36.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 125.049 1.34 . . . . 0.0 109.951 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.15 140.97 18.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -130.95 55.22 1.86 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.691 0.796 . . . . 0.0 109.688 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.38 156.67 19.65 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.52 -22.04 9.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.615 2.876 . . . . 0.0 112.34 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -149.51 156.8 42.57 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.736 0.414 . . . . 0.0 111.165 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -102.34 24.88 9.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.371 0.668 . . . . 0.0 110.774 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.53 25.25 12.01 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.448 0.699 . . . . 0.0 111.227 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 75.7 m -77.2 150.15 35.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 110.643 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.53 141.95 50.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -70.89 -10.26 59.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -97.51 6.02 48.74 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.511 0.596 . . . . 0.0 110.448 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -147.33 28.42 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.536 0.735 . . . . 0.0 109.841 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.95 -11.56 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.277 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -84.47 55.51 3.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.449 1.624 . . . . 0.0 109.979 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -133.41 149.07 51.82 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.607 0.763 . . . . 0.0 110.388 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -74.26 147.68 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 121' ' ' MET . 26.5 mt 63.79 126.33 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.592 1.557 . . . . 0.0 111.243 -172.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.79 -7.32 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.305 2.67 . . . . 0.0 112.889 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.506 ' H ' HG22 ' A' ' 119' ' ' ILE . 5.4 mpp? -85.81 25.87 1.05 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.385 0.539 . . . . 0.0 111.388 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -72.2 -20.71 61.53 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -92.47 10.15 31.36 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.227 -0.296 . . . . 0.0 110.949 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.55 -32.61 12.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 t -84.86 -27.68 26.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.7 -59.68 2.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.557 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.69 -24.77 41.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.82 -27.54 10.68 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 113.142 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -85.08 -18.77 33.27 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.6 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -87.37 -55.26 3.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.539 0.609 . . . . 0.0 109.738 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -87.3 4.49 42.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 m -139.58 -5.56 1.37 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 172.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.43 21.18 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.052 1.297 . . . . 0.0 112.092 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 t -100.63 30.14 4.11 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.371 -0.831 . . . . 0.0 111.384 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.57 24.36 8.57 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 110.218 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -140.43 156.51 46.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.354 1.062 . . . . 0.0 108.834 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -74.87 24.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.32 0.648 . . . . 0.0 112.082 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.06 160.67 13.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -82.17 -169.2 42.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.1 m 68.63 112.0 0.04 OUTLIER 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.331 1.053 . . . . 0.0 112.366 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.7 t 59.36 24.93 13.53 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.345 1.058 . . . . 0.0 112.606 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.44 -9.1 82.28 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -156.82 147.24 16.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.26 7.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.445 3.43 . . . . 0.0 115.67 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.72 6.0 5.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.031 0.832 . . . . 0.0 111.663 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.08 17.57 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.125 0.57 . . . . 0.0 111.645 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -135.12 40.41 2.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.01 0.924 . . . . 0.0 109.136 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.84 -53.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -115.51 128.23 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.814 0.816 . . . . 0.0 110.395 171.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.38 24.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.758 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -127.56 125.33 40.12 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.689 0.796 . . . . 0.0 109.546 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -146.41 153.38 40.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.612 0.365 . . . . 0.0 111.345 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.25 153.87 38.21 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.603 0.761 . . . . 0.0 109.053 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.45 137.82 37.31 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.863 2.375 . . . . 0.0 110.874 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.97 149.82 31.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.134 0.573 . . . . 0.0 110.386 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 19.0 tt -135.67 148.52 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.036 0.535 . . . . 0.0 110.316 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.2 28.79 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.12 151.96 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 122.618 0.367 . . . . 0.0 110.569 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -175.4 177.43 47.29 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -135.72 149.98 49.39 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.122 0.569 . . . . 0.0 110.999 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.2 177.63 52.3 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.55 142.7 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.16 0.584 . . . . 0.0 110.35 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.8 p -135.71 152.61 51.34 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.369 0.668 . . . . 0.0 110.719 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.6 t -135.74 143.32 45.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.128 0.571 . . . . 0.0 110.376 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -95.09 134.53 37.69 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.047 0.539 . . . . 0.0 110.459 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.71 134.97 39.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.109 0.564 . . . . 0.0 110.139 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.03 142.55 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.108 0.563 . . . . 0.0 110.149 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 76.7 p -83.82 145.88 28.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.819 0.447 . . . . 0.0 110.824 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -135.71 145.84 47.1 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.83 0.452 . . . . 0.0 111.025 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.19 148.26 48.04 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.73 0.812 . . . . 0.0 109.934 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.67 152.63 65.81 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.075 0.55 . . . . 0.0 110.403 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.05 156.89 38.48 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.811 3.007 . . . . 0.0 111.541 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 p -135.5 144.83 46.57 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.524 0.729 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -135.55 130.77 35.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.739 0.416 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 59.6 m -136.0 143.63 44.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.511 0.724 . . . . 0.0 110.266 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -71.53 161.47 54.21 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -135.92 145.8 46.66 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.104 0.562 . . . . 0.0 111.07 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.65 125.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.273 0.629 . . . . 0.0 109.379 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.2 155.06 48.62 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.06 160.06 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.945 3.097 . . . . 0.0 111.022 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -138.73 146.73 41.82 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.288 0.635 . . . . 0.0 110.345 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.0 m -135.74 124.33 23.65 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.822 0.449 . . . . 0.0 110.388 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.3 173.4 54.27 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -139.73 152.0 67.28 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.41 0.684 . . . . 0.0 109.912 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.793 2.995 . . . . 0.0 111.068 178.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.471 0.154 0 N-CA-C 112.546 0.171 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -135.38 147.14 48.95 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.253 0.621 . . . . 0.0 110.352 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -135.7 133.66 38.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.098 0.559 . . . . 0.0 110.122 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 4' ' ' LEU . 1.9 pt? -81.58 147.83 29.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.799 0.44 . . . . 0.0 111.373 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -80.56 104.04 10.82 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.08 141.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.106 0.562 . . . . 0.0 110.3 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -94.14 106.41 18.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -66.78 130.8 44.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.022 0.439 . . . . 0.0 111.112 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -153.03 153.39 29.64 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.117 0.567 . . . . 0.0 109.971 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.87 160.88 46.63 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.518 2.812 . . . . 0.0 110.586 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -135.21 136.08 41.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.606 0.362 . . . . 0.0 110.831 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.69 139.01 43.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.79 133.19 84.49 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 110.154 -0.314 . . . . 0.0 110.154 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.28 163.94 29.61 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.791 2.994 . . . . 0.0 110.762 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 65.4 mttp -82.56 -49.11 0.83 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.685 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 61.0 Cg_endo -78.81 177.33 8.84 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.771 2.314 . . . . 0.0 109.919 171.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -126.02 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.2 m -154.27 -1.63 0.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -158.73 123.62 4.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.101 0.864 . . . . 0.0 111.447 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -154.4 151.54 29.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.384 0.674 . . . . 0.0 109.596 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.3 m -92.05 19.22 6.99 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 m -140.25 81.9 1.83 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.5 mt -125.55 138.73 32.43 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.929 0.492 . . . . 0.0 110.829 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -81.05 164.85 19.71 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.15 3.233 . . . . 0.0 111.237 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.57 -0.83 4.85 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.452 3.435 . . . . 0.0 113.783 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.24 146.57 43.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.214 0.605 . . . . 0.0 112.427 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -73.31 163.05 28.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.989 0.915 . . . . 0.0 109.736 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.74 142.78 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.617 0.367 . . . . 0.0 110.783 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -127.73 24.11 6.15 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.05 91.88 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.46 143.16 25.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.949 0.499 . . . . 0.0 109.719 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -107.82 104.48 13.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.713 0.292 . . . . 0.0 110.33 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.2 ptm85 -142.69 160.41 40.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.288 0.635 . . . . 0.0 110.93 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.6 p -135.04 135.07 41.03 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.191 0.596 . . . . 0.0 109.822 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.66 126.05 53.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -112.4 140.88 46.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.752 0.821 . . . . 0.0 110.312 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mm -125.45 144.66 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.42 176.97 37.91 Favored Glycine 0 CA--C 1.524 0.651 0 O-C-N 121.863 -0.523 . . . . 0.0 112.206 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.78 19.7 73.55 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 40' ' ' VAL . 1.2 m -62.55 130.0 93.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 117.563 0.682 . . . . 0.0 111.242 -173.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.76 -10.35 6.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.13 3.22 . . . . 0.0 111.307 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 4.0 pp -82.03 156.08 24.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.684 1.193 . . . . 0.0 111.666 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -80.7 55.93 2.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.736 0.815 . . . . 0.0 112.109 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.1 mtm 50.73 55.34 9.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.14 0.976 . . . . 0.0 112.495 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 88.5 tttt -115.55 106.06 13.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.64 -15.71 63.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -84.17 -7.5 59.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.158 -0.339 . . . . 0.0 110.827 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -96.85 -20.74 17.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.405 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.72 -29.28 62.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.84 50.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.235 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -76.63 -13.11 60.09 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.792 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.96 -2.6 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -118.22 18.28 13.79 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.688 0.795 . . . . 0.0 110.291 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 40.3 ttmt -105.71 -35.51 0.19 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.442 -0.79 . . . . 0.0 113.035 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.1 Cg_exo -58.97 -23.97 70.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.645 2.23 . . . . 0.0 114.161 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -143.82 13.71 1.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.68 176.78 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.121 0.569 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -134.56 57.86 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.483 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.32 138.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -130.65 9.31 5.02 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -135.44 113.64 11.37 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.42 128.14 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.13 131.49 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mt -107.78 122.68 47.26 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -118.19 161.71 19.44 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 62.1 24.9 14.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.24 1.816 . . . . 0.0 112.783 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 m 52.6 26.44 4.35 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.841 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -141.05 -174.79 4.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.29 1.436 . . . . 0.0 109.122 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.58 30.65 0.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -87.95 81.36 7.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.379 0.991 . . . . 0.0 108.728 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.16 138.73 32.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.424 0.631 . . . . 0.0 112.242 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -136.02 131.67 35.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.952 0.901 . . . . 0.0 108.866 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -133.0 151.66 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 111.617 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -135.47 142.28 45.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.421 0.629 . . . . 0.0 111.597 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.22 152.77 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 125.103 1.361 . . . . 0.0 109.156 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -98.33 24.14 7.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.6 t -149.99 138.57 20.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.959 0.504 . . . . 0.0 110.09 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.66 -38.48 73.82 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -76.35 -15.94 59.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.241 -0.287 . . . . 0.0 111.587 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -86.28 -18.78 31.13 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.873 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.91 -22.56 42.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.94 -19.26 37.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.292 -0.255 . . . . 0.0 111.366 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -78.39 -43.38 26.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.466 0.575 . . . . 0.0 110.157 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' LEU . 3.1 mm? -75.37 -14.97 60.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.002 177.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -71.55 -43.3 66.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.764 0.711 . . . . 0.0 109.144 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -76.04 -12.4 60.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.419 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -92.35 -1.26 57.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.1 -0.375 . . . . 0.0 110.325 170.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -112.36 3.19 16.84 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.797 0.439 . . . . 0.0 111.429 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -135.02 1.69 3.01 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.15 55.17 1.77 Allowed 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.2 -0.28 20.65 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.804 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.02 3.02 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.912 0.856 . . . . 0.0 111.798 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -89.15 153.58 49.0 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 122.859 0.463 . . . . 0.0 109.776 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.53 -11.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.688 2.925 . . . . 0.0 112.062 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.08 153.14 21.5 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.786 0.435 . . . . 0.0 111.755 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -125.41 137.44 54.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 109.025 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -135.46 141.98 45.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -137.53 147.49 45.21 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.224 1.01 . . . . 0.0 109.552 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -135.13 160.49 38.2 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.12 175.08 33.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.36 148.83 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.122 0.969 . . . . 0.0 109.952 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -164.5 142.02 7.49 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -94.28 19.09 9.9 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.929 0.492 . . . . 0.0 111.496 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.9 175.93 21.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.328 0.489 . . . . 0.0 112.455 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.73 174.71 12.35 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.419 3.413 . . . . 0.0 110.771 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -64.71 151.35 45.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 122.746 0.418 . . . . 0.0 110.59 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -124.88 54.83 1.39 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.008 0.523 . . . . 0.0 111.015 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 68.2 m 56.07 55.93 6.39 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.248 0.619 . . . . 0.0 111.601 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.01 104.9 2.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.869 0.366 . . . . 0.0 110.444 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -135.71 172.61 12.76 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.51 1.124 . . . . 0.0 109.178 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -65.62 -7.28 14.26 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.082 -0.386 . . . . 0.0 111.579 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -73.98 0.26 14.12 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -135.12 16.73 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.578 1.151 . . . . 0.0 108.874 170.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.62 -18.29 18.94 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -131.34 24.35 4.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.286 0.635 . . . . 0.0 110.226 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.24 36.35 2.31 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.536 0.735 . . . . 0.0 110.657 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.08 133.48 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.814 0.446 . . . . 0.0 110.548 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 35.9 mm -131.49 133.98 25.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 119' ' ' ILE . 46.8 Cg_exo -61.04 -13.38 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.633 2.888 . . . . 0.0 115.797 -171.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -135.88 23.85 3.34 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -91.11 -12.4 35.69 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 121.641 -0.662 . . . . 0.0 110.911 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -88.59 -6.22 57.67 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.6 tp -101.41 -27.62 13.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.709 0.804 . . . . 0.0 109.601 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -80.98 -21.68 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.29 -44.44 10.24 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 0.0 111.199 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.58 -13.94 59.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.46 -17.31 11.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.903 0.774 . . . . 0.0 111.747 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -70.97 -25.65 62.81 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.867 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.89 -63.43 1.32 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.296 0.238 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -80.7 8.48 7.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -143.91 -17.69 0.59 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.421 ' CG2' HD21 ' A' ' 145' ' ' LEU . 1.5 t -135.6 24.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.914 1.234 . . . . 0.0 113.693 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.5 m -103.92 26.61 8.47 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.179 -0.951 . . . . 0.0 111.665 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.07 24.02 3.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.788 0.435 . . . . 0.0 111.218 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -148.14 -74.99 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.274 -0.266 . . . . 0.0 111.265 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -140.5 158.1 44.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.853 0.861 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.67 157.39 50.53 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.57 171.63 27.09 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 123.372 0.511 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 34.7 p -87.13 -5.55 58.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.206 0.602 . . . . 0.0 110.564 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.9 m -89.43 13.52 13.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.504 0.322 . . . . 0.0 110.167 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.51 -12.4 81.88 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -141.69 158.26 63.23 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.976 0.51 . . . . 0.0 110.135 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.15 14.47 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.297 3.332 . . . . 0.0 112.927 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 133' ' ' VAL . 2.9 pp -69.49 -6.0 27.71 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.899 0.772 . . . . 0.0 111.148 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -75.13 -1.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -137.62 34.03 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.47 1.108 . . . . 0.0 109.403 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.43 -16.99 0.38 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.475 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.03 -55.71 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.16 0 CA-C-N 118.623 1.212 . . . . 0.0 112.353 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.2 m 30.31 49.96 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.663 1.585 . . . . 0.0 114.495 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.79 153.67 34.71 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.798 -0.564 . . . . 0.0 109.578 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.03 24.94 6.32 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.29 146.86 62.65 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 121.985 -0.447 . . . . 0.0 110.429 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.13 17.3 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.756 3.638 . . . . 0.0 112.687 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.75 146.89 53.03 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.693 0.397 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.2 pt -129.44 157.1 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.456 0.702 . . . . 0.0 110.828 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -78.23 24.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.914 0.886 . . . . 0.0 113.003 -176.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.99 140.31 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.475 0.71 . . . . 0.0 110.069 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 75.52 -174.48 52.35 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.38 146.15 48.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.375 0.67 . . . . 0.0 110.259 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.39 9.2 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.811 -0.438 . . . . 0.0 112.664 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.36 134.49 28.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 117.81 0.805 . . . . 0.0 110.297 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.5 m -135.44 150.48 49.86 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.2 m -135.04 142.94 46.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.941 0.496 . . . . 0.0 110.725 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.25 158.85 20.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.337 0.655 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -127.67 147.68 50.38 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.27 0.628 . . . . 0.0 110.443 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.45 149.34 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.379 0.672 . . . . 0.0 110.295 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 81.1 p -135.13 155.94 49.84 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.395 0.678 . . . . 0.0 110.615 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -135.21 143.76 46.56 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.254 0.621 . . . . 0.0 110.087 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -135.16 150.81 50.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.272 0.629 . . . . 0.0 110.626 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -148.37 154.47 41.9 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.27 0.628 . . . . 0.0 110.162 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.13 167.78 25.16 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.563 2.842 . . . . 0.0 110.881 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 64.0 m -111.73 133.9 53.66 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.064 0.545 . . . . 0.0 109.98 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.42 137.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.716 0.407 . . . . 0.0 110.878 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.3 p -135.73 147.72 48.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.164 0.586 . . . . 0.0 110.659 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.9 166.1 54.73 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -135.44 27.1 3.43 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.397 0.679 . . . . 0.0 111.235 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -135.28 144.21 46.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.463 0.705 . . . . 0.0 109.616 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.81 163.89 51.74 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.29 171.99 16.94 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.399 3.399 . . . . 0.0 111.277 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -135.27 140.24 45.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.648 0.779 . . . . 0.0 109.42 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.4 m -114.0 129.26 56.62 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.816 0.446 . . . . 0.0 110.741 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.74 -179.27 52.86 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -147.15 136.18 11.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.529 2.82 . . . . 0.0 111.283 179.595 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.527 0.158 0 N-CA-C 113.117 0.391 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -137.48 54.98 1.81 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.797 0.439 . . . . 0.0 110.732 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.71 151.9 50.62 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.814 0.446 . . . . 0.0 111.288 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -135.35 24.44 3.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.401 0.68 . . . . 0.0 111.206 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -78.86 162.82 25.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.198 0.599 . . . . 0.0 111.682 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.48 138.51 53.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.594 0.757 . . . . 0.0 109.384 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.0 m -135.2 55.41 1.89 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.187 0.595 . . . . 0.0 110.553 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.35 152.12 45.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.615 0.366 . . . . 0.0 110.9 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -75.24 152.77 86.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.418 0.287 . . . . 0.0 110.506 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.53 174.38 12.9 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.051 3.167 . . . . 0.0 110.65 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -92.18 24.65 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.866 0.466 . . . . 0.0 111.436 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -85.05 152.61 23.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.76 0.424 . . . . 0.0 110.39 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -112.22 156.42 42.04 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 122.895 0.478 . . . . 0.0 110.78 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.63 167.28 6.85 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.094 3.196 . . . . 0.0 113.039 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -132.03 157.26 78.7 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.174 0.99 . . . . 0.0 108.887 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.26 161.07 35.69 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.293 2.662 . . . . 0.0 112.38 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.14 141.22 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.236 0.614 . . . . 0.0 111.523 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.499 ' H ' HG12 ' A' ' 150' ' ' VAL . 6.3 t 63.88 14.18 8.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.683 1.593 . . . . 0.0 115.191 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -147.89 39.19 0.93 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.56 -0.712 . . . . 0.0 111.313 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -130.67 152.06 50.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.338 0.655 . . . . 0.0 109.875 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.9 m -130.05 26.66 5.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.828 0.451 . . . . 0.0 111.919 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 m -133.21 55.82 1.88 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.56 133.38 46.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.65 154.51 34.91 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.573 2.849 . . . . 0.0 110.59 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.52 17.29 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.67 3.58 . . . . 0.0 112.128 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -131.02 158.37 40.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.3 t60 58.99 46.93 12.84 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.163 1.385 . . . . 0.0 112.559 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.9 tp -135.61 142.98 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -100.57 8.86 43.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.541 ' H ' HG13 ' A' ' 28' ' ' ILE . 13.7 m -135.62 104.72 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.322 0.649 . . . . 0.0 110.055 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -141.44 125.27 17.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.557 0.343 . . . . 0.0 111.027 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -144.86 51.23 1.24 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.869 0.868 . . . . 0.0 109.568 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -73.95 146.08 44.18 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 122.658 0.383 . . . . 0.0 111.458 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.5 m -134.91 143.87 47.18 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.118 0.967 . . . . 0.0 108.533 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -110.9 141.58 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -133.39 144.61 49.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.991 0.516 . . . . 0.0 110.634 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.87 155.04 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.705 0.802 . . . . 0.0 108.935 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.22 170.22 36.23 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.0 77.35 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.119 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 m -47.97 114.34 3.26 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.682 0.793 . . . . 0.0 111.714 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.21 -8.17 10.84 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.533 2.822 . . . . 0.0 113.058 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.93 -18.2 31.37 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.974 0.806 . . . . 0.0 111.182 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 33.71 49.98 0.28 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.032 1.333 . . . . 0.0 112.608 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.3 tpp -135.58 -75.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -150.94 166.76 29.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.286 0.565 . . . . 0.0 111.675 -169.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.37 -4.77 31.97 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.683 0.793 . . . . 0.0 112.31 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -83.84 -8.86 59.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.03 -0.419 . . . . 0.0 111.57 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.95 -30.13 19.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.73 -26.41 59.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.1 -19.43 36.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.33 -13.37 59.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.044 0.383 . . . . 0.0 110.798 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.5 -5.5 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.32 12.77 20.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.243 0.617 . . . . 0.0 110.991 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 16.8 tppt? -91.45 -39.69 0.38 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.327 -0.844 . . . . 0.0 113.215 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 93.7 Cg_endo -78.72 -20.01 10.84 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.794 1.663 . . . . 0.0 113.43 -173.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -136.25 17.23 3.19 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.751 0.705 . . . . 0.0 112.694 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.25 170.23 22.35 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.994 -0.442 . . . . 0.0 110.952 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.9 55.9 1.17 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.602 0.761 . . . . 0.0 109.722 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.76 138.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.105 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -131.27 7.28 4.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -145.89 127.83 15.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -141.35 128.18 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 123.33 0.652 . . . . 0.0 109.629 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.4 138.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 122.912 0.485 . . . . 0.0 109.972 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mt -107.86 104.79 14.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.031 0.932 . . . . 0.0 109.739 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -80.91 94.0 6.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.0 m120 63.21 127.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.774 1.23 . . . . 0.0 110.473 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -76.06 22.0 0.16 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -146.69 25.48 1.18 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.966 0.507 . . . . 0.0 110.52 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -135.45 -88.38 0.34 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.125 -0.359 . . . . 0.0 111.695 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -137.42 159.25 42.47 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 123.16 0.584 . . . . 0.0 111.708 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.6 143.86 45.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.57 0.748 . . . . 0.0 109.181 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.34 133.18 56.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -135.71 151.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -135.16 135.64 41.24 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.716 0.406 . . . . 0.0 111.003 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -109.17 152.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 124.675 1.19 . . . . 0.0 110.011 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -82.2 -1.4 48.98 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.4 m -144.78 127.42 16.14 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.751 0.82 . . . . 0.0 109.222 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -8.99 58.14 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.214 -0.304 . . . . 0.0 111.755 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -87.29 -14.85 39.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.095 0.407 . . . . 0.0 110.225 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -88.61 -17.71 29.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.24 -41.01 70.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -69.94 -20.32 63.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -86.39 -9.54 56.12 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.115 -0.366 . . . . 0.0 111.581 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.63 -49.38 19.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -25.44 67.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -71.16 -44.89 64.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -77.42 -26.63 51.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.553 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.87 -0.63 52.04 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.244 -0.285 . . . . 0.0 110.436 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -125.96 8.14 7.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.734 0.243 . . . . 0.0 111.575 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -135.42 15.29 3.45 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.68 49.83 2.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.337 0.517 . . . . 0.0 110.73 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.34 10.04 81.7 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.445 -0.642 . . . . 0.0 112.63 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.75 98.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.916 1.286 . . . . 0.0 111.78 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.28 154.32 93.06 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -10.98 29.78 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.601 2.868 . . . . 0.0 112.109 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 96' ' ' LEU . 23.9 mt -80.26 119.71 23.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.82 104.54 14.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -111.73 139.2 47.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.986 0.422 . . . . 0.0 111.455 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -146.14 159.17 43.66 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.482 1.113 . . . . 0.0 109.427 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -127.62 156.27 42.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.06 -175.04 14.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.21 141.22 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.127 0.464 . . . . 0.0 110.837 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.87 1.99 61.21 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.627 0.632 . . . . 0.0 113.932 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.76 31.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.429 1.114 . . . . 0.0 112.056 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.91 163.08 54.47 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.25 125.83 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.58 2.854 . . . . 0.0 111.875 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -149.64 22.95 0.9 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.448 0.299 . . . . 0.0 110.998 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -148.36 48.81 1.04 Allowed 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.113 -0.367 . . . . 0.0 110.527 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 34.7 t -135.18 55.41 1.89 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.702 0.401 . . . . 0.0 110.463 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 83.2 m -121.05 21.18 11.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.691 0.396 . . . . 0.0 111.343 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.15 149.53 32.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.178 0.591 . . . . 0.0 109.484 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -68.55 -15.74 63.64 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.79 6.56 41.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.135 -0.353 . . . . 0.0 111.1 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -135.19 24.23 3.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 109.606 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.55 -12.65 0.19 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.032 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -98.89 24.08 8.12 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.669 1.234 . . . . 0.0 110.941 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.9 t -147.72 143.7 27.77 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.426 0.69 . . . . 0.0 109.683 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.88 103.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -143.99 39.16 0.26 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.203 1.001 . . . . 0.0 111.514 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 43.7 Cg_endo -60.39 -35.97 88.92 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.142 2.561 . . . . 0.0 112.627 -169.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.17 14.26 3.04 Favored 'General case' 0 C--N 1.337 0.046 0 CA-C-N 118.117 0.417 . . . . 0.0 111.022 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -82.87 -18.15 41.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.148 -0.345 . . . . 0.0 111.054 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -97.88 -2.41 40.81 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 tp -109.8 -27.11 9.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -80.67 -26.58 37.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.45 -42.13 13.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.763 0.256 . . . . 0.0 111.539 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.36 -10.45 59.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.142 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -104.78 -20.69 13.52 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.912 0.778 . . . . 0.0 110.937 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.18 -13.82 58.22 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.012 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.12 -61.61 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -78.32 -0.42 28.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.3 m -138.97 -2.53 1.68 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.75 24.35 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.749 1.159 . . . . 0.0 111.208 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.5 p -72.84 55.06 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.755 -0.591 . . . . 0.0 111.828 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 137.68 42.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.195 0.598 . . . . 0.0 110.487 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 53.13 27.5 5.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.973 . . . . 0.0 112.432 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 78.4 m95 54.26 24.98 5.4 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.05 0.94 . . . . 0.0 112.759 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.01 170.38 54.66 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 176.18 147.0 6.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.4 m 58.2 7.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.325 1.45 . . . . 0.0 113.197 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.9 p -160.21 19.83 0.15 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.768 -0.583 . . . . 0.0 111.375 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -93.46 -21.89 28.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.206 -0.775 . . . . 0.0 114.001 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -149.09 160.77 34.23 Favored Pre-proline 0 C--O 1.227 -0.096 0 CA-C-N 118.515 1.158 . . . . 0.0 110.187 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.51 -1.27 0.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.28 3.32 . . . . 0.0 114.415 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.54 -8.14 56.0 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.809 0.732 . . . . 0.0 110.712 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.61 9.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.028 0.531 . . . . 0.0 110.553 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.1 p -128.31 31.51 5.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.05 0.54 . . . . 0.0 109.964 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.22 -26.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.55 65.24 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 121.556 0.693 . . . . 0.0 110.229 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 18' ' ' SER . 19.9 m -135.98 18.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -138.14 40.1 2.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -135.19 151.46 50.67 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 154' ' ' PRO . 25.5 tt0 -154.73 43.74 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 111.061 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 153' ' ' GLU . 60.9 Cg_endo -77.89 -18.46 13.15 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 48.28 52.44 13.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.638 0.775 . . . . 0.0 111.81 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 8.4 tt -133.97 141.09 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.86 109.09 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 m -83.93 68.02 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 121.343 0.592 . . . . 0.0 110.545 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.04 -163.09 12.32 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.57 104.6 3.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.131 0.466 . . . . 0.0 110.299 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -85.55 -169.62 46.17 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.363 0.506 . . . . 0.0 111.921 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -135.36 141.25 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.829 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.1 m -135.36 36.55 2.96 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.092 0.557 . . . . 0.0 111.15 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.0 m -82.25 40.18 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.323 0.649 . . . . 0.0 111.46 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -135.73 155.73 49.93 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.809 0.844 . . . . 0.0 110.637 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.32 146.35 48.37 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.008 0.523 . . . . 0.0 110.761 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.3 mt -134.97 139.28 47.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.747 0.819 . . . . 0.0 108.852 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 m -61.82 138.33 58.33 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.774 0.429 . . . . 0.0 111.108 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.82 40.26 0.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.558 0.743 . . . . 0.0 111.221 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.67 110.16 8.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 109.868 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 15.3 tpt -150.5 135.79 10.12 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.13 168.73 23.27 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.315 2.676 . . . . 0.0 111.066 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.5 p -127.54 32.4 5.01 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.474 0.71 . . . . 0.0 110.598 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -82.79 55.67 3.12 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.513 0.725 . . . . 0.0 110.88 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.6 m -134.7 128.48 33.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.198 0.599 . . . . 0.0 110.225 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.78 178.14 53.92 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -135.35 25.05 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.449 0.7 . . . . 0.0 111.068 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.66 154.66 51.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.708 0.803 . . . . 0.0 109.856 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.99 174.63 37.63 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.32 160.42 48.82 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 124.144 3.229 . . . . 0.0 111.427 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.51 151.63 50.54 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.034 0.933 . . . . 0.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.3 t -135.51 138.7 43.35 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.881 0.473 . . . . 0.0 110.541 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.47 176.76 41.42 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 185' ' ' PRO . 37.9 mtmm -85.47 -41.91 0.63 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.165 -0.922 . . . . 0.0 113.074 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 184' ' ' LYS . 85.0 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.204 1.936 . . . . 0.0 111.093 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.472 0.239 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -135.43 153.02 51.92 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.395 0.678 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.09 158.28 44.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.381 0.673 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.3 55.43 2.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.229 0.612 . . . . 0.0 110.666 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 55.08 34.8 23.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.104 0.961 . . . . 0.0 111.698 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.17 132.48 33.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 122.842 0.457 . . . . 0.0 109.847 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -66.73 120.99 14.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.15 156.63 46.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.194 0.598 . . . . 0.0 110.758 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 47.64 59.48 16.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.04 0.936 . . . . 0.0 112.272 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.87 171.36 12.4 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.669 2.913 . . . . 0.0 111.098 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.49 150.98 39.62 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.09 0.556 . . . . 0.0 110.824 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -133.01 45.65 2.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.993 0.517 . . . . 0.0 111.706 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -135.42 158.93 73.46 Favored Pre-proline 0 CA--C 1.529 0.173 0 C-N-CA 122.736 0.414 . . . . 0.0 110.192 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -55.6 151.81 36.88 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.218 3.279 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -152.06 47.66 0.42 Allowed Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.616 0.766 . . . . 0.0 110.993 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.6 -14.37 44.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.498 2.799 . . . . 0.0 113.375 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.27 -50.73 5.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.324 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.6 t -158.91 -65.45 0.08 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.026 0.375 . . . . 0.0 111.217 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -146.09 48.35 1.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.225 1.01 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.03 -48.43 64.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.945 0.898 . . . . 0.0 112.481 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 76.9 p 51.18 26.09 2.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.041 0.937 . . . . 0.0 113.124 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 m 65.36 101.2 0.04 OUTLIER 'General case' 0 C--N 1.339 0.109 0 C-N-CA 125.086 1.354 . . . . 0.0 111.696 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' HD22 ' A' ' 23' ' ' LEU . 2.5 mm? -87.45 157.94 52.32 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.127 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.56 148.08 87.12 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.653 2.235 . . . . 0.0 109.62 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.9 12.79 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.589 3.526 . . . . 0.0 113.278 -173.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -135.08 142.0 46.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 63.46 140.22 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.715 2.006 . . . . 0.0 114.994 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 30' ' ' VAL . 6.7 tp -75.65 137.71 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.52 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -113.32 24.69 12.01 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.053 0.541 . . . . 0.0 112.138 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' H ' HG13 ' A' ' 28' ' ' ILE . 55.4 t -106.16 -3.69 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.209 0.604 . . . . 0.0 109.722 174.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -141.34 32.72 1.69 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.868 0.867 . . . . 0.0 110.038 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 t -135.38 159.4 41.69 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.88 0.472 . . . . 0.0 111.256 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -111.85 129.39 56.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.404 1.082 . . . . 0.0 109.163 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -135.65 154.44 51.3 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.5 tp -121.32 115.46 23.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -89.02 135.96 33.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.218 1.007 . . . . 0.0 110.445 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.8 mm -127.48 104.69 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.56 164.07 13.03 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.225 0.347 . . . . 0.0 113.232 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 -47.74 3.0 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.99 1.281 . . . . 0.0 112.596 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m 37.64 48.64 1.35 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.375 1.47 . . . . 0.0 114.741 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.81 1.95 4.01 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.829 2.352 . . . . 0.0 110.159 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.44 43.49 0.55 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.874 1.67 . . . . 0.0 110.775 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 56.88 24.13 8.94 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.974 1.31 . . . . 0.0 112.57 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.3 ptt? 34.35 55.21 0.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.324 1.45 . . . . 0.0 113.575 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -128.68 129.32 45.64 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.96 -13.88 62.28 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -82.77 -14.67 54.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.284 0.493 . . . . 0.0 110.594 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -95.42 -24.81 16.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.191 -0.318 . . . . 0.0 110.347 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.71 -26.59 62.55 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.6 -20.36 36.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -79.44 -6.56 57.13 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.109 -0.369 . . . . 0.0 111.168 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.83 -3.25 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.17 -0.331 . . . . 0.0 111.889 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mp -113.44 15.68 19.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.532 0.733 . . . . 0.0 110.202 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttm -101.62 -40.06 0.21 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.566 169.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 32.5 Cg_exo -61.55 114.61 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.233 1.955 . . . . 0.0 110.344 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.81 30.88 5.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.55 0.74 . . . . 0.0 112.008 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.46 161.97 40.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.028 0.531 . . . . 0.0 110.883 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -138.7 85.74 2.1 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.672 0.389 . . . . 0.0 111.025 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.6 140.42 25.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -135.17 8.15 3.43 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.0 m -135.7 119.6 17.4 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.59 128.52 33.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.149 0.579 . . . . 0.0 110.122 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.39 143.77 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 171.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -125.4 137.86 54.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.626 1.17 . . . . 0.0 110.838 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -112.03 98.43 7.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -83.15 43.21 0.85 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.037 0.535 . . . . 0.0 111.765 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.02 -7.04 2.35 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.636 0.374 . . . . 0.0 110.914 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -153.21 35.03 0.47 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.735 0.414 . . . . 0.0 110.63 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 33.99 55.59 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.803 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -125.83 141.57 51.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.323 0.649 . . . . 0.0 111.029 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.98 154.28 47.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.293 0.568 . . . . 0.0 111.227 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -135.24 132.76 38.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.73 38.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.688 0.28 . . . . 0.0 111.379 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -135.42 129.97 34.1 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.117 0.484 . . . . 0.0 110.885 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.96 148.13 9.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.127 1.371 . . . . 0.0 108.984 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.17 24.26 11.75 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.4 t -148.72 132.16 16.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.848 0.859 . . . . 0.0 108.813 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -78.19 -14.63 59.38 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.137 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.58 -25.45 24.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -87.47 -16.37 34.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -47.84 67.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.11 -14.37 59.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.76 -11.37 48.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.477 0.581 . . . . 0.0 111.09 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.14 -41.5 17.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.08 -21.91 64.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.884 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -77.17 -26.2 52.71 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.707 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -68.56 -42.25 78.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -83.34 10.24 9.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.367 -0.208 . . . . 0.0 111.342 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -116.35 1.27 13.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.262 0.625 . . . . 0.0 109.716 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -135.58 18.57 3.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.875 0.47 . . . . 0.0 111.406 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -134.75 48.04 2.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.178 0.513 . . . . 0.0 110.957 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.88 -13.63 12.91 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.614 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.18 33.84 18.9 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.056 0.928 . . . . 0.0 113.413 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.722 ' H ' ' CD ' ' A' ' 95' ' ' PRO . 80.4 mt -136.21 -28.23 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.722 ' CD ' ' H ' ' A' ' 94' ' ' LEU . 76.9 Cg_exo -55.35 -31.64 78.05 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.075 1.85 . . . . 0.0 113.246 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt -143.2 143.22 31.68 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.422 0.689 . . . . 0.0 109.892 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -94.85 97.07 9.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.0 p -114.41 138.03 51.09 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -173.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -146.05 146.21 30.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.277 1.031 . . . . 0.0 109.127 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -135.08 160.52 38.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 110.917 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 165.7 37.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.13 142.28 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.743 0.817 . . . . 0.0 109.692 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.73 121.2 5.69 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.54 24.26 1.74 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.294 0.638 . . . . 0.0 111.136 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.59 178.94 52.73 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.54 161.92 41.14 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.02 3.147 . . . . 0.0 111.514 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -87.44 125.16 34.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.244 0.617 . . . . 0.0 110.477 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 52.58 30.68 8.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.236 1.014 . . . . 0.0 112.752 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 12.6 t -135.77 36.52 2.87 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.93 0.492 . . . . 0.0 110.114 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.63 141.67 45.1 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.21 0.604 . . . . 0.0 110.221 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -78.03 150.83 33.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.717 0.407 . . . . 0.0 110.042 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -70.18 -6.95 37.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -85.68 0.24 53.29 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.44 0.563 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -135.81 12.49 3.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.838 0.855 . . . . 0.0 109.953 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.45 -11.41 7.33 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -135.01 24.07 3.57 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.176 0.59 . . . . 0.0 110.0 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.4 m -139.99 137.89 35.06 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.934 0.894 . . . . 0.0 109.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.2 tt -90.06 130.98 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.714 0.293 . . . . 0.0 110.496 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -142.27 151.08 57.39 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 123.509 0.724 . . . . 0.0 109.928 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.19 176.92 8.5 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.557 2.838 . . . . 0.0 110.618 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.65 27.63 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.343 0.657 . . . . 0.0 112.483 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -15.43 51.75 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.711 -0.618 . . . . 0.0 111.294 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -85.43 -6.76 59.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.02 -42.8 9.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.53 0.732 . . . . 0.0 109.6 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -76.29 -16.74 59.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.56 -51.2 6.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.737 -0.602 . . . . 0.0 110.398 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.26 -8.68 58.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -112.81 -15.86 12.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.759 0.709 . . . . 0.0 111.487 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -20.99 61.07 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.54 -54.28 4.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.509 0.324 . . . . 0.0 110.561 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -82.91 6.14 19.53 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -147.37 0.68 0.7 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.53 15.25 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.269 0.94 . . . . 0.0 111.133 174.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.8 m -135.0 24.74 3.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.991 0.517 . . . . 0.0 109.911 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.5 151.24 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.057 0.943 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.81 20.79 1.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -141.91 24.27 2.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.458 0.703 . . . . 0.0 110.413 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.56 -159.74 35.75 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.479 0.562 . . . . 0.0 112.135 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.68 -154.28 2.37 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.091 0.853 . . . . 0.0 111.747 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.7 m -103.77 70.6 1.02 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 t 60.71 32.03 20.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.707 0.803 . . . . 0.0 111.829 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.27 79.6 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.959 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.7 -44.38 0.5 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 118.361 1.081 . . . . 0.0 113.305 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -90.53 -19.57 1.07 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.544 2.163 . . . . 0.0 113.43 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.65 -7.66 59.15 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -171.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.8 m -74.85 -0.8 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 CA-C-N 117.877 0.308 . . . . 0.0 111.241 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 t -147.67 23.22 1.12 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.367 1.067 . . . . 0.0 108.41 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.5 34.15 0.3 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.605 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.7 mm -49.0 -29.21 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 117.582 0.691 . . . . 0.0 111.956 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.3 m 44.2 29.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.55 1.54 . . . . 0.0 114.242 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -135.27 150.17 49.98 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.053 0.388 . . . . 0.0 110.555 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -133.47 24.63 4.09 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.569 0.748 . . . . 0.0 109.327 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -153.84 141.21 13.48 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.929 0.892 . . . . 0.0 108.689 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -67.78 158.35 57.65 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.169 2.579 . . . . 0.0 111.236 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.23 141.94 32.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.57 0.348 . . . . 0.0 110.856 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.58 129.8 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.014 0.526 . . . . 0.0 110.056 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 pp -135.43 151.44 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.641 0.776 . . . . 0.0 110.366 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.0 m -135.89 146.27 29.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.087 0.555 . . . . 0.0 110.866 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -85.29 -150.06 12.62 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 67.51 143.65 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.182 1.393 . . . . 0.0 113.315 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.53 177.01 45.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.21 130.44 51.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 122.75 0.42 . . . . 0.0 110.287 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.4 m -135.65 105.82 6.33 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.617 0.767 . . . . 0.0 109.125 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 t -135.76 151.09 49.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.854 0.461 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -135.41 152.18 51.16 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.849 0.859 . . . . 0.0 110.175 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.33 153.57 51.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.847 0.459 . . . . 0.0 111.36 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 tt -135.37 149.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.858 0.863 . . . . 0.0 109.632 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 80.7 p -135.11 152.77 51.94 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.866 0.466 . . . . 0.0 111.291 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 62.58 118.74 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.715 1.606 . . . . 0.0 113.091 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -135.45 33.34 3.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.493 0.717 . . . . 0.0 109.936 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.8 ptm -151.66 154.28 32.98 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 123.407 0.683 . . . . 0.0 110.119 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -71.41 148.43 54.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.391 2.727 . . . . 0.0 110.664 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.2 p -135.89 25.04 3.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.281 0.633 . . . . 0.0 111.168 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -102.14 24.74 9.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.187 0.595 . . . . 0.0 111.725 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 35.4 t -81.26 136.44 35.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.632 0.373 . . . . 0.0 110.829 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 174.98 160.81 23.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -142.96 152.11 41.64 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.208 0.603 . . . . 0.0 111.016 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 131.18 57.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.365 0.666 . . . . 0.0 109.488 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.64 158.61 48.94 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.34 159.91 42.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.954 3.103 . . . . 0.0 110.931 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -135.38 112.72 10.57 Favored 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.611 0.764 . . . . 0.0 109.475 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 65.2 p -135.96 131.11 34.68 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.509 . . . . 0.0 110.798 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.34 173.73 51.82 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 29.1 mtpp -85.53 -34.73 0.51 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.869 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 54.7 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.104 2.536 . . . . 0.0 112.451 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.527 0.155 0 N-CA-C 112.554 0.175 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.69 154.4 21.0 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.795 0.438 . . . . 0.0 110.806 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.81 144.74 52.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.568 0.347 . . . . 0.0 110.744 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.79 27.1 6.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.442 0.697 . . . . 0.0 111.544 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -80.6 44.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.26 1.024 . . . . 0.0 111.438 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.8 p -67.0 145.5 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.185 0.594 . . . . 0.0 110.783 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 t -75.18 148.91 39.17 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.985 0.514 . . . . 0.0 111.075 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -90.44 105.0 17.52 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.828 0.451 . . . . 0.0 109.852 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -148.09 156.01 43.56 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.041 0.537 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.66 158.57 56.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.342 2.695 . . . . 0.0 110.237 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -139.55 46.47 1.89 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.732 0.413 . . . . 0.0 110.594 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -64.69 140.29 58.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.517 0.327 . . . . 0.0 110.127 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -123.4 150.06 59.72 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.912 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 -172.13 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 124.34 3.36 . . . . 0.0 110.535 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.31 166.22 0.11 Allowed Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.04 1.336 . . . . 0.0 112.881 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.05 -176.87 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.727 3.618 . . . . 0.0 113.811 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.91 148.48 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.941 0.896 . . . . 0.0 112.018 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.429 ' H ' HG21 ' A' ' 150' ' ' VAL . 32.3 m -71.22 65.47 0.4 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.628 1.171 . . . . 0.0 111.77 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 72.81 29.81 1.85 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.754 1.622 . . . . 0.0 114.703 172.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.5 104.58 7.05 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 m -87.87 25.59 1.5 Allowed 'General case' 0 C--O 1.231 0.088 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' CD ' ' A' ' 24' ' ' PRO . 35.2 p -140.84 87.77 2.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.153 0.981 . . . . 0.0 109.362 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 6.9 mp -108.72 39.1 0.11 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.346 1.058 . . . . 0.0 112.114 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 23' ' ' LEU . 62.2 Cg_endo -76.73 172.18 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.938 2.425 . . . . 0.0 109.391 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.3 160.82 21.86 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.584 2.189 . . . . 0.0 110.548 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 59.25 24.48 12.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.952 0.901 . . . . 0.0 112.415 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -136.27 129.15 31.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.587 0.755 . . . . 0.0 109.039 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.41 ' CD1' HD23 ' A' ' 124' ' ' LEU . 5.1 tp -148.54 138.77 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.563 0.345 . . . . 0.0 110.685 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -137.86 22.87 2.86 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.97 125.32 18.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 119.757 1.162 . . . . 0.0 109.24 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.43 163.78 22.53 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.293 0.637 . . . . 0.0 111.74 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -130.47 145.81 51.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.952 0.901 . . . . 0.0 109.053 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -126.57 29.5 5.72 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 m -132.31 104.62 6.84 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -101.89 140.5 36.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -130.12 137.75 50.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.34 0.656 . . . . 0.0 110.124 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 71' ' ' ALA . 5.8 mm -120.33 113.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.83 160.7 16.92 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.31 17.98 74.71 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.639 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.44 130.15 34.12 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.388 1.094 . . . . 0.0 110.789 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.52 -0.6 10.54 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.43 2.753 . . . . 0.0 111.425 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.68 152.41 33.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.371 0.605 . . . . 0.0 111.44 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -97.28 55.36 1.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.1 ttt 62.96 70.14 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.564 1.145 . . . . 0.0 112.198 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.35 88.75 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.09 -11.58 20.87 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.613 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -82.91 -12.41 57.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.082 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -93.88 -22.59 18.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 118.938 -1.105 . . . . 0.0 110.55 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.65 -25.51 59.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.11 -18.07 38.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -76.47 -10.39 59.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.057 -0.402 . . . . 0.0 110.595 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.5 -4.69 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.44 17.52 19.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.45 0.7 . . . . 0.0 110.519 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 55' ' ' PRO . 88.6 tttt -114.13 -35.95 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 60.4 Cg_exo -56.91 -31.73 90.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.402 2.068 . . . . 0.0 113.648 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.18 22.78 2.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.856 0.298 . . . . 0.0 111.642 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.96 176.81 11.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.626 0.37 . . . . 0.0 110.733 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.49 76.05 1.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.003 0.43 . . . . 0.0 110.505 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.03 140.57 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -131.86 7.16 4.37 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -142.8 125.85 16.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.977 0.511 . . . . 0.0 109.729 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.75 127.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 122.965 0.506 . . . . 0.0 109.759 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.14 135.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mt -128.67 143.29 50.91 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.068 0.547 . . . . 0.0 111.639 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -123.26 104.68 9.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.27 1.028 . . . . 0.0 108.371 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -83.52 24.67 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -120.38 -3.5 9.94 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.232 -0.292 . . . . 0.0 111.725 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtm-85 -144.97 8.54 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.889 0.476 . . . . 0.0 111.304 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 51.76 42.45 29.9 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.23 0.612 . . . . 0.0 111.221 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -111.27 145.61 38.47 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.735 0.814 . . . . 0.0 110.113 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -140.83 150.64 43.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -125.03 127.18 46.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.9 151.1 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.476 0.125 . . . . 0.0 110.692 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.58 136.39 41.04 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.41 155.53 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 C-N-CA 124.48 1.112 . . . . 0.0 110.567 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -93.71 10.58 32.33 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.2 t -151.33 134.88 16.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.13 0.572 . . . . 0.0 109.913 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.55 -16.13 58.84 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.45 -25.35 33.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -83.91 -13.74 52.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.77 67.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -71.12 -18.88 62.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.777 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -82.01 -18.9 41.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.46 0.573 . . . . 0.0 111.6 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.47 -44.16 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 118.565 0.621 . . . . 0.0 109.809 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.26 -23.02 64.73 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.42 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -83.16 -10.42 58.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.884 -0.51 . . . . 0.0 110.77 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.0 -27.9 24.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -94.82 4.92 53.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.267 -0.271 . . . . 0.0 111.245 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -134.8 6.03 3.41 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -149.44 15.01 0.88 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -135.37 55.16 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.84 0.745 . . . . 0.0 110.931 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.27 83.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.201 -0.777 . . . . 0.0 113.394 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.1 74.08 0.26 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.995 0.897 . . . . 0.0 111.625 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.96 159.62 13.14 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.068 0.547 . . . . 0.0 111.265 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 -9.4 9.06 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.483 3.455 . . . . 0.0 114.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.95 128.57 36.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.587 0.63 . . . . 0.0 110.552 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -90.59 71.52 6.83 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.56 0.744 . . . . 0.0 109.083 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.6 m -74.89 129.86 38.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.146 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -135.68 149.11 49.17 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.387 1.075 . . . . 0.0 109.022 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -128.34 150.77 49.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.983 0.42 . . . . 0.0 111.575 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.51 -164.35 28.6 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.9 138.2 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.187 0.493 . . . . 0.0 110.394 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.21 12.52 37.71 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.429 0.538 . . . . 0.0 112.539 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -50.9 130.75 25.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.576 0.75 . . . . 0.0 111.428 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.37 -177.95 17.92 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.17 157.02 60.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.608 2.872 . . . . 0.0 110.556 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 88.2 mtm-85 50.84 55.01 10.2 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.541 0.736 . . . . 0.0 111.198 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -52.44 125.89 17.64 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.61 0.764 . . . . 0.0 111.312 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.9 m 54.91 27.69 9.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 0.0 113.4 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.5 m -121.74 11.37 10.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.897 0.317 . . . . 0.0 111.288 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -147.73 151.66 36.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 108.877 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -73.1 -2.57 21.93 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.252 -0.28 . . . . 0.0 111.414 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.68 5.94 41.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.913 0.485 . . . . 0.0 110.284 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -136.84 33.86 2.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.007 0.923 . . . . 0.0 109.779 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 176.03 -14.14 0.03 OUTLIER Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.09 -0.839 . . . . 0.0 113.693 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -135.17 25.03 3.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.867 1.334 . . . . 0.0 111.214 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.5 m -135.57 148.83 49.23 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.886 0.875 . . . . 0.0 109.536 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.4 tt -135.5 145.67 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 122.644 0.377 . . . . 0.0 111.018 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.93 157.95 75.98 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.016 0.926 . . . . 0.0 109.415 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.05 166.66 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.434 2.756 . . . . 0.0 111.012 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -124.85 25.66 7.31 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.823 0.449 . . . . 0.0 111.48 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -83.59 -9.87 58.63 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.813 -0.554 . . . . 0.0 111.217 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -88.8 3.25 51.74 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.407 0.283 . . . . 0.0 110.589 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.41 HD23 ' CD1' ' A' ' 28' ' ' ILE . 2.9 tp -90.66 -50.4 5.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.741 0.816 . . . . 0.0 108.887 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.6 m -77.65 -19.9 54.66 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.197 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.35 -45.82 12.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.043 -0.411 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.5 -19.12 39.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.273 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.87 -20.8 17.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.693 0.679 . . . . 0.0 110.997 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -67.36 -35.17 78.83 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.667 170.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.6 -77.66 0.1 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.145 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -89.15 18.71 4.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.5 t -138.89 -4.31 1.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.67 170.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 t -136.44 24.22 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.294 0.952 . . . . 0.0 111.27 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.8 p -73.64 24.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.133 -0.979 . . . . 0.0 112.952 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.06 24.13 3.56 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.958 -0.464 . . . . 0.0 111.087 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -147.0 144.07 28.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.668 0.787 . . . . 0.0 109.355 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -72.79 104.71 4.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.98 -179.8 49.5 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -81.81 -153.98 12.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m 67.4 104.56 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.227 1.411 . . . . 0.0 113.371 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m 54.47 30.11 12.33 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.4 -33.27 53.53 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -140.78 167.05 18.85 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.29 5.56 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.462 1 C-N-CA 125.437 4.091 . . . . 0.0 116.332 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.25 22.89 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.56 1.073 . . . . 0.0 111.769 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.73 1.48 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.785 0.834 . . . . 0.0 111.171 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.6 p -127.68 24.83 6.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.4 -21.85 4.27 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mm -102.72 0.93 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.45 0.625 . . . . 0.0 111.028 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.429 HG21 ' H ' ' A' ' 18' ' ' SER . 28.3 m -135.47 4.85 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 122.074 -0.391 . . . . 0.0 111.952 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -157.57 156.32 31.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.277 0.489 . . . . 0.0 110.71 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.86 31.66 0.61 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.823 0.849 . . . . 0.0 112.991 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.435 ' N ' ' HD2' ' A' ' 154' ' ' PRO . 26.4 tp10 -74.81 -38.67 3.18 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 153' ' ' GLU . 86.7 Cg_endo -77.09 160.31 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.991 1.794 . . . . 0.0 111.823 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.63 131.44 34.16 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.286 0.635 . . . . 0.0 109.886 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.3 tt -91.91 132.05 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.521 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -135.37 129.79 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.706 0.802 . . . . 0.0 109.174 175.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.43 137.31 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.064 0 C-N-CA 122.583 0.353 . . . . 0.0 110.673 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.4 0.03 85.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.62 104.31 7.06 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.14 0.576 . . . . 0.0 110.022 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -91.35 -4.55 68.25 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.08 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.1 p -85.93 140.72 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.0 0.9 . . . . 0.0 110.715 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.5 m -135.51 156.45 48.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.508 0.723 . . . . 0.0 110.45 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 79.8 p -134.44 149.53 50.76 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.258 0.623 . . . . 0.0 110.541 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -80.62 141.54 34.89 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.819 0.447 . . . . 0.0 110.884 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.48 25.82 3.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.414 0.686 . . . . 0.0 110.752 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 18.3 tt -80.77 142.12 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.091 0.556 . . . . 0.0 111.109 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.7 t -137.18 145.63 43.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.491 0.717 . . . . 0.0 109.991 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -135.29 135.17 40.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.974 0.509 . . . . 0.0 110.368 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.59 159.89 40.44 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.577 0.751 . . . . 0.0 110.381 178.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.0 128.4 9.31 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 163.77 37.9 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.865 3.043 . . . . 0.0 112.66 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -135.85 145.55 46.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.118 0.567 . . . . 0.0 110.459 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -136.31 143.48 44.18 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.055 0.542 . . . . 0.0 110.602 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.3 p -135.39 24.75 3.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.207 0.603 . . . . 0.0 111.106 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.15 -1.59 90.51 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.417 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -74.77 104.52 5.44 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.714 0.757 . . . . 0.0 109.837 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.72 136.5 54.49 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.874 0.87 . . . . 0.0 109.333 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.49 144.51 33.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.75 153.49 33.69 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.701 2.934 . . . . 0.0 111.247 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -145.4 131.55 19.41 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.301 0.64 . . . . 0.0 109.449 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.4 p -135.86 147.07 48.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.876 0.47 . . . . 0.0 111.151 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.15 177.01 54.48 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.3 157.86 71.82 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.26 0.624 . . . . 0.0 110.102 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 124.009 3.139 . . . . 0.0 112.428 178.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo . . . . . 0 N--CA 1.472 0.218 0 N-CA-C 112.76 0.254 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -135.6 142.69 45.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.11 0.564 . . . . 0.0 110.264 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -135.7 149.14 49.15 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.039 0.536 . . . . 0.0 110.81 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.1 152.98 52.16 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.699 0.8 . . . . 0.0 110.279 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -69.15 152.42 45.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.918 0.487 . . . . 0.0 110.311 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.77 139.61 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 122.826 0.451 . . . . 0.0 111.107 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 m -75.05 144.31 43.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.981 0.512 . . . . 0.0 111.518 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -135.65 144.31 45.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.613 0.765 . . . . 0.0 109.195 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -71.52 143.09 87.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 122.426 -0.171 . . . . 0.0 110.642 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.9 168.63 21.88 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.06 3.173 . . . . 0.0 111.354 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -92.64 158.23 16.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.332 0.653 . . . . 0.0 110.082 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -63.76 149.47 46.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.352 0.261 . . . . 0.0 110.737 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -126.37 155.0 74.86 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.593 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.3 167.09 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.638 2.892 . . . . 0.0 110.701 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.75 153.99 76.11 Favored Pre-proline 0 CA--C 1.528 0.134 0 C-N-CA 123.133 0.573 . . . . 0.0 110.4 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.9 174.82 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.833 3.022 . . . . 0.0 110.561 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.24 116.08 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.3 t -135.87 136.55 40.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.043 0.537 . . . . 0.0 109.821 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -75.05 120.78 21.04 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.509 0.671 . . . . 0.0 111.497 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 63.17 57.69 1.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.262 . . . . 0.0 112.779 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.9 p -135.04 -170.27 2.54 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.678 0.791 . . . . 0.0 110.254 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -99.02 55.95 1.03 Allowed 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.893 0.877 . . . . 0.0 111.042 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.729 ' H ' HD22 ' A' ' 23' ' ' LEU . 1.5 mm? -66.75 135.99 94.5 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 122.591 0.357 . . . . 0.0 110.386 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.56 112.46 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.515 2.81 . . . . 0.0 109.577 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.9 149.05 25.68 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.127 2.552 . . . . 0.0 112.247 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.09 -4.56 2.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.971 0.508 . . . . 0.0 111.041 171.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -157.66 104.09 1.95 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CD1' ' H ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -140.36 133.54 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' N ' HD13 ' A' ' 28' ' ' ILE . 75.0 mmtt -132.62 20.21 4.27 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.616 ' H ' ' CD1' ' A' ' 28' ' ' ILE . 7.0 m -135.49 39.78 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.196 0.999 . . . . 0.0 109.69 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.89 121.94 15.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.093 0.557 . . . . 0.0 110.223 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.7 t -79.23 131.03 36.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -135.11 -4.29 2.42 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.297 0.239 . . . . 0.0 111.283 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -142.36 136.67 29.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.82 133.62 47.05 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.59 145.22 46.7 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.307 0.575 . . . . 0.0 111.521 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.91 153.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.007 0.923 . . . . 0.0 109.361 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.29 164.47 30.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.25 19.97 79.29 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.35 -0.694 . . . . 0.0 112.724 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -48.63 129.72 13.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.114 0.957 . . . . 0.0 111.175 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -85.0 5.57 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.309 3.339 . . . . 0.0 111.458 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.98 159.63 24.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 112.291 -170.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.06 63.55 6.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.559 0.744 . . . . 0.0 109.764 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.5 ptm 51.31 104.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.126 2.17 . . . . 0.0 114.475 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.75 102.43 3.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.26 -19.33 65.79 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -85.21 -7.08 59.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.139 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -98.14 -21.57 16.67 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.306 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.09 -28.87 62.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.07 -22.26 45.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.521 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.22 -14.14 60.5 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.181 -0.324 . . . . 0.0 111.202 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.19 -0.67 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.194 -0.316 . . . . 0.0 111.783 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.1 10.89 28.0 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.421 0.688 . . . . 0.0 109.585 170.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 25.3 ttmm -78.77 -33.89 0.93 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.622 171.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.0 Cg_exo -57.7 115.04 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.444 2.096 . . . . 0.0 111.951 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 51.22 24.27 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.703 1.201 . . . . 0.0 113.455 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.8 157.29 41.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.124 0.57 . . . . 0.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -132.46 56.47 1.83 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.123 0.569 . . . . 0.0 110.298 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.42 139.04 15.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -129.3 3.37 5.16 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -135.05 121.25 20.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.051 -0.405 . . . . 0.0 110.288 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.98 129.17 43.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.497 0.719 . . . . 0.0 109.925 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.65 141.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 1.6 tt -134.23 121.72 21.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.214 . . . . 0.0 110.476 -169.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -100.87 104.4 15.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.068 0.547 . . . . 0.0 109.976 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -86.94 24.49 1.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.056 0.542 . . . . 0.0 111.812 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -127.37 2.61 6.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.735 0.414 . . . . 0.0 110.649 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -136.12 7.74 3.17 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.2 32.5 10.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.07 0.948 . . . . 0.0 111.446 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -134.39 152.62 51.91 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.409 0.683 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . . . -135.76 156.3 49.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.548 0.739 . . . . 0.0 110.235 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.85 134.39 49.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.78 151.45 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -135.1 139.37 44.64 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.453 0.644 . . . . 0.0 112.018 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.71 161.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 125.988 1.715 . . . . 0.0 109.172 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -108.27 22.59 15.72 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -152.59 137.48 17.14 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.201 0.6 . . . . 0.0 109.734 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.97 -9.59 58.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.316 -0.24 . . . . 0.0 111.502 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -86.84 -18.02 31.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -88.12 -22.1 24.29 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.24 43.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.09 -21.86 33.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.35 -0.219 . . . . 0.0 110.657 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.59 -19.47 38.36 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 122.014 -0.429 . . . . 0.0 110.871 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.76 -43.16 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.93 -17.0 62.7 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.075 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -74.46 -28.45 61.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.463 0.574 . . . . 0.0 109.532 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -76.1 -28.29 57.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.973 -0.454 . . . . 0.0 109.827 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -93.09 6.94 46.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.409 0.284 . . . . 0.0 111.013 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.02 16.28 3.51 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.381 0.272 . . . . 0.0 111.313 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -135.72 -8.02 2.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 -23.12 15.15 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.04 0.836 . . . . 0.0 110.786 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.21 1.16 0.63 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.832 1.206 . . . . 0.0 115.614 172.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.55 45.1 1.94 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.064 1.432 . . . . 0.0 112.159 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.81 142.69 28.19 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.52 -11.66 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.311 3.341 . . . . 0.0 112.821 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 80.1 mt -86.51 146.13 26.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.973 0.351 . . . . 0.0 110.799 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.13 104.59 10.97 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.4 m -103.49 134.7 46.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.313 0.645 . . . . 0.0 111.327 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -136.81 153.45 50.81 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.335 1.054 . . . . 0.0 108.925 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -123.4 144.8 49.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.934 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.22 148.62 17.24 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 104' ' ' PHE . 12.4 p -92.88 138.24 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.082 0.553 . . . . 0.0 110.694 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.06 5.59 82.37 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.62 0.629 . . . . 0.0 112.788 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.514 ' H ' HG22 ' A' ' 102' ' ' VAL . 67.0 t80 -116.46 144.49 44.25 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.642 0.721 . . . . 0.0 110.484 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.7 178.35 42.74 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.03 0.347 . . . . 0.0 112.592 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.86 175.72 9.98 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 124.396 3.398 . . . . 0.0 111.151 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -131.9 153.48 50.21 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 123.731 0.812 . . . . 0.0 110.475 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -134.99 51.8 2.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 110.226 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 15.9 t -135.33 42.56 2.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.272 0.629 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 48.7 t -135.88 147.97 48.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.74 0.816 . . . . 0.0 109.95 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.55 142.03 58.55 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -69.25 -9.31 52.51 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -83.61 -1.86 54.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.632 0.651 . . . . 0.0 110.465 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.91 3.65 2.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.692 0.797 . . . . 0.0 110.253 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.66 -19.5 24.73 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -93.55 32.51 1.38 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.12 0.568 . . . . 0.0 110.011 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.7 t -136.13 146.62 47.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.981 0.912 . . . . 0.0 109.478 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 118' ' ' ILE . 2.7 mp -85.9 84.33 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.411 ' N ' ' CD ' ' A' ' 120' ' ' PRO . 30.3 pt -139.62 46.5 1.06 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 119' ' ' ILE . 92.1 Cg_endo -69.47 -2.4 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.582 2.855 . . . . 0.0 112.626 -174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 mtt -121.87 20.36 10.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.783 0.433 . . . . 0.0 111.004 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -135.01 -8.82 2.33 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -89.71 -4.52 57.68 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.248 0.476 . . . . 0.0 109.938 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -92.5 -45.54 8.08 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.397 1.079 . . . . 0.0 109.303 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -80.83 -23.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.637 -0.22 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.59 -48.57 8.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.018 0.372 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.95 -14.13 56.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.166 -173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -98.37 -41.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.612 0.642 . . . . 0.0 110.891 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -76.34 -16.16 59.81 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -93.71 -52.42 4.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.982 -0.449 . . . . 0.0 110.523 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -83.49 3.8 30.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.16 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -135.85 -4.24 2.24 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 25.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.734 1.152 . . . . 0.0 112.263 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.4 p -72.46 55.71 0.35 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.937 -0.477 . . . . 0.0 111.638 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 53.89 46.41 25.72 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 111.161 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -82.0 49.76 1.44 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.588 0.755 . . . . 0.0 111.062 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 75.3 m95 54.5 35.2 22.79 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -173.47 45.31 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.57 -170.64 50.54 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 t -132.71 45.28 2.77 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.0 m 53.21 34.21 17.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.383 -172.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.96 -49.61 0.08 OUTLIER Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.01 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 145' ' ' LEU . 57.0 mt-30 62.06 170.53 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 119.166 1.483 . . . . 0.0 112.414 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.32 -9.9 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.744 3.629 . . . . 0.0 115.702 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -64.03 -61.39 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.91 0.777 . . . . 0.0 109.477 174.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.3 20.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.596 . . . . 0.0 111.445 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.3 m -101.47 30.84 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 -25.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 146' ' ' VAL . 5.1 pt -100.92 46.9 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.645 0.778 . . . . 0.0 111.213 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.37 36.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.155 0.582 . . . . 0.0 112.347 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 149' ' ' ILE . 55.4 t80 -75.29 175.08 8.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.161 0.984 . . . . 0.0 110.173 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -50.33 139.0 15.88 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 111.593 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -67.18 134.86 93.55 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.142 0.577 . . . . 0.0 110.22 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.49 179.91 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.994 3.13 . . . . 0.0 111.236 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.77 149.11 47.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.213 0.605 . . . . 0.0 110.468 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.9 pt -65.62 153.68 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.395 0.678 . . . . 0.0 111.681 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 157' ' ' ILE . 2.1 mp -77.88 107.96 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.46 26.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.647 0.779 . . . . 0.0 110.411 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -172.52 177.76 44.95 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -135.61 29.76 3.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.339 0.656 . . . . 0.0 111.189 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -68.17 149.64 50.27 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.69 158.56 39.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.855 0.862 . . . . 0.0 110.284 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.4 t -99.71 131.3 45.78 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.641 0.376 . . . . 0.0 110.389 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.0 p -88.68 154.64 20.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.03 0.532 . . . . 0.0 111.428 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -135.17 154.13 51.73 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.502 0.721 . . . . 0.0 110.475 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.16 32.79 3.13 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.057 0.543 . . . . 0.0 111.022 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 15.8 tt -135.38 128.78 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.011 0.524 . . . . 0.0 110.125 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 79.0 p -146.55 22.15 1.31 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.061 0.544 . . . . 0.0 111.141 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -90.56 54.99 2.87 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.394 0.677 . . . . 0.0 110.406 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -135.5 130.78 35.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.642 0.777 . . . . 0.0 109.692 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.36 157.88 33.66 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.216 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.19 158.98 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.542 2.828 . . . . 0.0 110.678 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 p -134.44 144.27 48.04 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 122.787 0.435 . . . . 0.0 111.177 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -135.63 152.42 51.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.001 0.92 . . . . 0.0 109.586 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.7 p -131.11 24.12 4.9 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.521 0.328 . . . . 0.0 111.812 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 62.38 -153.43 43.07 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -108.42 157.45 18.4 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.794 0.838 . . . . 0.0 109.492 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -79.65 49.49 1.04 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.35 0.66 . . . . 0.0 111.789 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.22 -179.96 52.51 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.01 168.65 23.37 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.286 3.324 . . . . 0.0 111.028 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -120.34 141.21 50.26 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.516 0.727 . . . . 0.0 109.94 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.2 m 53.64 38.84 29.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.419 0.688 . . . . 0.0 111.888 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.23 164.22 47.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 75.1 mmtt -88.23 -33.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.368 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 184' ' ' LYS . 64.3 Cg_exo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.078 2.519 . . . . 0.0 112.485 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.471 0.18 0 N-CA-C 112.472 0.143 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -135.6 141.83 45.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.168 0.587 . . . . 0.0 110.191 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.81 136.98 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.72 0.408 . . . . 0.0 110.973 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -83.75 58.74 4.79 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.166 0.586 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -70.34 121.0 16.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.841 0.456 . . . . 0.0 110.147 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.18 152.24 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.588 0.755 . . . . 0.0 110.225 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -135.58 154.06 51.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.257 0.623 . . . . 0.0 110.543 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -134.99 39.47 2.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.384 0.674 . . . . 0.0 109.668 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 19.8 t-20 -64.05 140.68 97.94 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.824 0.449 . . . . 0.0 109.912 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' ASN . 52.7 Cg_exo -56.42 151.92 42.57 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.633 2.889 . . . . 0.0 113.387 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -135.73 154.02 51.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.744 0.817 . . . . 0.0 110.195 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.59 148.76 38.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.602 0.239 . . . . 0.0 110.709 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.73 79.8 62.91 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 123.286 0.634 . . . . 0.0 110.114 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.26 160.28 48.31 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.52 2.813 . . . . 0.0 110.814 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -76.03 135.4 70.4 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 122.967 0.507 . . . . 0.0 110.543 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.87 161.94 32.78 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.592 2.862 . . . . 0.0 111.76 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.65 -41.12 18.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.2 m -146.59 -46.38 0.19 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.207 0.603 . . . . 0.0 110.237 171.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -149.92 12.82 0.78 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -146.12 147.4 31.51 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -118.97 171.71 8.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.249 0.62 . . . . 0.0 112.026 -172.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t 50.8 55.37 9.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.842 1.257 . . . . 0.0 111.506 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.74 152.76 66.75 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.586 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.73 165.58 31.61 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.094 3.196 . . . . 0.0 110.624 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.63 -8.25 22.82 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.654 2.903 . . . . 0.0 111.749 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -80.69 142.54 33.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -82.4 21.76 0.92 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 30' ' ' VAL . 7.3 tp -146.06 144.14 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -122.97 24.59 8.91 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.26 0.624 . . . . 0.0 110.562 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.544 ' H ' HG13 ' A' ' 28' ' ' ILE . 2.7 t -135.49 22.8 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.643 0.777 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -145.54 37.2 1.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.038 0.535 . . . . 0.0 110.226 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.5 m -126.76 119.87 27.98 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.649 0.261 . . . . 0.0 111.662 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -100.13 78.06 2.04 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 t -135.33 162.78 31.63 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.61 130.58 55.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.673 1.189 . . . . 0.0 108.521 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -107.28 143.27 35.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.21 0.604 . . . . 0.0 110.602 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.0 mm -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.91 0.884 . . . . 0.0 108.876 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.56 31.45 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.32 23.25 74.94 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.1 m -53.04 123.8 34.9 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 117.527 0.663 . . . . 0.0 112.013 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.26 -4.26 13.04 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.734 2.956 . . . . 0.0 111.07 171.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.85 162.7 28.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.145 0.578 . . . . 0.0 110.5 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.22 32.79 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.537 0.735 . . . . 0.0 111.347 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.7 mtm 57.41 47.98 15.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.154 0.981 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -128.55 133.71 48.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.811 0.844 . . . . 0.0 109.134 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.02 -6.77 47.69 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -85.11 -15.77 42.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.029 -0.419 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -89.53 -26.19 21.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.96 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.01 -29.9 65.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.1 -17.66 58.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.796 -0.565 . . . . 0.0 110.422 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.21 -4.44 58.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 m -123.19 -4.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.14 0.26 5.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 39.6 ttpt -88.04 -38.78 0.47 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.28 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 50.7 Cg_exo -59.33 135.46 65.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.481 2.121 . . . . 0.0 111.997 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 51.48 28.23 4.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.168 0.987 . . . . 0.0 113.078 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.87 167.95 21.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.152 0.581 . . . . 0.0 110.683 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.08 40.91 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.662 0.385 . . . . 0.0 111.251 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.84 136.93 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -129.85 -3.43 4.64 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -137.1 136.45 38.33 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.074 -0.391 . . . . 0.0 111.047 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.46 115.03 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -113.91 104.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.22 110.57 23.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -76.52 104.3 6.96 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -82.46 24.17 0.71 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.861 0.864 . . . . 0.0 111.134 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -135.14 5.47 3.28 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.233 0.613 . . . . 0.0 110.319 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -140.38 -0.67 1.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.239 0.615 . . . . 0.0 110.859 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 51.46 34.9 12.98 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.897 0.879 . . . . 0.0 111.774 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -135.4 151.86 50.86 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 123.599 0.76 . . . . 0.0 109.46 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.25 154.0 51.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -117.26 125.18 50.7 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.009 1.324 . . . . 0.0 107.711 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.03 148.58 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 120.486 0.184 . . . . 0.0 110.56 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -130.2 135.76 48.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.927 0.394 . . . . 0.0 111.942 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.92 148.55 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 125.275 1.43 . . . . 0.0 109.32 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -82.54 -3.18 55.53 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.2 m -143.3 132.91 23.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -72.58 -18.02 61.65 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.048 0.385 . . . . 0.0 110.808 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -74.81 -14.28 60.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.99 -0.444 . . . . 0.0 109.983 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -93.1 -8.6 42.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.04 -43.31 44.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 -17.93 60.64 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.489 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.72 -16.2 54.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.196 0.453 . . . . 0.0 110.388 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -85.47 -23.74 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 O-C-N 121.938 -0.476 . . . . 0.0 110.526 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.74 -23.93 53.02 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.014 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.69 -15.51 57.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.42 -45.42 31.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -76.84 -0.27 23.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.337 -0.227 . . . . 0.0 111.387 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -112.35 -4.76 14.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.984 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.44 22.51 3.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.701 0.682 . . . . 0.0 112.574 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -135.23 55.18 1.9 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.285 0.493 . . . . 0.0 111.278 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.83 82.83 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.473 -0.626 . . . . 0.0 113.254 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.63 60.51 3.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.836 0.818 . . . . 0.0 111.72 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.79 151.43 15.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.089 0.556 . . . . 0.0 110.857 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.47 -0.93 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.102 3.201 . . . . 0.0 113.113 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.5 mt -63.63 138.11 58.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.494 0.588 . . . . 0.0 110.318 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -105.51 121.4 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.7 p -135.34 145.05 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 111.997 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -143.23 148.41 36.39 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 109.405 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 -128.41 158.75 37.44 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.863 0.363 . . . . 0.0 111.888 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.4 168.94 25.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 104' ' ' PHE . 12.6 p -133.69 144.5 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.059 0.544 . . . . 0.0 110.541 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 4.36 69.66 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.163 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' H ' HG22 ' A' ' 102' ' ' VAL . 64.5 t80 -70.75 131.23 43.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.974 0.887 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.52 171.2 51.88 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.48 164.25 36.32 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.971 3.114 . . . . 0.0 110.998 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -90.52 151.78 21.21 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 110.799 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 133.61 38.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.7 0.4 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 78.5 m -134.11 38.49 3.16 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.031 0.933 . . . . 0.0 109.01 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 75.2 m -123.66 169.16 11.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.109 0.964 . . . . 0.0 110.846 -174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.74 155.88 21.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.202 0.601 . . . . 0.0 109.949 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.74 -5.93 18.51 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -94.75 2.36 55.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.109 0.413 . . . . 0.0 110.777 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -139.57 17.84 2.54 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.082 0.953 . . . . 0.0 110.306 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.3 -6.67 0.17 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.085 -0.842 . . . . 0.0 114.046 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -84.8 55.78 3.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.033 1.416 . . . . 0.0 110.001 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.4 m -130.97 151.67 51.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.606 0.762 . . . . 0.0 110.52 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.1 pt -119.12 31.64 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.383 0.673 . . . . 0.0 111.149 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 tp -135.75 49.93 3.88 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 123.247 0.619 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.29 -14.2 34.17 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 111.783 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -81.19 15.89 1.76 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.925 0.329 . . . . 0.0 111.763 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -135.33 1.73 2.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.545 0.738 . . . . 0.0 109.957 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -86.02 -13.42 47.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.118 -0.364 . . . . 0.0 110.581 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.9 pp -101.0 -12.89 18.52 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.606 0.185 . . . . 0.0 110.722 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 50.4 p -88.98 -22.07 23.2 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.87 -41.12 12.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -16.27 50.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -113.33 -15.63 12.64 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.013 0.824 . . . . 0.0 112.019 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.98 -20.66 48.58 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.649 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.56 -63.23 1.34 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -79.81 -1.14 37.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.4 m -139.91 6.3 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 145' ' ' LEU . 5.1 t -137.77 20.51 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 120.19 1.359 . . . . 0.0 110.384 170.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.4 t -106.12 52.69 0.72 Allowed 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.49 172.03 13.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.04 0.936 . . . . 0.0 110.679 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -58.63 151.63 20.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.243 0.617 . . . . 0.0 110.791 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -64.1 147.96 50.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.22 0.608 . . . . 0.0 111.646 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.06 -15.29 0.59 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.376 -0.689 . . . . 0.0 111.376 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 144' ' ' PRO . . . 75.62 161.87 10.7 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.725 0.679 . . . . 0.0 112.365 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.668 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 90.2 m 68.45 102.38 0.05 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m 54.6 43.45 30.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.39 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.534 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 144' ' ' PRO . 64.5 tt0 -164.81 -51.86 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 120.234 2.017 . . . . 0.0 115.884 175.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 140' ' ' THR . 22.9 Cg_endo -85.93 -5.79 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.696 2.931 . . . . 0.0 115.753 -166.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.478 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -70.71 -2.62 15.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.098 1.317 . . . . 0.0 111.959 -176.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.406 ' N ' HD12 ' A' ' 145' ' ' LEU . 32.3 m -75.84 0.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 123.186 0.594 . . . . 0.0 110.926 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -142.14 24.68 1.96 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.511 1.124 . . . . 0.0 108.487 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.55 43.57 0.12 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mm -42.45 -41.34 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.561 1.145 . . . . 0.0 112.278 174.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.8 m 44.66 29.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.407 1.483 . . . . 0.0 113.452 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -139.97 149.28 43.07 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.352 0.661 . . . . 0.0 109.625 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.05 35.92 3.05 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -141.27 137.37 16.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.98 168.15 22.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.332 2.688 . . . . 0.0 111.123 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.97 55.43 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 110.394 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 tt -110.41 146.25 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.31 0.644 . . . . 0.0 109.613 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.13 56.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.988 0.515 . . . . 0.0 110.716 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.21 146.49 30.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.84 0.456 . . . . 0.0 110.482 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.52 176.67 38.99 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -135.55 149.99 49.6 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.976 0.51 . . . . 0.0 110.996 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -79.88 -174.08 46.34 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.48 156.18 41.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.682 0.793 . . . . 0.0 109.961 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -133.14 148.46 52.1 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.856 0.462 . . . . 0.0 111.144 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.5 t -135.97 152.56 51.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.573 0.749 . . . . 0.0 110.131 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -135.25 151.95 51.07 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 123.226 0.61 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.36 144.79 46.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.202 0.601 . . . . 0.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 58.7 mt -135.15 141.72 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.6 m -60.89 142.07 56.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.858 0.463 . . . . 0.0 110.907 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -135.37 151.37 50.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.028 0.531 . . . . 0.0 111.178 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.5 145.06 43.83 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.055 0.542 . . . . 0.0 110.322 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 93.0 mtp -113.81 153.14 46.06 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.278 0.631 . . . . 0.0 110.171 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -70.64 165.17 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.641 2.894 . . . . 0.0 111.445 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.0 p -135.1 157.91 45.71 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 123.722 0.809 . . . . 0.0 110.168 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -133.24 140.08 47.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.968 0.507 . . . . 0.0 110.509 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.8 m -135.46 146.51 48.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.335 0.654 . . . . 0.0 110.55 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -74.2 -178.66 39.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -135.34 146.43 48.41 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.199 0.6 . . . . 0.0 110.706 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -135.78 160.44 38.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.393 0.677 . . . . 0.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -176.4 173.51 46.33 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.3 155.07 36.98 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.187 3.258 . . . . 0.0 112.548 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -135.93 136.31 40.34 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.399 0.68 . . . . 0.0 109.976 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -135.47 142.67 45.57 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.149 0.579 . . . . 0.0 110.573 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.2 169.44 37.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -141.28 152.98 65.73 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.55 0.74 . . . . 0.0 109.932 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--O 1.252 1.208 0 C-N-CA 123.817 3.011 . . . . 0.0 111.068 178.574 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 CA--C 1.527 0.156 0 N-CA-C 112.585 0.186 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -135.11 24.81 3.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.253 0.621 . . . . 0.0 111.071 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -98.35 24.57 7.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.359 0.664 . . . . 0.0 111.443 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.85 142.81 46.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.917 0.487 . . . . 0.0 109.763 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -135.5 113.59 11.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.75 0.42 . . . . 0.0 110.129 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -135.42 135.7 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.581 0.752 . . . . 0.0 109.015 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.3 t -135.67 135.39 40.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.508 0.323 . . . . 0.0 111.012 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -140.28 147.65 40.25 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.892 0.877 . . . . 0.0 109.555 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.65 140.89 29.08 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 122.407 0.283 . . . . 0.0 110.242 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.09 163.8 30.26 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.869 3.046 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -138.69 147.09 42.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.345 0.658 . . . . 0.0 110.236 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -135.6 128.6 31.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.689 0.396 . . . . 0.0 110.408 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -147.96 58.86 4.16 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.96 0.504 . . . . 0.0 110.102 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -67.34 148.29 79.51 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.173 2.582 . . . . 0.0 110.949 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 25.4 ttmm -151.32 117.76 3.25 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.281 0.632 . . . . 0.0 109.488 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 40.1 Cg_exo -62.24 172.39 4.24 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.573 3.515 . . . . 0.0 114.035 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.13 159.29 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.578 ' H ' HG12 ' A' ' 150' ' ' VAL . 29.7 m 65.24 30.71 11.16 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.71 87.87 2.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.92 142.71 50.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.159 0.584 . . . . 0.0 111.919 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.4 p -135.42 48.62 2.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.917 0.887 . . . . 0.0 109.642 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p 52.41 43.55 30.81 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.758 1.223 . . . . 0.0 111.689 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pp -94.95 157.37 36.75 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.96 0.904 . . . . 0.0 110.46 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.77 152.15 74.15 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.218 2.612 . . . . 0.0 112.491 -174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.55 20.28 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.478 4.119 . . . . 0.0 112.34 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.98 161.63 8.08 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.777 0.431 . . . . 0.0 111.327 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -60.68 -42.37 96.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 29' ' ' LYS . 6.2 tp -153.2 161.58 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.826 0.739 . . . . 0.0 112.29 -176.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' H ' HD12 ' A' ' 28' ' ' ILE . 22.2 tptm 66.65 43.19 2.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 122.669 1.223 . . . . 0.0 108.21 178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 30' ' ' VAL . 6.9 m -89.77 104.88 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.115 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -146.11 151.35 37.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.355 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.6 t -90.49 141.94 28.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -130.12 136.1 48.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.069 0.547 . . . . 0.0 109.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -135.78 108.85 7.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -85.52 104.57 15.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -82.34 140.32 33.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.348 0.659 . . . . 0.0 110.313 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.1 129.8 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.01 166.53 26.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.081 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.74 75.59 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.415 -0.658 . . . . 0.0 112.195 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -53.57 125.34 44.77 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 117.996 0.898 . . . . 0.0 111.186 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.31 -2.68 12.15 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.444 2.763 . . . . 0.0 111.364 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.32 154.53 27.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.923 0.489 . . . . 0.0 111.017 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -84.43 53.66 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.28 0.632 . . . . 0.0 110.38 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.2 ttt 56.48 64.74 1.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.387 1.075 . . . . 0.0 112.708 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -131.13 107.94 9.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.84 -13.08 58.89 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.798 0.439 . . . . 0.0 112.011 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -81.84 -12.23 58.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 122.244 -0.285 . . . . 0.0 111.077 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -93.32 -22.73 18.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.518 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 -27.88 60.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.57 -23.74 42.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.911 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.64 -6.93 58.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.007 0.367 . . . . 0.0 111.638 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.58 -4.62 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 118.153 0.433 . . . . 0.0 111.243 171.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -109.52 15.36 23.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.08 0.952 . . . . 0.0 109.247 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 40.7 ttmt -75.53 -34.77 1.64 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 82.4 Cg_endo -73.55 124.27 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 CA-C-N 121.356 1.52 . . . . 0.0 111.068 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 51.53 23.06 1.71 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.98 1.312 . . . . 0.0 113.062 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.83 154.58 35.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.964 0.506 . . . . 0.0 110.546 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.51 64.68 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.91 128.61 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -103.71 -3.76 24.62 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -168.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -142.24 131.15 22.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.053 0.388 . . . . 0.0 110.904 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.15 129.86 38.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.26 139.54 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 110.7 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mt -122.73 120.31 33.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.133 1.373 . . . . 0.0 108.387 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -138.74 157.17 46.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.837 0.455 . . . . 0.0 111.337 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 65.5 151.49 0.05 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.857 1.263 . . . . 0.0 113.13 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -82.79 25.08 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.267 0.627 . . . . 0.0 111.216 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.72 24.4 7.75 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.813 0.845 . . . . 0.0 110.702 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 53.48 49.49 19.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.146 0.978 . . . . 0.0 112.599 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -96.57 104.75 16.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.93 148.33 44.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.114 0.483 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -135.52 145.11 46.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.397 0.679 . . . . 0.0 109.375 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.92 155.5 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.21 135.68 41.17 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.969 0.414 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.15 148.66 15.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 124.519 1.128 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -95.46 19.18 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.8 t -151.25 141.25 22.07 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.795 0.438 . . . . 0.0 110.198 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -74.46 -22.7 58.97 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -82.35 -14.74 54.8 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.62 -20.67 23.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.66 53.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.19 -15.8 35.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.262 -0.274 . . . . 0.0 110.732 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.38 -22.87 38.05 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.272 0.487 . . . . 0.0 110.607 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.53 -46.19 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.42 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.8 mm? -67.55 -19.77 65.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.614 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -75.89 -40.77 53.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.382 0.992 . . . . 0.0 109.659 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -76.33 -13.44 60.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -117.28 15.1 14.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -128.2 3.89 5.79 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -142.36 -8.19 0.88 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -153.0 24.75 0.56 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.241 0.928 . . . . 0.0 112.035 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 15.69 0.04 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.964 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.98 3.8 16.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.648 1.224 . . . . 0.0 111.791 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 95' ' ' PRO . 3.1 mm? -98.7 -54.78 0.19 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.715 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 94' ' ' LEU . 86.0 Cg_endo -74.5 -23.52 14.87 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.355 2.036 . . . . 0.0 112.867 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 96' ' ' LEU . 36.4 mt -137.84 149.12 46.05 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.13 0.423 . . . . 0.0 111.219 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -106.09 102.7 12.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.3 p -98.15 130.79 44.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.246 0.618 . . . . 0.0 111.276 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -143.94 136.86 27.34 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.973 0.909 . . . . 0.0 109.028 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -118.58 126.91 52.99 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.096 0.407 . . . . 0.0 111.175 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.64 145.48 18.36 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.42 148.37 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.933 0.893 . . . . 0.0 109.529 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.76 121.57 5.82 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -138.98 27.3 2.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.543 0.737 . . . . 0.0 111.074 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.91 157.47 53.35 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 122.1 -0.375 . . . . 0.0 112.883 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.53 169.52 22.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 124.252 3.301 . . . . 0.0 110.527 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -74.61 141.55 44.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.483 0.313 . . . . 0.0 110.382 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -135.92 145.3 46.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 110.857 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.9 t 54.27 38.06 28.6 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.805 0.842 . . . . 0.0 111.928 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.65 104.33 11.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -142.1 151.83 42.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.416 0.687 . . . . 0.0 109.804 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -72.79 -4.67 33.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.71 -0.57 34.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.22 0.463 . . . . 0.0 109.802 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -135.25 24.11 3.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 109.802 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.86 -1.25 1.0 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.498 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -110.26 47.92 0.93 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.858 0.829 . . . . 0.0 109.473 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -135.03 153.59 52.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.704 0.801 . . . . 0.0 110.297 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.69 30.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.374 0.669 . . . . 0.0 112.367 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mt -73.3 133.84 80.56 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.2 -13.49 38.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.418 2.745 . . . . 0.0 113.746 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.5 ptm -83.97 8.26 15.76 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -95.06 -17.37 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.185 -0.322 . . . . 0.0 111.149 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.13 -4.13 58.79 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.96 -32.49 13.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.108 0.563 . . . . 0.0 109.582 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.5 t -82.59 -19.47 38.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.049 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.94 -47.06 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.911 -0.493 . . . . 0.0 110.968 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -76.48 -13.79 60.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.49 -9.6 11.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.818 0.736 . . . . 0.0 112.264 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -73.33 -18.25 61.21 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 166.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.403 ' HE3' ' CH2' ' A' ' 131' ' ' TRP . 64.3 tttp -87.51 -60.13 2.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.318 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.403 ' CH2' ' HE3' ' A' ' 130' ' ' LYS . 11.8 m95 -80.4 9.96 5.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -147.16 -6.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.65 17.17 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 119.619 1.099 . . . . 0.0 112.036 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 m -81.01 35.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.403 -0.811 . . . . 0.0 111.247 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.34 24.47 3.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.45 0.7 . . . . 0.0 110.223 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -138.55 147.33 42.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.777 0.831 . . . . 0.0 109.653 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -81.72 42.79 0.72 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.307 0.643 . . . . 0.0 111.05 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.99 -169.9 36.72 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.69 157.68 27.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.1 p 48.74 24.55 0.83 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.008 1.323 . . . . 0.0 112.913 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -154.92 24.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.34 0.656 . . . . 0.0 111.024 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.34 -12.11 16.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.507 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -146.37 164.98 21.65 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 118.622 1.211 . . . . 0.0 110.053 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.49 -12.18 16.33 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.363 2.708 . . . . 0.0 113.311 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.48 -6.43 46.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.12 0.418 . . . . 0.0 112.123 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -77.55 25.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -135.41 -15.43 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.208 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.43 -11.34 17.84 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 118.797 -1.002 . . . . 0.0 113.221 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.1 mm -66.79 60.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-O 122.312 1.053 . . . . 0.0 109.067 167.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 18' ' ' SER . 1.4 m -128.63 5.11 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.947 1.299 . . . . 0.0 109.775 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -115.87 154.95 28.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.654 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.61 59.46 4.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 112.24 -175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.17 69.64 29.98 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.31 179.37 6.56 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.154 3.236 . . . . 0.0 111.281 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -135.18 161.63 34.82 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.878 0.871 . . . . 0.0 110.069 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.82 146.0 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 122.87 0.468 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.1 mm -122.99 123.34 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.6 154.01 34.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 123.043 0.537 . . . . 0.0 111.397 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 84.71 141.52 5.32 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.933 0.778 . . . . 0.0 111.768 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.56 141.8 24.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.326 0.651 . . . . 0.0 109.755 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -73.82 172.09 51.45 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.67 140.52 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.041 0.536 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 49.8 m -135.97 55.02 1.88 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.436 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.9 t -135.19 130.19 34.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.583 0.353 . . . . 0.0 110.857 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -135.9 151.72 50.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 124.137 0.975 . . . . 0.0 109.868 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.27 124.03 23.86 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.68 0.392 . . . . 0.0 110.546 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 8.2 tp -141.91 144.68 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.447 0.699 . . . . 0.0 109.816 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.6 t -135.88 136.9 40.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.897 0.479 . . . . 0.0 110.408 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -135.91 133.76 38.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.18 0.592 . . . . 0.0 110.013 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -135.84 144.35 45.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.338 0.655 . . . . 0.0 110.089 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 92.9 mtp -135.76 152.07 75.32 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 123.352 0.661 . . . . 0.0 109.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.45 160.1 49.52 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.657 2.905 . . . . 0.0 111.081 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.3 t -138.47 149.0 44.98 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 110.51 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.67 149.75 49.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.425 0.69 . . . . 0.0 110.516 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 60.0 m -135.17 132.21 37.7 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.931 0.493 . . . . 0.0 110.624 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 166.85 160.12 13.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -141.09 129.11 21.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.796 0.438 . . . . 0.0 110.477 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -135.87 149.7 49.11 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.452 0.701 . . . . 0.0 110.533 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.47 179.04 38.99 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.29 158.45 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.362 3.375 . . . . 0.0 112.485 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -135.8 143.04 44.97 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.482 0.713 . . . . 0.0 109.897 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.8 m -133.47 124.94 27.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.837 0.455 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.37 168.55 29.7 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.689 ' H ' ' CD ' ' A' ' 185' ' ' PRO . 40.6 ttmt -151.04 -38.05 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.655 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.689 ' CD ' ' H ' ' A' ' 184' ' ' LYS . 53.9 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 123.016 2.477 . . . . 0.0 112.303 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.471 0.176 0 N-CA-C 112.519 0.161 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.75 148.02 31.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.825 0.45 . . . . 0.0 110.974 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.72 140.24 44.24 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.07 24.6 4.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.599 0.76 . . . . 0.0 110.606 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.64 143.48 34.63 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.913 0.485 . . . . 0.0 110.705 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.49 138.7 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.187 0.595 . . . . 0.0 110.198 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.9 p -135.84 31.38 3.03 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.423 0.689 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -80.98 55.02 2.34 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.407 0.683 . . . . 0.0 110.963 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.72 150.62 37.17 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 123.204 0.602 . . . . 0.0 110.194 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.23 152.24 55.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.444 2.763 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -145.63 143.16 29.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.13 0.572 . . . . 0.0 110.257 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -135.85 140.2 43.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.951 0.501 . . . . 0.0 110.648 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -152.03 73.89 7.73 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.129 0.572 . . . . 0.0 109.781 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -67.58 152.51 78.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.407 2.738 . . . . 0.0 110.623 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -138.56 152.8 71.71 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.591 0.756 . . . . 0.0 109.982 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.29 170.16 16.5 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.242 3.294 . . . . 0.0 112.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -75.3 158.17 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.658 0.783 . . . . 0.0 109.816 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.577 ' H ' HG12 ' A' ' 150' ' ' VAL . 35.2 m 61.82 42.5 10.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.173 0.989 . . . . 0.0 112.639 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.59 43.77 2.58 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.181 0.593 . . . . 0.0 109.541 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.82 52.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.926 1.691 . . . . 0.0 114.623 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.2 m -135.92 8.3 3.25 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -162.03 24.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.63 136.46 12.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 119.55 1.068 . . . . 0.0 113.277 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.82 156.46 18.17 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 124.08 3.187 . . . . 0.0 110.497 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.99 134.24 14.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.619 2.879 . . . . 0.0 111.959 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -142.75 148.27 36.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.86 1.264 . . . . 0.0 108.12 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 53.05 29.64 8.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.564 -173.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.49 151.55 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.328 1.051 . . . . 0.0 110.244 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.64 12.96 3.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.64 42.93 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 122.762 0.425 . . . . 0.0 111.457 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -135.74 146.87 48.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.234 0.214 . . . . 0.0 110.817 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 p -65.09 145.17 56.65 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.353 0.661 . . . . 0.0 111.815 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -126.07 -7.59 6.56 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -155.53 154.04 31.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.057 0.39 . . . . 0.0 111.042 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.2 tp -117.97 126.0 51.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.995 0.518 . . . . 0.0 109.668 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.53 146.21 32.14 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.398 0.679 . . . . 0.0 110.444 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mm -128.02 135.01 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.22 165.87 13.66 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.77 15.43 80.75 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.289 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' N ' ' CD ' ' A' ' 41' ' ' PRO . 34.0 m -70.19 -14.22 0.25 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 40' ' ' VAL . 70.2 Cg_exo -56.99 -2.81 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.259 1.973 . . . . 0.0 114.612 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.89 -14.91 60.71 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.337 0.971 . . . . 0.0 112.68 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -148.59 -12.54 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.2 mtt 51.6 28.85 4.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -135.81 142.77 44.9 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.193 0.451 . . . . 0.0 110.79 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.66 -6.63 42.43 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -86.74 -10.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.296 -0.252 . . . . 0.0 111.067 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.69 -27.09 18.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.86 -30.09 65.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.02 -19.38 44.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.458 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -76.54 -15.51 59.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.058 -0.401 . . . . 0.0 111.155 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.75 -3.34 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.61 10.65 22.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.384 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.8 pttt -88.61 -28.04 0.35 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.582 170.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 27.2 Cg_exo -65.14 117.88 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.782 1.655 . . . . 0.0 110.945 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 50.27 24.37 1.47 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.405 1.082 . . . . 0.0 113.191 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.5 155.38 43.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.956 0.502 . . . . 0.0 110.497 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -133.73 60.63 1.7 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.976 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -70.12 141.53 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -129.75 5.82 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -135.8 119.36 17.02 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 118.064 0.393 . . . . 0.0 110.457 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.89 127.66 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.531 0.732 . . . . 0.0 109.526 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.55 139.62 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 122.847 0.459 . . . . 0.0 110.048 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.5 mt -114.94 122.66 46.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.541 0.737 . . . . 0.0 109.036 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -123.02 173.02 8.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.087 0.955 . . . . 0.0 111.064 -171.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 55.59 55.6 7.07 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.799 0.84 . . . . 0.0 111.258 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t 55.68 43.16 28.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.078 0.551 . . . . 0.0 110.924 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? 55.48 44.16 27.39 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.195 0.998 . . . . 0.0 111.248 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -124.3 0.97 8.41 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 111.052 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -146.48 142.89 28.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 149.13 48.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.14 134.43 45.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.298 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.34 149.78 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -135.14 135.63 41.27 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.013 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.16 157.35 14.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 124.782 1.233 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -102.85 9.06 39.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -146.41 138.51 24.96 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.057 0.543 . . . . 0.0 109.973 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -76.62 -13.62 60.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -85.27 -23.0 28.37 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.2 -18.08 37.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.29 -45.49 59.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.85 -20.51 62.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.005 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -82.01 -16.79 49.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.408 0.549 . . . . 0.0 111.338 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.6 -25.5 8.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-N 118.566 0.621 . . . . 0.0 110.25 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.21 -22.18 55.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.913 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -76.08 -22.26 55.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.579 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -79.88 -23.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -83.53 -4.0 58.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.7 3.76 11.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.7 0.4 . . . . 0.0 111.049 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -135.77 17.9 3.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -86.36 -1.31 57.42 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.481 -0.762 . . . . 0.0 111.573 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.49 -15.0 0.45 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.798 1.19 . . . . 0.0 115.548 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.42 12.39 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.486 1.643 . . . . 0.0 113.483 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 35.09 53.05 1.59 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.694 1.198 . . . . 0.0 113.751 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.9 -11.93 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.425 2.75 . . . . 0.0 111.275 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -133.82 133.93 42.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.411 1.084 . . . . 0.0 108.312 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -100.01 98.47 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.3 m -93.49 129.36 39.72 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.96 0.504 . . . . 0.0 111.198 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -145.69 142.13 28.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.31 0.644 . . . . 0.0 109.91 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -97.04 150.21 21.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.941 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.83 160.46 14.04 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.07 139.69 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 124.014 0.926 . . . . 0.0 110.097 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.15 126.03 7.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -135.71 148.2 48.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.446 0.698 . . . . 0.0 110.01 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.52 152.88 48.48 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.31 123.24 9.4 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.576 2.85 . . . . 0.0 110.433 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -135.72 151.4 50.12 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.991 0.916 . . . . 0.0 109.426 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -135.26 43.83 2.63 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.001 0.52 . . . . 0.0 110.105 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 20.7 t -135.38 55.21 1.89 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.163 0.585 . . . . 0.0 109.936 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 26.4 p -135.56 149.76 49.52 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.149 0.579 . . . . 0.0 110.884 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -135.87 152.71 51.32 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.526 0.731 . . . . 0.0 110.16 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -68.21 -16.92 64.17 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.3 6.79 46.88 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.03 -0.418 . . . . 0.0 110.102 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -135.66 24.5 3.4 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.074 0.949 . . . . 0.0 109.705 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -151.91 -11.97 0.08 OUTLIER Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.457 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.2 24.88 4.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.713 1.256 . . . . 0.0 110.671 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -135.58 158.46 44.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.914 0.886 . . . . 0.0 110.063 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -68.94 148.38 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 122.4 0.28 . . . . 0.0 110.61 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -137.29 136.95 21.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.47 170.11 21.0 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.708 2.939 . . . . 0.0 111.283 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.55 13.27 0.49 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -87.27 -8.8 56.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.959 -0.463 . . . . 0.0 110.448 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -81.9 -9.13 59.68 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 149' ' ' ILE . 8.4 tp -88.18 -40.31 13.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.2 p -75.21 -17.76 60.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.995 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.69 -19.34 14.36 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.593 0.633 . . . . 0.0 112.141 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.87 -12.07 45.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.89 0.768 . . . . 0.0 110.814 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.74 -21.72 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.78 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -74.33 -21.36 59.73 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.794 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 131' ' ' TRP . 38.8 ttpt -91.2 -60.04 2.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.415 -0.178 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.457 ' CE2' ' HE3' ' A' ' 130' ' ' LYS . 8.6 m95 -77.26 0.89 20.32 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 m -142.12 -5.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.86 23.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.949 1.25 . . . . 0.0 112.083 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -75.11 38.02 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.407 -0.808 . . . . 0.0 111.523 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.48 24.22 3.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.597 0.759 . . . . 0.0 110.07 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -141.77 140.22 33.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.748 0.819 . . . . 0.0 109.438 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -84.83 52.63 2.47 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.842 0.457 . . . . 0.0 111.824 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.95 -7.37 0.39 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.292 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 68.51 -166.39 45.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.12 0.96 . . . . 0.0 111.212 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.0 p 67.33 116.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.848 1.659 . . . . 0.0 112.51 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.1 m 61.4 27.61 17.18 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.6 1.16 . . . . 0.0 112.893 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.56 -16.48 68.41 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -155.56 151.71 22.86 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.05 10.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.992 3.128 . . . . 0.0 115.236 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.99 -0.1 15.23 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.277 0.944 . . . . 0.0 110.966 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.45 22.34 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.109 0.564 . . . . 0.0 112.071 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 10.2 5.12 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.301 0.24 . . . . 0.0 111.57 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.04 -19.46 0.32 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 124' ' ' LEU . 18.3 mm -80.0 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-O 121.753 0.787 . . . . 0.0 109.322 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 18' ' ' SER . 35.4 m -129.37 24.72 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.185 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.1 151.25 23.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.07 0.548 . . . . 0.0 110.516 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -94.94 44.41 1.1 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.442 0.697 . . . . 0.0 111.968 -175.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -128.57 146.69 61.03 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.447 0.299 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.63 -178.73 4.85 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.448 3.432 . . . . 0.0 111.257 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.54 136.11 44.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.423 0.689 . . . . 0.0 109.684 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.6 tt -135.97 147.38 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.39 119.38 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.308 0.643 . . . . 0.0 110.637 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.2 30.91 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 122.919 0.488 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -172.17 -175.7 40.47 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.876 -0.515 . . . . 0.0 112.446 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.18 24.94 2.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.401 0.68 . . . . 0.0 111.426 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 77.17 169.34 31.56 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.255 0.455 . . . . 0.0 112.758 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.94 162.79 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.148 0.979 . . . . 0.0 109.748 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.0 m -55.52 138.54 46.33 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.716 0.406 . . . . 0.0 110.759 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.0 p -135.48 157.06 47.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.939 0.496 . . . . 0.0 111.656 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -135.68 162.44 32.74 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.21 1.004 . . . . 0.0 110.147 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.84 130.6 42.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 9.8 tp -135.78 144.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.437 0.295 . . . . 0.0 110.803 -176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.8 t -135.97 150.13 49.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.293 0.637 . . . . 0.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -135.6 138.03 42.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.961 0.904 . . . . 0.0 109.177 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -74.46 113.22 11.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.9 tpp -73.19 136.33 79.13 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.99 162.1 43.46 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.049 2.5 . . . . 0.0 110.606 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.3 p -130.35 24.1 5.17 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.999 0.519 . . . . 0.0 110.614 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -110.51 39.4 2.21 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.709 0.804 . . . . 0.0 110.488 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.9 t -135.23 150.4 50.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.504 0.721 . . . . 0.0 109.495 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 142.99 44.74 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -83.88 104.92 14.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -133.7 55.27 1.91 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.305 0.642 . . . . 0.0 110.179 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.73 178.16 36.84 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.52 154.57 68.51 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.689 2.926 . . . . 0.0 110.564 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -135.88 24.46 3.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.692 0.397 . . . . 0.0 112.07 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.0 p -94.49 127.1 40.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.976 0.51 . . . . 0.0 110.394 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.22 167.23 54.57 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -73.71 137.78 77.05 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.885 0.474 . . . . 0.0 109.976 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.252 1.189 0 C-N-CA 123.643 2.896 . . . . 0.0 110.939 175.415 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 CA--C 1.527 0.163 0 N-CA-C 112.505 0.156 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -135.54 147.02 48.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.181 0.593 . . . . 0.0 110.438 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.15 27.17 3.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.999 0.52 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.7 tp -135.47 54.96 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.613 0.765 . . . . 0.0 108.958 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -85.08 55.78 3.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.526 0.73 . . . . 0.0 110.664 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.68 139.63 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.031 0.533 . . . . 0.0 110.612 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 t -135.79 146.89 48.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.366 0.666 . . . . 0.0 110.362 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -92.67 135.23 34.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -71.26 151.47 94.42 Favored Pre-proline 0 N--CA 1.454 -0.238 0 C-N-CA 122.347 0.259 . . . . 0.0 110.379 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 153.25 66.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.365 2.71 . . . . 0.0 110.722 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -143.69 158.41 43.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.125 0.57 . . . . 0.0 110.305 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.43 146.63 43.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.805 0.442 . . . . 0.0 110.451 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -135.35 149.6 70.17 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 122.287 0.235 . . . . 0.0 111.591 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.95 -176.6 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 124.845 3.697 . . . . 0.0 110.8 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -64.07 154.97 80.56 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -70.61 156.9 60.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.069 2.512 . . . . 0.0 110.595 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.37 -21.15 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 122.739 0.416 . . . . 0.0 110.337 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 t -152.87 179.68 8.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.991 0.916 . . . . 0.0 109.129 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -104.59 24.41 11.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.312 0.645 . . . . 0.0 110.854 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.35 146.84 24.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -127.9 24.5 6.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.857 0.463 . . . . 0.0 111.294 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -133.05 48.51 2.4 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.613 0.765 . . . . 0.0 109.076 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.78 127.96 91.2 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.41 157.14 36.91 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.484 2.789 . . . . 0.0 112.271 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.12 -3.93 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.497 3.465 . . . . 0.0 111.538 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -73.19 110.44 7.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 111.741 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 49.87 21.01 0.63 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.622 1.969 . . . . 0.0 114.825 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 28' ' ' ILE . 26.5 pt -135.75 162.26 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.482 ' H ' ' CD2' ' A' ' 124' ' ' LEU . 48.3 tptt -106.53 32.49 4.47 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 121.244 0.545 . . . . 0.0 110.914 -170.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.21 46.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.287 0.635 . . . . 0.0 110.514 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -59.14 144.15 46.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.85 0.46 . . . . 0.0 110.979 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -136.5 141.44 43.45 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.012 0.525 . . . . 0.0 110.617 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -119.01 128.16 54.12 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.1 p -88.43 124.73 34.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.948 0.499 . . . . 0.0 110.253 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.5 tp -102.85 122.08 43.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -114.21 131.09 56.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.352 0.261 . . . . 0.0 110.748 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.8 mm -104.3 143.42 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.9 163.56 27.99 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.72 18.28 70.07 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -54.21 138.38 57.35 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.78 0.79 . . . . 0.0 110.982 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.11 -15.39 20.53 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.166 2.577 . . . . 0.0 110.969 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.16 123.46 14.76 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -106.98 24.6 12.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.506 0.322 . . . . 0.0 110.463 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.3 ttp -139.31 24.21 2.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -147.08 85.84 1.62 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.7 -14.51 52.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 110.717 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -83.11 -8.21 59.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.883 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -94.99 -21.16 18.79 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.411 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.76 -26.79 60.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.32 -21.4 39.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.45 -13.16 60.37 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.088 -0.383 . . . . 0.0 110.739 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.52 -3.05 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.9 12.01 25.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.478 0.711 . . . . 0.0 110.371 170.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 65.1 tttp -95.22 -31.77 0.27 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 71.9 Cg_exo -54.63 -33.96 81.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.629 2.219 . . . . 0.0 114.728 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -139.38 17.06 2.57 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.463 0.574 . . . . 0.0 112.444 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.31 172.82 17.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.703 0.401 . . . . 0.0 110.088 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.76 55.61 1.89 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.016 0.526 . . . . 0.0 110.071 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.23 140.77 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.558 0.743 . . . . 0.0 110.215 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -120.26 3.52 10.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.7 m -139.16 126.86 21.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.341 0.518 . . . . 0.0 110.866 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.13 128.16 21.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 123.435 0.694 . . . . 0.0 109.348 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.63 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 109.732 173.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.42 147.37 46.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.292 1.037 . . . . 0.0 110.383 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -134.47 135.37 42.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.128 0.571 . . . . 0.0 109.906 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -80.87 41.3 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.682 0.793 . . . . 0.0 111.27 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -128.89 105.12 8.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 55.36 26.87 9.2 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.659 0.784 . . . . 0.0 111.448 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 49.46 54.65 10.63 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.348 1.059 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -88.53 141.31 28.63 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.527 0.331 . . . . 0.0 110.766 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.45 148.6 49.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.717 0.407 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -135.17 131.35 36.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.42 151.27 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.811 0.444 . . . . 0.0 110.028 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -137.33 136.82 38.3 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.42 164.64 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.664 1.585 . . . . 0.0 109.677 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.2 16.88 25.0 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.613 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -151.94 137.12 17.44 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.674 0.79 . . . . 0.0 109.018 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -12.68 61.33 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -87.13 -15.53 38.15 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -83.71 -21.03 32.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.56 54.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.0 -21.19 63.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.214 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -89.45 -9.61 49.51 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.953 -0.467 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 t -87.41 -25.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.794 -0.566 . . . . 0.0 109.919 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 85' ' ' LEU . 2.7 mm? -74.82 -27.88 60.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -81.44 -14.78 56.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.698 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -71.19 -43.92 66.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -85.02 -1.44 56.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.465 -0.147 . . . . 0.0 111.346 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.35 -0.61 26.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.424 0.29 . . . . 0.0 110.811 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -131.89 11.9 4.75 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.6 -5.37 59.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.423 0.556 . . . . 0.0 110.736 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.91 -3.1 10.43 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.684 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.63 4.54 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.238 1.519 . . . . 0.0 113.542 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 94' ' ' LEU . 8.3 mp 38.45 55.56 4.79 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.18 0.992 . . . . 0.0 112.057 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.68 -15.83 26.97 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.221 2.614 . . . . 0.0 112.175 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.4 mt -136.86 146.06 45.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.532 0.733 . . . . 0.0 110.752 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -107.03 130.8 54.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -135.04 140.55 45.68 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.847 0.459 . . . . 0.0 111.338 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -138.84 147.47 42.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.147 0.979 . . . . 0.0 109.232 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -121.66 157.5 30.71 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.774 0.321 . . . . 0.0 111.227 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.51 -178.85 31.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.86 137.59 48.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.115 0.566 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.72 127.59 8.8 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.33 147.53 38.27 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.627 0.371 . . . . 0.0 110.923 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.33 -134.73 2.42 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.97 -174.58 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.495 2.797 . . . . 0.0 110.154 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -51.3 141.2 15.49 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.733 0.413 . . . . 0.0 110.404 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.96 136.04 56.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.0 0.52 . . . . 0.0 111.521 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 16.0 t -112.9 26.9 10.08 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.594 0.758 . . . . 0.0 110.496 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 78.5 m -73.11 148.33 44.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.957 0.503 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -135.69 158.73 43.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.348 0.659 . . . . 0.0 109.822 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.64 15.47 18.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -79.5 -7.15 58.26 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.608 0.64 . . . . 0.0 110.419 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -138.29 7.77 2.64 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.531 0.733 . . . . 0.0 110.03 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.87 -15.56 42.08 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -94.22 24.44 4.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.977 0.511 . . . . 0.0 110.25 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -135.62 151.58 50.39 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.047 0.939 . . . . 0.0 109.704 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.7 tt -85.04 21.08 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.981 0.419 . . . . 0.0 111.07 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.457 ' N ' ' HD3' ' A' ' 120' ' ' PRO . 24.8 pt -141.47 56.75 6.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.644 0.778 . . . . 0.0 111.509 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 119' ' ' ILE . 51.5 Cg_exo -58.76 -21.52 56.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.366 2.044 . . . . 0.0 112.442 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 46.3 ttp -85.27 49.48 1.76 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.629 0.771 . . . . 0.0 110.216 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -135.43 -41.5 0.71 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.524 0.33 . . . . 0.0 111.039 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -79.78 -14.44 58.71 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.774 0.261 . . . . 0.0 110.337 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' CD2' ' H ' ' A' ' 29' ' ' LYS . 55.7 tp -88.78 -26.94 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -78.39 -20.76 50.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.28 -47.6 7.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.173 -0.33 . . . . 0.0 110.932 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -79.93 -14.56 58.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.56 -22.32 13.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.415 0.552 . . . . 0.0 111.321 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.98 -28.71 63.6 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.36 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -84.04 -57.38 3.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.703 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.2 7.14 26.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -171.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.3 m -143.14 -0.53 1.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' HD21 ' A' ' 145' ' ' LEU . 2.0 t -135.28 14.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.563 1.074 . . . . 0.0 112.12 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.9 m -90.35 24.13 2.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.817 -0.552 . . . . 0.0 109.773 169.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.75 43.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.569 1.148 . . . . 0.0 109.347 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -86.3 33.35 0.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -135.79 26.35 3.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.58 165.9 33.13 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.877 -0.514 . . . . 0.0 112.659 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA2' HD23 ' A' ' 145' ' ' LEU . . . 76.18 163.45 15.11 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.107 0.86 . . . . 0.0 112.686 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.6 t -98.29 -30.08 12.8 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.725 -0.28 . . . . 0.0 111.464 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -151.79 22.69 0.69 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.703 0.401 . . . . 0.0 111.334 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.61 -9.41 68.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.352 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.602 ' H ' ' CD ' ' A' ' 144' ' ' PRO . 59.9 tt0 -163.78 -39.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 118.45 1.125 . . . . 0.0 113.335 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 46.0 Cg_exo -61.65 11.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.98 3.12 . . . . 0.0 115.878 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.606 HD21 ' CG2' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.2 14.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.112 0.869 . . . . 0.0 112.019 177.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.22 6.84 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.684 0.794 . . . . 0.0 111.59 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.8 t -136.03 30.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.627 1.171 . . . . 0.0 108.213 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.91 29.04 0.07 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.5 mm -44.16 -43.63 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 118.13 0.965 . . . . 0.0 111.632 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m 46.93 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.295 1.438 . . . . 0.0 113.914 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -111.78 149.68 31.37 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 118.221 0.464 . . . . 0.0 110.688 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -131.81 32.54 4.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.211 0.604 . . . . 0.0 111.196 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.32 146.72 59.21 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 122.514 0.325 . . . . 0.0 110.802 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.71 170.57 19.62 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.289 3.326 . . . . 0.0 111.685 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -135.64 163.48 30.04 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.729 0.812 . . . . 0.0 110.245 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 tp -121.59 30.98 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.353 0.597 . . . . 0.0 110.441 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.73 121.1 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 157.82 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 123.497 0.719 . . . . 0.0 110.598 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -157.82 -167.76 19.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.36 144.9 50.86 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.057 0.543 . . . . 0.0 110.793 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -78.77 -168.49 34.45 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.43 132.36 66.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.333 0.653 . . . . 0.0 109.632 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.5 p -91.06 152.45 20.64 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.236 0.615 . . . . 0.0 111.25 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.2 t -73.66 134.71 43.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.511 0.324 . . . . 0.0 110.446 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -136.02 154.37 51.08 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.533 0.733 . . . . 0.0 110.602 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 53.54 44.51 29.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.504 0.721 . . . . 0.0 111.727 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 9.0 tp -64.73 145.45 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.874 0.469 . . . . 0.0 110.601 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.7 m -64.96 146.82 54.47 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.126 0.571 . . . . 0.0 111.406 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -135.37 142.86 45.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.358 0.663 . . . . 0.0 109.915 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -135.22 154.92 51.43 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.355 0.662 . . . . 0.0 110.452 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.3 mmm -122.44 152.46 61.25 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 123.195 0.598 . . . . 0.0 110.115 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.07 170.92 17.82 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.802 3.001 . . . . 0.0 111.259 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 66.4 m -121.71 144.46 48.77 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.629 0.772 . . . . 0.0 109.485 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.13 145.77 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.809 0.444 . . . . 0.0 110.855 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.3 t -135.31 151.72 50.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.477 0.711 . . . . 0.0 109.854 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.94 158.29 29.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.64 152.76 51.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.449 0.7 . . . . 0.0 110.962 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -77.85 154.39 31.83 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.967 0.507 . . . . 0.0 110.19 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.444 ' H ' ' HD2' ' A' ' 180' ' ' PRO . . . -166.73 -46.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 179' ' ' GLY . 51.7 Cg_exo -58.56 161.94 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.546 2.831 . . . . 0.0 112.192 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -126.2 130.76 51.59 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.316 0.647 . . . . 0.0 109.964 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 29.1 t -140.53 148.47 41.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.159 0.584 . . . . 0.0 110.427 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.39 178.61 44.44 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -145.09 140.91 16.59 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.153 0.581 . . . . 0.0 109.636 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.833 3.022 . . . . 0.0 112.492 177.844 . . . . . . . . 0 0 . 1 stop_ save_